Citrus Sinensis ID: 035655
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M020 | 688 | Lectin-domain containing | yes | no | 0.944 | 0.920 | 0.511 | 0.0 | |
| Q66GN2 | 691 | Lectin-domain containing | no | no | 0.941 | 0.913 | 0.509 | 0.0 | |
| Q9SR87 | 693 | Probable L-type lectin-do | no | no | 0.910 | 0.880 | 0.523 | 1e-180 | |
| Q9M021 | 682 | L-type lectin-domain cont | no | no | 0.919 | 0.903 | 0.512 | 1e-176 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.862 | 0.853 | 0.461 | 1e-154 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.883 | 0.877 | 0.457 | 1e-153 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.894 | 0.888 | 0.454 | 1e-152 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.865 | 0.866 | 0.455 | 1e-151 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.859 | 0.860 | 0.457 | 1e-150 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.867 | 0.849 | 0.452 | 1e-148 |
| >sp|Q9M020|LRK63_ARATH Lectin-domain containing receptor kinase VI.3 OS=Arabidopsis thaliana GN=LECRK63 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 665 bits (1715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/680 (51%), Positives = 450/680 (66%), Gaps = 47/680 (6%)
Query: 9 LRLFFFPVIAALSQQ------KEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA 62
L LF I +Q+ K EFIF GF+ ++N I A+ +K G LRLTD
Sbjct: 2 LVLFLLLTIPTRAQRTTTETPKTEFIFRGFSGNQSN---IVTTGAATIKLDGLLRLTDRN 58
Query: 63 HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS 122
NV G +FY+KP+++L+ +TS S+ SFST FVF I+ +S GGFG FT+SP P
Sbjct: 59 SNVTGTSFYHKPVRLLETNTS-STNSTIRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPD 117
Query: 123 FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLE 182
G ++ YLG+LN ND +NH+FA+EFDTV G+ + +D GNH+G+N NS+ S E
Sbjct: 118 RTGAESAQYLGLLNKANDGNSTNHVFAVEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQE 177
Query: 183 PAAYYEN---GTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQP 239
P YY+N KEDF L+SGDP++A +DYDG + +N+T+ P N K++ P +P
Sbjct: 178 PVVYYDNEDPNRKEDFPLQSGDPIRAILDYDGPTQTLNLTVYPANLKSR-------PVRP 230
Query: 240 LLSLPL-DLSPAFQETMYVGFSASTGRKVSS-HFILGWSFSMNGAAPSLNLSQI---PSL 294
L+S P+ LS QE MYVGF+A+TGR SS H+++GWSFS G + + + P
Sbjct: 231 LISRPVPKLSQIVQEEMYVGFTAATGRDQSSAHYVMGWSFSSGGDLLTEDTLDLLELPRP 290
Query: 295 PIERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYR-RIAQFEILEDWELDCPHRFR 353
P + ++ Q+ LI ALS V VILL L F +Y+ R+ Q E+LEDWE++ PHR R
Sbjct: 291 PPNTAKKRGYNSQVLALIVALSGVTVILLALLFFFVMYKKRLQQGEVLEDWEINHPHRLR 350
Query: 354 YSDLYTATKGFKQSEVIGTGGFGEVYKG--------------VLPTRM---REFAAEIES 396
Y DLY AT GFK++ ++GTGGFG V++G + P M REF AEIES
Sbjct: 351 YKDLYAATDGFKENRIVGTGGFGTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIES 410
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKG 453
LGRLRHK+LVNLQGWCK+K DLLL+YDYIPNGSLDSLL+ VLSW RF I KG
Sbjct: 411 LGRLRHKNLVNLQGWCKQKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKG 470
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
IA+GLLYLHEEWE+VVIHRD+K NVLI+ DMN RLGDFGLARL++ G S+TT VVGTI
Sbjct: 471 IASGLLYLHEEWEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTI 530
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573
GY+APELAR GK+S ++DVFA+GVLLLEI +GRRP DS F L DWV+E G++L V
Sbjct: 531 GYMAPELARNGKSSSASDVFAFGVLLLEIVSGRRPTDSGTFFLADWVMELHARGEILHAV 590
Query: 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDN-WSSLDSQ 632
DP LG Y E L L +GLLC HQ+ +RP+MR VLRYLNGD+ +P IDN W DS
Sbjct: 591 DPRLGFGYDGVEARLALVVGLLCCHQRPTSRPSMRTVLRYLNGDDDVPEIDNDWGYSDSS 650
Query: 633 RSEMNSRYLEIISTDNITTS 652
RS++ S + +S+D ++S
Sbjct: 651 RSDLGSNFEGYVSSDRASSS 670
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q66GN2|LRK64_ARATH Lectin-domain containing receptor kinase VI.4 OS=Arabidopsis thaliana GN=LECRK64 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 638 bits (1646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/675 (50%), Positives = 453/675 (67%), Gaps = 44/675 (6%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
FIF+GF K NQ I + S + +G LRLTD +V+G AFY+KP+++LD S S+
Sbjct: 30 FIFHGF---KGNQSEIHMQGDSTITSNGLLRLTDRNSDVVGTAFYHKPVRLLD---SNST 83
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
SFST F+F I + ++ GGFG FT+SP P+ E Y+G+LN ND SNH
Sbjct: 84 NTTVRSFSTSFIFIIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGNSSNH 143
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYEN--GTKEDFTLESGDPVQ 204
+FA+EFDTV G+ + ++ GNH+G+N NS+ S EP AY+ N KE+F L SG+P+Q
Sbjct: 144 VFAVEFDTVQGFKDGTNRIGNHIGLNFNSLSSDVQEPVAYFNNNDSQKEEFQLVSGEPIQ 203
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPL-DLSPAFQETMYVGFSAST 263
++DY G + +N+T+ P +L + KP PL+S + LS + M+VGF+A+T
Sbjct: 204 VFLDYHGPTKTLNLTVYP----TRLGY---KPRIPLISREVPKLSDIVVDEMFVGFTAAT 256
Query: 264 GR--KVSSHFILGWSFSMNGAAP---SLNLSQIPSLPIERSSSNSFSLQIKILIAALSTV 318
GR + S+H+++GWSF+ G P L++SQ+P P ++ ++ ++ LI ALSTV
Sbjct: 257 GRHGQSSAHYVMGWSFASGGEHPLAAMLDISQLPPPPPNKAKKRGYNGKVIALIVALSTV 316
Query: 319 AVILLGTLLIFKLYR-RIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGE 377
I+L L +F +Y+ R+ Q EILEDWE+D PHRFRY DLY AT+GFK++ V+GTGGFG
Sbjct: 317 ISIMLVLLFLFMMYKKRMQQEEILEDWEIDHPHRFRYRDLYKATEGFKENRVVGTGGFGI 376
Query: 378 VYKG-------------VLPTRM---REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421
VY+G + P M REF AEIESLGRLRHK+LVNLQGWCK + DLLL+
Sbjct: 377 VYRGNIRSSSDQIAVKKITPNSMQGVREFVAEIESLGRLRHKNLVNLQGWCKHRNDLLLI 436
Query: 422 YDYIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
YDYIPNGSLDSLL+ VLSW RF I KGIA+GLLYLHEEWEQ+VIHRDVK N
Sbjct: 437 YDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEQIVIHRDVKPSN 496
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VLID+DMN RLGDFGLARL++ G S TT VVGTIGY+APELAR G +S ++DVFA+GVL
Sbjct: 497 VLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPELARNGNSSSASDVFAFGVL 556
Query: 539 LLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSH 598
LLEI +GR+P DS F + DWV+E Q G++L +DP LGS Y E L L +GLLC H
Sbjct: 557 LLEIVSGRKPTDSGTFFIADWVMELQASGEILSAIDPRLGSGYDEGEARLALAVGLLCCH 616
Query: 599 QKAEARPTMRQVLRYLNGDELLPII-DNWSSLDSQRSEMNSRYLEIISTDNITTSQLSSS 657
K E+RP MR VLRYLN DE +P I DNW DS R+++ S+ + IS+D ++S +S
Sbjct: 617 HKPESRPLMRMVLRYLNRDEDVPEIHDNWGYSDSSRTDLGSKLVGYISSDRASSSHSHTS 676
Query: 658 FGV--ISSNSIEAGR 670
+ ISS S+ +GR
Sbjct: 677 SSLTRISSTSLISGR 691
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR87|LRK61_ARATH Probable L-type lectin-domain containing receptor kinase VI.1 OS=Arabidopsis thaliana GN=LECRK61 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 339/648 (52%), Positives = 444/648 (68%), Gaps = 38/648 (5%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLS 85
+F F GF E +T+ + T ++I + LRLT+ NV G AFY KPI++ + + S
Sbjct: 35 KFTFIGFKENQTD--IQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRL--RELTNS 90
Query: 86 SKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSN 145
S SFST FVF I+ + G GGFG FT+SP P+ PG ++ YLG+LN TN+ PSN
Sbjct: 91 SDIKVCSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNRTNNGNPSN 150
Query: 146 HLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYEN-GTKEDFTLESGDPVQ 204
H+FA+EFDTV G+ + +D +GNH+G+N N++ S EP YY+ KEDF LESG+P++
Sbjct: 151 HVFAVEFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYYDTEDRKEDFQLESGEPIR 210
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPL-DLSPAFQETMYVGFSAST 263
IDYDG + +NVTI P +L F KP +PL+S + +LS ++ MYVGF+A+T
Sbjct: 211 VLIDYDGSSETLNVTIYP----TRLEF---KPKKPLISRRVSELSEIVKDEMYVGFTAAT 263
Query: 264 GRKVSS-HFILGWSFSMNGAAPS---LNLSQIPSLPIERSSSNSFSLQIKILIAALSTVA 319
G+ SS H+++GWSFS G P L +S++P P S+ ++ Q+ +LI ALS V
Sbjct: 264 GKDQSSAHYVMGWSFSSCGENPMADWLEISRLPP-PPRLSNKKGYNSQVIVLIVALSIVT 322
Query: 320 VILLGTLLIFKLY-RRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEV 378
++LL L IF +Y RRI + + LEDWE+D PHRFRY DLY ATK FK+SE+IGTGGFG V
Sbjct: 323 LVLLVLLFIFVMYKRRIQEEDTLEDWEIDYPHRFRYRDLYLATKKFKESEIIGTGGFGIV 382
Query: 379 YKGVLPTR---------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423
Y+G L + +REF AEIESLGRL HK+LVNLQGWCK K +LLL+YD
Sbjct: 383 YRGNLSSSGPIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHKNELLLIYD 442
Query: 424 YIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480
YIPNGSLDSLL+ VL W+ RF IIKGIA+GLLYLHEEWEQ+V+HRDVK NVL
Sbjct: 443 YIPNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIVVHRDVKPSNVL 502
Query: 481 IDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLL 540
ID DMNA+LGDFGLARL++ G ++ TT +VGT+GY+APEL R GK S ++DVFA+GVLLL
Sbjct: 503 IDEDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTASDVFAFGVLLL 562
Query: 541 EIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQK 600
EI G +P ++++F L DWV+EF G +L VVD NLGSS+ E +L L +GLLC HQK
Sbjct: 563 EIVCGNKPTNAENFFLADWVMEFHTNGGILCVVDQNLGSSFNGREAKLALVVGLLCCHQK 622
Query: 601 AEARPTMRQVLRYLNGDELLPIID-NWSSLDSQRSEMNSRYLEIISTD 647
+ RP+MR VLRYLNG+E +P ID NW DS R + S + +S+D
Sbjct: 623 PKFRPSMRMVLRYLNGEENVPQIDENWGFSDSSRDDHKSNVVGYVSSD 670
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M021|LRK62_ARATH L-type lectin-domain containing receptor kinase VI.2 OS=Arabidopsis thaliana GN=LECRK62 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1595), Expect = e-176, Method: Compositional matrix adjust.
Identities = 339/662 (51%), Positives = 438/662 (66%), Gaps = 46/662 (6%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
F F GFN NQ I E A+++KP G LRLTD NV G AFY+KP+++L+++ S+
Sbjct: 33 FAFRGFN---GNQSKIRIEGAAMIKPDGLLRLTDRKSNVTGTAFYHKPVRLLNRN---ST 86
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
SFST FVF I+ +S GFG FT+SP P + YLG+ N N+ P NH
Sbjct: 87 NVTIRSFSTSFVFVIIPSSSSNKGFGFTFTLSPTPYRLNAGSAQYLGVFNKENNGDPRNH 146
Query: 147 LFAIEFDTVNG-YNETSDSQGNHVGINVNSMKSIKLEPAAYYEN---GTKEDFTLESGDP 202
+FA+EFDTV G ++ +D GN +G+N NS S EP YY N KEDF LESG+P
Sbjct: 147 VFAVEFDTVQGSRDDNTDRIGNDIGLNYNSRTSDLQEPVVYYNNDDHNKKEDFQLESGNP 206
Query: 203 VQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPL-DLSPAFQETMYVGFSA 261
+QA ++YDG +++NVT+ P +L F KP++PL+S + L QE MYVGF+A
Sbjct: 207 IQALLEYDGATQMLNVTVYPA----RLGF---KPTKPLISQHVPKLLEIVQEEMYVGFTA 259
Query: 262 STGR-KVSSHFILGWSFSMNGAAP---SLNLSQIPSLPIERSSSNSFSLQIKILIAALST 317
STG+ + S+H+++GWSFS G P L LS++P P ++ + Q+ ++I ALS
Sbjct: 260 STGKGQSSAHYVMGWSFSSGGERPIADVLILSELPPPPPNKAKKEGLNSQVIVMIVALSA 319
Query: 318 VAVILLGTLLIFKLYR-RIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFG 376
V +++L L F +Y+ R+ Q E LEDWE+D P R RY DLY AT GFK++ +IGTGGFG
Sbjct: 320 VMLVMLVLLFFFVMYKKRLGQEETLEDWEIDHPRRLRYRDLYVATDGFKKTGIIGTGGFG 379
Query: 377 EVYKGVLPTR---------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421
V+KG LP +REF AEIESLG+LRHK+LVNLQGWCK K DLLL+
Sbjct: 380 TVFKGKLPNSDPIAVKKIIPSSRQGVREFVAEIESLGKLRHKNLVNLQGWCKHKNDLLLI 439
Query: 422 YDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
YDYIPNGSLDSLL+ VLSW RF I KGIA+GLLYLHEEWE++VIHRDVK N
Sbjct: 440 YDYIPNGSLDSLLYTVPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEKIVIHRDVKPSN 499
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VLID+ MN RLGDFGLARL++ G +S TT +VGTIGY+APEL+R G S ++DVFA+GVL
Sbjct: 500 VLIDSKMNPRLGDFGLARLYERGTLSETTALVGTIGYMAPELSRNGNPSSASDVFAFGVL 559
Query: 539 LLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSH 598
LLEI GR+P DS F LVDWV+E G++L +DP LGS Y E L L +GLLC H
Sbjct: 560 LLEIVCGRKPTDSGTFFLVDWVMELHANGEILSAIDPRLGSGYDGGEARLALAVGLLCCH 619
Query: 599 QKAEARPTMRQVLRYLNGDELLPIIDN-WSSLDSQRSEMNSRYLEIISTDNIT----TSQ 653
QK +RP+MR VLRYLNG+E +P ID+ W S RSE S+ + +S+ +IT TS+
Sbjct: 620 QKPASRPSMRIVLRYLNGEENVPEIDDEWGYSKSSRSEFGSKLVGYVSSTSITRVSSTSR 679
Query: 654 LS 655
+S
Sbjct: 680 IS 681
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1404), Expect = e-154, Method: Compositional matrix adjust.
Identities = 290/629 (46%), Positives = 400/629 (63%), Gaps = 51/629 (8%)
Query: 21 SQQKEEFIFNGFNETKTN---QGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQM 77
S Q F +NGF+ T+ QGL T + P+G L+LT+ + GHAF + I+
Sbjct: 21 SSQNLNFTYNGFHPPLTDISLQGLAT------VTPNGLLKLTNTSVQKTGHAFCTERIRF 74
Query: 78 LDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNS 137
D S N SSFST FVF I + G G+AF V+P P Y+G+ N
Sbjct: 75 KD-----SQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNI 129
Query: 138 TNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTK-EDFT 196
+N+ +NH+FA+EFDT+ +E D NHVGI++N ++S A Y ++ K ++ +
Sbjct: 130 SNNGNDTNHIFAVEFDTIQS-SEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLS 188
Query: 197 LESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256
L S +Q WIDYD + ++VT+ P + KP +PL+S DLS E MY
Sbjct: 189 LISRKRIQVWIDYDNRSHRIDVTVAPFDSD--------KPRKPLVSYVRDLSSILLEDMY 240
Query: 257 VGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALS 316
VGFS++TG +S HF++GWSF +NG AP L+LS++P LP S +I + + +LS
Sbjct: 241 VGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLS 300
Query: 317 TVAVILLGTLLIFKLYRRIAQFEI-LEDWELD-CPHRFRYSDLYTATKGFKQSEVIGTGG 374
+ I+ L F + RR ++E L+DWE + +RFR+ +LY ATKGFK+ +++G+GG
Sbjct: 301 LIFSIIF---LAFYIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGG 357
Query: 375 FGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418
FG VY+G+LPT M+EF AEI S+GR+ H++LV L G+C+R+ +L
Sbjct: 358 FGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGEL 417
Query: 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
LLVYDY+PNGSLD L++N L W+QR IIKG+A+GL YLHEEWEQVVIHRDVK+ N
Sbjct: 418 LLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASN 477
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VL+DAD N RLGDFGLARL+DHG TT+VVGT+GY+APE +RTG+A+ +TDV+A+G
Sbjct: 478 VLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAF 537
Query: 539 LLEIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPNLGSS-YVVAEMELVLQL 592
LLE+ +GRRPI+ D F+LV+WV G +++ DP LGSS Y + E+E+VL+L
Sbjct: 538 LLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKL 597
Query: 593 GLLCSHQKAEARPTMRQVLRYLNGDELLP 621
GLLCSH ARP+MRQVL+YL GD LP
Sbjct: 598 GLLCSHSDPRARPSMRQVLQYLRGDMALP 626
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1394), Expect = e-153, Method: Compositional matrix adjust.
Identities = 293/641 (45%), Positives = 397/641 (61%), Gaps = 49/641 (7%)
Query: 21 SQQKEEFIFN-GFNETK--TNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQM 77
S Q F +N GFN + QG+ T + P+G L+LT+ GHAFY KPI+
Sbjct: 21 SSQSLNFAYNNGFNPPTDLSIQGITT------VTPNGLLKLTNTTVQKTGHAFYTKPIRF 74
Query: 78 LDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNS 137
D S SSFST FVF I + + G G+AF V+P S P G Y+G+ N
Sbjct: 75 KD-----SPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNL 129
Query: 138 TNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYY-ENGTKEDFT 196
N+ +NH+FA+E DT+ E +D+ NHVGI++NS+KS++ PA Y+ E G ++ T
Sbjct: 130 ANNGNETNHVFAVELDTILS-TEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLT 188
Query: 197 LESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256
L S P+Q W+DYDG ++VT+ P N+ KP++PL++ DLS + MY
Sbjct: 189 LISRKPMQVWVDYDGRTNKIDVTMAPFNED--------KPTRPLVTAVRDLSSVLLQDMY 240
Query: 257 VGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALS 316
VGFS++TG +S H+ILGWSF +N AP L LS++P LP S +I + + +L
Sbjct: 241 VGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLF 300
Query: 317 TVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFG 376
+ + I + R+ A+ + E +RFR+ DLY ATKGFK+ ++GTGGFG
Sbjct: 301 LIFSFIFLVCYIVRRRRKFAEELEEWEKEFG-KNRFRFKDLYYATKGFKEKGLLGTGGFG 359
Query: 377 EVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420
VYKGV+P M+EF AEI S+GR+ H++LV L G+C+R+ +LLL
Sbjct: 360 SVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLL 419
Query: 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480
VYDY+PNGSLD L++ L+W+QR +I G+A+GL YLHEEWEQVVIHRDVK+ NVL
Sbjct: 420 VYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVL 479
Query: 481 IDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLL 540
+D ++N RLGDFGLARL+DHG TT+VVGT+GY+APE RTG+A+ +TDVFA+G LL
Sbjct: 480 LDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLL 539
Query: 541 EIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLL 595
E+A GRRPI+ + F+LVDWV + G +L DPN+GS E+E+VL+LGLL
Sbjct: 540 EVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLL 599
Query: 596 CSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEM 636
CSH ARP+MRQVL YL GD LP + S LD S M
Sbjct: 600 CSHSDPRARPSMRQVLHYLRGDAKLPEL---SPLDLSGSGM 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 537 bits (1384), Expect = e-152, Method: Compositional matrix adjust.
Identities = 298/656 (45%), Positives = 398/656 (60%), Gaps = 57/656 (8%)
Query: 21 SQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDK 80
S Q F +N F+ TN I+ + + + +G L+LTD GHAFY +PI+ D
Sbjct: 23 SSQSLNFTYNSFHRPPTN---ISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKD- 78
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
S SSFST FV I + G G+AF ++P P A YLG+ +STN+
Sbjct: 79 ----SPNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNN 134
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTK-EDFTLES 199
+NH+ A+EFDT+ E D+ NHVGIN+NS+ S+K Y++ + + TL S
Sbjct: 135 GNDTNHILAVEFDTIMN-PEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLIS 193
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
+Q W+DYD ++VT+ P + KP + L+S+ DLS F + MY+GF
Sbjct: 194 RKRMQVWVDYDDRTNQIDVTMAPFGEV--------KPRKALVSVVRDLSSVFLQDMYLGF 245
Query: 260 SASTGRKVSSHFILGWSFSMNG-AAPSLNLSQIPSLP------IERSSSNSFSLQIKILI 312
SA+TG +S HF+ GWSF + G AP L LS++P P ++R N L +LI
Sbjct: 246 SAATGYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLI 305
Query: 313 AALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDC-PHRFRYSDLYTATKGFKQSEVIG 371
L V++I L + F + RR E EDWE + +R R+ DLY ATKGFK +++G
Sbjct: 306 PVLFVVSLIFL---VRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLG 362
Query: 372 TGGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRK 415
+GGFG VY+GV+PT ++EF AEI S+GR+ H++LV L G+C+R+
Sbjct: 363 SGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRR 422
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+LLLVYDY+PNGSLD L+D L W+QRFN+I G+A+GL YLHEEWEQVVIHRD+K
Sbjct: 423 DELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIK 482
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ NVL+DA+ N RLGDFGLARL DHG TT VVGT GY+AP+ RTG+A+ +TDVFA+
Sbjct: 483 ASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAF 542
Query: 536 GVLLLEIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590
GVLLLE+A GRRPI+ + +LVD V F G +LD DPNLGS Y E+E VL
Sbjct: 543 GVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVL 602
Query: 591 QLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRS----EMNSRYLE 642
+LGLLCSH + RPTMRQVL+YL GD LP + S LD + S MN R+ E
Sbjct: 603 KLGLLCSHSDPQVRPTMRQVLQYLRGDATLP---DLSPLDFRGSGKMLGMNHRFSE 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 286/628 (45%), Positives = 389/628 (61%), Gaps = 48/628 (7%)
Query: 21 SQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDK 80
S Q +F +NGF T+ ++ + + P+G L+LT+ GHAFY KPI+ D
Sbjct: 22 SSQIIDFTYNGFRPPPTDISILG---IATITPNGLLKLTNTTMQSTGHAFYTKPIRFKD- 77
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
S SSFST FVF I + G+AF ++P P P G YLG+ N TN+
Sbjct: 78 ----SPNGTVSSFSTTFVFAIHS--QIPIAHGMAFVIAPNPRLPFGSPLQYLGLFNVTNN 131
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYY-ENGTKEDFTLES 199
NH+FA+E DT+ E +D+ NHVGI++NS+ S+K PA Y+ EN + TL S
Sbjct: 132 GNVRNHVFAVELDTIMNI-EFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFHNLTLIS 190
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
+Q W+D+DG L++VT+ P + KP +PL+S+ DLS + M+VGF
Sbjct: 191 SKRMQVWVDFDGPTHLIDVTMAPFGEV--------KPRKPLVSIVRDLSSVLLQDMFVGF 242
Query: 260 SASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNS----FSLQIKILIAAL 315
S++TG VS F+LGWSF +NG A L LS++P LP+ + + ++ L
Sbjct: 243 SSATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLL 302
Query: 316 STVAVILLGTLLIFKLYRRIAQFEILEDWELDC-PHRFRYSDLYTATKGFKQSEVIGTGG 374
+I+ I K R+ A E +EDWE + +R R+ DLY ATKGFK ++G+GG
Sbjct: 303 IPFLLIIFLVRFIMKRRRKFA--EEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGG 360
Query: 375 FGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418
FG VYKG++P ++EF AEI S+G++ H++LV L G+C+R+ +L
Sbjct: 361 FGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDEL 420
Query: 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
LLVYDY+PNGSLD L+++ L W+QRF +I G+A+ L YLHEEWEQVVIHRDVK+ N
Sbjct: 421 LLVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASN 480
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VL+DA++N RLGDFGLA+L DHG TT VVGT GY+AP+ RTG+A+ +TDVFA+GVL
Sbjct: 481 VLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVL 540
Query: 539 LLEIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLG 593
LLE+A GRRPI+ + +LVDWV F +LD DPNLGS Y E+E+VL+LG
Sbjct: 541 LLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLG 600
Query: 594 LLCSHQKAEARPTMRQVLRYLNGDELLP 621
LLCSH ARPTMRQVL+YL GD +LP
Sbjct: 601 LLCSHSDPLARPTMRQVLQYLRGDAMLP 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1374), Expect = e-150, Method: Compositional matrix adjust.
Identities = 289/632 (45%), Positives = 391/632 (61%), Gaps = 56/632 (8%)
Query: 19 ALSQQKE-EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQM 77
ALSQ +E EF FNG+ N G+ +I G ++LT+++ GH FYN P++
Sbjct: 19 ALSQSEEGEFGFNGY--LYDNSGI------AITNSKGLMKLTNSSEFSYGHVFYNSPVR- 69
Query: 78 LDKSTSLSSKPNA--SSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGIL 135
+ PN SSFST FVF IV+ + G GLAF +SP P + YLG+
Sbjct: 70 ------FKNSPNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLF 123
Query: 136 NSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYEN--GTKE 193
N TN+ PSNH+ A+EFDT E D NHVGI++NS+ S K A YYE+ GT +
Sbjct: 124 NLTNNGDPSNHIVAVEFDTFQN-QEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFK 182
Query: 194 DFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE 253
+ L + P+QAWI+YD R +NVTI P+ H KP PLLSL DLSP +
Sbjct: 183 NIRLINQKPIQAWIEYDSSRRQLNVTIHPI--------HLPKPKIPLLSLTKDLSPYLFD 234
Query: 254 TMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIA 313
+MYVGF+++TGR SSH+ILGW+F +NG A ++++S++P LP R S ++ +I +
Sbjct: 235 SMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLP--RDSRSTSVKKILAISL 292
Query: 314 ALSTVAVILLGTLLIFKLYRRIAQFEILEDWELD-CPHRFRYSDLYTATKGFKQSEVIGT 372
+L+++A+++ T+ +R E+LEDWE+ PHRF Y DLY ATKGF+ SE++G
Sbjct: 293 SLTSLAILVFLTISYMLFLKRKKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGK 352
Query: 373 GGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKR 416
GGFG+VYKG L T MREF AEI ++GRLRH +LV L G+C+RK
Sbjct: 353 GGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKG 412
Query: 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476
+L LVYD +P GSLD L+ L W QRF IIK +A+GL YLH +W QV+IHRD+K
Sbjct: 413 ELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKP 472
Query: 477 GNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYG 536
NVL+D MN +LGDFGLA+L +HG T+NV GT GYI+PEL+RTGKAS S+DVFA+G
Sbjct: 473 ANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFG 532
Query: 537 VLLLEIATGRRPI-----DSDHFILVDWVLEFQHLGQVLDVVDPNL--GSSYVVAEMELV 589
+L+LEI GRRP+ +L DWVL+ +L VVD + Y+ ++ LV
Sbjct: 533 ILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWE-DDILQVVDERVKQDDKYLEEQVALV 591
Query: 590 LQLGLLCSHQKAEARPTMRQVLRYLNGDELLP 621
L+LGL CSH A RP+M V+++L+G LP
Sbjct: 592 LKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLP 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 524 bits (1350), Expect = e-148, Method: Compositional matrix adjust.
Identities = 290/641 (45%), Positives = 399/641 (62%), Gaps = 60/641 (9%)
Query: 25 EEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSL 84
++F F GF + N +T + + P+GA+RLT VIGHAFY+ PI+
Sbjct: 24 QDFSFIGFKKASPN---LTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRF------- 73
Query: 85 SSKP----NASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
KP A SFST F +V GG GLAF ++P P G YLG+LNS+
Sbjct: 74 --KPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRV 131
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYY-ENGTKEDFTLES 199
+ S+H FA+EFDTV E D NHVGI++NSM+S PA Y+ N TK++ L+
Sbjct: 132 NF-SSHFFAVEFDTVRDL-EFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDG 189
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G +QAWIDYD + ++V + P ++K KLS LLS +DLS + MYVGF
Sbjct: 190 GRVIQAWIDYDSNKKRLDVKLSPFSEKPKLS---------LLSYDVDLSSVLGDEMYVGF 240
Query: 260 SASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLP--IERSSSNSFSLQIKI-LIAALS 316
SASTG SSH+ILGW+F+M+G A SL+L +P +P I++ SL + + L+ +L
Sbjct: 241 SASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLL 300
Query: 317 TVAVILLGTLLIFKLYRRIAQFEILEDWELD-CPHRFRYSDLYTATKGFKQSEVIGTGGF 375
AV++ +L + R++ + +E+WELD PHRF Y +L AT GF E++G+GGF
Sbjct: 301 IFAVLVAASLFVV---RKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGF 357
Query: 376 GEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419
G+VYKG LP +REF +E+ S+G LRH++LV L GWC+R+ DLL
Sbjct: 358 GKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLL 417
Query: 420 LVYDYIPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
LVYD++PNGSLD LFD N +L+W+QRF IIKG+A+GLLYLHE WEQ VIHRD+K+ N
Sbjct: 418 LVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAAN 477
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VL+D++MN R+GDFGLA+L++HG T VVGT GY+APEL ++GK + STDV+A+G +
Sbjct: 478 VLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAV 537
Query: 539 LLEIATGRRPIDS----DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594
LLE+A GRRPI++ + ++VDWV G + DVVD L + E+ +V++LGL
Sbjct: 538 LLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGL 597
Query: 595 LCSHQKAEARPTMRQVLRYLNGD----ELLPIIDNWSSLDS 631
LCS+ E RPTMRQV+ YL E++P D + DS
Sbjct: 598 LCSNNSPEVRPTMRQVVMYLEKQFPSPEVVPAPDFLDANDS 638
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | ||||||
| 332083027 | 668 | lectin receptor-like kinase [Gossypium h | 0.940 | 0.943 | 0.636 | 0.0 | |
| 224087800 | 660 | predicted protein [Populus trichocarpa] | 0.943 | 0.957 | 0.587 | 0.0 | |
| 255571419 | 675 | kinase, putative [Ricinus communis] gi|2 | 0.974 | 0.967 | 0.598 | 0.0 | |
| 224139244 | 660 | predicted protein [Populus trichocarpa] | 0.946 | 0.960 | 0.604 | 0.0 | |
| 224139246 | 660 | predicted protein [Populus trichocarpa] | 0.946 | 0.960 | 0.601 | 0.0 | |
| 356506567 | 677 | PREDICTED: lectin-domain containing rece | 0.941 | 0.932 | 0.583 | 0.0 | |
| 359481281 | 1435 | PREDICTED: uncharacterized protein LOC10 | 0.941 | 0.439 | 0.615 | 0.0 | |
| 356566703 | 683 | PREDICTED: lectin-domain containing rece | 0.940 | 0.922 | 0.560 | 0.0 | |
| 356523344 | 681 | PREDICTED: lectin-domain containing rece | 0.934 | 0.919 | 0.574 | 0.0 | |
| 449440251 | 667 | PREDICTED: probable L-type lectin-domain | 0.964 | 0.968 | 0.554 | 0.0 |
| >gi|332083027|gb|AEE00746.1| lectin receptor-like kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/668 (63%), Positives = 502/668 (75%), Gaps = 38/668 (5%)
Query: 5 VSFALRLF-FFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH 63
++F L F FFPVIA + FIF+GFN ++ +T + ASI PSGAL LT+++
Sbjct: 1 MAFLLFWFIFFPVIA--QPRPTNFIFHGFNRSEPK---LTLDGASIRSPSGALELTNDSR 55
Query: 64 NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSF 123
+ IGHAFY++PIQMLD +S S K +SSFST FV IVTP+SG+GG GLAFT+SP F
Sbjct: 56 DAIGHAFYSEPIQMLDDKSSPSPK--SSSFSTTFVLAIVTPSSGRGGHGLAFTLSPSKQF 113
Query: 124 PGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEP 183
PG EHY+GI NS D SNH+ A+EFDTVNGYN+ DS+GNHVGIN+N+M S EP
Sbjct: 114 PGALPEHYMGIFNSETDGSSSNHIVAVEFDTVNGYNDRLDSKGNHVGININTMYSNATEP 173
Query: 184 AAYYENGT--KEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLL 241
AAYY N T KED LESGD +QAWI+YDG VNVTICP FH KPS+PL+
Sbjct: 174 AAYYVNNTELKEDMILESGDAIQAWIEYDG--NFVNVTICP--------FHLNKPSKPLI 223
Query: 242 SLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSS 301
S P+DL+P QETMYVGFSASTG+K SSH+ILGWSFS NG A LN S+IP P +++
Sbjct: 224 SHPIDLTPFVQETMYVGFSASTGQKSSSHYILGWSFSTNGTAAQLNTSRIPMAPSKQNDG 283
Query: 302 NSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTAT 361
+SF ++ LI ALSTV V+LLG L+ F LY+R A++E LEDWELDCPHRFR DLY AT
Sbjct: 284 SSFDTRVIGLIVALSTVTVLLLGILIYFTLYKRNAKYEDLEDWELDCPHRFRCKDLYAAT 343
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHL 405
+GF+ SE+IG GGF VYKGVLPT +REF AEIESLGRLRHK+L
Sbjct: 344 RGFQLSEIIGVGGFAAVYKGVLPTTGTEVAVKKITQSSIQGLREFVAEIESLGRLRHKNL 403
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEE 464
V LQGWCKRK DLLLVYDYIPNGSL SLLF+ E FVLSWE+RFNIIKGIAAGLLYLHEE
Sbjct: 404 VYLQGWCKRKNDLLLVYDYIPNGSLYSLLFNQEQGFVLSWEKRFNIIKGIAAGLLYLHEE 463
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
WE VVIHRDVKS NVLIDADMNARLGDFGLARL+DHG SHTTN+VGT+GYIAPELAR G
Sbjct: 464 WELVVIHRDVKSSNVLIDADMNARLGDFGLARLYDHGTDSHTTNIVGTVGYIAPELARNG 523
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584
KAS S+DVFAYGVLLLEI GR+P+DS +F LVDWV+E +G +LD +DP L SSYV
Sbjct: 524 KASTSSDVFAYGVLLLEIVCGRKPVDSRNFFLVDWVIECHQMGHILDAMDPKLNSSYVTE 583
Query: 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEII 644
E++LVL LGLLCSH K E RP+M +++RYLNGDE +P IDNW + DS E ++LE +
Sbjct: 584 EVKLVLLLGLLCSHPKPEVRPSMSKIVRYLNGDERIPSIDNWEAFDSS-DETYLKFLETV 642
Query: 645 STDNITTS 652
S+D+IT S
Sbjct: 643 SSDSITKS 650
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224087800|ref|XP_002308233.1| predicted protein [Populus trichocarpa] gi|222854209|gb|EEE91756.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/671 (58%), Positives = 510/671 (76%), Gaps = 39/671 (5%)
Query: 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKST 82
Q EF+FNGFN ++ N +T ++ SI+KPSG LRLT+ N +GHAFY++ +QML++S+
Sbjct: 6 QDVEFLFNGFNGSEAN---LTLDKVSIIKPSGLLRLTNKTQNAVGHAFYSEKVQMLNRSS 62
Query: 83 SLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHK 142
S S ASSFST FVFQI++P+ G+GGFG AFT+SP PG +A HYLG+ NSTND
Sbjct: 63 SSSPN--ASSFSTAFVFQIISPSKGEGGFGFAFTLSPSDRLPGAEARHYLGLFNSTNDGS 120
Query: 143 PSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTK----EDFTLE 198
SN++FA+EFDTVNG+N+++DS GNHVGIN+NS+ S +PA+Y ++ + E+ L+
Sbjct: 121 SSNYIFAVEFDTVNGFNKSTDSVGNHVGININSVDSKAGKPASYNDDVNRLDSFEELVLD 180
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
SG P+QAW++Y+GV + NVTI PM+ GKP QPL+S P DLS +E MYVG
Sbjct: 181 SGKPIQAWVEYNGVTKCTNVTIAPMDH--------GKPIQPLISFPQDLSTYVREDMYVG 232
Query: 259 FSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTV 318
FSASTG K SSH+ILGWSFS G AP LNLS++P + ++ +S+SF + ++IA+L V
Sbjct: 233 FSASTGNKASSHYILGWSFSTKGEAPPLNLSRLP-IALQEKNSSSFRPSVIVIIASLCGV 291
Query: 319 AVILLGTLLIFKLYR-RIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGE 377
+L L +Y+ + Q E LEDWEL+CPHRFRY DLYTATKGFK+SE+IG GGFG
Sbjct: 292 TTLLFVILFFLTVYKIKWRQSEALEDWELECPHRFRYQDLYTATKGFKKSEIIGVGGFGA 351
Query: 378 VYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421
VYKG LPT +REF AEIESLGRLRHK+LVNLQGWCK+ DLLLV
Sbjct: 352 VYKGRLPTNGNEVAVKKINNNSIQGLREFTAEIESLGRLRHKNLVNLQGWCKKNNDLLLV 411
Query: 422 YDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480
YD+IPNGSL LLF NFVLSWEQRFNI+KG+AAGLLYLHEEWEQVVIHRDVKSGNVL
Sbjct: 412 YDFIPNGSLAGLLFSRINNFVLSWEQRFNIVKGVAAGLLYLHEEWEQVVIHRDVKSGNVL 471
Query: 481 IDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLL 540
IDA+MN RLGDFGLARL+DHG +SHTTN+VGTIGY+APEL RTG++S S+DV+AYG+LLL
Sbjct: 472 IDAEMNGRLGDFGLARLYDHGTMSHTTNIVGTIGYLAPELTRTGQSSTSSDVYAYGILLL 531
Query: 541 EIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQK 600
E+A GR+P+++ +FIL+D V+E+ +G+++D DP L S++VV EMELVL LGLLCSH+K
Sbjct: 532 EVACGRKPVETSNFILIDSVIEYHQMGRIIDAADPKLNSAFVVKEMELVLGLGLLCSHRK 591
Query: 601 AEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEI-ISTDNITTSQLSSSFG 659
+ARPTMRQV RYLN ++ LP+ID+ S DS R +++++E+ +S++ IT S SSS G
Sbjct: 592 PKARPTMRQVTRYLNWEDKLPVIDDLGSPDSLRG--STKFMEVSVSSNTITGSYPSSSIG 649
Query: 660 VISSNSIEAGR 670
++S+S++AGR
Sbjct: 650 YMTSSSMDAGR 660
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255571419|ref|XP_002526657.1| kinase, putative [Ricinus communis] gi|223533957|gb|EEF35679.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/692 (59%), Positives = 508/692 (73%), Gaps = 39/692 (5%)
Query: 1 MALTVSFALRLFFFPVIAALSQ-QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLT 59
MA + ++ F F + + Q Q EEF FNGFN + L+ +RAS+ KPSGALRLT
Sbjct: 1 MAASSMNSVVWFIFLLYTIVDQAQSEEFTFNGFN---GKEKLLALDRASVFKPSGALRLT 57
Query: 60 DNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSP 119
+ N IGHAFY+ IQM +K++ PN +SF T FVF IV P SG+GGFG F +SP
Sbjct: 58 NKTKNAIGHAFYSNTIQMFNKTS-----PNPTSFQTTFVFSIVPPASGEGGFGFGFALSP 112
Query: 120 QPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179
PG A HYLG+ N+ N+ + +NH+FA+EFDTV G+NET D+ GNH+GIN+NSM S
Sbjct: 113 TSQIPGAAAGHYLGLFNNLNNGESTNHIFAVEFDTVKGFNETGDTTGNHIGININSMDSN 172
Query: 180 KLEPAAYYE-NGTKED-FTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPS 237
+ + AAY N T+ED L G P+QAW++YDG ++V VTICPM + KP
Sbjct: 173 ETQAAAYISVNDTREDGLNLHDGKPIQAWVEYDGAKKVVTVTICPMGQP--------KPV 224
Query: 238 QPLLSLP-LDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPI 296
PL++ L+LS +E YVGFSASTG SSH+ILGWSFS GAAP+LNL ++P P
Sbjct: 225 IPLINFTGLNLSEIVKENTYVGFSASTGENASSHYILGWSFSTTGAAPALNLDELPMPPD 284
Query: 297 ERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSD 356
E+ SS SFS + LI+AL +AV+L+G LL LY+ +A FE LEDWEL+CPHRF Y D
Sbjct: 285 EKDSS-SFSRTVVALISALCVMAVLLIGILLCLTLYKSMATFESLEDWELECPHRFGYRD 343
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGVLP-----------TR-----MREFAAEIESLGRL 400
LYTATKGFK+SE+IG GGFG VYK V+ TR ++EF+AEIESLGRL
Sbjct: 344 LYTATKGFKESEIIGVGGFGIVYKAVMRNDGNEVAVKKITRNSVQGLKEFSAEIESLGRL 403
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLL 459
RHKHLVNLQGWCKR+ DL LVYDYIPNGSLDSLLF N VLSW+QRFNI+KGIAAGLL
Sbjct: 404 RHKHLVNLQGWCKRENDLFLVYDYIPNGSLDSLLFHPKNNSVLSWDQRFNIVKGIAAGLL 463
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
YLHEEW+QVVIHRDVKS NVLIDA+MN RLGDFGLARL+DHG SHTT+VVGTIGYIAPE
Sbjct: 464 YLHEEWDQVVIHRDVKSSNVLIDAEMNGRLGDFGLARLYDHGINSHTTSVVGTIGYIAPE 523
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
LARTGKAS S+DVFAYGVLLLE+ATGRRPI S FILVDWVLE Q +G++LD VDPNL S
Sbjct: 524 LARTGKASTSSDVFAYGVLLLEVATGRRPIGSGQFILVDWVLECQQVGKILDAVDPNLNS 583
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQR-SEMNS 638
+Y E+ELVL+LGLLC+HQ +++RP+MRQV YLNGD LP+I++W S +S SE+NS
Sbjct: 584 NYTAEEVELVLELGLLCAHQNSDSRPSMRQVTTYLNGDYKLPVIEDWGSYESHHLSEINS 643
Query: 639 RYLEIISTDNITTSQLSSSFGVISSNSIEAGR 670
R L++ + + +TS SSS +S++SI+AGR
Sbjct: 644 RLLKLSNCEMTSTSYRSSSIRYMSTSSIDAGR 675
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139244|ref|XP_002323017.1| predicted protein [Populus trichocarpa] gi|222867647|gb|EEF04778.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/673 (60%), Positives = 495/673 (73%), Gaps = 39/673 (5%)
Query: 1 MALTVSFALRLFFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTD 60
MA T+ L F +I + Q EFIFNGFNE++ N +T + ASI+KPSG LRLT+
Sbjct: 1 MASTICLFLLYMFISMI--VEAQSVEFIFNGFNESEKN---LTIDGASIIKPSGLLRLTN 55
Query: 61 NAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQ 120
+GHAFY+KPIQMLD TS +S PNASSFST FVFQIV+P G+GG GLAF ++P
Sbjct: 56 KTQYAVGHAFYSKPIQMLD--TSSNSSPNASSFSTTFVFQIVSPK-GKGGHGLAFALAPS 112
Query: 121 PSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIK 180
FPG AEHYLG+ N +N+ SNH+FA+EFDTVNG+NE SD++GNHVG+N+NSM+S
Sbjct: 113 NQFPGAAAEHYLGLFNPSNNGDSSNHIFAVEFDTVNGFNENSDTEGNHVGVNINSMRSKS 172
Query: 181 LEPAAYYENGTK---EDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPS 237
A+Y E+ E+ TLESG+P+QAWI+YDG +LV+VTI PM K +P
Sbjct: 173 SRAASYREDDNPDRYEELTLESGEPIQAWIEYDGAAKLVSVTIGPMEKS--------RPI 224
Query: 238 QPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGA-APSLNLSQIPSLPI 296
+PL+S P+DLS ++ MY GFS+STG+K SSH+ILGWSFS A A LNLS +P PI
Sbjct: 225 RPLISFPVDLSAVVKDNMYAGFSSSTGKKTSSHYILGWSFSTEKAGARPLNLSLLPRAPI 284
Query: 297 ERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSD 356
SS+SF + +IA+L V IL LL +YR Q E LEDWE+DCPHRFRY D
Sbjct: 285 SEESSSSFQPSVIAIIASLCGVTTILFAILLFHAVYRNWPQSEALEDWEVDCPHRFRYQD 344
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRL 400
L+TATKGFK+SE+IG GGFG VYKG LPT +R F AEIESLGRL
Sbjct: 345 LHTATKGFKKSEIIGAGGFGAVYKGRLPTNGNEVAVKRITTNSIQGLRGFTAEIESLGRL 404
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLL 459
RHK+LVNLQGWCKR DLLLVYDYIPNGSL LLF NFVLSWEQRFNI+KGIAAGLL
Sbjct: 405 RHKNLVNLQGWCKRNNDLLLVYDYIPNGSLAGLLFSRGNNFVLSWEQRFNIVKGIAAGLL 464
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
YLHEEWEQVVIHRDVKS NVLIDA MN RLGDFGLARL+DHG +SHTTN+VGTIGYIAPE
Sbjct: 465 YLHEEWEQVVIHRDVKSSNVLIDAGMNGRLGDFGLARLYDHGTMSHTTNIVGTIGYIAPE 524
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
LARTG+AS S+DV+AYG+LLLE+A GR+P+++ +FIL D+V+E G+VLD DP L S
Sbjct: 525 LARTGQASTSSDVYAYGILLLEVACGRKPVETSNFILTDFVIECHQKGRVLDAADPELNS 584
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSR 639
++VV EME+VL LGLLCSH K +ARPTMR+V+RYLN +E LP+ID+ S DS ++R
Sbjct: 585 AFVVKEMEVVLGLGLLCSHHKPKARPTMREVIRYLNWEEKLPVIDDLGSSDSPCR--STR 642
Query: 640 YLEIISTDNITTS 652
Y+ +S + IT+S
Sbjct: 643 YMGEVSIEMITSS 655
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139246|ref|XP_002323018.1| predicted protein [Populus trichocarpa] gi|222867648|gb|EEF04779.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/673 (60%), Positives = 492/673 (73%), Gaps = 39/673 (5%)
Query: 1 MALTVSFALRLFFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTD 60
MA T+ L F +I + Q EFIFNGFNE++ N +T + ASI+KPSG LRLT+
Sbjct: 1 MASTICLFLLYMFISMI--VEAQSVEFIFNGFNESEKN---LTIDGASIIKPSGLLRLTN 55
Query: 61 NAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQ 120
+GHAFY+KPIQMLD TS +S PNASSFST FVFQIV+P G+GG GLAF ++P
Sbjct: 56 KTQYAVGHAFYSKPIQMLD--TSSNSSPNASSFSTTFVFQIVSPK-GKGGHGLAFALAPS 112
Query: 121 PSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIK 180
FPG AEHYLG+ N +N+ SNH+FA+EFDTVNG+NE SD++GNHVG+N+NSM+S
Sbjct: 113 NQFPGAAAEHYLGLFNPSNNGDSSNHIFAVEFDTVNGFNENSDTEGNHVGVNINSMRSKS 172
Query: 181 LEPAAYYENGTK---EDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPS 237
A+Y E+ E+ TLESG+P+QAWI+YDG +LV+VTI PM K +P
Sbjct: 173 SRAASYREDDNPDRYEELTLESGEPIQAWIEYDGAAKLVSVTIGPMEKS--------RPI 224
Query: 238 QPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGA-APSLNLSQIPSLPI 296
+PL+S P+DLS ++ MY GFS+STG+K SSH+ILGWSFS A A LNLS +P PI
Sbjct: 225 RPLISFPVDLSAVVKDNMYAGFSSSTGKKTSSHYILGWSFSTEKAGARPLNLSLLPRAPI 284
Query: 297 ERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSD 356
SS+SF + +IA+L V IL L +YR Q E LEDWE+DCPHRFRY D
Sbjct: 285 SEESSSSFQPSVIAIIASLCGVTTILFAILFFHAVYRNWPQSEALEDWEVDCPHRFRYQD 344
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRL 400
L+TATKGFK+SE+IG GGFG VYKG LPT +R F AEIESLGRL
Sbjct: 345 LHTATKGFKKSEIIGAGGFGAVYKGRLPTNGNEVAVKRITPNSIQGLRGFTAEIESLGRL 404
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGLL 459
RHK+LVNLQGWCKR DLLLVYDYIPNG L LLF NFVLSWEQRFNI+K IAAGLL
Sbjct: 405 RHKNLVNLQGWCKRNNDLLLVYDYIPNGCLAGLLFSRGNNFVLSWEQRFNIVKDIAAGLL 464
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
YLHEEWEQVVIHRDVKS NVLIDA MN RLGDFGLARL+DHG +SHTTN+VGTIGYIAPE
Sbjct: 465 YLHEEWEQVVIHRDVKSSNVLIDAGMNGRLGDFGLARLYDHGTMSHTTNIVGTIGYIAPE 524
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
LARTG+AS S+DV+AYG+LLLE+A GR+P+++ +FIL D+V+E G+VLD DP L S
Sbjct: 525 LARTGQASTSSDVYAYGILLLEVACGRKPVETSNFILTDFVIECHQKGRVLDAADPELNS 584
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSR 639
++VV EME+VL LGLLCSH K +ARPTMR+V+RYLN +E LP+ID+ S DS +SR
Sbjct: 585 AFVVKEMEVVLGLGLLCSHHKPKARPTMREVIRYLNWEEKLPVIDDLGSSDSPCR--SSR 642
Query: 640 YLEIISTDNITTS 652
Y+ +S + IT+S
Sbjct: 643 YMGEVSIEMITSS 655
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356506567|ref|XP_003522051.1| PREDICTED: lectin-domain containing receptor kinase VI.3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/667 (58%), Positives = 483/667 (72%), Gaps = 36/667 (5%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
F F+GF+ ++ N +TRE S + P G L+LT +N++GHAFYNKPI++L+K+ S
Sbjct: 24 FQFHGFHNSERN---LTREGDSNVTPQGILQLTKRENNIVGHAFYNKPIKILEKTNSSVP 80
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
+ SSFSTCFVF IV+PNSG GGFGLAFT++P FP + H+LG+ N++ND SNH
Sbjct: 81 QTKFSSFSTCFVFSIVSPNSGLGGFGLAFTIAPTTQFPEAEGGHFLGLFNNSNDMNTSNH 140
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENG---TKEDFTLESGDPV 203
+ +EFDTVNGY + +D+ GNHVG+N+N M+S EPAAY+E G KE+F++E D V
Sbjct: 141 ILVVEFDTVNGYKDNTDTVGNHVGVNINGMQSKIAEPAAYFEEGMDAKKEEFSMEKEDAV 200
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPL-DLSPAFQETMYVGFSAS 262
AWI+YDG ++NVTI P+ K+S KPS+PL+S + D+ +ETM+ GFSAS
Sbjct: 201 CAWIEYDGETEILNVTIAPL----KVS----KPSKPLISQAIHDIKFVMKETMFFGFSAS 252
Query: 263 TG-RKVSSHFILGWSFSMNGA-APSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTVAV 320
TG RK SSH+ILGWS S+NG AP LN S +P P + ++SF +K+ +A LS +
Sbjct: 253 TGKRKASSHYILGWSVSVNGGIAPPLNFSLLPKPPPKEKDASSFPW-VKVAVAMLSALTF 311
Query: 321 ILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYK 380
LL L I Y+R FE LEDWELDCPHRFRY DL+ ATKGF +S++IG GGFG VYK
Sbjct: 312 TLLCLLFIVTRYKRYMMFETLEDWELDCPHRFRYRDLHIATKGFIESQLIGVGGFGAVYK 371
Query: 381 GVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424
GVLP+ MREFAAEIESLGRLRHK+LVNLQGWCK K DL+L+YDY
Sbjct: 372 GVLPSTGTEVAVKRIMRSPMQGMREFAAEIESLGRLRHKNLVNLQGWCKHKNDLILIYDY 431
Query: 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484
IPNGSLDSLLF N+N L W+QRFNIIKG+AAGLLYLHEEWEQVVIHRDVKS N+LID +
Sbjct: 432 IPNGSLDSLLF-NDNIALDWDQRFNIIKGVAAGLLYLHEEWEQVVIHRDVKSSNILIDGE 490
Query: 485 MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
NARLGDFGLARL+ H ++SHTT+VVGTIGYIAPEL RTGKAS S+DV+A+GVLLLE+
Sbjct: 491 FNARLGDFGLARLYSHDQVSHTTSVVGTIGYIAPELTRTGKASASSDVYAFGVLLLEVVA 550
Query: 545 GRRPI-DSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA 603
G RP+ S F+LVDWVLE LGQ+L+VVDP LGS+Y EMELVL+LGLLCS KAE
Sbjct: 551 GTRPVGSSGQFLLVDWVLENCQLGQILEVVDPKLGSAYDEEEMELVLKLGLLCSQYKAEY 610
Query: 604 RPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEIISTDNITTSQLSSSFGVISS 663
RP+M+QV RYLN D+ LP I +W DSQ S + +LE +ST I +S SS G S+
Sbjct: 611 RPSMKQVARYLNFDDSLPDISDWRYYDSQSSTNSLSFLEAMSTGKIASSYSLSSIGSRST 670
Query: 664 NSIEAGR 670
I+ GR
Sbjct: 671 LPIKTGR 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481281|ref|XP_002267556.2| PREDICTED: uncharacterized protein LOC100267833 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/681 (61%), Positives = 497/681 (72%), Gaps = 50/681 (7%)
Query: 18 AALSQQKE-EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQ 76
AA SQ +F++NGFN T+ N T + A+I+KPSGAL+LT+ + +VIGHAFY P
Sbjct: 777 AAQSQSSSLDFVYNGFNRTEKN---FTLKGATIIKPSGALKLTNRSRDVIGHAFYPDP-- 831
Query: 77 MLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILN 136
L+S N SSFST FVF I+ S GG+GLAF +SP G + H+LGILN
Sbjct: 832 ----INLLNSSNNISSFSTSFVFSIIPSGSDGGGYGLAFLLSPSTDLQGADSGHFLGILN 887
Query: 137 STNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGT--KED 194
STND SNH+FA+EFDTVNG+NE S+GNHVGIN+N M SI EPA+YY N T KE+
Sbjct: 888 STNDGDESNHIFAVEFDTVNGHNEGKSSEGNHVGININKMDSIASEPASYYVNDTDKKEE 947
Query: 195 FTLESGDPVQAWIDY-DGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE 253
L+SG +QAWIDY DGV VNVTI P++ +K P +PL+S ++L
Sbjct: 948 VNLDSGH-IQAWIDYADGV---VNVTIAPLSVPDK-------PMKPLMSKEIELPGVVTN 996
Query: 254 TMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIA 313
+MYVGFSASTG + SSH+ILGWSF +NG A LNLS +P PIE SS S IK+LI
Sbjct: 997 SMYVGFSASTGEERSSHYILGWSFCINGTARPLNLSILPVPPIETDSS-SLHTGIKVLIT 1055
Query: 314 ALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTG 373
L+ + +++ G LI LYRR + E LEDWELD PHRFRY DLYT+TKGFK SEVIG G
Sbjct: 1056 GLAVI-LLVFGAWLIRLLYRRKMKPEDLEDWELDYPHRFRYKDLYTSTKGFKVSEVIGVG 1114
Query: 374 GFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417
GF VYKGVLPT MREFAAEIESLGRLRHK+LVNLQGWCK K D
Sbjct: 1115 GFATVYKGVLPTNGNEVAVKKIVQNLTHGMREFAAEIESLGRLRHKNLVNLQGWCKHKND 1174
Query: 418 LLLVYDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476
LLLVYDYIPNGSLDSLLF +NFVLSW+QRF I++GIAAGLLYLHEEWE+VVIHRDVK+
Sbjct: 1175 LLLVYDYIPNGSLDSLLFHPPDNFVLSWDQRFKILRGIAAGLLYLHEEWEKVVIHRDVKA 1234
Query: 477 GNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYG 536
NVLID+DMN RLGDFGLARL+DHGK SHTT+VVGTIGYIAPEL RTGKAS S+DVFAYG
Sbjct: 1235 SNVLIDSDMNGRLGDFGLARLYDHGKNSHTTSVVGTIGYIAPELTRTGKASTSSDVFAYG 1294
Query: 537 VLLLEIATGRRPI------DSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590
VLLLE+A G+RPI SDHFIL+DWV E GQ+LD VDP + S YVV E+ELVL
Sbjct: 1295 VLLLEVACGKRPIRPADSQSSDHFILMDWVFECYQAGQILDAVDPRMNSVYVVEEVELVL 1354
Query: 591 QLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQR-SEMNSRYLEIISTDNI 649
+LGL CSH + EARPTMRQV RYL+ D+ LPI+D+W++ DS R S+++ R+L+I+STD I
Sbjct: 1355 RLGLFCSHPRPEARPTMRQVTRYLSRDDPLPIVDDWAAPDSSRFSDISPRFLQIVSTDTI 1414
Query: 650 TTSQLSSSFGVISSNSIEAGR 670
T+S SSS G ISS SI AGR
Sbjct: 1415 TSSCRSSSVGYISSGSIRAGR 1435
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566703|ref|XP_003551569.1| PREDICTED: lectin-domain containing receptor kinase VI.3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/667 (56%), Positives = 479/667 (71%), Gaps = 37/667 (5%)
Query: 28 IFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKS-TSLSS 86
IF GF+E + + +SI+K S L+LT+ + N++GHAFY P QML+K+ T+
Sbjct: 30 IFEGFDENSE----LNLQGSSIIKTSRLLKLTNRSTNIVGHAFYATPFQMLNKNNTNPPL 85
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
+P A SFST FVF IV+P SG GGFGLAFT++P FPG +A HYLG++NS ND SNH
Sbjct: 86 QPYAYSFSTNFVFSIVSPISGSGGFGLAFTIAPSTQFPGAEAGHYLGLVNSANDGNDSNH 145
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGT---KEDFTLESGDPV 203
+FA+EFDTVNGY + SD++GNHVG+N+N M SI EPAAY E GT KEDF + D V
Sbjct: 146 IFAVEFDTVNGYKDDSDTEGNHVGVNINGMDSIITEPAAYIEEGTDNVKEDFRMAKVDAV 205
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPL-LSLPLDLSPAFQETMYVGFSAS 262
Q WI+YDG + +NVTI P+ +PS+P+ ++ +DL +E+MYVGFSAS
Sbjct: 206 QVWIEYDGEKKTLNVTIAPLP--------LPRPSKPIIMNHNIDLYNVMEESMYVGFSAS 257
Query: 263 TGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTVAVIL 322
TG++ SSH++LGWSF +NG AP LN+S +P P + SF + + I LS + L
Sbjct: 258 TGQETSSHYLLGWSFVVNGVAPLLNISNLPKPPPKEKEPTSFPW-VNVAIGILSGLTFCL 316
Query: 323 LGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGV 382
L L YRR FE+LEDWE+DCPHRFRY DL+ ATKGF +S++IG GGFG VYKGV
Sbjct: 317 LCILFCLTCYRRYMDFEVLEDWEMDCPHRFRYKDLHIATKGFIESQLIGVGGFGAVYKGV 376
Query: 383 LPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426
LP+ MREFAAEIESLG+LRHK+LVNLQGWCK+K DLLLVYD+IP
Sbjct: 377 LPSTGAEVAVKRIVRSPFHGMREFAAEIESLGKLRHKNLVNLQGWCKKKNDLLLVYDFIP 436
Query: 427 NGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483
NGSLD +L+ N NFVL+W QRFNI+K I+AGLLYLHEEWEQVVIHRDVK+ N+LIDA
Sbjct: 437 NGSLDYVLYKPNNNNNFVLNWGQRFNILKDISAGLLYLHEEWEQVVIHRDVKTSNILIDA 496
Query: 484 DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIA 543
+NARLGDFGLARL++HG++SHTT+VVGTIGYIAPEL RTGKA +TDV+++GV+LLE+A
Sbjct: 497 HLNARLGDFGLARLYNHGQVSHTTSVVGTIGYIAPELTRTGKACANTDVYSFGVVLLEVA 556
Query: 544 TGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA 603
TG+RP+DSD F LV+WV+E HLGQ+L+VVDP L S Y E+ELVL+LGLLC+ +A+
Sbjct: 557 TGKRPLDSDQFFLVEWVIENYHLGQILEVVDPKLDSLYDEEEVELVLKLGLLCTQHRADY 616
Query: 604 RPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEIISTDNITTSQLSSSFGVISS 663
RP+M+QV RYLN D+ LP I +W S S ++ +LE+ S+ + S +S+
Sbjct: 617 RPSMKQVTRYLNFDDPLPDIADWGHDVSGSSRLSEGFLEVTSSMGTVEALGYLSSISMST 676
Query: 664 NSIEAGR 670
SI+AGR
Sbjct: 677 KSIDAGR 683
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523344|ref|XP_003530300.1| PREDICTED: lectin-domain containing receptor kinase VI.3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/667 (57%), Positives = 486/667 (72%), Gaps = 41/667 (6%)
Query: 28 IFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSK 87
IF GF++ + L E +SI+K S L+LT+ + N++GHAFY P QML+ + ++
Sbjct: 27 IFEGFDDENSELNL---EGSSIIKTSRLLKLTNRSTNIVGHAFYATPFQMLNNT----NQ 79
Query: 88 PNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHL 147
P A SFST FVF IV+P+SG GGFGLAFT++P FPG +A HYLG++NSTND SNH+
Sbjct: 80 PYAYSFSTNFVFSIVSPSSGSGGFGLAFTIAPSTQFPGAEAGHYLGLVNSTNDGNESNHI 139
Query: 148 FAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGT---KEDFTLESGDPVQ 204
FA+EFDT+NGY + SD++GNHVG+N+N M S EPAAY + GT KEDF + D VQ
Sbjct: 140 FAVEFDTMNGYKDDSDTEGNHVGVNINGMDSNITEPAAYIKEGTDKVKEDFRMAKVDAVQ 199
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLL-SLPLDLSPAFQETMYVGFSAST 263
AWI+YDG N+ +NVTI P++K +PS+P++ + +DL +E+MYVGFSAST
Sbjct: 200 AWIEYDGENKTLNVTIAPLSKP--------RPSKPIIKNHIIDLYNVMEESMYVGFSAST 251
Query: 264 GRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTVAVILL 323
G++ SSH++LGWSF++NG AP L +S +P+ P + SF + I I LS LL
Sbjct: 252 GQETSSHYLLGWSFAVNGVAPQLKISNLPNPPPKEKEPTSFPW-VNIAIGVLSASTFCLL 310
Query: 324 GTLLIFKLYRRI-AQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGV 382
L YRR FE+LEDWE+DCPHRFRY DL+ ATKGF +S +IG GGFG VYKGV
Sbjct: 311 CILFCITCYRRYYMDFEVLEDWEMDCPHRFRYKDLHLATKGFIESHLIGVGGFGAVYKGV 370
Query: 383 LPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426
LP+ MREFAAEIESLGRLRHK+LVNLQGWC +K DLLLVYD+IP
Sbjct: 371 LPSTGAEVAVKRIVRSPFHGMREFAAEIESLGRLRHKNLVNLQGWCNKKNDLLLVYDFIP 430
Query: 427 NGSLDSLLF--DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484
NGSLD +L+ +N NFVL+W QRFNI+KGI+AGLLYLHEEWEQVVIHRDVK+ N+LIDA
Sbjct: 431 NGSLDYVLYKPNNNNFVLNWGQRFNILKGISAGLLYLHEEWEQVVIHRDVKTSNILIDAH 490
Query: 485 MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
+NARLGDFGLARL++HG++SHTT+VVGTIGYIAPEL RTGKAS STDV+A+GV+LLE+AT
Sbjct: 491 LNARLGDFGLARLYNHGQLSHTTSVVGTIGYIAPELTRTGKASTSTDVYAFGVVLLEVAT 550
Query: 545 GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEAR 604
G+RP+DSD F LV+WV+E HLGQ+L+VVDP L S Y E+ELVL+LGLLC+ +A+ R
Sbjct: 551 GKRPLDSDQFFLVEWVIEKYHLGQILEVVDPKLDSLYDEEEIELVLKLGLLCTQHRADYR 610
Query: 605 PTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEII-STDNITTSQLSSSFGVISS 663
PTM+QV RYLN DE LP I +W S S ++S +LE+ S + T SS +S+
Sbjct: 611 PTMKQVTRYLNFDEPLPDIVDWGHGVSGSSRLSSGFLEVTYSMGTVETLGYLSSIS-MST 669
Query: 664 NSIEAGR 670
SI+AGR
Sbjct: 670 KSIDAGR 676
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440251|ref|XP_004137898.1| PREDICTED: probable L-type lectin-domain containing receptor kinase VI.1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/691 (55%), Positives = 480/691 (69%), Gaps = 45/691 (6%)
Query: 1 MALTVSFAL-RLFFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLT 59
MA+ AL +F F AL FI+ GFN T + RE AS++KP GALRLT
Sbjct: 1 MAIAAHLALLSVFIFFEAHALPSS---FIYPGFNNTS-----LDREGASVVKPYGALRLT 52
Query: 60 DNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSP 119
+ + NVIGHAF+ +M ++S+ S PN SFST FVF I + GQGG+GLAF ++P
Sbjct: 53 NISQNVIGHAFHPTSFRMFEQSSD--SSPNVLSFSTTFVFAIEPSSPGQGGYGLAFAIAP 110
Query: 120 QPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179
F G + HYLG+ NS+N+ PSNH+FAIEFDTVNG+ E +++GNHVGI++N + S+
Sbjct: 111 STKFSGAGSGHYLGLFNSSNNGNPSNHIFAIEFDTVNGHGEERNTKGNHVGIDINDISSV 170
Query: 180 KLEPAAY--YENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPS 237
+PA+Y Y + D ++SGDP+ W++YDG ++VNVTI P+ K K P+
Sbjct: 171 TSKPASYSDYGEAHEHDLQMDSGDPIIVWVEYDGPKKIVNVTIAPLKHKRK-------PT 223
Query: 238 QPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIE 297
+ LLS P+DL P +E M+VGFSASTG K SSH+ILGWSF+MN AP L+ S +P+ P E
Sbjct: 224 KSLLSYPIDLKPFLKEQMFVGFSASTGDKTSSHYILGWSFAMNEPAPPLDYSLLPNPPKE 283
Query: 298 RSS-SNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSD 356
+ S+S + + K+ +A +S +A+ LG + YR+ E LEDWE DCPHRF Y+D
Sbjct: 284 QDPPSSSPNSRYKVFVAVVSVIAI--LGIFFLAFWYRKTWHTERLEDWERDCPHRFHYTD 341
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRL 400
LYTATKGFK SE+IG GGFG VYKG + + M+EFAAEIESLGRL
Sbjct: 342 LYTATKGFKSSELIGIGGFGSVYKGQIRSTGIEIAVKRVRRNSGQGMKEFAAEIESLGRL 401
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLL 459
RHK+LVNLQGWCK+K DLL+VYDYIPNGSL SLL+ N +L+W+QRFNI+KGIAAGLL
Sbjct: 402 RHKNLVNLQGWCKKKNDLLIVYDYIPNGSLYSLLYHPKNNIILNWKQRFNILKGIAAGLL 461
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
YLHEEWEQVVIHRDVK NVLIDADMN RL DFGLAR +DH + SHTT VVGTIGYIAPE
Sbjct: 462 YLHEEWEQVVIHRDVKPSNVLIDADMNPRLSDFGLARQYDHDEASHTTGVVGTIGYIAPE 521
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
L RTGKAS STDVF YGVLLLE+A GR+P+ SD+FILVDWV+E G++L+ DP L
Sbjct: 522 LVRTGKASKSTDVFGYGVLLLEVACGRKPLKSDNFILVDWVMEQYEKGKILEAADPKLNW 581
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSR 639
Y EM++VL LGL CSHQ AEARPTMR+V+R L+GD+ + ++ W S S+ NSR
Sbjct: 582 EYEAEEMKMVLVLGLHCSHQIAEARPTMRRVMRILDGDDKIAAVEGWDCSQSY-SKSNSR 640
Query: 640 YLEIISTDNITTSQLSSSFGVISSNSIEAGR 670
E+IS TS SSS G IS SI+AGR
Sbjct: 641 MTEVIS----ATSYRSSSIGDISETSIDAGR 667
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | ||||||
| TAIR|locus:2097613 | 693 | AT3G08870 [Arabidopsis thalian | 0.594 | 0.574 | 0.486 | 2.5e-188 | |
| TAIR|locus:2149780 | 682 | LECRKA4.1 "lectin receptor kin | 0.623 | 0.612 | 0.468 | 7.5e-187 | |
| TAIR|locus:2149795 | 688 | LECRKA4.2 "lectin receptor kin | 0.434 | 0.422 | 0.593 | 1.1e-172 | |
| TAIR|locus:2149810 | 691 | LECRKA4.3 "lectin receptor kin | 0.407 | 0.395 | 0.625 | 7e-169 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.904 | 0.897 | 0.451 | 1.3e-137 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.905 | 0.900 | 0.443 | 5.4e-134 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.910 | 0.901 | 0.435 | 3e-133 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.862 | 0.863 | 0.436 | 6.8e-127 | |
| TAIR|locus:2097533 | 659 | AT3G59740 [Arabidopsis thalian | 0.350 | 0.356 | 0.530 | 8.2e-123 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.831 | 0.826 | 0.444 | 4e-122 |
| TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 2.5e-188, Sum P(2) = 2.5e-188
Identities = 210/432 (48%), Positives = 277/432 (64%)
Query: 26 EFIFNGFNETKTNQGLITRERASILK-PSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSL 84
+F F GF E +T+ I E AS ++ + LRLT+ NV G AFY KPI++ + + S
Sbjct: 35 KFTFIGFKENQTD---IQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLRELTNSS 91
Query: 85 SSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPS 144
K SFST FVF I+ + G GGFG FT+SP P+ PG ++ YLG+LN TN+ PS
Sbjct: 92 DIK--VCSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNRTNNGNPS 149
Query: 145 NHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYEN-GTKEDFTLESGDPV 203
NH+FA+EFDTV G+ + +D +GNH+G+N N++ S EP YY+ KEDF LESG+P+
Sbjct: 150 NHVFAVEFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYYDTEDRKEDFQLESGEPI 209
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXXXXXXXXXXXXXAFQETMYVGFSAST 263
+ IDYDG + +NVTI P +L F K ++ MYVGF+A+T
Sbjct: 210 RVLIDYDGSSETLNVTIYP----TRLEFKPKKPLISRRVSELSEIV--KDEMYVGFTAAT 263
Query: 264 GRKVSS-HFILGWSFSMNGAAPS---LNLSQIPSLPIERSSSNSFSLQIKILIAALSTVA 319
G+ SS H+++GWSFS G P L +S++P P S+ ++ Q+ +LI ALS V
Sbjct: 264 GKDQSSAHYVMGWSFSSCGENPMADWLEISRLPPPP-RLSNKKGYNSQVIVLIVALSIVT 322
Query: 320 VILLGTLLIFKLY-RRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEV 378
++LL L IF +Y RRI + + LEDWE+D PHRFRY DLY ATK FK+SE+IGTGGFG V
Sbjct: 323 LVLLVLLFIFVMYKRRIQEEDTLEDWEIDYPHRFRYRDLYLATKKFKESEIIGTGGFGIV 382
Query: 379 YKGVLPTR---------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423
Y+G L + +REF AEIESLGRL HK+LVNLQGWCK K +LLL+YD
Sbjct: 383 YRGNLSSSGPIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHKNELLLIYD 442
Query: 424 YIPNGSLDSLLF 435
YIPNGSLDSLL+
Sbjct: 443 YIPNGSLDSLLY 454
|
|
| TAIR|locus:2149780 LECRKA4.1 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 7.5e-187, Sum P(2) = 7.5e-187
Identities = 214/457 (46%), Positives = 280/457 (61%)
Query: 5 VSFALRLFFFPVIAALSQQKE-EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH 63
VSF +LF F + +Q+ F F GFN NQ I E A+++KP G LRLTD
Sbjct: 10 VSFLFKLFLFLSVHVRAQRTTTNFAFRGFNG---NQSKIRIEGAAMIKPDGLLRLTDRKS 66
Query: 64 NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP-S 122
NV G AFY+KP+++L+++ S+ SFST FVF I+ +S GFG FT+SP P
Sbjct: 67 NVTGTAFYHKPVRLLNRN---STNVTIRSFSTSFVFVIIPSSSSNKGFGFTFTLSPTPYR 123
Query: 123 FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGY-NETSDSQGNHVGINVNSMKSIKL 181
G A+ YLG+ N N+ P NH+FA+EFDTV G ++ +D GN +G+N NS S
Sbjct: 124 LNAGSAQ-YLGVFNKENNGDPRNHVFAVEFDTVQGSRDDNTDRIGNDIGLNYNSRTSDLQ 182
Query: 182 EPAAYYEN---GTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXX 238
EP YY N KEDF LESG+P+QA ++YDG +++NVT+ P +L F K
Sbjct: 183 EPVVYYNNDDHNKKEDFQLESGNPIQALLEYDGATQMLNVTVYPA----RLGFKPTKPLI 238
Query: 239 XXXXXXXXXXXAFQETMYVGFSASTGRKVSS-HFILGWSFSMNGAAPS---LNLSQIPSL 294
QE MYVGF+ASTG+ SS H+++GWSFS G P L LS++P
Sbjct: 239 SQHVPKLLEIV--QEEMYVGFTASTGKGQSSAHYVMGWSFSSGGERPIADVLILSELPPP 296
Query: 295 PIERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYR-RIAQFEILEDWELDCPHRFR 353
P ++ + Q+ ++I ALS V +++L L F +Y+ R+ Q E LEDWE+D P R R
Sbjct: 297 PPNKAKKEGLNSQVIVMIVALSAVMLVMLVLLFFFVMYKKRLGQEETLEDWEIDHPRRLR 356
Query: 354 YSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAAEIESLG 398
Y DLY AT GFK++ +IGTGGFG V+KG LP +REF AEIESLG
Sbjct: 357 YRDLYVATDGFKKTGIIGTGGFGTVFKGKLPNSDPIAVKKIIPSSRQGVREFVAEIESLG 416
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLF 435
+LRHK+LVNLQGWCK K DLLL+YDYIPNGSLDSLL+
Sbjct: 417 KLRHKNLVNLQGWCKHKNDLLLIYDYIPNGSLDSLLY 453
|
|
| TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 890 (318.4 bits), Expect = 1.1e-172, Sum P(2) = 1.1e-172
Identities = 177/298 (59%), Positives = 213/298 (71%)
Query: 380 KGVLPTRM---REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD 436
K + P M REF AEIESLGRLRHK+LVNLQGWCK+K DLLL+YDYIPNGSLDSLL+
Sbjct: 391 KKITPNSMQGVREFIAEIESLGRLRHKNLVNLQGWCKQKNDLLLIYDYIPNGSLDSLLYS 450
Query: 437 N---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
VLSW RF I KGIA+GLLYLHEEWE+VVIHRD+K NVLI+ DMN RLGDFG
Sbjct: 451 RPRQSGVVLSWNARFKIAKGIASGLLYLHEEWEKVVIHRDIKPSNVLIEDDMNPRLGDFG 510
Query: 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
LARL++ G S+TT VVGTIGY+APELAR GK+S ++DVFA+GVLLLEI +GRRP DS
Sbjct: 511 LARLYERGSQSNTTVVVGTIGYMAPELARNGKSSSASDVFAFGVLLLEIVSGRRPTDSGT 570
Query: 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
F L DWV+E G++L VDP LG Y E L L +GLLC HQ+ +RP+MR VLRY
Sbjct: 571 FFLADWVMELHARGEILHAVDPRLGFGYDGVEARLALVVGLLCCHQRPTSRPSMRTVLRY 630
Query: 614 LNGDELLPIIDN-WSSLDSQRSEMNSRYLEIISTDNITTSQLXXXXXXXXXXXIEAGR 670
LNGD+ +P IDN W DS RS++ S + +S+D ++S + +GR
Sbjct: 631 LNGDDDVPEIDNDWGYSDSSRSDLGSNFEGYVSSDRASSSVPSFSVTRVSSSSVISGR 688
|
|
| TAIR|locus:2149810 LECRKA4.3 "lectin receptor kinase a4.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 7.0e-169, Sum P(2) = 7.0e-169
Identities = 175/280 (62%), Positives = 208/280 (74%)
Query: 380 KGVLPTRM---REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD 436
K + P M REF AEIESLGRLRHK+LVNLQGWCK + DLLL+YDYIPNGSLDSLL+
Sbjct: 392 KKITPNSMQGVREFVAEIESLGRLRHKNLVNLQGWCKHRNDLLLIYDYIPNGSLDSLLYS 451
Query: 437 N---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
VLSW RF I KGIA+GLLYLHEEWEQ+VIHRDVK NVLID+DMN RLGDFG
Sbjct: 452 KPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEQIVIHRDVKPSNVLIDSDMNPRLGDFG 511
Query: 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
LARL++ G S TT VVGTIGY+APELAR G +S ++DVFA+GVLLLEI +GR+P DS
Sbjct: 512 LARLYERGSQSCTTVVVGTIGYMAPELARNGNSSSASDVFAFGVLLLEIVSGRKPTDSGT 571
Query: 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
F + DWV+E Q G++L +DP LGS Y E L L +GLLC H K E+RP MR VLRY
Sbjct: 572 FFIADWVMELQASGEILSAIDPRLGSGYDEGEARLALAVGLLCCHHKPESRPLMRMVLRY 631
Query: 614 LNGDELLPII-DNWSSLDSQRSEMNSRYLEIISTDNITTS 652
LN DE +P I DNW DS R+++ S+ + IS+D ++S
Sbjct: 632 LNRDEDVPEIHDNWGYSDSSRTDLGSKLVGYISSDRASSS 671
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 298/660 (45%), Positives = 403/660 (61%)
Query: 3 LTVSFALRLFFFPVIAALSQQKEEFIFN-GFNE-TKTN-QGLITRERASILKPSGALRLT 59
LT+ F FFF +I S Q F +N GFN T + QG+ T + P+G L+LT
Sbjct: 6 LTIFF---FFFFNLIFQSSSQSLNFAYNNGFNPPTDLSIQGITT------VTPNGLLKLT 56
Query: 60 DNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSP 119
+ GHAFY KPI+ D S SSFST FVF I + + G G+AF V+P
Sbjct: 57 NTTVQKTGHAFYTKPIRFKD-----SPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAP 111
Query: 120 QPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179
S P G Y+G+ N N+ +NH+FA+E DT+ E +D+ NHVGI++NS+KS+
Sbjct: 112 NASLPYGNPSQYIGLFNLANNGNETNHVFAVELDTILS-TEFNDTNDNHVGIDINSLKSV 170
Query: 180 KLEPAAYY-ENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXX 238
+ PA Y+ E G ++ TL S P+Q W+DYDG ++VT+ P N+ K
Sbjct: 171 QSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNED--------KPTR 222
Query: 239 XXXXXXXXXXXAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLP-IE 297
+ MYVGFS++TG +S H+ILGWSF +N AP L LS++P LP E
Sbjct: 223 PLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFE 282
Query: 298 RSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDL 357
+ F +I + + +L + + I + R+ A+ E+ E + +RFR+ DL
Sbjct: 283 PKRISEF-YKIGMPLISLFLIFSFIFLVCYIVRRRRKFAE-ELEEWEKEFGKNRFRFKDL 340
Query: 358 YTATKGFKQSEVIGTGGFGEVYKGVLP-TR---------------MREFAAEIESLGRLR 401
Y ATKGFK+ ++GTGGFG VYKGV+P T+ M+EF AEI S+GR+
Sbjct: 341 YYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMS 400
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++LV L G+C+R+ +LLLVYDY+PNGSLD L++ L+W+QR +I G+A+GL YL
Sbjct: 401 HRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYL 460
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
HEEWEQVVIHRDVK+ NVL+D ++N RLGDFGLARL+DHG TT+VVGT+GY+APE
Sbjct: 461 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHT 520
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPN 576
RTG+A+ +TDVFA+G LLE+A GRRPI+ + F+LVDWV + G +L DPN
Sbjct: 521 RTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPN 580
Query: 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEM 636
+GS E+E+VL+LGLLCSH ARP+MRQVL YL GD LP + S LD S M
Sbjct: 581 MGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL---SPLDLSGSGM 637
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 297/670 (44%), Positives = 397/670 (59%)
Query: 12 FFFPVIAAL----SQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIG 67
FFF ++ + S Q F +N F+ TN I+ + + + +G L+LTD G
Sbjct: 10 FFFIILLSKPLNSSSQSLNFTYNSFHRPPTN---ISIQGIATVTSNGILKLTDKTVISTG 66
Query: 68 HAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGK 127
HAFY +PI+ D S SSFST FV I + G G+AF ++P P
Sbjct: 67 HAFYTEPIRFKD-----SPNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAM 121
Query: 128 AEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYY 187
A YLG+ +STN+ +NH+ A+EFDT+ E D+ NHVGIN+NS+ S+K Y+
Sbjct: 122 ASQYLGLFSSTNNGNDTNHILAVEFDTIMN-PEFDDTNDNHVGININSLTSVKSSLVGYW 180
Query: 188 ENGTK-EDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXXXXXXXXXX 246
+ + + TL S +Q W+DYD ++VT+ P + K
Sbjct: 181 DEINQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEV--------KPRKALVSVVRD 232
Query: 247 XXXAFQETMYVGFSASTGRKVSSHFILGWSFSMNG-AAPSLNLSQIPSLP------IERS 299
F + MY+GFSA+TG +S HF+ GWSF + G AP L LS++P P ++R
Sbjct: 233 LSSVFLQDMYLGFSAATGYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRF 292
Query: 300 SSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQF-EILEDWELDC-PHRFRYSDL 357
N L +LI L V++I L ++ RR +F E EDWE + +R R+ DL
Sbjct: 293 YKNRMPLFSLLLIPVLFVVSLIFLVRFIV----RRRRKFAEEFEDWETEFGKNRLRFKDL 348
Query: 358 YTATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRLR 401
Y ATKGFK +++G+GGFG VY+GV+PT ++EF AEI S+GR+
Sbjct: 349 YYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMS 408
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++LV L G+C+R+ +LLLVYDY+PNGSLD L+D L W+QRFN+I G+A+GL YL
Sbjct: 409 HRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYL 468
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
HEEWEQVVIHRD+K+ NVL+DA+ N RLGDFGLARL DHG TT VVGT GY+AP+
Sbjct: 469 HEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHV 528
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPID----SDHFIL-VDWVLEFQHLGQVLDVVDPN 576
RTG+A+ +TDVFA+GVLLLE+A GRRPI+ SD +L VD V F G +LD DPN
Sbjct: 529 RTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPN 588
Query: 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSE- 635
LGS Y E+E VL+LGLLCSH + RPTMRQVL+YL GD LP + S LD + S
Sbjct: 589 LGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLPDL---SPLDFRGSGK 645
Query: 636 ---MNSRYLE 642
MN R+ E
Sbjct: 646 MLGMNHRFSE 655
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
Identities = 288/661 (43%), Positives = 404/661 (61%)
Query: 5 VSFALRLFFFPV--IAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA 62
V L FFF + I S Q F +NGF+ T+ I+ + + + P+G L+LT+ +
Sbjct: 3 VKLKLIFFFFLLCQIMISSSQNLNFTYNGFHPPLTD---ISLQGLATVTPNGLLKLTNTS 59
Query: 63 HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS 122
GHAF + I+ D S N SSFST FVF I + G G+AF V+P
Sbjct: 60 VQKTGHAFCTERIRFKD-----SQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLG 114
Query: 123 FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLE 182
P Y+G+ N +N+ +NH+FA+EFDT+ +E D NHVGI++N ++S
Sbjct: 115 LPFALPSQYIGLFNISNNGNDTNHIFAVEFDTIQS-SEFGDPNDNHVGIDLNGLRSANYS 173
Query: 183 PAAYYENGTK-EDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXXXXX 241
A Y ++ K ++ +L S +Q WIDYD + ++VT+ P F K
Sbjct: 174 TAGYRDDHDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAP--------FDSDKPRKPLV 225
Query: 242 XXXXXXXXAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLP-IERSS 300
E MYVGFS++TG +S HF++GWSF +NG AP L+LS++P LP E
Sbjct: 226 SYVRDLSSILLEDMYVGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRR 285
Query: 301 SNSFSLQIKILIAALSTV-AVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYT 359
+ F +I + + +LS + ++I L ++ + + + + E E +RFR+ +LY
Sbjct: 286 ISEF-YKIGMPLISLSLIFSIIFLAFYIVRRKKKYEEELDDWET-EFG-KNRFRFKELYH 342
Query: 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHK 403
ATKGFK+ +++G+GGFG VY+G+LPT M+EF AEI S+GR+ H+
Sbjct: 343 ATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHR 402
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
+LV L G+C+R+ +LLLVYDY+PNGSLD L++N L W+QR IIKG+A+GL YLHE
Sbjct: 403 NLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHE 462
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
EWEQVVIHRDVK+ NVL+DAD N RLGDFGLARL+DHG TT+VVGT+GY+APE +RT
Sbjct: 463 EWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRT 522
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPID-----SDHFILVDWVLEFQHLGQVLDVVDPNLG 578
G+A+ +TDV+A+G LLE+ +GRRPI+ D F+LV+WV G +++ DP LG
Sbjct: 523 GRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLG 582
Query: 579 SS-YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLD-SQRSEM 636
SS Y + E+E+VL+LGLLCSH ARP+MRQVL+YL GD LP + + LD S S M
Sbjct: 583 SSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPEL---TPLDLSAGSVM 639
Query: 637 N 637
N
Sbjct: 640 N 640
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
Identities = 275/630 (43%), Positives = 375/630 (59%)
Query: 19 ALSQQKE-EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQM 77
ALSQ +E EF FNG+ N G+ +I G ++LT+++ GH FYN P++
Sbjct: 19 ALSQSEEGEFGFNGY--LYDNSGI------AITNSKGLMKLTNSSEFSYGHVFYNSPVRF 70
Query: 78 LDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNS 137
+ S SSFST FVF IV+ + G GLAF +SP P + YLG+ N
Sbjct: 71 KN-----SPNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNL 125
Query: 138 TNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYEN--GTKEDF 195
TN+ PSNH+ A+EFDT E D NHVGI++NS+ S K A YYE+ GT ++
Sbjct: 126 TNNGDPSNHIVAVEFDTFQN-QEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNI 184
Query: 196 TLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKXXXXXXXXXXXXXXAFQETM 255
L + P+QAWI+YD R +NVTI P+ H K ++M
Sbjct: 185 RLINQKPIQAWIEYDSSRRQLNVTIHPI--------HLPKPKIPLLSLTKDLSPYLFDSM 236
Query: 256 YVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIE-RSSSNSFSLQIKILIAA 314
YVGF+++TGR SSH+ILGW+F +NG A ++++S++P LP + RS+S L I + + +
Sbjct: 237 YVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTS 296
Query: 315 LSTVAVILLGTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGG 374
L+ + + + +L K + + E E + PHRF Y DLY ATKGF+ SE++G GG
Sbjct: 297 LAILVFLTISYMLFLKRKKLMEVLEDWEV-QFG-PHRFAYKDLYIATKGFRNSELLGKGG 354
Query: 375 FGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418
FG+VYKG L T MREF AEI ++GRLRH +LV L G+C+RK +L
Sbjct: 355 FGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGEL 414
Query: 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478
LVYD +P GSLD L+ L W QRF IIK +A+GL YLH +W QV+IHRD+K N
Sbjct: 415 YLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPAN 474
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VL+D MN +LGDFGLA+L +HG T+NV GT GYI+PEL+RTGKAS S+DVFA+G+L
Sbjct: 475 VLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGIL 534
Query: 539 LLEIATGRRPI-----DSDHFILVDWVLEFQHLGQVLDVVDPNL--GSSYVVAEMELVLQ 591
+LEI GRRP+ +L DWVL+ +L VVD + Y+ ++ LVL+
Sbjct: 535 MLEITCGRRPVLPRASSPSEMVLTDWVLDCWE-DDILQVVDERVKQDDKYLEEQVALVLK 593
Query: 592 LGLLCSHQKAEARPTMRQVLRYLNGDELLP 621
LGL CSH A RP+M V+++L+G LP
Sbjct: 594 LGLFCSHPVAAVRPSMSSVIQFLDGVAQLP 623
|
|
| TAIR|locus:2097533 AT3G59740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 8.2e-123, Sum P(2) = 8.2e-123
Identities = 129/243 (53%), Positives = 169/243 (69%)
Query: 387 MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLF---DNENFV-L 442
M EF AEI ++GRLRH +LV L G+CK K +L LVYD++PNGSLD L NEN L
Sbjct: 372 MSEFLAEISTIGRLRHPNLVRLLGYCKHKENLYLVYDFMPNGSLDRCLTRSNTNENQERL 431
Query: 443 SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502
+WEQRF IIK +A LL+LH+EW QV++HRD+K NVL+D MNARLGDFGLA+L+D G
Sbjct: 432 TWEQRFKIIKDVATALLHLHQEWVQVIVHRDIKPANVLLDHGMNARLGDFGLAKLYDQGF 491
Query: 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID----SDHFILVD 558
T+ V GT+GYIAPEL RTG+A+ STDV+A+G+++LE+ GRR I+ + +LVD
Sbjct: 492 DPQTSRVAGTLGYIAPELLRTGRATTSTDVYAFGLVMLEVVCGRRLIERRAAENEAVLVD 551
Query: 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618
W+LE G++ D + ++ E+ELVL+LGLLC+H RP M VL+ LNG
Sbjct: 552 WILELWESGKLFDAAEESIRQEQNRGEIELVLKLGLLCAHHTELIRPNMSAVLQILNGVS 611
Query: 619 LLP 621
LP
Sbjct: 612 HLP 614
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 265/596 (44%), Positives = 360/596 (60%)
Query: 54 GALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGL 113
G L LT+N + GHAFYN PI+ ++SLSS SFST FVF I G G+
Sbjct: 51 GPLHLTNNTNTGTGHAFYNIPIKFT--ASSLSS----FSFSTEFVFAIFPLQKSTYGHGM 104
Query: 114 AFTVSPQPSF-PGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGIN 172
AF VSP G A LGI N ND+K + H+FA+E DT N +E+ D GN VGI+
Sbjct: 105 AFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDT-NQNSESFDKGGNDVGID 163
Query: 173 VNSMKSIKLEPAAYYE--NGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLS 230
+NS+ S++ A+Y+ G L SG + WIDYDG+ +++NVT+ P+ S
Sbjct: 164 INSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDS 223
Query: 231 FHFG---KXXXXXXXXXXXXXXAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLN 287
+F K F ETMYVGFS STG S+ +ILGWSF G A SL+
Sbjct: 224 PYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLD 283
Query: 288 LSQIPSLPIERSSSNSFSLQIKILIAALSTVAVILLGTLLIFKLYRRIAQFEILEDWELD 347
+S++ + P S F L+ ++L A +ST+A + LG ++ ++ A+ + E
Sbjct: 284 ISRLSNPP---PSPKRFPLK-EVLGATISTIAFLTLGGIVYLYKKKKYAEVLEQWEKEYS 339
Query: 348 CPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAA 392
P R+ + LY ATKGF++++++G GGFG+VYKG+LP+ M+++ A
Sbjct: 340 -PQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPSGTQIAVKRVYHDAEQGMKQYVA 398
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV-LSWEQRFNII 451
EI S+GRLRHK+LV+L G+C+RK +LLLVYDY+PNGSLD LF L+W QR NII
Sbjct: 399 EIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNII 458
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG 511
KG+A+ LLYLHEEWEQVV+HRD+K+ N+L+DAD+N +LGDFGLAR D G T VVG
Sbjct: 459 KGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVG 518
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD----HFILVDWVLEFQHLG 567
TIGY+APEL G + TDV+A+G +LE+ GRRP+D D ILV WV
Sbjct: 519 TIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRD 578
Query: 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPII 623
+ D VD L + V E +L+L+LG+LCS E RP+MRQ+L+YL G+ +P I
Sbjct: 579 ALTDTVDSKL-IDFKVEEAKLLLKLGMLCSQINPENRPSMRQILQYLEGNVSVPAI 633
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9M020 | LRK63_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5117 | 0.9447 | 0.9200 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pm.C_LG_VI000363 | hypothetical protein (660 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 670 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 5e-85 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 4e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 5e-85
Identities = 107/258 (41%), Positives = 151/258 (58%), Gaps = 25/258 (9%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV--IGHAFYNKPIQMLDKSTS 83
F FNGF+ ++N +T + + + +GAL+LT++ +G A Y+KP+++ D +T
Sbjct: 2 SFNFNGFSSDQSN---LTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTG 58
Query: 84 LSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKP 143
+SFST F F I PN GG GLAF ++P S P + YLG+ NS+N+
Sbjct: 59 -----KVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNS 113
Query: 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPV 203
SNH+ A+EFDT E D NHVGI+VNS+ S+K A Y+++ + L+SG P+
Sbjct: 114 SNHIVAVEFDTFQN-PEFGDPDDNHVGIDVNSLVSVK---AGYWDD---DGGKLKSGKPM 166
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST 263
QAWIDYD ++ ++VT+ KP +PLLS P+DLS E +YVGFSAST
Sbjct: 167 QAWIDYDSSSKRLSVTLAYSGVA--------KPKKPLLSYPVDLSKVLPEEVYVGFSAST 218
Query: 264 GRKVSSHFILGWSFSMNG 281
G H+IL WSFS NG
Sbjct: 219 GLLTELHYILSWSFSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 4e-79
Identities = 107/254 (42%), Positives = 146/254 (57%), Gaps = 27/254 (10%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLS 85
F +NGF+ L + A++L P+G L+LT+ +N G A Y+KPI++ D ST
Sbjct: 4 SFNYNGFS---NVSNLTLQGDATVL-PNGLLQLTNVTNNSAGRALYSKPIRLWDSSTG-- 57
Query: 86 SKPNASSFSTCFVFQIV-TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPS 144
+SFST FVF I P S GG GLAF ++P + PG + YLG+ NS+N+ S
Sbjct: 58 ---KVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSS 114
Query: 145 NHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQ 204
NH+ A+EFDT E +D NHVGI+VNS+ S+ E A + L SG P+Q
Sbjct: 115 NHIVAVEFDTFLN-PEFNDIDDNHVGIDVNSIISVASESA------SFVPLDLNSGKPIQ 167
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTG 264
WIDYDG ++ ++VT+ + KP +PLLS +DLS E +YVGFSASTG
Sbjct: 168 VWIDYDGSSKRLSVTL----------AYPNKPKRPLLSASVDLSTVLPEWVYVGFSASTG 217
Query: 265 RKVSSHFILGWSFS 278
SH++L WSFS
Sbjct: 218 GATESHYVLSWSFS 231
|
Length = 231 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 8e-47
Identities = 73/267 (27%), Positives = 111/267 (41%), Gaps = 31/267 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------------AEIESLGRLRHKHL 405
++ +G+G FG VYK + A EI L RL H ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V L + K L LV +Y G L L LS ++ I I GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+IHRD+K N+L+D + ++ DFGLA+ S T VGT Y+APE+ G
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 526 -ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584
DV++ GV+L E+ TG+ P ++ + ++ ++L +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-----RILG-PPLEFDEPKWSS 228
Query: 585 EMELVLQLGLLCSHQKAEARPTMRQVL 611
E L C ++ RPT ++L
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA-----------------EIESLGRLRHKHLV 406
++ E +G G FG+VY + A EI+ L +L+H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L + + L LV +Y G L LL + ++ I + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSKG- 117
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
++HRD+K N+L+D D + +L DFGLAR D G T VGT Y+APE+
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFVGTPEYMAPEVLLGKGY 173
Query: 527 SCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ D+++ GV+L E+ TG+ P D
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-41
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 43/272 (15%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+ +G G FGEVYKG L ++ EF E + +L H ++V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C + L++V +Y+P G L L N LS + IA G+ YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
+ IHRD+ + N L+ ++ ++ DFGL+R I ++APE + GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 527 SCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582
+ +DV+++GVLL EI T G P + + +++++ + L + P +
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE--VLEYLKKGYRLPK------PPNCPPEL 233
Query: 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
M L C + E RPT +++ L
Sbjct: 234 YKLM-------LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 2e-40
Identities = 68/192 (35%), Positives = 98/192 (51%), Gaps = 24/192 (12%)
Query: 370 IGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLVNLQGWC 412
+G GGFG VY + + E EIE L +L H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472
+ + L LV +Y GSL LL +NE LS ++ I+ I GL YLH +IHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 473 DVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR-TGKASCST 530
D+K N+L+D+D +L DFGL++L K S +VGT Y+APE+ G S +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 531 DVFAYGVLLLEI 542
D+++ GV+L E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 367 SEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHL 405
+ +G G FGEVYKG L ++ EF E + +L H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V L G C + L +V +Y+ G L S L N LS + IA G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLE--- 119
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+ IHRD+ + N L+ ++ ++ DFGL+R I ++APE + GK
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 526 ASCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581
+ +DV+++GVLL EI T G +P + ++ +++++ L Q P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLEYLKNGYRLPQ------PPNCPPE 231
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+ M L C + E RPT +++ L
Sbjct: 232 LYDLM-------LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 79/277 (28%), Positives = 121/277 (43%), Gaps = 46/277 (16%)
Query: 368 EVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRLRHKHLVN 407
+ +G G FGEVYKG L + ++F E + +L H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLL-------FDNENFVLSWEQRFNIIKGIAAGLLY 460
L G C + L LV +Y+ G L L E LS + + IA G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPE 519
L + +HRD+ + N L+ D+ ++ DFGL+R ++D T I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
+ G + +DV+++GVLL EI T G P + + VLE+ G L P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG---LSNEEVLEYLRKGYRLP--KP--- 229
Query: 579 SSYVVAEM-ELVLQLGLLCSHQKAEARPTMRQVLRYL 614
Y E+ EL+L C E RPT +++ L
Sbjct: 230 -EYCPDELYELMLS----CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 61/285 (21%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
+ + +G G FGEVYKG L EF E + +L H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V L G C + L +V +Y+P G L L + L+ + + IA G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE 119
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI-----A 517
+ +HRD+ + N L+ ++ ++ DFGL+R G + A
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMA 172
Query: 518 PELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD-- 574
PE + GK + +DV+++GVLL EI T G +P E +VL++++
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNE-----EVLELLEDG 220
Query: 575 -----PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
P + M L C E RPT +++ L
Sbjct: 221 YRLPRPENCPDELYELM-------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 364 FKQSEVIGTGGFGEVYKG------------------VLPTRMREFAAEIESLGRLRHKHL 405
+ + E++G G FG VY + EI L L+H ++
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 406 VNLQGWCKRKRD---LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN--IIKG----IAA 456
V G +R + L + +Y+ GSL SLL + F + +I+ I
Sbjct: 62 VRYYG-SERDEEKNTLNIFLEYVSGGSLSSLL---KKF-----GKLPEPVIRKYTRQILE 112
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGY 515
GL YLH ++HRD+K N+L+D+D +L DFG A+ + T V GT +
Sbjct: 113 GLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
+APE+ R + + D+++ G ++E+ATG+ P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 65/256 (25%), Positives = 92/256 (35%), Gaps = 41/256 (16%)
Query: 28 IFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSK 87
+ A++ SG LRLT + N G A+Y PI +
Sbjct: 3 LNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLSK-------- 54
Query: 88 PNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEH-----YLGILNSTNDHK 142
F+T F F + T + G G+AF + P+ G Y GI NS
Sbjct: 55 ----DFTTTFKFYLGTKGTN-GADGIAFVLQNDPAGALGGGGGGGGLGYGGIGNS----- 104
Query: 143 PSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDP 202
A+EFDT + +D GNH+ I+VN + A G+
Sbjct: 105 -----VAVEFDTYKND-DNNDPNGNHISIDVNGNGN--NTALATSLGSASLPNGTGLGNE 156
Query: 203 VQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262
I YD + V L S +++P+DL Y GF+AS
Sbjct: 157 HTVRITYDPTTNTLTVY---------LDNGSTLTS-LDITIPVDLIQLGPTKAYFGFTAS 206
Query: 263 TGRKVSSHFILGWSFS 278
TG + H IL WSF+
Sbjct: 207 TGGLTNLHDILNWSFT 222
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 21/197 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMR---------------EFAAEIESLGRLRHKHLVNL 408
F +G+G FGEV++G+ R+R +F E+++L RLRHKHL++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
C + ++ + + GSL + L E VL ++ +A G+ YL EQ
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPELARTGKAS 527
IHRD+ + N+L+ D+ ++ DFGLARL + +S + + APE A G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 528 CSTDVFAYGVLLLEIAT 544
+DV+++G+LL E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 73/275 (26%), Positives = 134/275 (48%), Gaps = 50/275 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------------EFAAEIESLGRLRHKHLVN 407
+VIG G FGEV +G L + +F E +G+ H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L+G + R ++++ +Y+ NGSLD L +N+ + Q +++GIA+G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLS---EM 125
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG---TIGYIAPELARTG 524
+HRD+ + N+L+++++ ++ DFGL+R + + ++TT G I + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAIAYR 183
Query: 525 KASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY-V 582
K + ++DV+++G+++ E+ + G RP W + Q V+ V+ Y +
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPY---------WDMSNQ---DVIKAVE----DGYRL 227
Query: 583 VAEM---ELVLQLGLLCSHQKAEARPTMRQVLRYL 614
M + QL L C + RPT Q++ L
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 34/207 (16%)
Query: 364 FKQSEVIGTGGFGEVYKG------------VLP----TRMREFAAEIESLGRLRHKHLVN 407
F+ E IG GGFGEVYK V+ + + EI+ L + +H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLYL 461
G +K +L +V ++ GSL LL S Q + K + GL YL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL-------KSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H +IHRD+K+ N+L+ +D +L DFGL+ K +T VGT ++APE+
Sbjct: 115 HS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVI 169
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRP 548
D+++ G+ +E+A G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 34/208 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGV------------------LPTRMREFAAEIESLGRLRHKHL 405
++ ++IG G FG VYKG+ ++ EI+ L L+H ++
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLL--FD--NENFVLSWEQRFNIIKGIAAGLLYL 461
V G + L ++ +Y NGSL ++ F E+ V + + + GL YL
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY------VYQVLQGLAYL 115
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGTIGYIAPEL 520
HE Q VIHRD+K+ N+L D +L DFG+A +L D K + VVGT ++APE+
Sbjct: 116 HE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRP 548
AS ++D+++ G ++E+ TG P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 76/304 (25%), Positives = 118/304 (38%), Gaps = 30/304 (9%)
Query: 363 GFKQSEVIGTGGFGEVYKGVL----------------PTRMREFAAEIESLGRLRH-KHL 405
++ +G G FGEVY + F EI+ L L H ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF-VLSWEQRFNIIKGIAAGLLYLHEE 464
V L + + + L LV +Y+ GSL+ LL LS + I+ I + L YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS- 119
Query: 465 WEQVVIHRDVKSGNVLIDADMN-ARLGDFGLARLFDHGKISHTTN-----VVGTIGYIAP 518
+ +IHRD+K N+L+D D +L DFGLA+L + + VGT GY+AP
Sbjct: 120 --KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 519 ELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575
E+ AS S+D+++ G+ L E+ TG P + + L +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSE 635
L S + L + + R + L + L + S L
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 636 MNSR 639
R
Sbjct: 298 APLR 301
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 364 FKQSEVIGTGGFGEVY-------------KGVLPTRM----REFA-AEIESLGRLRHKHL 405
++ + IG G FG+VY K + + M RE A E++ L +L H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLL---------FDNENFVLSW-EQRFNIIKGIA 455
+ + K L +V +Y G L + F E +L W Q +
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP-EEQILDWFVQ-------LC 113
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
L YLH + ++HRD+K N+ + ++ +LGDFG++++ + VVGT Y
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYY 169
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
++PEL + + +D+++ G +L E+ T + P + ++
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/209 (30%), Positives = 115/209 (55%), Gaps = 29/209 (13%)
Query: 365 KQSEVIGTGGFGEVYKGVL--PTRM------------------REFAAEIESLGRLRHKH 404
K EVIG G FGEV +G L P + R+F +E +G+ H +
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+++L+G + R ++++ +++ NG+LDS L N+ + Q +++GIAAG+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLS-- 123
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT-TNVVG---TIGYIAPEL 520
E +HRD+ + N+L+++++ ++ DFGL+R + T T+ +G I + APE
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 521 ARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
K + ++DV++YG+++ E+ + G RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAA-EIESLGRLRHKHL 405
F+ IG G FG V+K V + R RE A E L +L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ K L +V +Y NG L LL L +Q + I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+ ++HRD+KS N+ +DA N ++GD G+A+L T +VGT Y++PEL
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585
+ +DV+A GV+L E TG+ P D+++ + + +++ V P + Y
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGVFPPVSQMYSQQL 229
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLR 612
+L+ Q C + RP Q+LR
Sbjct: 230 AQLIDQ----CLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 365 KQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHK 403
K + +G G FG+V +F EIE L L H+
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 404 HLVNLQGWC--KRKRDLLLVYDYIPNGSLDSLL------FDNENFVLSWEQRFNIIKGIA 455
++V +G C R L L+ +Y+P+GSL L + + +L Q I
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ-------IC 119
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--I 513
G+ YL Q IHRD+ + N+L++++ ++ DFGLA++ K + G I
Sbjct: 120 KGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ APE RT K S ++DV+++GV L E+ T P
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 75/255 (29%), Positives = 111/255 (43%), Gaps = 36/255 (14%)
Query: 370 IGTGGFGEVYKGVL------------PTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV+ G P M F E + + +LRH LV L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ +V +Y+ GSL L E L Q ++ IA G+ YL + IHRD+
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLA 130
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELARTGKASCSTDV 532
+ N+L+ ++ ++ DFGLARL + T G I + APE A G+ + +DV
Sbjct: 131 ARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 533 FAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQ 591
+++G+LL EI T GR P +VL+ V+ E +
Sbjct: 188 WSFGILLTEIVTYGRVPYPG------------MTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 592 LGLLCSHQKAEARPT 606
L L C + E RPT
Sbjct: 236 LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 18/194 (9%)
Query: 370 IGTGGFGEVYKGVL------------PTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV++G+ P M ++F AE + + +LRH L+ L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ +V + + GSL L L Q ++ +A+G+ YL Q IHRD+
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLA 130
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ NVL+ + ++ DFGLAR+ I + APE A + S +DV+++
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190
Query: 536 GVLLLEIAT-GRRP 548
G+LL EI T GR P
Sbjct: 191 GILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/223 (29%), Positives = 93/223 (41%), Gaps = 28/223 (12%)
Query: 363 GFKQSEVIGTGGFGEVY-------------------KGVLPTRMREFAAEIESLGRLRHK 403
F+ VIG G FG+V K V +R E L L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAAGLLYLH 462
LVNL + + ++ LV D + G L L F S EQ +F I I L YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF--SEEQVKF-WICEIVLALEYLH 117
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
+ +IHRD+K N+L+D + + DF +A + TT+ GT GY+APE+
Sbjct: 118 S---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLC 172
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQH 565
S + D ++ GV E G+RP + D + Q
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 29/200 (14%)
Query: 367 SEVIGTGGFGEVYKGVL-------------PTRMREFAAEIESLGRLRHKHLVNLQGWCK 413
IG G FG+V G T + F AE + LRH +LV L G
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ L +V +Y+ GSL L V++ Q+ + G+ YL E+ +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 474 VKSGNVLIDADMNARLGDFGLARL----FDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
+ + NVL+ D+ A++ DFGLA+ D GK+ + + APE R K S
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--------VKWTAPEALREKKFSTK 179
Query: 530 TDVFAYGVLLLEI-ATGRRP 548
+DV+++G+LL EI + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 57/206 (27%), Positives = 112/206 (54%), Gaps = 27/206 (13%)
Query: 366 QSEVIGTGGFGEVYKGVLPTRMR--------------------EFAAEIESLGRLRHKHL 405
+ +VIG G FGEV++G+L R +F +E +G+ H ++
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ L+G + + +++ +Y+ NG+LD L D++ S+ Q +++GIAAG+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYLS--- 124
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIG--YIAPELART 523
+ +HRD+ + N+L+++++ ++ DFGL+R+ + T G I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
K + ++DV+++G+++ E+ + G RP
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 38/265 (14%)
Query: 369 VIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRLRHKHLVNLQGW 411
V+G G G VYK ++ E+++L ++V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA----GLLYLHEEWEQ 467
++ ++ +V +Y+ GSL LL E ++ IA GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIP---EP---VLAYIARQILKGLDYLHTKRHI 121
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
IHRD+K N+LI++ ++ DFG++++ ++ T VGT+ Y++PE + S
Sbjct: 122 --IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYS 178
Query: 528 CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587
+ D+++ G+ LLE A G+ P + F+ + + D P+L + E
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPG--QPSF---FELMQAICDGPPPSLPAEEFSPEFR 233
Query: 588 LVLQLGLLCSHQKAEARPTMRQVLR 612
+ C + + RP+ ++L+
Sbjct: 234 DFIS---ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 370 IGTGGFGEVY------------------KGVLPTRMREFA-AEIESLGRLRHKHLVNLQG 410
+G G FG+V K ++ + E E L R+ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 411 WC--KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAAGLLYLHEEWEQ 467
+ + L LV +Y P G L S L ++ S E+ RF I L YLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLHS---L 112
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
+I+RD+K N+L+DAD + +L DFGLA+ S T GT Y+APE+
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 528 CSTDVFAYGVLLLEIATGRRPIDSD 552
+ D ++ GVLL E+ TG+ P ++
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 9e-23
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 45/212 (21%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ E +G G +G VYK G+ T +RE I L L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELK 56
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIA----AG 457
H ++V L +R L LV++Y L L D LS N+IK I G
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLS----PNLIKSIMYQLLRG 110
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
L Y H ++HRD+K N+LI+ D +L DFGLAR F ++T VV T+ Y A
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 518 PEL---ARTGKASCSTDVFAYGVLLLEIATGR 546
PE+ ++ S + D+++ G + E+ TG+
Sbjct: 167 PEILLGSK--HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 59/208 (28%), Positives = 113/208 (54%), Gaps = 29/208 (13%)
Query: 365 KQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKH 404
K +VIG G FGEV G L + R+F +E +G+ H +
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHE 463
+++L+G + + +++V +Y+ NGSLD+ L ++ F + Q +++GIA+G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYLS- 123
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIG--YIAPELA 521
+ +HRD+ + N+L+++++ ++ DFGL+R+ + + T G I + APE
Sbjct: 124 --DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 522 RTGKASCSTDVFAYGVLLLEIAT-GRRP 548
K + ++DV++YG+++ E+ + G RP
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 368 EVIGTGGFGEVYK-----------------GVLPTRMRE-FAAEIESLGRLRHKHLVNLQ 409
E IG G FG V K G + + ++ +E+ L L+H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 410 GWC--KRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLH--E 463
+ + L +V +Y G L L+ E + E + I+ + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+ V+HRD+K N+ +DA+ N +LGDFGLA++ H S VGT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPYYMSPEQLNH 184
Query: 524 GKASCSTDVFAYGVLLLEIATGRRP 548
+D+++ G L+ E+ P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 43/219 (19%)
Query: 368 EVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRLRHKHL 405
+G G FG+V+ G ++F E E L +H+++
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLL------------FDNENFVLSWEQRFNIIKG 453
V G C ++V++Y+ +G L+ L D+ L+ Q I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR---LFDHGKISHTTNVV 510
IA+G++YL Q +HRD+ + N L+ D+ ++GDFG++R D+ ++ T +
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML- 186
Query: 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
I ++ PE K + +DV+++GV+L EI T G++P
Sbjct: 187 -PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 23/196 (11%)
Query: 368 EVIGTGGFGEVYKGVLPTRM----------------REFAAEIESLGRLRHKHLVNLQGW 411
E IG G FG+VYKGVL R+F E E L + H ++V L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471
C +K+ + +V + +P GSL + L +N L+ ++ + AAG+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLES---KNCIH 116
Query: 472 RDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI--GYIAPELARTGKASCS 529
RD+ + N L+ + ++ DFG++R + G I ++ + I + APE G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 530 TDVFAYGVLLLEIATG 545
+DV++YG+LL E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 33/204 (16%)
Query: 370 IGTGGFGEVYKG-------------VLPTRMRE-----FAAEIESLGRLRHKHLVNLQGW 411
IG G +G+VYK + +E EI+ L +LRH ++V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 412 C--KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
K K + +V++Y+ + L LL D+ + Q +K + GL YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKCYMKQLLEGLQYLHS---NGI 121
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL----ARTGK 525
+HRD+K N+LI+ D +L DFGLAR + + TN V T+ Y PEL R G
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181
Query: 526 ASCSTDVFAYGVLLLEIATGRRPI 549
D+++ G +L E+ G +PI
Sbjct: 182 EV---DMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 47/268 (17%)
Query: 370 IGTGGFGEVYKG-------VLPTRMRE-------FAAEIESLGRLRHKHLVNLQGWCKRK 415
+G+G FG V+ G V +RE F E + + +L H +LV L G C ++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
R + +V +Y+ NG L + L + + L E ++ + + YL IHRD+
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 476 SGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGT---IGYIAPELARTGKASCSTD 531
+ N L+ D ++ DFGLAR + D T+ GT + + PE+ + S +D
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 532 VFAYGVLLLEIAT-GRRPIDSDHFILVDW----VLEFQHLGQVLDVVDPNLGSSYVVAEM 586
V+++GVL+ E+ + G+ P + + V+E G L P L + V M
Sbjct: 184 VWSFGVLMWEVFSEGKMPYER-------FSNSEVVESVSAGYRLY--RPKLAPTEVYTIM 234
Query: 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614
C H+K E RP +++L L
Sbjct: 235 Y-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 78/261 (29%), Positives = 128/261 (49%), Gaps = 39/261 (14%)
Query: 370 IGTGGFGEV----YKGVLPTRMR----------EFAAEIESLGRLRHKHLVNLQGWCKRK 415
+GTG FG V ++G ++ EF E + + +L H+ LV L G C ++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
R + +V +Y+ NG L + L ++ Q + K + G+ YL E +Q IHRD+
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRDLA 127
Query: 476 SGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGT---IGYIAPELARTGKASCSTD 531
+ N L+D ++ DFGL+R + D T+ VG+ + + PE+ K S +D
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 532 VFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590
V+A+GVL+ E+ + G+ P + + + + Q L + P+L S V A M
Sbjct: 184 VWAFGVLMWEVYSLGKMPYE-----RFNNSETVEKVSQGLRLYRPHLASEKVYAIM---- 234
Query: 591 QLGLLCSHQKAEARPTMRQVL 611
C H+KAE RPT +Q+L
Sbjct: 235 ---YSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 370 IGTGGFGEVYKGVL------------PTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV+ G P M F E + + +LRH LV L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE- 72
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ +V +Y+ GSL L D E L ++ +AAG+ Y+ IHRD++
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLR 129
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
S N+L+ + ++ DFGLARL + + + I + APE A G+ + +DV+++
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 536 GVLLLEIAT-GRRP 548
G+LL E+ T GR P
Sbjct: 190 GILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
++ +V+G+G FG VYKGV P +E E + + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN-----FVLSW-EQRFNIIKGIAA 456
H+V L G C + + L+ +P G L + ++++ ++L+W Q IA
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------IAK 120
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG-KISHTTNVVGTIGY 515
G+ YL E + ++HRD+ + NVL+ + ++ DFGLA+L D K H I +
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDS 551
+A E + +DV++YGV + E+ T G +P +
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 27/199 (13%)
Query: 368 EVIGTGGFGEVYKG------------VLPTR--MREFAAEIESLGRLRHKHLVNLQGWCK 413
E +G G +G VYK V+P ++E EI L + ++V G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ DL +V +Y GS+ ++ N L+ E+ I+ GL YLH IHRD
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRD 124
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTT----NVVGTIGYIAPELARTGKASCS 529
+K+GN+L++ + A+L DFG++ G+++ T V+GT ++APE+ + +
Sbjct: 125 IKAGNILLNEEGQAKLADFGVS-----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 530 TDVFAYGVLLLEIATGRRP 548
D+++ G+ +E+A G+ P
Sbjct: 180 ADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 33/203 (16%)
Query: 360 ATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419
A K FK+SE +V K T +RE ++ L +LRH+++VNL+ +RK L
Sbjct: 30 AIKKFKESE-----DDEDVKK----TALRE----VKVLRQLRHENIVNLKEAFRRKGRLY 76
Query: 420 LVYDYIPNGSLDSLLFDNENFVLSWEQR---FNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476
LV++Y+ L+ LL + + R + +++ IA Y H +IHRD+K
Sbjct: 77 LVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIA----YCHS---HNIIHRDIKP 128
Query: 477 GNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL----ARTGKASCSTDV 532
N+L+ +L DFG AR S T+ V T Y APEL GK DV
Sbjct: 129 ENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP---VDV 185
Query: 533 FAYGVLLLEIATGRR--PIDSDH 553
+A G ++ E+ G P DSD
Sbjct: 186 WAIGCIMAELLDGEPLFPGDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEI-------------------ESLGRL-RHK 403
FK ++IG G F V +E+A +I E L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL---- 459
++ L + + +L V +Y PNG L + + + AA +L
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL------DEKCTRFYAAEILLALE 116
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS--------------- 504
YLH + +IHRD+K N+L+D DM+ ++ DFG A++ D
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 505 ----HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ VGT Y++PEL A S+D++A G ++ ++ TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 50/276 (18%)
Query: 365 KQSEVIGTGGFGEVYKGV---------------------LPTRMREFAAEIESLGRLRHK 403
++ E++G+G FG VY+G+ +++ EI L +L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
++V G + + +L + + +P GSL LL +F + I GL YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSF--PEPVIRLYTRQILLGLEYLH- 119
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LAR 522
++ +HRD+K N+L+D + +L DFG+A+ + S + G+ ++APE +A+
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQ 175
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582
G + D+++ G +LE+ATG+ P W + + + V +G S
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP----------WS-QLEGVAAVF-----KIGRSKE 219
Query: 583 VAEMELVLQLG-----LLCSHQKAEARPTMRQVLRY 613
+ + L L C + RPT ++L +
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-19
Identities = 83/324 (25%), Positives = 148/324 (45%), Gaps = 42/324 (12%)
Query: 318 VAVILLGTLLIFKLYRRIAQFEILED----WELD-----CPHRFRYSDLYTATKGFKQSE 368
+ + L+ +F R + + +E+ WEL +D+ ++ K +
Sbjct: 640 LVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK---EEN 696
Query: 369 VIGTGGFGEVYKGVLPTRMREF------------AAEIESLGRLRHKHLVNLQGWCKRKR 416
VI G G YKG +F ++EI +G+L+H ++V L G C+ ++
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK 756
Query: 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476
L+++YI +L +L + LSWE+R I GIA L +LH V+ ++
Sbjct: 757 GAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 477 GNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYG 536
++ID L RL G + T + Y+APE T + +D++ +G
Sbjct: 812 EKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFG 865
Query: 537 VLLLEIATGRRPIDSD---HFILVDWVLEFQHLGQVLDV-VDPNLGSSYVVAEMELV--L 590
++L+E+ TG+ P D++ H +V+W + + LD+ +DP++ V + E+V +
Sbjct: 866 LILIELLTGKSPADAEFGVHGSIVEWA-RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924
Query: 591 QLGLLCSHQKAEARPTMRQVLRYL 614
L L C+ ARP VL+ L
Sbjct: 925 NLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 31/260 (11%)
Query: 370 IGTGGFGEVYKG------------VLPTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV+ G + P M F E + + +LRH+ LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ +V +Y+ GSL L L Q ++ IA+G+ Y+ +HRD++
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLR 129
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ N+L+ ++ ++ DFGLARL + + + I + APE A G+ + +DV+++
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 536 GVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594
G+LL E+ T GR P +V+ +VLD V+ E + L
Sbjct: 190 GILLTELTTKGRVPYPG----MVN--------REVLDQVERGYRMPCPPECPESLHDLMC 237
Query: 595 LCSHQKAEARPTMRQVLRYL 614
C ++ E RPT + +L
Sbjct: 238 QCWRKEPEERPTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 364 FKQSEVIGTGGFGEVY----------------------KGVLPTRMREFAAEIESLGRLR 401
+ + + +GTG F Y + EI + RL
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H H++ + G L +++ GS+ LL F + + + + GL YL
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGLSYL 119
Query: 462 HEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLA-RLFDHGKISHTT----NVVGTIGY 515
HE +IHRDVK N+LID+ R+ DFG A RL K + ++GTI +
Sbjct: 120 HE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL--AAKGTGAGEFQGQLLGTIAF 174
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPID----SDHFILV 557
+APE+ R + S DV++ G +++E+AT + P + S+H L+
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------EIESLGRLRHKHLVNL 408
+K E IG G GEVYK +E A EI + +H ++V+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+L +V +Y+ GSL ++ ++ Q + + + GL YLH Q
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHS---QN 136
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
VIHRD+KS N+L+ D + +L DFG A K S +VVGT ++APE+ +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 529 STDVFAYGVLLLEIATGRRP 548
D+++ G++ +E+A G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 50/272 (18%)
Query: 369 VIGTGGFGE-------------VYKGVLPTR-----MREFAAEIESLGRLRHKHLVNLQG 410
V+G G FGE V+K V TR R+ EI L L+H +++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 411 WCKRKRDLLLVYDYIPNGSL-------DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
LL+ +Y G+L LF+ E + Q I + + Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVSYIHK 119
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
++HRD+K+ N+ + +LGDFG++++ + S VVGT Y++PEL +
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQG 175
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYV 582
K + +D++A G +L E+ T +R D+ + + LV +++ G VV Y
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNYTPVVSV-----YS 226
Query: 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+ LV Q E RPT +VL
Sbjct: 227 SELISLVHS----LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 60/198 (30%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 370 IGTGGFGEVY-----------------KGVLPTRMREFAA--EIESLGRLRHKHLVNLQG 410
+G GGFGEV K L R E A E + L ++ + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
+ K DL LV + G L +++ + I GL +LH+ ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
+RD+K NVL+D N R+ D GLA GK GT GY+APE+ + S
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 531 DVFAYGVLLLEIATGRRP 548
D FA G L E+ GR P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 366 QSEVIGTGGFGEVYKGV------------------LPTRMREFAAEIESLGRLRHKHLVN 407
+ IG G FG+VY V P ++E A E++ L L+H +LV
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLL----FDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
G + + + +Y G+L+ LL +E+ + + + + GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI----RVY--TLQLLEGLAYLHS 117
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTT--NVVGTIGYIAPEL 520
++HRD+K N+ +D + +LGDFG A +L ++ ++ GT Y+APE+
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 521 ARTGKASC---STDVFAYGVLLLEIATGRRP 548
GK + D+++ G ++LE+ATG+RP
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 26/200 (13%)
Query: 370 IGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCK 413
+G G FG+VYK + +F EI+ L +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ L ++ ++ G+LDS++ + E L+ Q + + + L +LH VIHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHS---HKVIHRD 128
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA-----RTGKASC 528
+K+GN+L+ D + +L DFG++ T +GT ++APE+ +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDY 187
Query: 529 STDVFAYGVLLLEIATGRRP 548
D+++ G+ L+E+A P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 31/199 (15%)
Query: 370 IGTGGFGEVYKG--------VLPTRMREFAA----------EIESLGRLRHKHLVNLQGW 411
IG G +G VYK V +++ EI+ L L H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLF---DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ K DL LV+++ +D+ L+ + L + + + GL + H
Sbjct: 67 FRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGKAS 527
++HRD+K N+LI+ + +L DFGLAR F + T+ V T Y APE L S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 528 CSTDVFAYGVLLLEIATGR 546
D+++ G + E+ + R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 58/168 (34%), Positives = 87/168 (51%), Gaps = 19/168 (11%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSL-LFDNE-NFVLSWEQRFNI 450
EI L +LRH++LVNL +RK+ L LV++++ + LD L + N + + F I
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI 109
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510
++GI + H +IHRD+K N+L+ +L DFG AR + T+ V
Sbjct: 110 LRGIE----FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYV 161
Query: 511 GTIGYIAPEL----ARTGKASCSTDVFAYGVLLLEIATGRR--PIDSD 552
T Y APEL + G+A D++A G L+ E+ TG P DSD
Sbjct: 162 ATRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTGEPLFPGDSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 365 KQSEVIGTGGFGEVYKG-------VLPTRMRE-------FAAEIESLGRLRHKHLVNLQG 410
K + +G G FGEV+ G V +++ F AE + +L+H LV L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
+ + ++ +Y+ NGSL L E L+ + ++ IA G+ ++ + I
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
HRD+++ N+L+ + ++ DFGLARL + + + I + APE G + +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 531 DVFAYGVLLLEIAT-GRRP 548
DV+++G+LL EI T GR P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 370 IGTGGFGEVYKGVLP---------------TRMREFAAEIESLGRLRHKHLVNLQGWCKR 414
+G G +GEVY+GV + EF E + ++H +LV L G C R
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV 474
+ ++ +++ G+L L + ++ + I++ + YL ++ IHRD+
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 130
Query: 475 KSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFA 534
+ N L+ + ++ DFGL+RL + I + APE K S +DV+A
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 190
Query: 535 YGVLLLEIAT 544
+GVLL EIAT
Sbjct: 191 FGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVL--PTRM------------------REFAAEIESLGRLR 401
K K ++GTG FGE+ +G L P++ R F AE +LG+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H ++V L+G R +++V +Y+ NG+LDS L +E L Q ++ G+A+G+ YL
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYL 123
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
E +H+ + + VL+++D+ ++ F + I T + + + APE
Sbjct: 124 S---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 522 RTGKASCSTDVFAYGVLLLEI-ATGRRP 548
+ S ++DV+++G+++ E+ + G RP
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 50/218 (22%)
Query: 368 EVIGTGGFGEVYKGV--------------LPTRMRE------------FAAEIESLGRLR 401
E+IG G +G VY + LP + +EIE+L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAA 456
H ++V G+ + L + +Y+P GS+ S L F+ E V + ++ +
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE-EQLVRFFTEQ------VLE 119
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR----LFDHGKISHTTNVVGT 512
GL YLH + ++HRD+K+ N+L+DAD ++ DFG+++ ++D+ ++ G+
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN---DQNMSMQGS 173
Query: 513 IGYIAPELARTGKASCS--TDVFAYGVLLLEIATGRRP 548
+ ++APE+ + S D+++ G ++LE+ GRRP
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 47/218 (21%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
++ EVIG G VY + T + E E++++ + H ++V
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLL--------FDNENFVLSWEQRFNIIKGIAAGL 458
+L LV Y+ GSL ++ D E + + ++K + GL
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-EAIIAT------VLKEVLKGL 115
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL-ARLFDHGKISHT--TNVVGTIGY 515
YLH IHRD+K+GN+L+ D + ++ DFG+ A L D G + VGT +
Sbjct: 116 EYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 516 IAPEL--ARTG---KASCSTDVFAYGVLLLEIATGRRP 548
+APE+ G KA D++++G+ +E+ATG P
Sbjct: 173 MAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 20/190 (10%)
Query: 368 EVIGTGGFGEVYKGVL---------------PTRMR-EFAAEIESLGRLRHKHLVNLQGW 411
E++G G FGEV+KG L P ++ +F +E L + H ++V L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471
C +++ + +V + +P G S L ++ L +Q AAG+ YL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLES---KNCIH 116
Query: 472 RDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTD 531
RD+ + N L+ + ++ DFG++R D G S + I + APE G+ S +D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 532 VFAYGVLLLE 541
V++YG+LL E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 33/261 (12%)
Query: 370 IGTGGFGEVYKG-------VLPTRMRE-------FAAEIESLGRLRHKHLVNLQGWCKRK 415
+G+G FG V+ G V + E F E + + +L H LV L G C ++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ L +V +++ NG L + L + LS + ++ + + G+ YL IHRD+
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ N L+ + ++ DFG+ R + + ++ + + PE+ K S +DV+++
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187
Query: 536 GVLLLEIAT-GRRPIDS-DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLG 593
GVL+ E+ T G+ P + ++ +V+ + L + P L S V M
Sbjct: 188 GVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------PKLASMTVYEVM------- 234
Query: 594 LLCSHQKAEARPTMRQVLRYL 614
C H+K E RPT ++LR +
Sbjct: 235 YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 38/209 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-----------------AEIESLGRLRHKHLV 406
F E IG G FGEVYK + + A EI+ L + R ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLL---FDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
G + L ++ +Y GS LL +E ++ I++ + GL YLHE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF------ILREVLLGLEYLHE 116
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPE 519
+ IHRD+K+ N+L+ + + +L DFG++ G+++ T + VGT ++APE
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ + D+++ G+ +E+A G P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 31/265 (11%)
Query: 365 KQSEVIGTGGFGEVYKG-------VLPTRMRE-------FAAEIESLGRLRHKHLVNLQG 410
+ IG+G FG V+ G V +RE F E + + +L H LV L G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C + + LV++++ +G L L + S E + + G+ YL VI
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLES---SNVI 122
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
HRD+ + N L+ + ++ DFG+ R + + +T + + +PE+ K S +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 531 DVFAYGVLLLEI-ATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589
DV+++GVL+ E+ + G+ P ++ V+E + G L P L S V M+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRS---NSEVVETINAGFRL--YKPRLASQSVYELMQ-- 235
Query: 590 LQLGLLCSHQKAEARPTMRQVLRYL 614
C ++ E RP+ +L L
Sbjct: 236 -----HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 370 IGTGGFGEVYKG------------VLPTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV+ G + P M F E + + +LRH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ +V +++ GSL L + + L Q ++ IA G+ Y+ IHRD++
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLR 129
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ N+L+ ++ ++ DFGLARL + + + I + APE A G+ + +DV+++
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 536 GVLLLEIAT-GRRP 548
G+LL E+ T GR P
Sbjct: 190 GILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRD--LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNI 450
EI L L H+++V +G C + L L+ +Y+P GSL L ++ L+ Q
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLF 112
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510
+ I G+ YLH Q IHRD+ + NVL+D D ++GDFGLA+ G +
Sbjct: 113 AQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 511 GT--IGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
G + + A E + K S ++DV+++GV L E+ T
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 18/194 (9%)
Query: 370 IGTGGFGEVYKG------------VLPTRM--REFAAEIESLGRLRHKHLVNLQGWCKRK 415
+G G FGEV+ G + P M + F E + L+H LV L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
+ ++ +Y+ GSL L +E + + + IA G+ Y+ + IHRD++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLR 130
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ NVL+ + ++ DFGLAR+ + + + I + APE G + +DV+++
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 536 GVLLLEIAT-GRRP 548
G+LL EI T G+ P
Sbjct: 191 GILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 37/204 (18%)
Query: 368 EVIGTGGFGEVYKG--------VLPTRM-REFAA--------EIESLGRL-RHKHLVNLQ 409
+ +G G FG VY V +M ++F + E++SL +L H ++V L+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ +L V++Y+ G+L L+ D + S +II I GL ++H+
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGF 120
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT------TNVVGTIGYIAPE-LAR 522
HRD+K N+L+ ++ DFGLAR T+ V T Y APE L R
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 523 TGKASCSTDVFAYGVLLLEIATGR 546
+ S D++A G ++ E+ T R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
F + E IG G FGEV+KG+ + + EI L + ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G + L ++ +Y+ GS LL E L Q I++ I GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
IHRD+K+ NVL+ +L DFG+A +I VGT ++APE+ +
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAY 178
Query: 527 SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586
D+++ G+ +E+A G P H + V +++ + P L +Y
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--------PPTLEGNYSKPLK 230
Query: 587 ELVLQLGLLCSHQKAEARPTMRQVLRY 613
E V C +++ RPT +++L++
Sbjct: 231 EFVEA----CLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 44/271 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA------------------EIESLGRLRHKHL 405
F + E IG G FGEVYKG+ R +E A EI L + ++
Sbjct: 6 FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGLLYLH 462
G + L ++ +Y+ GS LL E ++ + I++ I GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLH 118
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
E + IHRD+K+ NVL+ + +L DFG+A +I T VGT ++APE+ +
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 174
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582
D+++ G+ +E+A G P H + V +++ P L Y
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--------PPTLEGQYS 226
Query: 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
E V C ++ RPT +++L++
Sbjct: 227 KPFKEFVEA----CLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 47/230 (20%)
Query: 359 TATKGFKQSEVIGTGGFGEVYKGV---------------------LP-TRMREFAAEIES 396
+ + ++ +G G FGEVYK P T +RE I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKI 60
Query: 397 LGRLRHKHLVNLQGWC-----KRKRDLLLVYDYIPNGSLD-SLLFDNENFVLSWEQRFNI 450
L +L+H ++V L K KR VY P D S L +N + L+ Q
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD-------HGKI 503
+ + G+ YLHE ++HRD+K+ N+LID ++ DFGLAR +D G
Sbjct: 121 MLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 504 SHT---TNVVGTIGYIAPEL-ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
T TN+V T Y PEL + + + D++ G + E+ T RRPI
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 43/274 (15%)
Query: 362 KGFKQSEVIGTGGFGEVYK-----------------GVLPTRMREFAAEIESLGRLRHKH 404
+ +G G G V K + ++ E++ L + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGL 458
+V G D+ + +Y+ GSLD +L + R I + GL
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKIL-------KEVQGRIPERILGKIAVAVLKGL 113
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGTIGYIA 517
YLHE+ + +IHRDVK N+L+++ +L DFG++ +L + S VGT Y+A
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMA 167
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577
PE + S +D+++ G+ L+E+ATGR P F+ L +++ P L
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP---ENDPPDGIFELLQYIVNEPPPRL 224
Query: 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVL 611
S + + + LC + RP+ +++L
Sbjct: 225 PSGKFSPDFQDFVN---LCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 370 IGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKHLVNLQG 410
+G GGFG V + ++ R FA +E E L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
K K+ + ++ +Y G L ++L D F + RF I + YLH + +I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARF-YIACVVLAFEYLHN---RGII 115
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
+RD+K N+L+D++ +L DFG A+ G+ + T GT Y+APE+ S
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNKGYDFSV 173
Query: 531 DVFAYGVLLLEIATGRRPIDSD 552
D ++ G+LL E+ TGR P D
Sbjct: 174 DYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 367 SEVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRLRHKH 404
E +G G FG+VYKG L P +EF E E + L+H +
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNI 450
+V L G C +++ ++++Y+ +G L L N L +I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF---DHGKISHTT 507
IAAG+ YL +HRD+ + N L+ + ++ DFGL+R D+ ++
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS-- 184
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
+ + ++ PE GK + +D++++GV+L EI
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 364 FKQSEVIGTGGFGEV----YKG--------VLP----TRMREFA---AEIESLGRLRHKH 404
F+ + +GTG FG V +KG +L ++++ E L +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
LVNL G + +L LV +Y+P G L S L + F RF + + L YLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQ-VVLALEYLHSL 120
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART- 523
+++RD+K N+L+D+D ++ DFG A+ T + GT Y+APE+ +
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYLAPEIILSK 173
Query: 524 --GKASCSTDVFAYGVLLLEIATGRRPIDSD 552
GKA D +A G+L+ E+ G P D
Sbjct: 174 GYGKAV---DWWALGILIYEMLAGYPPFFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 57/272 (20%)
Query: 370 IGTGGFGEVYKGV--------------------LPTRMREFAAEIESLGRLRHKHLVNLQ 409
+G G FG V KGV + +EF E + +L H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENF----VLSWEQRFNIIKGIAAGLLYLHEEW 465
G CK + L+LV + P G L L + + +A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES-- 113
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELART 523
+ +HRD+ + NVL+ A++ DFG++R G + G + + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRPI----DSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
GK S +DV++YGV L E + G +P ++ V+ G+ L P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGERLP--RPEEC 223
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQV 610
+ + M L C + E RPT ++
Sbjct: 224 PQEIYSIM-------LSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 33/267 (12%)
Query: 362 KGFKQSEVIGTGGFGEV----YKGVL--------PTRMREFAAEIESLGRLRHKHLVNLQ 409
K K + IG G FG+V Y+G + F AE + +LRH +LV L
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 410 G-WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
G + K L +V +Y+ GSL L VL + + + YL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
+HRD+ + NVL+ D A++ DFGL + + T + + + APE R K S
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFST 178
Query: 529 STDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587
+DV+++G+LL EI + GR P I + V+ G +D D G VV +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKGYKMDAPD---GCPPVV--YD 230
Query: 588 LVLQLGLLCSHQKAEARPTMRQVLRYL 614
++ Q C H A RP+ Q+ L
Sbjct: 231 VMKQ----CWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 368 EVIGTGGFGEVYKG-VLPTRM-----------REFAAEIESLGRLRHKHLVNLQGWCKRK 415
E+IG G FG V +G ++ + F E + +L HK+LV L G
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG-VILH 70
Query: 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475
L +V + + G+L + L ++S Q +A G+ YL + ++HRD+
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLA 127
Query: 476 SGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535
+ N+L+ D A++ DFGLAR+ G N + + APE + K S +DV++Y
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183
Query: 536 GVLLLEI-ATGRRP 548
GVLL E+ + GR P
Sbjct: 184 GVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 20/171 (11%)
Query: 384 PTRMREFAAEIESLGRLRHKHLVNLQGWC--KRKRDLLLVYDYIPNGSLDSLL------F 435
+R+F EIE L L+H ++V +G C +R+L LV +Y+P GSL L
Sbjct: 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL 105
Query: 436 DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495
D+ +L Q I G+ YL + +HRD+ + N+L++++ ++GDFGL
Sbjct: 106 DHRKLLLYASQ-------ICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLT 155
Query: 496 RLFDHGKISHTTNVVGT--IGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
++ K + G I + APE K S ++DV+++GV+L E+ T
Sbjct: 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 368 EVIGTGGFGEVYKG--------------------VLPTRMREFAAEIESLGRLRHKHLVN 407
+ +G G FG V +G L M +F E + L H++L+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN--FVLSWEQRFNIIKGIAAGLLYLHEEW 465
L G L++V + P GSL L + F++S + + IA G+ YL
Sbjct: 61 LYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYLES-- 115
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT--NVVGTIGYIAPELART 523
+ IHRD+ + N+L+ +D ++GDFGL R + + ++ + APE RT
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
S ++DV+ +GV L E+ T G P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGV-LPTR----------------MREFAAEIESLGRLRH---K 403
+++ E+IG G +G VY+G +PT + + E+ L +LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 404 HLVNLQG-WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN--IIKGIAAGLLY 460
++ G + K R L ++ +Y GS+ +L+ +++ II+ + L Y
Sbjct: 63 NITKYYGSYLKGPR-LWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKY 116
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
+H+ VIHRD+K+ N+L+ N +L DFG+A L + +T VGT ++APE+
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 521 ARTGKA-SCSTDVFAYGVLLLEIATGRRP 548
GK D+++ G+ + E+ATG P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 32/212 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV---------LPTRMR------------EFAAEIESLGRLRH 402
K+ +V+G+G FG VYKG+ +P ++ EF E + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
HLV L G C + LV +P+G L + ++++ + S + N IA G++YL
Sbjct: 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGS-QLLLNWCVQIAKGMMYLE 126
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG---TIGYIAPE 519
E + ++HRD+ + NVL+ + + ++ DFGLARL + + + N G I ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY--NADGGKMPIKWMALE 181
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT-GRRPID 550
K + +DV++YGV + E+ T G +P D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 68/233 (29%), Positives = 96/233 (41%), Gaps = 78/233 (33%)
Query: 370 IGTGGFGEVYKGVL--PTRMREFAA-------------------EIESLGRLRHKHLVNL 408
IG G +G VYK +E+A EI L L+H+++V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 409 QGWC--KRKRDLLLVYDY-------------------IPNGSLDSLLFDNENFVLSWEQR 447
+ + L++DY IP + SLL+ Q
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----------QI 117
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR----LGDFGLARLFDH--G 501
N G+ YLH W V+HRD+K N+L+ + R +GD GLARLF+
Sbjct: 118 LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 502 KISHTTNVVGTIGYIAPEL---AR--TGKASCSTDVFAYGVLLLEIATGRRPI 549
++ VV TI Y APEL AR T KA D++A G + E+ T PI
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYT-KA---IDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 39/212 (18%)
Query: 369 VIGTGGFGEVYKGV--------------LPT-------RMRE----FAAEIESLGRLRHK 403
+IG+G FG VY G+ LP+ R R A EI L L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF--NIIKGIAAGLLYL 461
++V G L + +Y+P GS+ +LL N ++E+ N ++ I GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYL 122
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-----VVGTIGYI 516
H + +IHRD+K N+L+D ++ DFG+++ + +S TN + G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRP 548
APE+ + + D+++ G L++E+ TG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 57/221 (25%)
Query: 369 VIGTGGFGEVYKGV---------------------LP-TRMREFAAEIESLGRLRHKHLV 406
IG G +G+VYK P T +R EI+ L +L H+++V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQLNHRNIV 69
Query: 407 NLQ----------GWCKRKRDLLLVYDYIPN---GSLDSLLFD-NENFVLSWEQRFNIIK 452
NL+ + K K LV++Y+ + G L+S L +E+ + S +K
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS------FMK 123
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT 512
+ GL Y H ++ +HRD+K N+L++ +L DFGLARL++ + TN V T
Sbjct: 124 QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 513 IGYIAPEL----ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
+ Y PEL R G A DV++ G +L E+ T ++PI
Sbjct: 181 LWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 41/276 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRH 402
+ + EV+G G +G VY G+ + E++ L L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V G C + + +++P GS+ S+L ++ K I G+ YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT--KQILDGVAYLH 119
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD----HGKISHT-TNVVGTIGYIA 517
V+HRD+K NV++ + +L DFG AR HG S+ ++ GT ++A
Sbjct: 120 N---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577
PE+ +D+++ G + E+ATG+ P+ S +D + ++G ++ P L
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS-----MDRLAAMFYIGAHRGLM-PRL 230
Query: 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
S+ A ++ V C + RP+ Q+LR+
Sbjct: 231 PDSFSAAAIDFV----TSCLTRDQHERPSALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 23/179 (12%)
Query: 388 REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDS----------LLFDN 437
++F E E L L+H+H+V G C L++V++Y+ +G L+ +L D
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 438 E----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
+ L Q +I IA+G++YL Q +HRD+ + N L+ A++ ++GDFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFG 168
Query: 494 LARLF---DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
++R D+ ++ T + I ++ PE K + +DV+++GV+L EI T G++P
Sbjct: 169 MSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 36/208 (17%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+K IG G G V+K G+ +RE I++L +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQ 57
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H ++V L +LV +Y+P L +L D E L Q + ++ + G+ Y+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYM 115
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL- 520
H ++HRD+K N+LI AD ++ DFGLARLF + ++ V T Y APEL
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 521 --ARTGKASCSTDVFAYGVLLLEIATGR 546
AR K D++A G + E+ G
Sbjct: 173 YGAR--KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429
I G E G+ T +RE I+ L L+H +++ L K ++ LV++++
Sbjct: 33 IKLGERKEAKDGINFTALRE----IKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TD 87
Query: 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489
L+ ++ +++ VL+ + + GL YLH W ++HRD+K N+LI +D +L
Sbjct: 88 LEKVI-KDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKL 143
Query: 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPEL---ARTGKASCSTDVFAYGVLLLEIATGR 546
DFGLAR F T VV T Y APEL AR D+++ G + E+ R
Sbjct: 144 ADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR--HYGVGVDMWSVGCIFAELLL-R 199
Query: 547 RPI---DSD 552
P DSD
Sbjct: 200 VPFLPGDSD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 53/176 (30%), Positives = 93/176 (52%), Gaps = 20/176 (11%)
Query: 388 REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLF-----------D 436
++F E E L L+H+H+V G C L++V++Y+ +G L+ L
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 437 NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496
N L+ Q +I + IAAG++YL Q +HRD+ + N L+ ++ ++GDFG++R
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
Query: 497 LF---DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
D+ ++ T + I ++ PE K + +DV++ GV+L EI T G++P
Sbjct: 169 DVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA-----------------EIESLGRLRHKHLV 406
++ + IG+G +G+VYK E A EI L RH ++V
Sbjct: 5 YELIQRIGSGTYGDVYKARD-IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G R+ L +V +Y GSL + + LS Q + + GL YLHE
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA---RT 523
IHRD+K N+L+ D + +L DFG++ I+ + +GT ++APE+A R
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 524 GKASCSTDVFAYGVLLLEIATGRRP 548
G D++A G+ +E+A + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 370 IGTGGFGEVY-----------------KGVLPTRMREFAAEIES--LGRLRHKHLVNLQG 410
+G GGFGEV K L R A +E L ++ + +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLF--DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ K DL LV + G L ++ D EN + I +GL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
+I+RD+K NVL+D D N R+ D GLA G+ S T GT G++APEL + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 529 STDVFAYGVLLLEIATGRRP 548
S D FA GV L E+ R P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 49/142 (34%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 415 KRDLLLVYDYIPNGSLDSLLFDNENF-VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
K++L LV +Y+P G L SLL EN L + I I L YLH +IHRD
Sbjct: 65 KKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRD 118
Query: 474 VKSGNVLIDADMNARLGDFGLAR-------LFDHGKISHTTNVVGTIGYIAPELARTGKA 526
+K N+LID++ + +L DFGL++ + + +VGT YIAPE+
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 527 SCSTDVFAYGVLLLEIATGRRP 548
S + D ++ G +L E G P
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 7/150 (4%)
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
LV L + L L+ DY+ G L + L+ E+F S E R I + + A L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA-LDHLHQ- 123
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+I+RD+K N+L+D++ + L DFGL++ F + + GTI Y+APE+ R G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 525 KA--SCSTDVFAYGVLLLEIATGRRPIDSD 552
+ D ++ GVL E+ TG P D
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 60/198 (30%), Positives = 86/198 (43%), Gaps = 24/198 (12%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHK-------------------HLVNLQG 410
+G GGFGEV + + +A + RL+ K +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
+ K L LV + G L +++ L E+ + I G+L+LH ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
+RD+K NVL+D N RL D GLA GK T GT GY+APE+ + S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 531 DVFAYGVLLLEIATGRRP 548
D FA G + E+ GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 61/200 (30%), Positives = 85/200 (42%), Gaps = 35/200 (17%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLRHKHLVN 407
IG G +G V+K R RE EI L +L+H +LVN
Sbjct: 9 IGEGSYGVVFK----CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L +RKR L LV++Y + L+ L + + II + + H+
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHK---H 119
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG--K 525
IHRDVK N+LI +L DFG AR+ + T+ V T Y APEL G +
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELL-VGDTQ 177
Query: 526 ASCSTDVFAYGVLLLEIATG 545
DV+A G + E+ TG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 43/216 (19%)
Query: 365 KQSEVIGTGGFGEVYKGVLPT----------RM---------REFAAEIESLGRL-RHKH 404
K +VIG G FG+V K + RM R+FA E+E L +L H +
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--------------VLSWEQRFNI 450
++NL G C+ + L L +Y P+G+L L + LS +Q +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510
+A G+ YL + + IHRD+ + N+L+ + A++ DFGL+R G+ + +
Sbjct: 130 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTM 182
Query: 511 G--TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
G + ++A E + ++DV++YGVLL EI +
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 368 EVIGTGGFGEVYKGVL---------------PTRMREFAAEIESLGRL-RHKHLVNLQGW 411
EVIG G +G+VYK E E L + H ++ G
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG- 70
Query: 412 CKRKRD-------LLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLH 462
K++ L LV + GS+ L+ + L E I++ GL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE--- 519
E VIHRD+K N+L+ + +L DFG++ D + +GT ++APE
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTFIGTPYWMAPEVIA 186
Query: 520 ----LARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ A DV++ G+ +E+A G+ P
Sbjct: 187 CDEQPDASYDARS--DVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 49/220 (22%)
Query: 370 IGTGGFGEVY----KGVLPTRMR-----------------EFAAEIESLGRLRHKHLVNL 408
+G G FG+V+ +LP + + +F E E L L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 409 QGWCKRKRDLLLVYDYIPNGSL---------DSLLFDNENFV----LSWEQRFNIIKGIA 455
G C R LL+V++Y+ +G L D+ + V L+ Q I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 456 AGLLY---LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF---DHGKISHTTNV 509
+G++Y LH +HRD+ + N L+ + ++GDFG++R D+ ++ T +
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
I ++ PE K + +D++++GV+L EI T G++P
Sbjct: 187 --PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
F + E IG G FGEV+KG+ + + EI L + ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLL----FDNENFVLSWEQRFNIIKGIAAGLLYLH 462
G + L ++ +Y+ GS LL FD Q ++K I GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF-------QIATMLKEILKGLDYLH 118
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
E + IHRD+K+ NVL+ + +L DFG+A +I T VGT ++APE+ +
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQ 174
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
D+++ G+ +E+A G P H
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 364 FKQSEVIGTGGFGEVY------------KGVLPTRM--REFAAEIESLGRLRHKHLVNLQ 409
K + +G G FGEV+ K + P M F AE + L+H LV L
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
++ + ++ +++ GSL L +E + + IA G+ ++ + +
Sbjct: 68 AVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 123
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
IHRD+++ N+L+ A + ++ DFGLAR+ + + + I + APE G +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 530 TDVFAYGVLLLEIAT-GRRP 548
+DV+++G+LL+EI T GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 57/242 (23%), Positives = 113/242 (46%), Gaps = 21/242 (8%)
Query: 378 VYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN 437
V+ G + ++ E++ + R ++V+ G + ++ + +++ GSLD +
Sbjct: 38 VHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--K 95
Query: 438 ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497
+ + E I + GL YL+ ++HRD+K N+L+++ +L DFG++
Sbjct: 96 KGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-- 151
Query: 498 FDHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP-----ID 550
G++ S VGT Y++PE + GK + +DV++ G+ ++E+A G+ P ID
Sbjct: 152 ---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208
Query: 551 SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQV 610
D +L+ Q++ P L SS ++ + C + RPT +Q+
Sbjct: 209 DDGQDDPMGILDLLQ--QIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQL 263
Query: 611 LR 612
Sbjct: 264 CA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 368 EVIGTGGFGEVY--KG---------------VLPTRMREFAA-EIESLGRLRHKHLVNLQ 409
+ IG G FG++Y K +P + +E + E+ L +++H ++V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ L +V +Y G L + + S +Q + I+ GL ++H+ + +
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKI 122
Query: 470 IHRDVKSGNVLIDAD-MNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
+HRD+KS N+ + + M A+LGDFG+AR L D ++++T VGT Y++PE+ + +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYN 180
Query: 528 CSTDVFAYGVLLLEIATGRRPIDSDHF 554
TD+++ G +L E+ T + P + ++
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 368 EVIGTGGFGEVYKG----------------VLPTRMR-EFAAEIESLGRLRHKHLVNLQG 410
E IG G FGEV+ G LP ++ +F E L + H ++V L G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C +K+ + +V + + G + L E L ++ +++ AAG+ YL + I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT-IGYIAPELARTGKASCS 529
HRD+ + N L+ ++ DFG++R + G + T + + + APE G+ S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 530 TDVFAYGVLLLE 541
+DV+++G+LL E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 364 FKQSEVIGTGGFGEV-----------------YKGVLPTRMREFAA--EIESLGRLRHKH 404
F+Q V+G GGFGEV K + R E A E + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+VNL + K L LV + G L +++ N E+ I GL LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
++RD+K N+L+D + R+ D GLA G+ VGT+GY+APE+
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQ 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRP 548
+ + S D + G L+ E+ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 64/280 (22%), Positives = 118/280 (42%), Gaps = 53/280 (18%)
Query: 370 IGTGGFGEVYKGVLP----------------------TRMREFAAEIESLGRLRHKHLVN 407
+G G FG VY+G+ EF E + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLF----DNENF----VLSWEQRFNIIKGIAAGLL 459
L G + L+V + + G L S L + EN + ++ + IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAP 518
YL + +HRD+ + N ++ D+ ++GDFG+ R +++ + + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 519 ELARTGKASCSTDVFAYGVLLLEIAT-GRRP-IDSDHFILVDWVLEFQHLGQVLDVVD-- 574
E + G + +DV+++GV+L E+AT +P + + VL+F G LD+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFVIDGGHLDLPENC 246
Query: 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
P+ +L+L +C + RPT +++ L
Sbjct: 247 PD-----------KLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLR 401
FK + IG G F VYK + R A EI+ L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLL 459
H +++ +L +V + G L ++ F + ++ + + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT---NVVGTIGYI 516
++H + ++HRD+K NV I A +LGD GL R F S TT ++VGT Y+
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGTPYYM 173
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD 558
+PE + +D+++ G LL E+A + P D L
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 60/186 (32%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 364 FKQSEVIGTGGFGEVYKG-------------VLPTRMRE-FAA----EIESLGRLRHKHL 405
+++ IG G FGEV+K VL +E F EI+ L L+H+++
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73
Query: 406 VNLQGWCKRKR--------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAG 457
VNL C+ K LV+++ + L LL N+N + + ++K + G
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNG 131
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVVGTIG 514
L Y+H ++HRD+K+ N+LI D +L DFGLAR F K S TN V T+
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 515 YIAPEL 520
Y PEL
Sbjct: 189 YRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 369 VIGTGGFGEVYKG------------VLPTR-MRE---FAAEIESLGRLRHKHLVNLQGWC 412
V+G G +G VY +P R R EI L+H+++V G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 413 KRKRDLLLVYDYIPNGSLDSLL-------FDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ + +P GSL +LL DNE ++ + K I GL YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT------KQILEGLKYLH--- 125
Query: 466 EQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+ ++HRD+K NVL++ ++ DFG ++ G T GT+ Y+APE+ G
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKG 184
Query: 525 KA--SCSTDVFAYGVLLLEIATGRRP 548
D+++ G ++E+ATG+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 32/201 (15%)
Query: 370 IGTGGFGEVYKGVLPTRMREFA-----------------AEIESLGRLRHKHLVNLQGWC 412
IG+G G VYK + R +A EIE L + H ++V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472
++ ++ +++ GSL+ +E F+ ++ + I +G+ YLH + ++HR
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLA------DVARQILSGIAYLHR---RHIVHR 192
Query: 473 DVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART----GKAS- 527
D+K N+LI++ N ++ DFG++R+ + + VGTI Y++PE T G
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQ-TMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
Query: 528 CSTDVFAYGVLLLEIATGRRP 548
+ D+++ GV +LE GR P
Sbjct: 252 YAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 58/219 (26%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMR---EFAA------------------EIESLGRLRH 402
FKQ E +G G + VYKG R R E A EI + L+H
Sbjct: 2 FKQLEKLGEGTYATVYKG----RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPN------------GSLDSLLFDNENFVLSWEQRFNI 450
+++V L + L+LV++Y+ G+LD ++F + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTV--KSFT------YQL 109
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510
+KGIA + HE V+HRD+K N+LI+ +L DFGLAR F ++ +N V
Sbjct: 110 LKGIA----FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-PVNTFSNEV 161
Query: 511 GTIGYIAPEL---ARTGKASCSTDVFAYGVLLLEIATGR 546
T+ Y AP++ +RT S S D+++ G ++ E+ TGR
Sbjct: 162 VTLWYRAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 20/178 (11%)
Query: 384 PTRMREFA---AEIESLGRLRHKHLVNL--QGWCKRKRDLLLVYDYIPNGSLDSLLFDNE 438
P + A E RL H ++V L G L V++Y+P +L +L +
Sbjct: 16 PEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVL-AAD 73
Query: 439 NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLA 495
L + ++ + L H Q ++HRD+K N+++ +A++ DFG+
Sbjct: 74 G-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 496 RLF------DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRR 547
L D ++ TT V+GT Y APE R + ++D++A+G++ LE TG+R
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRH 402
++ +++G G FGEVY RE A EI+ L LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 403 KHLVNLQGWCKR---KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
+V G C R ++ L + +Y+P GS+ L + +R+ + I G+
Sbjct: 64 DRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT--RQILQGVS 120
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT--TNVVGTIGYIA 517
YLH +++HRD+K N+L D+ N +LGDFG ++ +S T +V GT +++
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRP 548
PE+ DV++ ++E+ T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 43/213 (20%)
Query: 368 EVIGTGGFGEVYKGVL---------PTRM----------REFAAEIESLGRL-RHKHLVN 407
+VIG G FG+V + ++ +M R+FA E+E L +L H +++N
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLL-----------FDNEN---FVLSWEQRFNIIKG 453
L G C+ + L + +Y P G+L L F E+ L+ +Q
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG-- 511
+A G+ YL E + IHRD+ + NVL+ ++ +++ DFGL+R G+ + +G
Sbjct: 128 VATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRL 180
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
+ ++A E + +DV+++GVLL EI +
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRH 402
+++ +++G G FG VY RE AA EI+ L L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 403 KHLVNLQGWCKR---KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
+ +V G C R ++ L + +Y+P GS+ L S +++ + I G+
Sbjct: 64 ERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--RQILEGMS 120
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT--TNVVGTIGYIA 517
YLH +++HRD+K N+L D+ N +LGDFG ++ +S T +V GT +++
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRP 548
PE+ DV++ G ++E+ T + P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 56/221 (25%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+ + E IG G +G VYK GV T +RE I L L+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQ 57
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYI------------PNGSLDSLLFDNENFVLSWEQRFN 449
H ++V LQ ++ L L+++++ +D+ L V S+
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL------VKSY----- 106
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
+ I G+L+ H + V+HRD+K N+LID +L DFGLAR F +T V
Sbjct: 107 -LYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 510 VGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGRRPI 549
V T+ Y APE L + + S D+++ G + E+AT ++P+
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 364 FKQSEVIGTGGFGEV-----------------YKGVLPTRMREFAA--EIESLGRLRHKH 404
F+Q V+G GGFGEV K + R E A E + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V+L + K L LV + G L ++ + I GL LH+E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+++RD+K N+L+D + R+ D GLA G+ VGT+GY+APE+ +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRP 548
+ + S D +A G LL E+ G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 21/232 (9%)
Query: 385 TRMREFAAEIES--LGRLRHKHLVNL-QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV 441
+R AAE E+ L +L+H ++V + W L +V + G L L + + +
Sbjct: 39 SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL 98
Query: 442 LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501
L Q IA L YLHE+ ++HRD+K+ NV + ++GD G+AR+ ++
Sbjct: 99 LPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN- 154
Query: 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS-DHFILVDWV 560
+ + ++GT Y++PEL + +DV+A G + E+AT + ++ D LV +
Sbjct: 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+E + L + P LG ++A M L ++ E RP+++ +LR
Sbjct: 215 IEGK-LPPMPKDYSPELGE--LIATM--------LS--KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 50/218 (22%)
Query: 370 IGTGGFGEVYK----GVLPTR------------------MREFAAEIESLGRLRHKHLVN 407
IG G FG V++ G+LP +F E + H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV--------------------LSWEQR 447
L G C + + L+++Y+ G L+ L LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR---LFDHGKIS 504
I K +AAG+ YL E + +HRD+ + N L+ +M ++ DFGL+R D+ K S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
N I ++ PE + + +DV+AYGV+L EI
Sbjct: 190 E--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 364 FKQSEVIGTGGFGEVY--------KGVL--------PTRMREFAA--EIESLGRLRHKHL 405
+++ V+G G FG V+ K V+ T+ AA E + L L H ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ + L++V +Y P G+L + N +L + I+ LL LH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVH 118
Query: 466 EQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
++++HRD+K+ N+L+D M ++GDFG++++ S VVGT YI+PEL
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDS 551
+ +D++A G +L E+A+ +R ++
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGV---------LPTRMR------------EFAAEIESLGRLRH 402
++ +++G+G FG V+KG+ +P ++ E + ++G L H
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V L G C L LV P GSL + + + L ++ N IA G+ YL
Sbjct: 69 AYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLE 126
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT-IGYIAPELA 521
E ++HR++ + N+L+ +D ++ DFG+A L + + T I ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 522 RTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLE 562
G+ + +DV++YGV + E+ + G P V +LE
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 57/278 (20%)
Query: 368 EVIGTGGFGEVYKG-VLPTRMREFAAEIESLGR-------------------LRHKHLVN 407
VIG G FG VY G ++ + ++ ++SL R H ++++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 408 LQGWCKRKRDL-LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG-------IAAGLL 459
L G C L+V Y+ +G L NF+ S E +K +A G+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL-------RNFIRS-ETHNPTVKDLIGFGLQVAKGME 112
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFD--HGKISHTTNVVGTIGYI 516
YL + +HRD+ + N ++D ++ DFGLAR ++D + + + T + ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 517 APELARTGKASCSTDVFAYGVLLLEIAT-GRRPI-DSDHFILVDWVLEFQHLGQVLDVVD 574
A E +T K + +DV+++GVLL E+ T G P D D F + ++L+ + L Q D
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229
Query: 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
P + ++ L C H K E RPT +++
Sbjct: 230 P-------------LYEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRH 402
+++ +++G G FG VY RE A EI+ L L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 403 KHLVNLQGWCKRKRDLLLVY-DYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAG 457
+ +V G C R + L ++ +Y+P GS+ L E + ++ I G
Sbjct: 64 ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEG 116
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD--HGKISHTTNVVGTIGY 515
+ YLH +++HRD+K N+L D+ N +LGDFG ++ + +V GT +
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
++PE+ DV++ G ++E+ T + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 55/220 (25%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ E IG G +G VYK GV T +RE I L L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELN 56
Query: 402 HKHLVNLQGWCKRKRDLLLVYDY-----------IPNGSLDSLLFDNENFVLSWEQRFNI 450
H ++V L + L LV+++ P LD L ++++ + +
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--KSYL------YQL 108
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510
++GIA Y H V+HRD+K N+LID + +L DFGLAR F ++T VV
Sbjct: 109 LQGIA----YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 511 GTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPI 549
T+ Y APE+ + S D+++ G + E+ RRP+
Sbjct: 162 -TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG-IAAGLLYLHE 463
LV L + L L+ DYI G L + L E F EQ I G I L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHK 123
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+I+RD+K N+L+D++ + L DFGL++ F ++ + GTI Y+AP++ R
Sbjct: 124 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 524 GKASC--STDVFAYGVLLLEIATGRRPIDSD 552
G + D ++ GVL+ E+ TG P D
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 48/253 (18%)
Query: 389 EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV------- 441
+F E++ L RL ++ L G C L ++ +Y+ NG L+ L +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 442 --LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LF 498
LS+ + IA+G+ YL +HRD+ + N L+ + ++ DFG++R L+
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 499 --DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI 555
D+ ++ I ++A E GK + +DV+A+GV L EI T R
Sbjct: 182 SSDYYRVQ--GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ------- 232
Query: 556 LVDWVLEFQHLG--QVLDVVDPNLGSSYVVAEMELVLQ-----------LGLLCSHQKAE 602
++HL QV++ N G + ++ L L L C + E
Sbjct: 233 ------PYEHLTDQQVIE----NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282
Query: 603 ARPTMRQVLRYLN 615
RPT R++ +L
Sbjct: 283 DRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 370 IGTGGFGEVYKG------------VLPTR----MREFAAEIESLGRLRHKHLVNLQGWCK 413
+G G FG+VYK V+ T+ + ++ EIE L H ++V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
L ++ ++ P G++D+++ + + L+ Q I + + L YLH +IHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE--LARTGKAS---C 528
+K+GNVL+ D + +L DFG++ + + + +GT ++APE + T K +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 529 STDVFAYGVLLLEIATGRRP 548
D+++ G+ L+E+A P
Sbjct: 195 KADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
F++ E IG G +G VYK GV T +RE I L L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELN 57
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNG---SLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
H ++V L + L LV++++ +D+ L F +++G+A
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--- 114
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
+ H V+HRD+K N+LI+ + +L DFGLAR F ++T VV T+ Y AP
Sbjct: 115 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 519 ELARTGK-ASCSTDVFAYGVLLLEIATGRR--PIDSD 552
E+ K S + D+++ G + E+ T R P DS+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 63/201 (31%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAA-------------------EIESLGRLRHKHLVNL-- 408
IG G +G VY+ T E A EI L LRH ++V L
Sbjct: 15 IGEGTYGIVYRA-RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 409 --QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G K + LV +Y L SLL DN S Q ++ + GL YLHE +
Sbjct: 74 VVVG--KHLDSIFLVMEYCEQ-DLASLL-DNMPTPFSESQVKCLMLQLLRGLQYLHENF- 128
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGK 525
+IHRD+K N+L+ ++ DFGLAR + T VV T+ Y APE L
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTT 185
Query: 526 ASCSTDVFAYGVLLLEIATGR 546
+ + D++A G +L E+ +
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 43/213 (20%)
Query: 368 EVIGTGGFGEVYKGVL---------PTRM----------REFAAEIESLGRL-RHKHLVN 407
+VIG G FG+V K + + R+FA E+E L +L H +++N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLL-----------FDNEN---FVLSWEQRFNIIKG 453
L G C+ + L L +Y P+G+L L F N LS +Q +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG-- 511
+A G+ YL + + IHRD+ + N+L+ + A++ DFGL+R G+ + +G
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 173
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
+ ++A E + ++DV++YGVLL EI +
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 384 PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRD--LLLVYDYIPNGSLDSLLFDNENFV 441
P ++ E+E + ++V G + + + +Y GSLDS+ V
Sbjct: 40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK----V 95
Query: 442 LSWEQRFN------IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495
R I + + GL YLH + +IHRD+K N+L+ +L DFG++
Sbjct: 96 KKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
Query: 496 RLFDHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
G++ S GT Y+APE + S ++DV++ G+ LLE+A R P +
Sbjct: 153 -----GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 363 GFKQSEVIGTGGFGEVYK-----------------GVLPTRMREFAA-EIESLGRLRHKH 404
FK + +G G +G VYK G + + RE A EI L + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--VLSWEQRFNIIKGIAAGLLYLH 462
+++ + L +V +Y P G L + + ++ ++ + I + GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
E Q ++HRD+KS N+L+ A+ ++GD G++++ K + +GT Y+APE+ +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRP 548
S +D+++ G LL E+AT P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 41/218 (18%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ E IG G +G VYK GV T +RE I L ++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIRE----ISLLKEMQ 59
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIP---NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
H ++V LQ ++ L LV++Y+ +DS +N L + I++GIA
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA--- 116
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
Y H V+HRD+K N+LID NA +L DFGLAR F + T VV T+ Y A
Sbjct: 117 -YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171
Query: 518 PELARTGKA-SCSTDVFAYGVLLLEIATGRR--PIDSD 552
PE+ + S D+++ G + E+ + P DS+
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209
|
Length = 294 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 370 IGTGGFGE-------------VYKGVLPTRMR-----EFAAEIESLGRLRHKHLVNLQGW 411
IG G FG+ V K + ++M E E+ L ++H ++V Q
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471
+ +L +V DY G L + + +Q + I L ++H+ + ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILH 124
Query: 472 RDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTD 531
RD+KS N+ + D +LGDFG+AR+ + + +GT Y++PE+ + +D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRPYNNKSD 183
Query: 532 VFAYGVLLLEIAT 544
++A G +L E+ T
Sbjct: 184 IWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 370 IGTGGFGEVYKG------------VLPTR----MREFAAEIESLGRLRHKHLVNLQGWCK 413
+G G FG+VYK V+ T+ + ++ EI+ L H ++V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ +L ++ ++ G++D+++ + E L+ Q + K L YLHE +IHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHE---NKIIHRD 128
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE--LARTGKA---SC 528
+K+GN+L D + +L DFG++ + I + +GT ++APE + T K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 529 STDVFAYGVLLLEIATGRRP 548
DV++ G+ L+E+A P
Sbjct: 188 KADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 66/231 (28%), Positives = 91/231 (39%), Gaps = 52/231 (22%)
Query: 369 VIGTGGFGEVY-------KGVLPT-RMRE-----------FAAEIESLGRLRHKHLVNLQ 409
VIG G FGEV+ V +R+ AE + L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ + L LV +Y+P G L +LL + F RF I + + A L +
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA----LDSVHKLGF 122
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLA------------------RLFDHGKISHTTN--- 508
IHRD+K N+LIDAD + +L DFGL LF + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 509 -------VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
VGT YIAPE+ R D ++ GV+L E+ G P SD
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 48/279 (17%)
Query: 370 IGTGGFGEVYKGVLPTRMR-------------------EFAAEIESLGRLRHKHLVNLQG 410
IG G FG+V G M F E++ L H +++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK---GIAAGLLYLHEEWEQ 467
C LLV ++ P G L + L N V Q+ + + +A+GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLA--RLFDHGKISHTTNVVGTIGYIAPELA---- 521
IH D+ N + AD++ ++GD+GLA + + I+ + V + ++APEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIRG 178
Query: 522 ---RTGKASCSTDVFAYGVLLLEIAT-GRRPID--SDHFILVDWVLEFQHLGQVLDVVDP 575
+ +++++ GV + E+ T +P SD +L V E Q + + P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-----QDIKLPKP 233
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
L Y E V+Q L E RPT +V L
Sbjct: 234 QLDLKYSDRWYE-VMQFCWLDP----ETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 367 SEVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLV 406
IG G FG+VY+GV P+ +F E + + H H+V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G + + +V + P G L S L N+ L ++ L YL
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLES--- 125
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
+ +HRD+ + NVL+ + +LGDFGL+R + + I ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 527 SCSTDVFAYGVLLLEI 542
+ ++DV+ +GV + EI
Sbjct: 186 TSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 39/99 (39%), Positives = 59/99 (59%), Gaps = 8/99 (8%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR--LFDHGKISHTTNVVG 511
IA GL +LH + +I+RD+K NV++DA+ + ++ DFG+ + +F GK + T G
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTRT--FCG 163
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550
T YIAPE+ S D +A+GVLL E+ G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 8/156 (5%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRK--RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNI 450
EIE L L H+++V +G C + L+ +++P+GSL L N+N + + +Q+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-NLKQQLKY 114
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT--N 508
I G+ YL + +HRD+ + NVL++++ ++GDFGL + + K +T +
Sbjct: 115 AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
+ + + APE K ++DV+++GV L E+ T
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ IG G +G VYK G+ + +RE A ++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFE 59
Query: 402 HKHLVNLQGWC-----KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA 456
H ++V L C R+ L LV++++ + L + L L E ++++ +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
G+ +LH ++HRD+K N+L+ +D ++ DFGLAR++ T+VV T+ Y
Sbjct: 119 GVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYR 173
Query: 517 APE-LARTGKASCSTDVFAYGVLLLEIATGRRPI 549
APE L ++ A+ D+++ G + E+ RRP+
Sbjct: 174 APEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 40/215 (18%)
Query: 370 IGTGGFGEVYKGVL---------PTRM--------------REFAAEIESLGRLRHKHLV 406
+G+G FGEVY+G P R+ +EF E + H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENF---VLSWEQRFNIIKGIAAGLLYL 461
L G C ++ + + G L S L D E F +L+ ++ +I +A G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 462 HEEWEQV-VIHRDVKSGNVLI-----DADMNARLGDFGLAR-LFDHGKISHTTNVVGTIG 514
EQ+ IHRD+ + N L+ DAD ++GDFGLAR ++ + +
Sbjct: 123 ----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 515 YIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
++APE GK + +DV+++GVL+ EI T G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA--------------------EIESLGRLRHK 403
++ + +GTG FG V+ V + A E L + H
Sbjct: 3 LERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
++ L +R L ++ +Y+P G L S L ++ F S F + I L YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-TGLFYASE-IVCALEYLHS 119
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+ +++RD+K N+L+D + + +L DFG A+ T + GT Y+APE+ ++
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVIQS 172
Query: 524 GKASCSTDVFAYGVLLLEIATGRRP 548
+ + D +A G+L+ E+ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQ--GWCKRKRDLL 419
K F+ +G GG+G+V+ + ++ EI +L R++ L L +RD+L
Sbjct: 1 KDFQILTQVGQGGYGQVFLA----KKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55
Query: 420 ----------LVY------------DYIPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAA 456
L+Y +Y+P G +LL N VLS + RF + + A
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEA 113
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
+ LHE IHRD+K N LIDA + +L DFGL++ G +++ +VVG+ Y+
Sbjct: 114 -VDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYM 165
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
APE+ R + D ++ G +L E G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+H L L + K L V +Y+ G L + + F RF + I GL +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RARFYAAE-IVLGLQF 111
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR--LFDHGKISHTTNVVGTIGYIAP 518
LHE + +I+RD+K NVL+D++ + ++ DFG+ + + T+ GT YIAP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP 165
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
E+ + D +A GVLL E+ G+ P + D
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 44/214 (20%)
Query: 368 EVIGTGGFGEVYKGVL-------PTRM---------------REFAAEIESLGRLRHKHL 405
E +G FG+VYKG L T+ EF E RL+H ++
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLF-----------DNENFV---LSWEQRFNII 451
V L G +++ L +++ Y + L L D++ V L +I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF---DHGKISHTTN 508
IAAG+ +L V+H+D+ + NVL+ +N ++ D GL R D+ K+ N
Sbjct: 131 TQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL--MGN 185
Query: 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
+ I +++PE GK S +D+++YGV+L E+
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 11/99 (11%)
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF------DHGKISHTTNVVG 511
LL +H + +IHRD+KS N+L+ ++ +LGDFG ++++ D G+ G
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR-----TFCG 207
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550
T Y+APE+ R S D+F+ GVLL E+ T +RP D
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 364 FKQSEVIGTGGFGEV-------------YKGVLPTRMREFAAEIESLG------RLRHKH 404
F+ V+G GGFGEV K + R+++ E +L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V+L + K L LV + G L +++ N E+ I GL LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+++RD+K N+L+D + R+ D GLA G+ VGT+GY+APE+ +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNE 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRP 548
+ + S D + G L+ E+ G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 36/269 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----LPTRMREFA--------------AEIESLGRLRHKH 404
F+ + IG G F EVY+ +P +++ EI+ L +L H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ +L +V + G L ++ F + ++ + + + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
+ V+HRD+K NV I A +LGD GL R F K + ++VGT Y++PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 179
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD-PNLGSSY 581
+ +D+++ G LL E+A + P D + L + ++ D P L S +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------MNLYSLCKKIEQCDYPPLPSDH 232
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQV 610
E+ QL +C + E RP + V
Sbjct: 233 YSEELR---QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 364 FKQSEVIGTGGFGEVYKG---------------VLPTRMREFAAEIESLGRL-RHKHLVN 407
F+ E++G G +G+VYKG V E EI L + H+++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 408 LQGWCKRKR------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
G +K L LV ++ GS+ L+ + + L E I + I GL +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H+ VIHRD+K NVL+ + +L DFG++ D + +GT ++APE+
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVI 183
Query: 522 RTGKASCST-----DVFAYGVLLLEIATGRRPIDSDH 553
+ +T D+++ G+ +E+A G P+ H
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRH 402
++ +++G G FG VY RE A EI+ L L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 403 KHLVNLQGWCK--RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+ +V G + +R L + +++P GS+ L + +++ + I G+ Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSY 121
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT--TNVVGTIGYIAP 518
LH +++HRD+K N+L D+ N +LGDFG ++ +S T +V GT +++P
Sbjct: 122 LHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRP 548
E+ D+++ G ++E+ T + P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA 456
L +++H ++V + + L +V +Y G L + + + +
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
G+ ++HE + V+HRD+KS N+ + + +LGDFG ARL ++ VGT Y+
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYV 167
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD---HFIL 556
PE+ + +D+++ G +L E+ T + P ++ + IL
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 49/133 (36%), Positives = 68/133 (51%), Gaps = 17/133 (12%)
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTN 508
I I L YLH + VIHRDVK NVLI+ + +L DFG++ L D ++ T +
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTID 163
Query: 509 VVGTIGYIAPEL---ARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564
G Y+APE K +DV++ G+ ++E+ATGR P DS W FQ
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-------WKTPFQ 215
Query: 565 HLGQVLDVVDPNL 577
L QV++ P L
Sbjct: 216 QLKQVVEEPSPQL 228
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 58/289 (20%)
Query: 368 EVIGTGGFGEVYKG------------VLPTRM-------REFA---AEIESLGRL-RHKH 404
+ +G G FG+V K + +M ++ + +E+E + + +HK+
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN------ENFVLSWEQRFNIIK------ 452
++NL G C ++ L +V +Y +G+L L + + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 453 --GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH---TT 507
+A G+ +L + IHRD+ + NVL+ D ++ DFGLAR D I + TT
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTT 192
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL 566
N + ++APE + +DV+++GVLL EI T G P I V+ + +
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG---IPVEELFKLLKE 249
Query: 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
G ++ P + + M C H+ RPT +Q++ L+
Sbjct: 250 GYRME--KPQNCTQELYHLM-------RDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 364 FKQSEVIGTGGFGEVYKG---------------VLPTRMREFAAEIESLGRL-RHKHLVN 407
F+ EV+G G +G+VYKG V E EI L + H+++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 408 LQGWCKRKR------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
G +K L LV ++ GS+ L+ + + L + I + I GL +L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H VIHRD+K NVL+ + +L DFG++ D + +GT ++APE+
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVI 193
Query: 522 RTGKASCST-----DVFAYGVLLLEIATGRRPIDSDH 553
+ +T D+++ G+ +E+A G P+ H
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEI----ESLGR-----LRHKHLVNLQGWCK- 413
F+ +VIG G FGEV + R +A +I E L R R + V + G C+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 414 ---------RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+ L LV DY G L +LL E+ + RF I A +L +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----AEMVLAIHSI 118
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFG-LARLFDHGKISHTTNVVGTIGYIAPELART 523
+ +HRD+K NVL+D + + RL DFG ++ G + + VGT YI+PE+ +
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGTPDYISPEILQA 177
Query: 524 -----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI 555
GK D ++ GV + E+ G P ++ +
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 46/164 (28%), Positives = 86/164 (52%), Gaps = 23/164 (14%)
Query: 393 EIESLGRLRHKHLVNLQ----GWCKRKRDLLLVYDYIPNGSLDSLLFDN-ENFVLSWEQR 447
EI L +L+H ++V ++ G + +V +Y+ + L SL+ + F+ S +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS--EV 108
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR----LGDFGLARLFDHGKI 503
++ + +G+ +LH+ W ++HRD+K+ N+L +N R + DFGLAR +
Sbjct: 109 KCLMLQLLSGVAHLHDNW---ILHRDLKTSNLL----LNNRGILKICDFGLAREYGSPLK 161
Query: 504 SHTTNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
+T VV T+ Y APE L + S + D+++ G + E+ T +
Sbjct: 162 PYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAAEIESLGR----------------------LRHKHL 405
+V+G G FG+V L + FA +++L + + L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFA--VKALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGLL 459
+L + K L V +++ G L F + + RF++ + I GL
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDL--------MFHIQDKGRFDLYRATFYAAEIVCGLQ 110
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+LH + +I+RD+K NV++D D + ++ DFG+ + G + + GT YIAPE
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPE 166
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
+ + K + S D +++GVLL E+ G+ P D
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 51/281 (18%)
Query: 369 VIGTGGFGEVYKGV----------LPTRMR------------EFAAEIESLGRLRHKHLV 406
+G G FGEVY+G+ L ++ +F E + + H+++V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN-----FVLSWEQRFNIIKGIAAGLLYL 461
L G + ++ + + G L S L +N L+ + + +A G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 462 HEEWEQVVIHRDVKSGNVLID---ADMNARLGDFGLARLF---DHGKISHTTNVVGTIGY 515
E IHRD+ + N L+ A++ DFG+AR + + + I +
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML--PIKW 187
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEI-ATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574
+ PE G + TDV+++GVLL EI + G P V+EF G LD
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVMEFVTGGGRLDPPK 244
Query: 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
G Y ++ C E RP +L +
Sbjct: 245 GCPGPVY---------RIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 7/158 (4%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
EI+ L + H+ ++NL + K + +V +P D + + + L EQ I +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVG 511
+ L YLH + +IHRDVK+ N+ +D NA LGDFG A +L H G
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
T+ +PEL TD+++ G++L E++ +
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 362 KGFKQSEVIGTGGFGEVY-----------------KGVLPTR--MREFAAEIESLGRLRH 402
K F ++G G FGEV K VL + + F E + L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+ LQ + K +L LV +Y P G L SLL E+ +F + + + A +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----IH 116
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
+ +HRD+K NVLID + +L DFG A K+ ++ VGT YIAPE+
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 523 T--GKASCSTDV----FAYGVLLLEIATGRRPIDSD 552
T G + V ++ GV+ E+ GR P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 10/138 (7%)
Query: 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV 474
K L LV +Y+ G SL+ W +++ I + G+ LH+ +IHRD+
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDI 123
Query: 475 KSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFA 534
K N+LID + +L DFGL+R K VGT Y+APE +D ++
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 535 YGVLLLEIATGRRPIDSD 552
G ++ E G P ++
Sbjct: 179 LGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 46/139 (33%), Positives = 72/139 (51%), Gaps = 16/139 (11%)
Query: 415 KRDLLLVYDYIPNGSL-----DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
K L V +Y+ G L S FD RF + I GL +LH++ +
Sbjct: 68 KEHLFFVMEYLNGGDLMFHIQSSGRFDEA------RARFYAAE-IICGLQFLHKKG---I 117
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
I+RD+K NVL+D D + ++ DFG+ + +G+ + GT YIAPE+ + K + S
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNES 176
Query: 530 TDVFAYGVLLLEIATGRRP 548
D +++GVLL E+ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAAGLLY 460
H LV L + + L V +++ G L + L E RF + I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNF 111
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
LHE + +I+RD+K NVL+DA+ + +L D+G+ + T+ GT YIAPE+
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEI 167
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPID 550
R S D +A GVL+ E+ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 6/146 (4%)
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
LV L + L LV +Y+ G L + L E I L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHE- 114
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+ +I+RD+K NVL+DAD + +L D+G+ + G T+ GT YIAPE+ R
Sbjct: 115 --RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 525 KASCSTDVFAYGVLLLEIATGRRPID 550
+ S D +A GVL+ E+ GR P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG-IAAGLLYLHE 463
LV L + + L L+ DY+ G + + L+ +NF E G I L +LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLHK 123
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+++RD+K N+L+D++ + L DFGL++ F + T + GTI Y+APE+ R
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 524 ----GKASCSTDVFAYGVLLLEIATGRRP 548
GKA D ++ G+L+ E+ TG P
Sbjct: 181 KGGHGKA---VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 9/167 (5%)
Query: 384 PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
P + E++ L ++V G ++ + +++ GSLD +L + +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGK 502
+ +I + GL YL E+ + ++HRDVK N+L+++ +L DFG++ +L D
Sbjct: 104 ILGKVSI--AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156
Query: 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
S + VGT Y++PE + S +D+++ G+ L+E+A GR PI
Sbjct: 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 35/101 (34%), Positives = 60/101 (59%), Gaps = 7/101 (6%)
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTN 508
I + GL YL E+ + ++HRDVK N+L+++ +L DFG++ +L D S +
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANS 157
Query: 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
VGT Y++PE + + +D+++ G+ L+E+A GR PI
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 34/261 (13%)
Query: 387 MREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL----------- 434
+ + +E+E + + +HK+++NL G C + L ++ +Y G+L L
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 435 FDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491
FD L+++ + +A G+ YL Q IHRD+ + NVL+ D ++ D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIAD 177
Query: 492 FGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPI 549
FGLAR + + TTN + ++APE + +DV+++GVLL EI T G P
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
Query: 550 DSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQ 609
I V+ + + G +D + E+ ++++ C H RPT +Q
Sbjct: 238 PG---IPVEELFKLLKEGHRMD------KPANCTHELYMIMR---ECWHAVPSQRPTFKQ 285
Query: 610 VLRYLNGDELLPIIDNWSSLD 630
++ L D +L + LD
Sbjct: 286 LVEDL--DRVLTVTSTDEYLD 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 346 LDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHL 405
L C H+ + A K FK SE EV + T +RE ++ L L+ +++
Sbjct: 18 LKCRHK--ETKEIVAIKKFKDSE-----ENEEVKE----TTLRE----LKMLRTLKQENI 62
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V L+ +R+ L LV++Y+ L+ LL + N V + R I + I A +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKA----IHWCH 117
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+ ++HRD+K N+LI + +L DFG AR G ++ T V T Y +PEL
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 526 ASCSTDVFAYGVLLLEIATGR 546
+ D+++ G +L E++ G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------I 454
+H L L + K L V +Y+ G L F + ++F+ + +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDL--------MFQIQRSRKFDEPRSRFYAAEV 105
Query: 455 AAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTI 513
L++LH VI+RD+K N+L+DA+ + +L DFG+ + +G TT GT
Sbjct: 106 TLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTP 160
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
YIAPE+ + + S D +A GVL+ E+ G+ P ++D+
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
FK+ +V+G+G FG VYKG+ P +E E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
H+ L G C + L+ +P G L + ++++ + S + N IA G+ YL
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYLE 126
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD-HGKISHTTNVVGTIGYIAPELA 521
E + ++HRD+ + NVL+ + ++ DFGLA+L K H I ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 522 RTGKASCSTDVFAYGVLLLEIAT-GRRPID 550
+ +DV++YGV + E+ T G +P D
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 40/212 (18%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
E +G FG++YKG L P + EF E + L H ++V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLF------------DNENFV---LSWEQRFNII 451
L G +++ + ++++Y+ G L L D + V L +I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVV 510
IAAG+ YL + +H+D+ + N+LI ++ ++ D GL+R ++ +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
I ++ PE GK S +D++++GV+L EI
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 32/205 (15%)
Query: 369 VIGTGGFGEVYKG-----------------VLPTR-----MREFAAEIESLGRLRHKHLV 406
+G G FGEV+ L EF E++ +L HK++V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV-------LSWEQRFNIIKGIAAGLL 459
L G C+ ++ +Y G L L ++ LS +Q+ + IA G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+L +HRD+ + N L+ + ++ L++ + + N + + ++APE
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT 544
+ S +DV+++GVL+ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 382 VLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL------- 434
V T +F EI+ + RL++ +++ L G C L ++ +Y+ NG L+ L
Sbjct: 56 VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES 115
Query: 435 -FDNENFV--LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491
F + N + +S + IA+G+ YL +HRD+ + N L+ ++ D
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIAD 172
Query: 492 FGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
FG++R L+ V I ++A E GK + ++DV+A+GV L E+ T
Sbjct: 173 FGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H LV L + + L V +Y+ G L + L E I+ L YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV-VGTIGYIAPEL 520
HE + +I+RD+K NVL+D++ + +L D+G+ + + + TT+ GT YIAPE+
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI 167
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPID 550
R S D +A GVL+ E+ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 46/272 (16%)
Query: 370 IGTGGFGEVYKGVL--PT----------------RMREFAAEIESLGRLRHKHLVNLQGW 411
+G G +G VYK VL PT + + E++ L + ++V+ G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA----GLLYLHEEWEQ 467
+ + + +Y+ GSLD L E ++++ I GL +L EE
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE---DVLRRITYAVVKGLKFLKEEHN- 123
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA- 526
+IHRDVK NVL++ + +L DFG++ ++ T +G Y+APE ++G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-ASLAKTN--IGCQSYMAPERIKSGGPN 179
Query: 527 -----SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581
+ +DV++ G+ +LE+A GR P + + + F L ++D P L S Y
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-----FAQLSAIVDGDPPTLPSGY 234
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
+ V C ++ RPT Q+L +
Sbjct: 235 SDDAQDFV----AKCLNKIPNRRPTYAQLLEH 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 362 KGFKQSEVIGTGGFGEVY--------KGVLPTRM-----------REFAAEIESLGRLRH 402
K F IG G FG VY + V +M ++ E+ L +LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+ + +G R+ LV +Y + D L + L + + G GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+IHRDVK+GN+L+ +LGDFG A + ++ VGT ++APE+
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVIL 184
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
G+ DV++ G+ +E+A + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
I+ GL +LH + +I+RD+K NV++D++ + ++ DFG+ + ++ T GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT-TRTFCGTP 165
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
YIAPE+ S D +AYGVLL E+ G+ P D +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 364 FKQSEVIGTGGFGEV-----------------YKGVLPTRMREFAA--EIESLGRLRHKH 404
F+ V+G GGFGEV K + R E A E L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V+L + K L LV + G L +++ N ++ + GL L E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+++RD+K N+L+D + R+ D GLA G+ VGT+GY+APE+
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRP 548
K + S D + G L+ E+ G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKH 404
F+ + IG G F EVY+ + A EI+ L +L H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ +L +V + G L ++ F + ++ + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
+ V+HRD+K NV I A +LGD GL R F K + ++VGT Y++PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 179
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
+ +D+++ G LL E+A + P D
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFA-----------------AEIESLGRLRHKHLVNLQG 410
E++G G G VYK R A +E+E L + +++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
+ + + +++ GSLD E+ VL I + GL YL W ++
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEH-VLG-----RIAVAVVKGLTYL---WSLKIL 117
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
HRDVK N+L++ +L DFG++ + S VGT Y+APE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 531 DVFAYGVLLLEIATGRRP 548
DV++ G+ +E+A GR P
Sbjct: 175 DVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H+++VNL G C +L++ +Y G L + L L+ E + +A G+ +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT------IGY 515
+ IHRD+ + NVL+ ++ DFGLAR I + +N V + +
Sbjct: 158 AS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKW 209
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEI 542
+APE + +DV++YG+LL EI
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 44/121 (36%), Positives = 70/121 (57%), Gaps = 12/121 (9%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF--DHGKIS-HTTNVV 510
I GL Y+H V+HRD+K GN+L++AD ++ DFGLAR F + G+ + T V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 511 GTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569
T Y APE+ + ++ + + DV++ G +L E+ GR+P+ F D+V + + QV
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV----FKGKDYVDQLNQILQV 225
Query: 570 L 570
L
Sbjct: 226 L 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
K+ +V+G+G FG VYKG+ P +E E + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ L G C + LV +P G L + +N++ + S + N IA G+ YL
Sbjct: 69 PYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGS-QDLLNWCVQIAKGMSYLE 126
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELA 521
E ++HRD+ + NVL+ + + ++ DFGLARL D + H I ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 522 RTGKASCSTDVFAYGVLLLEIAT-GRRPIDS 551
+ + +DV++YGV + E+ T G +P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 45/211 (21%)
Query: 368 EVIGTGGFGEVYKG--------VLPTRMR---------EFAA-EIESLGRLRHKHLVNLQ 409
E IG G +G V+K V R+R A EI L L+HK++V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 410 GWCKRKRDLLLVYDYIP----------NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
+ L LV++Y NG +D V S+ F ++KG+A
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP------EIVKSF--MFQLLKGLA---- 113
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ H V+HRD+K N+LI+ + +L DFGLAR F ++ VV T+ Y P+
Sbjct: 114 FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPD 169
Query: 520 LARTGKA-SCSTDVFAYGVLLLEIATGRRPI 549
+ K S S D+++ G + E+A RP+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 368 EVIGTGGFGEVYK------GVLPTRMREFAAEIESLGR---------------------- 399
E +G+G FG VYK G ++E + G+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL----DSLLFDNENFVLSWEQRFNIIKGIA 455
LRH ++V L +V D I L +SL + F + E+ +NI +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIWNIFVQMV 123
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
L YLH+E + ++HRD+ N+++ D + DFGLA+ S T+VVGTI Y
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551
PE+ + DV+A+G +L ++ T + P S
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 46/129 (35%), Positives = 66/129 (51%), Gaps = 17/129 (13%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGT 512
I L YL E+ VIHRDVK N+L+DA N +L DFG++ RL D + T + G
Sbjct: 123 IVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD--SKAKTRS-AGC 177
Query: 513 IGYIAPEL----ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568
Y+APE K DV++ G+ L+E+ATG+ P + EF+ L +
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTK 230
Query: 569 VLDVVDPNL 577
+L P+L
Sbjct: 231 ILQEEPPSL 239
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGL 458
+ + + L + +L+ DYI +G LFD E + E + II+ + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVK-KIIRQLVEAL 122
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMN-ARLGDFGLARLFDHGKISHTTNVV-GTIGYI 516
LH + +IH D+K NVL D + L D+GL KI T + GT+ Y
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC------KIIGTPSCYDGTLDYF 173
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+PE + S D +A GVL E+ TG+ P D
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 39/241 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEI----ESLGRLR---------------HKH 404
F+ +VIG G FGEV L + FA +I E L R ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA--GLLYLH 462
+ L + + +L LV DY G L +LL E+ + RF + + + A + LH
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFG-LARLFDHGKISHTTNVVGTIGYIAPELA 521
+HRD+K N+L+D + + RL DFG +L + G + + VGT YI+PE+
Sbjct: 123 ------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEIL 175
Query: 522 RT-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-----LVDWVLEFQHLGQVLD 571
+ GK D ++ GV + E+ G P ++ + +++ FQ QV D
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 572 V 572
V
Sbjct: 236 V 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 34/256 (13%)
Query: 387 MREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL----------- 434
+ + +E+E + + +HK+++NL G C + L ++ +Y G+L L
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 435 ---FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491
LS++ + +A G+ YL + IHRD+ + NVL+ D ++ D
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIAD 183
Query: 492 FGLARLFDH-GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPI 549
FGLAR H TTN + ++APE + +DV+++GVLL EI T G P
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 550 DSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQ 609
+ V+ + + G +D S E+ ++++ C H RPT +Q
Sbjct: 244 PG---VPVEELFKLLKEGHRMD------KPSNCTNELYMMMR---DCWHAVPSQRPTFKQ 291
Query: 610 VLRYLNGDELLPIIDN 625
++ L D +L + N
Sbjct: 292 LVEDL--DRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 389 EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL-------------- 434
+F E++ L RL+ +++ L G C + L ++ +Y+ NG L+ L
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 435 ---FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491
+ +S+ ++ IA+G+ YL +HRD+ + N L+ ++ ++ D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 492 FGLAR-LF--DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
FG++R L+ D+ +I V I ++A E GK + ++DV+A+GV L EI
Sbjct: 182 FGMSRNLYAGDYYRIQ--GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 50/225 (22%)
Query: 364 FKQSEVIGTGGFGEVYKGVLP---------------------TRMREFAAEIESLGRLRH 402
K +++G G FG V +G L + + EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 403 KHLVNLQGWCKRKRDL------LLVYDYIPNGSLDSLLFDN------ENFVLSWEQRFNI 450
+++ L G C L +++ ++ +G L S L + E L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 451 IKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR------LFDHGKIS 504
IA G+ YL + IHRD+ + N ++ DM + DFGL++ + G+I+
Sbjct: 121 --DIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+ +IA E + +DV+A+GV + EIAT G+ P
Sbjct: 176 KM-----PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNL------------QGWC---- 412
+IG GGFGEVY + +A + R++ K L G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 413 ------KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L + D + G L L + F E RF + I GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-EMRFYATE-IILGLEHMHNRF- 117
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
V++RD+K N+L+D + R+ D GLA F K H + VGT GY+APE+ + G A
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYMAPEVLQKGTA 172
Query: 527 -SCSTDVFAYGVLLLEIATGRRP 548
S D F+ G +L ++ G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 39/209 (18%)
Query: 368 EVIGTGGFGEVYKG-------------------VLPTRMREF------AAEIESLGRLRH 402
E +G G F +++KG VL R + AA + S +L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMS--QLSH 58
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV-LSWEQRFNIIKGIAAGLLYL 461
KHLV G C + ++V +Y+ GSLD+ L N+N + +SW + + K +A L +L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIA 517
++ + H +V + NVL+ + + + G+ +L D G IS T ++ I ++
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG-ISITVLPKEILLERIPWVP 172
Query: 518 PELARTGKA-SCSTDVFAYGVLLLEIATG 545
PE + S + D +++G L EI +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 65/258 (25%), Positives = 119/258 (46%), Gaps = 38/258 (14%)
Query: 387 MREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL----------- 434
+ + +E+E + + +HK+++NL G C + L ++ +Y G+L L
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 435 FDNENFV---LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491
+D ++++ + +A G+ YL Q IHRD+ + NVL+ + ++ D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIAD 180
Query: 492 FGLARLFDHGKISH---TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRR 547
FGLAR D I + TTN + ++APE + +DV+++GVL+ EI T G
Sbjct: 181 FGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238
Query: 548 PIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTM 607
P I V+ + + G +D + E+ ++++ C H RPT
Sbjct: 239 PYPG---IPVEELFKLLKEGHRMD------KPANCTNELYMMMR---DCWHAIPSHRPTF 286
Query: 608 RQVLRYLNGDELLPIIDN 625
+Q++ L D +L + N
Sbjct: 287 KQLVEDL--DRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
IA GL +LH + +I+RD+K NV++D++ + ++ DFG+ + ++ T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT-TKTFCGTP 165
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
YIAPE+ S D +A+GVLL E+ G+ P + +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 362 KGFKQSEVIGTGGFGEVY--------KGVLPTRM-----------REFAAEIESLGRLRH 402
K F IG G FG VY + V +M ++ E++ L R++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+ + +G R+ LV +Y + D L + L + I G GL YLH
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+IHRD+K+GN+L+ +L DFG A + S + VGT ++APE+
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVIL 194
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
G+ DV++ G+ +E+A + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 29/211 (13%)
Query: 368 EVIGTGGFGEV----YKGVLPTRMREFAAEIESLGRLRHKHLVN-------------LQG 410
+VIG G FGEV +K + ++ E + R +Q
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 411 WCKRKRD--LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+C + D L +V +Y+P G L +L+ N + W + + A +L L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHSMG 162
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART----G 524
+IHRDVK N+L+D + +L DFG D + VGT YI+PE+ ++ G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDHFI 555
D ++ GV L E+ G P +D +
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IA 455
H L +L + K +L V +Y+ G L F + +F++ + I
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDL--------MFHIQSCHKFDLPRATFYAAEII 106
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
GL +LH + +++RD+K N+L+D D + ++ DFG+ + G + T GT Y
Sbjct: 107 CGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDY 162
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
IAPE+ K + S D +++GVLL E+ G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 368 EVIGTGGFGEVY--------------------KGVLPTRMR-EFAAEIESLGRLRHKHLV 406
+V+G G FG+V+ K L R R E + L + H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L + + L L+ D++ G L + L E + +F + + +A L +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE-LALALDHLHS--- 116
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGK 525
+I+RD+K N+L+D + + +L DFGL++ DH K + GT+ Y+APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 174
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
+ S D +++GVL+ E+ TG P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 46/167 (27%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 384 PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
P + E++ L ++V G ++ + +++ GSLD +L
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 103
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGK 502
+ +I + GL YL E+ + ++HRDVK N+L+++ +L DFG++ +L D
Sbjct: 104 ILGKVSI--AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156
Query: 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
S + VGT Y++PE + S +D+++ G+ L+E+A GR PI
Sbjct: 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV------------------LPTRMREFAAEIESLGRLRHKHL 405
+K E IG+G +G V + +PT + E++ L +H ++
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 406 VNLQGWCKRK----RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
+ ++ + +D+ +V D + + L ++ ++ + F + + GL Y+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYI 123
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVVGTIGYIAP 518
H VIHRD+K N+L++ D R+GDFG+AR H T V T Y AP
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 519 ELART-GKASCSTDVFAYGVLLLEIATGRRPI 549
EL + + + + D+++ G + E+ GRR +
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV----VGTIGY 515
Y+H VIHRD+K N+L+++D +L DFGLAR + + V V T Y
Sbjct: 122 YIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 516 IAPE--LARTGKASCSTDVFAYGVLLLEIATGR 546
APE L T + + D+++ G +L E+ G+
Sbjct: 179 RAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 35/202 (17%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAA--------------------EIESLGRLRHKHLVNLQ 409
IG G FG VY R E A E+ L +LRH + + +
Sbjct: 23 IGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G R+ LV +Y + D + + L + I G GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHS---HER 136
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE--LAR-TGKA 526
IHRD+K+GN+L+ +L DFG A L +S + VGT ++APE LA G+
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 527 SCSTDVFAYGVLLLEIATGRRP 548
DV++ G+ +E+A R+P
Sbjct: 192 DGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 37/215 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA------------EIESL----------GRLR 401
F+ V+G G FG+V +A E+ESL R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA----G 457
H LVNL + + + V +Y G D ++ + + F AA G
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVF-----YAACVVLG 113
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
L YLHE +++RD+K N+L+D + ++ DFGL + G T+ GT ++A
Sbjct: 114 LQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLA 169
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
PE+ + + D + GVL+ E+ G P D
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL-----------FDNENF---VLSWEQ 446
+HK+++NL G C ++ L ++ +Y G+L L FD LS++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISH 505
+ +A G+ YL + IHRD+ + NVL+ D ++ DFGLAR + D
Sbjct: 136 LVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
T+N + ++APE + +DV+++G+L+ EI T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 39/152 (25%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+H+++V + +L ++ +++ G+L ++ L+ EQ + + + L Y
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCY 132
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
LH Q VIHRD+KS ++L+ D +L DFG + ++VGT ++APE+
Sbjct: 133 LHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPYWMAPEV 188
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
D+++ G++++E+ G P SD
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 17/160 (10%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLV---YDYIPNGSLDSLLFDN----ENFVLSWE 445
EI +LGRL H++++ ++ + + + ++ YD+ L S ++D ++ L +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQ 268
Query: 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505
R I+K + + Y+H+ + +IHRD+K N+ ++ D LGDFG A F+ + +
Sbjct: 269 TR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 506 TTNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIAT 544
VGT+ +PE LA G TD+++ G++LL++ +
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
I + L++LH++ +I+RD+K NVL+D + + +L DFG+ + + T+ GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-TSTFCGTP 160
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
YIAPE+ + S D +A GVLL E+ G P +++
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 72/255 (28%), Positives = 101/255 (39%), Gaps = 76/255 (29%)
Query: 364 FKQSEVIGTGGFGEVY------------------KGVLPTRMREFAAEIES----LGRLR 401
F + + IG G FGEV VL MR AA +++ L
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEAD 59
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
++ +V L + K +L V DYIP G + SLL F RF I + + + +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIAE-LTCAIESV 117
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD-------HGKISHTT------- 507
H+ IHRD+K N+LID D + +L DFGL F + K H
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 508 ----------------------------NVVGTIGYIAPE-LARTG-KASCSTDVFAYGV 537
++VGT YIAPE L RTG C D ++ GV
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWSVGV 232
Query: 538 LLLEIATGRRPIDSD 552
+L E+ G+ P +D
Sbjct: 233 ILYEMLVGQPPFLAD 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL---FDNENFVLSWEQRFN 449
E+ L L+H ++V L +R L LV++Y LDS L DN ++S
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKI 107
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
+ + GL Y H+ + ++HRD+K N+LI+ +L DFGLAR +++ V
Sbjct: 108 FMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164
Query: 510 VGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
V T+ Y P+ L + + S D++ G +L E+ATGR
Sbjct: 165 V-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAA-----EIESLGR------------LRHKH 404
+ F +VIG G FGEV + V ++ A + E + R + H +
Sbjct: 43 EDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 405 ---LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
+V L + + L +V +Y+P G L +L+ N + W RF + + A L +
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKW-ARFYTAEVVLA-LDAI 158
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H IHRDVK N+L+D + +L DFG D + VGT YI+PE+
Sbjct: 159 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 522 RT----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI 555
++ G D ++ GV L E+ G P +D +
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 54/217 (24%)
Query: 364 FKQSEVIGTGGFGEV----------YKGVLPTRMREF---------AAEIESLGRLRHKH 404
F+ E +GTG FG V Y + + RE A E L L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL-----FDNE-------NFVLSWEQRFNIIK 452
+VN+ + + + + +++ G L + L F N+ VL++E
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------- 132
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT-NVVG 511
YLH + +I+RD+K N+L+D + ++ DFG A+ K+ T + G
Sbjct: 133 -------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
T Y+APE+ ++ + D + GVLL E G P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 350 HRFRYSDLYTATKGFKQSEVIGTGGFGEV----YKG--VLPTRMREFA------------ 391
++ +Y D F +GTG FG V YK P ++ F
Sbjct: 25 NKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 392 --AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN 449
+E + L + H VNL G K + L LV +++ G + L N+ F N
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP-------N 130
Query: 450 IIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507
+ A + L E+ Q +++RD+K N+L+D D ++ DFG A++ D + T
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTY 186
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV 557
+ GT YIAPE+ + D + G+ + EI G P ++ +L+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 66/276 (23%), Positives = 121/276 (43%), Gaps = 51/276 (18%)
Query: 370 IGTGGFGEVYKGVLP--------TR-----------MRE---FAAEIESLGRLRHKHLVN 407
+G G FG VY+G+ TR MRE F E + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLF----DNENFVL----SWEQRFNIIKGIAAGLL 459
L G + + L++ + + G L S L + EN + S ++ + IA G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAP 518
YL+ +HRD+ + N ++ D ++GDFG+ R +++ + + +++P
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 519 ELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD--P 575
E + G + +DV+++GV+L EIAT +P + + VL F G +LD D P
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---MSNEQVLRFVMEGGLLDKPDNCP 247
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVL 611
+++ +L +C + RP+ +++
Sbjct: 248 -----------DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 369 VIGTGGFGEVYKG------------VLP---TRMREFAAEIES-----LGRLRHKHLVNL 408
VIG G FG+V VL ++ I + L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ L V DY+ G L L E RF + IA+ L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAE-IASALGYLHS---LN 116
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
+I+RD+K N+L+D+ + L DFGL + T+ GT Y+APE+ R
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 529 STDVFAYGVLLLEIATGRRPIDS-DHFILVDWVL 561
+ D + G +L E+ G P S D + D +L
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 369 VIGTGGFGEVY-------------KGVLPTRMREFAAEIESLGRLRHKHLVNLQGWC--- 412
+IG GGFGEVY K + R++ E +L LV+ G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFI 59
Query: 413 -------KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
L + D + G L L + F + E RF + I GL ++H +
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRFYAAE-IILGLEHMHNRF 117
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
V++RD+K N+L+D + R+ D GLA F K H + VGT GY+APE+ + G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYMAPEVLQKGV 171
Query: 526 A-SCSTDVFAYGVLLLEIATGRRP 548
A S D F+ G +L ++ G P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHL 405
K + + E IG G G VY + +E A EI + +H ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
VN +L +V +Y+ GSL ++ + + Q + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS-- 133
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
VIHRD+KS N+L+ D + +L DFG + +T +VGT ++APE+
Sbjct: 134 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++ +E+ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 370 IGTGGFGEVYKGVLPTRMR-------------------EFAAEIESLGRLRHKHLVNLQG 410
+G+G FG V KGV R + E E E + +L + ++V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C+ + L+LV + G L+ L ++ ++ ++ ++ G+ YL + +
Sbjct: 63 VCEAE-ALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELARTGKASC 528
HRD+ + NVL+ A++ DFGL++ + G + + APE K S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 529 STDVFAYGVLLLE-IATGRRP 548
+DV++YG+ + E + G++P
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 49/235 (20%)
Query: 370 IGTGGFGEVYK-----------------------GVLPTRMREFAAEIESLGRLRHKHLV 406
IG G +G+V+K G+ + +RE A + L H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67
Query: 407 NLQGWCK-----RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
L C R+ L LV++++ + L + L + E +++ + GL +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H V+HRD+K N+L+ + +L DFGLAR++ T+VV T+ Y APE+
Sbjct: 127 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 181
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPI---DSDHFILVDWVLEFQHLGQVLDVV 573
+ D+++ G + E+ R+P+ SD VD LG++LDV+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSD----VD------QLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
E+ L L+H ++V L ++ L LV++Y+ + L L D N + + + +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT 512
+ GL Y H + V+HRD+K N+LI+ +L DFGLAR +++ VV T
Sbjct: 113 -LLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-T 167
Query: 513 IGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
+ Y P+ L + S D++ G + E++TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGTIGYI 516
L YL EE + +IHRDVK N+L+D + N +L DFG++ +L D I+ T + G Y+
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRD-AGCRPYM 174
Query: 517 APE-LARTGKAS--CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573
APE + + + +DV++ G+ L E+ATG+ P W F L QV+
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-------WNSVFDQLTQVVKGD 227
Query: 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARP 605
P L +S + LC + RP
Sbjct: 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 9e-10
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 57/219 (26%)
Query: 369 VIGTGGFGEVYKGV--------------LPTRMREFAA----EIESLGRLRHKHLVNLQG 410
IG+G +G V V A EI+ L LRH++++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL-- 64
Query: 411 WCKRKRDLL------------LVYDYIPNGSLDSLLFDNENFVLSWEQRF--NIIKGIAA 456
D+L +V + + L ++ + Q F I++G
Sbjct: 65 -----LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG--- 115
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF--DHGKISHTTNVVGTIG 514
L YLH VIHRD+K N+L++++ + ++ DFGLAR D + T V T
Sbjct: 116 -LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 515 YIAPEL----ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
Y APEL +R KA D+++ G + E+ T R+P+
Sbjct: 172 YRAPELLLSSSRYTKA---IDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA-----------------EIESLGRLRHKHLV 406
F+ + IG+G +G+VYK E AA EI + +H ++V
Sbjct: 11 FELIQRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G R+ L + ++ GSL + + LS Q + + GL YLH + +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA---RT 523
+HRD+K N+L+ + + +L DFG++ I+ + +GT ++APE+A R
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
G + D++A G+ +E+A + P+ H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 32/202 (15%)
Query: 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQG 410
IG G FG VY + ++ E++ L +L+H + + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
++ LV +Y + D L + L + I G GL YLH +I
Sbjct: 89 CYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL---ARTGKAS 527
HRD+K+GN+L+ +L DFG A K S + VGT ++APE+ G+
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 528 CSTDVFAYGVLLLEIATGRRPI 549
DV++ G+ +E+A + P+
Sbjct: 199 GKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 47/289 (16%)
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGVL----PTRMREF--------AAEIE--------- 395
+ + S+++ G FG ++ G+L P + E A+EI+
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 396 SLGRLRHKHLVNLQGWCKRKRDLLLV-YDYIPNGSLDSLLFD------NENFVLSWEQRF 448
L L H++++ + C + V Y Y+ G+L L N LS +Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 449 NIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTT 507
++ IA G+ YLH+ + VIH+D+ + N +ID ++ ++ D L+R LF
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP-IDSDHFILVDWVLEFQH 565
N + ++A E + S ++DV+++GVLL E+ T G+ P ++ D F + ++ +
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237
Query: 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
L Q ++ D E+ V+ C E RP+ Q+++ L
Sbjct: 238 LAQPINCPD----------ELFAVM---ACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
E+ L L+H ++V L + L LV++Y+ + L + D N ++S +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN-IMSMHNVKIFLY 111
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT 512
I GL Y H + V+HRD+K N+LI+ +L DFGLAR +++ VV T
Sbjct: 112 QILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-T 167
Query: 513 IGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
+ Y P+ L + + S D++ G + E+A+GR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 393 EIESLGRLRHKHLVNLQG-WCKRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRF 448
E++ L LRH+++++L + D+ V + + L LL + F+ Q F
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFI----QYF 113
Query: 449 NIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508
+ I GL Y+H V+HRD+K N+LI+ + + ++ DFGLAR+ D T
Sbjct: 114 --LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTG 164
Query: 509 VVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGR 546
V T Y APE+ T K D+++ G + E+ G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 51/282 (18%)
Query: 370 IGTGGFGEVYKGV--------LPTRMR--------------EFAAEIESLGRLRHKHLVN 407
+G G FG VY+G TR+ EF E + H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLF----DNEN----FVLSWEQRFNIIKGIAAGLL 459
L G + + L+V + + +G L S L + EN + ++ + IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAP 518
YL+ + +HRD+ + N ++ D ++GDFG+ R +++ + + ++AP
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 519 ELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD--P 575
E + G + S+D++++GV+L EI + +P + + VL+F G LD D P
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG---LSNEQVLKFVMDGGYLDQPDNCP 247
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617
E V L +C + RPT +++ L D
Sbjct: 248 -----------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 17/168 (10%)
Query: 389 EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL---------FDNEN 439
+F EI+ + RL+ +++ L C L ++ +Y+ NG L+ L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 440 FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LF 498
+S+ + IA+G+ YL +HRD+ + N L+ + ++ DFG++R L+
Sbjct: 125 VTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 499 --DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
D+ +I V I +++ E GK + ++DV+A+GV L EI T
Sbjct: 182 SGDYYRIQ--GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 356 DLYTATKGFKQSEVIGTGGFGEV----YKGVLPTRMREFAAEIESLGR------------ 399
DL + ++ +VIG G FGEV +K + ++ E + R
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 400 ---LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA 456
+V L + R L +V +Y+P G L +L+ N + W + + A
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYT-----AE 150
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
+L L IHRDVK N+L+D + +L DFG + + VGT YI
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 517 APELART----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI 555
+PE+ ++ G D ++ GV L E+ G P +D +
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 369 VIGTGGFGEVY--------------------KGVLPTRMREFA---AEIESLGRLRHKHL 405
V+G GG+G+V+ K + ++ A AE L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V+L + L L+ +Y+ G L L + E + F + + I+ L +LH+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSE-ISLALEHLHQ-- 118
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH-GKISHTTNVVGTIGYIAPE-LART 523
Q +I+RD+K N+L+DA + +L DFGL + H G ++HT GTI Y+APE L R+
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRS 175
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
G + D ++ G L+ ++ TG P +++
Sbjct: 176 GHGK-AVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHL 405
K + + E IG G G V+ + +E A EI + L++ ++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
VN +L +V +Y+ GSL ++ + + Q + + L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA-- 133
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
VIHRD+KS NVL+ D + +L DFG + S + +VGT ++APE+
Sbjct: 134 -NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKA 191
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++ +E+ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEI----ESLGR-----LRHKHLVNLQGWCK- 413
F+ +VIG G FGEV + + +A +I E L R R + V + G +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 414 ---------RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+ +L LV DY G L +LL E+ + RF + A +L +
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL----AEMVLAIDSV 118
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFG-LARLFDHGKISHTTNV-VGTIGYIAPELAR 522
+ +HRD+K NVL+D + + RL DFG RL G + +NV VGT YI+PE+ +
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVGTPDYISPEILQ 176
Query: 523 -----TGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
G+ D ++ GV + E+ G P ++
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 442 LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL---- 497
L +Q I K I GL YLH Q +IHRDVK+ N+ I+ +GD G A+
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 498 -FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
G + GT+ APE+ K + D+++ G++L E+
Sbjct: 211 PAFLG-------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 60/230 (26%)
Query: 370 IGTGGFGEVYKGVLPT--------RMREFAAEIESLGR-----------LRHKHLVNLQG 410
IG GG GEVY P ++RE +E L + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR---------------FNIIKGIA 455
C + YI +L SLL W++ +I I
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKS------VWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL------------FDHGKI 503
A + Y+H + V+HRD+K N+L+ + D+G A D I
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 504 SHTT-----NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
+++ +VGT Y+APE AS STD++A GV+L ++ T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 29/202 (14%)
Query: 370 IGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVNLQ 409
+G+G FG V KG+ P E E + +L + ++V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G C+ + +LV + G L+ L N++ ++ + ++ ++ G+ YL E
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELARTGKAS 527
+HRD+ + NVL+ A++ DFGL++ + + G + + APE K S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 528 CSTDVFAYGVLLLE-IATGRRP 548
+DV+++GVL+ E + G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 37/147 (25%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H+++V++ +L +V +++ G+L ++ ++ EQ + + L YL
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYL 134
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H Q VIHRD+KS ++L+ +D +L DFG ++ ++VGT ++APE+
Sbjct: 135 HN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVI 190
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++++E+ G P
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 369 VIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRLRHKHLV 406
+G G FG+V K + +R+ +E L ++ H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLL----------------------FDNENFVLSW 444
L G C + LLL+ +Y GSL S L + + L+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKI 503
+ I+ G+ YL E ++HRD+ + NVL+ ++ DFGL+R +++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544
+ + ++A E + +DV+++GVLL EI T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKR----- 416
K + + E IG G G VY + +E A + +L + K L+ + R+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 417 -----------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+L +V +Y+ GSL ++ + + Q + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS-- 133
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
VIHRD+KS N+L+ D + +L DFG + S + +VGT ++APE+
Sbjct: 134 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKA 191
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++ +E+ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 50/213 (23%)
Query: 364 FKQSEVIGTGGFGEVYKG----------VLPTRMRE-----FAA--EIESLGRLRHKHLV 406
+++ E +G G + VYKG + R++E F A E L L+H ++V
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 407 NLQGWCKRKRDLLLVYDYI-----------PNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
L K L LV++Y+ P G L +N L F +++G++
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG----LHPENVKLFL-----FQLLRGLS 117
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT-TNVVGTIG 514
Y+H+ + ++HRD+K N+LI +L DFGLAR SHT +N V T+
Sbjct: 118 ----YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLW 168
Query: 515 YIAPE--LARTGKASCSTDVFAYGVLLLEIATG 545
Y P+ L T ++C D++ G + +E+ G
Sbjct: 169 YRPPDVLLGSTEYSTC-LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKR----- 416
K + + E IG G G VY + +E A +L + K L+ + R+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 417 -----------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+L +V +Y+ GSL ++ + + Q + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS-- 134
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
VIHRD+KS N+L+ D + +L DFG + S + +VGT ++APE+
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKA 192
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++ +E+ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 14/98 (14%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
GL Y+H V+HRD+K N+L++A+ + ++ DFGLAR K T V T Y
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYR 175
Query: 517 APELARTGKASCS-----TDVFAYGVLLLEIATGRRPI 549
APEL +CS DV++ G + E+ GR+P+
Sbjct: 176 APELL----LNCSEYTTAIDVWSVGCIFAEL-LGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 52/215 (24%)
Query: 364 FKQSEVIGTGGFGEVYKG----------VLPTRMRE-----FAA--EIESLGRLRHKHLV 406
+K+ + +G G + VYKG + R+ F A E L L+H ++V
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 407 NLQGWCKRKRDLLLVYDYI-----------PNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
L K+ L LV++Y+ G L N L F +++G+A
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFL-----FQLLRGLA 117
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI--SHT-TNVVGT 512
Y H+ + V+HRD+K N+LI +L DFGLAR K S T +N V T
Sbjct: 118 ----YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSKTYSNEVVT 166
Query: 513 IGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
+ Y P+ L + + S S D++ G + E+ATGR
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD--HGKISHTTNVVG 511
I GL Y+H V+HRD+K N+L++ + + ++ DFGLAR+ D H T V
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 512 TIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPI 549
T Y APE+ K + + D+++ G +L E+ + RP+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 48/234 (20%)
Query: 370 IGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLRHKHLVN 407
IG G +G VYK G+ + +RE A ++ L H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 408 LQGWC-----KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
L C R+ + LV++++ + L + L L E ++++ GL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
++HRD+K N+L+ + +L DFGLAR++ T VV T+ Y APE+
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLL 180
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPI---DSDHFILVDWVLEFQHLGQVLDVV 573
+ D+++ G + E+ R+P+ +S E LG++ D++
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS----------EADQLGKIFDLI 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 35/136 (25%), Positives = 69/136 (50%), Gaps = 15/136 (11%)
Query: 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476
+L +V +++ G+L ++ ++ EQ + + L +LH Q VIHRD+KS
Sbjct: 90 ELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHA---QGVIHRDIKS 143
Query: 477 GNVLIDADMNARLGDFGLARLFDHGKISHTT----NVVGTIGYIAPELARTGKASCSTDV 532
++L+ +D +L DFG ++S ++VGT ++APE+ D+
Sbjct: 144 DSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 533 FAYGVLLLEIATGRRP 548
++ G++++E+ G P
Sbjct: 199 WSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
E L RH L +L+ + K L V +Y+ G L F LS E+ F+ +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--------FFHLSRERVFSEDR 96
Query: 453 G------IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
I + L YLH +++RD+K N+++D D + ++ DFGL + G
Sbjct: 97 TRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAA 150
Query: 507 T--NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI-DSDHFILVDWVL 561
T GT Y+APE+ + D + GV++ E+ GR P + DH L + +L
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 392 AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNII 451
AE L ++ +V L+ + L LV +I G L F + L E RF++
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL----FHH----LQREGRFDLS 93
Query: 452 KG---IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508
+ A L L + VI+RD+K N+L+D + L DFGL +L + T
Sbjct: 94 RARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNT 152
Query: 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
GT Y+APEL + + D + GVLL E+ TG P
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 76/253 (30%)
Query: 364 FKQSEVIGTGGFGEVYKG-------------------VLPTRMREFAAEIESLGRLRHKH 404
F + + +G G FGEV +L ++ AE + L ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V L + K +L V DYIP G + SLL F + + I + + +H+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY--IAELTCAVESVHK- 119
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF------------DHGK---------- 502
IHRD+K N+LID D + +L DFGL F DH +
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 503 --------------------------ISHTTNVVGTIGYIAPE-LARTGKASCSTDVFAY 535
++H+ +VGT YIAPE L RTG D ++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHS--LVGTPNYIAPEVLLRTGYTQL-CDWWSV 234
Query: 536 GVLLLEIATGRRP 548
GV+L E+ G+ P
Sbjct: 235 GVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 62/233 (26%), Positives = 87/233 (37%), Gaps = 52/233 (22%)
Query: 364 FKQSEVIGTGGFGEVY-------------KGVLPTRMREF------AAEIESLGRLRHKH 404
FK+ +++G G G V+ K + M + E E L L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAAGLLYLHE 463
L L + + L LV DY P G L LL LS E RF + + A L YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA-LEYLHL 121
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGL---------ARLFDHGKISHTTNV----- 509
+++RD+K N+L+ + L DF L K S ++V
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 510 --------------VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
VGT YIAPE+ + D + G+LL E+ G P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 37/148 (25%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+H+++V + +L +V +++ G+L ++ ++ EQ + + L
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSV 131
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
LH Q VIHRD+KS ++L+ D +L DFG ++ ++VGT ++APEL
Sbjct: 132 LHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEL 187
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRP 548
D+++ G++++E+ G P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAA-----------------EIESLGRLRHKHLVNLQGWC 412
+G+G +G+VYK E AA EI + +H ++V G
Sbjct: 17 VGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472
+ L + +Y GSL + + LS Q + + GL YLH + + +HR
Sbjct: 76 LSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 473 DVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA---RTGKASCS 529
D+K N+L+ + + +L DFG+A I+ + +GT ++APE+A + G +
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 530 TDVFAYGVLLLEIATGRRPIDSDH 553
D++A G+ +E+A + P+ H
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 11/135 (8%)
Query: 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQR--FNIIKGIAAGLLYLHEEWEQVVIHRDV 474
DL LV DY+ G L L F E R F I + + A L +LH+ +++RD+
Sbjct: 70 DLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLA-LEHLHK---YDIVYRDL 122
Query: 475 KSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA-SCSTDVF 533
K N+L+DA + L DFGL++ + T GT Y+APE+ K + D +
Sbjct: 123 KPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181
Query: 534 AYGVLLLEIATGRRP 548
+ GVL+ E+ G P
Sbjct: 182 SLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------I 454
RH L L+ + L V +Y G L F LS E+ F+ + I
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--------FFHLSRERVFSEDRARFYGAEI 104
Query: 455 AAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTI 513
+ L YLH E V++RD+K N+++D D + ++ DFGL + G T GT
Sbjct: 105 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 160
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI-DSDHFILVDWVL 561
Y+APE+ + D + GV++ E+ GR P + DH L + +L
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 25/175 (14%)
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG--- 453
L RH L L+ + L V +Y G L F F LS E+ F+ +
Sbjct: 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL----F----FHLSRERVFSEDRARFY 100
Query: 454 ---IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH---TT 507
I + L YLH V++RD+K N+++D D + ++ DFGL + IS
Sbjct: 101 GAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMK 153
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI-DSDHFILVDWVL 561
GT Y+APE+ + D + GV++ E+ GR P + DH L + +L
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 392 AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN-- 449
+E+ L H +V K LLL+ +Y G L+ + +QR
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----------KQRLKEH 163
Query: 450 -IIKGIAAGLLY------LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHG 501
+ GLL+ L E + ++HRD+KS N+ + +LGDFG ++ + D
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ ++ GT Y+APEL + S D+++ GV+L E+ T RP
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 393 EIESLGR-LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNII 451
E S+ R + HKH+V L G C R + ++V +++ G LD L ++ VL+ +F +
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD-LFMHRKSDVLTTPWKFKVA 111
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHG---KISHTT 507
K +A+ L YL ++ ++H +V + N+L+ + ++ G F +L D G +
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQ 166
Query: 508 NVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEI 542
V I +IAPE K S + D +++G L EI
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA 456
L L+H LV L + L V DY+ G L E L RF + +A+
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYAAE-VAS 107
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
+ YLH +I+RD+K N+L+D+ + L DFGL + + T+ GT Y+
Sbjct: 108 AIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYL 163
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551
APE+ R + D + G +L E+ G P S
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 55/245 (22%), Positives = 107/245 (43%), Gaps = 46/245 (18%)
Query: 368 EVIGTGGFGEVYKGVLP--------------------TRMREFAAEIESLGRLRHKHLVN 407
+ +G G FG V +G L + M +F +E + H +++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 408 LQGWCKRKRDL------LLVYDYIPNGSLDSLLF----DNENFVLSWEQRFNIIKGIAAG 457
L G C + + +++ ++ +G L S L + L + + IA+G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR------LFDHGKISHTTNVVG 511
+ YL + IHRD+ + N +++ +MN + DFGL++ + G+I+
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM----- 176
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDS-DHFILVDWVLEFQHLGQV 569
+ +IA E + +DV+++GV + EIAT G+ P ++ + D++ + L Q
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 570 LDVVD 574
D +D
Sbjct: 237 PDCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 64/226 (28%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFA-----AEIES 396
+++ E IG G +G+VYK G+ PT +RE + +E
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 397 LGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR-------- 447
+ RL +H+ G K L LV++Y LDS D + F+ S +
Sbjct: 63 IVRLLDVEHVEEKNG----KPSLYLVFEY-----LDS---DLKKFMDSNGRGPGRPLPAK 110
Query: 448 ------FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDH 500
+ ++KG+A + H+ V+HRD+K N+L+D ++ D GL R F
Sbjct: 111 TIKSFMYQLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 501 GKISHTTNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATG 545
S+T +V T+ Y APE L + S D+++ G + E++
Sbjct: 164 PVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
E L RH L L+ + L V +Y G L F LS E+ F +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--------FFHLSRERVFTEER 96
Query: 453 G------IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
I + L YLH + V++RD+K N+++D D + ++ DFGL + G
Sbjct: 97 ARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA 150
Query: 507 T--NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI-DSDHFILVDWVL 561
T GT Y+APE+ + D + GV++ E+ GR P + DH L + +L
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
I GL YLH ++HRD+K GN+L++++ ++ DFGLAR+ + + H T V T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 514 GYIAPELARTGKA--SCSTDVFAYGVLLLEIATGR 546
Y APE+ G + + D+++ G + E+ R
Sbjct: 169 YYRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 72/253 (28%), Positives = 99/253 (39%), Gaps = 76/253 (30%)
Query: 364 FKQSEVIGTGGFGEV------------------YKGVLP-TRMREFAAEIESLGRLRHKH 404
F + + +G G FGEV K VL ++ AE + L ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--VLSWEQRFNIIKGIAAGLLYLH 462
+V L + K +L V DYIP G + SLL E F VL+ RF I A L +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYI----AELTLAIE 115
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD-------HGKISHTT-------- 507
+ IHRD+K N+LID D + +L DFGL F + K SH
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 508 -------------------------------NVVGTIGYIAPE-LARTGKASCSTDVFAY 535
++VGT YIAPE L R G D ++
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSV 234
Query: 536 GVLLLEIATGRRP 548
GV+L E+ G+ P
Sbjct: 235 GVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 67/247 (27%), Positives = 99/247 (40%), Gaps = 65/247 (26%)
Query: 364 FKQSEVIGTGGFGEV-------------YKGVLPTRMRE------FAAEIESLGRLRHKH 404
F+ +VIG G FGEV K + + M E AE + L +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V L + + L L+ +Y+P G + +LL + F E RF I A +L +
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYI----AETILAIDSI 117
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGL------------ARLFDHGKISHTT----- 507
+ IHRD+K N+L+DA + +L DFGL R+ H S+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 508 --------------------NVVGTIGYIAPE-LARTG-KASCSTDVFAYGVLLLEIATG 545
+ VGT YIAPE +TG C D ++ GV++ E+ G
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEMLVG 235
Query: 546 RRPIDSD 552
P SD
Sbjct: 236 YPPFCSD 242
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 24/188 (12%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAAEIES---LGRLRHKHLVNLQGWCKRKRDLLLVYDY 424
+++G G V VL + R+ A E+ + +L HKHLV L G C R + ++V +Y
Sbjct: 23 DIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEY 81
Query: 425 IPNGSLDSLLFDNENFV-LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL-ID 482
+ G LD L +N V L W + ++ K +A+ L YL ++ ++H +V N+L
Sbjct: 82 VKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILVAR 136
Query: 483 ADMN------ARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST--DVFA 534
+N +L D G+ + V I +IAPE R G+AS + D ++
Sbjct: 137 YGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWS 191
Query: 535 YGVLLLEI 542
+G LLEI
Sbjct: 192 FGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA-------------------EIESLGRLRHKH 404
+K EVIG G +G V + T E A EI+ L LRH
Sbjct: 2 YKIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 405 LVNLQGW----CKRK-RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
+V ++ +R+ +D+ +V++ + L ++ N++ Q F + + L
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFF--LYQLLRALK 117
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR--LFDHGKISHTTNVVGTIGYIA 517
Y+H V HRD+K N+L +AD ++ DFGLAR D T+ V T Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 518 PELART--GKASCSTDVFAYGVLLLEIATGR 546
PEL + K + + D+++ G + E+ TG+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 368 EVIGTGGFGEVYK------GVL-------PTRM--REFAAEIESLGRL-RHKHLVNLQGW 411
E IG G +G+VYK G L P E AE L L H ++V G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 412 CKRKR-----DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLY 460
+ L LV + GS+ L+ +L QR + I+ G GL +
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
LH +IHRDVK N+L+ + +L DFG++ ++ T+ VGT ++APE+
Sbjct: 144 LHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEV 199
Query: 521 ARTGK-------ASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ A C DV++ G+ +E+ G P+ H
Sbjct: 200 IACEQQYDYSYDARC--DVWSLGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 15/176 (8%)
Query: 385 TRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL------LLVYDYIPNGSLDSLLF--- 435
+ + EF E + H +++ L G R R +++ ++ +G L + L
Sbjct: 43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR 102
Query: 436 -DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494
E F L + + IA+G+ YL + IHRD+ + N +++ +M + DFGL
Sbjct: 103 IGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159
Query: 495 ARLFDHGKISHTTNVVG-TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
++ G + ++A E + +DV+A+GV + EI T G+ P
Sbjct: 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 49/156 (31%), Positives = 71/156 (45%), Gaps = 8/156 (5%)
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA 456
L ++H LV L + L V DYI G L L E L RF + IA+
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAE-IAS 107
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGY 515
L YLH +++RD+K N+L+D+ + L DFGL + +H T+ GT Y
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEY 162
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551
+APE+ + D + G +L E+ G P S
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 48/235 (20%)
Query: 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV-LSWEQRFNIIKGIA 455
+ ++ H HL + G C R + ++V +++ +G LD L + V ++W + + + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG----DFGLARLFDHGKISHTT---- 507
+ L YL ++ ++H +V + N+L+ ARLG +L D G +S T
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPG-VSFTALSRE 178
Query: 508 NVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIA-------TGRRPIDSDHFILVDW 559
V I +IAPE G + S + D +++G LLEI R P + + F
Sbjct: 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF----- 233
Query: 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
E +H ++ + L + L+ Q C + RP+ R +LR L
Sbjct: 234 -YEKKH--RLPEPSCKELAT--------LISQ----CLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 58/242 (23%)
Query: 364 FKQSEVIGTGGFGEV---------YKGVLPTRMREFAAEIESLGRLRHKHLVNLQG---W 411
F+ +VIG G FGEV + + + E E +G +R + + ++ W
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 412 CKR-------KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+ K +L L+ +++P G + +LL + Q + IA +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY-----IAETVLAIDSI 117
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLA------------RLFDHGKISHTT----- 507
+ IHRD+K N+L+D+ + +L DFGL R +H S T
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 508 -----------------NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550
+ VGT YIAPE+ + D ++ GV++ E+ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 551 SD 552
S+
Sbjct: 238 SE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 77/232 (33%)
Query: 370 IGTGGFGEVYK--------------------GVLPTRMREFAAEIESLGRLRHKHLVNLQ 409
+G G +G VYK G+ + RE A L L+H ++++LQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIAL----LRELKHPNVISLQ 64
Query: 410 G--WCKRKRDLLLVYDY-----------------------IPNGSLDSLLFDNENFVLSW 444
R + L++DY +P G + SLL+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR----LGDFGLARLFDH 500
I G+ YLH W V+HRD+K N+L+ + R + D G ARLF+
Sbjct: 117 ---------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 501 --GKISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPI 549
++ VV T Y APEL + + + D++A G + E+ T PI
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
GL Y+H +IHRD+K GN+ ++ D ++ DFGLAR D S T V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYR 182
Query: 517 APELARTGKASCST-DVFAYGVLLLEIATGR 546
APE+ T D+++ G ++ E+ TG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 34/206 (16%)
Query: 370 IGTGGFGEVYKGVLP--TRMREFA--------------AEIESLGRLRHKHLVNLQG--W 411
+G G +G VYK +E+A EI L L+H +++ LQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLF------DNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
R + L++DY + + F + + L +++ I G+ YLH W
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 466 EQVVIHRDVKSGNVLIDADMNAR----LGDFGLARLFDH--GKISHTTNVVGTIGYIAPE 519
V+HRD+K N+L+ + R + D G ARLF+ ++ VV T Y APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 520 LARTGKA-SCSTDVFAYGVLLLEIAT 544
L + + + D++A G + E+ T
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 368 EVIGTGGFGEVY-----------------KGVLPTRMRE---FAAEIESLGRLRHKHLVN 407
+VIG G FG+V K ++ R + A L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L + L V D++ G L L +F RF + IA+ L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAAE-IASALGYLHS---I 115
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV-VGTIGYIAPELARTGKA 526
+++RD+K N+L+D+ + L DFGL + + S TT GT Y+APE+ R
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 527 SCSTDVFAYGVLLLEIATGRRP 548
+ D + G +L E+ G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 58/242 (23%)
Query: 364 FKQSEVIGTGGFGEV---------YKGVLPTRMREFAAEIESLGRLRHKH--LVNLQG-W 411
F+ +VIG G FGEV + + + E E + +R + LV G W
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 412 CKR-------KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+ KR+L L+ +++P G + +LL + Q + IA +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY-----IAETVLAIDAI 117
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLA------------RLFDHGKISHTT----- 507
+ IHRD+K N+L+DA + +L DFGL R H S +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 508 -----------------NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550
+ VGT YIAPE+ + D ++ GV++ E+ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 551 SD 552
S+
Sbjct: 238 SE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFD--HGKISHTTNVVGTI 513
GL Y+H V+HRD+K NV I+ D+ ++GDFGLAR+ D + + + + T
Sbjct: 126 GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 514 GYIAPELART----GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
Y +P L + KA D++A G + E+ TG+ H
Sbjct: 183 WYRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 3/97 (3%)
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
I + + + YLHE +IHRD+K+ N+ I+ + LGDFG A +
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR 546
GTI APEL + D+++ G++L E+AT
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 29/158 (18%)
Query: 411 WC--KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+C + KR L +V +Y+ G +LL N + R + + A L YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLA-LEYLHNYG--- 121
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-----------------VVG 511
++HRD+K N+LI + + +L DFGL+++ G +S TTN V G
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 512 TIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGRRP 548
T YIAPE + R G D +A G++L E G P
Sbjct: 179 TPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 48/234 (20%)
Query: 370 IGTGGFG-----EVYKGVLPTRM--------------REFAAEIESLGRLRHKHLVNLQG 410
IG G FG EV G P ++ +F E + L+H +L+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
C LLV ++ P G L L + + QR + IA GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHK-- 118
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT-----IGYIAPEL 520
IH D+ N L+ AD+ ++GD+GL+ H K V + +IAPEL
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 521 AR-------TGKASCSTDVFAYGVL---LLEIATGRRPIDSDHFILVDWVLEFQ 564
+ ++V++ GV L E+ + SD +L V E Q
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
++ I GL Y+H +IHRD+K N+ ++ D ++ DFGLAR D T
Sbjct: 123 LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGY 175
Query: 510 VGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
V T Y APE + + + D+++ G ++ E+ TG+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
GL Y+H +IHRD+K NV ++ D R+ DFGLAR D T V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYR 182
Query: 517 APELARTGKASCST-DVFAYGVLLLEIATGRRPIDSDHFI 555
APE+ T D+++ G ++ E+ G+ + +I
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
+I I GL Y+H +IHRD+K N+ ++ D ++ DFGLAR D T
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGY 177
Query: 510 VGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGR 546
V T Y APE+ + + D+++ G ++ E+ TGR
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 15/96 (15%)
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV--GT----IGYIAPELART 523
IHRDV + NVL+ A++ DFGLAR I + +N V G + ++APE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFD 288
Query: 524 GKASCSTDVFAYGVLLLEI-ATGRRPIDSDHFILVD 558
+ +DV++YG+LL EI + G+ P ILV+
Sbjct: 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPG---ILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 37/202 (18%)
Query: 370 IGTGGFGEV---------YKGVLPTRMREFAAEI------ESLGRLRHKHLVNLQGWCKR 414
+G+G +G V K + R F +EI L L+H N+ G
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 415 K---------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+D LV Y+ L ++ LS ++ ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+IHRD+K GN+ ++ D ++ DFGLAR D + T V T Y APE+
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWM 190
Query: 526 ASCST-DVFAYGVLLLEIATGR 546
T D+++ G ++ E+ TG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 368 EVIGTGGFGEVYKG------------VLPTRMRE---FAA--EIESLGRLRHKHLVNLQG 410
E +G G + VYKG V+ + E F A E L L+H ++V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR---FNIIKGIAAGLLYLHEEWEQ 467
K L V++Y+ + L + + + + R F +++G+A Y+H Q
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA----YIHG---Q 122
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGKA 526
++HRD+K N+LI +L DFGLAR ++++ VV T+ Y P+ L
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 527 SCSTDVFAYGVLLLEIATGR 546
S + D++ G + +E+ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 14/127 (11%)
Query: 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481
Y + + +LL D+ + L+ + +A G+ +L + +HRD+ + NVL+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 482 DADMNARLGDFGLARLFDHGKISHTTNVVGT------IGYIAPELARTGKASCSTDVFAY 535
++ DFGLAR I H +N V + ++APE + +DV++Y
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 536 GVLLLEI 542
G+LL EI
Sbjct: 326 GILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA------------EIES----LGRLR-HKHLVNLQG 410
E IG G +G+V+K VL + AA EIE+ L L H ++V G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 411 WCKRKR-----DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLL 459
+K L LV + GS+ L+ L +R I+ GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+LH IHRDVK N+L+ + +L DFG++ ++ T+ VGT ++APE
Sbjct: 139 HLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPE 194
Query: 520 -------LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
L T A C DV++ G+ +E+ G P+ H
Sbjct: 195 VIACEQQLDSTYDARC--DVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 30/173 (17%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD-----NENFVLSWEQR 447
E++ + ++H++++ L D+ + D+I N +D + D + L+ Q
Sbjct: 70 ELKIMNEIKHENIMGL-------VDVYVEGDFI-NLVMDIMASDLKKVVDRKIRLTESQV 121
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT- 506
I+ I GL LH+ + +HRD+ N+ I++ ++ DFGLAR + + S T
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 507 ------------TNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIATGR 546
T+ V T+ Y APEL K + D+++ G + E+ TG+
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT--NVVGTIGYIA 517
Y+H E +IHRD+K+ NVL++ + LGDFG A F G S + GT+ A
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTVDTNA 330
Query: 518 PELARTGKASCSTDVFAYGVLLLEIAT------------GRRPIDS 551
PE+ + S D+++ G+++ E A RRP D+
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDA 376
|
Length = 461 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/159 (24%), Positives = 80/159 (50%), Gaps = 23/159 (14%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
G+ Y+H+ + ++HRD+K+ N+ + ++ ++GDFG++RL G T GT Y+
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYM 172
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD-- 574
+PE + +D+++ G +L E+ + +F+ V VL +V+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-----------VLRIVEGP 221
Query: 575 -PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
P+L +Y ++ ++Q L ++ RP+ ++LR
Sbjct: 222 TPSLPETY-SRQLNSIMQSML---NKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 353 RYSDLYTATKGFKQSEVIGTGGFGEV------------------YKGVLPTRMREFAAEI 394
+Y D + ++ + IG G FGEV Y+G+ + E+
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63
Query: 395 ESLGRLRHKHLVNL--QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR--FNI 450
+ L+HK++V + K + L ++ ++ G L + E+ +I
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 451 IKGIAAGLLYLHEEWE----QVVIHRDVKSGNVL----------IDADMN-------ARL 489
+ + L Y H + + V+HRD+K N+ I A N A++
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPELA--RTGKASCSTDVFAYGVLLLEIATGRR 547
GDFGL++ ++H+ VGT Y +PEL T +D++A G ++ E+ +G+
Sbjct: 184 GDFGLSKNIGIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 548 P 548
P
Sbjct: 242 P 242
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 6/125 (4%)
Query: 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481
Y NE+ LS+ +A G+ +L + +HRD+ + NVLI
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272
Query: 482 DADMNARLGDFGLAR--LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLL 539
++ DFGLAR + D IS + + + ++APE + +DV+++G+LL
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILL 331
Query: 540 LEIAT 544
EI T
Sbjct: 332 WEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 34/152 (22%)
Query: 370 IGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKHLVNLQG 410
I G FG+VY G + +A AE ++L + +V+L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ ++ LV +Y+ G + SLL FD E V I +A L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV-------KYISEVALALDYLHR-- 122
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497
+IHRD+K N+LI + + +L DFGL+++
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 358 YTATKGFKQSEVIGTGGFGEV---YKGVL---------------PTRMREFAAEIESLGR 399
+T K ++Q + IG+G G V + VL T + E+ L
Sbjct: 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76
Query: 400 LRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453
+ HK++++L Q + +D+ LV + +D+ L + L E+ ++
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-----MDANLCQVIHMELDHERMSYLLYQ 131
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
+ G+ +LH +IHRD+K N+++ +D ++ DFGLAR + T V T
Sbjct: 132 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTR 186
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATG 545
Y APE+ + D+++ G ++ E+ G
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 61/212 (28%)
Query: 370 IGTGGFGEVYKGVLPTRMREFAA------------------EIESLGRLR-HKHLVNLQG 410
IG G F EV K + ++ A EI++L RL H +++ L
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL-- 63
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFD-----------------NENFVLSWEQRFNIIKG 453
+ +++D G L +L+F+ E V S+ + ++K
Sbjct: 64 -------IEVLFD-RKTGRL-ALVFELMDMNLYELIKGRKRPLPEKRVKSY--MYQLLKS 112
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
L ++H + HRD+K N+LI D +L DFG R + K + T + T
Sbjct: 113 ----LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPY-TEYISTR 162
Query: 514 GYIAPE-LARTGKASCSTDVFAYGVLLLEIAT 544
Y APE L G D++A G + EI +
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 24/154 (15%)
Query: 364 FKQSEVIGTGGFGEV-------------YKGVLPTRM------REFAAEIESLGRLRHKH 404
F +VIG G FGEV K +L + M AE + L
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+V+L + + L L+ +++P G L ++L + F RF + A +L +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYM----AECVLAIEAV 117
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498
+ IHRD+K N+LID + +L DFGL+ F
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 49/279 (17%)
Query: 370 IGTGGFG-----EVYKGVLPTR--MREFAAEIESLGR------------LRHKHLVNLQG 410
IG G FG E+Y R ++E A S + L+H +++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNE----NFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
C LLV++Y G L S L + N L QR IAAG+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMHK--- 117
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGTIGYIAPELAR--- 522
+H D+ N + +D+ ++GD+G+ + I + + ++APEL
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 523 ----TGKASCSTDVFAYGVLLLEI---ATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575
T + + ++V+A GV L E+ A SD +L + + Q + + P
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-----VKLFKP 232
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
L Y E VLQ L E R T +V R L
Sbjct: 233 QLELPYSERWYE-VLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 51/270 (18%)
Query: 358 YTATKGFKQSEVIGTGGFGEV---YKGVLP---------------TRMREFAAEIESLGR 399
+T K ++ + IG+G G V Y +L T + E+ +
Sbjct: 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYD-YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
+ HK+++ L ++ L D YI +D+ L L E+ ++ + G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
+LH +IHRD+K N+++ +D ++ DFGLAR G T V T Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
E+ + D+++ G ++ E+ G V+ P G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG-------------------------VLFP--G 227
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMR 608
+ ++ +++ QLG C + +PT+R
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 20/136 (14%)
Query: 434 LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
+ + + L E + +A G+ +L + IHRD+ + N+L+ ++ DFG
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFG 259
Query: 494 LARLFDHGKISHTTNVVGT------IGYIAPELARTGKASCSTDVFAYGVLLLEIAT--- 544
LAR I + +N V + ++APE + +DV++YG+LL EI +
Sbjct: 260 LAR-----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 314
Query: 545 ---GRRPIDSDHFILV 557
P+DS + ++
Sbjct: 315 SPYPGMPVDSKFYKMI 330
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 51/270 (18%)
Query: 358 YTATKGFKQSEVIGTGGFGEV---YKGVL---------------PTRMREFAAEIESLGR 399
+T K ++ + IG+G G V Y VL T + E+ +
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYD-YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
+ HK++++L ++ L D Y+ +D+ L L E+ ++ + G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
+LH +IHRD+K N+++ +D ++ DFGLAR G T V T Y AP
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
E+ + D+++ G ++ E+ H IL G
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVR--------HKILFP-------------------G 220
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMR 608
Y+ +++ QLG C + +PT+R
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 37/169 (21%), Positives = 71/169 (42%), Gaps = 19/169 (11%)
Query: 392 AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNII 451
EI + +L+H +++ +L +V + GS + LL + L I+
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFIL 107
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGK-----ISH 505
K + L Y+H + IHR VK+ ++L+ D L + + HGK
Sbjct: 108 KDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164
Query: 506 TTNVVGTIGYIAPELAR------TGKASCSTDVFAYGVLLLEIATGRRP 548
+ V + +++PE+ + K +D+++ G+ E+A G P
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEK----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 15/148 (10%)
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
IHRD+ + N+L+ + ++ DFGLAR ++ + + ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 529 STDVFAYGVLLLEI-ATGRRPIDSDHFILVDWVLEF-QHLGQVLDVVDPNLGSSYVVAEM 586
+DV+++GVLL EI + G P +D EF + L + + P+ Y EM
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVK---IDE--EFCRRLKEGTRMRAPD----YTTPEM 311
Query: 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614
Q L C H + RPT +++ +L
Sbjct: 312 ---YQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 63/258 (24%), Positives = 109/258 (42%), Gaps = 59/258 (22%)
Query: 359 TATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA------------EIESLGRLRHKHLV 406
+ K +K +IG G FG VY+ + + A E+ + L H +++
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINII 122
Query: 407 NLQGW----CKRKRD----LLLVYDYIP-------------NGSLDSLLFDNENFVLSWE 445
L+ + C +K + L +V ++IP N +L L ++ L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--- 179
Query: 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKIS 504
L Y+H ++ + HRD+K N+LID + + +L DFG A+ G+ S
Sbjct: 180 ---------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227
Query: 505 HTTNVVGTIGYIAPELARTGKASCST--DVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562
+ + + Y APEL G + +T D+++ G ++ E+ G PI S + V
Sbjct: 228 --VSYICSRFYRAPELM-LGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRI 283
Query: 563 FQHLG----QVLDVVDPN 576
Q LG L ++PN
Sbjct: 284 IQVLGTPTEDQLKEMNPN 301
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
IHRD+ + N+L+ + ++ DFGLAR ++ + + ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 529 STDVFAYGVLLLEIAT 544
+DV+++GVLL EI +
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 1/74 (1%)
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
IHRD+ + N+L+ + ++ DFGLAR ++ + + ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 529 STDVFAYGVLLLEI 542
+DV+++GVLL EI
Sbjct: 256 QSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.65 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.65 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.54 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.38 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.33 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.3 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.05 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.75 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.75 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.72 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 98.6 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.51 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.28 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.22 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.14 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.31 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.16 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.11 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.8 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.75 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.37 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.3 | |
| PLN02236 | 344 | choline kinase | 93.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.97 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.17 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 88.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.87 |
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=443.68 Aligned_cols=233 Identities=45% Similarity=0.760 Sum_probs=210.1
Q ss_pred eeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC--CCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 25 EEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA--HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 25 ~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~--~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
++|+|++|.....+ |.++|+|.+.++|.|+||++. ..++|||+|++||+||++.++ +++||+|+|+|.|.
T Consensus 1 ~~f~f~~f~~~~~~---l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~-----~~~sFst~F~F~i~ 72 (236)
T cd06899 1 LSFNFNGFSSDQSN---LTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTG-----KVASFSTSFSFSIT 72 (236)
T ss_pred CceecCCCCCCCCC---EEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCC-----CceeEEEEEEEEEE
Confidence 47999999764345 999999999768999999998 899999999999999999988 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLE 182 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~ 182 (670)
+.+...+||||||+|+|....++++.|++|||++.++.+.+.+++|||||||++| .+++||++||||||+|++.|..+.
T Consensus 73 ~~~~~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n-~~~~D~~~nHigIdvn~~~S~~~~ 151 (236)
T cd06899 73 PPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQN-PEFGDPDDNHVGIDVNSLVSVKAG 151 (236)
T ss_pred cCCCCCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccC-cccCCCCCCeEEEEcCCcccceee
Confidence 8766788999999999987766688999999999988777889999999999999 777899999999999999887765
Q ss_pred ccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeec
Q 035655 183 PAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262 (670)
Q Consensus 183 ~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsas 262 (670)
.+.. ....|.+|+.++|||+||+.+++|+|+|...+. .+|..|+|+..+||+++|+++||||||||
T Consensus 152 ~~~~------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~--------~~~~~~~ls~~vdL~~~l~~~~~vGFSas 217 (236)
T cd06899 152 YWDD------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGV--------AKPKKPLLSYPVDLSKVLPEEVYVGFSAS 217 (236)
T ss_pred cccc------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCC--------CCCcCCEEEEeccHHHhCCCceEEEEEeE
Confidence 5332 234578999999999999999999999998776 58899999999999999999999999999
Q ss_pred CCceeeeEEEeccccccC
Q 035655 263 TGRKVSSHFILGWSFSMN 280 (670)
Q Consensus 263 tg~~~~~h~i~sW~fs~~ 280 (670)
||...|.|+|++|+|+++
T Consensus 218 TG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 218 TGLLTELHYILSWSFSSN 235 (236)
T ss_pred cCCCcceEEEEEEEEEcC
Confidence 999999999999999975
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=460.60 Aligned_cols=270 Identities=45% Similarity=0.779 Sum_probs=242.0
Q ss_pred CCCccchhhHHHhhcCccccceEeeeCceeEEEeeccc--------------h-HHHHHHHHHHHhccccCceeeeeeee
Q 035655 348 CPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT--------------R-MREFAAEIESLGRLRHKHLVNLQGWC 412 (670)
Q Consensus 348 ~~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~-~~~f~~Ei~~L~~l~H~nIv~l~g~~ 412 (670)
..+.|+|.++..||++|...+.||+|+||.||+|.+.+ . .++|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999998755 2 57899999999999999999999999
Q ss_pred eccC-eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 413 KRKR-DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 413 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999876543799999999999999999999999888999999999999999999999999
Q ss_pred ecCceeccC-CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC----CcchhHHHHHHHhhc
Q 035655 492 FGLARLFDH-GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS----DHFILVDWVLEFQHL 566 (670)
Q Consensus 492 FGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~----~~~~~~~~~~~~~~~ 566 (670)
||+|+.... ........ .||.+|+|||++..+..+.|+||||||++|+||+||+++.+. ....+.+|++.....
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976544 22111111 899999999999999999999999999999999999999875 344589999999999
Q ss_pred CCcccccCCCCC-CcccH-HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 567 GQVLDVVDPNLG-SSYVV-AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 567 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
+++.+++||++. ..++. ++++.+..++++|++.+|.+||+|.||++.|+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 66665 78999999999999999999999999999995443
|
|
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=431.46 Aligned_cols=233 Identities=43% Similarity=0.737 Sum_probs=205.1
Q ss_pred ceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC-CeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 24 KEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH-NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 24 ~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~-~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
+++|+|+.|.. ..+ +.+.|+|.+..+|+|+||++.. +++|||+|++||+|||..++ +++||+|+|+|.|.
T Consensus 1 ~~~F~~~~F~~-~~~---~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~-----~~~sF~t~F~f~i~ 71 (236)
T PF00139_consen 1 SVSFSFPSFSN-SSN---LTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTG-----NVASFSTSFSFSIT 71 (236)
T ss_dssp EEEEEESSBTT-GTT---EEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTT-----EBEEEEEEEEEEEE
T ss_pred CceEEcCCCCC-CCc---eEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCc-----ceeeeeeEEEEEEe
Confidence 37899999922 356 9999999995589999999987 99999999999999999998 89999999999996
Q ss_pred cC--CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccc
Q 035655 103 TP--NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIK 180 (670)
Q Consensus 103 ~~--~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~ 180 (670)
.. ....+||||||||+|....+.++.|++||+++.++.+.+.+++|||||||++| ++++||++||||||+|++.|..
T Consensus 72 ~~~~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N-~~~~d~~~nHIgI~~n~~~s~~ 150 (236)
T PF00139_consen 72 NGPGSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKN-PEYNDPDDNHIGIDVNSVVSNK 150 (236)
T ss_dssp ESSSSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTC-GGGTTTSSSEEEEEESSSSESE
T ss_pred ccCCCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeec-ccccccCCCEEEEECCCCcccc
Confidence 43 45678999999999998777788999999999887777789999999999999 8889999999999999999998
Q ss_pred ccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEe
Q 035655 181 LEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260 (670)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFs 260 (670)
+.+++++ .....++.+|+.++|||+||+.+++|+|++.... .+|..|+|+..+||+.+|+++||||||
T Consensus 151 ~~~~~~~---~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~---------~~~~~~~l~~~vdL~~~l~~~v~vGFs 218 (236)
T PF00139_consen 151 TASAGYY---SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS---------SKPSSPVLSVNVDLSAVLPEQVYVGFS 218 (236)
T ss_dssp EEE-------EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT---------TTSEEEEEEEE--HHHHSCSEEEEEEE
T ss_pred ccccccc---ccccccccCCcEEEEEEEEcCCccEEEEEEeccc---------CCCcceeEEEEEchHHhcCCCcEEEEE
Confidence 8776654 2356788999999999999999999999999874 478899999999999999999999999
Q ss_pred ecCCceeeeEEEeccccc
Q 035655 261 ASTGRKVSSHFILGWSFS 278 (670)
Q Consensus 261 astg~~~~~h~i~sW~fs 278 (670)
||||...|.|.|++|+|+
T Consensus 219 asTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 219 ASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp EEESSSSEEEEEEEEEEE
T ss_pred eecCCCcceEEEEEEEeC
Confidence 999999999999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=381.00 Aligned_cols=237 Identities=32% Similarity=0.502 Sum_probs=198.3
Q ss_pred ccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccccCceeeeeeeeeccC-eeEEEEeccCC
Q 035655 366 QSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKR-DLLLVYDYIPN 427 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~ 427 (670)
..+.||+|+||+||+|.+... .++|.+|+.+|.+++|||||+++|+|.+.. .+++|+|||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999987551 348999999999999999999999999887 79999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce-EEecccCCCcEEecCCC-cEEEEeecCceeccCCCcce
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV-VIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~~~ 505 (670)
|+|.++|++..+..+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ .+||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999988555689999999999999999999999 66 99999999999999997 99999999998766533 23
Q ss_pred eeccccCcCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 506 TTNVVGTIGYIAPELAR--TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.+...||+.|||||++. ..+|+.|+||||||+++|||+||+.||.......+... ....+. +...+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~--v~~~~~---------Rp~~p~ 269 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA--VVVGGL---------RPPIPK 269 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHhcCC---------CCCCCc
Confidence 34478999999999999 56999999999999999999999999987544222221 111111 112222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.....+..++..||+.||..||++.+++..|+..
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 2446678888899999999999999999999854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=386.43 Aligned_cols=239 Identities=32% Similarity=0.521 Sum_probs=207.2
Q ss_pred CccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
.+..++.||+|.||.||.|.+.. ..++|.+|+++|++|+|+|||+++|+|..++.++||+|||++|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34557899999999999998755 2478999999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.+||+...+..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+|||||+...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999998667789999999999999999999999 999999999999999999999999999999666655555555
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
..-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.... . .++.+.++...+-..+..++.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n----------~ev~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--N----------EEVLELLERGYRLPRPEGCPD 431 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--H----------HHHHHHHhccCcCCCCCCCCH
Confidence 566789999999999999999999999999999999 999987522 1 122333334444455556778
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+++..||+.+|++|||++.+...|+.
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 89999999999999999999999888864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=363.49 Aligned_cols=237 Identities=26% Similarity=0.400 Sum_probs=198.7
Q ss_pred cccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-eeEEEEeccC
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR-DLLLVYDYIP 426 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~ 426 (670)
+..+.||+|..|+|||+.++. ..+++.+|++++++.+||+||.++|.|...+ +..++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 346889999999999998764 3578899999999999999999999999998 5999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|||++++... ..+++...-+|+.+|++||.|||++ .+||||||||+|||++..|++||||||.++..... ..
T Consensus 162 gGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 99999999655 4599999999999999999999963 89999999999999999999999999999877664 45
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
.+.+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+........+|..-+. .+..-..|++... ...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---~Iv~~ppP~lP~~---~fS 308 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---AIVDEPPPRLPEG---EFS 308 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH---HHhcCCCCCCCcc---cCC
Confidence 6789999999999999999999999999999999999999999764222222221111 1111123333332 245
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.++..++..||++||.+||+++|+++|-
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 6788899999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.39 Aligned_cols=234 Identities=26% Similarity=0.423 Sum_probs=197.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
..|...+.||+|||+.||.+++.. ..+...+||++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 568889999999999999998722 3567889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
|+|++++|..+++ .++.+++.+++.+++||+.||.|||+ .+|+|||||..|++|++++++||+|||||.....+.
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999996 44679999999999999999999999 999999999999999999999999999999887543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
....+.+||+.|+|||++.....+..+||||+|||+|-|++|++||+..... +....-+.-+-. ++
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------ety~~Ik~~~Y~-------~P 238 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ETYNKIKLNEYS-------MP 238 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HHHHHHHhcCcc-------cc
Confidence 3345679999999999999889999999999999999999999999864321 111110111111 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
........+|+..+|++||.+|||+++|+.+=
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 12234567888899999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=379.02 Aligned_cols=242 Identities=29% Similarity=0.462 Sum_probs=204.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
...+....+.||+|.||+||+|.... ..++|.+|+++|..|+|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34556778899999999999997532 35789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
+|+|+|||..|+|.+||..+. ..+|+..+.+.||.|||.||.||-+ +.+|||||.++|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 999999999999999996421 2238999999999999999999999 9999999999999999999
Q ss_pred cEEEEeecCceeccCCCccee-eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC-cchhHHHHHH
Q 035655 486 NARLGDFGLARLFDHGKISHT-TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSD-HFILVDWVLE 562 (670)
Q Consensus 486 ~~kL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~-~~~~~~~~~~ 562 (670)
.|||+||||++.....+..+. ....-..+|||||.+..+++|++||||||||+|||+++ |+.|+.+- +.. +.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----VIe 716 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----VIE 716 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----HHH
Confidence 999999999986554443332 24455789999999999999999999999999999999 99999762 222 233
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....++++ +.+..++.++..|++.||+.+|.+||+++||-..|+..
T Consensus 717 ~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 CIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 33444432 34455668899999999999999999999999999754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.61 Aligned_cols=242 Identities=23% Similarity=0.391 Sum_probs=195.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeee-eeccCe-eEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGW-CKRKRD-LLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~-~~~~~~-~~lV 421 (670)
.+|++.++||+|.||+|||+.... ..++...|+.+|++|+|||||+++++ +.++++ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357888999999999999987532 34567899999999999999999995 445555 8999
Q ss_pred EeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
||||..|+|.+.++. ..++.+++..+++++.|++.||..+|..+.. .|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999864 4456799999999999999999999996643 4899999999999999999999999999988
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... .-....+|||.||+||.+...+|+.||||||+||++|||+.-+.||.++.. .... .....++. |++.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~-~KI~qgd~-----~~~p 249 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLC-KKIEQGDY-----PPLP 249 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHH-HHHHcCCC-----CCCc
Confidence 7644 334567999999999999999999999999999999999999999987632 2211 11222211 1121
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.-....+..++..|+..||+.||+...+++.+.
T Consensus 250 ---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 ---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1344567788899999999999998554444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=344.77 Aligned_cols=236 Identities=23% Similarity=0.414 Sum_probs=189.1
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
..+|...+.||+|.|+.||+|++++. .+....|+.+|+.++|||||++++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35688888899999999999987651 234568999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC------CcEEEEeecCce
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD------MNARLGDFGLAR 496 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~------~~~kL~DFGla~ 496 (670)
|||.+|+|.+||+.++ .+++...+.++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997764 59999999999999999999999 999999999999999765 458999999999
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
....+. ...+.+|++-|||||++..++|+.|+|+||+|+++||+++|+.||+.... .+..........+..
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~--~eL~~~~~k~~~~~~----- 234 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP--KELLLYIKKGNEIVP----- 234 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhccccccC-----
Confidence 887543 34567999999999999999999999999999999999999999986322 222222222222111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+......+.++...-++.+|.+|-+..+-..+
T Consensus 235 ---~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 235 ---VLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ---chhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1112222334456666677788888776665544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=374.07 Aligned_cols=252 Identities=28% Similarity=0.517 Sum_probs=216.1
Q ss_pred CccchhhHHHhhcC---------ccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhcc
Q 035655 350 HRFRYSDLYTATKG---------FKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRL 400 (670)
Q Consensus 350 ~~~~~~~l~~~t~~---------f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l 400 (670)
..++|+|-..|-+. ..+.++||.|.||.||+|+++. ..++|+.|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 35677766555444 3567899999999999998753 467899999999999
Q ss_pred ccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEE
Q 035655 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480 (670)
Q Consensus 401 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 480 (670)
.||||++|.|+.......+||.|||+||+|+.||+.+.+ .+++.+..-++++||.||.||.+ .++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhee
Confidence 999999999999999999999999999999999998875 59999999999999999999998 99999999999999
Q ss_pred ecCCCcEEEEeecCceeccCCCcceeeccc--cCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhH
Q 035655 481 IDADMNARLGDFGLARLFDHGKISHTTNVV--GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILV 557 (670)
Q Consensus 481 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~ 557 (670)
++.+..+|++||||++..+++.....+... -+.+|.|||.+...++|.+|||||||||+||+++ |.+||=+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd------ 837 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD------ 837 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc------
Confidence 999999999999999988766533333332 3468999999999999999999999999999988 9999743
Q ss_pred HHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 558 DWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 558 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+.+.+++..+...++-..+.+++..|.+|++.|||+|-.+||++.||+..|.+.
T Consensus 838 ------mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 838 ------MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ------cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 122334445555555566777889999999999999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.64 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=196.8
Q ss_pred hcCccccceEeeeCceeEEEeeccch-----------------------HHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR-----------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~-----------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.+.|...+.||+|+||.|-+|..+.+ .....+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34577789999999999999876441 1234589999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecC
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGL 494 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGl 494 (670)
.|+|+||++||+|.+.+-.+. .+.+..-.-+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999997664 47777788999999999999999 999999999999999766 7899999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCC---CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKA---SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
|+.... ...+.+.+||+.|.|||++.+... ..|.|+||+||+||-++||..||........ ..+....+++.
T Consensus 326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI~~G~y~- 400 (475)
T KOG0615|consen 326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQILKGRYA- 400 (475)
T ss_pred hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHHhcCccc-
Confidence 998764 345677899999999999987643 3478999999999999999999986322110 11111122211
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+.+..++.++++.++|..||++||++.|+++|-|-
T Consensus 401 -----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 401 -----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred -----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 1123455677889999999999999999999999998663
|
|
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=322.33 Aligned_cols=203 Identities=29% Similarity=0.418 Sum_probs=170.3
Q ss_pred eEEccceeeCC-CCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCC
Q 035655 42 ITRERASILKP-SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQ 120 (670)
Q Consensus 42 ~~~~g~a~~~~-~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~ 120 (670)
+.+.|+|.+.+ ++.|+||++..+++||++|++||++| ++|+|+|+|.|.+.. ..+||||||+|+|.
T Consensus 16 ~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~------------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~ 82 (223)
T cd01951 16 WQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS------------KDFTTTFKFYLGTKG-TNGADGIAFVLQND 82 (223)
T ss_pred cEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc------------CCEEEEEEEEEeCCC-CCCCCcEEEEEecC
Confidence 99999999975 78999999989999999999999996 579999999999764 57899999999998
Q ss_pred CCCCCCCCC--cccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccc--ccccccccCCCccccc
Q 035655 121 PSFPGGKAE--HYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIK--LEPAAYYENGTKEDFT 196 (670)
Q Consensus 121 ~~~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~--~~~~~~~~~~~~~~~~ 196 (670)
+..+.+..| ++||+ .+.++.+||||||++| .+++||+.||||||+|+..+.. ..+.++.. .+..
T Consensus 83 ~~~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N-~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~----~~~~ 150 (223)
T cd01951 83 PAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKN-DDNNDPNGNHISIDVNGNGNNTALATSLGSAS----LPNG 150 (223)
T ss_pred CCCccccCCCCCccCc-------cccCCeEEEEEecccc-CCCCCCCCCEEEEEcCCCCCCcccccccceee----CCCc
Confidence 765555555 88887 4567899999999999 7778999999999999987541 12222211 1222
Q ss_pred cCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEeccc
Q 035655 197 LESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWS 276 (670)
Q Consensus 197 l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~ 276 (670)
..+|+.++|||+||+.+++|+|++.... .|..|.++.++||+..++++||||||||||...+.|+|++|+
T Consensus 151 ~~~g~~~~v~I~Y~~~~~~L~v~l~~~~----------~~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~ws 220 (223)
T cd01951 151 TGLGNEHTVRITYDPTTNTLTVYLDNGS----------TLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWS 220 (223)
T ss_pred cCCCCEEEEEEEEeCCCCEEEEEECCCC----------ccccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEE
Confidence 2239999999999999999999997543 256789999999999999999999999999999999999999
Q ss_pred ccc
Q 035655 277 FSM 279 (670)
Q Consensus 277 fs~ 279 (670)
|+.
T Consensus 221 f~~ 223 (223)
T cd01951 221 FTS 223 (223)
T ss_pred ecC
Confidence 973
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=338.71 Aligned_cols=243 Identities=27% Similarity=0.442 Sum_probs=194.9
Q ss_pred cCccccceEeeeCceeEEEeeccc------------h----HHHHHHHHHHHhccccCceeeeeeeeeccC--eeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------R----MREFAAEIESLGRLRHKHLVNLQGWCKRKR--DLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~----~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~E 423 (670)
.++...+.||+|.||.||++...+ . .+.+.+|+.+|++|+|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456678899999999999998754 1 344789999999999999999999754444 6999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeecCceeccC--
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDH-- 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFGla~~~~~-- 500 (670)
|+++|+|.+++.+... .+++..+..+.+||++||+|||+ ++++||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988776 79999999999999999999998 99999999999999999 79999999999987663
Q ss_pred CCcceeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
..........||+.|||||++..+. ...++|||||||+++||+||+.||... ....++........ .-|
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-----~~P---- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-----SLP---- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-----CCC----
Confidence 2222344578999999999998643 345999999999999999999999752 11122221111111 112
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
..+........+++..|++.+|++|||+.++++|..-..
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 223334466778889999999999999999999865443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=326.18 Aligned_cols=228 Identities=26% Similarity=0.333 Sum_probs=188.3
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
..++|+..++||+|+||+||..+..+ ..+...+|..+|.+++||.||+++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35689999999999999999987654 23456689999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|+||+.||.|..+|.+.. .+++..+.-++..|+.||.|||+ ++||||||||+|||||++|.++|+||||++....
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999997654 58999999999999999999999 9999999999999999999999999999985544
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. ..+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.. .+... ...+++ ..
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~--~~~~~-I~~~k~---------~~ 244 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--KMYDK-ILKGKL---------PL 244 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--HHHHH-HhcCcC---------CC
Confidence 32 3445589999999999999999999999999999999999999999875422 11111 111110 01
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARP 605 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RP 605 (670)
.+.-......+++...++.||++|-
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111224556777788999999995
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.79 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=191.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc-C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK-R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~ 416 (670)
.++|+..++||+|+||.||+|.... ..+.+.+|+.+++++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 4678899999999999999986310 134678999999999 899999999998764 4
Q ss_pred eeEEEEeccCCCCchhhcccCC----------------------------------------------------------
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE---------------------------------------------------------- 438 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 438 (670)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999986432
Q ss_pred --ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCC
Q 035655 439 --NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGY 515 (670)
Q Consensus 439 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y 515 (670)
...+++.++.+++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1348889999999999999999998 8999999999999999999999999999986543221 112234567889
Q ss_pred CCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHH
Q 035655 516 IAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594 (670)
Q Consensus 516 ~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 594 (670)
+|||++.+..++.++|||||||++|||++ |+.||....... ... .....+.. +.. +......+.+++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~-~~~~~~~~-----~~~----~~~~~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFC-QRLKDGTR-----MRA----PENATPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHH-HHHhcCCC-----CCC----CCCCCHHHHHHHH
Confidence 99999999999999999999999999997 999997632211 111 11111111 111 1122356788999
Q ss_pred hhccCCCCCCCCHHHHHHHhcC
Q 035655 595 LCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 595 ~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+||+.||.+||++.|+++.|+.
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.14 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=204.5
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.+-....+.+.....||+|.||+||+|.+-+ ..+.|++|+.++++-||.||+-+.|||..... .
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3334445566778999999999999998743 56899999999999999999999999998877 9
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
||..+|+|-+|+.+|+..+ ..+...+.++|++|||+|+.|||. ++|||||||..||+|.++++|||+||||+....
T Consensus 464 IiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999998765 468999999999999999999999 999999999999999999999999999997544
Q ss_pred CCC-cceeeccccCcCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 500 HGK-ISHTTNVVGTIGYIAPELARTG---KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 500 ~~~-~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
.-. ........|...|||||+++.+ +|+..+||||||||+|||+||..||.......+-|. .++-.-..|.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-----VGrG~l~pd~ 614 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-----VGRGYLMPDL 614 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-----ecccccCccc
Confidence 321 1122334678899999998754 689999999999999999999999984332222221 1111111111
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC-CCCCCC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL-LPIIDN 625 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~-~p~~~~ 625 (670)
. .......+.+.+|+..||..++++||.+.+|+..|+...+ +|.+.+
T Consensus 615 s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 615 S---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred h---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 1 1122345677888899999999999999999998876654 555443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=374.11 Aligned_cols=247 Identities=29% Similarity=0.501 Sum_probs=204.0
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
...+...+.||+|+||.||+|..... .....+|++.+++++||||++++|+|.+.+..++||||+++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 34577889999999999999986421 112346799999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.++++ .++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||........ ..
T Consensus 769 ~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~ 837 (968)
T PLN00113 769 NLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TK 837 (968)
T ss_pred cHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CC
Confidence 9999994 38999999999999999999997666899999999999999999988876 6665433221 22
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC---cchhHHHHHHHhhcCCcccccCCCCCC--cccH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD---HFILVDWVLEFQHLGQVLDVVDPNLGS--SYVV 583 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~ 583 (670)
..+|..|||||++.+..++.|+|||||||++|||++|+.||+.. .....+|+............+|+.+.. ..+.
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 36889999999999999999999999999999999999999642 334666766554444455566666643 3455
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
+++.++.+++.+||+.+|++||+|+||++.|+...
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 67778999999999999999999999999998653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=366.84 Aligned_cols=240 Identities=27% Similarity=0.432 Sum_probs=198.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++....+.||+|.||.||.|...+ ...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667899999999999997633 356899999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC-----ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 419 LLVYDYIPNGSLDSLLFDNE-----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
+|++|||++|+|..||++.+ ...|+..+.+.++.|||+|+.||++ +++|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 3468999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc-hhHHHHHHHhhcCCcc
Q 035655 494 LARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF-ILVDWVLEFQHLGQVL 570 (670)
Q Consensus 494 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~-~~~~~~~~~~~~~~~~ 570 (670)
||+.+...... ......-...|||||.+..+.++.|+|||||||++||++| |..||..... ..... ....+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---~~~gg--- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---VLEGG--- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---HHhCC---
Confidence 99954443322 2222244578999999999999999999999999999999 9999976321 11111 11122
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+ -+.+..+++.+.+++..||+.+|++||++..+++.+..
T Consensus 922 -----R--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 922 -----R--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred -----c--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 1 12344566788999999999999999999999998765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.29 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=199.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.+.|+..+.||.|..+.||+|+... ..+.+.+|+..|+.++||||++++..|..++.+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578889999999999999997532 35778899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
||.+||+.++++..-...+.+..+..|++++++||.|||+ +|.||||||+.||||+++|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999988776779999999999999999999999 9999999999999999999999999998765543322
Q ss_pred ce--e-eccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 504 SH--T-TNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 504 ~~--~-~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.. . .+.+||++|||||++.. ..|+.|+|||||||..+||.+|..||.......+ .-....+......-..+.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHhcCCCCCcccccCC
Confidence 21 1 45699999999999543 3689999999999999999999999986432211 111111111111111222
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+........+.+++..|+++||.+|||+++++++-
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 223333446788999999999999999999999853
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.00 Aligned_cols=234 Identities=28% Similarity=0.474 Sum_probs=196.2
Q ss_pred ccceEeeeCceeEEEeeccchH------HHHH-HHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCC
Q 035655 366 QSEVIGTGGFGEVYKGVLPTRM------REFA-AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE 438 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~~~------~~f~-~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~ 438 (670)
+.+-||.|+.|.||+|++.... ++.+ .+|+-|++|+||||+.+.|+|.....+|||||||..|-|...|+..
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~- 206 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG- 206 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-
Confidence 4678999999999999987642 2222 5899999999999999999999999999999999999999999654
Q ss_pred ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCc
Q 035655 439 NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518 (670)
Q Consensus 439 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 518 (670)
..++.....++.++||.||.|||. +.|||||||.-||||..+..+||+|||-++..... .....++||..||||
T Consensus 207 -~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAP 280 (904)
T KOG4721|consen 207 -RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAP 280 (904)
T ss_pred -CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCH
Confidence 468889999999999999999999 99999999999999999999999999999866543 344567999999999
Q ss_pred cccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhcc
Q 035655 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSH 598 (670)
Q Consensus 519 E~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 598 (670)
|++++.+.++|.||||||||||||+||.-||.+-+..-+-|- .. .. .|.-..+..+++-+.-|+.+||+
T Consensus 281 EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG--VG--sN-------sL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 281 EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG--VG--SN-------SLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred HHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe--cc--CC-------cccccCcccCchHHHHHHHHHHh
Confidence 999999999999999999999999999999976332222221 11 11 12223344455667788999999
Q ss_pred CCCCCCCCHHHHHHHhcCC
Q 035655 599 QKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 599 ~dP~~RPs~~evl~~L~~~ 617 (670)
..|..||++++++.||+-.
T Consensus 350 sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCCCCCccHHHHHHHHhhc
Confidence 9999999999999999744
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.87 Aligned_cols=236 Identities=24% Similarity=0.323 Sum_probs=191.0
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.|+..+.||+|+||.||++.... ....+.+|+.++++++|+||+++.+++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 36778999999999999987632 12346789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988866555568999999999999999999998 899999999999999999999999999998754322
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .......... . ...++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------~--~~~~~ 225 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--------D--QEEYS 225 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--------c--cccCC
Confidence 2234578999999999999999999999999999999999999997633211 1111110000 0 01122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
......+.+++..||+.||.+||+ +++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 223456788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.33 Aligned_cols=240 Identities=28% Similarity=0.438 Sum_probs=192.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.+.. ..+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 3568889999999999999986421 22468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 368999999999999999999998 8999999999999999999999999998765432
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
..........++..|+|||.+.+..++.++|||||||+++|+++ |+.||...... +..... ..+. .+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~-~~~~-----~~~--- 228 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAV-EDGF-----RLP--- 228 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH-HCCC-----CCC---
Confidence 22121222345678999999999999999999999999999775 99999753221 111111 1111 011
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.+++..||+++|.+||+++++.+.|..
T Consensus 229 -~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 -APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 112234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=310.70 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=191.0
Q ss_pred cCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+.|+...++|+|+||.||||+.+++ .+-..+||++|++|+|+|+|.|+.+|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999988662 2334599999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
||+..-|.+ |.... ..++.+.+.+++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||+|+.... ..
T Consensus 82 ~~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 998754444 43333 358899999999999999999999 9999999999999999999999999999998764 23
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-------------HhhcCCc
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE-------------FQHLGQV 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~-------------~~~~~~~ 569 (670)
...+..+.|..|.|||.+.+ .+|....||||+||++.||++|...|.+....-.-+... +......
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44566788999999999887 689999999999999999999999997633211111100 1111111
Q ss_pred c--cccCCCCCCc---ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 L--DVVDPNLGSS---YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~--~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. .+..+.-... -.+....-+++++..|++.||.+|++-+|++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 1111111111 112234578999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=327.15 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=193.8
Q ss_pred cCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV 421 (670)
+.|+..++||+|.||.|||++...+ ..-..+||.+|++|.||||++|.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3466778999999999999987442 12345999999999999999999998766 689999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+|||+. +|.-++... .-.++..++..+++|++.||.|||+ ++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 787777543 3479999999999999999999999 99999999999999999999999999999998887
Q ss_pred CcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccCC--CC
Q 035655 502 KISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDP--NL 577 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~--~l 577 (670)
.....+..+-|+.|.|||++.+. .|+...|+||.||||.||+.|+..|.+... .....+ +...+...+..-+ .|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI--fklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI--FKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH--HHHhCCCChhccccccC
Confidence 76667788899999999988875 799999999999999999999999987322 111111 1111111111111 00
Q ss_pred --------CCcccHH-------HHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 578 --------GSSYVVA-------EMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 578 --------~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+... .....++|+..+|..||.+|.|+.++++.=
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 1111111 134567888889999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.76 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=196.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccch---------HHHH--------HHHHHHHhccc-cCceeeeeeeeeccC-eeEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR---------MREF--------AAEIESLGRLR-HKHLVNLQGWCKRKR-DLLL 420 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~---------~~~f--------~~Ei~~L~~l~-H~nIv~l~g~~~~~~-~~~l 420 (670)
..++|...++||.|.||.||+|+.... ++.| .+|++.|++|+ |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356788899999999999999986541 1222 38999999999 999999999999887 9999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|||||+ .+|++.++++ +..+++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+||....
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 999994 6999999887 6789999999999999999999998 9999999999999999999999999999997654
Q ss_pred CCcceeeccccCcCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhc------------
Q 035655 501 GKISHTTNVVGTIGYIAPELA-RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHL------------ 566 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~------------ 566 (670)
. ...+..+.|..|.|||++ +.+.|+.+.|+||+|||++|+.+-+..|.+... ..+-.+.+....
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3 345667899999999975 567899999999999999999999999976322 111111111100
Q ss_pred CCcccccCCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 567 GQVLDVVDPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 567 ~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+...-|... .........++++++..|++-||.+|||++|++++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000111111111 111222567788999999999999999999999974
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.77 Aligned_cols=239 Identities=29% Similarity=0.429 Sum_probs=194.6
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
+....++||+|+||.||+|.+.. ...+|.+|+++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999997632 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|||+|.||+|++||.+... .++..++++++.+.|+||+|||+ +.++||||.++|+|++.++.+||+||||++...
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999988764 69999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l 577 (670)
. .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+.... ...++. . ...
T Consensus 314 ~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~---------~~~ 380 (474)
T KOG0194|consen 314 Q-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---K---------NGY 380 (474)
T ss_pred c-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---h---------cCc
Confidence 1 1111112245689999999999999999999999999999999 89999863322 111110 1 111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
+...+...+..+..++..||..+|++||+|.++.+.|+...
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 11222233456677778999999999999999999997653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.12 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=191.3
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------------------hHHHHHHHHHHHhccccCceeee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------------------RMREFAAEIESLGRLRHKHLVNL 408 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------------------~~~~f~~Ei~~L~~l~H~nIv~l 408 (670)
++|...++||+|+||.||++.+.. ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999986311 23468899999999999999999
Q ss_pred eeeeeccCeeEEEEeccCCCCchhhcccCC-----------------ccccCHHHHHHHHHHHHHHhhhccccccceEEe
Q 035655 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNE-----------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471 (670)
Q Consensus 409 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 471 (670)
++++.+.+..++||||+++|+|.+++.... ...++|.++++++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999985421 1247889999999999999999998 89999
Q ss_pred cccCCCcEEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCC
Q 035655 472 RDVKSGNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT--GRRP 548 (670)
Q Consensus 472 rDIkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t--G~~p 548 (670)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||+++||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865443221 1223456789999999988899999999999999999987 5667
Q ss_pred CCCCc-chhHHHHHHHhhcC-CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 549 IDSDH-FILVDWVLEFQHLG-QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 549 f~~~~-~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
|.... ......+....... ....... +......+.+++.+||+.+|.+||+++||.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76422 11222221111111 0000001 1122356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.66 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=197.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccchH-------------------HHHHHHHHHHhcc-ccCceeeeeeeeeccCee
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPTRM-------------------REFAAEIESLGRL-RHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~~~-------------------~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 418 (670)
...++|..++.||+|.|++|++|+..... +....|-.+|.+| .||.|++|+--|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567888999999999999999876522 2344788899999 799999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
|+|+||++||+|.++|++.+ .+++...+-++.+|+.||+|||+ .|||||||||+|||||++|++||.|||-|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999997764 58999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCcc----------e--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc
Q 035655 499 DHGKIS----------H--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 499 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~ 566 (670)
...... . ....+||..|.+||++.....+..+|+|+||||||+|+.|+.||......+.- +
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-----q-- 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-----Q-- 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-----H--
Confidence 643221 1 14479999999999999999999999999999999999999999875433221 1
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+++ .++-.+...+ .+.+.+|+...|..||.+|++.+||.+|.
T Consensus 298 -kI~-~l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 -KIQ-ALDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -HHH-HhcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111 1122222223 35667788888999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.20 Aligned_cols=241 Identities=26% Similarity=0.432 Sum_probs=197.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..++||+|+||.||+|.... ..+.+.+|+.++++++|+||+++++.+...+..++++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 3578889999999999999997543 24578899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.+.....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999977655678999999999999999999998 8999999999999999999999999999987654332222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||++..+.++.++|||||||+++||++ |+.||....... ...... ... ..... ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~-~~~-----~~~~~----~~~ 229 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQ-RGY-----RMPRM----ENC 229 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHH-cCC-----CCCCC----CCC
Confidence 33456778999999998889999999999999999998 999997532211 111111 110 01111 112
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+|++++|++||+++++.+.|+.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.34 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=197.5
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccC
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKR 416 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~ 416 (670)
....+|...+.||+|.||+|++|.... ..+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999996532 1234558999999999 999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCc
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLA 495 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla 495 (670)
..++||||+.+|+|.+++.+ ..++.+.+...++.|+++|++|||+ ++|+||||||+|||+|.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999977 3468999999999999999999999 999999999999999999 99999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGK-AS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 573 (670)
.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+......... . ...++ ..
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--k-i~~~~---~~ 241 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--K-IRKGE---FK 241 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH--H-HhcCC---cc
Confidence 9874 2223455679999999999999877 76 78999999999999999999998743221111 1 11111 00
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
-|. ... ...+..++..|+..||.+|+++.+++++=+-.
T Consensus 242 ~p~---~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 242 IPS---YLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred CCC---CcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 111 111 45678899999999999999999999875544
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.57 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=196.2
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.+|...+.||+|+||.||+|...+ ..+++.+|++++++++||||++++++|......++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 457788999999999999997643 24578899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 9999999977655679999999999999999999998 8999999999999999999999999999987654332222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||.+.+..++.++|||||||+++||++ |..||...... +....... . ..+ ..+...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~-~-----~~~----~~~~~~ 230 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK-G-----YRM----ERPEGC 230 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC-C-----CCC----CCCCCC
Confidence 22344678999999998899999999999999999998 99998753321 11111111 0 111 111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+||+.+|++||++.++++.|+.
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 3567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.27 Aligned_cols=240 Identities=26% Similarity=0.459 Sum_probs=194.5
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|+..+.||+|+||.||+|.... ....|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999986421 1346889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCc--------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 420 LVYDYIPNGSLDSLLFDNEN--------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
++|||+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999965321 458899999999999999999998 8999999999999999999
Q ss_pred cEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHH
Q 035655 486 NARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEF 563 (670)
Q Consensus 486 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~ 563 (670)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+++||++ |..||...... +. ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~-~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EV-IEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHH
Confidence 999999999986543221 22233466889999999988899999999999999999998 99998753221 11 111
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.. ...+...+..+.+++.+||+.||.+||+++||+++|++
T Consensus 239 i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 11222344678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=322.17 Aligned_cols=234 Identities=32% Similarity=0.550 Sum_probs=185.3
Q ss_pred ccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 366 QSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
..+.||+|.||.||+|.+.. ..++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 46789999999999998761 247899999999999999999999999988889999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI- 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~- 503 (670)
+++|+|.++|.......+++.++.+|+.||++||.|||+ .+++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999988755679999999999999999999998 8999999999999999999999999999987733222
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
...........|+|||.+....++.++||||||+++|||++ |+.||..... .+..... ....... .+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~-~~~~~~~---------~~ 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL-KQGQRLP---------IP 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH-HTTEETT---------SB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc-cccccce---------ec
Confidence 22233467789999999999889999999999999999999 7889865322 2222222 1111111 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
......+.+++..||+.+|.+||+++++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12235677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.61 Aligned_cols=241 Identities=28% Similarity=0.434 Sum_probs=196.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|++|.||+|.... ..++|.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568889999999999999987533 24678899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.......+++..+.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 9999999977655578999999999999999999998 8999999999999999999999999999987754322222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....+..|+|||++.+..++.++||||||++++||++ |+.||....... ........ . . ...+...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~-~----~----~~~~~~~ 229 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQG-Y----R----MPCPPGC 229 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC-C----C----CCCCCcC
Confidence 22233468999999998899999999999999999999 999997533211 11111111 0 0 0111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+.+++.+|++.+|.+||+++++++.|+.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 4678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.16 Aligned_cols=234 Identities=24% Similarity=0.389 Sum_probs=197.3
Q ss_pred CccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.|....+||+|.-|.||.+.... ..+-..+|+.+|+.++|+|||++++.+..++++++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 45666889999999999986533 23446799999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+.+... .+++.++..|+.++++||+|||. ++|+|||||.+||||+.++.+||+|||++..+..... ..
T Consensus 354 ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999998543 48999999999999999999999 9999999999999999999999999999988766543 55
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...+||+.|||||++....|.+|.||||||++++||+-|..||-.+......|... ..+ .|++ ..+....
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa--~ng------~P~l--k~~~klS 496 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNG------TPKL--KNPEKLS 496 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--hcC------CCCc--CCccccC
Confidence 66799999999999999999999999999999999999999997655433333211 111 1222 2233445
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+.+++.+||+.|+.+||++.|+|+|
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 678889999999999999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.54 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=191.4
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999998743 13457789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++++.|..+... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998877655432 2358999999999999999999998 8999999999999999999999999999987654333
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH-HHHH------------HhhcCCcc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD-WVLE------------FQHLGQVL 570 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~-~~~~------------~~~~~~~~ 570 (670)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||......... .... ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 3334457899999999999888999999999999999999999999763221100 0000 00000000
Q ss_pred cccCCCCC------CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLG------SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+... ..+.......+.+++..||+.||++||+++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00001110 00111134568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=330.06 Aligned_cols=233 Identities=27% Similarity=0.398 Sum_probs=197.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|.+.+.||+|.||.||||+-+. ..+...+|++++++|+||||+.+++||+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999997644 23457899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+.+ +|..+|... ..++++.+..++.++..||.|||+ .+|+|||+||.||||+..+.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 9976 999999665 459999999999999999999999 999999999999999999999999999999887644
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
...+...||+-|||||+..+++|+..+|.||+||++||+++|++||..... ...+..... ||. .++.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I~~--------d~v---~~p~ 221 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSILK--------DPV---KPPS 221 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHHhc--------CCC---CCcc
Confidence 445667999999999999999999999999999999999999999975321 111111111 111 1223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+..++...+++||..|.+..+++.|-
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 4456677888889999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.45 Aligned_cols=232 Identities=18% Similarity=0.282 Sum_probs=186.9
Q ss_pred cceEeeeCceeEEEeeccc--------------h---HHHHHHHHHHHhccccCceeeeeeeeec----cCeeEEEEecc
Q 035655 367 SEVIGTGGFGEVYKGVLPT--------------R---MREFAAEIESLGRLRHKHLVNLQGWCKR----KRDLLLVYDYI 425 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~--------------~---~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~E~~ 425 (670)
...||+|+++.||+|.... . .+.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3679999999999998643 1 3567799999999999999999999876 35789999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.+. ..++|....+++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999764 3689999999999999999999972 478899999999999999999999999998654321
Q ss_pred eeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 506 TTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.......... .+.+ +.
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~-----~~~~----~~ 245 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKNN-----SLKL----PL 245 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcCC-----CCCC----CC
Confidence 23468899999999876 68899999999999999999999999864321 11111111110 1111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.....+.+++.+||+.||.+||+++|+++.|+..
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 2345688899999999999999999999998754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.20 Aligned_cols=237 Identities=26% Similarity=0.465 Sum_probs=192.9
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|+..+.||+|+||.||++.... ...+|.+|++++++++||||++++++|...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 457888999999999999987643 245788999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999987543 358999999999999999999998 89999999999999999999999999999765433322222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc-hhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
...++..|+|||++.+..++.++||||||++++||++ |+.||..... ...... ..... ...+.. .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~~~~---~~~~~~-------~ 226 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SRGFR---LYRPKL-------A 226 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCC---CCCCCC-------C
Confidence 3345678999999988889999999999999999999 8999975432 111111 11111 111111 2
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++.+||+.+|.+||+++++++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.24 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=193.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3678999999999999999987643 13468899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999996543 58999999999999999999997 246999999999999999999999999999765432
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhh-c--CCcc----------
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQH-L--GQVL---------- 570 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~-~--~~~~---------- 570 (670)
......||..|+|||++.+..++.++|||||||++|||++|+.||................ . ....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2234578999999999999899999999999999999999999997533211111000000 0 0000
Q ss_pred ---------------------c-ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 571 ---------------------D-VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 571 ---------------------~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+ +................+.+++.+||+.||++||+++|++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0 00000000000112356889999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.80 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred hcCccccceEeeeCceeEEEeecc-----c-----------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP-----T-----------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~-----~-----------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 417 (670)
.++|+..++||+|+||.||+|... + ..+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457888999999999999998531 0 234678999999999 89999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC-----------------------------------------------------------
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE----------------------------------------------------------- 438 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 438 (670)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986422
Q ss_pred --------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 439 --------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 439 --------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
...++|..+++++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1247899999999999999999998 89999999999999999999999999999866443221
Q ss_pred e-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 505 H-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
. .....++..|+|||++.+..++.++|||||||+++||++ |..||........ .. .....+.. ...+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~-~~~~~~~~--~~~~~------ 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FY-KMIKEGYR--MLSPE------ 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HH-HHHHhCcc--CCCCC------
Confidence 1 122345678999999999999999999999999999998 8889865321111 11 11111100 00111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+.+++.+||+.||++||++.||++.|+.
T Consensus 341 -~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 -CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 113467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.90 Aligned_cols=238 Identities=25% Similarity=0.406 Sum_probs=207.7
Q ss_pred CccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++...++||-|.||.||.|++++ ..++|..|..+|+.++|||+|+|+|+|.....+|||.|||.+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45567899999999999999876 357899999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+||++..+..++-...+.++.||++||.||.. +.+|||||.++|+|+.++..+|++||||++++..+......
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999999998888788999999999999999999998 89999999999999999999999999999999876655444
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...-.+.|.|||-+....++.|+|||+||++||||.| |..||.+-+...+ .+.+...++.+-+..++
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV------------Y~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------YGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH------------HHHHhccccccCCCCCC
Confidence 4556789999999999999999999999999999999 9999986433211 12223334445566677
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+.+|+++||+-+|.+||+++|+-+.++
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 88999999999999999999999988775
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.46 Aligned_cols=243 Identities=25% Similarity=0.411 Sum_probs=191.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
..++|+..+.||+|+||.||+++... ....+.+|+.+++.+ +||||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34578899999999999999876311 124578999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCC----------------------------------------------------------
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE---------------------------------------------------------- 438 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 438 (670)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999985421
Q ss_pred ----------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc-eee
Q 035655 439 ----------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS-HTT 507 (670)
Q Consensus 439 ----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~ 507 (670)
...+++.++++++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1247889999999999999999998 89999999999999999999999999999865443221 112
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|||||++.+..++.++|||||||++|||++ |+.||....... ... .....+ .....+ ....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~-~~~~~~--~~~~~~-------~~~~ 341 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY-KMVKRG--YQMSRP-------DFAP 341 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH-HHHHcc--cCccCC-------CCCC
Confidence 2345678999999998899999999999999999997 999997532211 111 111111 000111 1123
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++..||+.||.+||++.++++.|+.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.24 Aligned_cols=239 Identities=28% Similarity=0.512 Sum_probs=194.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.+.. ...+|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999987531 23568899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++++|.+++..... .+++.++++++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999976543 68999999999999999999998 9999999999999999999999999999987752
Q ss_pred CCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.... ......++..|+|||.+.+..++.++||||||++++||++ |..||...... ..... ..... .+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~----~~-- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV----EDGYR----LP-- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCC----CC--
Confidence 2211 1222345678999999998899999999999999999998 99998653211 11111 11100 00
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.+++.+||+.+|++||+++|++++|+.
T Consensus 229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111234567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.89 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=201.6
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
....+.++||+|.||+|.++.... ..++|.+|+++|.+|+||||++|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345678999999999999987543 3578999999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-cc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK-IS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~-~~ 504 (670)
++|+|.+||.++....+.-.....|+.|||+||+||.+ ..+|||||.++|+|+|.++++||+|||+++....+. ..
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999988865555667778899999999999999 999999999999999999999999999999655444 33
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCC-cchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT--GRRPIDSD-HFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t--G~~pf~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....+-+.+|||||.+..++++.++|||+||+.+||+++ ..+||+.- +...++-...+...+ .+......
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~------~~~~~l~~ 768 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ------GRQVVLSR 768 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC------CcceeccC
Confidence 3445567889999999999999999999999999999754 88898752 222222222221111 11111223
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+.-++..+.++++.||..+..+||+++++..+|..+
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 344567788999999999999999999999999754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=326.42 Aligned_cols=240 Identities=24% Similarity=0.311 Sum_probs=193.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468899999999999999997643 1245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999654 358999999999999999999998 8999999999999999999999999999975543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .+.. ....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~--~~~~-~~~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKETLQ--RPVY-DDPR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhcccccc--CCCC-Cccc
Confidence 23345799999999999998999999999999999999999999976432111 111111011110 1111 0000
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++..||+.+|.+||++++++++-.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 123456778889999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=318.46 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=186.9
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc---ccCceeeeeeeee-----c
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL---RHKHLVNLQGWCK-----R 414 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~-----~ 414 (670)
++|+..+.||+|+||.||++.... ....+.+|+.+++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999997521 113466788777766 6999999999985 2
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
....++|+||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 699999977655678999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhc---CCc-
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHL---GQV- 569 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~---~~~- 569 (670)
++..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ............ ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9866543 223345789999999999888999999999999999999999999976322 111111111000 000
Q ss_pred ------ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 ------LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+... ........+.+.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000000 00111223566789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=313.34 Aligned_cols=237 Identities=30% Similarity=0.461 Sum_probs=192.7
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|...+.||+|+||.||++.... ...+|.+|+.++++++||||++++++|.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 457788999999999999996532 235788999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++..... .+++.++++++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999976543 68999999999999999999998 89999999999999999999999999999866443322222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... ..+.. +.. +...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~-----~~~----~~~~ 226 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLR-----LYR----PHLA 226 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCC-----CCC----CCCC
Confidence 3345678999999988889999999999999999999 99998753321 11111 11110 000 1112
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++..||+.+|.+||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 367789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.91 Aligned_cols=255 Identities=31% Similarity=0.431 Sum_probs=196.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHh--ccccCceeeeeeeeeccC----eeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLG--RLRHKHLVNLQGWCKRKR----DLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~--~l~H~nIv~l~g~~~~~~----~~~lV~E 423 (670)
....+..+.||+|+||.||||.+.. ..+.|.+|-++.+ .++|+||+++++.-+... +++||+|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4456667899999999999998765 4567887766655 568999999999877665 8999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc------ccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE------WEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
|.++|||.+||..+ .++|....+|+..+++||+|||++ .+++|+|||||++|||+.+|+.+.|+|||||..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999655 689999999999999999999985 367899999999999999999999999999998
Q ss_pred ccCCCcc-eeeccccCcCCCCccccccC-CC-----CccchhHHHHHHHHHHHhCCCCCCC---------------Ccch
Q 035655 498 FDHGKIS-HTTNVVGTIGYIAPELARTG-KA-----SCSTDVFAYGVLLLEIATGRRPIDS---------------DHFI 555 (670)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~-----t~ksDV~S~Gvvl~el~tG~~pf~~---------------~~~~ 555 (670)
+..+... .....+||.+|||||++.+. .+ -.+.||||+|.|||||++....++. .+.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP- 444 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP- 444 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC-
Confidence 8765432 23447999999999998754 12 2479999999999999996654421 011
Q ss_pred hHHHHHHHhhcCCcccccCCCCCCccc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 035655 556 LVDWVLEFQHLGQVLDVVDPNLGSSYV-VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPII 623 (670)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~ 623 (670)
..+-++.... .+...|.+..... ...+..+.+.+..||..||+.|-|+.=+.+.+.....+.+.
T Consensus 445 t~e~mq~~VV----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVV----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHH----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111111 1122333322111 13467788999999999999999999999998877666553
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.02 Aligned_cols=240 Identities=29% Similarity=0.506 Sum_probs=198.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+..+|+..++||+|+||.||+|.... ...++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 35678889999999999999987643 245788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+.....+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999987666679999999999999999999998 89999999999999999999999999999766443221
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....++..|+|||.+.+..++.++||||||+++++|++ |+.||...... ..... .. . .....+
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~-~---------~~~~~~ 226 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TA-G---------YRMPCP 226 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---Hh-C---------CcCCCC
Confidence 223356778999999988899999999999999999998 89999753321 11111 11 0 001112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.+++.+||+.+|.+||+++++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2334567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.87 Aligned_cols=232 Identities=23% Similarity=0.286 Sum_probs=190.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368889999999999999998652 1235778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999654 358999999999999999999998 99999999999999999999999999999865432
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....||+.|+|||++.+..++.++|||||||+++||++|+.||....... ..... ..+. .. ++
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i-~~~~------~~----~~ 218 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKI-LAGK------LE----FP 218 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HhCC------cC----CC
Confidence 223578999999999998889999999999999999999999997643211 11111 1111 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 615 (670)
......+.+++..||+.||.+||+ ++++++|-+
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 112345778999999999999995 888887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.61 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=192.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..++||+|+||.||++.... ....+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4678999999999999999987642 12468899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999654 358999999999999999999997 247999999999999999999999999998755332
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc------------
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD------------ 571 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 571 (670)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.................+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 1233468999999999998889999999999999999999999997533221111111000000000
Q ss_pred ---ccCCCCC-----------------Cccc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 572 ---VVDPNLG-----------------SSYV-VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 572 ---~~d~~l~-----------------~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+... ...+ ......+.+++.+||+.||.+||+++|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000000 0000 012245789999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=295.27 Aligned_cols=236 Identities=24% Similarity=0.361 Sum_probs=201.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|++++.||+|.||.||.|+.++ ..+++.+|+++-+.|+||||+++++||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4578999999999999999998765 246788999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||.++|+|...|.......+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+..||+|||.+.....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 999999999999987777779999999999999999999998 9999999999999999999999999999976543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
....+.+||..|++||...+..++.+.|+|++|++.+|++.|..||+..... + ....-.-.+..+|
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--e----tYkrI~k~~~~~p------ 242 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--E----TYKRIRKVDLKFP------ 242 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--H----HHHHHHHccccCC------
Confidence 3456679999999999999999999999999999999999999999863311 1 1111111122222
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........+++..|+..+|.+|....|+++|-+
T Consensus 243 -~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 243 -STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred -cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 233456778999999999999999999998754
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.33 Aligned_cols=237 Identities=26% Similarity=0.422 Sum_probs=191.4
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
.+|+..+.||+|+||.||++.... ....|.+|++++++++||||+++++++...+..++|+||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 357788999999999999987532 235788999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++..+.. .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999976543 68999999999999999999998 89999999999999999999999999999865433222222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... . .... .+....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~-~-----~~~~----~~~~~~ 227 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSA-G-----YRLY----RPKLAP 227 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHc-C-----CcCC----CCCCCC
Confidence 2234568999999998899999999999999999999 899987532211 1111111 0 1111 111234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..+.+++.+||+.+|++||++.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.42 Aligned_cols=249 Identities=20% Similarity=0.232 Sum_probs=191.5
Q ss_pred cCccccceEeeeCceeEEEeeccc----------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
++|+..++||+|+||.||++.... ....+.+|++++++|+||||+++++++......++|+|++. ++|.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 579999999999999999998754 23457899999999999999999999999999999999995 7898
Q ss_pred hhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecccc
Q 035655 432 SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG 511 (670)
Q Consensus 432 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g 511 (670)
+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..............|
T Consensus 171 ~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 245 (391)
T PHA03212 171 CYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245 (391)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccC
Confidence 888654 358999999999999999999998 899999999999999999999999999997543322223344679
Q ss_pred CcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc--------hhHHHHHHHhhc----------CCcc---
Q 035655 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF--------ILVDWVLEFQHL----------GQVL--- 570 (670)
Q Consensus 512 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--------~~~~~~~~~~~~----------~~~~--- 570 (670)
|+.|+|||++.+..++.++|||||||++|||++|+.|+..... ............ ..+.
T Consensus 246 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~ 325 (391)
T PHA03212 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY 325 (391)
T ss_pred ccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHH
Confidence 9999999999988999999999999999999999988643110 000000000000 0000
Q ss_pred ------cccCCCCCCcc--cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 571 ------DVVDPNLGSSY--VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 571 ------~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+...... .......+.+++.+||+.||.+|||++|++++-.-
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 326 IGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 00001000000 11234568889999999999999999999986543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.18 Aligned_cols=231 Identities=23% Similarity=0.276 Sum_probs=190.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 568889999999999999997643 1245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999754 358899999999999999999999 899999999999999999999999999998664322
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .....+. ..+ +
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~-~~i~~~~------~~~----p 235 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--Y-EKILAGR------LKF----P 235 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--H-HHHhcCC------cCC----C
Confidence 235799999999999998999999999999999999999999976432110 0 1111111 011 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 614 (670)
......+.+++..||+.||.+||+ ++++++|-
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 112245678999999999999986 78888774
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.32 Aligned_cols=228 Identities=22% Similarity=0.265 Sum_probs=185.7
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||++.... ....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999987643 1235678999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 999998654 368999999999999999999998 899999999999999999999999999987532211 22334
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..||+.|+|||++.+..++.++|||||||+++||++|+.||......... .....+ +..+ +......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~~~~~------~~~~----p~~~~~~ 221 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELILME------EIRF----PRTLSPE 221 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HHHHcC------CCCC----CCCCCHH
Confidence 57999999999999999999999999999999999999999764322110 111111 1111 1223356
Q ss_pred HHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 589 VLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+.+++..||+.||++|| ++.++++|-
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 77899999999999999 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.73 Aligned_cols=239 Identities=28% Similarity=0.476 Sum_probs=193.5
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|++.++||+|+||.||++.... ..+.|.+|+.++++++|+|++++++++.+ ...+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 467888999999999999997543 24678899999999999999999998854 568999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.+.....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999999977555568999999999999999999998 89999999999999999999999999999876543322222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|+|||.+.+..++.++||||||++++||++ |+.||...... +....... . ..+ ..+....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~-~-----~~~----~~~~~~~ 229 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVER-G-----YRM----PCPQDCP 229 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-C-----CCC----CCCCcCC
Confidence 3345678999999988899999999999999999999 89998753221 11111111 0 011 1122234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++.+|++++|.+||+++++.+.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.21 Aligned_cols=234 Identities=26% Similarity=0.426 Sum_probs=196.7
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
..|...++||+|.||.||||.+.. ...+..+|+.+|..++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999998754 345677899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
|.+|++.+.|... ..+.+..+.-|+++++.||.|||+ .+.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999544 345788888899999999999999 89999999999999999999999999999887665433
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
. .+.+||+.|||||++....|+.|+||||||++.+||.+|..|+...+.. ...--+.....|.+.+ .
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L~~----~ 234 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRLDG----D 234 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcccc----c
Confidence 3 6789999999999999889999999999999999999999998753321 0111112223444444 3
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++..|+++||+.||++.++++|
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 44567888999999999999999999985
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.03 Aligned_cols=241 Identities=24% Similarity=0.427 Sum_probs=192.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.+++|+..+.||+|+||.||+|.... ...+|.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999876421 23458899999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC--------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE--------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
.++|+||+++|+|.+++.+.. ...+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 1246889999999999999999998 89999999999999999999999
Q ss_pred EeecCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
+|||+++......... .....+++.|+|||.+.++.++.++|||||||+++||++ |..||...... ... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~-~~~~~~ 237 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL-RFVMEG 237 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH-HHHHcC
Confidence 9999987554332211 122345788999999998899999999999999999999 78898753221 111 111111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... . .+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 238 ~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GLL-----D----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CcC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111 0 11122356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.44 Aligned_cols=235 Identities=25% Similarity=0.397 Sum_probs=201.2
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe-eEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD-LLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-~~lV~ 422 (670)
++|...+.+|+|+||.++..+.+. ..+...+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 568888999999999998765433 34467799999999999999999999998887 99999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
+|++||+|.+.|.+..+..++++++.+++.|++.|+.|||+ ..|+|||||+.||+++.+..|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999988777789999999999999999999997 999999999999999999999999999999887754
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. ++... . +......
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---~----------~~~~~Pl 226 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---N----------RGLYSPL 226 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---h----------hccCCCC
Confidence 2345679999999999999999999999999999999999999999875432 22111 1 1111223
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+......+..++..|++.+|..||++.+++.+
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 34445678889999999999999999999985
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.93 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=191.2
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.+|+..+.||+|+||.||+|.+.. ..++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468899999999999999996421 235688999999999999999999999765 5789
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997653 358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCccee-eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKISHT-TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||+...... .. .....+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~-~~~~~~~~--~~~~--- 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS-SILEKGER--LPQP--- 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH-HHHhCCCC--CCCC---
Confidence 332211 22344678999999999999999999999999999998 999997643221 11 11111110 0011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+.+++..||+.+|.+||++.++++.|...
T Consensus 234 ----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 234 ----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11224577899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.81 Aligned_cols=241 Identities=27% Similarity=0.464 Sum_probs=194.5
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|...+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457788999999999999986311 23568899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc
Q 035655 421 VYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 486 (670)
||||+++++|.+++..+. ...++|..+++++.||+.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999996532 2348999999999999999999998 89999999999999999999
Q ss_pred EEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHh
Q 035655 487 ARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQ 564 (670)
Q Consensus 487 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~ 564 (670)
+||+|||++........ .......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence 99999999975543321 11233456789999999998899999999999999999998 999986533211 11111
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..+.... .+...+..+.+++.+||+++|.+||+++++++.|+..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 239 TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 1112335678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.37 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=191.3
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|+..+.||+|+||.||+|.... ....|.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 457788999999999999987310 12568899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC---------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 421 VYDYIPNGSLDSLLFDNE---------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
||||+++++|.+++.... ...+++.+++.++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 2358899999999999999999998 8999999999999999999
Q ss_pred cEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHH
Q 035655 486 NARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEF 563 (670)
Q Consensus 486 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~ 563 (670)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+++||++ |..||...... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543321 12233356778999999988889999999999999999998 99998653221 11111
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....... . .+......+.+++.+||+++|.+||++.+++++|..
T Consensus 239 ~~~~~~~-----~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLL-----P----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC-----C----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111 1 111223567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.70 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=188.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|...++||+|+||.||+|.... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 568889999999999999997542 123577999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++ |+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 97 49999886543 357899999999999999999998 899999999999999999999999999997654322 1
Q ss_pred eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHh------------hcCCcc
Q 035655 505 HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQ------------HLGQVL 570 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~------------~~~~~~ 570 (670)
......+++.|+|||++.+ ..++.++||||+||+++||++|+.||...... ......... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233468999999998865 56899999999999999999999999763321 111111100 000001
Q ss_pred cccCCCCCCc----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLGSS----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+..... ........+.+++..|++.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111100 001123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.73 Aligned_cols=240 Identities=28% Similarity=0.451 Sum_probs=194.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
..+|...++||+|+||.||+|.... ..+.|.+|++++++++||||+++++.+.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 3568889999999999999997643 23578899999999999999999998754 56899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++.+.....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 9999999976555568999999999999999999998 8999999999999999999999999999987655433222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||+..+..++.++|||||||+++||++ |+.||........ ....... ... ......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~~-----~~~----~~~~~~ 228 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERG-----YRM----PCPPEC 228 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhcC-----CCC----CCcccc
Confidence 33456778999999988899999999999999999999 8888875322111 1111100 001 112234
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+.+++.+|++++|.+||++.++++.|+.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 4667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.51 Aligned_cols=233 Identities=24% Similarity=0.295 Sum_probs=191.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999996432 12356789999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999996543 58999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. .+
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~i~~~~~------~~--- 247 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY---QKILEGII------YF--- 247 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH---HHHhcCCC------CC---
Confidence 2 23457999999999999888999999999999999999999999864322111 11111110 11
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHhc
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYLN 615 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 615 (670)
+......+.+++..|++.||.+|+ +++++++|-.
T Consensus 248 -p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 248 -PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred -CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 111224567889999999999995 8999988743
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.17 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=191.7
Q ss_pred CccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
+|+..+.||+|+||.||+|.... ..+++.+|+.++++++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999986421 13468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC----------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCc
Q 035655 421 VYDYIPNGSLDSLLFDNE----------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 478 (670)
++||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999985421 2358899999999999999999998 899999999999
Q ss_pred EEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchh
Q 035655 479 VLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFIL 556 (670)
Q Consensus 479 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~ 556 (670)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976533221 11223356778999999988889999999999999999999 999997533211
Q ss_pred HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 557 VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.+....... .. ..+......+.+++..||+++|.+||+++++++.|++.
T Consensus 238 ---~~~~~~~~~-----~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 ---LFNLLKTGY-----RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ---HHHHHhCCC-----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111111110 01 11122235678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=306.90 Aligned_cols=235 Identities=30% Similarity=0.413 Sum_probs=194.2
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|...+.||+|++|.||++.... ..+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47778999999999999997632 345788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 999999999987655679999999999999999999998 8999999999999999999999999999987654322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......|++.|+|||+..+..++.++|||||||+++||++|+.||...... ... .....+. .+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~-----~~~----~~~~ 224 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALI-LKIIRGV-----FPP----VSQM 224 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHcCC-----CCC----Cccc
Confidence 223346889999999999989999999999999999999999999764321 111 1111111 111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 34568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.89 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=193.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~ 417 (670)
.++|.+.++||+|+||.||+|+... ..+.|.+|+++|+++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5678889999999999999986411 1356889999999996 9999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC-----------------------------------------------------------
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE----------------------------------------------------------- 438 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 438 (670)
.++||||+++|+|.++|.++.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886431
Q ss_pred -----------------------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC
Q 035655 439 -----------------------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483 (670)
Q Consensus 439 -----------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~ 483 (670)
...+++.++++++.|+++||.|||+ .+++||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1247889999999999999999998 89999999999999999
Q ss_pred CCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHH
Q 035655 484 DMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVL 561 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~ 561 (670)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |..||........ ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 999999999999865433221 1223456788999999998899999999999999999997 9999875321110 11
Q ss_pred HHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 562 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.....+. .+ ..+......+.+++.+||+.+|++||++.++.+.|+..
T Consensus 351 ~~~~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKIKSGY-----RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHhcCC-----CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1111110 01 11122345678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.03 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=192.1
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.+++|...+.||+|++|.||+|.... ....|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678999999999999999987643 12468899999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCc-----cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNEN-----FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARL 489 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL 489 (670)
.++||||+++++|.+++..... ..++|.++++++.||+.||+|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865431 358999999999999999999998 8999999999999998765 5999
Q ss_pred EeecCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
+|||+++......... ......+..|+|||++.+..++.++|||||||+++||++ |+.||....... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence 9999998663322111 112234568999999998999999999999999999997 999997533211 111111111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
. ...+......+.+++.+|++.+|++||++.+|+++|+
T Consensus 239 ~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 R----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 1112223356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=307.55 Aligned_cols=239 Identities=27% Similarity=0.464 Sum_probs=193.0
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|...+.||+|++|.||++.... ..+.|.+|++++++++|||++++++++.. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 457888999999999999987533 23568899999999999999999998754 568999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 999999977655568999999999999999999998 89999999999999999999999999999876543322222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|+|||...+..++.++||||||++++||++ |+.||...... +....... . ..+ ..+....
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~-~-----~~~----~~~~~~~ 229 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVER-G-----YRM----PCPQGCP 229 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc-C-----CCC----CCCcccC
Confidence 3356778999999988899999999999999999999 89998753221 11111111 0 001 1112234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++.+||+++|.+||+++++++.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 668889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=336.52 Aligned_cols=236 Identities=22% Similarity=0.305 Sum_probs=191.4
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.|...+.||+|++|.||++.... ....+.+|+.+|++++||||++++++|...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999986432 1245678999999999999999999999999999999999
Q ss_pred CCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 426 PNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
++|+|.++|... ....+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23468899999999999999999998 8999999999999999999999999999987654322
Q ss_pred -ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 -SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||...... +..... ..+.. ++ .+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~-~~~~~----~~-----~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQV-LYGKY----DP-----FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhCCC----CC-----CC
Confidence 1234457999999999999999999999999999999999999999753321 111111 11111 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+.+++..||+.+|.+||++++++++
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1223467889999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=313.36 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=188.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..++||+|+||.||+|.... ....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4679999999999999999997642 12356789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 68888876543 358899999999999999999999 899999999999999999999999999997543322
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcc----------cc
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVL----------DV 572 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~----------~~ 572 (670)
.......+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.................+... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568999999998765 45788999999999999999999999763221111110000000000 00
Q ss_pred cCCC-CC--Cccc-H------HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 VDPN-LG--SSYV-V------AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 ~d~~-l~--~~~~-~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.++. .. .... . .....+.+++..|++.||++|||++|+++|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0000 00 0000 0 01245678999999999999999999998644
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.56 Aligned_cols=238 Identities=25% Similarity=0.301 Sum_probs=189.1
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCee
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~ 418 (670)
+|+..+.||+|+||.||++.... ..+.+..|++++++++ ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 47889999999999999876421 1234678999999995 89999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++|+|.+++..+ ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999654 358999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
............||+.|+|||++.+. .++.++|||||||+++||++|+.||..... ........... ..++.
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------~~~~~ 229 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL------KCDPP 229 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh------cCCCC
Confidence 44333334456799999999998765 478899999999999999999999964221 11111111110 11222
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHhc
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYLN 615 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 615 (670)
+.. .....+.+++.+||+.||++|| ++++++++-+
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 230 FPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 222 2234567889999999999999 7889988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.62 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=192.0
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+|+..++||+|+||.||++.... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47788999999999999987532 11346789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999998876555569999999999999999999999 899999999999999999999999999998754332
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......... ....++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~ 225 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------DQEEYS 225 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------cccccC
Confidence 12234789999999999988999999999999999999999999976332111 111110000 001122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
......+.+++..||+.||.+|| ++++++++-
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 23345678899999999999999 888988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=290.28 Aligned_cols=257 Identities=26% Similarity=0.342 Sum_probs=200.0
Q ss_pred cCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|...++||+|.||.||+|++..+ .....+||+.|+.++|+||+.|+++|-+.+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999987541 2346699999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
||+ .+|+..++++. ..++..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 996 49999997765 479999999999999999999999 8999999999999999999999999999998876543
Q ss_pred ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC----
Q 035655 504 SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG---- 578 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~---- 578 (670)
.. +..+-|..|.|||.+.+. .|....||||.|||+.||+-|..-|.++. .+.+...-+...+...+..-|.+.
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 33 333789999999988875 68999999999999999999877665522 222222222222221111111111
Q ss_pred ------------CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC-CCCCCCCC
Q 035655 579 ------------SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD-ELLPIIDN 625 (670)
Q Consensus 579 ------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~~~~ 625 (670)
...-.......++++..++..||.+|+++.|++++=.-. .|.|..+.
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~ 294 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS 294 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence 112223345679999999999999999999999875432 45555443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.30 Aligned_cols=240 Identities=28% Similarity=0.467 Sum_probs=195.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..++||+|+||.||++.... ...+|.+|+.++++++|+||+++++++. .+..++++||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3568889999999999999997643 2467899999999999999999999874 457899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 9999999977666679999999999999999999998 8999999999999999999999999999987654332223
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||++....++.++||||||++++||++ |+.||...... +....... .. ... .+...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~-~~-----~~~----~~~~~ 228 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLER-GY-----RMP----RPDNC 228 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHc-CC-----CCC----CCCCC
Confidence 33456788999999998889999999999999999999 99999753211 11111111 10 001 11122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+|++.+|++||+++++++.|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 3568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=320.82 Aligned_cols=234 Identities=24% Similarity=0.424 Sum_probs=182.8
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+|+..++||+|+||.||+++... ..+.+.+|++++++++|+||+++++++.+.+.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 34557889999999999997642 1356889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+.. ...+..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 999997643 35677888999999999999998 899999999999999999999999999998764432 12
Q ss_pred eeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 506 TTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|......... ...+ .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~---~~~~----~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICM---SQPP----E 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhc---cCCC----C
Confidence 234579999999998753 23356899999999999999999999742211 12111110000 0011 1
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........+.+++..||+.||.+||++.|+++|-.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 11223356788999999999999999999999744
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.86 Aligned_cols=239 Identities=25% Similarity=0.441 Sum_probs=193.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|...+.||+|+||.||+|.... ..+.|.+|+++|++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467888999999999999986521 235788999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc
Q 035655 419 LLVYDYIPNGSLDSLLFDNE------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 486 (670)
++||||+++++|.+++.... ...+++.++..++.|++.||.|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999996532 2458899999999999999999998 89999999999999999999
Q ss_pred EEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc-hhHHHHHHH
Q 035655 487 ARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF-ILVDWVLEF 563 (670)
Q Consensus 487 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~-~~~~~~~~~ 563 (670)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||+++||++ |+.||..... ...+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~--- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI--- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence 99999999976533221 11223356788999999999999999999999999999998 9999865322 112111
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+... ..+......+.+++..||+.||.+||++.|+++.|+
T Consensus 238 -~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 -TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 111123356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.30 Aligned_cols=239 Identities=25% Similarity=0.395 Sum_probs=190.0
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|+..+.||+|+||.||+|.+.. ..+++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467778999999999999987521 12456778889999999999999998864 55788
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
++||+++|+|.+++.... ..++|..++.++.||+.||.|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997643 368999999999999999999998 8999999999999999999999999999986643
Q ss_pred CCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......++..|+|||.+.++.++.++|||||||++||+++ |+.||........... ...+.. ...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~~~--~~~~~~- 235 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LEKGER--LAQPQI- 235 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCc--CCCCCC-
Confidence 3221 2233467789999999998899999999999999999998 9999976432211111 111111 111111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....+.+++..||+.+|.+||++.|+++.|...
T Consensus 236 ------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 236 ------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred ------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 124567788999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.66 Aligned_cols=228 Identities=22% Similarity=0.266 Sum_probs=184.2
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||++.... ....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999987543 1235668999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999988654 358999999999999999999998 899999999999999999999999999987532221 12234
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ..... ..+ +......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~-~~~~~------~~~----p~~~~~~ 221 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FEL-ILMEE------IRF----PRTLSPE 221 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHH-HhcCC------CCC----CCCCCHH
Confidence 5799999999999999999999999999999999999999975332111 000 00010 111 1122355
Q ss_pred HHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 589 VLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+.+++..||+.||.+|| ++.+++++-
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 67899999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.92 Aligned_cols=239 Identities=28% Similarity=0.346 Sum_probs=192.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|...+.||+|+||.||++.... ....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 468899999999999999998652 2345778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 468999999999999999999999 999999999999999999999999999998654432
Q ss_pred ----------------------------cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Q 035655 503 ----------------------------ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF 554 (670)
Q Consensus 503 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~ 554 (670)
........||+.|+|||++.+..++.++|||||||+++||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345799999999999999999999999999999999999999976442
Q ss_pred hhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHHhc
Q 035655 555 ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT-MRQVLRYLN 615 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 615 (670)
.. ........... ...|.. . .....+.+++..|++ +|.+||+ +++++++..
T Consensus 236 ~~--~~~~i~~~~~~--~~~p~~-~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 236 QE--TYNKIINWKES--LRFPPD-P----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HH--HHHHHhccCCc--ccCCCC-C----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 11 11111110000 001110 0 123557788889997 9999999 999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.97 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=189.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|+..+.||+|+||.||+|.... ..+.|.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999986532 124678899999999 799999999999999999999
Q ss_pred EeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 422 YDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
+||+++++|.+++.+.. ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 1358899999999999999999998 899999999999999999999
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhc
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~ 566 (670)
||+|||++...... ........+..|+|||++.+..++.++|||||||+++||++ |+.||...... +..... ..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~-~~ 233 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKL-PQ 233 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-hc
Confidence 99999998643221 11111233567999999988889999999999999999997 99999764321 111111 11
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+ ..+. .+......+.+++..||+.+|.+||+++++++.|+..
T Consensus 234 ~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 234 G-----YRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred C-----CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111 1112235678899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=316.33 Aligned_cols=225 Identities=24% Similarity=0.260 Sum_probs=182.6
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||.||++.... ....+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999997643 124567899999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9999654 358999999999999999999998 899999999999999999999999999997543222 2234457
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
||+.|+|||++.+..++.++|||||||+++||++|+.||...... ....... ... .. ++......+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~~~~-~~~------~~----~~~~~~~~~~ 221 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYRKIL-QEP------LR----FPDGFDRDAK 221 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHHHHH-cCC------CC----CCCcCCHHHH
Confidence 999999999999999999999999999999999999999764321 1111111 110 11 1112234567
Q ss_pred HHHHhhccCCCCCCCC---HHHHHHH
Q 035655 591 QLGLLCSHQKAEARPT---MRQVLRY 613 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs---~~evl~~ 613 (670)
+++..||+.||.+||+ +.|+++|
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 8899999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.13 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=194.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
..++|+..+.||+|+||.||++.... ....+.+|+++++++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578889999999999999986421 124578899999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccC--------------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 417 DLLLVYDYIPNGSLDSLLFDN--------------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
..+++|||+++|+|.+++... ....+++..+++++.|++.||.|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999998642 23468999999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWV 560 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~ 560 (670)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 9999999999999866543221 1222345678999999988899999999999999999998 9999875332111
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+. ....+......+.+++.+||+.+|.+|||++|+++.|+.
T Consensus 244 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11111111 011122234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.28 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=197.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|+... ....+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 478889999999999999997532 1246789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988542 23458899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
... ......|++.|+|||.+.+..++.++||||||++++||++|+.||.........+........ .+..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~--- 228 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPL--- 228 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC------CCCC---
Confidence 321 122346888999999998888999999999999999999999999764433333222211111 1111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1123346688899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=312.76 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=193.1
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|.+.+.||+|+||+||++.... ..+.+.+|++++++++||||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 568889999999999999986311 23468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC-----------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 421 VYDYIPNGSLDSLLFDNE-----------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
|+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2358999999999999999999998 89999999999999999999999
Q ss_pred EeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... .......+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~~~ 238 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECITQG 238 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC
Confidence 99999976543221 11223345778999999998889999999999999999998 999987533211 11111111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
... ..... ....+.+++.+||+++|.+||+++++++.|+..
T Consensus 239 ~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 239 RVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred CcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111 11111 224578999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.40 Aligned_cols=232 Identities=25% Similarity=0.354 Sum_probs=194.0
Q ss_pred ccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
|+.++.||+|+-|.|-+|+...+ .....+||-+|+.+.|||+++++++++++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56678999999999998876441 23456899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|-|.++|..++ ++++.+..+++.||+.|+.|+|. .+|+|||+||+|+|||.++++||+|||+|.+...+.
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 99999999997654 69999999999999999999999 899999999999999999999999999998766554
Q ss_pred eeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
...+.+|.++|.|||++.+.+|. .++||||.|||||.|++|+.||+++... .. ....+.|.. +++.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--~L-LlKV~~G~f----------~MPs 233 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VL-LLKVQRGVF----------EMPS 233 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--HH-HHHHHcCcc----------cCCC
Confidence 33456999999999999999985 7999999999999999999999965432 11 111122211 1122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....++.+|+.+|+..||.+|.|++||++|-.
T Consensus 234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 234 NISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 23345678888999999999999999999853
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.50 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=194.2
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------------------hHHHHHHHHHHHhccccCceeee
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------------------RMREFAAEIESLGRLRHKHLVNL 408 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------------------~~~~f~~Ei~~L~~l~H~nIv~l 408 (670)
...++|...+.||+|.||.|-+++... ..+...+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345789999999999999999987532 12477899999999999999999
Q ss_pred eeeeecc--CeeEEEEeccCCCCchhhcccCCccc-cCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 409 QGWCKRK--RDLLLVYDYIPNGSLDSLLFDNENFV-LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 409 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
+.+..+. +.+|||+|||..|.+...- .... ++..+.++++.++..||.|||. ++||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCC
Confidence 9998765 6799999999998886653 2334 9999999999999999999999 9999999999999999999
Q ss_pred cEEEEeecCceeccCCCc----ceeeccccCcCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCcc-hh
Q 035655 486 NARLGDFGLARLFDHGKI----SHTTNVVGTIGYIAPELARTGK----ASCSTDVFAYGVLLLEIATGRRPIDSDHF-IL 556 (670)
Q Consensus 486 ~~kL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~ 556 (670)
.+||+|||.+.....+.. ......+||+.|||||...++. ...+.||||+||.||.|+.|+.||-.+.. .+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999987643321 1122358999999999887743 35689999999999999999999975321 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 557 VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
.+ .++...+.-.-.+++.+.+.+|++.+|++||..|.+..+|..|.+-...
T Consensus 328 ~~------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FD------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HH------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11 1222222222223456788899999999999999999999999875443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=306.05 Aligned_cols=241 Identities=29% Similarity=0.482 Sum_probs=196.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|.+.++||+|+||.||++.... ..+++.+|+.++++++|+||+++++++......++|+||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678899999999999999987543 24678999999999999999999999999899999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.+.....+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++...........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 9999999987665679999999999999999999998 8999999999999999999999999999987654322222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||.+.+..++.++||||||++++|+++ |+.||...... ........ .. ... .+...
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~--~~----~~~----~~~~~ 229 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVER--GY----RMP----RPPNC 229 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc--CC----CCC----CCCCC
Confidence 23345678999999998889999999999999999999 99999653211 11111110 00 001 11112
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+|++.+|.+||+++++.+.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 3568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.33 Aligned_cols=228 Identities=23% Similarity=0.271 Sum_probs=185.2
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||++.... ....+.+|+.++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999987533 2345778999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999988654 358999999999999999999998 899999999999999999999999999987533221 22234
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..||+.|+|||++.+..++.++|||||||+++||++|+.||....... .... .... +..+ +......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~-~~~~------~~~~----p~~~~~~ 221 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL-ILME------DIKF----PRTLSAD 221 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHH-hccC------CccC----CCCCCHH
Confidence 579999999999998899999999999999999999999997533211 1100 0000 1111 1122345
Q ss_pred HHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 589 VLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+.+++..||+.||.+|| ++.|++++-
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 77888999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.19 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=184.9
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----CeeE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RDLL 419 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~ 419 (670)
+|+..++||+|+||.||+|+... ....+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47888999999999999997643 124577899999999999999999988543 3589
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+. ++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6899988654 358999999999999999999999 899999999999999999999999999998543
Q ss_pred CCCc--ceeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh---------
Q 035655 500 HGKI--SHTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH--------- 565 (670)
Q Consensus 500 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~--------- 565 (670)
.... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 3221 11234579999999999865 67899999999999999999999999753321 1111100000
Q ss_pred -----cCCcccccCCCCCCccc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 566 -----LGQVLDVVDPNLGSSYV---VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 566 -----~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+.+.....+. ......+.+++..||+.||++||+++|++++-
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00000001110000000 11234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.27 Aligned_cols=239 Identities=26% Similarity=0.293 Sum_probs=191.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 478899999999999999987643 2245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997653 368999999999999999999999 899999999999999999999999999998765544
Q ss_pred cceeeccccCcCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 503 ISHTTNVVGTIGYIAPELAR------TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...............+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i~~~~~~~~~~~-- 232 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TYNNIMNFQRFLKFPE-- 232 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HHHHHHcCCCccCCCC--
Confidence 33334457999999999886 4567899999999999999999999997643211 1111111111111100
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+.+++..|++ +|.+||+++++++|-
T Consensus 233 -----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 233 -----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred -----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 01123456778888997 999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.47 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=189.7
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc-Ce
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK-RD 417 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~~ 417 (670)
++|++.+.||+|+||.||+|.... ..+.+..|+.+++++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999985311 124567899999999 899999999988654 56
Q ss_pred eEEEEeccCCCCchhhcccCC-----------------------------------------------------------
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE----------------------------------------------------------- 438 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 438 (670)
.++++||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 899999999999999985422
Q ss_pred ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCC
Q 035655 439 NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIA 517 (670)
Q Consensus 439 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~a 517 (670)
...++|..+.+++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999998 89999999999999999999999999999865433221 1223456778999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhh
Q 035655 518 PELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLC 596 (670)
Q Consensus 518 PE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 596 (670)
||++.+..++.++|||||||+++||++ |+.||....... ... .....+... ..+......+.+++.+|
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~-~~~~~~~~~---------~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC-RRLKEGTRM---------RAPEYATPEIYSIMLDC 312 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH-HHHhccCCC---------CCCccCCHHHHHHHHHH
Confidence 999999999999999999999999998 999997522110 111 111111100 01112235688999999
Q ss_pred ccCCCCCCCCHHHHHHHhcC
Q 035655 597 SHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 597 l~~dP~~RPs~~evl~~L~~ 616 (670)
|+.+|.+||++.|++++|+.
T Consensus 313 l~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred ccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.04 Aligned_cols=240 Identities=27% Similarity=0.499 Sum_probs=193.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
+++|+..+.||+|+||.||+|.... ..+.+..|++++++++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999997531 13468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 468999999999999999999998 8999999999999999999999999999986654
Q ss_pred CCcceee--ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKISHTT--NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
....... ....+..|+|||++.+..++.++|||||||++|||++ |+.||...... +......... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~-----~~~-- 230 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF-----RLP-- 230 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC-----CCC--
Confidence 3222111 1223457999999988889999999999999999998 99999653221 1111111110 001
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.72 Aligned_cols=236 Identities=30% Similarity=0.420 Sum_probs=191.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeee-ccCeeEEEEeccCCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCK-RKRDLLLVYDYIPNG 428 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~~g 428 (670)
++|+..+.||+|+||.||++.... ..+.|.+|+.++++++|+|++++++++. .++..++|+||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 468888999999999999986532 3457889999999999999999999764 456789999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.+++.+.....+++..+++++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 99999977665568999999999999999999998 899999999999999999999999999987543322 22
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
..++..|+|||++.+..++.++|||||||+++||++ |+.||..... ......... +. .+ ........
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~-~~-----~~----~~~~~~~~ 226 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GY-----KM----DAPDGCPP 226 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CC-----CC----CCCCCCCH
Confidence 345678999999998889999999999999999998 9999875332 111111111 10 01 11122345
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+++.+||+.+|++||++.++++.|+.
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 67889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.61 Aligned_cols=237 Identities=24% Similarity=0.382 Sum_probs=191.8
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|+..+.||+|++|.||++.... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578999999999999999996532 12457789999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+++||||||+||++++++++||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998654 358899999999999999999998 8999999999999999999999999999976543
Q ss_pred CCccee--eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKISHT--TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~---------~~ 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP---------TN 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHHHhccC---------CC
Confidence 221111 234678899999999998899999999999999999999999975322111 11111100 01
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+......+.+++..||+.+|.+||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 112222335678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=309.86 Aligned_cols=239 Identities=25% Similarity=0.422 Sum_probs=193.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|...+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999986531 234678999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC--------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEE
Q 035655 419 LLVYDYIPNGSLDSLLFDNE--------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
++|+||+++|+|.+++.... ...++|..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986532 2247899999999999999999998 899999999999999999999999
Q ss_pred eecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcC
Q 035655 491 DFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLG 567 (670)
Q Consensus 491 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~ 567 (670)
|||+++....... .......++..|+|||.+.++.++.++|||||||+++|+++ |+.||...... ...+. ..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV----IDG 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH----hcC
Confidence 9999976544322 12233456789999999988889999999999999999998 99998653221 11111 111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... .. +......+.+++..||+.+|++||++.++++.|+
T Consensus 238 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHL-----DL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC-----CC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 11 1112457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.51 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=189.0
Q ss_pred ccccceEeeeCceeEEEeecc---------------------chHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLP---------------------TRMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLL 420 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~---------------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l 420 (670)
|+..+.||+|+||+||++... .....|.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 378899999999999875321 0235678999999999999999999998654 45899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++++|.+++... .+++.+++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999643 48999999999999999999998 8999999999999999999999999999986654
Q ss_pred CCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHHhhcCCcccccCC
Q 035655 501 GKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWV---LEFQHLGQVLDVVDP 575 (670)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~---~~~~~~~~~~~~~d~ 575 (670)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........+.. ..........+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 3211 11223456679999999888899999999999999999999999865321111100 000000111111111
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+......+.+++..||+++|++||+++++++.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111112223346788999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.73 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=191.6
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
..++|+..++||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999987643 12346789999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998543 47888899999999999999998 8999999999999999999999999999987654
Q ss_pred CCcceeeccccCcCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTG----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ + ........... .|.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~-~~i~~~~~~~~--~~~ 270 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-Y-SKIMDHKNSLT--FPD 270 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-H-HHHHcCCCcCC--CCC
Confidence 333333456799999999988653 478999999999999999999999986443211 1 11111000000 010
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHhc
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYLN 615 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 615 (670)
.......+.+++..|++.+|.+ ||+++++++|-.
T Consensus 271 -----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 271 -----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 1112356778889999999987 999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=304.73 Aligned_cols=232 Identities=27% Similarity=0.412 Sum_probs=184.8
Q ss_pred ceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 368 EVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
+.||+|+||.||+|.... ....|.+|++++++++||||++++++|......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 468999999999987632 135688999999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee-ecc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT-TNV 509 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~ 509 (670)
.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99996543 358999999999999999999998 8999999999999999999999999999875443221111 111
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..+..|+|||.+.++.++.++|||||||+++||++ |..||........ ....... .....+......
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~ 224 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---REAIEQG---------VRLPCPELCPDA 224 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HHHHHcC---------CCCCCcccCCHH
Confidence 23457999999999999999999999999999998 8888864322111 1111110 001112223456
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 589 VLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.+++.+|++.+|.+||++.++++.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.63 Aligned_cols=232 Identities=28% Similarity=0.358 Sum_probs=184.3
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||.||++.... ..+.+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999987643 122345699999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 999876665679999999999999999999998 899999999999999999999999999998664432 223457
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHHhhcCCcccccCCCCCCcccHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW-VLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 589 (670)
|+..|+|||++.+..++.++|||||||++|||++|+.||.......... +........ .. .. .......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~--~~---~~~~~~~~ 226 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE----VK--FE---HQNFTEES 226 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc----cc--cc---cccCCHHH
Confidence 8999999999998889999999999999999999999997532211110 000000000 00 00 01123457
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 590 LQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 590 ~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+++..||+.||.+||+++|+++.+.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhh
Confidence 88999999999999999977765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.13 Aligned_cols=239 Identities=30% Similarity=0.458 Sum_probs=189.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578888999999999999997532 224677899999999 89999999999999999999
Q ss_pred EEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc
Q 035655 421 VYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 486 (670)
|+||+++++|.+++.+.. ...+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 999999999999996532 2358899999999999999999998 89999999999999999999
Q ss_pred EEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhh
Q 035655 487 ARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQH 565 (670)
Q Consensus 487 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~ 565 (670)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||+++||++ |..||...... +.......
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ 238 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHHhc
Confidence 999999998643211 11122234678999999988889999999999999999998 99999753221 11111110
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
. ... ..+......+.+++.+||+.+|.+||+++++++.|+.
T Consensus 239 -~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 239 -G-----YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred -C-----CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 000 1111123457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=309.87 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=190.6
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|...++||+|+||.||++.... ....|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 467778999999999999985311 23578899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCc-------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 421 VYDYIPNGSLDSLLFDNEN-------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999865421 358999999999999999999998 899999999999999999999
Q ss_pred EEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhh
Q 035655 488 RLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQH 565 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~ 565 (670)
||+|||++......... ......+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... +.... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~-~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIEC-IT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHH-HH
Confidence 99999999765432211 1122345788999999998899999999999999999998 99998653221 11111 11
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+.. +. .+......+.+++.+||+.||.+||+++++++.|+
T Consensus 239 ~~~~-----~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRE-----LE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCcc-----CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1110 01 11112345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.75 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=194.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------------------hHHHHHHHHHHHhccccCceee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------------------RMREFAAEIESLGRLRHKHLVN 407 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------------------~~~~f~~Ei~~L~~l~H~nIv~ 407 (670)
..+|+..+.||+|+||.||++.... ..+.|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999875421 2356788999999999999999
Q ss_pred eeeeeeccCeeEEEEeccCCCCchhhcccCC---------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCc
Q 035655 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE---------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478 (670)
Q Consensus 408 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 478 (670)
++++|..++..++++||+++++|.+++.+.. ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999996643 1268999999999999999999998 899999999999
Q ss_pred EEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCcc-
Q 035655 479 VLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT--GRRPIDSDHF- 554 (670)
Q Consensus 479 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t--G~~pf~~~~~- 554 (670)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543321 12233456789999999988889999999999999999998 6778764221
Q ss_pred hhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 555 ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.............. .......+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 241 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111 000011112233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.73 Aligned_cols=227 Identities=24% Similarity=0.337 Sum_probs=179.7
Q ss_pred ceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhc-cccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGR-LRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++..... .+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999976431 2234556666665 4899999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999986543 58999999999999999999999 899999999999999999999999999998643322 2234
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||........ ...... . .+.+ +.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~-~------~~~~----~~~~~~ 221 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSILN-D------RPHF----PRWISK 221 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHc-C------CCCC----CCCCCH
Confidence 45799999999999988999999999999999999999999976432111 111110 0 1111 112234
Q ss_pred HHHHHHHhhccCCCCCCCCHH-HHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMR-QVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~-evl~~ 613 (670)
.+.+++..||+.+|.+||++. +++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 567888999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.35 Aligned_cols=238 Identities=27% Similarity=0.359 Sum_probs=183.9
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.|...+.||+|+||+||+++... ..+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57889999999999999997633 12457789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999996543 58899999999999999999998 8999999999999999999999999999764311000
Q ss_pred ----------------------------------------------ceeeccccCcCCCCccccccCCCCccchhHHHHH
Q 035655 504 ----------------------------------------------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGV 537 (670)
Q Consensus 504 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gv 537 (670)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012347999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHh--hccCCCCCCCCHHHHHHHh
Q 035655 538 LLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLL--CSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 538 vl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~~L 614 (670)
+++||++|+.||.......... ........... +. ..... ..+.+++.+ |+.++|..||+++|+++|-
T Consensus 237 il~elltG~~Pf~~~~~~~~~~--~i~~~~~~~~~--~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL--KVINWENTLHI--PP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH--HHHccccccCC--CC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999999999997643221111 11110000000 10 01122 233444433 6777888899999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.51 Aligned_cols=187 Identities=28% Similarity=0.404 Sum_probs=163.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||+||++.... ....+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478899999999999999997643 1235678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999654 368999999999999999999998 999999999999999999999999999987543211
Q ss_pred c----------------------------------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 035655 503 I----------------------------------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548 (670)
Q Consensus 503 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~p 548 (670)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234799999999999999999999999999999999999999
Q ss_pred CCCCc
Q 035655 549 IDSDH 553 (670)
Q Consensus 549 f~~~~ 553 (670)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.87 Aligned_cols=231 Identities=27% Similarity=0.357 Sum_probs=183.8
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||+||++.... ..+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999987642 113456899999999999999999999999999999999999999
Q ss_pred hhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 431 DSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 431 ~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
..++... ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 33468999999999999999999998 8999999999999999999999999999976544322 2234
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. .. .... ..++......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~---~~~~--~~~~~~~~~~ 227 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RI---LNDS--VTYPDKFSPA 227 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hh---cccC--CCCcccCCHH
Confidence 5789999999999999999999999999999999999999975322111000000 00 0000 0122233456
Q ss_pred HHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 589 VLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
+.+++..||+.||.+|| +++++++|
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 78899999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.94 Aligned_cols=232 Identities=29% Similarity=0.436 Sum_probs=187.1
Q ss_pred ceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 368 EVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
++||+|+||.||+|.... ....|.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999997532 1236889999999999999999999999999999999999999999
Q ss_pred hhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecccc
Q 035655 432 SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG 511 (670)
Q Consensus 432 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g 511 (670)
+++.... ..+++..+..++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9986543 358999999999999999999998 899999999999999999999999999997654433222222345
Q ss_pred CcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 512 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
+..|+|||++.++.++.++||||||++++|+++ |..||........ ........ .. ..+......+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~~~-----~~----~~~~~~~~~~~ 224 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEKGY-----RM----SCPQKCPDDVY 224 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcCC-----CC----CCCCCCCHHHH
Confidence 678999999998899999999999999999998 9999975322111 11111110 01 11112345788
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 591 QLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+++.+|++.+|.+||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.17 Aligned_cols=237 Identities=24% Similarity=0.406 Sum_probs=186.1
Q ss_pred cccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeecc------Cee
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK------RDL 418 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~ 418 (670)
.+.+.||+|+||.||+|.... ..+.|.+|+.++++++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999987532 235678899999999999999999987532 246
Q ss_pred EEEEeccCCCCchhhcccC----CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDN----ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
++++||+++|+|.+++... ....+++.+...++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987432 23458999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 495 ARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 495 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .. ......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~-~~~~~~~~~~-- 233 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EI-YDYLRQGNRL-- 233 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHHHHcCCCC--
Confidence 98765433211 122346678999999998899999999999999999999 88898653221 11 1111111111
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
. .+......+.+++.+||+++|.+||++.++++.|+.
T Consensus 234 ---~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 234 ---K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ---C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 111223557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=322.83 Aligned_cols=243 Identities=22% Similarity=0.287 Sum_probs=189.6
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
....++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3445789999999999999999987643 123467899999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999998543 47889999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCcceeeccccCcCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTG----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
............||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..............
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~--- 267 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GTYSKIMDHKNSLN--- 267 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCcccC---
Confidence 54333233456799999999998654 3788999999999999999999999764321 11111111111000
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 615 (670)
. .........+.+++..|++.++.+ ||++.|+++|-+
T Consensus 268 --~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 268 --F--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred --C--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0 011112345667777888755543 899999999843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.64 Aligned_cols=239 Identities=25% Similarity=0.464 Sum_probs=194.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..++||+|+||.||++.... ..+.|.+|++++++++|+||+++.+.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4578889999999999999987532 23578899999999999999999999887 77899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.+.....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9999999977655678999999999999999999998 8999999999999999999999999999986654332222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
....++..|+|||++....++.++|+|||||+++|+++ |+.||...... ...+. ..+... .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~---------~~~~~ 227 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGYRM---------PRPEN 227 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hCCCCC---------CCccc
Confidence 33356678999999998889999999999999999999 99999753321 11111 111000 11112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+.+++.+|++++|++||++.++++.|+.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.30 Aligned_cols=230 Identities=24% Similarity=0.364 Sum_probs=184.0
Q ss_pred eEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 369 VIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
.||+|+||.||+|.+.. ..+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 58999999999985421 2357889999999999999999999885 45679999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce--e
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH--T 506 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~--~ 506 (670)
+|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999654 358999999999999999999998 899999999999999999999999999998765433221 1
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||.+....++.++|||||||+++||++ |+.||...... ...... ..+.. +.. +...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i-~~~~~-----~~~----~~~~ 223 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI-ESGER-----MEC----PQRC 223 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HCCCC-----CCC----CCCC
Confidence 22244678999999988889999999999999999998 99999764321 111111 11111 111 1123
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+||+.||.+||++++|.+.|++
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.78 Aligned_cols=240 Identities=27% Similarity=0.419 Sum_probs=191.1
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc------C
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK------R 416 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~------~ 416 (670)
.++..|+..+.||+|+||.||+|.... ....+.+|+.+++++ +||||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 467788999999999999999997643 245788999999998 699999999998653 4
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++||||+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 58999999999999999977555578999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||.......... . .. ..
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~-~~-~~---- 231 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-L-IP-RN---- 231 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-H-Hh-cC----
Confidence 654322 2233457899999999886 3457889999999999999999999997533211111 0 00 00
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+... .......+.+++.+||+.+|.+||++.+++++
T Consensus 232 -~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 -PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 011111 11223467889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.53 Aligned_cols=228 Identities=25% Similarity=0.329 Sum_probs=184.4
Q ss_pred ceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 368 EVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++||+|+||.||++.... ....+.+|+.+|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 679999999999986421 123456899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|+|.+++... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 9999999998654 357888999999999999999998 899999999999999999999999999987543322 2
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......||+.|+|||++.+..++.++|||||||+++||++|+.||...... ...... ..+. ..+ +..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~-~~~~------~~~----~~~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKI-LKGK------LNL----PPY 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHH-HcCC------CCC----CCC
Confidence 233457999999999999888999999999999999999999999764321 111111 1111 011 111
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 585 EMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
....+.+++..||+++|.+|| ++++++++-
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 234577899999999999999 899988864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.68 Aligned_cols=237 Identities=30% Similarity=0.430 Sum_probs=195.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
.++|+..+.||+|+||.||++...+ ..+++.+|+.++++++|+||+++++++......++|+||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3578889999999999999987643 246788999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 999999977655579999999999999999999998 9999999999999999999999999999986633221
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....+..|+|||.+.++.++.++||||||++++|+++ |+.||........ ........ .+ ..+...+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~-----~~----~~~~~~~ 225 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVEKGY-----RM----EAPEGCP 225 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhcCC-----CC----CCccCCC
Confidence 2345678999999988889999999999999999998 9999875432111 11111110 01 1111224
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 667889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=310.35 Aligned_cols=239 Identities=28% Similarity=0.396 Sum_probs=190.8
Q ss_pred CccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
+|+..+.||+|+||.||+|.... ..+.|.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46678899999999999997421 12457899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccC--------------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc
Q 035655 421 VYDYIPNGSLDSLLFDN--------------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 486 (670)
++||+++++|.+++... .+..+++..+.+++.|++.||.|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999998532 12358899999999999999999998 89999999999999999999
Q ss_pred EEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHh
Q 035655 487 ARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQ 564 (670)
Q Consensus 487 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~ 564 (670)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||+++||++ |..||..... .++... .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~-i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEM-I 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH-H
Confidence 99999999886543321 12233456789999999988889999999999999999998 8888865322 111111 1
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...... ..+......+.+++..||+.+|.+||++++|++.|+.
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 1122334567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=290.86 Aligned_cols=221 Identities=28% Similarity=0.359 Sum_probs=183.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||.|+||+|.+.+.+. +.+...+|-.+|+.+.||.++++.+-|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 457788999999999999988755 2234558999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||.+||.|..+|++.+ ++++...+-++.||+.||+|||+ ..|++|||||+|||||.+|.+||.|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999997664 59999999999999999999999 99999999999999999999999999999976542
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
+-+.+||+.|+|||+++...+...+|-|||||++|||++|..||..... +.-+ +....+++ .++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY--~KI~~~~v----------~fP 261 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIY--EKILEGKV----------KFP 261 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHH--HHHHhCcc----------cCC
Confidence 5668999999999999999999999999999999999999999987543 1111 11111111 122
Q ss_pred HHHHHHHHHHHHhhccCCCCCC
Q 035655 583 VAEMELVLQLGLLCSHQKAEAR 604 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~R 604 (670)
.-....+.+|+...++.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 2222345566667778888877
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.57 Aligned_cols=238 Identities=26% Similarity=0.330 Sum_probs=187.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478899999999999999997643 1234678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999654 358999999999999999999998 899999999999999999999999999987543211
Q ss_pred cc-------------------------------------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhC
Q 035655 503 IS-------------------------------------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATG 545 (670)
Q Consensus 503 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG 545 (670)
.. ......||+.|+|||++....++.++|||||||+++||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999988999999999999999999999
Q ss_pred CCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHHh
Q 035655 546 RRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT---MRQVLRYL 614 (670)
Q Consensus 546 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 614 (670)
+.||........ ............. +. . ......+.+++..|+. +|.+|++ ++|++++-
T Consensus 236 ~~Pf~~~~~~~~--~~~i~~~~~~~~~--~~---~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 236 YPPFCSDNPQET--YRKIINWKETLQF--PD---E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCHHHH--HHHHHcCCCccCC--CC---C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 999976432111 1111111110000 10 0 0112445677777886 8999998 99998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.35 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=188.6
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe-----
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD----- 417 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~----- 417 (670)
|+..+.||+|+||.||+|.... ....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999987531 13468899999999999999999999876554
Q ss_pred -eEEEEeccCCCCchhhcccC----CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 418 -LLLVYDYIPNGSLDSLLFDN----ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 418 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
.++++||+++|+|..++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998542 23468999999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcc
Q 035655 493 GLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVL 570 (670)
Q Consensus 493 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~ 570 (670)
|+++......... .....++..|+|||.+.+..++.++|||||||+++||++ |..||...... +..... ..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~-~~~~~- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL-RHGNR- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCC-
Confidence 9998665433211 122345678999999988889999999999999999999 88998653321 111111 11111
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+. .+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 234 ----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 234 ----LK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ----CC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 112234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.98 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=193.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 417 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+++++++ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 3568899999999999999885310 124588999999999 79999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++|+||+++|+|.+++.......+++.++..++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999976554458999999999999999999998 8999999999999999999999999999986
Q ss_pred ccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 498 FDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
....... ......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... .. ......+. .+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~-~~~~~~~~-----~~ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KF-YKLIKEGY-----RM 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HH-HHHHHcCC-----cC
Confidence 5443211 1222356788999999998899999999999999999998 999987533210 00 01111110 00
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+......+.+++.+|++++|.+||++.|+++.|+.
T Consensus 264 ----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 ----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0111123568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.59 Aligned_cols=235 Identities=24% Similarity=0.430 Sum_probs=201.7
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
....++||+|-||.||+|+... ..+.|.+|..+|++++||||++|+|+|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 4456789999999999997522 457899999999999999999999999764 689999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
|+++.|.|..||..+.. .|+......++.||+.||+|||+ ..+|||||.++|||+.+...+||+|||+++.++.+.
T Consensus 470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999987654 79999999999999999999999 999999999999999999999999999999998887
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
....+...-+..|||||-+.-.+++.+||||.||+++||++. |.+||.+-. ..++.-.+...-+...
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------NsDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------NSDVIGHIENGERLPC 613 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------ccceEEEecCCCCCCC
Confidence 766666677889999999999999999999999999999988 999998621 1122222222223345
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
++.++..+..|+-+||..+|.+||.+.|+...|.
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 6666778899999999999999999999988774
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.30 Aligned_cols=238 Identities=26% Similarity=0.465 Sum_probs=193.1
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
.+|+..+.||+|+||.||++.+.. ...+|.+|++++++++|||++++++++......++|+||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 467788999999999999986542 236789999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.... ..++++.+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++............
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999986543 358999999999999999999998 89999999999999999999999999999865443222222
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... ......... .....+.. ..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~---~~~~~~~~-------~~ 227 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAG---FRLYKPRL-------AS 227 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCC---CCCCCCCC-------CC
Confidence 3345678999999998899999999999999999998 99999753321 111111111 11111221 23
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.+.+++.+||+.+|.+||++.+++++|.
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 56889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.31 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=192.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.+++|++.++||+|+||.||+|...+ ....+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999985321 12357789999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC--------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE--------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
.++||||+++|+|.+++.+.. ...+++..+.+++.|++.||.|||+ ++++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996522 2346778899999999999999998 89999999999999999999999
Q ss_pred EeecCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
+|||+++......... .....++..|+|||.+.++.++.++|||||||+++||++ |..||...... +.. .....+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~-~~~~~~ 237 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVL-KFVMDG 237 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-HHHHcC
Confidence 9999997554322111 122345678999999998899999999999999999999 78888653211 111 111111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
... . .+......+.+++.+|++.+|.+||++.++++.|+..
T Consensus 238 ~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 238 GYL-----D----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCC-----C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 110 1 1112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.64 Aligned_cols=230 Identities=25% Similarity=0.324 Sum_probs=182.7
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ..+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999997643 123466788888776 799999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999988654 358999999999999999999998 899999999999999999999999999987532211 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC------cchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD------HFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||... ......+.......... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----C
Confidence 457999999999999999999999999999999999999999531 11112222222111111 1 1
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCC------HHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPT------MRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 613 (670)
+......+.+++..||+.||.+||+ +.++++|
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2222356778999999999999998 5787765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.49 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=193.3
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR- 416 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~- 416 (670)
+.....++|.+.+.||+|+||.||++.... ....+.+|+..+..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 334456799999999999999999997532 2346778999999999999999988765432
Q ss_pred -------eeEEEEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 417 -------DLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 417 -------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
.+++||||+++|+|.++|... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 368999999999999998653 23468999999999999999999999 899999999999999999999
Q ss_pred EEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc
Q 035655 488 RLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 488 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~ 566 (670)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... ...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~~~~~-~~~ 259 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EVMHK-TLA 259 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-Hhc
Confidence 9999999987644221 2233457999999999999999999999999999999999999999764321 11111 111
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.. + ..+......+.+++..||+.||.+||++.+++++
T Consensus 260 ~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1 1112233567889999999999999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.93 Aligned_cols=238 Identities=29% Similarity=0.424 Sum_probs=189.7
Q ss_pred ccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
|+..+.||+|+||+||++..... .....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56789999999999999987551 123346999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++. ....+++..++.++.|+++||.+||+ .+++|+||||+||++++++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred cccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccc
Confidence 9999999997 23468999999999999999999999 8999999999999999999999999999986522 2233
Q ss_pred eeccccCcCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....++..|+|||++. +..++.++||||+|+++++|++|+.||........................ . ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~ 228 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-Q-----QSRE 228 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-T-----SHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-c-----ccch
Confidence 44567899999999998 788999999999999999999999999864211111111111111100000 0 0000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++..||+.||++||++.+++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12678899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.61 Aligned_cols=231 Identities=24% Similarity=0.374 Sum_probs=183.5
Q ss_pred eEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 369 VIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
.||+|+||.||+|.+.. ..+.|.+|+.++++++||||++++++|.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 38999999999986421 13568899999999999999999999864 57899999999999
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee--e
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT--T 507 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~--~ 507 (670)
|.+++.... ..+++.++++++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986543 468999999999999999999998 8999999999999999999999999999986544322111 1
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|+|||.+.+..++.++|||||||+++|+++ |+.||...... +.. .....+.. ...+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~-~~~~~~~~---------~~~~~~~~ 224 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM-SFIEQGKR---------LDCPAECP 224 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH-HHHHCCCC---------CCCCCCCC
Confidence 1234578999999988889999999999999999996 99999753221 111 11111111 11122234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++..||+.+|++||++.+|.+.|+.
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 677889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.72 Aligned_cols=232 Identities=24% Similarity=0.314 Sum_probs=185.4
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccC-ceeeeeeeeeccCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHK-HLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~ 422 (670)
+|+..+.||+|+||.||+|.... ..+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999997643 224567899999999765 6888999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999998654 358999999999999999999998 899999999999999999999999999987532221
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ..... .. .+. ++
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~-~~------~~~----~~ 221 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIM-EH------NVS----YP 221 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH-cC------CCC----CC
Confidence 223345799999999999999999999999999999999999999976432111 11111 11 011 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
......+.+++..||+.||.+||+. ++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1223567789999999999999976 676665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.26 Aligned_cols=232 Identities=31% Similarity=0.474 Sum_probs=183.2
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+|.+.+ ..+.+.+|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999997532 124677899999999 799999999999999999999999999
Q ss_pred CCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 428 GSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 428 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
|+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1348899999999999999999998 899999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
++...... ........+..|+|||++....++.++|||||||+++||++ |..||...... +....... .
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~-~----- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ-G----- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhC-C-----
Confidence 98632211 11111234567999999988889999999999999999997 99999653211 11111111 0
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+......+.+++..||+.+|.+||++.++++.|+.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 ----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0001111223467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=301.07 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=195.7
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ...++.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999998532 2346788999999999999999999999999999999
Q ss_pred eccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+++++|.+++.. .....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864 223468999999999999999999998 8999999999999999999999999999876644
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
... ......++..|+|||++.+..++.++||||||++++||++|..||.............. .....+...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~-- 229 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI------EQCDYPPLP-- 229 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh------hcCCCCCCC--
Confidence 321 12334688999999999888899999999999999999999999975433222221111 111112111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+.+.+++.+||+.+|.+|||+.+|++.++.
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 230 -SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred -cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11234568889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=316.42 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=194.2
Q ss_pred chhhHHHhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeee
Q 035655 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCK 413 (670)
Q Consensus 353 ~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~ 413 (670)
.+.++....++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345555667899999999999999999997643 1234678999999999999999999999
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
+.+..++||||+++|+|.+++... .++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999998543 47888899999999999999998 999999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTG----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||...... ............
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~ 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNS 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCc
Confidence 9987654433333456799999999998653 3788999999999999999999999864321 111111111111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHhc
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYLN 615 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 615 (670)
....+ .......+.+++..|++.++.+ ||++++++++..
T Consensus 266 ~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 266 LTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11111 1122355677888899744443 789999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.01 Aligned_cols=238 Identities=27% Similarity=0.491 Sum_probs=192.2
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+|+..+.||+|+||.||+|.... ..+.|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 567888999999999999986521 235688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997654 368999999999999999999998 89999999999999999999999999999876543
Q ss_pred Ccceee--ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc-hhHHHHHHHhhcCCcccccCCCC
Q 035655 502 KISHTT--NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 502 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.....+ ...++..|+|||++.+..++.++|||||||+++|+++ |+.||..... ...... ..... +.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~~------~~- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EEGYR------LP- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hCCCc------CC-
Confidence 322211 1233568999999998889999999999999999886 9999965322 111111 11000 01
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+..+.+++.+|++++|.+||++.++++.|+.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 230 ---APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 111223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.82 Aligned_cols=259 Identities=23% Similarity=0.278 Sum_probs=201.8
Q ss_pred cCccccceEeeeCceeEEEeeccchHH------------------HHHHHHHHHhccccCceeeeeeeeecc--CeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTRMR------------------EFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~~~------------------~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV 421 (670)
+.|+..++|++|.||.||+|+++.+.+ ...+||.+|.+++|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 458888999999999999999876321 245999999999999999999887643 679999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
||||+. +|...+.... +++...++..++.|+++|++|||+ ..|+|||||++|+|+...|.+||+|||+|+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999976 8888887654 579999999999999999999999 89999999999999999999999999999988764
Q ss_pred CcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCc-chhHHHHHHHhhcCCcccccCCCC--
Q 035655 502 KISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDH-FILVDWVLEFQHLGQVLDVVDPNL-- 577 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~d~~l-- 577 (670)
. ...+..+-|..|.|||++.+. .|++..|+||+|||+.||++++..|.+.. ....+. -+...+...+.+.|.+
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~--If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK--IFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH--HHHHhCCCccccCCCccc
Confidence 3 445667889999999988765 58999999999999999999999987632 222222 2222232223332322
Q ss_pred -----------------CCcccHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC-CCCCCCCCCCCc
Q 035655 578 -----------------GSSYVVA-EMELVLQLGLLCSHQKAEARPTMRQVLRYLNG-DELLPIIDNWSS 628 (670)
Q Consensus 578 -----------------~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~~~~~~ 628 (670)
+..+... ..+.-.+++...+..||.+|-|+.|.++|=.- +.|+|..|...+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFP 377 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcC
Confidence 1112111 23556778888899999999999999998654 346666554433
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.48 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=198.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 578899999999999999997642 2456889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+++++|.+++... ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 33468999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
... ......++..|+|||.+.+..++.++|||||||+++||++|+.||........+....... +. .+...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-----~~~~~-- 229 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CD-----YPPLP-- 229 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CC-----CCCCC--
Confidence 321 1233468899999999988889999999999999999999999997654333332211111 11 01111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 230 -~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 -ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.23 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=190.9
Q ss_pred hcCccccceEeeeCceeEEEeecc---------------------------------chHHHHHHHHHHHhccccCceee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP---------------------------------TRMREFAAEIESLGRLRHKHLVN 407 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~---------------------------------~~~~~f~~Ei~~L~~l~H~nIv~ 407 (670)
.++|+..++||+|+||.||++... ....+|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999987321 02356889999999999999999
Q ss_pred eeeeeeccCeeEEEEeccCCCCchhhcccCCc---------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCc
Q 035655 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN---------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478 (670)
Q Consensus 408 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 478 (670)
+++++...+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 99999999999999999999999999865321 247888999999999999999998 899999999999
Q ss_pred EEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCcch
Q 035655 479 VLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT--GRRPIDSDHFI 555 (670)
Q Consensus 479 ILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t--G~~pf~~~~~~ 555 (670)
||++.++.+||+|||+++........ ......++..|++||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999765433211 1222345678999999888889999999999999999998 77888642211
Q ss_pred -hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 556 -LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 556 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
............. .....+. +......+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111110 0111111 1122356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.38 Aligned_cols=229 Identities=23% Similarity=0.285 Sum_probs=184.0
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||++.... ....+..|++++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999987532 1245678999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.+++... ..+++.++..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 999988654 358999999999999999999996 2689999999999999999999999999987543222 12234
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..||+.|+|||++.+..++.++|||||||+++||++|+.||........ . ...... ...+.. .....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~-~~i~~~------~~~~p~----~~~~~ 222 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--F-ELILME------EIRFPR----TLSPE 222 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--H-HHHhcC------CCCCCC----CCCHH
Confidence 5799999999999999999999999999999999999999976432111 0 011011 011111 12345
Q ss_pred HHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 589 VLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+.+++.+||+.||.+|+ +++++++|-
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 67889999999999996 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.41 Aligned_cols=240 Identities=27% Similarity=0.405 Sum_probs=191.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
++|.+.+.||+|+||.||++.... ...++.+|+++++++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 568899999999999999885310 234677899999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
..++|+||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999997542 1358999999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWV 560 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~ 560 (670)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |+.||...... +..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHH
Confidence 9999999999998765432211 1122234578999999998889999999999999999998 88898653321 111
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.... .... .+.+......+.+++..||+.+|.+||++.++++.|+.
T Consensus 253 ~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 253 KLLK-EGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHH-cCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1111 1110 01112233567789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.31 Aligned_cols=242 Identities=25% Similarity=0.403 Sum_probs=193.3
Q ss_pred hcCccccceEeeeCceeEEEeecc------------------------chHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP------------------------TRMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~------------------------~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
..+|...+.||+|+||.||++... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888899999999999988531 0234678999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+..++||||+++|+|.+++.... ...++|.++..++.||++||.|||+ .+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999997532 2358899999999999999999998 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++++||++ |..||..... .+.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~ 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EEL 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHH
Confidence 99999999999999876543222 1223356678999999988889999999999999999998 7888865321 111
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...... .... ..+......+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 249 ~~~~~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 249 FKLLKE-GHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHc-CCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111111 1100 01112345678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.17 Aligned_cols=231 Identities=23% Similarity=0.304 Sum_probs=183.2
Q ss_pred ccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHH---hccccCceeeeeeeeeccCeeEEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESL---GRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L---~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
|++.+.||+|+||.||++.... ..+.+.+|++++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5678899999999999997643 123455565544 567899999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|..++.+ ..+++.++..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 358999999999999999999998 99999999999999999999999999998753322
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... .. +..
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~~~i~~-~~------~~~---- 220 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VFDSIVN-DE------VRY---- 220 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CC------CCC----
Confidence 1 22334679999999999999899999999999999999999999997643211 1111111 11 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+......+.+++.+||+.||.+|| ++.+++++-
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 112235567899999999999999 678887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.64 Aligned_cols=238 Identities=28% Similarity=0.329 Sum_probs=184.3
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+|+..+.||+|+||.||++.... ....+.+|+++|++++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68899999999999999997643 12456789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK- 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~- 502 (670)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999654 358889999999999999999998 899999999999999999999999999975321000
Q ss_pred -----------------------------------------cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHH
Q 035655 503 -----------------------------------------ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLE 541 (670)
Q Consensus 503 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e 541 (670)
........||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCC---CHHHHHHHhc
Q 035655 542 IATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARP---TMRQVLRYLN 615 (670)
Q Consensus 542 l~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L~ 615 (670)
|++|+.||........ ............ .+. .... ...+.+++..|+ .+|.+|+ ++.|+++|-.
T Consensus 237 ll~G~~Pf~~~~~~~~--~~~i~~~~~~~~--~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 237 MLVGQPPFLADTPAET--QLKVINWETTLH--IPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred hhhCCCCCCCCCHHHH--HHHHhccCcccc--CCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 9999999986432211 111111000000 011 1112 233445555555 4999999 8999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.57 Aligned_cols=241 Identities=23% Similarity=0.303 Sum_probs=196.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccc-cCceeeeeeeee-c------cC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLR-HKHLVNLQGWCK-R------KR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~-~------~~ 416 (670)
..+.++.+.|.+|||+.||.+.+.. ..+...+||++|++|+ |+|||.+++.+. . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4456778999999999999997644 3456779999999998 999999999331 1 23
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
+.+|+||||++|+|-+++..+....|++.++++|+.|+++|+++||. ++++|||||||.+||||..+++.||||||-|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 68999999999999999987666679999999999999999999998 56789999999999999999999999999986
Q ss_pred eccCCCcc--------eeeccccCcCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhh
Q 035655 497 LFDHGKIS--------HTTNVVGTIGYIAPELA---RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQH 565 (670)
Q Consensus 497 ~~~~~~~~--------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~ 565 (670)
..-..... ......-|+.|.|||.+ .+..+++|+|||||||+||-|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 43322210 01122468999999965 56789999999999999999999999998632
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
-+.+++..+.-.-.......+.+|+..||++||.+||++.||+.++...
T Consensus 263 ---~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 ---KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ---ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1233444443333356778999999999999999999999999988654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=300.35 Aligned_cols=231 Identities=29% Similarity=0.451 Sum_probs=185.5
Q ss_pred ceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++||+|+||.||+|+... ..+++.+|+++++++.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999986421 2356889999999999999999999876 4568999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee-
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT- 506 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~- 506 (670)
|+|.+++.+.. .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 68999999999999999999998 8999999999999999999999999999986654332211
Q ss_pred -eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 507 -TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 507 -~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
....++..|+|||.+.+..++.++|||||||+++||++ |+.||...... ...+. .. .... ..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~---~~-~~~~---------~~~~ 221 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML---ES-GERL---------PRPE 221 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---Hc-CCcC---------CCCC
Confidence 12234568999999998899999999999999999998 99999753321 11111 11 1110 1111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.....+.+++.+||+++|.+||++.++++.|++.
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.53 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=190.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------------------hHHHHHHHHHHHhccccCceeeee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------------------RMREFAAEIESLGRLRHKHLVNLQ 409 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------------------~~~~f~~Ei~~L~~l~H~nIv~l~ 409 (670)
.++|+..+.||+|+||.||++.... ....|.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999875321 134688999999999999999999
Q ss_pred eeeeccCeeEEEEeccCCCCchhhcccCC----------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcE
Q 035655 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNE----------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNV 479 (670)
Q Consensus 410 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 479 (670)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 99999999999999999999999985432 1247899999999999999999998 8999999999999
Q ss_pred EecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCcc-h
Q 035655 480 LIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT--GRRPIDSDHF-I 555 (670)
Q Consensus 480 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t--G~~pf~~~~~-~ 555 (670)
+++.++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||+++||++ |..||..... .
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765433211 1222345778999999988899999999999999999998 5667764221 1
Q ss_pred hHHHHHHHhhc-CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 556 LVDWVLEFQHL-GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 556 ~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........... ........ +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111 11000111 1112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.71 Aligned_cols=232 Identities=23% Similarity=0.302 Sum_probs=185.3
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+|...+.||+|+||.||++.... ..+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999997643 123456677888777 5899999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999998654 358999999999999999999998 899999999999999999999999999997543222
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ... . .++
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~-~~~------~----~~p 221 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIM-EHN------V----AYP 221 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHH-hCC------C----CCC
Confidence 123345799999999999999999999999999999999999999986432211 11111 111 1 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
......+.+++..|++.+|.+|++. .++.++
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 2233567889999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.62 Aligned_cols=237 Identities=26% Similarity=0.382 Sum_probs=181.6
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||+|.... ....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999986421 1246888999999999999999999999999999999999999
Q ss_pred CchhhcccCC---ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 429 SLDSLLFDNE---NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 429 sL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
+|.+++.... ....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996532 2356788888999999999999998 899999999999999999999999999997544332211
Q ss_pred -eeccccCcCCCCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 506 -TTNVVGTIGYIAPELARTG-------KASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
.....++..|+|||++.+. .++.++||||||++++||++ |+.||........ .............++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVREQQLKLPKPR 234 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhhcccCCCCCCc
Confidence 1234578889999988642 35789999999999999997 9999975322111 1111112222222333
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+... ..+.+.+++..|| .+|.+||+++||++.|+
T Consensus 235 ~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2211 2244667888898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.57 Aligned_cols=235 Identities=22% Similarity=0.351 Sum_probs=192.3
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+|+..++||+|+||.||++.... ..+.+.+|+.++++++|+||+++++.+..++.+++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47788999999999999986532 2356778999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999999876555568999999999999999999998 899999999999999999999999999998664432 12
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....|+..|+|||++.+..++.++||||||+++++|++|+.||........ ..... .+... .+ +...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~-~~~~~-----~~----~~~~ 224 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILKVC-QGSYK-----PL----PSHY 224 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHHHh-cCCCC-----CC----Cccc
Confidence 2345788999999999888899999999999999999999999976432211 11111 11110 01 1122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+.+++.+||+.||.+||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3457788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=304.54 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=192.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..++||+|+||.||+|.... ..+++.+|+.++++++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4578889999999999999986321 23467789999999999999999999975 4578
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+++||+++|+|.+++..+. ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997643 368999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCC
Q 035655 500 HGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 576 (670)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +..+. ..+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~-----~ 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL----EKGERL-----P 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcC-----C
Confidence 432211 112245678999999998899999999999999999998 99998753321 11111 111100 0
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELL 620 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 620 (670)
.+......+.+++..||+.||.+||++.++++.|+.....
T Consensus 232 ----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 ----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0112234678899999999999999999999988755443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=317.30 Aligned_cols=236 Identities=26% Similarity=0.339 Sum_probs=180.8
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.|...++||+|+||.||+++... ..+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999997633 12457789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK- 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~- 502 (670)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999654 358899999999999999999998 899999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeeccccCcCCCCccccccCCCCccchhHHHHH
Q 035655 503 ---------------------------------------------ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGV 537 (670)
Q Consensus 503 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gv 537 (670)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012347999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 035655 538 LLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT---MRQVLRY 613 (670)
Q Consensus 538 vl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 613 (670)
++|||++|+.||........ ............ .|.. .... ..+.+++..|+ .+|.+|++ ++++++|
T Consensus 237 il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~--~p~~-~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET--QMKVINWQTSLH--IPPQ-AKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH--HHHHHccCCCcC--CCCc-ccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999976432111 111111000000 0110 1122 23344444444 48999987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.68 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=188.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.|.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3578889999999999999986320 23578899999999999999999998754 3468
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999996543 358999999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCccee--eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhh----cCCcccc
Q 035655 499 DHGKISHT--TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQH----LGQVLDV 572 (670)
Q Consensus 499 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 572 (670)
........ ....++..|+|||++.+..++.++|||||||+++||++|..|+................ ...+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 44322111 11233456999999988889999999999999999999887764321111000000000 0000000
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+........+......+.+++.+||+.+|++|||++|+++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 11010011112233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.96 Aligned_cols=230 Identities=25% Similarity=0.319 Sum_probs=183.6
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ..+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999997643 123467899999988 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999988654 369999999999999999999998 899999999999999999999999999987432211 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC------cchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD------HFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.. .....++......... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~---- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRI---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCC----
Confidence 457999999999999999999999999999999999999999631 1111222222221111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCC------HHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPT------MRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 613 (670)
+......+.+++..||+.||.+||+ ++++++|
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1122345778999999999999997 7888876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.36 Aligned_cols=236 Identities=25% Similarity=0.357 Sum_probs=189.7
Q ss_pred ccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
|+..+.||+|+||.||++.... ..+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999987643 123467899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999876555569999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......|+..|+|||++.+..++.++|||||||+++||++|+.||........ ........ . ..... ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~--~----~~~~~----~~ 226 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--E----VQEEY----SE 226 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh--h----hhhhc----Cc
Confidence 12234789999999999999999999999999999999999999975322111 00000000 0 00111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHh
Q 035655 584 AEMELVLQLGLLCSHQKAEARPT-----MRQVLRYL 614 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 614 (670)
.....+.+++..||+.||.+||+ ++|++++-
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 12345778899999999999999 88988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.88 Aligned_cols=249 Identities=21% Similarity=0.217 Sum_probs=189.2
Q ss_pred hcCccccceEeeeCceeEEEeeccch----------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR----------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~----------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
..+|.+.+.||+|+||.||++..... ...+.+|+++|++|+|+||+++++++..++..++|||++. ++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 45789999999999999999987652 2356789999999999999999999999999999999994 789
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc-eeecc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS-HTTNV 509 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~ 509 (670)
.+++.... ..++|.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 247 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 247 YTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 88886543 369999999999999999999998 89999999999999999999999999999866433211 22345
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc---------chhHHHHHHHhhc-CCcccc-------
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH---------FILVDWVLEFQHL-GQVLDV------- 572 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~---------~~~~~~~~~~~~~-~~~~~~------- 572 (670)
.||..|+|||++.+..++.++|||||||++|||++|..|+.... ..+...+...... ......
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 79999999999999999999999999999999999876653211 0111111110000 000000
Q ss_pred ---------cCCCCCCcccH---HHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 573 ---------VDPNLGSSYVV---AEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 573 ---------~d~~l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..+........ .....+.+++.+||+.||.+|||+.|++++-
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 00000000000 1123577899999999999999999999863
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.58 Aligned_cols=227 Identities=24% Similarity=0.296 Sum_probs=182.2
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ..+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999997643 123456788888876 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.+. ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987543222 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...... .. +.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~-i~~~~~------~~----~~~~~~ 221 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEA-ILNDEV------VY----PTWLSQ 221 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHH-HhcCCC------CC----CCCCCH
Confidence 4579999999999998899999999999999999999999997643211 1111 111110 11 111234
Q ss_pred HHHHHHHhhccCCCCCCCCH------HHHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTM------RQVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~------~evl~~ 613 (670)
.+.+++..|++.||.+||+. +++++|
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 57789999999999999998 677665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.01 Aligned_cols=228 Identities=25% Similarity=0.319 Sum_probs=183.4
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+|.... ..+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999997643 123466788888866 799999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987543222 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ... ...| .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~i~-~~~---~~~p-------~~~~~ 221 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFESIL-HDD---VLYP-------VWLSK 221 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHHHHH-cCC---CCCC-------CCCCH
Confidence 4579999999999998899999999999999999999999998643211 111111 111 0011 11224
Q ss_pred HHHHHHHhhccCCCCCCC-------CHHHHHHHh
Q 035655 588 LVLQLGLLCSHQKAEARP-------TMRQVLRYL 614 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RP-------s~~evl~~L 614 (670)
.+.+++..||+.||.+|| ++++++++-
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 577889999999999999 888888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.44 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=185.3
Q ss_pred CccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhcc---ccCceeeeeeeeec-----cC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRL---RHKHLVNLQGWCKR-----KR 416 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~-----~~ 416 (670)
+|+..+.||+|+||.||++..... ...+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999976431 13456788877766 69999999998864 24
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++|+||++ ++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999997 589998876555568999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc---CCc---
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL---GQV--- 569 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~---~~~--- 569 (670)
...... ......||..|+|||++.+..++.++|||||||+++||++|+.||...... ........... ...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 664322 223456899999999999889999999999999999999999999753221 11111110000 000
Q ss_pred c----cccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 L----DVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~----~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. ....+... ........+.+.+++..|++.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000 01112234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.10 Aligned_cols=241 Identities=27% Similarity=0.454 Sum_probs=192.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..++|.+|+.++++++||||++++++|..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4678899999999999999986421 135688999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC--------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCc
Q 035655 419 LLVYDYIPNGSLDSLLFDNE--------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGN 478 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 478 (670)
++|+||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999996421 1347899999999999999999998 899999999999
Q ss_pred EEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchh
Q 035655 479 VLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFIL 556 (670)
Q Consensus 479 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~ 556 (670)
|+++.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||+++||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876543221 11222345678999999988899999999999999999998 88888643211
Q ss_pred HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 557 VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+.... ...+.... .+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 240 -~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 11121111 111223568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.37 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=187.9
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-----eeE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR-----DLL 419 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~ 419 (670)
+|+..+.||+|+||.||++.... ..+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47888999999999999997532 2346789999999999999999999998776 789
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5788877543 368999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCC---------
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQ--------- 568 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~--------- 568 (670)
...........+|+.|+|||++.+. .++.++|||||||+++||++|+.||...... ..+..........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4433333445789999999998764 4789999999999999999999999763321 1111100000000
Q ss_pred -----cc-cccCC-CCC--CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 -----VL-DVVDP-NLG--SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 -----~~-~~~d~-~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+. ....+ ... ........+.+.+++.+|++.||.+||++.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 00000 000 001111245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.58 Aligned_cols=239 Identities=24% Similarity=0.289 Sum_probs=185.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|...++||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468889999999999999987532 1245678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999654 358899999999999999999998 899999999999999999999999999996432110
Q ss_pred c------------c----------------------------------eeeccccCcCCCCccccccCCCCccchhHHHH
Q 035655 503 I------------S----------------------------------HTTNVVGTIGYIAPELARTGKASCSTDVFAYG 536 (670)
Q Consensus 503 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~G 536 (670)
. . ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCC---CCCHHHHHHH
Q 035655 537 VLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA---RPTMRQVLRY 613 (670)
Q Consensus 537 vvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~---RPs~~evl~~ 613 (670)
|+++||++|+.||........ ............. |.. ......+.+++..|++ +|.+ ||++.|++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~--p~~-----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET--YRKIINWRETLYF--PDD-----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH--HHHHHccCCccCC--CCC-----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999976432111 1111110110111 110 0112446677778887 6665 5699999997
Q ss_pred hc
Q 035655 614 LN 615 (670)
Q Consensus 614 L~ 615 (670)
-.
T Consensus 306 p~ 307 (377)
T cd05629 306 PF 307 (377)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=300.15 Aligned_cols=242 Identities=23% Similarity=0.359 Sum_probs=191.3
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
|++.+++++.....||+|+||.||+|.... ..+.+.+|+.++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 345567788888899999999999997543 2357889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCcccc--CHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeecCce
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVL--SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLAR 496 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFGla~ 496 (670)
+|+||+++++|.+++..... .+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999975422 34 888899999999999999998 89999999999999986 6799999999987
Q ss_pred eccCCCcceeeccccCcCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhhcCCccccc
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 573 (670)
....... ......|+..|+|||++.+.. ++.++||||||++++||++|+.||....... ..+..... ..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~ 229 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------KI 229 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-------cc
Confidence 6543221 122346889999999986643 7889999999999999999999986432111 11110000 01
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+ ..+......+.+++.+||+.+|.+||++.|++++
T Consensus 230 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11 1222233567889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.81 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=191.4
Q ss_pred hcCccccceEeeeCceeEEEeecc------------------------chHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP------------------------TRMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~------------------------~~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
..+|.+.++||+|+||.||++... .....+.+|+++++++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356888999999999999998531 0234678999999999 699999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+..++|+||+++|+|.+++.... ...++|.++.+++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 99999999999999999996532 2358999999999999999999998 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence 99999999999999865432211 1112234567999999988889999999999999999999 89998653321 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........... ..+......+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 245 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111111 11112234677899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=298.39 Aligned_cols=233 Identities=30% Similarity=0.487 Sum_probs=191.0
Q ss_pred ceEeeeCceeEEEeeccch--------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~--------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++..... .+.+.+|++.+++++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999977531 46788999999999999999999999999999999999999
Q ss_pred CCchhhcccCC-------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 428 GSLDSLLFDNE-------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 428 gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
++|.+++.... ...+++.++.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 3569999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
... .......++..|+|||.+....++.++||||+|++++||++ |+.||...... ... .....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~-~~~~~~~-----~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVL-EYLRKGY-----RL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHH-HHHHcCC-----CC---
Confidence 331 12233467889999999988889999999999999999999 69999764221 111 1111111 01
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+......+.+++.+||+.+|.+||++.|++++|+
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222466888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.55 Aligned_cols=235 Identities=27% Similarity=0.373 Sum_probs=188.4
Q ss_pred ccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
|+..+.||+|+||+||++.... ....+.+|++++++++|+||+++.+.+..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677899999999999987642 113467899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999999876555579999999999999999999998 899999999999999999999999999997654322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......|+..|+|||++.+..++.++|+|||||+++||++|+.||........ ..... ..... .+. +..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-----~~~~~-~~~----~~~ 226 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-----RVLET-EEV----YSA 226 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-----hhhcc-ccc----cCc
Confidence 22345789999999999988999999999999999999999999975332111 11111 00000 011 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
.....+.+++..|++.||.+||+ +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 22345678899999999999999 6676664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=315.21 Aligned_cols=183 Identities=25% Similarity=0.345 Sum_probs=158.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccch----------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR----------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~----------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
...+|.+.+.||+|+||.||+|..... ......|+.++++++||||+++++++......++|+|++ .++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCc
Confidence 346799999999999999999987542 234457999999999999999999999999999999999 468
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecc
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 509 (670)
|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 143 l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~ 216 (357)
T PHA03209 143 LYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGL 216 (357)
T ss_pred HHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--cccccc
Confidence 988886543 468999999999999999999998 89999999999999999999999999999753322 122345
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf 549 (670)
.||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 7999999999999999999999999999999999965554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.79 Aligned_cols=235 Identities=23% Similarity=0.358 Sum_probs=196.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
..+|++.+.||+|.||+|-++.... ++....+||++|+.|+||||+.++.+|+.++...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3467788999999999999987522 234566999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||..+|.|++|+.+. ..|++.+.+.+++||.+|+.|+|. ++++|||||.+|||||.++++||+||||+.++...
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999655 469999999999999999999998 99999999999999999999999999999888765
Q ss_pred CcceeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. -.++++|++-|.+||++.+.+|. +..|-||||++||-|+.|..||++.+.. ..+.+ ...+.+.+--.
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lvrQ-Is~GaYrEP~~------ 275 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLVRQ-ISRGAYREPET------ 275 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--HHHHH-hhcccccCCCC------
Confidence 4 34567999999999999998884 7899999999999999999999873321 11111 12232222111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+....-|+.|||..||.+|.|+.+|..|.+-
T Consensus 276 -----PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 -----PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1234568889999999999999999999863
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.17 Aligned_cols=237 Identities=30% Similarity=0.524 Sum_probs=190.0
Q ss_pred CccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.|+..+.||+|+||.||+|.... ..++|..|+.++++++||||+++++++.++...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999987531 2357889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997643 368999999999999999999998 899999999999999999999999999987654432
Q ss_pred ccee-e-ccc--cCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCC
Q 035655 503 ISHT-T-NVV--GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 503 ~~~~-~-~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 576 (670)
.... . ... .+..|+|||.+.+..++.++|||||||+++|+++ |..||...... ...+. .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i---~~~~------~~- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDY------RL- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH---HcCC------cC-
Confidence 1111 1 111 2457999999998999999999999999999886 99999753321 11111 1100 00
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+.+..+.+++..||+.+|.+||+++++++.|+.
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0111223557889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.55 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=191.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~ 417 (670)
.++|...++||+|+||.||+|++.. ..+.+.+|+++|.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 4567788999999999999997421 1246889999999997 9999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC-----------------------------------------------------------
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE----------------------------------------------------------- 438 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 438 (670)
.++|+||+++|+|.+++++..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532
Q ss_pred -------------------------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 439 -------------------------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 439 -------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
...++|..+++++.|++.||.|||+ ++++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 1247888899999999999999998 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~ 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--Q 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--H
Confidence 9999999999999986543221 11223457789999999998889999999999999999998 899986532111 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.......+. .+ ..+......+.+++..||+.+|.+||++++|++.|++
T Consensus 351 ~~~~~~~~~-----~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 351 FYNAIKRGY-----RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111110 01 1111223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.20 Aligned_cols=235 Identities=28% Similarity=0.417 Sum_probs=190.4
Q ss_pred cCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
++|...+.||+|+||.||++...+ ....+.+|+.++++++||||+++++++... ..++|+||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 457888999999999999986533 335788999999999999999999998664 4799999999999
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecc
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 509 (670)
|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 9999977655578999999999999999999998 899999999999999999999999999987543321 122
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHH
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 588 (670)
..+..|+|||.+.++.++.++|||||||+++||++ |+.||...... ...... ..+.. + .........
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~-~~~~~-----~----~~~~~~~~~ 225 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECV-EKGYR-----M----EPPEGCPAD 225 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH-hCCCC-----C----CCCCcCCHH
Confidence 34568999999988899999999999999999998 99999754321 111111 11110 0 111123356
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 589 VLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+.+++.+||+.+|.+||+++++++.|+.
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.52 Aligned_cols=237 Identities=24% Similarity=0.357 Sum_probs=179.4
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
+.||+|+||.||+|.... ....|.+|++.++.++||||+++++.|.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999985421 1346789999999999999999999999999999999999999
Q ss_pred CchhhcccCCc---cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 429 SLDSLLFDNEN---FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 429 sL~~~l~~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
+|.+++..... ...++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 235788889999999999999998 899999999999999999999999999987543322111
Q ss_pred -eeccccCcCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 506 -TTNVVGTIGYIAPELART-------GKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... ..... ..........+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~ 234 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQV-VREQDIKLPKPQ 234 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHH-hhccCccCCCCc
Confidence 122345678999998743 356889999999999999999 788886532111 01111 111112222232
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+... ....+.+++..|| .||.+||++++|++.|.
T Consensus 235 ~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222 2344566777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.69 Aligned_cols=241 Identities=23% Similarity=0.285 Sum_probs=185.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..++||+|+||.||++.... ....|.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999997643 1234778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997643 368999999999999999999998 999999999999999999999999999997654433
Q ss_pred cceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............. -|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~--~p~~ 232 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKERFQ--FPAQ 232 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCcccc--CCCc
Confidence 33333457999999999886 346789999999999999999999999764321 11111111110000 0111
Q ss_pred CCcccHHHHHHHHHHHHhhcc--CCCCCCCCHHHHHHHh
Q 035655 578 GSSYVVAEMELVLQLGLLCSH--QKAEARPTMRQVLRYL 614 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~L 614 (670)
. ......+.+++..|+. +++..||+++|+++|-
T Consensus 233 ~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 233 V----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred c----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 1 1122345556666554 4445578999999873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=300.46 Aligned_cols=233 Identities=27% Similarity=0.458 Sum_probs=186.0
Q ss_pred ceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 368 EVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+.||+|+||.||+|.... ...+|.+|++++++++||||++++++|...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999987531 234677899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCC-----ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-----cEEEEeecC
Q 035655 425 IPNGSLDSLLFDNE-----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-----NARLGDFGL 494 (670)
Q Consensus 425 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-----~~kL~DFGl 494 (670)
+++++|.+++.+.. ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2348899999999999999999998 8999999999999999887 899999999
Q ss_pred ceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 495 ARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 495 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
++....... .......++..|+|||++.++.++.++|||||||+++||++ |+.||...... +...... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~-~~~---- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVT-AGG---- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHh-cCC----
Confidence 976543221 11222345788999999999999999999999999999998 99998653221 1111111 110
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+......+.+++.+||+++|.+||+++++++.|+
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111223456789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.72 Aligned_cols=242 Identities=24% Similarity=0.296 Sum_probs=185.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.|.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999987643 1234778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999996532 358999999999999999999998 899999999999999999999999999997665433
Q ss_pred cceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +............. +.+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~-~~~~- 232 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKEHFQ-FPPD- 232 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCccc-CCCc-
Confidence 333334579999999999863 45788999999999999999999999764321 11111111111111 1111
Q ss_pred CCcccHHHHHHHHHHHHhhc--cCCCCCCCCHHHHHHHhc
Q 035655 578 GSSYVVAEMELVLQLGLLCS--HQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~L~ 615 (670)
... ..+.+.+++..|+ ..++..||+++++++|-.
T Consensus 233 ~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 233 VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 111 1233445555544 455555899999999843
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=297.28 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=193.9
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||.+.... ..+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999888776422 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+.....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999977655578999999999999999999998 8999999999999999999999999999987654332
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......+++.|+|||.+.+..++.++||||||++++||++|+.||...... +...... .+.... ....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~-~~~~~~---------~~~~ 224 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVKIV-QGNYTP---------VVSV 224 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-cCCCCC---------Cccc
Confidence 233456899999999998888899999999999999999999999763321 1111111 111111 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
....+.+++.+||+.+|.+||+++++++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.75 Aligned_cols=227 Identities=25% Similarity=0.317 Sum_probs=183.6
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ....+..|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999997643 123456788888888 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++.+. ..+++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987532221 2223
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||........ ... ..... +. ++.....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~-i~~~~------~~----~~~~~~~ 221 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQS-ILEDE------VR----YPRWLSK 221 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHH-HHcCC------CC----CCCcCCH
Confidence 45789999999999999999999999999999999999999976432111 111 11111 11 1112235
Q ss_pred HHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
.+.+++..||+.||.+||++ .+++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 67889999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.09 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=189.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 3568889999999999999997532 234577899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 9999999998654 358999999999999999999998 899999999999999999999999999998664322 1
Q ss_pred eeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......|+..|+|||.+. ...++.++|||||||+++||++|+.||.......... ..... ....+....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~---~~~~~~~~~-- 233 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKS---NFQPPKLKD-- 233 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecC---CCCCCCCcc--
Confidence 123346889999999874 3457889999999999999999999986422110000 00000 001111110
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+.+++.+||+.+|.+||++++++++|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112235678899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.44 Aligned_cols=227 Identities=24% Similarity=0.327 Sum_probs=180.5
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999997643 123455677777754 899999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987532222 2234
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||....... .. ...... .+.+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~-~~~~~~------~~~~~~----~~~~ 221 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LF-ESIRVD------TPHYPR----WITK 221 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH-HHHHhC------CCCCCC----CCCH
Confidence 5679999999999999999999999999999999999999997643211 11 111111 111111 1234
Q ss_pred HHHHHHHhhccCCCCCCCCHH-HHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMR-QVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~-evl~~ 613 (670)
.+.+++..||+.||.+||++. ++++|
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 567889999999999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.64 Aligned_cols=240 Identities=22% Similarity=0.366 Sum_probs=192.8
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999998531 1356889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCc-------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 420 LVYDYIPNGSLDSLLFDNEN-------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 258999999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
|+++..............++..|+|||.+.+..++.++||||||++++||++ |..||...... ..... ...+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~-~~~~~~~~ 238 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNR-LQAGKLEL 238 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHH-HHcCCcCC
Confidence 9987543332222333456778999999988889999999999999999999 88888642211 11111 11111110
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.........+.+++.+||+.+|.+||++.|+++.|+
T Consensus 239 --------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 --------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011122356888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.59 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=191.1
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|+||.||++.... ...++.+|++++++++||||+++++.|..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468899999999999999987532 124578999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+. ..+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999654 458999999999999999999997 2589999999999999999999999999987553321
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc-CC---------------
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL-GQ--------------- 568 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~-~~--------------- 568 (670)
.....|+..|+|||++.+..++.++|||||||+++||++|+.||................. ..
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2345788999999999888899999999999999999999999865321111110000000 00
Q ss_pred ------------cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 ------------VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 ------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+.. ......+.+++.+||+.+|++||+++|++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000011100 012345789999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.13 Aligned_cols=235 Identities=25% Similarity=0.387 Sum_probs=191.1
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec-cCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-KRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E 423 (670)
+|+..+.||+|++|.||++.... ..+.+.+|++++++++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47889999999999999987533 22457789999999999999999998764 446899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999977555578999999999999999999998 899999999999999999999999999998764332
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.......+++.|+|||++.+..++.++|||||||+++||++|+.||...... ....... .+.. +. .+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~-~~~~-----~~----~~~ 224 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRII-EGKL-----PP----MPK 224 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH-hcCC-----CC----Ccc
Confidence 2233456889999999999999999999999999999999999999754321 1111111 1111 11 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++.+|++.+|.+||++.+++++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.69 Aligned_cols=227 Identities=24% Similarity=0.368 Sum_probs=180.9
Q ss_pred ceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhc-cccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGR-LRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+|..... .+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999986431 2345567788876 4899999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987532221 2234
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .. .+... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~-~~------~~~~~----~~~~~ 221 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIR-MD------NPCYP----RWLTR 221 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-hC------CCCCC----ccCCH
Confidence 457999999999999889999999999999999999999999764321 1111111 11 11111 11234
Q ss_pred HHHHHHHhhccCCCCCCCCHH-HHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMR-QVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~-evl~~ 613 (670)
.+.+++..||+.||.+||++. ++.++
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 567889999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.77 Aligned_cols=227 Identities=23% Similarity=0.306 Sum_probs=182.2
Q ss_pred ceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 368 EVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
+.||+|+||.||++.... ....+..|+++|++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 579999999999875411 12346689999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 99999998654 358999999999999999999998 899999999999999999999999999997654332 223
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ...... ... .. .+....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~i~-~~~------~~----~p~~~~ 222 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMTMIL-KAK------LG----MPQFLS 222 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHHHHH-cCC------CC----CCCCCC
Confidence 34579999999999998889999999999999999999999997643211 111111 110 01 111223
Q ss_pred HHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 587 ELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
..+.+++..||+.||.+||+ +++++++
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 45678899999999999999 5556544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.86 Aligned_cols=225 Identities=26% Similarity=0.431 Sum_probs=178.7
Q ss_pred ceEeeeCceeEEEeeccc----------------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 368 EVIGTGGFGEVYKGVLPT----------------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
+.||+|+||.||+|+... ....|.+|+.+++.++||||++++++|..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997421 1236778999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc-------EEEEee
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN-------ARLGDF 492 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-------~kL~DF 492 (670)
+|+||+++|+|+.++.... ..+++..+++++.||++||+|||+ ++|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999986543 358999999999999999999998 89999999999999987664 899999
Q ss_pred cCceeccCCCcceeeccccCcCCCCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCcchhHHHHHHHhhcCCcc
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIA-TGRRPIDSDHFILVDWVLEFQHLGQVL 570 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~el~-tG~~pf~~~~~~~~~~~~~~~~~~~~~ 570 (670)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ .|+.|+.......... .... . .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~~-~-~ 226 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---FYEG-Q-C 226 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHhc-C-c
Confidence 998654321 2345788999999886 466899999999999999998 4888876532211111 1110 0 0
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... .. ....+.+++..||+.||.+||++.++++.++
T Consensus 227 ~~~-----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 MLV-----TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCC-----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 011 11 1245788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.32 Aligned_cols=236 Identities=23% Similarity=0.337 Sum_probs=186.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..++||+|+||.||+|.... ..++|.+|++++++++||||++++++|...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 357788999999999999997532 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 46888899999999999999998 99999999999999999999999999999765432
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||..|+|||++.+..++.++|||||||+++||++|+.||...... ........... .....+.+. .
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~ 222 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---VDEDPPVLP---V 222 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---hccCCCCCC---C
Confidence 223457899999999999889999999999999999999999999642110 00000000000 000111111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++.+|++.+|.+||+++|++++..
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 112345788999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=302.79 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=193.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeec-cCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-KRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~ 418 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5678889999999999999997643 13557899999999999999999998876 4678
Q ss_pred EEEEeccCCCCchhhcccCCc------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 419 LLVYDYIPNGSLDSLLFDNEN------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865422 468999999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcc
Q 035655 493 GLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVL 570 (670)
Q Consensus 493 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~ 570 (670)
|+++.+....... .....++..|+|||++.+..++.++|||||||+++|+++ |+.||...... ++.........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-- 237 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLKDGYR-- 237 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHHcCCC--
Confidence 9998654432211 122356778999999988889999999999999999999 99999753321 11111111110
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
... .......+.+++.+||+.+|++||++.++++.|+.
T Consensus 238 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 238 ----LAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred ----CCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 011 11123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.85 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=185.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccch------------HHHHHHHHHHHhccccCceeeeeeeeecc--------CeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWCKRK--------RDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--------~~~~ 419 (670)
..++|+..+.||+|+||.||+|..... .....+|+.+|++++||||+++++++... ..++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 346799999999999999999986431 23345799999999999999999876432 2467
Q ss_pred EEEeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCce
Q 035655 420 LVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLAR 496 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~ 496 (670)
+||||+++ +|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999974 77776643 233568999999999999999999999 8999999999999999765 69999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc--------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL-------- 566 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~-------- 566 (670)
...... ......||+.|+|||++.+. .++.++|||||||+++||++|+.||...... ...........
T Consensus 220 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 220 NLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 664432 22335789999999988654 6899999999999999999999999763221 11111100000
Q ss_pred --CCcccccCC-----CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 567 --GQVLDVVDP-----NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 567 --~~~~~~~d~-----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+..-+ .+...++......+.+++..||+.||.+||++.|+++|-.
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 000000001 1111122223457889999999999999999999998754
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.82 Aligned_cols=227 Identities=25% Similarity=0.295 Sum_probs=178.0
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHH-HHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIE-SLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+++... ....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999997643 1123444544 67889999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999888653 358889999999999999999998 899999999999999999999999999987532221 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... ..... ... . ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~-~~~------~----~~~~~~~~ 221 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YDNIL-HKP------L----QLPGGKTV 221 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HHHHh-cCC------C----CCCCCCCH
Confidence 45799999999999988999999999999999999999999976432111 11111 110 0 11112235
Q ss_pred HHHHHHHhhccCCCCCCCCHH----HHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMR----QVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~----evl~~ 613 (670)
.+.+++.+|++.+|.+||+.. +++++
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 678899999999999998753 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.53 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=188.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|...++||+|+||.||+|+... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 568889999999999999997642 123577899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++ +|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 8888876543 358999999999999999999998 8999999999999999999999999999976543221
Q ss_pred eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh------------cCCcc
Q 035655 505 HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH------------LGQVL 570 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~------------~~~~~ 570 (670)
......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... .......... .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223467899999998865 46889999999999999999999999763321 1100000000 00000
Q ss_pred cccCCCCCC----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 571 DVVDPNLGS----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 571 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..-.+.... .........+.+++..|++.||.+|||++|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000 000112345678999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.62 Aligned_cols=238 Identities=26% Similarity=0.408 Sum_probs=194.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++++......++++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3678889999999999999998753 24678899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 82 AGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999999986543 468999999999999999999998 8999999999999999999999999999986654321 22
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....++..|+|||++.+..++.++||||||++++||++|+.||.......... . ......+.+ ..+....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~----~~~~~~~~~--~~~~~~~ 226 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----M----IPNKPPPTL--SDPEKWS 226 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----h----hccCCCCCC--CchhhcC
Confidence 33468899999999998899999999999999999999999997532211000 0 000001111 1122233
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+.+++..||+.+|.+||++.|++++
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 567889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.06 Aligned_cols=233 Identities=27% Similarity=0.400 Sum_probs=188.3
Q ss_pred ceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++||+|++|.||+|.+.. ..+.|.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997532 23568899999999999999999999988 889999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc--e
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS--H 505 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~--~ 505 (670)
++|.+++.+.....++|..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999977543568999999999999999999998 89999999999999999999999999999876543221 1
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....++..|+|||++.+..++.++|||||||+++||++ |+.||...... +........... . ..+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~-------~--~~~~~ 225 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGER-------L--ERPEA 225 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCc-------C--CCCcc
Confidence 123457789999999998899999999999999999998 99999653221 111111111110 0 01112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+..+.+++.+|++.+|.+||++.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 3356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.81 Aligned_cols=238 Identities=23% Similarity=0.354 Sum_probs=192.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||+|+... ....+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 3578889999999999999997532 235678999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+ ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 999999999854 258999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......+++.|+|||.+.+..++.++|||||||+++||++|+.||....... .+. ....... +.+ ..+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~-~~~~~~~------~~~--~~~~~ 241 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALY-LIATNGT------PEL--QNPEK 241 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHH-HHhcCCC------CCC--CCccc
Confidence 1233468899999999988889999999999999999999999997643211 111 1111110 111 11222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+.+++.+||+.+|.+||++.+++++-.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 3356788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=290.53 Aligned_cols=239 Identities=25% Similarity=0.368 Sum_probs=194.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccchH------------------------HHHHHHHHHHhcc-ccCceeeeeeeeec
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTRM------------------------REFAAEIESLGRL-RHKHLVNLQGWCKR 414 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~~------------------------~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 414 (670)
.-+.|...+.||.|..+.|-+++.+.+. ++-.+|+.+|+++ .||+|+.+.+.++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778888999998888877664421 2334799999998 59999999999999
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
+.-.++|+|.|+.|.|.+||... -.++++...+|++|+.+|+.|||. ..||||||||+|||+|++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999654 469999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELART------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
+.....+. .....+||++|+|||.+.. ..|+...|+|++|+++|-|+.|..||-.... -........++
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlMLR~ImeGk 244 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLMLRMIMEGK 244 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHHHHHHhcc
Confidence 99887654 4567899999999998753 3578899999999999999999999853111 11112222222
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. ....+-..+......+|+.+|++.||.+|-|.+|+++|-
T Consensus 245 y------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 245 Y------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred c------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 2 122333445567788999999999999999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.70 Aligned_cols=242 Identities=25% Similarity=0.399 Sum_probs=189.6
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--Cee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 418 (670)
+.|++.+.||+|+||.||++.... ....+.+|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 457888999999999999886310 235688999999999999999999998775 568
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++++|.+++.+.. ..++|.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 358999999999999999999998 99999999999999999999999999999866
Q ss_pred cCCCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh------------HHHHHHHh
Q 035655 499 DHGKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL------------VDWVLEFQ 564 (670)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~------------~~~~~~~~ 564 (670)
...... ......++..|+|||++.+..++.++|||||||+++||++++.|........ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 543221 1223456778999999988889999999999999999999887653211000 00000001
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.. ...+......+.+++.+||+.+|.+||+++++++.|+.
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 11110 01112234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.90 Aligned_cols=230 Identities=25% Similarity=0.308 Sum_probs=182.6
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||+||++.... ..+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999997643 123467899999888 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999988654 359999999999999999999999 899999999999999999999999999987532211 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC----cchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD----HFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||... .....++......... ..+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~----p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRI----PR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCC----CC
Confidence 457999999999999999999999999999999999999999641 1112222222221111 111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC------HHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPT------MRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 613 (670)
.....+.+++..||+.||.+||+ ++++++|
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 12245678889999999999998 4677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.33 Aligned_cols=238 Identities=25% Similarity=0.397 Sum_probs=190.2
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|...++||+|+||.||+|.... ..+.|.+|+.++++++||||++++++|.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999987421 23468899999999999999999999875 457899
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999996643 358999999999999999999998 89999999999999999999999999999876544
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.........++..|+|||.+....++.++||||||++++|+++ |+.||....... ...... .+... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~-~~~~~-----~~--- 229 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIE-NGERL-----PM--- 229 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-cCCcC-----CC---
Confidence 3222223345578999999988889999999999999999986 999997643211 111111 11100 11
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++.+|+..+|.+||++.++++.|++
T Consensus 230 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 230 -PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.72 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=192.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|+||+||++.... ..+.+.+|+++++.++||||+++++.+...+.+++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 467888999999999999987642 235788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+. ..+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999998654 358999999999999999999997 2589999999999999999999999999987543321
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch---------hHHHHHHHhhcCCcccccCC
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI---------LVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~d~ 575 (670)
.....|+..|+|||++.+..++.++|||||||+++|+++|+.||...... ..++...... ...+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ------EPPP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh------ccCC
Confidence 22357899999999998888999999999999999999999999753221 1111111110 0011
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.. ......+.+++.+|+++||.+||++.|++++..-
T Consensus 232 ~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 232 RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 1111 1133567889999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.23 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=192.8
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
.+|.+.+.||+|+||.||++.... ..+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457889999999999999885310 235688999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
..++++||+++|+|.+++.... ...++|.+++.++.|++.||+|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999986532 2358899999999999999999998 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWV 560 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~ 560 (670)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |..||..... .+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~ 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EELF 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Confidence 9999999999999865442211 1122344568999999999899999999999999999998 8888865332 1111
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.... ..... ..+......+.+++..||+.+|.+||++.|+++.|+...
T Consensus 247 ~~~~-~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 KLLK-EGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHH-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111 11100 111122356788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.11 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=189.2
Q ss_pred cCccccceEeeeCceeEEEeeccchHHH------------HHHHHHHHhccccCceeeeeeeeeccC-----eeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTRMRE------------FAAEIESLGRLRHKHLVNLQGWCKRKR-----DLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~~~~------------f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~lV~E~ 424 (670)
-.|...+++|+|.||.||+|......+. =-+|+++|+++.|||||+|+-+|.... .+.+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3567789999999999999988664222 228999999999999999999886432 45799999
Q ss_pred cCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCceeccCC
Q 035655 425 IPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHG 501 (670)
Q Consensus 425 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~~~~~~ 501 (670)
||. +|.++++.. .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+....+
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 986 898888642 23467888888899999999999999 999999999999999977 89999999999988776
Q ss_pred CcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHh---------hcCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQ---------HLGQV 569 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~---------~~~~~ 569 (670)
... ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|+..|.++... +...+..+. .....
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 544 233557899999988875 6999999999999999999999999874321 221111111 01111
Q ss_pred ccccCCCCCCc-----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPNLGSS-----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+...|.+... +......+.++++.++++.+|.+|.++.|++++
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 12222333221 223345678899999999999999999999986
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.15 Aligned_cols=233 Identities=26% Similarity=0.416 Sum_probs=181.2
Q ss_pred ceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeee-ccCeeEEEEeccC
Q 035655 368 EVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCK-RKRDLLLVYDYIP 426 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~ 426 (670)
+.||+|+||.||+|.... ..+.+.+|+.+++.++||||++++++|. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999987421 1346778999999999999999999876 4556899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc---
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI--- 503 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~--- 503 (670)
+|+|.+++.+.. ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997543 346888889999999999999998 8999999999999999999999999999975543221
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATG-RRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......++..|+|||.+.+..++.++|||||||+++||++| ..||..... .+....... +. .+.. +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~-~~-----~~~~----~ 224 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQ-GR-----RLLQ----P 224 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhc-CC-----CCCC----C
Confidence 111233567789999999888999999999999999999995 556654221 111111111 10 0110 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+..+.+++..||+++|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.88 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=187.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+++... ....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999997643 1234678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997643 368999999999999999999998 999999999999999999999999999998765443
Q ss_pred cceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... +............. ..+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~-~p~~~ 233 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHEERFQ-FPSHI 233 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHHHHHHcCCCccc-CCCcc
Confidence 333344579999999998875 56788999999999999999999999764321 11111111110000 11111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHh
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYL 614 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 614 (670)
....+.+.+++..|++.++++ |++++++++|.
T Consensus 234 -----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 234 -----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred -----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 112345667777777765543 57899998874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.49 Aligned_cols=248 Identities=24% Similarity=0.254 Sum_probs=189.1
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
.+|.+.+.||+|+||.||++...+ ..+.+.+|+++|++++||||+++++++......++|||++. +
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 468889999999999999986432 12355789999999999999999999999999999999995 6
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-ceee
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-SHTT 507 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~ 507 (670)
+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 171 ~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 171 DLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence 88888843 3469999999999999999999998 8999999999999999999999999999976544322 2223
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-----hHHHHHHHhhc----------------
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-----LVDWVLEFQHL---------------- 566 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-----~~~~~~~~~~~---------------- 566 (670)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..........
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 457999999999999999999999999999999999999999653211 11100000000
Q ss_pred CCcccccCCCCC-Ccc--cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 567 GQVLDVVDPNLG-SSY--VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 567 ~~~~~~~d~~l~-~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........+... ... .......+.+++..||+.||.+||++.|++++-.
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 000000000000 000 0011245677889999999999999999998743
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=298.06 Aligned_cols=237 Identities=25% Similarity=0.383 Sum_probs=188.0
Q ss_pred ccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
|+..+.||+|+||.||+|.... ..+.+.+|+++++.++||||++++++|...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667889999999999997643 235688999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|..++.+.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99999886533 468999999999999999999998 899999999999999999999999999987543321 1223
Q ss_pred ccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 508 NVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
...++..|+|||++. +..++.++|||||||++|||++|+.||...... ......... . .+.+ ..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~-~-----~~~~--~~~ 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS-E-----PPTL--AQP 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhc-C-----CCCC--CCc
Confidence 356899999999874 345788999999999999999999999753311 111111111 0 0111 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++..||+.+|.+||++.+++++-.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 122356788999999999999999999998644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.28 Aligned_cols=235 Identities=26% Similarity=0.349 Sum_probs=190.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
..++|+....||+|+||.||+++-++ ..+.+.+|-.+|....+|+||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56789999999999999999998654 33556789999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||++||++..+|... ..|++.....++.+++.|+.-||+ .|+|||||||+|+|||..|.+||+||||+.-...
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999665 469999999999999999999999 9999999999999999999999999999853321
Q ss_pred C----------------------Ccc-----ee-------------------eccccCcCCCCccccccCCCCccchhHH
Q 035655 501 G----------------------KIS-----HT-------------------TNVVGTIGYIAPELARTGKASCSTDVFA 534 (670)
Q Consensus 501 ~----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~t~ksDV~S 534 (670)
. ... .. ...+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 000 00 1147999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcch-----hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCC---C
Q 035655 535 YGVLLLEIATGRRPIDSDHFI-----LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARP---T 606 (670)
Q Consensus 535 ~Gvvl~el~tG~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s 606 (670)
+|||+|||+.|.+||..+... +..|...+... .+. ....+..+|+.+|+. ||.+|- .
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------~~~--------~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------EEV--------DLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------CcC--------cccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999875432 22232111110 011 112556788888888 999996 4
Q ss_pred HHHHHHHh
Q 035655 607 MRQVLRYL 614 (670)
Q Consensus 607 ~~evl~~L 614 (670)
++||-+|-
T Consensus 439 ~~EIK~HP 446 (550)
T KOG0605|consen 439 AEEIKKHP 446 (550)
T ss_pred HHHHhcCC
Confidence 77777653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=286.58 Aligned_cols=238 Identities=24% Similarity=0.306 Sum_probs=194.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+++|+..+.||+|.|+.||++.... +.+++.+|+++-+.|+||||++|..-..+.+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 5678888999999999999987654 3345668999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~~ 499 (670)
|+|.|++|..-|-.+ ..+++..+-..+.||+++|.|+|. ++|||||+||+|+||-+. --+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997666443 467888888999999999999999 999999999999999543 358999999999877
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
........+||++|||||+++..+|+..+|||+.|+||+-|+.|+.||.++... +-+ ....+. -...
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye----~I~~g~------yd~~ 232 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE----QIKAGA------YDYP 232 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH----HHhccc------cCCC
Confidence 334556679999999999999999999999999999999999999999864322 111 111111 1122
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.+.....+...+|+.+|+..||.+|.|+.|.++|-+
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 2233344566778899999999999999999998755
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.45 Aligned_cols=225 Identities=25% Similarity=0.412 Sum_probs=178.8
Q ss_pred ceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 368 EVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+.||+|+||.||+|.... ..+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999996521 124577899999999999999999999998999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc--------EEEEeecCce
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN--------ARLGDFGLAR 496 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--------~kL~DFGla~ 496 (670)
+++|+|.+++..+.. .+++..+++++.||+.||+|||+ ++|+||||||+||+++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 68999999999999999999998 99999999999999987765 6999999886
Q ss_pred eccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCC-CCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGR-RPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
.... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+........ .. .... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~--~----- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQ-FYED--R----- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HH-HHHc--c-----
Confidence 5432 2234678899999998864 5789999999999999999985 55543221111 10 1110 0
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+ +......+.+++..||+.+|.+||+++++++.|+
T Consensus 222 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111 1112245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.63 Aligned_cols=224 Identities=23% Similarity=0.359 Sum_probs=177.2
Q ss_pred eEeeeCceeEEEeeccc----------------------------------------hHHHHHHHHHHHhccccCceeee
Q 035655 369 VIGTGGFGEVYKGVLPT----------------------------------------RMREFAAEIESLGRLRHKHLVNL 408 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~----------------------------------------~~~~f~~Ei~~L~~l~H~nIv~l 408 (670)
.||+|+||.||+|.... ...+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999987411 12467789999999999999999
Q ss_pred eeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---
Q 035655 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM--- 485 (670)
Q Consensus 409 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~--- 485 (670)
+++|.+....++||||+++|+|+.++.+.. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986543 368999999999999999999998 8999999999999997654
Q ss_pred ----cEEEEeecCceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCcchhHHH
Q 035655 486 ----NARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIA-TGRRPIDSDHFILVDW 559 (670)
Q Consensus 486 ----~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~-tG~~pf~~~~~~~~~~ 559 (670)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988643221 12357788999998865 56899999999999999995 6999987533221111
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. ... ...... ....+.+++..||+.+|.+||++.++++.|.
T Consensus 233 ~~--~~~--------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FY--EKK--------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH--Hhc--------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 100 011111 1235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.61 Aligned_cols=236 Identities=30% Similarity=0.488 Sum_probs=191.0
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
|+..+.||+|+||.||++.... ..+.+..|+..+++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999987653 2457889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999976544348999999999999999999998 899999999999999999999999999998766543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
........++..|+|||.+.+..++.++||||+|++++||++ |+.||...... ...... ...... ..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~-~~~~~~---------~~ 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYL-KKGYRL---------PK 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-hcCCCC---------CC
Confidence 222222347789999999988889999999999999999998 78888653211 111111 111111 11
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+......+.+++.+|++.+|.+||++.|+++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111345678899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.33 Aligned_cols=234 Identities=26% Similarity=0.437 Sum_probs=192.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||.|++|.||+|.... ....+.+|+++++.++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 367788999999999999997643 235678999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998654 68999999999999999999998 899999999999999999999999999998775432 2
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......++..|+|||++.+..++.++||||||+++|||++|+.||....... ...... ....+.+... .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~------~~~~~~~~~~---~ 222 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIP------KNNPPSLEGN---K 222 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhh------hcCCCCCccc---c
Confidence 2334578889999999998889999999999999999999999997543211 111111 1111121111 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++..||+.+|.+||++++++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 33457788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.07 Aligned_cols=245 Identities=28% Similarity=0.328 Sum_probs=186.7
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|++|.||+|.... ..+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47788999999999999997642 124678999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
++ ++|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988886533 2568999999999999999999998 899999999999999999999999999997654322
Q ss_pred ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc-------------
Q 035655 504 SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV------------- 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~------------- 569 (670)
.......+++.|+|||++.+. .++.++|||||||+++||++|+.||.........+.. ....+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhCCCChhhhhcchhhHH
Confidence 122334678899999987654 5789999999999999999999999764322111100 0000000
Q ss_pred -ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 -LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 -~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.... ..........+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 00011123566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.46 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=195.4
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeeec-
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCKR- 414 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~- 414 (670)
.++.++..+...|+..+.||+|+||.||+|.... ...++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4667777788999999999999999999988643 235678899999998 69999999999853
Q ss_pred -----cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 415 -----KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 415 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
....+++|||+++|+|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEE
Confidence 4578999999999999999976555568899999999999999999998 89999999999999999999999
Q ss_pred EeecCceeccCCCcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh
Q 035655 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~ 564 (670)
+|||++....... .......|+..|+|||.+. ...++.++|||||||+++||++|+.||.......... .
T Consensus 163 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--~-- 237 (282)
T cd06636 163 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--L-- 237 (282)
T ss_pred eeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--h--
Confidence 9999987553321 1223356899999999875 3467889999999999999999999996532111000 0
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+... .......+.+++..||+.||.+||++.|++++
T Consensus 238 ----~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 ----IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0011111111 11233568889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.99 Aligned_cols=227 Identities=25% Similarity=0.283 Sum_probs=178.8
Q ss_pred ceEeeeCceeEEEeeccch-------------------HHHHHHHHH-HHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEIE-SLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||+||++..... .+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987431 123344444 56789999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999998654 368999999999999999999998 899999999999999999999999999987532221 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||...... +...... ... ..+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~-~~~------~~~~~~----~~~ 221 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDNIL-NKP------LRLKPN----ISV 221 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHHHH-cCC------CCCCCC----CCH
Confidence 457999999999999999999999999999999999999999764321 1111111 110 111111 235
Q ss_pred HHHHHHHhhccCCCCCCCCHH----HHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMR----QVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~----evl~~ 613 (670)
.+.+++..|++.||.+||+++ +++++
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 577899999999999999884 66553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=294.45 Aligned_cols=236 Identities=24% Similarity=0.362 Sum_probs=180.3
Q ss_pred eEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 369 VIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
.||+|+||.||+|.... ..+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 58999999999985321 23578899999999999999999999999999999999999999
Q ss_pred chhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-ccee
Q 035655 430 LDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK-ISHT 506 (670)
Q Consensus 430 L~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~-~~~~ 506 (670)
|.+++.+.. ....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 2346777888999999999999998 899999999999999999999999999986432211 1122
Q ss_pred eccccCcCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 507 TNVVGTIGYIAPELART-------GKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
....++..|+|||++.. ..++.++|||||||+++||++ |..||...... +..... ..+......++.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~~~ 235 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNHV-IKDQQVKLFKPQLE 235 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HhhcccccCCCccC
Confidence 34567889999998743 245789999999999999997 57788643211 111111 11222233344443
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+. ..+.+++..|| .+|.+||++++|++.|.
T Consensus 236 ~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3332 45666778899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=291.40 Aligned_cols=235 Identities=23% Similarity=0.393 Sum_probs=192.6
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||++.... ..+++.+|+.++++++||||+++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47888999999999999986532 234688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.......+++.++++++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 999999999976555568999999999999999999998 899999999999999999999999999998654432 1
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......|++.|+|||++.+..++.++|||||||+++||++|+.||...... +...... .+.. +. .+..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~-~~~~-----~~----~~~~ 224 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NLVLKII-RGSY-----PP----VSSH 224 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HHHHHHh-cCCC-----CC----Cccc
Confidence 122346888999999999888999999999999999999999999754321 1111111 1111 11 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++.+||+.+|.+||++.+|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.13 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=194.2
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeee--
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCK-- 413 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~-- 413 (670)
+.++.+..+.++|+..+.||+|+||.||++.... ...++.+|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4456667788999999999999999999987633 124677899999999 6999999999884
Q ss_pred ---ccCeeEEEEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEE
Q 035655 414 ---RKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR 488 (670)
Q Consensus 414 ---~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 488 (670)
.++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 345689999999999999987532 23468999999999999999999998 8999999999999999999999
Q ss_pred EEeecCceeccCCCcceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH
Q 035655 489 LGDFGLARLFDHGKISHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF 563 (670)
Q Consensus 489 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~ 563 (670)
|+|||+++....... ......|+..|+|||++.. ..++.++|||||||+++||++|+.||...... ... ...
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~-~~~ 241 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RAL-FKI 241 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHH-hhc
Confidence 999999986644321 2233478999999998753 45788999999999999999999998753221 000 000
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. ........++. .....+.+++.+||+.+|.+||++.|+++++
T Consensus 242 ~-~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 P-RNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c-ccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00000111111 1224578899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.34 Aligned_cols=233 Identities=28% Similarity=0.428 Sum_probs=189.7
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.|+..+.||+|+||.||+|.+.. ..+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667889999999999997632 2346789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999999854 358999999999999999999998 8999999999999999999999999999976544321 1
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....++..|+|||.+.+..++.++|||||||+++||++|+.|+.........+ . ......+.+ ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~------~~~~~~~~~----~~~~ 225 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L------IPKNSPPTL----EGQY 225 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--h------hhcCCCCCC----Cccc
Confidence 223468889999999998889999999999999999999999986532111100 0 000111111 2233
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+.+++.+||+.+|.+||++.+++++-
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 45678899999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.59 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=187.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc-C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK-R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~ 416 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 3578899999999999999986310 134577899999999 689999999988654 5
Q ss_pred eeEEEEeccCCCCchhhcccCC----------------------------------------------------------
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE---------------------------------------------------------- 438 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 438 (670)
..++|+||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986421
Q ss_pred -------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-ceeeccc
Q 035655 439 -------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-SHTTNVV 510 (670)
Q Consensus 439 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~ 510 (670)
...+++.++.+++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1247889999999999999999998 8999999999999999999999999999976533221 1122234
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 589 (670)
++..|+|||.+.+..++.++||||||++++||++ |..||....... ..... ...+.... .+. . ....+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~-~~~~~~~~--~~~---~----~~~~~ 311 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRR-LKEGTRMR--APD---Y----TTPEM 311 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHH-HhccCCCC--CCC---C----CCHHH
Confidence 5678999999988899999999999999999997 999986532111 11111 11111100 011 1 12457
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 590 LQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 590 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+++..||+.+|.+||++.|++++|+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.08 Aligned_cols=239 Identities=26% Similarity=0.425 Sum_probs=191.4
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.+|+..+.||+|+||.||+|.... ...++.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999987421 23567899999999999999999999987 78999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976543 58999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCccee-eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKISHT-TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
...... ....++..|+|||.+....++.++||||||++++|+++ |+.||...... +...... .+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~-~~~~--~~~~--- 233 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLE-KGER--LPQP--- 233 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHh-CCCC--CCCC---
Confidence 322111 11234568999999988889999999999999999998 99999764321 1111111 1110 0011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+.+++..||..+|.+||++.++++.|+..
T Consensus 234 ----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 ----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11224577889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.78 Aligned_cols=238 Identities=26% Similarity=0.342 Sum_probs=184.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ....+.+|+.++.+++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999987643 1245678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999654 358999999999999999999998 999999999999999999999999999987543211
Q ss_pred c----------------------------------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 035655 503 I----------------------------------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548 (670)
Q Consensus 503 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~p 548 (670)
. .......||+.|+|||++.+..++.++|||||||+++||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234799999999999999999999999999999999999999
Q ss_pred CCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHHh
Q 035655 549 IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT---MRQVLRYL 614 (670)
Q Consensus 549 f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 614 (670)
|........ ........... ...+.. . ....+.+++..|+ .+|.+|++ ++|+++|-
T Consensus 236 f~~~~~~~~--~~~i~~~~~~~-~~p~~~--~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 236 FCSETPQET--YRKVMNWKETL-VFPPEV--P----ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCHHHH--HHHHHcCCCce-ecCCCC--C----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence 976432211 11111100000 011111 1 1234555666655 49999984 78888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.96 Aligned_cols=243 Identities=19% Similarity=0.237 Sum_probs=183.2
Q ss_pred ccceEeee--CceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 366 QSEVIGTG--GFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 366 ~~~~lG~G--~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
..++||+| +|++||++.... ..+.+.+|+++++.++||||++++++|..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 789999987643 1234668999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc-
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS- 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~- 504 (670)
++|+|.+++..+....+++..+++++.|++.||.|||+ .+|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976555568999999999999999999998 89999999999999999999999999865433211100
Q ss_pred -----eeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC---
Q 035655 505 -----HTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD--- 574 (670)
Q Consensus 505 -----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d--- 574 (670)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||.......... .. ..+......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK-LNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH--HH-hcCCccccccccc
Confidence 1122356778999999875 458899999999999999999999997522111000 00 0000000000
Q ss_pred ----------------C-----------------CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 575 ----------------P-----------------NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 575 ----------------~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. .............+.+++.+||+.||++|||++|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0 000011122345688999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=292.45 Aligned_cols=224 Identities=30% Similarity=0.481 Sum_probs=180.4
Q ss_pred ceEeeeCceeEEEeeccc-------------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+.||+|+||.||+|.... ....|.+|+.++++++||||++++++|.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 468999999999987642 13467889999999999999999999988 7889999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-------cEEEEeecCc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-------NARLGDFGLA 495 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-------~~kL~DFGla 495 (670)
||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999976543 68999999999999999999998 8999999999999999888 7999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
..... .....++..|+|||++... .++.++||||||++++||++ |..|+...... .+..... .....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~-~~~~~-- 225 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ-DQHRL-- 225 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh-cCCCC--
Confidence 76543 2233567789999998876 78999999999999999999 57777653211 1111111 10000
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+ ....+.+++.+||+.+|.+||++.++++.|+
T Consensus 226 ~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 PMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 1156789999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.65 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=192.2
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~ 418 (670)
+.|+..+.||+|+||.||++.... ..++|.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 456778999999999999997421 14578999999999999999999999987 5578
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976542 59999999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH---hhcCCccccc
Q 035655 499 DHGKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF---QHLGQVLDVV 573 (670)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~---~~~~~~~~~~ 573 (670)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.|+.........+.... .......+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 1123456679999999888999999999999999999999999865221110000000 0000000000
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
........+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 0111111112233668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.72 Aligned_cols=228 Identities=24% Similarity=0.273 Sum_probs=177.8
Q ss_pred ceEeeeCceeEEEeeccch-------------------HHHHHHHH-HHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEI-ESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei-~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+++.... ...+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999976431 12233443 356788999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++... ..+++.....++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 9999999654 357888889999999999999998 899999999999999999999999999997543221 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||...... +....... .. ..+ ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~-~~------~~~----~~~~~~ 221 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN-KP------LQL----KPNITN 221 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh-CC------cCC----CCCCCH
Confidence 457999999999999999999999999999999999999999754321 11111111 10 011 112234
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+.+++..|++.+|.+||+..+.+..+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 567888999999999999877444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.97 Aligned_cols=181 Identities=28% Similarity=0.414 Sum_probs=150.3
Q ss_pred cceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCeeEEEEeccCCC
Q 035655 367 SEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDLLLVYDYIPNG 428 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~g 428 (670)
.++||+|+||.||+|.... ....+.+|++++++++||||+++++++.. +...++|+||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 4689999999999998532 12457899999999999999999998854 456899999985 5
Q ss_pred CchhhcccC-------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe----cCCCcEEEEeecCcee
Q 035655 429 SLDSLLFDN-------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARL 497 (670)
Q Consensus 429 sL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kL~DFGla~~ 497 (670)
+|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888776432 12358999999999999999999998 899999999999999 4567899999999987
Q ss_pred ccCCCc--ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 498 FDHGKI--SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
...... .......||+.|+|||++.+. .++.++||||+||+++||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 654321 122345789999999998764 588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.16 Aligned_cols=241 Identities=25% Similarity=0.392 Sum_probs=193.9
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478889999999999999997532 246788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 468999999999999999999998 9999999999999999999999999999876654332
Q ss_pred c---eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 504 S---HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 504 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
. ......|+..|+|||.+... .++.++|||||||+++||++|+.||........ ....... ..+.+..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~------~~~~~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN------DPPSLET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC------CCCCcCC
Confidence 2 12334689999999998877 789999999999999999999999975322111 0010000 1111111
Q ss_pred cc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 580 SY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 580 ~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. .......+.+++..||+.||.+||++++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 12334667899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.24 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=186.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-----
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR----- 416 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----- 416 (670)
..++|+..+.||+|+||.||++.... ....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999997532 2346778999999999999999999986443
Q ss_pred -eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 417 -DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 417 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 5666653 247889999999999999999999 89999999999999999999999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC-------
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ------- 568 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~------- 568 (670)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ..|.......+.
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHH
Confidence 7543321 223457899999999999999999999999999999999999999753211 111100000000
Q ss_pred -----ccc--ccCCCCC----------------CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 -----VLD--VVDPNLG----------------SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 -----~~~--~~d~~l~----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... ...+... ..........+.+++..||+.||++|||+.|+++|-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000 0000000 0011112356788999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=295.04 Aligned_cols=235 Identities=25% Similarity=0.431 Sum_probs=183.9
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~ 418 (670)
.+|+..+.||+|+||.||++.... ....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478889999999999999997532 12357789999999999999999998865 3578
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999996543 48999999999999999999998 89999999999999999999999999999765
Q ss_pred cCCC--cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 499 DHGK--ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 499 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
.... ........++..|+|||++.+..++.++|||||||+++||++|+.||...... ........ ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~~~~~~-----~~~~~~ 229 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAIFKIAT-----QPTNPQ 229 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHHHHHhc-----CCCCCC
Confidence 3311 11122346889999999999888999999999999999999999999753211 11111111 011122
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+ +....+.+..++ .||..+|.+||+++||++|
T Consensus 230 ~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 L----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 2 222223344444 6999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=312.59 Aligned_cols=228 Identities=23% Similarity=0.400 Sum_probs=184.1
Q ss_pred ccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC--eeEEEEe
Q 035655 366 QSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR--DLLLVYD 423 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV~E 423 (670)
...+||+|.|-+||||.+.. ..+.|..|+.+|+.|+||||++++..+.+.. ..-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35679999999999998744 3467889999999999999999999887654 4889999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCceeccCCC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGK 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~~~~~~~ 502 (670)
.|..|+|..|+.+.+ .++...+.+|++||++||.|||+. .++|||||||.+||+|+.+ |.|||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999998765 478889999999999999999995 5899999999999999754 799999999998876643
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHhhcCCcccccCCCCCCc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
...+.|||.|||||.+. ..|++..||||||++++||+|+..||..-... +-..+..-.....+..+-|
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------ 270 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------ 270 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC------
Confidence 44579999999999887 78999999999999999999999999742110 1111111011111111112
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.++.+++..|+.. .++|||+.|+|++
T Consensus 271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3467888999999 9999999999984
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.74 Aligned_cols=181 Identities=28% Similarity=0.421 Sum_probs=150.1
Q ss_pred cceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeee--ccCeeEEEEeccCCC
Q 035655 367 SEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCK--RKRDLLLVYDYIPNG 428 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~g 428 (670)
..+||+|+||.||+|.... ....+.+|++++++++||||+++++++. .+...++|+||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 4689999999999998542 1236789999999999999999999885 35678999999864
Q ss_pred CchhhcccC-------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe----cCCCcEEEEeecCcee
Q 035655 429 SLDSLLFDN-------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARL 497 (670)
Q Consensus 429 sL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kL~DFGla~~ 497 (670)
+|.+++... ....+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 777776421 12358899999999999999999998 899999999999999 5667899999999987
Q ss_pred ccCCCc--ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 498 FDHGKI--SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
...... .......||+.|+|||++.+. .++.++|||||||+++||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 654322 122345789999999988764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.90 Aligned_cols=246 Identities=26% Similarity=0.292 Sum_probs=189.6
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999997643 12457799999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++++.|..++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999998877543 358999999999999999999999 9999999999999999999999999999987654321
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc------------CCc-
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL------------GQV- 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~------------~~~- 569 (670)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||.........+....... ...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223467889999998876 4578999999999999999999999975332111111110000 000
Q ss_pred ccccCCCCCCcc-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPNLGSSY-----VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+...... .......+.+++.+||+++|.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000011110000 01124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.61 Aligned_cols=237 Identities=25% Similarity=0.388 Sum_probs=188.8
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+.|++.++||+|+||.||+|.... ..+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999997643 2456888999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|..++.+.. ..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999998876543 368999999999999999999998 899999999999999999999999999987543321 22
Q ss_pred eeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 506 TTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... ......... ..+.. .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~------~~~~~--~ 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS------EPPTL--S 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHhcC------CCccC--C
Confidence 23456889999999884 345688999999999999999999998753321 111111111 11111 0
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+......+.+++.+||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111223457789999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=304.04 Aligned_cols=232 Identities=24% Similarity=0.313 Sum_probs=183.7
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+|+..+.||+|+||.||++.... ..+.+..|+.+++.+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 46778999999999999997643 1234667888888886 577888999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998654 358999999999999999999998 899999999999999999999999999987543222
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ...... .. .. ++
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~-~~------~~----~p 221 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQSIME-HN------VS----YP 221 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-CC------CC----CC
Confidence 122345699999999999988999999999999999999999999976432111 111111 11 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
......+.+++.+|++++|.+|++. +++.+|
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1223456788999999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.76 Aligned_cols=239 Identities=28% Similarity=0.463 Sum_probs=189.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..+.||+|+||.||+|.... ...++.+|+.++++++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567788999999999999986421 123678999999999999999999999754 467
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999987643 358999999999999999999998 899999999999999999999999999998665
Q ss_pred CCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCC
Q 035655 500 HGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 576 (670)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..++. ..+... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~--~~~- 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----EKGERL--PQP- 233 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HCCCCC--CCC-
Confidence 43221 1222345778999999998899999999999999999997 99999753221 11111 111100 001
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+.+++..||..+|++||+++++++.|+..
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 234 ------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11234577899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.44 Aligned_cols=232 Identities=30% Similarity=0.464 Sum_probs=186.3
Q ss_pred ceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 368 EVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
++||+|+||.||++.... ....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999997642 2357889999999999999999999999999999999999999999
Q ss_pred hhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee-eccc
Q 035655 432 SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT-TNVV 510 (670)
Q Consensus 432 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 510 (670)
+++.+.. ..+++..+..++.+++.+|+|||+ ++++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9996643 368999999999999999999998 8999999999999999999999999999976543221111 1223
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 589 (670)
++..|+|||.+.++.++.++||||||++++||++ |..||........ ..... .. .. ...+......+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~~~-~~--~~-------~~~~~~~~~~~ 224 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERIE-SG--YR-------MPAPQLCPEEI 224 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHHHh-cC--CC-------CCCCccCCHHH
Confidence 4667999999988899999999999999999999 8888865332111 10110 00 00 01112234568
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 590 LQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 590 ~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+++.+|++.+|.+||++.|+++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 88999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.36 Aligned_cols=233 Identities=24% Similarity=0.465 Sum_probs=188.5
Q ss_pred ccccceEeeeCceeEEEeeccc-------------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-------------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
|...+.||+|++|.||+|.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5677899999999999997532 014577899999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999654 358999999999999999999998 89999999999999999999999999999866
Q ss_pred cCCCc-----ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc
Q 035655 499 DHGKI-----SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 499 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 573 (670)
..... .......|+..|+|||.+.+..++.++|||||||+++||++|+.||....... -.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~------~~~~ 228 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIFKI------GENA 228 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHHHH------hccC
Confidence 53211 11123468899999999998889999999999999999999999997532211 11110 0111
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+.+ +......+.+++.+||+++|.+||++.|++++
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1222 22234567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.97 Aligned_cols=223 Identities=25% Similarity=0.304 Sum_probs=176.0
Q ss_pred ceEeeeCceeEEEeeccc-------------------hHHHHHHHHH-HHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT-------------------RMREFAAEIE-SLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||++.... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999997543 1123445554 46779999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999988654 368999999999999999999998 899999999999999999999999999987532211 2233
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||....... ...... .... ...+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~~~-~~~~--~~~~--------~~~~ 221 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDNIL-HKPL--VLRP--------GASL 221 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HHHHHH-cCCc--cCCC--------CCCH
Confidence 4579999999999999999999999999999999999999997643211 111111 1110 1111 1234
Q ss_pred HHHHHHHhhccCCCCCCCCHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQ 609 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~e 609 (670)
.+.+++..|++.+|.+||++++
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCC
Confidence 5678889999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.12 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=194.2
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
+.+.++..++++|+..+.||+|+||.||++.... ....+.+|+.+++++ +|||+++++++|...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 4556777788999999999999999999987643 134667899999999 799999999998754
Q ss_pred -----CeeEEEEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEE
Q 035655 416 -----RDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR 488 (670)
Q Consensus 416 -----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 488 (670)
+..++|+||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999988642 23468999999999999999999998 8999999999999999999999
Q ss_pred EEeecCceeccCCCcceeeccccCcCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH
Q 035655 489 LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF 563 (670)
Q Consensus 489 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~ 563 (670)
|+|||++........ ......|+..|+|||.+... .++.++|||||||+++||++|+.||........ ....
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKI 245 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHH
Confidence 999999876543221 12234688999999987644 368899999999999999999999975322100 1111
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. .... +.+. .+.+....+.+++.+||+.+|.+||++.|++++
T Consensus 246 ~-~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 P-RNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred h-cCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 1111 1110 111223468889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=293.77 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=188.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|...+.||+|+||.||++.... ....+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 3468888999999999999997633 224577899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 99999999986543 58999999999999999999998 899999999999999999999999999987654322 2
Q ss_pred eeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......|+..|+|||++. ...++.++|||||||+++||++|+.||.........+.. ..... ..+....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~---~~~~~~~-- 233 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TKSNF---QPPKLKD-- 233 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hccCC---CCCcccc--
Confidence 223457899999999874 456889999999999999999999998653321111110 00110 0111110
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.......+.+++..|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00122457789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.61 Aligned_cols=237 Identities=27% Similarity=0.391 Sum_probs=199.3
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+.....++||+|.||.|++|.+.. .+.+|.+|+.+|-+|+|||+++|+|+..+ ...++|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344557899999999999997743 46899999999999999999999999887 778999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+|+++.|||.+.|++..+..|.-.....++.|||.||.||.+ +++|||||.++|+||-....+||+||||.+.+..+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999988666678889999999999999999999 99999999999999999999999999999987665
Q ss_pred Cccee--eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KISHT--TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
..... ....-...|+|||.++...++.++|||+|||.||||++ |..||-+-... .+++.+|.+-+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------qIL~~iD~~er 333 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------QILKNIDAGER 333 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------HHHHhcccccc
Confidence 53332 22345678999999999999999999999999999999 89999763322 11222232222
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
-.-++.+.+.+.++++.||..+|.+||++..|.+.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 334556778999999999999999999999998544
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=330.29 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=189.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..++||+|+||.||+|.... ..+.|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 478899999999999999997642 1346889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccC---------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 423 DYIPNGSLDSLLFDN---------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 423 E~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
||+++|+|.+++... ....+++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 12346778889999999999999998 899999999999999999999999999
Q ss_pred CceeccCCCc-----------------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Q 035655 494 LARLFDHGKI-----------------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL 556 (670)
Q Consensus 494 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~ 556 (670)
+++....... .......||+.|||||++.+..++.++|||||||+++||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986622110 01122469999999999999999999999999999999999999997532211
Q ss_pred HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHhcC
Q 035655 557 VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARP-TMRQVLRYLNG 616 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 616 (670)
.... ... .++.-.. .....+..+.+++.+|++.||++|| +++++++.|+.
T Consensus 239 i~~~------~~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR------DVI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh------hhc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100 000 0110000 0112234577889999999999996 56666666653
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=291.50 Aligned_cols=240 Identities=26% Similarity=0.375 Sum_probs=193.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3678899999999999999997643 246788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999986642 368999999999999999999998 899999999999999999999999999987654322 1
Q ss_pred eeeccccCcCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELARTG---KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......++..|+|||.+.+. .++.++|||||||+++||++|+.||........... ...... ..+.+ ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~~~~~~---~~~~~--~~ 228 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---ISKSNF---PPPKL--KD 228 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhccC---CCccc--cc
Confidence 22345788899999998776 789999999999999999999999975332111111 011100 01111 12
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=292.27 Aligned_cols=234 Identities=24% Similarity=0.401 Sum_probs=190.7
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47788999999999999986532 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~ 503 (670)
+++++|.+++.+.....+++..+.+++.|++.+|.|||+ ++++|+||||+||+++++. .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999987655668999999999999999999998 8999999999999998654 57999999998765432
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......++..|+|||.+.+..++.++||||||+++++|++|+.||...... ........ .... . .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~-~~~~-----~----~~~ 223 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMS-GTFA-----P----ISD 223 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHh-cCCC-----C----CCC
Confidence 122346889999999999888999999999999999999999999764321 11111111 1100 0 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++..||+.+|.+||+++|++++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 223567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.54 Aligned_cols=238 Identities=27% Similarity=0.403 Sum_probs=190.5
Q ss_pred CccccceEeeeCceeEEEeeccc---------------------------hHHHHHHHHHHHhc-cccCceeeeeeeeec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------------------RMREFAAEIESLGR-LRHKHLVNLQGWCKR 414 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------------------~~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~ 414 (670)
+|+..+.||+|+||.||++.... ...++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999998643 11346678888875 799999999999999
Q ss_pred cCeeEEEEeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
++..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998854 233468999999999999999999996 268999999999999999999999999
Q ss_pred cCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ..... .....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~~~~~-~~~~~-- 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKIV-EAVYE-- 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--HHHHh-hccCC--
Confidence 9998765433 33445789999999999988899999999999999999999999975432211 11111 11111
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.. .......+.+++.+||+.||++||++.|+.++++
T Consensus 232 --~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 --PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 0112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=294.66 Aligned_cols=234 Identities=27% Similarity=0.411 Sum_probs=192.2
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.|+..++||+|+||.||+|.... ....+.+|+.++++++||||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 46678899999999999997643 2346789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 99999999854 358899999999999999999998 8999999999999999999999999999976644321 2
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....++..|+|||++.+..++.++|||||||+++||++|+.||.......... ..............
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~ 225 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------------LIPKNNPPTLTGEF 225 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------------hhhcCCCCCCchhh
Confidence 233468889999999988889999999999999999999999987532211100 00011112233345
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++..||+.+|.+||++++++++-.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 567889999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.13 Aligned_cols=236 Identities=22% Similarity=0.364 Sum_probs=191.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+.+++.++||||++++++|...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3678899999999999999997532 235678899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999999854 358999999999999999999998 8999999999999999999999999999986544322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......+++.|+|||.+.+..++.++|||||||++++|++|+.||.......... .....+ .+.+ ..+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~~~~~~------~~~~--~~~~~ 240 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIATNG------TPEL--QNPER 240 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--eeccCC------CCCC--CCccc
Confidence 1233468899999999998889999999999999999999999997533210000 000000 0111 11222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++..||+.+|.+||++++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33557788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.82 Aligned_cols=245 Identities=21% Similarity=0.268 Sum_probs=186.8
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK----- 415 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 415 (670)
...++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 346789999999999999999986532 234677899999999999999999988643
Q ss_pred -CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
...++||||+++ +|.+++. ..+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999965 6766663 248899999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhh---------
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQH--------- 565 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~--------- 565 (670)
++...... ......||..|+|||++.+..++.++|||||||+++||++|+.||...... ..+......
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 98654322 223457899999999999889999999999999999999999999763311 111100000
Q ss_pred -------------cCCcccccCCCC--------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 566 -------------LGQVLDVVDPNL--------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 566 -------------~~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.........+.. ...........+.+++.+|++.||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000000 0011112245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=292.42 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=190.9
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV~ 422 (670)
+|+..+.||.|+||.||++.... ..+.+..|++++++++||||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47778999999999999986532 23467889999999999999999998754 45689999
Q ss_pred eccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccc--cceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 423 DYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEW--EQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 423 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
||+++++|.+++... ....+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2356899999999999999999999321 289999999999999999999999999999876
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
..... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...... .... ....+. .+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-~~~~~~-----~~--- 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLAS-KIKEGK-----FR--- 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHH-HHhcCC-----CC---
Confidence 55432 123346899999999999888999999999999999999999999864321 1111 111111 11
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+......+.+++.+|++.+|.+||++++|+++
T Consensus 229 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222334678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=276.92 Aligned_cols=247 Identities=25% Similarity=0.287 Sum_probs=194.4
Q ss_pred HhhcCccccceEeeeCceeEEEeecc----------------chHHHHHHHHHHHhccccCceeeeeeeeecc-----Ce
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLP----------------TRMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RD 417 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~----------------~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 417 (670)
...++|.+.++||+|||+.||++..- ++.+...+|++.-++++|||++++++++..+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34578999999999999999998621 2456678999999999999999999988543 45
Q ss_pred eEEEEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 418 LLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
.||+++|...|+|.+.+... ++..+++.+.++|+.+|++||.+||+. .++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 99999999999999998753 344699999999999999999999982 235999999999999999999999999998
Q ss_pred eeccCCCc--------ceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh
Q 035655 496 RLFDHGKI--------SHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564 (670)
Q Consensus 496 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~ 564 (670)
....-... .......-|..|.|||.+. +...++++|||||||+||+|+.|..||+.. ..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~ 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQ 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------hh
Confidence 65432110 1112235688999999875 445789999999999999999999999741 11
Q ss_pred hcCCcc-cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 565 HLGQVL-DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 565 ~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+. .+..+.+...-.....+.+.+++.+|++.||.+||++.+++..++.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 222222 1222233222223356889999999999999999999999998864
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.44 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=186.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK----- 415 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 415 (670)
...++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 345789999999999999999987532 234677899999999999999999987543
Q ss_pred -CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
...++||||+++ +|.+++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 7777763 247899999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcC-------
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG------- 567 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~------- 567 (670)
++...... ......||..|+|||++.+..++.++|||||||+++||++|+.||...... ..+.......+
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 98654322 223457899999999999999999999999999999999999999753211 01100000000
Q ss_pred ---------------Ccc----cccCCCC----CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 568 ---------------QVL----DVVDPNL----GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 568 ---------------~~~----~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
... +...+.. ...........+.+++.+|++.||.+|||+.|+++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000 0000000 0011111234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=293.21 Aligned_cols=236 Identities=26% Similarity=0.431 Sum_probs=188.3
Q ss_pred CccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+|...+.||+|+||.||+|.... ....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778999999999999986522 124577899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999654 358899999999999999999998 89999999999999999999999999998754321
Q ss_pred C-----cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 502 K-----ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 502 ~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
. ........|+..|+|||++.+..++.++|||||||+++||++|+.||...+... .. ........ ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~-~~~~~~~~----~~~~ 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AM-FYIGAHRG----LMPR 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HH-HHhhhccC----CCCC
Confidence 1 111223468999999999998889999999999999999999999997532211 11 00011000 1111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.. .....+.+++.+||+++|.+||++.+++++
T Consensus 230 ~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPD----SFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 211 233567889999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=316.41 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=185.2
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccC------ceeeeeeeeec
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHK------HLVNLQGWCKR 414 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~------nIv~l~g~~~~ 414 (670)
++...+++|++.++||+|+||+||++.... ..+++..|++++++++|. +++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 334457889999999999999999997643 123456788888887654 58899998876
Q ss_pred c-CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC--------
Q 035655 415 K-RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-------- 485 (670)
Q Consensus 415 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-------- 485 (670)
. ...|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5689999988 77898888654 368999999999999999999997 25999999999999998765
Q ss_pred --------cEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-h
Q 035655 486 --------NARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-L 556 (670)
Q Consensus 486 --------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~ 556 (670)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864322 234468999999999999999999999999999999999999999763321 1
Q ss_pred HHHHHHHh---------------------hcCCcccccCCCC----CC-c--ccHHHHHHHHHHHHhhccCCCCCCCCHH
Q 035655 557 VDWVLEFQ---------------------HLGQVLDVVDPNL----GS-S--YVVAEMELVLQLGLLCSHQKAEARPTMR 608 (670)
Q Consensus 557 ~~~~~~~~---------------------~~~~~~~~~d~~l----~~-~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 608 (670)
...+.... ..+.+....++.. .. . ........+++|+..||+.||.+|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 11100000 0000000000000 00 0 0001124577999999999999999999
Q ss_pred HHHHHhcC
Q 035655 609 QVLRYLNG 616 (670)
Q Consensus 609 evl~~L~~ 616 (670)
|+++|-.-
T Consensus 434 e~L~Hp~~ 441 (467)
T PTZ00284 434 QMTTHPYV 441 (467)
T ss_pred HHhcCccc
Confidence 99996543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.25 Aligned_cols=239 Identities=26% Similarity=0.458 Sum_probs=188.9
Q ss_pred CccccceEeeeCceeEEEeeccc--------------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--------------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR 416 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 416 (670)
+|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46678899999999999996432 0135678999999999999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 368999999999999999999998 899999999999999999999999999997
Q ss_pred eccCCCcc-eeeccccCcCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc
Q 035655 497 LFDHGKIS-HTTNVVGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 573 (670)
........ ......|+..|+|||.+.... ++.++||||||++++|+++|+.||...... ......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~~~~ 233 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNK-RSAPPI 233 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhcc-ccCCcC
Confidence 65432211 123456889999999987654 789999999999999999999999643321 111111111 111111
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
++ .........+.+++..||+++|.+||++++|+++
T Consensus 234 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 1212234677889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=303.94 Aligned_cols=239 Identities=24% Similarity=0.287 Sum_probs=201.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~ 419 (670)
....|+..+.||+|.||.||+++.+. ....+.+|+++|+++. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999998754 1247789999999998 999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC----CcEEEEeecCc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD----MNARLGDFGLA 495 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~----~~~kL~DFGla 495 (670)
+|||++.||.|.+.|... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999766 39999999999999999999999 999999999999999643 47999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
..... .......+||+.|+|||++....|+...||||+|+++|.|++|..||..+....... ....++ .
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~------~ 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGD------F 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCC------C
Confidence 98776 345667899999999999999999999999999999999999999998754222111 111111 1
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+......+.+.+++..|+..||.+|+++.++++|-|
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 2333344455677888999999999999999999999854
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.06 Aligned_cols=237 Identities=23% Similarity=0.381 Sum_probs=191.6
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
++|+..+.||.|++|.||+|.... ..+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468899999999999999987532 2456788999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.+. .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999998543 58999999999999999999999 8999999999999999999999999999876544321 1
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ........ . +.+ ..+...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~-~-----~~~--~~~~~~ 241 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNG-T-----PEL--QNPEKL 241 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcC-C-----ccc--CCcccC
Confidence 2334688999999999988899999999999999999999999976432111 11111110 0 001 011122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++.+||+.+|.+||++.+++++=.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 345778899999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=294.39 Aligned_cols=239 Identities=24% Similarity=0.396 Sum_probs=191.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|++.+.||+|+||.||++.... ..+.|.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 4678889999999999999998643 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.+.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999986643 369999999999999999999998 899999999999999999999999999987543322 2
Q ss_pred eeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 505 HTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ....... ... .+.+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-~~~-----~~~~~- 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKIL-KSE-----PPTLD- 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHh-cCC-----CCCcC-
Confidence 223456899999999874 345678999999999999999999999753321 1111111 110 11110
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+......+.+++..||+.+|.+||++.+++++-
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 230 -QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred -CcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 1112234577889999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.21 Aligned_cols=238 Identities=25% Similarity=0.297 Sum_probs=191.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|++|.||++.... ..+.+.+|++++++++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999997643 2245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999976555679999999999999999999998 899999999999999999999999999987553321
Q ss_pred cc----------------------------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Q 035655 503 IS----------------------------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF 554 (670)
Q Consensus 503 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~ 554 (670)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01124688999999999988899999999999999999999999975332
Q ss_pred hhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC----HHHHHHH
Q 035655 555 ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT----MRQVLRY 613 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 613 (670)
.. .+ .... ...............+.+++.+||+.+|.+||+ ++|++++
T Consensus 238 ~~-~~-~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DE-TF-SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH-HH-HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 11 0000 111100011113467889999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=329.73 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=188.7
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec--c
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--K 415 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~ 415 (670)
+.....++|.+.++||+|+||.||++.... ....|..|+.+|++|+||||+++++++.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 334456789999999999999999987533 23568899999999999999999998854 4
Q ss_pred CeeEEEEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccc----cceEEecccCCCcEEecCC-----
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEW----EQVVIHRDVKSGNVLIDAD----- 484 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~----~~~ivHrDIkp~NILld~~----- 484 (670)
..++|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.. .++|+||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999996532 246999999999999999999999732 1459999999999999642
Q ss_pred ------------CcEEEEeecCceeccCCCcceeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 485 ------------MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 485 ------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
..+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999998654332 2234579999999998854 458899999999999999999999997
Q ss_pred CCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 551 SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.... .......... . +.+.. ......+.+|+..||+.+|.+||++.|++++
T Consensus 245 ~~~~-~~qli~~lk~-~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANN-FSQLISELKR-G-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCc-HHHHHHHHhc-C-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5321 1111111111 1 11110 1123557889999999999999999999964
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=297.91 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=188.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|...++||+|+||.||+|.... ....+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 468889999999999999997642 123577899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++ ++|.+++.+.. ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 59999886543 358999999999999999999998 8999999999999999999999999999975443221
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHh------------hcCCcc
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQ------------HLGQVL 570 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~------------~~~~~~ 570 (670)
......+++.|+|||.+.+. .++.++|||||||+++||++|+.||...... ......... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12234578899999987654 5788999999999999999999999764321 111110000 000000
Q ss_pred cccCCCCCCcc----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 571 DVVDPNLGSSY----VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 571 ~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..-.+.....+ .......+.+++.+|++.||.+|||++|++++-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00001111111 0112345678999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=317.47 Aligned_cols=236 Identities=28% Similarity=0.422 Sum_probs=195.6
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++..++||+|+||+||||.+-. ...++.+|+.+|.+|+|||+++|+|+|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456899999999999997621 3578899999999999999999999998876 89999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
+||+.|+|.+|++.++ ..+.-+..+.|+.|||+||.|||+ ++++||||.++|||+.+-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998764 478889999999999999999998 999999999999999999999999999999887765
Q ss_pred cceee-ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 503 ISHTT-NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 503 ~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
..... ...-.+.|||-|.+....++.++|||||||.+||++| |.+|++......+ ..+.+.+. +-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI---~dlle~ge---------RLs 920 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI---PDLLEKGE---------RLS 920 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---hHHHhccc---------cCC
Confidence 43332 2234568999999999999999999999999999999 9999986332111 11111111 123
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.++-....+..++..||..|+..||+++++...+..
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 344455678889999999999999999999987764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=295.02 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=193.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhc--cccCceeeeeeeeecc----CeeEEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGR--LRHKHLVNLQGWCKRK----RDLLLVY 422 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~~----~~~~lV~ 422 (670)
..++....+.||+|.||.||+|.+.. +.+.+.+|.++.+. |||+||+.+++.-..+ .+++||.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 44678888999999999999998866 46778888888775 6999999999876543 3689999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc-----ccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE-----WEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
+|.++|||.|||.. ..++.+..++++..+|.||++||.+ .++.|.|||||+.|||+..++.+.|+|+|||..
T Consensus 289 dYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred ecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 99999999999965 4699999999999999999999985 378899999999999999999999999999987
Q ss_pred ccCCCcc---eeeccccCcCCCCccccccCC------CCccchhHHHHHHHHHHHhC----------CCCCCC---Ccch
Q 035655 498 FDHGKIS---HTTNVVGTIGYIAPELARTGK------ASCSTDVFAYGVLLLEIATG----------RRPIDS---DHFI 555 (670)
Q Consensus 498 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~el~tG----------~~pf~~---~~~~ 555 (670)
....... .....+||.+|||||++...- .-..+||||||.|+||++.. +.||.+ .++.
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 7654321 234569999999999986431 12469999999999999873 245543 1111
Q ss_pred hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 556 LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
.. -........++...++.+. ...+.+..+.+++..||..+|..|-|+-.+-+.|.+...
T Consensus 446 ~e-eMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 FE-EMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HH-HHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 1111111122222222222 234567888999999999999999999988888875543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.22 Aligned_cols=239 Identities=25% Similarity=0.405 Sum_probs=189.4
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+|+..+.||+|+||.||++.... ....+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 57788999999999999997642 1356889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 426 PNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++++|.+++.... ...+++..+..++.|++.||.|||+ +.+++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 9999999986532 2368999999999999999999996 258999999999999999999999999998765332
Q ss_pred eeeccccCcCCCCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 505 HTTNVVGTIGYIAPELARTGK------ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
......++..|+|||.+.+.. ++.++|||||||+++||++|+.||......... .... .......+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~---~~~~~~~~~~- 230 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF--AQLS---AIVDGDPPTL- 230 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH--HHHH---HHhhcCCCCC-
Confidence 123346888999999886543 478999999999999999999999753221111 1110 0111111112
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+......+.+++.+||+.+|.+||++++++++-+
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 231 ---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ---CcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 2224456778999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=294.88 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=191.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368889999999999999997643 12467899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++++.|..++... ..+++.++..++.||+.||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987777665433 358999999999999999999998 8999999999999999999999999999987655443
Q ss_pred ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH-h------------hcCCc
Q 035655 504 SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF-Q------------HLGQV 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~-~------------~~~~~ 569 (670)
.......++..|+|||++.+. .++.++||||||++++||++|+.||.........+.... . .....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233445788999999999887 789999999999999999999999975432111110000 0 00000
Q ss_pred c--cccCCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 L--DVVDPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~--~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. ...+.... ..++......+.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000000 01112235778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.15 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=184.3
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------------------hHHHHHHHHHHHhccccCce
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------------------RMREFAAEIESLGRLRHKHL 405 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------------------~~~~f~~Ei~~L~~l~H~nI 405 (670)
..++|++.++||+|+||+||++.... ....+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999875321 12356789999999999999
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCC---ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE---NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
+++++++...+..++|+|++. ++|.+++.... .......+...++.||+.||.|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999984 57777764422 1223456677899999999999998 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCcchhHHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRP-IDSDHFILVDWVL 561 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~p-f~~~~~~~~~~~~ 561 (670)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..+ +............
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987765443334456799999999999999999999999999999999998754 4322111100000
Q ss_pred HHhh-cCC-----------cccccCCC-C--CCcccH------HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 562 EFQH-LGQ-----------VLDVVDPN-L--GSSYVV------AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 562 ~~~~-~~~-----------~~~~~d~~-l--~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.... ... +.+.++.. + ...... .....+.+++.+|++.||.+||++.|++++-.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 0000 000 00000000 0 000000 01234567788999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=303.92 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=184.9
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK----- 415 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 415 (670)
...++|...+.||+|+||.||++.... ..+.+.+|+++|++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 446789999999999999999997532 124567899999999999999999987543
Q ss_pred -CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 7899888743 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC-----
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG----- 567 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~----- 567 (670)
++..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ............
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 234578999999999876 56889999999999999999999999753321 000000000000
Q ss_pred ---------CcccccCCCCCCc----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 568 ---------QVLDVVDPNLGSS----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 568 ---------~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...... +..... ........+.+++..|++.||.+|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 241 KKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000 000000 0001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.97 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=190.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~ 422 (670)
++|...++||.|++|.||++.... ....+.+|++++++++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999998743 235688999999999999999999988643 4689999
Q ss_pred eccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998754 223458999999999999999999998 8999999999999999999999999999875433
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc---hhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF---ILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~---~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+....... ..... .....
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~ 232 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPE-LKDEP 232 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchh-hccCC
Confidence 22 1234678899999999988999999999999999999999999976421 11111111111 01111 11111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
. ........+.+++.+||+.+|.+||++.|++++-+
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 233 G--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred C--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 00122456889999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=296.00 Aligned_cols=245 Identities=29% Similarity=0.385 Sum_probs=189.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..++||+|+||.||+|.... ..+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468889999999999999998743 12457789999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|+++.... ..++|.+++.++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998876543 348999999999999999999998 899999999999999999999999999998664433
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcc------------
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVL------------ 570 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~------------ 570 (670)
.......++..|+|||++.+ ..++.++||||||++++||++|+.||...... ..+.......+...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233467899999998865 45788999999999999999999998753321 11110000000000
Q ss_pred --cccCCCCCCc-----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 --DVVDPNLGSS-----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 --~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+..... ........+.+++.+||+.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000110000 011234668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.29 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=187.8
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|++|.||+|+... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47888999999999999997642 124688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+. ++|.+++.......+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 95 689999876655679999999999999999999998 899999999999999999999999999987654322 1
Q ss_pred eeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC--------
Q 035655 505 HTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP-------- 575 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-------- 575 (670)
......++..|+|||++.+.. ++.++|||||||+++||++|+.||........ ........+.......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHHHH
Confidence 123335788999999887644 58899999999999999999999976432110 00000000000000000
Q ss_pred -----CC-CC---cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 -----NL-GS---SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 -----~l-~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. .. .........+.+++.+||+.||.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 00 0001122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.60 Aligned_cols=241 Identities=27% Similarity=0.402 Sum_probs=191.1
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC------
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~------ 416 (670)
.++++|+..+.||+|++|.||+|.... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 357889999999999999999998743 235788999999999 6999999999997644
Q ss_pred eeEEEEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
..++||||+++++|.+++.... +..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999986533 4578999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
+....... .......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... .. ....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~-~~~~------ 230 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RA-LFKI------ 230 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HH-HHHh------
Confidence 87654322 22334568999999998753 34678999999999999999999999753211 00 0010
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+. ......+.+.+++.+||..||.+||++.|++++
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111111 112234577899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=291.56 Aligned_cols=235 Identities=24% Similarity=0.426 Sum_probs=191.4
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999987643 234678999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~ 503 (670)
+++++|.+++.+.....+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999976655568999999999999999999998 8999999999999999886 46999999997664322
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.......|++.|+|||+..+..++.++||||||++++||++|+.||..... ..+...... ... .+ ...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~----~~-----~~~ 224 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--HQLVLKICQ-GYF----AP-----ISP 224 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHhc-ccC----CC-----CCC
Confidence 122334688999999999888899999999999999999999999975321 222222111 111 11 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 223567888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=285.94 Aligned_cols=233 Identities=26% Similarity=0.444 Sum_probs=189.2
Q ss_pred CccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+|+..+.||+|++|.||+|.... ..+.+.+|+.++++++|+||+++.+++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36677899999999999997642 225688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999654 358999999999999999999998 89999999999999999999999999998865443
Q ss_pred CcceeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. ......|+..|++||.+.... ++.++|+||||++++||++|+.||...... ............ + .
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----~----~ 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGRSKEL-----P----P 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHHhcccC-----C----C
Confidence 2 223456889999999987766 899999999999999999999999754311 111111111111 1 1
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+......+.+++.+||+.+|.+||++.+++++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111223566788999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=309.22 Aligned_cols=239 Identities=25% Similarity=0.371 Sum_probs=193.5
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+.|.++..||.|+||+|||+..+. ...+|.-||++|..+.||+||+|++.+...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 446678889999999999998754 3467889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
.||..+.++..-++ .|++.++.-++.|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 112 ~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 99999999876543 79999999999999999999999 9999999999999999999999999999753322 2234
Q ss_pred eeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 506 TTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
...+.||+.|||||++. ..+|++++||||||+.|.||..+.+|-..-..- .+.-...... .|.|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSe-----PPTLl-- 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE-----PPTLL-- 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcC-----CCccc--
Confidence 45679999999999764 468999999999999999999999996542211 1111111111 22221
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+..-...+.+++..||.+||..||+..++++|-.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 11222356778888999999999999999999754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=295.64 Aligned_cols=245 Identities=25% Similarity=0.303 Sum_probs=185.0
Q ss_pred CccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||+++.... ...+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999976431 23567899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++ ++|.+++.... ..+++..++.++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 97 58888876543 358999999999999999999998 899999999999999999999999999998654322 1
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC--------cccccC-
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ--------VLDVVD- 574 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~d- 574 (670)
......++..|+|||++.+. .++.++|||||||+++||++|+.|+.................+. .....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234678899999988764 46899999999999999999999864322111110000000000 000000
Q ss_pred ---CCCCC-----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 575 ---PNLGS-----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 575 ---~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.... .........+.+++..||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 1111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.80 Aligned_cols=246 Identities=25% Similarity=0.300 Sum_probs=188.9
Q ss_pred cCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCc-eeeeeeeeeccC------
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKH-LVNLQGWCKRKR------ 416 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~------ 416 (670)
..|...++||+|.||+||+|+.... -..-.+|+.+|++|+|+| |++|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678899999999999986541 123469999999999999 999999998877
Q ss_pred eeEEEEeccCCCCchhhcccCCc--cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNEN--FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
.+++|+||+. -+|..++..... ..++...+..++.||+.||+|||+ ++|+||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 7899999995 599999976543 357778999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+...-.. ...+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.++.. ......-+...+..-+..
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccC
Confidence 99665433 224556889999999998876 689999999999999999999988876432 111111111111111111
Q ss_pred CC----------CCCCc-----ccHH---HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 574 DP----------NLGSS-----YVVA---EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 574 d~----------~l~~~-----~~~~---~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
-| ..... .... ......+++.+|++.+|.+|.|++.+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01 00000 0011 11356788999999999999999999986
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.67 Aligned_cols=235 Identities=23% Similarity=0.373 Sum_probs=185.5
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--Cee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 418 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578889999999999999987532 124577899999999999999999988764 468
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++... ..+++...++++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998654 347889999999999999999998 89999999999999999999999999998755
Q ss_pred cCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 499 DHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ...... . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-~----~~~-- 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIAT-Q----PTN-- 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHHhc-C----CCC--
Confidence 43211 112334688999999999888899999999999999999999999975321111 011100 0 011
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+......+.+++..|+. +|.+||++++++++
T Consensus 228 --~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 --PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 12233344566777888884 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.10 Aligned_cols=245 Identities=26% Similarity=0.335 Sum_probs=190.6
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 47788999999999999997632 135688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+ +++|.+++.... ..+++.+++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986544 469999999999999999999998 89999999999999999999999999999876554322
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc--------------
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV-------------- 569 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~-------------- 569 (670)
......++..|+|||.+.+. .++.++||||+||+++||++|+.||..... ...+.......+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 23345789999999988654 468999999999999999999888765321 11111111110000
Q ss_pred ccccCCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+... .....+....+.+++.+|++.+|.+||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00111234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.85 Aligned_cols=232 Identities=27% Similarity=0.431 Sum_probs=188.9
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
-|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 36678899999999999997532 2246788999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 99999999854 358999999999999999999998 999999999999999999999999999987654322 11
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....++..|+|||.+.+..++.++|||||||+++||++|..||....... ...... ... .+.+ ....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-~~~-----~~~~----~~~~ 225 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP-KNN-----PPTL----EGNY 225 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh-cCC-----CCCC----Cccc
Confidence 233468889999999988889999999999999999999999997532211 111111 110 1111 1223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3567789999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=291.61 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=185.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++++|...+.||+|+||.||+|.... ....+.+|+.++++++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 56789999999999999999997532 1235778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+. ++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 67777765443 357888999999999999999998 899999999999999999999999999997543322
Q ss_pred cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHHhh------------cC
Q 035655 503 ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD--WVLEFQH------------LG 567 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~--~~~~~~~------------~~ 567 (670)
.......++..|+|||.+.+. .++.++|||||||+++||++|+.||+........ ..+.... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112234578999999988754 5788999999999999999999999753321111 0110000 00
Q ss_pred CcccccCCC-CCCcc---c--HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 568 QVLDVVDPN-LGSSY---V--VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 568 ~~~~~~d~~-l~~~~---~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.......+. ..... . ......+.+++.+|++.||.+|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000 00000 0 0113466788999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.98 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=185.7
Q ss_pred cCccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|++|.||+|..+.. ...+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5788899999999999999976421 23467899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++ +|.+++.+... .+++.....++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 984 99998876543 68999999999999999999998 899999999999999999999999999987543221 1
Q ss_pred eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc----------
Q 035655 505 HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV---------- 573 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 573 (670)
......++..|+|||++.+ ..++.++||||+|++++||++|+.||.................+......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122356889999998865 45789999999999999999999999653311111100000000000000
Q ss_pred ---------CCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 574 ---------DPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 574 ---------d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+.... .......+.+++..|++.+|.+||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 00012567789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.75 Aligned_cols=227 Identities=24% Similarity=0.279 Sum_probs=176.1
Q ss_pred EeeeCceeEEEeeccch-------------------HHHHHHHHHHHhcc---ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 370 IGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRL---RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
||+|+||.||+++.... ...+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999976431 12234566666665 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.+. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999998654 358999999999999999999998 899999999999999999999999999987543222 2233
Q ss_pred ccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...||..|+|||++.+. .++.++|||||||++|||++|+.||....... .. .....+. ..+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~-~~i~~~~------~~~~~~---~~~ 222 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MY-RNIAFGK------VRFPKN---VLS 222 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HH-HHHHcCC------CCCCCc---cCC
Confidence 45799999999998764 47899999999999999999999997643211 11 1111111 011111 123
Q ss_pred HHHHHHHHhhccCCCCCCC----CHHHHHHHh
Q 035655 587 ELVLQLGLLCSHQKAEARP----TMRQVLRYL 614 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RP----s~~evl~~L 614 (670)
..+.+++..||+.||.+|| ++.++++|-
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 4567889999999999998 577777653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=287.95 Aligned_cols=237 Identities=26% Similarity=0.438 Sum_probs=189.8
Q ss_pred CccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
+|+..+.||+|++|.||++.... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999986422 13568899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceecc
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFD 499 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~ 499 (670)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999654 368999999999999999999998 8999999999999998876 59999999997665
Q ss_pred CCCcc---eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCC
Q 035655 500 HGKIS---HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 500 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~ 575 (670)
..... ......++..|+|||.+.+..++.++||||+|++++||++|+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---------
Confidence 43211 122346889999999998888999999999999999999999999753221 11111111000
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+......+.+++.+|++.+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01112233344667889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=300.46 Aligned_cols=236 Identities=21% Similarity=0.378 Sum_probs=190.9
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+.|++.++||+||-++||+....+ ...-|..|+..|.+|+ |.+||+|++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458889999999999999987653 3456889999999996 8999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|= ..+|..+|.+.......| .+..+.+|++.++.++|+ .+|||.||||.|.|+- .|.+||+|||+|..+..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 86 569999998876655667 778899999999999999 8999999999999984 57999999999998876654
Q ss_pred c-eeeccccCcCCCCccccccC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 504 S-HTTNVVGTIGYIAPELARTG-----------KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
. .....+||+.||+||.+... +..+++||||+|||||+|+.|+.||..-. . ...++..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n------~~aKl~a 584 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----N------QIAKLHA 584 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----H------HHHHHHh
Confidence 3 33457999999999977432 25689999999999999999999997411 0 1123344
Q ss_pred ccCCCCCCcccHHH-HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 VVDPNLGSSYVVAE-MELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.+|...-+|+.-- ...+++++..||+.||++||+..|+|+|
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 55554332332211 1228899999999999999999999985
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=284.94 Aligned_cols=237 Identities=27% Similarity=0.454 Sum_probs=189.9
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||+|.... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47788999999999999997532 345788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999654 348899999999999999999998 89999999999999999999999999999876543322
Q ss_pred ee---eccccCcCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 505 HT---TNVVGTIGYIAPELARTGK---ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 505 ~~---~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.. ....++..|+|||++.+.. ++.++||||||++++|+++|+.||...+.. +........ ...+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~~----~~~~~~~ 228 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGA----GHKPPIP 228 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHhc----CCCCCCC
Confidence 21 1356788999999988766 889999999999999999999999753211 111111111 1111111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. ......+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 229 DS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred cc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11 1123556789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=289.53 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=191.8
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeec---
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKR--- 414 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--- 414 (670)
+.......|...+.||+|+||.|+.+..... .+.-.+|+++|++++|+||+.+.+.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3344556677788999999999999987552 2344589999999999999999998865
Q ss_pred --cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 415 --KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 415 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
-+..|+|+|+| ..+|.+.|+.+ ..|+.....-++.|+++||.|+|+ .+|+||||||+|+|++.+...||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 35789999999 66999998654 348999999999999999999999 99999999999999999999999999
Q ss_pred cCceeccCCC-cceeeccccCcCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHH------
Q 035655 493 GLARLFDHGK-ISHTTNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEF------ 563 (670)
Q Consensus 493 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~------ 563 (670)
|+|+...... ....+..+.|..|.|||++. ...|+...||||.|||+.||++|+..|.+.+.. ......+.
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999876431 23346678899999999765 467999999999999999999999999763221 11111110
Q ss_pred -----hhc---CCcccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 564 -----QHL---GQVLDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 564 -----~~~---~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
... .+.+....+.-...+ -+......++|+.++|..||.+|+|++|.++|-
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 000 001111111111111 112234567889999999999999999999964
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.84 Aligned_cols=240 Identities=27% Similarity=0.357 Sum_probs=185.0
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|...+.||+|+||.||++.... ....+.+|+.++.++. |+||+++++++..++..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567889999999999987643 2346788999999996 99999999999999999999999
Q ss_pred cCCCCchhh---cccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 425 IPNGSLDSL---LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 425 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
++. +|.++ +.......+++..+.+++.|++.||+|||+ +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443 333334579999999999999999999997 258999999999999999999999999999755432
Q ss_pred CcceeeccccCcCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KISHTTNVVGTIGYIAPELARTG---KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
. ......|+..|+|||.+.+. .++.++|||||||+++||++|+.||..... ...... +......+.+.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~------~~~~~~~~~~~ 232 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLT------QVVKGDPPILS 232 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHh------hhcCCCCCcCC
Confidence 2 12233688999999998766 688999999999999999999999975331 111111 11111112222
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..........+.+++.+||+.+|.+||++++|+++-
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 222223456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=291.72 Aligned_cols=239 Identities=23% Similarity=0.253 Sum_probs=187.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999987543 1345678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 358999999999999999999998 899999999999999999999999999987421110
Q ss_pred --------------cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC
Q 035655 503 --------------ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 503 --------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
........++..|+|||.+.+..++.++|+|||||+++||++|+.||...... +.... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~-~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQ-VISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHhcc
Confidence 00112246788999999998888999999999999999999999999753321 11111 11111
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.... .....+.+++.+||+.+|.+||+..++.+.|+
T Consensus 233 ---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 233 ---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11111111 12345788999999999999999655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=290.42 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=187.5
Q ss_pred CccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+|+..+.||+|+||.||+|.... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47778899999999999997642 113456899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+ +|+|.+++.... ..+++..+.+++.||++||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997654 369999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHh---------hcCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQ---------HLGQVL 570 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~---------~~~~~~ 570 (670)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|..||...... ......... ......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 21 2233356788999998854 45789999999999999999998777653221 111110000 000000
Q ss_pred cccCCCCCCc-----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLGSS-----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.......... ........+.+++..||+++|.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000001 112234678899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=289.47 Aligned_cols=230 Identities=26% Similarity=0.320 Sum_probs=189.7
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468889999999999999997643 1245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999665 468999999999999999999998 99999999999999999999999999999876543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||...... ........+. ..+ +
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~------~~~----~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGK------VRF----P 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCC------ccC----C
Confidence 23346889999999998888899999999999999999999999764411 0111111111 111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
......+.+++..||+.+|.+|| +++|++++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11235677899999999999999 77888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.78 Aligned_cols=237 Identities=25% Similarity=0.388 Sum_probs=191.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357778899999999999997752 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999997653 468999999999999999999997 36899999999999999999999999999875533221
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc---chhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH---FILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
....++..|+|||++.+..++.++||||||+++++|++|+.||.... ....+...... ....+.+...
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~- 227 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV------NEPPPRLPSG- 227 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh------cCCCCCCChh-
Confidence 12578899999999998899999999999999999999999997532 11111111111 1111111111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++..||+.+|.+||++.+++++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 134567889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.28 Aligned_cols=234 Identities=25% Similarity=0.459 Sum_probs=188.9
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc---cCceeeeeeeeeccCeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR---HKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.|+..+.||+|+||.||+|.... ...++.+|+.++++++ |||+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 46778899999999999998632 2356788999999997 999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998543 68999999999999999999998 899999999999999999999999999998765443
Q ss_pred cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.......|+..|+|||.+.++ .++.++||||||++++||++|+.||...... .... .......+.+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~------~~~~~~~~~~~~~- 225 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAMM------LIPKSKPPRLEDN- 225 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhhh------ccccCCCCCCCcc-
Confidence 223345789999999988754 4688999999999999999999999753321 1110 0011111222211
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+.+++..||+.||.+||++.+++++-
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 1335678899999999999999999998854
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=286.80 Aligned_cols=233 Identities=27% Similarity=0.319 Sum_probs=191.5
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+|+..+.||.|+||.||++.... ..+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 57889999999999999997642 23577899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++... ..+++.++..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999654 468999999999999999999998 899999999999999999999999999987654432
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......|+..|+|||.+.+..++.++|+||||+++++|++|+.||........+........ .. ...+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--------~~~~~ 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--AD--------VLYPA 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--cc--------ccCcc
Confidence 22345688899999999888899999999999999999999999986443222222221111 00 11122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCH--HHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTM--RQVLR 612 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~ 612 (670)
.....+.+++.+||+.+|.+||+. +|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 233677889999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.29 Aligned_cols=237 Identities=24% Similarity=0.421 Sum_probs=185.0
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC------
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 416 (670)
|...+.||+|+||.||+|.+.. ..+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567889999999999986421 2346789999999999999999999886432
Q ss_pred eeEEEEeccCCCCchhhcccC----CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 417 DLLLVYDYIPNGSLDSLLFDN----ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
..++++||+++|+|.+++... ....+++...++++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887432 12358899999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCc
Q 035655 493 GLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQV 569 (670)
Q Consensus 493 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~ 569 (670)
|+++....... .......++..|++||.+.+..++.++|||||||+++||++ |+.||...... +..+. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~~- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL---IKGNR- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH---HcCCc-
Confidence 99986543321 11223345678999999988889999999999999999999 88998753321 11111 11111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
... +......+.+++.+||+.+|.+||++.++++.|++
T Consensus 234 -----~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 234 -----LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 11223578899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.30 Aligned_cols=234 Identities=21% Similarity=0.329 Sum_probs=187.0
Q ss_pred ccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
|.....||+|+||.||++.... ..+.+.+|+..+++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 3334679999999999987532 234678999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.. ..+++.++..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 999998843 258999999999999999999999 899999999999999999999999999987554322 2223
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...|+..|+|||.+.+..++.++||||||++++||++|+.||........ .... .....+.+.. ......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~------~~~~~~~~~~--~~~~~~ 246 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRRI------RDNLPPRVKD--SHKVSS 246 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH------HhcCCCcccc--ccccCH
Confidence 35689999999999888899999999999999999999999975432111 1010 0111111111 111234
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+.+++..|++.||.+||++++++++-
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 567888899999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.66 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=187.6
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~ 419 (670)
..++|...++||+|.||+|+++..+. ..+..+.|-+++... +||.+++|+.+|..++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 45689999999999999999987654 345566787777766 5999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||..||++..+.+ ...+++..+.-++..|+.||+|||+ ++||+||||.+|||||.+|.+||+||||++.--
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999655543 2469999999999999999999999 999999999999999999999999999998533
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
. ....+.+.+||+.|||||++.+..|+...|-|||||+||||+.|..||.+++. .+-+.+.. .|+
T Consensus 520 ~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------d~~--- 585 (694)
T KOG0694|consen 520 G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------DEV--- 585 (694)
T ss_pred C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------CCC---
Confidence 1 22356778999999999999999999999999999999999999999986443 22222110 112
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTM 607 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 607 (670)
.|+.-...+.+.++.+.+.++|++|--+
T Consensus 586 -~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2334445667788889999999999765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.08 Aligned_cols=236 Identities=23% Similarity=0.380 Sum_probs=191.2
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 578889999999999999997532 2356788999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.+. .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998543 47899999999999999999998 8999999999999999999999999999876544322 2
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....+++.|+|||.+....++.++||||||++++|+++|+.||........ .......+ .+.. ......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~~~~~------~~~~--~~~~~~ 241 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNG------TPEL--QNPEKL 241 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeehhcCC------CCCC--CCcccc
Confidence 2334688899999999888899999999999999999999999975332100 00000000 0111 111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+.+++..||+.+|.+||++.+++++-
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 45678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=291.82 Aligned_cols=235 Identities=27% Similarity=0.404 Sum_probs=187.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+.|+..+.||+|+||.||+|.... ..+++.+|++++++++||||+++.++|.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4568888999999999999997532 124678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99997 67777765433 368999999999999999999998 89999999999999999999999999998765432
Q ss_pred CcceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KISHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
....++..|+|||++. .+.++.++||||||+++|||++|+.||.......... .... . ..+.+.
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~--~~~~-~-----~~~~~~ 235 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ-N-----DSPTLS 235 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH--HHhc-C-----CCCCCC
Confidence 2346788999999874 4568899999999999999999999987543211111 1110 0 011111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+.+.+++.+||+.+|.+||++.+++++..-
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 12234568899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.87 Aligned_cols=236 Identities=24% Similarity=0.339 Sum_probs=182.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHH-HhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIES-LGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|++.+.||+|+||.||++.... ...++..|+.. ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468889999999999999997643 12345566665 566789999999999999999999999
Q ss_pred ccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|++ |+|.+++... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887542 23468999999999999999999998 5 899999999999999999999999999986543
Q ss_pred CCcceeeccccCcCCCCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELART----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
.. ..+...++..|+|||.+.+ ..++.++|+|||||+++||++|+.||.......... .... ....+.
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~------~~~~~~ 227 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQVV------EEPSPQ 227 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH-HHHH------hcCCCC
Confidence 21 1233468899999998764 456889999999999999999999997422111111 1110 111111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.. ....+.+.+++..||+.+|.+||++++++++
T Consensus 228 ~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1123567889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.24 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=187.6
Q ss_pred cCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV 421 (670)
++|+..+.||+|+||.||+|..+.. ...+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688889999999999999987531 12467899999999999999999998877 889999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||++ ++|.+++.... ..+++.+++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 59999886543 368999999999999999999998 89999999999999999999999999999866543
Q ss_pred CcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHH-----------h----
Q 035655 502 KISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEF-----------Q---- 564 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~-----------~---- 564 (670)
. .......++..|+|||.+.+. .++.++|+||||++++||++|+.||...... ........ .
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 112334578899999988754 4689999999999999999999999753211 00000000 0
Q ss_pred --hcCCcccccCCCCCCcccHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 565 --HLGQVLDVVDPNLGSSYVVA-EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 565 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
............+...++.. ..+.+.+++..||+.+|++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000001111111122222 24567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=289.06 Aligned_cols=244 Identities=25% Similarity=0.290 Sum_probs=186.8
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
|+..+.||+|++|.||+|.... ..+.+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 5667899999999999997642 1246789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
+ ++|.+++.......+++..+.+++.|+++||.|||+ ++++||||+|+||+++.++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 699999876654568999999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchh--HHHHHHHhhcC-----------Ccc-
Q 035655 506 TTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFIL--VDWVLEFQHLG-----------QVL- 570 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~--~~~~~~~~~~~-----------~~~- 570 (670)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... ........... ...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2233568899999987654 56889999999999999999999997643211 11110000000 000
Q ss_pred ---cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 ---DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.. ..........+.+++.+|++++|.+||+++|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 01111223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=278.12 Aligned_cols=235 Identities=29% Similarity=0.466 Sum_probs=191.8
Q ss_pred CccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
+|...+.||+|++|.||++.... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 36778899999999999998742 23568899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999987653 468999999999999999999998 9999999999999999999999999999987655432 3
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....++..|+|||.+....++.++||||||+++++|++|+.||...... ........ ... +.+.. .....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~-----~~~~~--~~~~~ 224 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT-NGP-----PGLRN--PEKWS 224 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh-cCC-----CCcCc--ccccC
Confidence 3457889999999998888999999999999999999999999764211 11111111 111 11110 01113
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+.+++..||+.||.+||++.|++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 567889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=281.58 Aligned_cols=236 Identities=27% Similarity=0.413 Sum_probs=193.8
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLVY 422 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~ 422 (670)
+|+..+.||+|++|.||+|.... ..+.+.+|+..+++++||||+++++++... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 46778999999999999998652 245788999999999999999999999988 8899999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++.... .+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 79999999999999999999998 899999999999999999999999999998776543
Q ss_pred cc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 IS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.. ......++..|+|||.+.+...+.++||||||+++++|++|+.||...... ......... .......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---------~~~~~~~ 225 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-MAALYKIGS---------SGEPPEI 225 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHhccc---------cCCCcCC
Confidence 21 123456889999999998888999999999999999999999999764411 111111111 0111112
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+......+.+++.+|++.+|.+||++.+++++
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22224678889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=304.47 Aligned_cols=230 Identities=27% Similarity=0.405 Sum_probs=189.0
Q ss_pred ceEeeeCceeEEEeeccch----------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 368 EVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
-+||+|.||+||-|++.+. .+-+..||..-++|+|+|||+++|.|.+++.+-+.||.+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999987552 244668999999999999999999999999999999999999999
Q ss_pred hhcccCCcccc--CHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEEEeecCceeccCCCcceeec
Q 035655 432 SLLFDNENFVL--SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 432 ~~l~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+.|+..=+ ++ .+...--+.+||++||.|||+ +.|||||||-.|+|++ -.|.+||+|||-++.... -.+.+.+
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 99975422 34 667777899999999999999 9999999999999996 578999999999986643 3355667
Q ss_pred cccCcCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 509 VVGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
.-||.-|||||++..++ |...+|||||||.+.||.||++||..-........ . --+-.+.| +.+.+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF----k--VGmyKvHP----~iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF----K--VGMYKVHP----PIPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh----h--hcceecCC----CCcHHHH
Confidence 88999999999998764 78899999999999999999999975221111110 0 01112223 4566677
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
.+...++++|..++|.+||+++++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 88899999999999999999999987
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=284.46 Aligned_cols=237 Identities=24% Similarity=0.387 Sum_probs=194.1
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|++|.||++.... ..+.+.+|++.+++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999997653 246788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++... ..+++..+++++.|+++||.|||+. .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999654 4689999999999999999999962 79999999999999999999999999999876543322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.....++..|+|||.+.+..++.++||||||++++||++|+.||..... ...+...... . ...+.+ +.
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~----~~~~~~----~~ 225 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--D----GPPPSL----PA 225 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--c----CCCCCC----Cc
Confidence 2345688999999999988899999999999999999999999976431 1111111111 1 111111 11
Q ss_pred H-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 A-EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. ..+.+.+++..||+++|.+||++.|++++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 34678889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=291.67 Aligned_cols=234 Identities=22% Similarity=0.340 Sum_probs=186.9
Q ss_pred ccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
|+....||+|+||.||++.... ..+.+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 3345679999999999997532 235678999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 999998743 358999999999999999999998 899999999999999999999999999987554322 2223
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...|+..|+|||++.+..++.++|||||||+++||++|+.||........ ........ .+... .......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~------~~~~~--~~~~~~~ 245 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRDSP------PPKLK--NAHKISP 245 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhccC------CCCcc--ccCCCCH
Confidence 45789999999999988899999999999999999999999975432211 11111100 01010 0111234
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+.+++..||+.+|.+||++++++++-
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 577889999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.85 Aligned_cols=241 Identities=18% Similarity=0.250 Sum_probs=176.3
Q ss_pred hcCccccceEeeeCceeEEEeeccch---H---------------------------HHHHHHHHHHhccccCceeeeee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR---M---------------------------REFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~---~---------------------------~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
.++|++.++||+|+||.||+|..... . .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999975432 0 01122334456678999999999
Q ss_pred eeeccC----eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc
Q 035655 411 WCKRKR----DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486 (670)
Q Consensus 411 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 486 (670)
++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+ .+++||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 876543 3477788764 3666655432 235788899999999999999998 89999999999999999999
Q ss_pred EEEEeecCceeccCCCc------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHH
Q 035655 487 ARLGDFGLARLFDHGKI------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVD 558 (670)
Q Consensus 487 ~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~ 558 (670)
+||+|||+++....... .......||+.|+|||+..+..++.++|||||||+++||++|+.||..... ....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986643221 111234799999999999999999999999999999999999999976421 1111
Q ss_pred HH-HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 559 WV-LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 559 ~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. .+.. .++. .+.+. .......+.+++..|++.+|.+||++.++++.++
T Consensus 245 ~~~~~~~--~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFI--KRLH---EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHH--HHhh---hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10 0000 0000 01100 0112356788999999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=286.29 Aligned_cols=235 Identities=20% Similarity=0.303 Sum_probs=189.3
Q ss_pred CccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.|...++||+|++|.||++.... ..+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 34556799999999999997532 23457899999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence 9999999865 358999999999999999999998 899999999999999999999999999887554322 122
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....|+..|+|||.+.+..++.++||||||++++||++|+.||...... ......... ..+... ......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~------~~~~~~--~~~~~~ 242 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDN------LPPKLK--NLHKVS 242 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhc------CCCCCc--ccccCC
Confidence 3356899999999998888999999999999999999999998754321 111111111 011111 111133
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..+.+++.+||+.+|.+||++.+++++-
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 5688999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=287.39 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=187.5
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEEEe
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLVYD 423 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~E 423 (670)
|+..+.||+|+||.||+|.... ..+.+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999997643 124578899999999999999999999887 88999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++ +|.+++.... ..+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 8988886543 468999999999999999999998 8999999999999999999999999999987655432
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc---C---Cccc----
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL---G---QVLD---- 571 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~---~---~~~~---- 571 (670)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.||...... ........... . ....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22334467889999997764 46789999999999999999999999764321 11111110000 0 0000
Q ss_pred -ccCC------CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 -VVDP------NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 -~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+ .+...+...+...+.+++..||+.+|.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 00000111125678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=285.90 Aligned_cols=232 Identities=27% Similarity=0.351 Sum_probs=189.6
Q ss_pred hcCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+.|..-++||+||||.||-++.+.+ .....+|-.+|.+++.+.||.+--.++.++.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35588889999999999999876542 22344789999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+..|.||+|.-+|.......+++..++-++.+|+.||.+||. .+||.||+||+|||||+.|+++|+|.|||..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999998887889999999999999999999999 89999999999999999999999999999987765
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.. ....+||.+|||||++.++.|+...|-||+||+||||+.|+.||.... ..+.| .....++.+ | ..++
T Consensus 341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K-eKvk~---eEvdrr~~~--~---~~ey 409 (591)
T KOG0986|consen 341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK-EKVKR---EEVDRRTLE--D---PEEY 409 (591)
T ss_pred Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh-hhhhH---HHHHHHHhc--c---hhhc
Confidence 42 233489999999999999999999999999999999999999997421 11111 000111100 1 1234
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPT 606 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs 606 (670)
+....+....+....|++||.+|--
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhcc
Confidence 4444566677777888999998854
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.50 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=186.0
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..+.||+|++|.||+|.... ..+.+.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468889999999999999997642 12457889999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeecCceeccCCC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFGla~~~~~~~ 502 (670)
|++ ++|.+++.......+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 588888866555557888999999999999999998 89999999999999985 5579999999997654322
Q ss_pred cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc----------
Q 035655 503 ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD---------- 571 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 571 (670)
.......+++.|+|||++.+. .++.++|||||||+++||++|+.||...... ..........+....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccch
Confidence 112334678899999988664 5789999999999999999999999753221 111000000000000
Q ss_pred ---ccCCCCCC----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 ---VVDPNLGS----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ---~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..-+.... .........+.+++.+|++.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0111223557889999999999999999999974
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=283.53 Aligned_cols=233 Identities=24% Similarity=0.391 Sum_probs=191.6
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..++||+|+||.||++.... ...++.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999986532 234677899999999999999999999999999999999
Q ss_pred cCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
+++++|.+++.+. ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 23468999999999999999999998 89999999999999999999999999999876554
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......++..|++||.+.+..++.++|+||||++++||++|+.||......... .. ...+. .....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--~~-~~~~~---------~~~~~ 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--YK-VQRGK---------YPPIP 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HhcCC---------CCCCc
Confidence 222346888999999999888999999999999999999999999764321111 11 11111 11112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+.+++..|++.+|.+||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2344668899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=281.29 Aligned_cols=228 Identities=26% Similarity=0.355 Sum_probs=185.2
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|++|.||+++... ..+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999998753 224688999999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999664 358999999999999999999998 999999999999999999999999999998765432 223346
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
++..|++||.+.+..++.++|+||||+++|||++|+.||................ + .....++......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-G--------NGKLEFPNYIDKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-c--------CCCCCCCcccCHHHH
Confidence 8899999999988889999999999999999999999997643211111111110 0 001112222246788
Q ss_pred HHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 591 QLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
+++..||+.+|.+||+ ++|++++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 9999999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.16 Aligned_cols=241 Identities=28% Similarity=0.415 Sum_probs=193.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+-+++...+||.|.||.||-|...+ ..+...+|.+++..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999998754 234567999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
||||++|+|.+.+.... .+++.....+..|++.|++|||+ .+||||||||.||+|+.+|-+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999985442 36666777788999999999999 99999999999999999999999999999877654
Q ss_pred Cc---ceeeccccCcCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 502 KI---SHTTNVVGTIGYIAPELARTGK---ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 502 ~~---~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
.. .......||+.|||||++.+.. ...+.||||+|||++||+||++||..-+ .+|...+... .
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---ne~aIMy~V~--------~ 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---NEWAIMYHVA--------A 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---chhHHHhHHh--------c
Confidence 31 2223568999999999997643 4568999999999999999999997522 1343332211 1
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.-....+.....+-.+++..|++.||++|.++.|++++=-+
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 11123344455566788899999999999999999987543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.85 Aligned_cols=229 Identities=27% Similarity=0.344 Sum_probs=182.1
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||+||++.... ..+.+..|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999986532 123456899999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++.+.....+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 999977655579999999999999999999998 899999999999999999999999999987654322 223346
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 589 (670)
++..|+|||.+.+..++.++||||||++++||++|+.||...... ....... .... ... ..+......+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~-~~~----~~~~~~~~~~ 225 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-----RTLE-MAV----EYPDKFSPEA 225 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-----cccc-ccc----cCCccCCHHH
Confidence 788999999998888999999999999999999999999753321 1111000 0000 011 1112224567
Q ss_pred HHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 590 LQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 590 ~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
.+++..||+.+|.+|| +..+++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 8899999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.15 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=195.9
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
..+++|+..+.||+|++|.||++.... ..+.+.+|++.+++++|+|++++++.+......++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 456778889999999999999998752 14578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997654 369999999999999999999998 999999999999999999999999999986554322
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.......++..|++||.+.+..++.++||||||++++||++|+.||......... .... .... +... ...
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~-~~~~-----~~~~--~~~ 240 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLIT-TKGI-----PPLK--NPE 240 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-hcCC-----CCCc--chh
Confidence 1223345788999999998888999999999999999999999999754322111 1111 1111 0110 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.+++.+|++.+|.+||++.+++++..
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 12356788999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.40 Aligned_cols=246 Identities=24% Similarity=0.283 Sum_probs=184.4
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCe-----
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRD----- 417 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~----- 417 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999998643 1246778999999995 6999999999877655
Q ss_pred eEEEEeccCCCCchhhcccCC---ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeec
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE---NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFG 493 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFG 493 (670)
.++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8988886532 2468999999999999999999998 89999999999999998 8899999999
Q ss_pred CceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
+++....... ......+++.|+|||++.+ ..++.++||||||++++||++|..||....... .........+.....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCChh
Confidence 9986543221 1223356889999998765 457899999999999999999999997533211 110000000000000
Q ss_pred cC------------CCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 573 VD------------PNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 573 ~d------------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. +... ....+.....+.+++..||++||.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000 00011234667889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=284.90 Aligned_cols=234 Identities=25% Similarity=0.397 Sum_probs=197.7
Q ss_pred ccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
|.+.++||+|.||.|||++++. +.++...|+.++++++.|++|+++|.+.....+++|||||-.|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 6778999999999999998754 57889999999999999999999999999999999999999999
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecc
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 509 (670)
..+.++-+. ++|++.++..+++..++||+|||. ..-+|||||+.||||+-+|.+||+|||.|..+... .....++
T Consensus 115 iSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTV 189 (502)
T KOG0574|consen 115 ISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTV 189 (502)
T ss_pred HHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCcc
Confidence 999997654 589999999999999999999998 77899999999999999999999999999766442 2445668
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc--ccHHHHH
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS--YVVAEME 587 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~ 587 (670)
.||+-|||||++..-.|..++||||+|+...||..|+.||.+-+.- +-.-++...-... -+..-..
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------------RAIFMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------------RAIFMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------------ceeEeccCCCCCCCCChHhhhh
Confidence 9999999999999999999999999999999999999999752211 1111111111111 2333456
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+-+++..|+-+.|++|-|+-++++|-
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 788999999999999999999999863
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.00 Aligned_cols=246 Identities=25% Similarity=0.334 Sum_probs=187.0
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+|+..++||+|++|.||+|+... ....+.+|++++++++||||+++++++...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 57889999999999999998743 1346678999999999999999999999999999999999
Q ss_pred CCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 426 PNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++ +|.+++.... ...+++.++.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||++....... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-N 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-c
Confidence 85 8888886543 3468999999999999999999998 899999999999999999999999999997554322 1
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHH------------hhcCCcc
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEF------------QHLGQVL 570 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~------------~~~~~~~ 570 (670)
......++..|++||++.+. .++.++|||||||+++||++|+.||...... ........ .......
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234578899999987654 5688999999999999999999999763321 11110000 0000000
Q ss_pred cccCCCC---CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNL---GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....... .....+.....+.+++..|++.||.+||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 001111224567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.43 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=188.4
Q ss_pred CccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.|+..+.||+|+||.||++.... ....+.+|++++++++|||+++++++|.+++..++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 36677899999999999987532 12467889999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++ |+|.+++... ...++|.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 996 5787777543 3468999999999999999999998 8999999999999999999999999999875433
Q ss_pred ceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 504 SHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.....|+..|+|||++. .+.++.++|||||||+++||++|+.||........ ......... +...
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~~------~~~~-- 245 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES------PTLQ-- 245 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHhccC------CCCC--
Confidence 22346888999999873 45688999999999999999999999865321111 001111100 1111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPI 622 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 622 (670)
.......+.+++.+||+.+|.+||++.++++++......+.
T Consensus 246 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 246 -SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred -CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 11223457889999999999999999999998876554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.99 Aligned_cols=235 Identities=24% Similarity=0.444 Sum_probs=193.3
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++|||++++.+.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 47788999999999999998652 235678999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 3579999999999999999999998 899999999999999999999999999998765543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......|++.|+|||......++.++||||+|+++++|++|+.||...... ....... ... .+.+ +
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~-~~~-----~~~~----~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKIL-KGQ-----YPPI----P 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHHHh-cCC-----CCCC----C
Confidence 2233457889999999998888999999999999999999999999764321 1111111 111 1111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+.+++.+||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1223567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=281.80 Aligned_cols=239 Identities=24% Similarity=0.300 Sum_probs=183.2
Q ss_pred hHHHhhcCccccceE--eeeCceeEEEeeccchH----------HHH-HHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 356 DLYTATKGFKQSEVI--GTGGFGEVYKGVLPTRM----------REF-AAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 356 ~l~~~t~~f~~~~~l--G~G~fg~Vykg~~~~~~----------~~f-~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
+.....++|+..+.+ |+|+||.||++...... ..+ ..|+.....+ +||||+++++++...+..++|
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 334445666666666 99999999999864421 111 1233333323 699999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDH 500 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~ 500 (670)
|||+++++|.+++..+. .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999996553 79999999999999999999998 8999999999999999998 999999999876543
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. ....++..|+|||++.+..++.++||||||++++||++|+.||................... .. .
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~--~ 228 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------KL--P 228 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------cC--C
Confidence 2 22368899999999998899999999999999999999999997532221111110010010 00 1
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPT-MRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 613 (670)
........+.+++..||+.+|.+||+ ++|++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11133456788999999999999995 6999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=286.40 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=187.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR---- 416 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~---- 416 (670)
...++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345788999999999999999998743 1235678999999999999999999987654
Q ss_pred ------eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEE
Q 035655 417 ------DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 417 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
..++|+||+++ +|..++... ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 777777554 3468999999999999999999999 899999999999999999999999
Q ss_pred eecCceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC-
Q 035655 491 DFGLARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG- 567 (670)
Q Consensus 491 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~- 567 (670)
|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ....+.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765443222233456788999998764 45788999999999999999999999753321 111111110000
Q ss_pred --Ccccc--------cCC------CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 568 --QVLDV--------VDP------NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 568 --~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..... .++ .....+ ......+.+++..||+.+|.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000 000000 1124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=276.04 Aligned_cols=233 Identities=28% Similarity=0.458 Sum_probs=191.4
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|+..+.||+|++|.||++.... ....+.+|++++++++|||++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47778999999999999987542 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998655 468999999999999999999998 89999999999999999999999999999876554321
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....++..|+|||...+..++.++|||++|+++++|++|+.||.........+. .. ... .+.+ +..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~--~~-~~~-----~~~~----~~~ 222 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR--IV-QDD-----HPPL----PEG 222 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH--Hh-ccC-----CCCC----CCC
Confidence 2334688999999998888889999999999999999999999975432221111 11 011 1111 112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++.+||+.+|++||++.+++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 23567889999999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=282.56 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=188.3
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
|+..+.||+|++|.||++.... ....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4567899999999999997642 1346778999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++ +|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 8888886643 478999999999999999999998 899999999999999999999999999998765543 12
Q ss_pred eeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc------CCccc------
Q 035655 506 TTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL------GQVLD------ 571 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~------~~~~~------ 571 (670)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||...+.. ........... ....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334678899999998776 7899999999999999999999999753321 11111000000 00000
Q ss_pred ccCCCC----CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 VVDPNL----GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..-+.. ...........+.+++..||++||.+||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 011122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=281.22 Aligned_cols=235 Identities=23% Similarity=0.382 Sum_probs=186.3
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--Cee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 418 (670)
.+|+..+.||+|+||.||++.... ..+.+.+|++++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478889999999999999997532 124677899999999999999999998654 468
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++++||+++++|.+++.... .+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 48899999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 499 DHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
..... .......++..|+|||++.+..++.++|||||||+++||++|+.||...... .-..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---------~~~ 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKIA---------TQP 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHHH---------cCC
Confidence 33111 1122346889999999998888999999999999999999999999753211 1111111 011
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+....+.+.+++..||+ +|..||+..+++.|
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1112233344667888889998 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=283.91 Aligned_cols=229 Identities=24% Similarity=0.282 Sum_probs=176.8
Q ss_pred eEeeeCceeEEEeeccch-------------------HHHHHHHHHHHh---ccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 369 VIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLG---RLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~---~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.||+|+||.||++..... ...+.+|..+++ ..+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999876431 122344544443 3479999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 99999998654 359999999999999999999998 899999999999999999999999999987554322 2
Q ss_pred eccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||................ ..... .+...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~----~~~~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TVNVE----LPDSF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cCCcC----Ccccc
Confidence 23468999999998864 557899999999999999999999997532211111111110 11111 22223
Q ss_pred HHHHHHHHHhhccCCCCCCC-----CHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARP-----TMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 615 (670)
...+.+++..||+.||.+|| +++|+++|..
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 45677889999999999999 6999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.84 Aligned_cols=232 Identities=28% Similarity=0.411 Sum_probs=189.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+.|...+.||.|.||.||-+++.. .-.++..||..|++++|||++.+.||+......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346667889999999999998643 2356789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||| -||-.|+|.-.. +++-+.++..|+.+.+.||+|||+ .+.||||||+.||||.+.|.|||+|||.|....+
T Consensus 106 EYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 999 568888775543 579999999999999999999999 8999999999999999999999999999987654
Q ss_pred cceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
...++|||.|||||++. .+.|+-|.|||||||...||.-.++|+-.-+. +. +...... .-.|.|..
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MS--ALYHIAQ-----NesPtLqs 247 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MS--ALYHIAQ-----NESPTLQS 247 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HH--HHHHHHh-----cCCCCCCC
Confidence 45679999999999874 67899999999999999999999999754211 11 1111111 11233332
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+-...+.+++..|+++-|.+|||.+++++|-
T Consensus 248 ---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 248 ---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 22345678888899999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=291.43 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=187.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK----- 415 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~----- 415 (670)
...++|+..+.||+|+||.||++.... ....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 345789999999999999999997532 124567899999999999999999988643
Q ss_pred -CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
...++|+||+. ++|.+++.. .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 588887743 28899999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC------
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ------ 568 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~------ 568 (670)
++...... ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+.. ..+.......+.
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 98654432 123346789999999999999999999999999999999999999753311 111100000000
Q ss_pred ---------------------cccccC----CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 ---------------------VLDVVD----PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 ---------------------~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...... +.............+.+++.+||+.||++||++.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 000000 0000111122355678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=280.91 Aligned_cols=242 Identities=23% Similarity=0.230 Sum_probs=182.7
Q ss_pred ccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeecc--CeeEEEEe
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRK--RDLLLVYD 423 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV~E 423 (670)
|+..++||+|+||.||++.... ......+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5667899999999999997632 1123447899999985 99999999999887 88999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++ ++|.+++.... ..++|.++..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 58888876543 368999999999999999999998 89999999999999999 9999999999986643321
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHh-----------hcCCcc
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQ-----------HLGQVL 570 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~-----------~~~~~~ 570 (670)
.....++..|+|||++.. +.++.++|||||||+++||++|+.||...+. ....+..... ......
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 123467889999997654 5578899999999999999999999976332 1111111100 000000
Q ss_pred cccCCCCCC----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLGS----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.... .........+.+++..||+++|.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 111111000 0112335788999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=300.01 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=192.5
Q ss_pred CccccceEeeeCceeEEEeeccch---------------HHHHHHHHHHHhccc-c-----CceeeeeeeeeccCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAAEIESLGRLR-H-----KHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~---------------~~~f~~Ei~~L~~l~-H-----~nIv~l~g~~~~~~~~~lV 421 (670)
+|.+.+.||+|.||.|-||.+.+. .++-..|+.+|.+|+ | -|+|+++++|...+.+|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 788999999999999999987652 234457999999997 4 4899999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC--cEEEEeecCceecc
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM--NARLGDFGLARLFD 499 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~--~~kL~DFGla~~~~ 499 (670)
+|.+ .-+|.++|+.+.-..++...++.++.||+.||.+||+ .+|||+||||+||||.+-. .+||+|||.+....
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999 5699999998887789999999999999999999998 9999999999999997544 79999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHH-----------Hh---
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLE-----------FQ--- 564 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~-----------~~--- 564 (670)
... .....+..|.|||++.+.+|+.+.||||||||+.||++|...|.++.. .....+.+ ..
T Consensus 343 q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 343 QRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred Ccc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 532 245678899999999999999999999999999999999888866321 11111111 00
Q ss_pred -----h-cC--------C-----------------cccccCC-C---CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHH
Q 035655 565 -----H-LG--------Q-----------------VLDVVDP-N---LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQ 609 (670)
Q Consensus 565 -----~-~~--------~-----------------~~~~~d~-~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 609 (670)
. .+ . ..+...| . +........-+.+++++..|+..||.+|+|..|
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 0 00 0 0000011 0 001111233467899999999999999999999
Q ss_pred HHHHhc
Q 035655 610 VLRYLN 615 (670)
Q Consensus 610 vl~~L~ 615 (670)
.++|-.
T Consensus 499 al~Hpf 504 (586)
T KOG0667|consen 499 ALNHPF 504 (586)
T ss_pred HhcCcc
Confidence 999754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=282.24 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=185.4
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhcc---ccCceeeeeeeeeccCe-----
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRL---RHKHLVNLQGWCKRKRD----- 417 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~~~~----- 417 (670)
|++.+.||+|+||.||++.... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999998743 013466788777666 59999999999988776
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.+++|||+. ++|.+++.......+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999997 589998876554569999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHhhcCCc------
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQHLGQV------ 569 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~~~~~~------ 569 (670)
...... .....++..|+|||++.+..++.++|||||||+++||++|+.||...... ..............
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 654321 12335788999999999889999999999999999999999998753321 11111000000000
Q ss_pred ---ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 ---LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ---~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......... ..........+.+++.+||+.||.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 11112334667889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=291.87 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=184.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----Cee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~ 418 (670)
+++|+..++||+|+||.||+|+... ....+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999997532 224577899999999999999999987644 358
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||++ ++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 488877743 358999999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCcc--eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhhc---CCccc
Q 035655 499 DHGKIS--HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQHL---GQVLD 571 (670)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~~---~~~~~ 571 (670)
...... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...+... .......... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432211 1233478999999998654 468899999999999999999999997533211 1111110000 00000
Q ss_pred ccC-----------CCCCCc---ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 VVD-----------PNLGSS---YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ~~d-----------~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+.+ ...... ........+.+++.+||+.+|.+||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000 011224568899999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=282.05 Aligned_cols=234 Identities=21% Similarity=0.365 Sum_probs=187.2
Q ss_pred CccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+|...++||+|+||.||++.... ...++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999886532 122456789999999999999999999999999999
Q ss_pred EeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 422 YDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||+++++|.+++.. .....+++.+++.++.|++.||.|||+ .+++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 233569999999999999999999998 89999999999999975 569999999997664
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... .......|+..|+|||.+.+..++.++|+||||+++++|++|+.||..... ........ ....+.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~------~~~~~~--- 224 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIV------EGPTPS--- 224 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHH------cCCCCC---
Confidence 332 122334678899999999888889999999999999999999999975322 11111111 111111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+......+.+++.+||+.+|.+||++.|++++
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 -LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 222334567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=287.16 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=184.2
Q ss_pred CccccceEeeeCceeEEEeeccc--h-------------------HHHHHHHHHHHhccccCceeeeeeeeecc--CeeE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--R-------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLL 419 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~ 419 (670)
+|+..++||+|+||.||+|.... . .+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999998643 1 14567899999999999999999999988 7899
Q ss_pred EEEeccCCCCchhhcccC---CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC----CCcEEEEee
Q 035655 420 LVYDYIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA----DMNARLGDF 492 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~----~~~~kL~DF 492 (670)
+||||+++ +|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666432 22368999999999999999999998 89999999999999999 999999999
Q ss_pred cCceeccCCCc--ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchh-----------HH
Q 035655 493 GLARLFDHGKI--SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-----------VD 558 (670)
Q Consensus 493 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-----------~~ 558 (670)
|++........ .......++..|+|||.+.+. .++.++|||||||+++||++|+.||....... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986644322 122334678999999987664 57899999999999999999999997532211 00
Q ss_pred HHHHH-----------hhcCCcccccCCCCCCccc---------H--HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 559 WVLEF-----------QHLGQVLDVVDPNLGSSYV---------V--AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 559 ~~~~~-----------~~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+..+ ..........+......++ . .....+.+++.+|++.||++||++.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0000000000000000000 0 223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=284.11 Aligned_cols=246 Identities=27% Similarity=0.362 Sum_probs=183.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 416 (670)
-++|+..++||+|+||.||++.... ....+.+|++++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 3578999999999999999997643 1224568999999999999999999987543
Q ss_pred --eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 417 --DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 417 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
..++|+||+. ++|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 48888875443 368999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcc---eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCc
Q 035655 495 ARLFDHGKIS---HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQV 569 (670)
Q Consensus 495 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~ 569 (670)
+......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||...... ......... +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~--~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC--GSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CCC
Confidence 9866443211 12234678899999987654 4688999999999999999999999764321 111111100 000
Q ss_pred ccccCCC-----------CCCcc---------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPN-----------LGSSY---------VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~-----------l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+.+. +.... .......+.+++.+||+.||.+||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 00000 00012456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=282.07 Aligned_cols=237 Identities=25% Similarity=0.316 Sum_probs=187.3
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCee
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 418 (670)
+|+..+.||+|++|.||++.... ..+.+.+|+++++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 47778999999999999886421 123567899999999 599999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++|+|.+++... ..+++..+..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998654 358999999999999999999998 89999999999999999999999999998865
Q ss_pred cCCCcceeeccccCcCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHhhcCCcccccC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~d 574 (670)
............|+..|+|||.+.+.. .+.++||||||++++||++|+.||...... .......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~ 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-------SK 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------cC
Confidence 544322233456889999999987665 788999999999999999999999642211 1111111110 01
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+..... ....+.+++.+||+.+|++|||++++.+.|+
T Consensus 229 ~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 229 PPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 111111 2245678899999999999999988877765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=288.39 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=182.9
Q ss_pred ceEeee--CceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTG--GFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G--~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
..||+| +||+||++.... ..+.+.+|+.+++.++||||++++++|..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 899999997632 135678899999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce--
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH-- 505 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~-- 505 (670)
++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999977655568999999999999999999998 899999999999999999999999998654332211110
Q ss_pred ----eeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc-------------
Q 035655 506 ----TTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL------------- 566 (670)
Q Consensus 506 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~------------- 566 (670)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||......... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHhcCCCCCCccccccchh
Confidence 0112356679999998764 4789999999999999999999999753211100 0000000
Q ss_pred ----------------------CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 567 ----------------------GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 567 ----------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+..+...........+.+++.+||+.||.+|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000011111222223345567899999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=291.77 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=189.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec----cCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----KRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4688999999999999999997542 23456789999999999999999998763 3468
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6899998654 348999999999999999999998 89999999999999999999999999999765
Q ss_pred cCCCcc---eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHh---------
Q 035655 499 DHGKIS---HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQ--------- 564 (670)
Q Consensus 499 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~--------- 564 (670)
...... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 443221 1233478899999998765 4688999999999999999999999976432111 0000000
Q ss_pred --hcCCc---ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 565 --HLGQV---LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 565 --~~~~~---~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..... ......... ..........+.+++..||+.+|.+||++++++++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 00000 000000000 01112235678899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=282.45 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=186.7
Q ss_pred ccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEecc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
|+..+.||+|++|.||+|..... .....+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56678999999999999987431 123457999999999 999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
+|+|.+++.......+++.++..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 8899999877654578999999999999999999998 899999999999999999999999999998654422 1
Q ss_pred eeccccCcCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH--------------HHHHHhhcCCcc
Q 035655 506 TTNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD--------------WVLEFQHLGQVL 570 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~--------------~~~~~~~~~~~~ 570 (670)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22346788999999875 445789999999999999999999999653221110 110000000000
Q ss_pred cccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+..... ..........+.+++.+||+.+|.+||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 01111123668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=290.27 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=183.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc------C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK------R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~ 416 (670)
.++|...+.||+|+||.||+|+... ....+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3789999999999999999997532 123577899999999999999999998654 3
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++|+||+.. +|.+++ ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999964 777665 2358999999999999999999998 899999999999999999999999999987
Q ss_pred eccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHh----------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQ---------- 564 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~---------- 564 (670)
..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ........
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 54332 223467889999998876 468899999999999999999999998643211 11000000
Q ss_pred -hc---CCcccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH--hcCCCC
Q 035655 565 -HL---GQVLDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY--LNGDEL 619 (670)
Q Consensus 565 -~~---~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 619 (670)
.. ............... .......+.+++..||+.||.+||++++++++ ++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 000000000000000 01123457799999999999999999999976 554433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=280.07 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=194.8
Q ss_pred cCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+.|+..+.||+|.-|+||++.+.+. ......|-+||+.+.||-++.|++.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4567789999999999999987652 233457889999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC--
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH-- 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~-- 500 (670)
|||+||+|...++++....+++..++-++..|+.||+|||- .|||.|||||+||||.++|.+-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999888899999999999999999999999 9999999999999999999999999999753311
Q ss_pred -------------------------------C-Cc---------------------ceeeccccCcCCCCccccccCCCC
Q 035655 501 -------------------------------G-KI---------------------SHTTNVVGTIGYIAPELARTGKAS 527 (670)
Q Consensus 501 -------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~t 527 (670)
. .. ......+||..|+|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 00 011225899999999999999999
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC-
Q 035655 528 CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT- 606 (670)
Q Consensus 528 ~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs- 606 (670)
.+.|-|+|||++|||+.|+.||.+.... ..+..++...+.-......+..+.+|+...|.+||.+|--
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-----------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch-----------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999864321 1122222222221112244567889999999999999988
Q ss_pred ---HHHHHHH
Q 035655 607 ---MRQVLRY 613 (670)
Q Consensus 607 ---~~evl~~ 613 (670)
+.||-+|
T Consensus 383 ~rGA~eIK~H 392 (459)
T KOG0610|consen 383 KRGAAEIKRH 392 (459)
T ss_pred ccchHHhhcC
Confidence 7777764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=289.89 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=186.4
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc--Cee
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~--~~~ 418 (670)
..++|+..+.||+|+||.||+|.+.. ....+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35678889999999999999997642 123466899999999 999999999998654 468
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||++ ++|.+++... .++|..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5999988543 68999999999999999999998 89999999999999999999999999999866
Q ss_pred cCCCc----ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHh--------
Q 035655 499 DHGKI----SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQ-------- 564 (670)
Q Consensus 499 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~-------- 564 (670)
..... .......|+..|+|||.+.+ ..++.++||||||++++||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 44322 12234578999999998754 45788999999999999999999999753211 111100000
Q ss_pred ------hcCCcccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 565 ------HLGQVLDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 565 ------~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+.+...-. ..........+.+++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00111134567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=283.32 Aligned_cols=251 Identities=26% Similarity=0.317 Sum_probs=187.8
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeecc--CeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l 420 (670)
.++|+..+.||+|+||.||+|..... ...+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999976431 12456899999999999999999998754 56899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|+||++ ++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 48888886543 468999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc--CCc-------
Q 035655 501 GKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL--GQV------- 569 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~--~~~------- 569 (670)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........... ...
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 32 11223345788999998865 45789999999999999999999999753221 11111110000 000
Q ss_pred -----ccccCCCCCC--cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 570 -----LDVVDPNLGS--SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 570 -----~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.......+.. .........+.+++..|++.||++||+++|++++-+-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0000000000 00001245667899999999999999999999976644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=312.99 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=197.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeec
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKR 414 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 414 (670)
..+++...+.||+|.||.|++|.... ..+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34455666799999999999996421 356889999999998 59999999999999
Q ss_pred cCeeEEEEeccCCCCchhhcccCC------------c--cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEE
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNE------------N--FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 480 (670)
++..++|.||++.|+|.+||+.++ . ..++..+.+.++.|||.|++||++ .+++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence 999999999999999999998765 0 138899999999999999999999 89999999999999
Q ss_pred ecCCCcEEEEeecCceeccCCCcceeeccc--cCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhH
Q 035655 481 IDADMNARLGDFGLARLFDHGKISHTTNVV--GTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILV 557 (670)
Q Consensus 481 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~ 557 (670)
+.++..+||+|||+|+...+......+... -...|||||.+....++.|+||||||++||||++ |..||..-.. ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence 999999999999999976655544333333 3456999999999999999999999999999999 9999975110 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 558 DWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 558 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+. .+....+.. .+.+..+..++.++++.||+.+|.+||++.|+.+.+..
T Consensus 530 ~l-~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 530 EL-LEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH-HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 222222322 22233345678899999999999999999999999986
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=281.65 Aligned_cols=234 Identities=26% Similarity=0.380 Sum_probs=190.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV 421 (670)
++|...+.||+|+||.||++.... ..+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468889999999999999997642 1345778999999998 99999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997653 69999999999999999999998 89999999999999999999999999999865443
Q ss_pred Cc-------------------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Q 035655 502 KI-------------------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562 (670)
Q Consensus 502 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~ 562 (670)
.. .......++..|+|||......++.++||||||++++|+++|+.||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH
Confidence 21 122234678999999999888899999999999999999999999975431110 001
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCH----HHHHHH
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTM----RQVLRY 613 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~ 613 (670)
.. .. . ..++....+.+.+++..||+.+|.+||++ ++++++
T Consensus 234 ~~---~~----~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 IL---KL----E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH---hc----C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 00 0 11112224567899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.51 Aligned_cols=244 Identities=19% Similarity=0.229 Sum_probs=182.6
Q ss_pred cceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 367 SEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
.+.+|.|+++.||++.... ..+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4445666666666664422 235788999999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc------c
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI------S 504 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~------~ 504 (670)
.+++.......+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999987655568999999999999999999998 8999999999999999999999999999875532211 1
Q ss_pred eeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc--------------CC
Q 035655 505 HTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL--------------GQ 568 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~--------------~~ 568 (670)
......++..|+|||++.. ..++.++|||||||+++||++|+.||.......... ...... ..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCC
Confidence 1123457789999999865 357899999999999999999999997533211100 000000 00
Q ss_pred ccc----ccCCC----CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 VLD----VVDPN----LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 ~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
... ..++. ............+.+++.+||+.||.+||++++++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000 00000 00111223345788899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=282.93 Aligned_cols=236 Identities=28% Similarity=0.395 Sum_probs=186.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+.|+..+.||+|+||.||+|+... ..+++.+|++++++++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347777899999999999997532 1245778999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 68887775433 358999999999999999999998 89999999999999999999999999998765432
Q ss_pred cceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
....++..|+|||.+. .+.++.++|||||||+++||++|+.||....... .... ..... .+...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~-~~~~~-----~~~~~- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH-IAQNE-----SPALQ- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH-HhhcC-----CCCcC-
Confidence 2346888999999874 3567889999999999999999999986532111 1111 11111 01111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.......+.+++.+||+.+|.+||++.+++++..-..
T Consensus 236 --~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1123355778999999999999999999999866443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=277.56 Aligned_cols=230 Identities=26% Similarity=0.376 Sum_probs=183.1
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||.||++.... ..+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5889999999998753 234677899999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-------
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI------- 503 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~------- 503 (670)
.+++.+.. .+++..+.+++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997643 68999999999999999999998 8999999999999999999999999999875543321
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.......++..|+|||.......+.++||||||++++||++|+.||...... ........ +.. . .....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-~~~----~--~~~~~-- 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILN-GKI----E--WPEDV-- 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-CCc----C--CCccc--
Confidence 1223346788999999998888999999999999999999999999754321 11111111 110 0 00000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.+++..||+.+|.+||++.++.+.|+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 02466788999999999999999955555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=288.67 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=186.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----Ce
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 417 (670)
.++|...+.||+|+||.||++.... ....+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4678999999999999999997532 234567899999999999999999988654 34
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999996 7898888654 359999999999999999999998 8999999999999999999999999999986
Q ss_pred ccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHh-----------
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQ----------- 564 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~----------- 564 (670)
..... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||...+... ........
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 64432 22233467889999998765 468899999999999999999999997543210 00000000
Q ss_pred hcCCcc-------cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 565 HLGQVL-------DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 565 ~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...... ...++... .........+.+++.+||+.+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 00001000 0111234667899999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=278.36 Aligned_cols=235 Identities=25% Similarity=0.351 Sum_probs=185.2
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCee
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 418 (670)
+|+..+.||+|+||.||++.... ..+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 47788999999999999876521 124567899999999 589999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999654 358899999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCcceeeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcCCcccccC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~d 574 (670)
............|+..|+|||.+... .++.++||||||++++||++|+.||..... ............ .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------~ 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------E 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------C
Confidence 54333333345689999999988753 467899999999999999999999964221 111111111111 1
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
+. ++......+.+++..||+.+|.+|| +.++++++
T Consensus 229 ~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 1122235677899999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=287.59 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=189.6
Q ss_pred CccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-----eeE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR-----DLL 419 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-----~~~ 419 (670)
+|+..+.||+|++|.||+++... ..+.+.+|+.+++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999997643 2356889999999999999999999998765 789
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58988886543 79999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCc--ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhh----------
Q 035655 500 HGKI--SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQH---------- 565 (670)
Q Consensus 500 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~---------- 565 (670)
.... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 5431 123344678899999999887 78999999999999999999999997643211 111100000
Q ss_pred -cCCccccc---CCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 566 -LGQVLDVV---DPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 566 -~~~~~~~~---d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+ ..... ..........+.+++.+||+.+|.+||++++++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00000000 00000 001111345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.55 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=183.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..+.||+|+||.||++.... ...++..|+.++.++. ||||++++++|.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999998752 2234667887777775 9999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+ .++++||||+|+||++++++.+||+|||++........
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 985 47777665433 378999999999999999999997 25899999999999999999999999999876543221
Q ss_pred ceeeccccCcCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 504 SHTTNVVGTIGYIAPELARTGK----ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
.....++..|+|||.+.+.. ++.++||||||++++||++|+.||....... +...... ... .+...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~-~~~-----~~~~~- 240 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKIL-QEE-----PPSLP- 240 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHh-cCC-----CCCCC-
Confidence 12335788999999987553 7889999999999999999999997522211 1111100 011 01110
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+.+++.+||+.||.+||++++++++..
T Consensus 241 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 241 -PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 00122356788999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=283.16 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=183.5
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeecc-------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK------- 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------- 415 (670)
.++|+..++||+|+||.||++..... ...+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999986431 13567899999999999999999987543
Q ss_pred -CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
..+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999965 677766543 3469999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcc----------eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHH
Q 035655 495 ARLFDHGKIS----------HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLE 562 (670)
Q Consensus 495 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~ 562 (670)
++........ ..+...+++.|+|||.+.+. .++.++|||||||+++||++|+.||...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765432211 11234678899999987654 5789999999999999999999999753221 1111111
Q ss_pred Hhhc---------CCccccc----CCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 563 FQHL---------GQVLDVV----DPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 563 ~~~~---------~~~~~~~----d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.... ..+.... .+...... .......+.+++.+|++.+|.+||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1000 0000000 00000000 01122567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.78 Aligned_cols=230 Identities=21% Similarity=0.306 Sum_probs=184.4
Q ss_pred cceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 367 SEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
..+||+|+||.||++.... ....+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 4679999999999997632 234578899999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++.. ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 998743 258999999999999999999998 899999999999999999999999999987554322 1223356
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
|+..|+|||.+.+..++.++||||||++++||++|+.||....... ....... ...+.+.. .......+.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~------~~~~~~~~--~~~~~~~l~ 247 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD------NLPPKLKN--LHKVSPSLK 247 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh------hCCcccCC--cccCCHHHH
Confidence 8899999999988889999999999999999999999997533211 1111110 01111110 111234567
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 035655 591 QLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+++.+||+.+|.+||++.+++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcC
Confidence 88899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=279.33 Aligned_cols=231 Identities=26% Similarity=0.411 Sum_probs=182.1
Q ss_pred ccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
|...++||+|+||.||+|.... ..+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999997532 124678899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+. |+|.+++.... ..+++.++..++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 57877775433 468999999999999999999998 8999999999999999999999999999864322
Q ss_pred eeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....|+..|+|||++. .+.++.++|||||||+++||++|+.||........ ...... ... +...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~-~~~-----~~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ-NDS-----PTLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh-cCC-----CCCC---
Confidence 23456889999999874 45688899999999999999999999875432111 111111 111 1111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+++.+||+.+|.+||++.+++++-.
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1112245778999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=290.95 Aligned_cols=236 Identities=23% Similarity=0.363 Sum_probs=196.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
...|.+...||+|.|++|.+++... ..+.+.+|+++|+.|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4678899999999999999997643 2355889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+.+|.+.+||.++.+ ........++.|+.++++|||+ +.|+|||||++||||+.++++||+|||++..+..+
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999988764 5668888999999999999999 99999999999999999999999999999888754
Q ss_pred cceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
....+.+|++.|.|||++.+.+| .++.|+||+|+++|-|++|..||++...- +.-++.+.+.+
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---------------~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---------------ELRPRVLRGKY 272 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------------cccchheeeee
Confidence 34456799999999999998877 57999999999999999999999863211 11111111111
Q ss_pred --cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 582 --VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 582 --~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
+.-....+.++++..+-.+|.+|+++++++++-+...
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1112345667888899999999999999999876543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=268.46 Aligned_cols=236 Identities=24% Similarity=0.341 Sum_probs=183.6
Q ss_pred CccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+.+....||.|.+|.|++++... ..+.....+.++.+-+ .|.||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 34456789999999999998754 2344555666665554 79999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
|. ..++..|.... .++++..+-++...+..||.||-+ +++|+|||+||+|||+|+.|++||||||++..+-...
T Consensus 173 Ms-~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HH-HHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 94 45666665443 468888888999999999999998 5899999999999999999999999999997665432
Q ss_pred eeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
..+..+|.+.|||||.+. ...|+.++||||||+.++||.||+.||........ ...++++...|.|....
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------~ltkvln~ePP~L~~~~ 319 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------VLTKVLNEEPPLLPGHM 319 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------HHHHHHhcCCCCCCccc
Confidence 334568999999999875 34788999999999999999999999987332211 11112222234443322
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....++++...||++|+.+||...++++|
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 134567888899999999999999999985
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=283.47 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=189.1
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec-c
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-K 415 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~ 415 (670)
.++...+++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++.++|.. .
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3556678999999999999999999987432 23567789999999999999999998865 5
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
...++|+||+ +++|.+++.. ..+++.....++.|+++||.|||+ .+++||||||+||++++++.+||+|||++
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 6789999998 5689888753 357888899999999999999999 89999999999999999999999999998
Q ss_pred eeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHH----------
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW-VLEF---------- 563 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~-~~~~---------- 563 (670)
...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... ....
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754332 123457889999998766 568999999999999999999999997543211100 0000
Q ss_pred -hhcCCccccc-CCCCCCccc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 564 -QHLGQVLDVV-DPNLGSSYV-----VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 564 -~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+.. ........+ ......+.+++..|++.+|.+||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 0000000000 000001111 11236788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=276.05 Aligned_cols=228 Identities=25% Similarity=0.288 Sum_probs=176.4
Q ss_pred eEeeeCceeEEEeeccch-------------------HHHHHHHHH---HHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 369 VIGTGGFGEVYKGVLPTR-------------------MREFAAEIE---SLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~---~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.||+|+||.||++..... ...+..|.. .++...||||+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999998875321 112344443 3444579999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988643 469999999999999999999998 899999999999999999999999999987553321 2
Q ss_pred eccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....|+..|+|||.+.++ .++.++||||+||+++||++|+.||............... ...++.+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~----~~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------LTMAVELPD----SF 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh------hccCCCCCC----cC
Confidence 234689999999998754 6899999999999999999999999764221111111111 011122211 22
Q ss_pred HHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 586 MELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
...+.+++..|++.+|.+|| ++.+++++-
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 35678889999999999999 999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=282.78 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=191.6
Q ss_pred CCccchhhHHHhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeee
Q 035655 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 349 ~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
+++....++...+++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++.+
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 3455566778889999999999999999999997532 1245778999999999999999999
Q ss_pred eeecc------CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC
Q 035655 411 WCKRK------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484 (670)
Q Consensus 411 ~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 484 (670)
++... ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence 88543 3467888876 7899888753 258999999999999999999998 899999999999999999
Q ss_pred CcEEEEeecCceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHH
Q 035655 485 MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLE 562 (670)
Q Consensus 485 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~ 562 (670)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .......
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999998754332 233467899999998866 56788999999999999999999999653211 1110000
Q ss_pred Hhhc--CCc------------ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 563 FQHL--GQV------------LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 563 ~~~~--~~~------------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.... ... ....+.... ..........+.+++..|++.||.+||++.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0000 000 000000000 0000012345778999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=270.17 Aligned_cols=227 Identities=23% Similarity=0.222 Sum_probs=175.0
Q ss_pred ceEeeeCceeEEEeeccch-------------------HHHHHHHHHH-HhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEIES-LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+.||+|+||.||+|..... ...+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999976321 1223344444 3455899999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999654 358999999999999999999998 8999999999999999999999999999875433 22
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...++..|+|||.+.+..++.++||||||++++||++|..||........ .......... ..+ ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~--~~~----~~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNILSRRIN--WPE----EVKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhcccC--CCC----cccccCCH
Confidence 34688899999999888889999999999999999999999975432211 1111111100 011 11112335
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+.+++..||+.+|++||++.++.+.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHH
Confidence 67889999999999999976544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.88 Aligned_cols=234 Identities=20% Similarity=0.291 Sum_probs=197.3
Q ss_pred CccccceEeeeCceeEEEeec-------------cc-----hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVL-------------PT-----RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~-------------~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
-|...+.||+|.|..|-+++. +. ....+.+|++.|+.++|||||+|+.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 366778899999999876643 11 235677999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL~DFGla~~~~~~~~ 503 (670)
-.+|+|.+||.+++. .+.+....+++.||+.|+.|+|+ ..+|||||||+|+.+- .-|-+||.|||++..+.++.
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 999999999988764 69999999999999999999998 8999999999999874 56789999999998777654
Q ss_pred ceeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
..++.+|.+.|-|||++.+..|+ +..||||||+|||-|+||+.||+.... .+.+..++|-++ ..+
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-----------SETLTmImDCKY--tvP 239 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-----------SETLTMIMDCKY--TVP 239 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-----------hhhhhhhhcccc--cCc
Confidence 45667999999999999999885 689999999999999999999985221 122333444433 345
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....++.+|+..||..||.+|.+.+||+.+-|
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 566788899999999999999999999998755
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.38 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=184.8
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC----
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR---- 416 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~---- 416 (670)
...++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999997532 1235778999999999999999999987553
Q ss_pred --eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 417 --DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 417 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 469999999 7799888753 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH-hhcCCc---
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF-QHLGQV--- 569 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~-~~~~~~--- 569 (670)
+...... .....+++.|+|||.+.+ ..++.++|+|||||++++|++|+.||...... ...... ......
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 9765432 223467889999998876 45789999999999999999999999753321 000000 000000
Q ss_pred -------------ccccCCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 570 -------------LDVVDPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 570 -------------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+ +... ..........+.+++.+|++.||.+||++.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 239 FVQKLQSEDAKNYVKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHhhcchhHHHHHHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 0000 001112234578899999999999999999999653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=274.38 Aligned_cols=244 Identities=26% Similarity=0.330 Sum_probs=186.6
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
|+..+.||+|++|.||+|+... ..+.+..|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567889999999999997653 1245778999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
+ ++|.+++.... ..+++..+.+++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 59999997653 369999999999999999999999 8999999999999999999999999999986644322 2
Q ss_pred eeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh---------cCCc--ccc
Q 035655 506 TTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH---------LGQV--LDV 572 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~---------~~~~--~~~ 572 (670)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||...... .......... .... .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233567789999998766 7899999999999999999999999764321 1111100000 0000 000
Q ss_pred cCCCCCC----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 573 VDPNLGS----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 573 ~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.-+.... ...+.....+.+++..||+.+|++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0001000 0011124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=285.26 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=186.7
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe---
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD--- 417 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~--- 417 (670)
...++|+..+.||+|++|.||+|.... ..+.+.+|+.++++++||||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 456789999999999999999997643 12446689999999999999999998866554
Q ss_pred ---eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 418 ---LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 418 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998854 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc------
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL------ 566 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~------ 566 (670)
+...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ...........
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9865432 233467889999998865 36789999999999999999999999753321 01100000000
Q ss_pred --------CCcccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 567 --------GQVLDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 567 --------~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
......+.......+ .......+.+++.+|++++|.+||++.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 000000000000011 011246788999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.68 Aligned_cols=238 Identities=26% Similarity=0.420 Sum_probs=178.9
Q ss_pred hhcCccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccccCceeeeeeeeec--------
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHKHLVNLQGWCKR-------- 414 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------- 414 (670)
-..+|++.+.||+||||.|||++.+-+ .....+|+..|++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 346799999999999999999986432 2446689999999999999999874410
Q ss_pred --------------------------------------------------------------------------------
Q 035655 415 -------------------------------------------------------------------------------- 414 (670)
Q Consensus 415 -------------------------------------------------------------------------------- 414 (670)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------c--------CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccc
Q 035655 415 -----------------------K--------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463 (670)
Q Consensus 415 -----------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 463 (670)
+ ..+||=||||+...|++++.++.... .-...++++.+|++||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 12688899999988888886653211 456788999999999999999
Q ss_pred cccceEEecccCCCcEEecCCCcEEEEeecCceecc----------------CC-CcceeeccccCcCCCCccccccC--
Q 035655 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD----------------HG-KISHTTNVVGTIGYIAPELARTG-- 524 (670)
Q Consensus 464 ~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~----------------~~-~~~~~~~~~gt~~y~aPE~~~~~-- 524 (670)
++||||||||.||+||++..|||+|||+|.... .+ .....+..+||.-|+|||++.+.
T Consensus 716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 899999999999999999999999999998621 00 11234567999999999998764
Q ss_pred -CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCC
Q 035655 525 -KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA 603 (670)
Q Consensus 525 -~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 603 (670)
+|+.|+|+||+|||++||+. ||...... +. +....+.+.+... ..+...++..-.+++.++++.||.+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMER-AS-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHH-HH-HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCcc
Confidence 49999999999999999986 56642211 11 1111111111111 2233344455568899999999999
Q ss_pred CCCHHHHHH
Q 035655 604 RPTMRQVLR 612 (670)
Q Consensus 604 RPs~~evl~ 612 (670)
|||+.|+++
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=280.04 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=185.6
Q ss_pred cCccc-cceEeeeCceeEEEeeccch-------------H-----------------HHHHHHHHHHhccccCceeeeee
Q 035655 362 KGFKQ-SEVIGTGGFGEVYKGVLPTR-------------M-----------------REFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 362 ~~f~~-~~~lG~G~fg~Vykg~~~~~-------------~-----------------~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
++|.. .+.||+|+||.||++..... . ..+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 46799999999999975420 0 13678999999999999999999
Q ss_pred eeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEE
Q 035655 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 411 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
++...+..++||||++ |+|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999988543 358999999999999999999998 899999999999999999999999
Q ss_pred eecCceeccCCC-------------cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-
Q 035655 491 DFGLARLFDHGK-------------ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI- 555 (670)
Q Consensus 491 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~- 555 (670)
|||++....... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998665111 1111223568899999988764 4689999999999999999999999764321
Q ss_pred hHHHHHHHhhcCC---ccc------------ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 556 LVDWVLEFQHLGQ---VLD------------VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 556 ~~~~~~~~~~~~~---~~~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+........ ... ...+.. ..........+.+++..||+.+|.+||+++|++.+-+-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 1111111100000 000 000000 00011124567899999999999999999999987654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=282.29 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=181.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeecc---------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--------- 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--------- 415 (670)
..+|...+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3678999999999999999997643 235688999999999999999999876543
Q ss_pred -----CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEE
Q 035655 416 -----RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARL 489 (670)
Q Consensus 416 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL 489 (670)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||+++. ++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35799999997 589888743 358999999999999999999998 89999999999999974 557899
Q ss_pred EeecCceeccCCCcc--eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-H-HHHHHh
Q 035655 490 GDFGLARLFDHGKIS--HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-D-WVLEFQ 564 (670)
Q Consensus 490 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~-~~~~~~ 564 (670)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||+++||++|+.||........ . ......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999765432111 1123367889999997654 4678899999999999999999999975322110 0 000000
Q ss_pred -----hcCCccccc---------CCCC-CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 565 -----HLGQVLDVV---------DPNL-GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 565 -----~~~~~~~~~---------d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......... .+.. ...........+.+++..||+.||.+||++.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 000000000 0000 00001122356788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.76 Aligned_cols=224 Identities=27% Similarity=0.334 Sum_probs=182.2
Q ss_pred EeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 370 IGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
||+|+||.||++.... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999987642 223678899999999999999999999999999999999999999
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccc
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVV 510 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 510 (670)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99996553 58999999999999999999998 999999999999999999999999999998664432 1233456
Q ss_pred cCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 511 GTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 511 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
++..|++||...+...+.++|+||||++++|+++|+.||...+.. ........ . .. .++......+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-~------~~----~~~~~~~~~l~ 221 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEKILK-D------PL----RFPEFLSPEAR 221 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHhc-C------CC----CCCCCCCHHHH
Confidence 889999999998888899999999999999999999999754321 11111110 0 01 11112245678
Q ss_pred HHHHhhccCCCCCCCCH---HHHHH
Q 035655 591 QLGLLCSHQKAEARPTM---RQVLR 612 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs~---~evl~ 612 (670)
+++..||..||.+||++ +++++
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHh
Confidence 89999999999999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=276.13 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=181.2
Q ss_pred CccccceEeeeCceeEEEeeccch--------------------HHHHHHHHHHHhcc-ccCceeeeeeeeecc----Ce
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRL-RHKHLVNLQGWCKRK----RD 417 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~--------------------~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~----~~ 417 (670)
+|+..+.||+|+||.||++..... .+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477889999999999999986432 24567899999999 499999999975432 45
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++++||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788889885 6899988543 458999999999999999999998 8999999999999999999999999999986
Q ss_pred ccCCCcc---eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHH---------
Q 035655 498 FDHGKIS---HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEF--------- 563 (670)
Q Consensus 498 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~--------- 563 (670)
....... ......||..|+|||.+.+ ..++.++|||||||++++|++|+.||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1233478999999998765 46889999999999999999999999753311 11000000
Q ss_pred --hhcCCc---ccccC--CCC-CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 564 --QHLGQV---LDVVD--PNL-GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 564 --~~~~~~---~~~~d--~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...... ..... +.. ...........+.+++.+|++.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000 000 000001123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=263.39 Aligned_cols=250 Identities=28% Similarity=0.339 Sum_probs=186.1
Q ss_pred cCccccceEeeeCceeEEEeeccch---------HHH-------------HHHHHHHHhccccCceeeeeeeeec-cCee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR---------MRE-------------FAAEIESLGRLRHKHLVNLQGWCKR-KRDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~---------~~~-------------f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~ 418 (670)
..|+.+..||+|.||.|||+.-.++ .+. ..+|+.+++.|+|||++.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4578889999999999999964331 122 2389999999999999999999876 7789
Q ss_pred EEEEeccCCCCchhhcccC---CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC----CcEEEEe
Q 035655 419 LLVYDYIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD----MNARLGD 491 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~----~~~kL~D 491 (670)
++++||.+. +|...|+-+ ....++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 888887543 23568999999999999999999999 789999999999999888 8999999
Q ss_pred ecCceeccCCCcc--eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-------H-HH
Q 035655 492 FGLARLFDHGKIS--HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-------D-WV 560 (670)
Q Consensus 492 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-------~-~~ 560 (670)
+|+++.+...-.+ ....++-|..|.|||++.+. .||.+.||||.|||+.||++-++.|...+..+. + ..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988664322 23456789999999998876 589999999999999999998877765221111 0 01
Q ss_pred HHHhhcCCcccccCCCCC--Ccc------------cH----H-------HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 561 LEFQHLGQVLDVVDPNLG--SSY------------VV----A-------EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~--~~~------------~~----~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+-+...+-..+..-|.+. .++ +. . -....++|...+++.||.+|.|.++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111111111111111110 000 00 0 0112567888899999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=285.72 Aligned_cols=183 Identities=33% Similarity=0.546 Sum_probs=159.0
Q ss_pred ccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccccCceeeeeeeeeccC------eeEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKR------DLLL 420 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~l 420 (670)
+...+.||+|+||.||+|+.+.. .+...+|+++|++|+|+|||++.+.=++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999997552 234458999999999999999999866544 5689
Q ss_pred EEeccCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec--CCCc--EEEEeecCc
Q 035655 421 VYDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID--ADMN--ARLGDFGLA 495 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~--~kL~DFGla 495 (670)
|||||.+|||+..|.+.+ ...|++.+.+.++.+++.||.|||+ ++|+||||||.||++- ++|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998744 3569999999999999999999998 9999999999999983 3343 599999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELAR-TGKASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
+..+.+. .....+||..|++||++. .+.|+...|.|||||++||++||..||..
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9887654 567789999999999998 48899999999999999999999999976
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=258.64 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=196.3
Q ss_pred hcCcccc-ceEeeeCceeEEEeeccchHHHHH-----------HHHHHHhcc-ccCceeeeeeeeec----cCeeEEEEe
Q 035655 361 TKGFKQS-EVIGTGGFGEVYKGVLPTRMREFA-----------AEIESLGRL-RHKHLVNLQGWCKR----KRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~-~~lG~G~fg~Vykg~~~~~~~~f~-----------~Ei~~L~~l-~H~nIv~l~g~~~~----~~~~~lV~E 423 (670)
|++|++. ++||-|-.|+|-.+..+...+.|. +|++.--+. .|||||+++++++. ...+++|||
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 4455543 578999999999999888666554 677665444 59999999999864 356899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~DFGla~~~~~ 500 (670)
+|+||.|.+.+.+++...+++.++-+|++||+.|+.|||+ ..|.||||||+|+|... |-.+||+|||+|+....
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999999888899999999999999999999999 99999999999999964 44689999999986553
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
. ....+.+-|+.|.|||++...+|+...|+||+||++|-|+||..||...... +..-.+.....+.. .+..
T Consensus 217 ~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy------~FP~ 288 (400)
T KOG0604|consen 217 P--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY------EFPE 288 (400)
T ss_pred C--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc------cCCC
Confidence 2 2345568899999999999999999999999999999999999999763321 11111111111111 1122
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc--CCCCCCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN--GDELLPI 622 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~--~~~~~p~ 622 (670)
+-.....+...+++...|..+|.+|-|+.|++++-+ +...+|.
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 233455677888999999999999999999999754 3344444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=291.63 Aligned_cols=250 Identities=21% Similarity=0.237 Sum_probs=166.3
Q ss_pred hhcCccccceEeeeCceeEEEeeccch----H---------HHHHHHHHHHhccc---cCceeeeeee------eeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR----M---------REFAAEIESLGRLR---HKHLVNLQGW------CKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~----~---------~~f~~Ei~~L~~l~---H~nIv~l~g~------~~~~~~ 417 (670)
..++|+..++||+|+||.||+|++... . +.-..|+.+..+++ +.++..+... +.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 567899999999999999999987543 1 11112333333333 2233222221 245678
Q ss_pred eEEEEeccCCCCchhhcccCCcc------------------ccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENF------------------VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNV 479 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 479 (670)
.++|+||+++++|.+++...... ...+..+..++.|++.||.|||+ ++|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 99999999999999998653210 11234456899999999999998 8999999999999
Q ss_pred EecC-CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC----------------------CCCccchhHHHH
Q 035655 480 LIDA-DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG----------------------KASCSTDVFAYG 536 (670)
Q Consensus 480 Lld~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV~S~G 536 (670)
|++. ++.+||+|||+++..............+++.|||||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 57999999999986654443344556889999999965322 234567999999
Q ss_pred HHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC----cccccCCCCCCc----c--cHHHHHHHHHHHHhhccCCCCCCCC
Q 035655 537 VLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ----VLDVVDPNLGSS----Y--VVAEMELVLQLGLLCSHQKAEARPT 606 (670)
Q Consensus 537 vvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~~l~~~Cl~~dP~~RPs 606 (670)
|++|||+++..+++.. +..+.......+. ......+....+ + .........+|+.+|++.||++|||
T Consensus 367 viL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 367 LIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 9999999987775432 1111111111110 001111111000 0 0001223457999999999999999
Q ss_pred HHHHHHHhc
Q 035655 607 MRQVLRYLN 615 (670)
Q Consensus 607 ~~evl~~L~ 615 (670)
++|+++|-.
T Consensus 444 a~e~L~Hpf 452 (566)
T PLN03225 444 AKAALAHPY 452 (566)
T ss_pred HHHHhCCcC
Confidence 999999743
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=262.06 Aligned_cols=209 Identities=17% Similarity=0.131 Sum_probs=167.5
Q ss_pred eCceeEEEeeccch-----------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccc
Q 035655 373 GGFGEVYKGVLPTR-----------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV 441 (670)
Q Consensus 373 G~fg~Vykg~~~~~-----------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~ 441 (670)
|.+|.||++.+... ...+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+.. .
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~ 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--N 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--C
Confidence 78999999887542 2245567666667789999999999999999999999999999999986543 5
Q ss_pred cCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCcccc
Q 035655 442 LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521 (670)
Q Consensus 442 l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 521 (670)
+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++++|||++...... .....++..|+|||.+
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVG 154 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCccc
Confidence 8999999999999999999998 89999999999999999999999999988655432 1223457789999999
Q ss_pred ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCC
Q 035655 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKA 601 (670)
Q Consensus 522 ~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 601 (670)
....++.++||||+|++++||++|+.|+....... ....... .+......+.+++.+|++.||
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~----~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLN----IPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccC----CcccCCHHHHHHHHHHccCCH
Confidence 88889999999999999999999998875321100 0000001 111223567789999999999
Q ss_pred CCCCCH
Q 035655 602 EARPTM 607 (670)
Q Consensus 602 ~~RPs~ 607 (670)
.+||++
T Consensus 218 ~~R~~~ 223 (237)
T cd05576 218 TERLGA 223 (237)
T ss_pred HHhcCC
Confidence 999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=295.12 Aligned_cols=131 Identities=31% Similarity=0.460 Sum_probs=119.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|.+.++||+|+||.||+|.... ....+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 3578999999999999999998752 125678899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
|||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999654 358899999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=259.06 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=194.9
Q ss_pred hhhHHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeee
Q 035655 354 YSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGW 411 (670)
Q Consensus 354 ~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~ 411 (670)
.+++.....+++...++-+|.||.||+|++.+ +...+..|-..+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555556678888899999999999997654 12335567777888899999999999
Q ss_pred eecc-CeeEEEEeccCCCCchhhccc------CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC
Q 035655 412 CKRK-RDLLLVYDYIPNGSLDSLLFD------NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484 (670)
Q Consensus 412 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 484 (670)
+.+. ...+.+|.++.-|+|..||.. +..+.++..+...++.|++.|++|||. .+|||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 8765 568999999999999999972 223468888999999999999999998 999999999999999999
Q ss_pred CcEEEEeecCceeccCCCcce-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc-hhHHHHH
Q 035655 485 MNARLGDFGLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF-ILVDWVL 561 (670)
Q Consensus 485 ~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~-~~~~~~~ 561 (670)
.++||+|=.+++..-+.+... ......+..||+||.+.+..|+..+||||||+++|||+| |+.|+..-+. +...+.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 999999999998654433222 222345678999999999999999999999999999999 9999865322 2222211
Q ss_pred HHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 562 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
. +. ++ ..+..++.++..++.-||...|++||+++|++.-|.
T Consensus 513 d----Gy-------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 513 D----GY-------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred c----cc-------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 1 11 11 123345677889999999999999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=279.68 Aligned_cols=232 Identities=21% Similarity=0.249 Sum_probs=186.6
Q ss_pred hcCccccceEeeeCceeEEEeeccchHHHH------------HHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTRMREF------------AAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~~~~f------------~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+..|.....+|.|+|+.|-++......+++ .+|+.++.+. +||||+++.+.+.++.+.++|||++.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 566777788999999999999876643333 3577666655 699999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe-cCCCcEEEEeecCceeccCCCccee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI-DADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-d~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+-|.+.+..... .. .++..|+.+|+.++.|||+ ++||||||||+|||+ ++.++++|+|||.++..... .
T Consensus 401 ~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 401 GELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred cHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 888777755432 23 7777899999999999999 999999999999999 68999999999999876654 3
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...+-|..|.|||++....|++++|+||||++||+|++|+.||...... .+ ..... ..+.+.....
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e-i~~~i------------~~~~~s~~vS 536 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE-IHTRI------------QMPKFSECVS 536 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH-HHHhh------------cCCccccccC
Confidence 3446788999999999999999999999999999999999999753222 00 00001 1122223445
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+...+|+.+||+.||.+||+|.++..+-+.
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 667788899999999999999999998765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=256.38 Aligned_cols=233 Identities=24% Similarity=0.292 Sum_probs=186.1
Q ss_pred hcCccccceEeeeCceeEEEeeccchH-------------------HHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTRM-------------------REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~~-------------------~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..++||+|.||+|-+++.+... ..-..|-++|+..+||.+..|.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999998765421 1123577899999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||..||.|.-+|.+. ..+++...+-+-..|..||.|||+ ++||.||||.+|.|||.+|.+||.||||++.-- .
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K 320 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-c
Confidence 9999999999999553 468998888899999999999999 999999999999999999999999999997432 2
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc-chhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH-FILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
....+.+.+||+.|+|||++....|....|-|.+|+|+|||+||+.||...+ ..+-+.+.. . |- .
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--e--------d~----k 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--E--------DL----K 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--h--------hc----c
Confidence 2345677899999999999999999999999999999999999999997632 222221111 0 11 1
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
++.....+...|....+.+||.+|- .++||.++
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 2222223445566677899999994 35666654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=253.23 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=187.5
Q ss_pred chhhHHHhhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccc-cCceeeeeeeeecc
Q 035655 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRK 415 (670)
Q Consensus 353 ~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~ 415 (670)
++.|+..-|. +.||+|+|+.|--++.-. ......+|++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4667766654 679999999998776432 2455679999999996 99999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEEee
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDF 492 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DF 492 (670)
..+|||||-|.||+|..+|.++ ..+++.+..++.++|+.||.+||. ++|.|||+||+|||..... -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999765 469999999999999999999999 9999999999999996554 4799999
Q ss_pred cCceeccCCC------cceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHH
Q 035655 493 GLARLFDHGK------ISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVL 561 (670)
Q Consensus 493 Gla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~ 561 (670)
.|........ .+...+.+|+..|||||+.. ...|+.+.|.||||+|+|-|++|..||.+.-..-..|-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9986543221 22234568999999999753 235789999999999999999999999762111112211
Q ss_pred HHh---hcCCcccccCCCCCCcccHH----HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 562 EFQ---HLGQVLDVVDPNLGSSYVVA----EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 562 ~~~---~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... ....+.+.+.... -+++.+ ...+..+++...+..++..|-++.+++++-+
T Consensus 304 Ge~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred CCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 000 0011111111110 123332 3455566777777899999999999998544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=279.64 Aligned_cols=243 Identities=20% Similarity=0.272 Sum_probs=171.1
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------------------------hHHHHH--------------HH
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------------------------RMREFA--------------AE 393 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------------------------~~~~f~--------------~E 393 (670)
..++|++.++||+|+||.||+|.... ..++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 36789999999999999999986310 012232 46
Q ss_pred HHHHhccccCce-----eeeeeeeec--------cCeeEEEEeccCCCCchhhcccCC----------------------
Q 035655 394 IESLGRLRHKHL-----VNLQGWCKR--------KRDLLLVYDYIPNGSLDSLLFDNE---------------------- 438 (670)
Q Consensus 394 i~~L~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 438 (670)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++|+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777877654 677888753 356899999999999999986421
Q ss_pred ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCc
Q 035655 439 NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518 (670)
Q Consensus 439 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 518 (670)
...++|..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235678899999999999999998 8999999999999999999999999999976544322222223457899999
Q ss_pred cccccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCCCcc----------hhHHHHHHHhh
Q 035655 519 ELARTGKA----------------------SCSTDVFAYGVLLLEIATGRR-PIDSDHF----------ILVDWVLEFQH 565 (670)
Q Consensus 519 E~~~~~~~----------------------t~ksDV~S~Gvvl~el~tG~~-pf~~~~~----------~~~~~~~~~~~ 565 (670)
|.+..... ..+.||||+||+++||++|.. |+..... .+..|. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence 98754321 235799999999999999875 6653110 011111 111
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCC---CCCCCHHHHHHHhc
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKA---EARPTMRQVLRYLN 615 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~L~ 615 (670)
... .+- ...........+++..++..+| .+|+|++|+++|-.
T Consensus 458 ~~~----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 458 GQK----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred ccC----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 110 010 1111223556777778888655 78999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.91 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=191.3
Q ss_pred hcCccccceEeeeCceeEEEeeccch---------------HHHHHHHHHHHhcccc--C----ceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAAEIESLGRLRH--K----HLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~---------------~~~f~~Ei~~L~~l~H--~----nIv~l~g~~~~~~~~~ 419 (670)
+++|.+..++|+|.||.|-.+.+... .+.-.-|+++|+++.+ | -+|++.+||.-.+..|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 78899999999999999999988653 2234469999999942 2 3788999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC----------------
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---------------- 483 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---------------- 483 (670)
+|+|.+ |-|+.++|..+.-.+++...+..|+.|+++++++||+ .+++|-||||+|||+-+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999998 6699999998887889999999999999999999999 99999999999999832
Q ss_pred ----CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc-ch-h-
Q 035655 484 ----DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH-FI-L- 556 (670)
Q Consensus 484 ----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~-~~-~- 556 (670)
+..+||+|||-|..-.... ...+.|..|.|||++.+-.++..+||||+||||.|+++|...|+..+ .+ +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 3358999999998654432 55688999999999999999999999999999999999999997632 11 1
Q ss_pred -HHHHHH--------------HhhcCCc-----------ccccCCC--CC--CcccHHHHHHHHHHHHhhccCCCCCCCC
Q 035655 557 -VDWVLE--------------FQHLGQV-----------LDVVDPN--LG--SSYVVAEMELVLQLGLLCSHQKAEARPT 606 (670)
Q Consensus 557 -~~~~~~--------------~~~~~~~-----------~~~~d~~--l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 606 (670)
.+.+.. ....+++ ....++. +. ......+...|.+|+..++..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 111100 0000000 0000000 00 0122345678999999999999999999
Q ss_pred HHHHHHH
Q 035655 607 MRQVLRY 613 (670)
Q Consensus 607 ~~evl~~ 613 (670)
++|+++|
T Consensus 400 l~EAL~H 406 (415)
T KOG0671|consen 400 LREALSH 406 (415)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=258.57 Aligned_cols=237 Identities=25% Similarity=0.317 Sum_probs=181.9
Q ss_pred cccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccC
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
+....||.|.||+|+|-..+. ..+++..|++...+- +.||||+++|.+..++..++.||+|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 346789999999999865433 456788888876655 68999999999999999999999994
Q ss_pred CCCchhhc---ccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 427 NGSLDSLL---FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 427 ~gsL~~~l---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
-||+.+. ..-.+..+++..+-.|......||.||-+ +..|||||+||+|||||..|.+||||||++..+...-
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 5776654 23344568998888999999999999998 4889999999999999999999999999997654422
Q ss_pred ceeeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 SHTTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
..+.-+|...|||||.+... .|+-+|||||||+.|+|+.||+-|+.... ..+.+...+...-.|.+....
T Consensus 223 -AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 223 -AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred -HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecCcc
Confidence 23445799999999988632 48899999999999999999999987522 222222222222223332211
Q ss_pred c-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 V-VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. ......+...+..|+-+|.++||+..++.++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 2234567888889999999999999998763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=248.74 Aligned_cols=209 Identities=30% Similarity=0.384 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccccc
Q 035655 387 MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466 (670)
Q Consensus 387 ~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 466 (670)
.+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..... +++..++.++.+++.++.|||+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~--- 105 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHS--- 105 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHH---
Confidence 57889999999999999999999999999999999999999999999865433 8999999999999999999999
Q ss_pred ceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCC
Q 035655 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR 546 (670)
Q Consensus 467 ~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~ 546 (670)
.+++|+||+|+||++++++.++|+|||.+....... ......++..|++||......++.++|||+||+++++|++|.
T Consensus 106 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 106 NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 899999999999999999999999999998765532 233456888999999998888999999999999999999999
Q ss_pred CCCCC-CcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 547 RPIDS-DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 547 ~pf~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
.||.. ..... .. ......... . ..........+.+++.+|+..+|++||++.++++
T Consensus 184 ~p~~~~~~~~~--~~-~~~~~~~~~----~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 184 PPFPGDDQLLE--LF-KKIGKPKPP----F---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCCcHHH--HH-HHHhccCCC----C---ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 99975 22111 11 111111000 0 0000003356888999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.12 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=185.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeee-cc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCK-RK 415 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~ 415 (670)
-.++|-..++||+|||+.|||+++-. -.+...+|..+-+.|.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34567778899999999999997632 1233458999999999999999999986 45
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec---CCCcEEEEee
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID---ADMNARLGDF 492 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kL~DF 492 (670)
+.+|-|+|||+|.+|+-||..+ +.+++.+.+.|+.||+.||.||.+ .+++|||-||||.||||- ..|.+||.||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999999765 468999999999999999999997 468999999999999994 4578999999
Q ss_pred cCceeccCCCcc------eeeccccCcCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Q 035655 493 GLARLFDHGKIS------HTTNVVGTIGYIAPELARTG----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562 (670)
Q Consensus 493 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~ 562 (670)
||+++++.+... .+....||..|++||++.-+ +++.|.||||.|||+|.++.|++||..+... .+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdIL-- 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDIL-- 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHH--
Confidence 999999765432 23446899999999987543 5789999999999999999999999863211 1111
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
....++....-.+. .-+....+...++.+||+..-++|....++..
T Consensus 695 --qeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 --QENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --hhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111111111110 01112244567888999999999987777653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=274.80 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=202.1
Q ss_pred chhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeeec--
Q 035655 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCKR-- 414 (670)
Q Consensus 353 ~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~-- 414 (670)
.++.+-..+.-|++.+.||.|.+|.||+++..+ ...+...|.++|+.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 444555667889999999999999999987644 345677888999988 58999999999853
Q ss_pred ---cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 415 ---KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 415 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
+++++||||||.+||.-|.++.-.+..+.|+.+.-|+..++.||.+||. ..++|||||=.||||+.++.|||.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence 4689999999999999999987667789999999999999999999998 9999999999999999999999999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELARTG-----KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~ 566 (670)
||++....... ....+..||+.|||||++... .|+..+|+||||++..||.-|..|+.+.+... ..
T Consensus 167 FGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------aL 237 (953)
T KOG0587|consen 167 FGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------AL 237 (953)
T ss_pred eeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------hh
Confidence 99998775533 334567899999999998643 46779999999999999999999987533211 11
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
-.+.....|.| .-+..-.+++.+.+..|+.+|-.+||++.++++|
T Consensus 238 F~IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 FLIPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccCCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 12222233333 2344556788999999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=283.92 Aligned_cols=251 Identities=27% Similarity=0.319 Sum_probs=198.3
Q ss_pred CCccchhhHHHhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeee
Q 035655 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQ 409 (670)
Q Consensus 349 ~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~ 409 (670)
|..-...+++...++|.+.++||+|+||.|...+.+. ....|..|-.+|..-+.+=|++|+
T Consensus 62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 3344556777778899999999999999999998754 234577888888888889999999
Q ss_pred eeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 410 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
-.|.+.+++|+|||||+||+|-..+.+.. .+++..++-++..|..||.-||+ .|+|||||||+|||||..|.+||
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEee
Confidence 99999999999999999999999997665 68999999999999999999999 99999999999999999999999
Q ss_pred EeecCceeccCCCcceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh
Q 035655 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~ 564 (670)
+|||-+-.+..+..-.....+|||.|++||+++. +.|.+.+|-||+||++|||++|..||..+. +++-.....
T Consensus 217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--lveTY~KIm 294 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--LVETYGKIM 294 (1317)
T ss_pred ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--HHHHHHHHh
Confidence 9999998887666566667799999999998862 578999999999999999999999997543 222111111
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC---HHHHHHHh
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT---MRQVLRYL 614 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 614 (670)
.....+...+ ..+..+...+|++.-+. +|..|-. ++++..|.
T Consensus 295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 295 NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1111111111 11233445555555443 5777777 89888875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=228.25 Aligned_cols=183 Identities=30% Similarity=0.408 Sum_probs=156.0
Q ss_pred CccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+|...++||+|.||+|+||+.... .....+||.+|+.|+|+|||++++..+.+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999986542 24567999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
|. .+|..|...- +..++.+....++.|+++||.++|+ +.+.|||+||.|.|++.+|+.|++|||+++.+.-...
T Consensus 83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 94 5787776543 3468999999999999999999999 8999999999999999999999999999997765321
Q ss_pred eeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHh-CCCCCCC
Q 035655 505 HTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIAT-GRRPIDS 551 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~t-G~~pf~~ 551 (670)
.....+-|..|.+|.++.+.+ |++..|+||-||++.|+.. |+..|.+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 223346789999999998765 7899999999999999988 6655655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=265.94 Aligned_cols=232 Identities=25% Similarity=0.361 Sum_probs=188.3
Q ss_pred cceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 367 SEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
.+.||+|.||+||-|+.++ +..++.+|+.+|++++||.||.+--.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5789999999999997654 346778999999999999999999999999999999999955
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceeccCCCcce
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~~~~~~~~ 505 (670)
+..+.|...++..|++..-.-++.||+.||.|||. ++|+|+||||+||||.+. -++||||||+|+++.... -
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 55444445555679998888999999999999999 999999999999999643 479999999999987654 3
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
...++||+.|+|||++++..|...-|+||.|+|+|--++|.-||..++. +.+-+ + .-.-+..| ....+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-IndQI----Q--NAaFMyPp----~PW~ei 791 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-INDQI----Q--NAAFMYPP----NPWSEI 791 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-hhHHh----h--ccccccCC----Cchhhc
Confidence 3457999999999999999999999999999999999999999976432 11111 1 11112222 223344
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....++++...+|..-++|-+..+.+.|-+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 556778888889999999999999888754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=243.98 Aligned_cols=247 Identities=29% Similarity=0.412 Sum_probs=184.6
Q ss_pred CccccceEeeeCceeEEEeeccchHHH------------------HHHHHHHHhccccCceeeeeeeeecc--------C
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTRMRE------------------FAAEIESLGRLRHKHLVNLQGWCKRK--------R 416 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~~~~------------------f~~Ei~~L~~l~H~nIv~l~g~~~~~--------~ 416 (670)
.|....+||+|.||.||+++...+.+. -.+|+++|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 345567899999999999987663322 23899999999999999999999643 3
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.+++||.+|+. +|.-.|... ...++..++.++++++..||.|+|. ..|+|||+||.|+|++.++.+||+|||+++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 48999999975 777777543 3468999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCC---cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCccc
Q 035655 497 LFDHGK---ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLD 571 (670)
Q Consensus 497 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~ 571 (670)
.+.... ....++.+-|..|.+||.+.+. .++++.|||.-|||+.||.++.+.+++.... ....+..+ .+....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L--cGs~tk 250 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL--CGSITK 250 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH--hccCCc
Confidence 765433 2223456779999999988764 6899999999999999999999888763211 11111111 111111
Q ss_pred ccCCC--------------CC-Ccc--cHHHH------HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 572 VVDPN--------------LG-SSY--VVAEM------ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 572 ~~d~~--------------l~-~~~--~~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
-+-|. +. +.+ ....+ ...++|+..++..||.+|+...+++.|-.-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 11111 10 000 01111 256788889999999999999999987543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=250.25 Aligned_cols=224 Identities=26% Similarity=0.348 Sum_probs=179.8
Q ss_pred cCccccceEeeeCceeEEEeeccchHHHHH-------------------HHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~~~~f~-------------------~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+|....+||+|+||+|.++.-+...+-++ .|-++|... +-|.+++++.+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999987655332221 355556555 457899999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+.+|+|--++++-+ .+.+..+.-++..||-||-+||+ ++|+.||||..|||||.+|.+||+|||+++.--.+
T Consensus 429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999997654 47888889999999999999999 99999999999999999999999999999743322
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
...+.+.+||+.|+|||++...+|....|-||||++||||+.|+.||++++.. +-..+ .+.. -.
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------------~ehn--vs 568 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------------MEHN--VS 568 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------HHcc--Cc
Confidence 23456689999999999999999999999999999999999999999985533 22111 1111 12
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARP 605 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RP 605 (670)
|+.....+...++..-+.+.|.+|-
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCcccc
Confidence 4444455666777778889999883
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=272.09 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=178.0
Q ss_pred ccccceEeeeCcee-EEEeeccchH-----------HHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCCCCc
Q 035655 364 FKQSEVIGTGGFGE-VYKGVLPTRM-----------REFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 364 f~~~~~lG~G~fg~-Vykg~~~~~~-----------~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
|...+.+|.|+-|+ ||+|...++. .-..+||..|+.- +|||||++++.-.+...+||..|.| ..+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 55567889999875 7999886632 1223799999887 5999999999888888999999999 5799
Q ss_pred hhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---C--CcEEEEeecCceeccCCCc
Q 035655 431 DSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---D--MNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 431 ~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~--~~~kL~DFGla~~~~~~~~ 503 (670)
++++... ......-...+.++.|+++||++||+ .+||||||||.||||+. + .+++|+|||+++....+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999774 11112224557889999999999999 99999999999999976 2 5789999999998876653
Q ss_pred ce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 504 SH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 504 ~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. .....||-||+|||.+...+.+...||||+|||+|++++ |.+||...-....+.... ... +..+.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~---~~~-L~~L~~----- 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG---NYT-LVHLEP----- 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC---ccc-eeeecc-----
Confidence 32 345689999999999999988999999999999999999 599998622111110000 000 111111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
. .++ +..+|+.+|++++|..||++.+|+.|
T Consensus 738 ~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 L-PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred C-chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 111 56788899999999999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=249.69 Aligned_cols=195 Identities=31% Similarity=0.442 Sum_probs=164.9
Q ss_pred cchhhHHHhh---cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeee
Q 035655 352 FRYSDLYTAT---KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQ 409 (670)
Q Consensus 352 ~~~~~l~~~t---~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~ 409 (670)
-.|-.|+.+. .-|..++.||-|+||+|.+++--+ .....++|-.||..-..+=||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 4455555554 348889999999999999986543 223456899999999999999999
Q ss_pred eeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 410 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
-.|.+++.+|+||||++||++-.+|.+.+ .+.++..+-++..+.+|+++.|. .|+|||||||+|||||.+|.+||
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceee
Confidence 99999999999999999999999996653 58888999999999999999998 99999999999999999999999
Q ss_pred EeecCceecc---------CCCc--------------------------------ceeeccccCcCCCCccccccCCCCc
Q 035655 490 GDFGLARLFD---------HGKI--------------------------------SHTTNVVGTIGYIAPELARTGKASC 528 (670)
Q Consensus 490 ~DFGla~~~~---------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ 528 (670)
.||||+.-+. .+.. ......+||+.|+|||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 9999985331 1100 0011257999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCCC
Q 035655 529 STDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 529 ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
.+|-||.||||+||+.|+.||..
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccC
Confidence 99999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=251.21 Aligned_cols=236 Identities=21% Similarity=0.293 Sum_probs=194.4
Q ss_pred cCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.+++.+..||-||||.|-+...... .+....|-.+|...+.|.||+|+--+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566678899999999988765442 234557889999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
|-|-||.|...|++++ .++.....-++..+.+|+.|||+ ++||.|||||+|++||.+|-+||.|||+|+....+
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999997654 58888888999999999999999 99999999999999999999999999999987665
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
..+-+.+||+.|.|||++.+...+...|.||||++++||++|+.||...+.- ..+-.-+ .-+|. .+++
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~IL-------kGid~---i~~P 641 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLIL-------KGIDK---IEFP 641 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHH-------hhhhh---hhcc
Confidence 3556789999999999999999999999999999999999999999874421 1111111 11111 2344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 615 (670)
....+...+|+...+..+|.+|-- +.+|-+|-+
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 445566778888888999999865 788888765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-28 Score=228.19 Aligned_cols=186 Identities=25% Similarity=0.369 Sum_probs=153.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.+.......||+|+||.|-+-++.. ..++...|+.+..+. ..|.+|.++|...+....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445556789999999886554322 346677888877665 6899999999999999999999
Q ss_pred eccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|.| ..||+.+-.+ ..+..+++..+-+|+..|.+||.|||+ +..++|||+||+|||++.+|++|+||||++..+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 4588877644 234578999999999999999999999 58899999999999999999999999999987655
Q ss_pred CCcceeeccccCcCCCCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELART----GKASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
.- ..+...|...|||||.+.. ..|+-|+||||||+.+.||.+++.||+.
T Consensus 202 Si--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 32 2233578899999998753 3688999999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=222.72 Aligned_cols=196 Identities=36% Similarity=0.576 Sum_probs=172.0
Q ss_pred EeeeCceeEEEeeccc-------------h----HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchh
Q 035655 370 IGTGGFGEVYKGVLPT-------------R----MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDS 432 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-------------~----~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 432 (670)
||+|.+|.||++.... . .+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6889999999998752 1 2568899999999999999999999999999999999999999999
Q ss_pred hcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeecCceeccCCCcceeecccc
Q 035655 433 LLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKISHTTNVVG 511 (670)
Q Consensus 433 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~g 511 (670)
++.... ..+++..+..++.+++++|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986543 368999999999999999999999 89999999999999999 89999999999987655321 1233467
Q ss_pred CcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHH
Q 035655 512 TIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590 (670)
Q Consensus 512 t~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 590 (670)
...|++||..... ..+.+.|+|++|+++++| ..+.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~~ 191 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PELK 191 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHHH
Confidence 8899999998877 788999999999999999 4577
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHh
Q 035655 591 QLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+++..|++.+|.+||++.++++++
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=226.87 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=184.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccc-cCceeeeeeeeecc--CeeEEEEe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRK--RDLLLVYD 423 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~~lV~E 423 (670)
..++|++.+++|+|.|+.|+.|+.-. ..+...+|+++|+.|+ ||||++|++...+. ....||+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 35689999999999999999987422 5678899999999998 99999999998765 56799999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGK 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~ 502 (670)
|..+.+..... ..|+...+.-.+.+++.||.|+|+ .||.|||+||.|+++|... ..+|+|+|+|..+..+.
T Consensus 116 ~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 116 YVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99998877664 357778888999999999999999 9999999999999999654 69999999999887654
Q ss_pred cceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-----HHHHHHhhcC----Ccccc
Q 035655 503 ISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-----DWVLEFQHLG----QVLDV 572 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-----~~~~~~~~~~----~~~~~ 572 (670)
. -...+.+..|.-||++-. ..|+..-|+|||||++.+|+..+.||-..+.+.. ..+....... +..-.
T Consensus 188 e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred e--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 2 223356778889998764 4678999999999999999999999965332211 1111111111 11111
Q ss_pred cCCCCCC---c--------ccH----H-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 573 VDPNLGS---S--------YVV----A-EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 573 ~d~~l~~---~--------~~~----~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+||++.. . +.. . ...+.++++...+..|-.+|||++|.++|
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 3333211 0 000 0 12456777888889999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=234.58 Aligned_cols=247 Identities=22% Similarity=0.347 Sum_probs=185.6
Q ss_pred ccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccccCceeeeeeeeecc-----CeeEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK-----RDLLL 420 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~~~l 420 (670)
.+..+.||-|+||.||...++.+ .+.+.+|+++|.-++|.|++..++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44568899999999998877652 35567899999999999999998876543 35789
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
+.|.|. .+|..+|-.. ..++-..+.-++.||++||.|||+ .+|.||||||.|.|+++|...||+|||+++..+.
T Consensus 135 ~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 999994 4787777543 468888888999999999999999 9999999999999999999999999999999888
Q ss_pred CCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHh-----------hcC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQ-----------HLG 567 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~-----------~~~ 567 (670)
+....++..+-|..|.|||++.+. .|+...||||.||++.||+-.+-.|+.... ...+.+.++. .++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 777778888889999999998875 589999999999999999998888865221 1111111111 111
Q ss_pred CcccccC-----CCCCCcc----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 568 QVLDVVD-----PNLGSSY----VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 568 ~~~~~~d-----~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....++. |.+.--| +..--.+...+...++..||++|.+..+.+.++..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111 1111000 00111233455667889999999999999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=228.38 Aligned_cols=229 Identities=25% Similarity=0.323 Sum_probs=177.5
Q ss_pred hcCccccceEeeeCceeEEEeeccchH-----HHHH--------------HHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTRM-----REFA--------------AEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~~-----~~f~--------------~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|...++||+|.|.+|..+++.+.. +-.+ .|-.+..+- +||.+|.|+.+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467899999999999999998876531 1122 233333333 69999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|.||.++|+|--++++. ..|+++..+-+...|+-||.|||+ .+|+.||||..|+|||.+|.+||.|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999998888654 359999999999999999999999 9999999999999999999999999999974322
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC-----CcchhHHHHHHHhhcCCcccccCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS-----DHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~-----~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
....+.+.+||+.|+|||++++..|....|-|++|++++||+.|+.||+- .+.+..++..+.....++ .
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-r---- 477 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-R---- 477 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-c----
Confidence 23445678999999999999999999999999999999999999999974 222333333332222111 0
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARP 605 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 605 (670)
.+.....+...+...-+++||.+|.
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111123344556677889998873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.95 Aligned_cols=273 Identities=23% Similarity=0.281 Sum_probs=201.2
Q ss_pred hhhhhccccccCCCccchhhHHHhhcCccccceEeeeCceeEEEeeccch---------------HHHHHHHHHHHhccc
Q 035655 337 QFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAAEIESLGRLR 401 (670)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~---------------~~~f~~Ei~~L~~l~ 401 (670)
..|..+++..++.|.....|.+. ..+|.+.++||-|.|++||++.+... .+.-..||++|++++
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~ 132 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVR 132 (590)
T ss_pred cccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHH
Confidence 34555677777788888888764 46899999999999999999987552 234568999999984
Q ss_pred -----c---Cceeeeeeeeecc----CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceE
Q 035655 402 -----H---KHLVNLQGWCKRK----RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469 (670)
Q Consensus 402 -----H---~nIv~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 469 (670)
| .+||+|+++|... ...|+|+|++ |.+|..+|....-+.++...+.+|++||+.||.|||++ .+|
T Consensus 133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgI 209 (590)
T KOG1290|consen 133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGI 209 (590)
T ss_pred hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCc
Confidence 2 5799999999754 4789999999 77999999877666799999999999999999999995 689
Q ss_pred EecccCCCcEEecCC-----------C-----------------------------------------------------
Q 035655 470 IHRDVKSGNVLIDAD-----------M----------------------------------------------------- 485 (670)
Q Consensus 470 vHrDIkp~NILld~~-----------~----------------------------------------------------- 485 (670)
||.||||+||||..+ +
T Consensus 210 IHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~ 289 (590)
T KOG1290|consen 210 IHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLA 289 (590)
T ss_pred cccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhc
Confidence 999999999997321 0
Q ss_pred --------------------------------------------------------------------------------
Q 035655 486 -------------------------------------------------------------------------------- 485 (670)
Q Consensus 486 -------------------------------------------------------------------------------- 485 (670)
T Consensus 290 ~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~ 369 (590)
T KOG1290|consen 290 GLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPS 369 (590)
T ss_pred ccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcC
Confidence
Q ss_pred ----------------------cEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHH
Q 035655 486 ----------------------NARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIA 543 (670)
Q Consensus 486 ----------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~ 543 (670)
+|||+|||-|.-..+ ..+.-..|.-|.|||++.+..|.+.+||||++|+++||+
T Consensus 370 s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELa 445 (590)
T KOG1290|consen 370 SPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELA 445 (590)
T ss_pred CccccccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhh
Confidence 022222222221111 111224678899999999999999999999999999999
Q ss_pred hCCCCCCCC-------cchhHHHHHH-------------------HhhcCCcccccCCCCC---------CcccHHHHHH
Q 035655 544 TGRRPIDSD-------HFILVDWVLE-------------------FQHLGQVLDVVDPNLG---------SSYVVAEMEL 588 (670)
Q Consensus 544 tG~~pf~~~-------~~~~~~~~~~-------------------~~~~~~~~~~~d~~l~---------~~~~~~~~~~ 588 (670)
||...|+.. +...++.+.+ +...+.+..+-.-+.. -+++.+++..
T Consensus 446 TGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~ 525 (590)
T KOG1290|consen 446 TGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQ 525 (590)
T ss_pred cCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHH
Confidence 999998751 1111111111 1122222222111111 2456778899
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 589 VLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 589 l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+.+++.-||+.+|++|||+.++++|-+-.
T Consensus 526 fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 526 FSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred HHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 99999999999999999999999986643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=277.46 Aligned_cols=200 Identities=17% Similarity=0.218 Sum_probs=144.7
Q ss_pred Hhcccc-Cceeeeeeee-------eccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce
Q 035655 397 LGRLRH-KHLVNLQGWC-------KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468 (670)
Q Consensus 397 L~~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 468 (670)
.++++| +||++++++| .+.+.++.++||+ +++|.++|.... ..+++.+++.++.||++||.|||+ ++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 456677 7899999988 2334678888987 669999996543 469999999999999999999998 99
Q ss_pred EEecccCCCcEEecCC-------------------CcEEEEeecCceeccCCCc---------------ceeeccccCcC
Q 035655 469 VIHRDVKSGNVLIDAD-------------------MNARLGDFGLARLFDHGKI---------------SHTTNVVGTIG 514 (670)
Q Consensus 469 ivHrDIkp~NILld~~-------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~ 514 (670)
|+||||||+||||+.. +.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666653211000 00112358889
Q ss_pred CCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHH
Q 035655 515 YIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594 (670)
Q Consensus 515 y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 594 (670)
|||||++.+..++.++|||||||+||||++|..|+.......... .. ...++... ........++.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~----~~-----~~~~~~~~-----~~~~~~~~~~~ 246 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL----RH-----RVLPPQIL-----LNWPKEASFCL 246 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH----HH-----hhcChhhh-----hcCHHHHHHHH
Confidence 999999999999999999999999999999988875322111111 00 01111111 11233467888
Q ss_pred hhccCCCCCCCCHHHHHHHhc
Q 035655 595 LCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 595 ~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+||+++|.+||++.|++++-.
T Consensus 247 ~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HhCCCChhhCcChHHHhhchh
Confidence 999999999999999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=246.07 Aligned_cols=181 Identities=26% Similarity=0.378 Sum_probs=158.6
Q ss_pred cCccccceEeeeCceeEEEeeccchH------------------------HHHHHHHHHHhccc---cCceeeeeeeeec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTRM------------------------REFAAEIESLGRLR---HKHLVNLQGWCKR 414 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~~------------------------~~f~~Ei~~L~~l~---H~nIv~l~g~~~~ 414 (670)
.+|...+.+|+|+||.|+.|+++... -....||++|.+|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 34788899999999999999886621 12337999999998 9999999999999
Q ss_pred cCeeEEEEeccC-CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 415 KRDLLLVYDYIP-NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 415 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
++.+||++|-.. +-+|.++|..+ ..+++.+..-|++||+.|+++||+ ++|||||||-+|+.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 999999999764 56899999654 459999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
.+.....+. -...+||.+|.|||++.+.+|- ..-|||++|++||-++....||.
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 997765543 3456899999999999998885 55899999999999999988875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=220.66 Aligned_cols=184 Identities=32% Similarity=0.497 Sum_probs=160.7
Q ss_pred ccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
|...+.||+|++|.||++.... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999997754 34578889999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999865432 28999999999999999999998 8999999999999999999999999999987755431122
Q ss_pred eccccCcCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 507 TNVVGTIGYIAPELA-RTGKASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=209.81 Aligned_cols=166 Identities=19% Similarity=0.159 Sum_probs=125.7
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.++. ..++|.+++.++.|++.||.|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 78999997543 469999999999999999999998 44 999999999999999 99998765422
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
..||+.|||||++.+..++.++|||||||++|||++|+.||...... ........... . ..++.-. ........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~--~-~~~~~~~-~~~~~~~~ 137 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGM--P-ADDPRDR-SNLESVSA 137 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHh--c-cCCcccc-ccHHHHHh
Confidence 26899999999999999999999999999999999999999753221 11111111000 0 0011100 11122222
Q ss_pred --HHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 588 --LVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 588 --~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+++..||+.+|.+||++.|+++++..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 58899999999999999999999998863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=216.54 Aligned_cols=236 Identities=21% Similarity=0.309 Sum_probs=174.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeee-eeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGW-CKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~-~~~~~~~~lV~E 423 (670)
.+.|.+.+.||+|.||.+-++.++. ..++|.+|...=-.| .|.||+.-++. |+..+.+.+++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3567888999999999999998765 457888888765555 48999987664 677788999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe-cC-CCcEEEEeecCceeccCC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI-DA-DMNARLGDFGLARLFDHG 501 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-d~-~~~~kL~DFGla~~~~~~ 501 (670)
|+|.|+|.+-+... .+.+....+++.|+++||.|+|+ +.+||||||.+|||+ +. ..++||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred cCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 99999999988553 47788888999999999999999 999999999999999 33 34899999999874332
Q ss_pred CcceeeccccCcCCCCcccccc---C--CCCccchhHHHHHHHHHHHhCCCCCCCC-cchhHHHHHHHhhcCCcccccCC
Q 035655 502 KISHTTNVVGTIGYIAPELART---G--KASCSTDVFAYGVLLLEIATGRRPIDSD-HFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~---~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~-~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
......-+..|.+||.... + ...+.+|||+||++++.++||+.||+.. .....-|.+..+..+... .-|
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--~~P 250 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--ALP 250 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--cCc
Confidence 1222344668999997643 3 2467899999999999999999999852 122233444444443332 122
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
+.-..+ .+.++++-..-+.++|++|-...++.+
T Consensus 251 ~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 251 KKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhhccc----CHHHHHHHHHhcCCcccccchhHHHHH
Confidence 222223 345566677788999999954444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=240.69 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=188.6
Q ss_pred hhcCccccceEeeeCceeEEEeeccch----------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
..++|+...++|.|.||.|||+++... .+-..+|+-+++..+||||+.++|-+-..+.++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788889999999999999987552 2334589999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
||.+|+|++.-+- ..++++.++...++..++||+|||+ .+=+|||||=.|||+++.+.+|++|||.+..+... .
T Consensus 93 ycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I 166 (829)
T ss_pred ecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh-h
Confidence 9999999998754 4579999999999999999999999 88899999999999999999999999998765432 2
Q ss_pred ceeeccccCcCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 504 SHTTNVVGTIGYIAPELA---RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.+.....||+.|||||+. +.+.|..++|||+.|+...|+---+.|..+.+.. . +..++..... -.|.+..
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r--~l~LmTkS~~---qpp~lkD- 239 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-R--ALFLMTKSGF---QPPTLKD- 239 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-H--HHHHhhccCC---CCCcccC-
Confidence 345667999999999975 4567899999999999999998877775432211 1 1111111110 1122211
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...-.+.+.+++..|+.++|++||+.+.+++|
T Consensus 240 -k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 -KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred -CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11223567889999999999999999887653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=222.19 Aligned_cols=242 Identities=22% Similarity=0.274 Sum_probs=180.2
Q ss_pred hcCccccceEeeeCceeEEEeecc---------c---------hHHHHHHHHHHHhccccCceeeeeeeeecc------C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP---------T---------RMREFAAEIESLGRLRHKHLVNLQGWCKRK------R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~---------~---------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~ 416 (670)
..+|...+.+|.|.- .|.-+.+. + ..+.-.+|...+..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 445555666776666 44433321 1 224455899999999999999999998533 4
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
+.|+|||+| ..+|...+. ..++.+.+..|..|+++|+.|||+ .+|+||||||+||++..+..+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 689999999 568888875 347888999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc-----
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD----- 571 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~----- 571 (670)
..+.. -..+..+.|..|.|||++.+..+.+..||||.||++.||++|+--|.+. ..+..|.+.....+..-.
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHH
Confidence 65543 3456678899999999999888999999999999999999999888742 223333322221111100
Q ss_pred ----------------------c-cCCCCC--CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 572 ----------------------V-VDPNLG--SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 572 ----------------------~-~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. .|.... .+.+........+++..||-.||++|-+.+++++|-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0 000000 011122345567888899999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-24 Score=225.24 Aligned_cols=258 Identities=23% Similarity=0.253 Sum_probs=194.7
Q ss_pred cCCCccchhhHHHhhcCccccceEeeeCceeEEEeeccchH---------------HHHHHHHHHHhccc------cCce
Q 035655 347 DCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRM---------------REFAAEIESLGRLR------HKHL 405 (670)
Q Consensus 347 ~~~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~~---------------~~f~~Ei~~L~~l~------H~nI 405 (670)
++..++.+.|+. -.+|.+....|+|-|++|.+|.+.... +.=+.|+++|++|+ ..++
T Consensus 419 EGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 419 EGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred cceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 445666666665 357888899999999999999875421 22348999999995 4689
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 484 (670)
++|+-.|...+.+|||+|-+ .-+|.+.|.+.+ +-.|....+..++.|+..||..|-. .+|+|.||||.|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence 99999999999999999987 569999997743 3458889999999999999999998 899999999999999976
Q ss_pred C-cEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc-chhHHHHHH
Q 035655 485 M-NARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH-FILVDWVLE 562 (670)
Q Consensus 485 ~-~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~-~~~~~~~~~ 562 (670)
. .+||||||-|.....+. .+...-+.-|.|||++.+-+|+...|+||.||.||||.||+-.|.+.. ..+..+..+
T Consensus 573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5 46999999998765543 222344567999999999999999999999999999999999997621 111111111
Q ss_pred Hh--------hcCC---------------------------cccccCC------CCC-----CcccHHHHHHHHHHHHhh
Q 035655 563 FQ--------HLGQ---------------------------VLDVVDP------NLG-----SSYVVAEMELVLQLGLLC 596 (670)
Q Consensus 563 ~~--------~~~~---------------------------~~~~~d~------~l~-----~~~~~~~~~~l~~l~~~C 596 (670)
+. ..+. ++..+.| .+. ..-.......+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 00 0000 0111111 000 111233456788899999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 035655 597 SHQKAEARPTMRQVLRY 613 (670)
Q Consensus 597 l~~dP~~RPs~~evl~~ 613 (670)
+..||.+|-+..|.|+|
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=218.93 Aligned_cols=185 Identities=28% Similarity=0.436 Sum_probs=154.9
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEE
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~l 420 (670)
...+.|..+++||+|.|++||++++.. ......+|+++|..+. +.||+++.+++..++..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 445678889999999999999998754 1245679999999995 8999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCceecc
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFD 499 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~~~~ 499 (670)
|+||++.....+++. .++..++...+..+..||.++|. ++||||||||+|+|.+.. ++-.|.|||||...+
T Consensus 113 vlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999888873 46788899999999999999999 999999999999999754 578999999997221
Q ss_pred CC--------------Cc-----------------------------ceeeccccCcCCCCcccccc-CCCCccchhHHH
Q 035655 500 HG--------------KI-----------------------------SHTTNVVGTIGYIAPELART-GKASCSTDVFAY 535 (670)
Q Consensus 500 ~~--------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~ 535 (670)
.. .. ......+||+||.|||++.. +..+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 00 00112479999999998764 567899999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 035655 536 GVLLLEIATGRRPIDS 551 (670)
Q Consensus 536 Gvvl~el~tG~~pf~~ 551 (670)
|+|++-+++++.||-.
T Consensus 265 GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeehhhcccccccc
Confidence 9999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=203.13 Aligned_cols=242 Identities=22% Similarity=0.214 Sum_probs=182.7
Q ss_pred CccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhcccc----Cceeeeeeee-eccCeeEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRH----KHLVNLQGWC-KRKRDLLL 420 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H----~nIv~l~g~~-~~~~~~~l 420 (670)
+|.+.++||+|+||.||++..... ...+..|+.++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999985431 1157789999999973 6888999888 47778899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-----CcEEEEeecCc
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-----MNARLGDFGLA 495 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-----~~~kL~DFGla 495 (670)
||+.+ +.+|.++........++..+.++|+.|++.+|.+||+ .+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 8899998766555689999999999999999999998 999999999999999865 46999999999
Q ss_pred e--eccCCCc-----c-e-eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh
Q 035655 496 R--LFDHGKI-----S-H-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH 565 (670)
Q Consensus 496 ~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~ 565 (670)
+ .+..... . . .....||..|.+++...+...+++.|+||++.++.|+..|..||...... ..........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3322111 1 1 22356999999999999999999999999999999999999999653221 1111111111
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.... .. .....+ ..+.++...+-..+..++|....+.+.|+..
T Consensus 255 ~~~~----~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 255 KLLT----DR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhcc----cc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1100 00 111122 3344444455568899999999999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-22 Score=193.72 Aligned_cols=233 Identities=20% Similarity=0.341 Sum_probs=181.0
Q ss_pred ccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 366 QSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
...+|.+..-|..|+|++.+ ..++|..|.-.|+-+.||||+.++|.|.....+.++..||+.||
T Consensus 194 l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34568888999999998865 23678899999999999999999999999999999999999999
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecc
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 509 (670)
|...|++...-..+..+..+++.++|+|++|||+- ++-|..--|.+..+++|++..++|+= +-+++.- .....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf-----qe~gr 346 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-----QEVGR 346 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee-----ecccc
Confidence 99999988877889999999999999999999983 34444556899999999999887631 1111110 11112
Q ss_pred ccCcCCCCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 510 VGTIGYIAPELARTGKAS---CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
.-.+.||+||.++..+-+ ..+|+|||.+++|||.|...||..-..-.. -+.+.-..++-..++...
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------gmkialeglrv~ippgis 415 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------GMKIALEGLRVHIPPGIS 415 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------hhhhhhccccccCCCCcc
Confidence 346789999998876543 579999999999999999999975221111 011112233344455556
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+|+.-|++.||.+||.+.+|+-.|++
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 678889999999999999999999988875
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-19 Score=181.45 Aligned_cols=187 Identities=24% Similarity=0.267 Sum_probs=130.4
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
+.+.|+|.+. ++.|+||++..++.|+++|+.|+++ ++|+|+|+|+|.... ..+||||||+++|..
T Consensus 22 w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~-------------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~ 86 (218)
T cd07308 22 WTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA-------------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEP 86 (218)
T ss_pred eEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccC-------------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 9999999997 8999999998899999999999976 579999999998763 568999999999865
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecC-Cccccc------ccccccccCCCccc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVN-SMKSIK------LEPAAYYENGTKED 194 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvn-s~~s~~------~~~~~~~~~~~~~~ 194 (670)
. ..|..+|. ....+-+||||||+.| . +-...+|.+-+| +..+.. ....+. -.
T Consensus 87 ~----~~g~~~G~-------~~~~~Glai~fdt~~n-~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~------c~ 145 (218)
T cd07308 87 G----SDGPLFGG-------PDKFKGLAIFFDTYDN-D---GKGFPSISVFLNDGTKSYDYETDGEKLELAS------CS 145 (218)
T ss_pred C----CCCccccc-------CCCCCEEEEEEEcCCC-C---CCCCCeEEEEEeCCCceecccCCCccccccc------ee
Confidence 3 23444554 2234569999999988 3 333344544333 211110 011000 11
Q ss_pred cccC-CCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEe
Q 035655 195 FTLE-SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFIL 273 (670)
Q Consensus 195 ~~l~-~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~ 273 (670)
+... ++++++++|.|+ .+.|.|.+..... ... .+-..++. ..+|+.+|+||||+||...+.|+|+
T Consensus 146 ~~~~~~~~~~~~~I~y~--~~~l~v~i~~~~~---------~~~--~~c~~~~~-~~l~~~~y~G~sA~tg~~~d~~dIl 211 (218)
T cd07308 146 LKFRNSNAPTTLRISYL--NNTLKVDITYSEG---------NNW--KECFTVED-VILPSQGYFGFSAQTGDLSDNHDIL 211 (218)
T ss_pred EecccCCCCeEEEEEEE--CCEEEEEEeCCCC---------CCc--cEEEEcCC-cccCCCCEEEEEeccCCCcCcEEEE
Confidence 2222 268999999999 6788888864321 111 12222221 1467889999999999999999999
Q ss_pred ccccc
Q 035655 274 GWSFS 278 (670)
Q Consensus 274 sW~fs 278 (670)
+|.+.
T Consensus 212 s~~~~ 216 (218)
T cd07308 212 SVHTY 216 (218)
T ss_pred EEEee
Confidence 99874
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=189.17 Aligned_cols=246 Identities=29% Similarity=0.402 Sum_probs=187.0
Q ss_pred ccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccC-ceeeeeeeeeccCeeEEEEeccC
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHK-HLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~-nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
|...+.||.|+|+.||++.... ....|.+|+.+++.+.|+ +|+++.+.+......++++|++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 5667889999999999997652 256788999999999988 79999999977777899999999
Q ss_pred CCCchhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCcc
Q 035655 427 NGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 427 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~~ 504 (670)
+++|.+++..... ..+.......++.|++.++.|+|+ .+++||||||+||+++... .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999977654432 268899999999999999999999 8899999999999999998 7999999999865543322
Q ss_pred -----eeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCC
Q 035655 505 -----HTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 505 -----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~ 575 (670)
......||..|++||.+.. ..+....|+|++|++++++++|..||...... ............... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cccc
Confidence 2356689999999999987 57889999999999999999999997654320 001111111111000 0001
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.............+.+++..|+..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111112223466788888999999999999987765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=201.51 Aligned_cols=151 Identities=21% Similarity=0.197 Sum_probs=119.4
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceee-eeeeeec
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVN-LQGWCKR 414 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~-l~g~~~~ 414 (670)
.....+|...+.||+|+||+||+|.... ..+.|.+|+++|++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3446789999999999999999996532 0234789999999999999985 4432
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEeccc-CCCcEEecCCCcEEEEeec
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV-KSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI-kp~NILld~~~~~kL~DFG 493 (670)
+..++||||+++++|... ... . ...++.|++++|.|||+ .+|+|||| ||+|||++.++++||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 111 1 14678999999999999 99999999 9999999999999999999
Q ss_pred CceeccCCCcc-------eeeccccCcCCCCccccccC
Q 035655 494 LARLFDHGKIS-------HTTNVVGTIGYIAPELARTG 524 (670)
Q Consensus 494 la~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 524 (670)
+|+........ ..+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99976543211 11356788999999988643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=214.03 Aligned_cols=238 Identities=21% Similarity=0.244 Sum_probs=178.5
Q ss_pred cccceEeeeCceeEEEeeccchH-----H-----------------HHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 365 KQSEVIGTGGFGEVYKGVLPTRM-----R-----------------EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~~~-----~-----------------~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
...+.+|.|.+|.|+........ + .+..|+.+=..|+|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999976655432211 1 1335666667789999998888888777666669
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++ +|...+... ..++..++..+++|++.|+.|||+ .+|.|||+|++|++++.++.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999998654 358888999999999999999999 999999999999999999999999999998765543
Q ss_pred c---ceeeccccCcCCCCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 503 I---SHTTNVVGTIGYIAPELARTGKASC-STDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 503 ~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
. ......+|+..|+|||++....|.+ -.||||.|+++..|++|+.||.........+ ..... ........-.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~-~~~~~~~~~~ 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNY-SDQRNIFEGP 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcc-ccccccccCh
Confidence 2 3445678999999999999999875 5899999999999999999986522111110 00000 0000000001
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
.........+...++..+++.+|.+|-++++|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1223344567788999999999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=198.94 Aligned_cols=216 Identities=24% Similarity=0.396 Sum_probs=163.8
Q ss_pred HhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCC
Q 035655 397 LGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476 (670)
Q Consensus 397 L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp 476 (670)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+... ...++|.....++++++.||.|||.. +-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 46789999999999999999999999999999999999764 45799999999999999999999992 3339999999
Q ss_pred CcEEecCCCcEEEEeecCceeccCC-CcceeeccccCcCCCCccccccC-------CCCccchhHHHHHHHHHHHhCCCC
Q 035655 477 GNVLIDADMNARLGDFGLARLFDHG-KISHTTNVVGTIGYIAPELARTG-------KASCSTDVFAYGVLLLEIATGRRP 548 (670)
Q Consensus 477 ~NILld~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~el~tG~~p 548 (670)
+|+++|..+.+||.|||+....... .........-..-|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431 11111222334579999998764 146789999999999999999999
Q ss_pred CCCCcchh--HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 549 IDSDHFIL--VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 549 f~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
|+...... .+.+..... .......|.+.... +....++.++..||..+|.+||++++|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 98622211 112222111 11222233322111 334468899999999999999999999998875533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=166.52 Aligned_cols=184 Identities=22% Similarity=0.309 Sum_probs=158.6
Q ss_pred CccccceEeeeCceeEEEeecc--------------chHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLP--------------TRMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~--------------~~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+|.+.++||+|.||..+.|..- ....++..|.+..+.|. .++|..++-+..++..-.||+|++ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 6888999999999999999642 24467888999998886 589999998888888889999998 7
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-----CcEEEEeecCceeccCCC
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-----MNARLGDFGLARLFDHGK 502 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-----~~~kL~DFGla~~~~~~~ 502 (670)
-||+|...- .+..++.+++..+|+|++.-++|+|+ +.+|.|||||+|.||..- ..+.++|||+|+.+....
T Consensus 108 PSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 108 PSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred cCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 899887643 34579999999999999999999999 999999999999999643 358999999999876543
Q ss_pred c------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 503 I------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 503 ~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
. ...+...||.+||+=....+.+.+.+.|+-|+|-|+++.+-|..||++
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 2 234557899999999999999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=161.67 Aligned_cols=171 Identities=19% Similarity=0.105 Sum_probs=130.5
Q ss_pred ccccceEeeeCceeEEEeeccch------------------HHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEec
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPTR------------------MREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~~------------------~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
+.+...|++|+||+||....++. ...|.+|+++|++|. |+++++++++ +..+++|||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 34567899999999997654331 124779999999996 4889999887 446999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEeccc-CCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV-KSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI-kp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
+++.+|.+.+.. ....++.|++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998764311 113578899999999999 99999999 79999999999999999999986554331
Q ss_pred c----e--------eeccccCcCCCCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCCC
Q 035655 504 S----H--------TTNVVGTIGYIAPELARTG-KAS-CSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 504 ~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
. . ..-...++.|+.|+...-- ..+ ...+-++-|+.+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 0112467889999854322 233 46788899999999999988753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-18 Score=164.16 Aligned_cols=243 Identities=20% Similarity=0.241 Sum_probs=178.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhcccc-CceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRH-KHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
...|...++||+|+||.+|.|..-. ...++.-|.++.+.|++ ..|..+..+..+.+.-.+||+..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 4578999999999999999997533 23467789999999986 67888888888888999999998
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceeccCCC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLFDHGK 502 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~~~~~ 502 (670)
+.||++...-.. ..++..+++-++-|++.-++|+|. ++++||||||+|.|..-+ .++.|+|||+|+.+....
T Consensus 94 -GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 -GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred -CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 789998875443 368999999999999999999998 999999999999998643 468999999998765432
Q ss_pred c------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 503 I------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 503 ~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
. .......||..|.+-....+...+.+.|+-|+|.+|..+--|..||++-......-..+... +.-+...-..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~-EkK~s~~ie~ 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS-EKKMSTPIEV 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH-HhhcCCCHHH
Confidence 1 22345689999998888878888999999999999999999999998732211110001000 1111111111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+...++ .++.-.+.-|-..--++-|...-+.+.
T Consensus 248 LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 248 LCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred HhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 222232 334445556777777788876555544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-18 Score=195.70 Aligned_cols=235 Identities=21% Similarity=0.220 Sum_probs=166.7
Q ss_pred CccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHH--hccccCceeeeeeeeeccCeeEEEEecc
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESL--GRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L--~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
++...+.||++.|=+|.+|.++. ..+.|.++++-+ ..++|||.+++.-+-......|+|-+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 45556777888777777766544 245666555444 4558999999999988888889999998
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee--ccCCCc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL--FDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~--~~~~~~ 503 (670)
.+ +|.|.|. .+.-+...+...|+.|++.||..+|. .+|+|+|||.+|||++.-.-+.|+||.--+- ...+..
T Consensus 104 kh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 104 KH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 54 8888884 34457888888999999999999998 9999999999999999998999999976542 122222
Q ss_pred ceee----ccccCcCCCCccccccC-----------CCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHH-Hhhc
Q 035655 504 SHTT----NVVGTIGYIAPELARTG-----------KASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLE-FQHL 566 (670)
Q Consensus 504 ~~~~----~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~-~~~~ 566 (670)
..-+ +.....+|+|||.+... ..+++-||||+||++.||++ |+.||+-.. +.++... ....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--L~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--LLAYRSGNADDP 255 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--HHhHhccCccCH
Confidence 2211 12334589999965431 25788999999999999998 788886311 1111000 0000
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+.+++.+ +-..+.++++.|++.||++|-++++.++.-.+
T Consensus 256 e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 256 EQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0111110 01246789999999999999999999987554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=168.14 Aligned_cols=196 Identities=24% Similarity=0.266 Sum_probs=137.4
Q ss_pred ccCceeeeeeeeec---------------------------cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHH
Q 035655 401 RHKHLVNLQGWCKR---------------------------KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453 (670)
Q Consensus 401 ~H~nIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 453 (670)
+|||||++.+.|.+ ...+|+||.-.+ .+|..|+..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999998732 235789988764 58999986543 455566779999
Q ss_pred HHHHhhhccccccceEEecccCCCcEEe--cCCC--cEEEEeecCceeccCCC-----cceeeccccCcCCCCccccccC
Q 035655 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLI--DADM--NARLGDFGLARLFDHGK-----ISHTTNVVGTIGYIAPELARTG 524 (670)
Q Consensus 454 ia~gL~yLH~~~~~~ivHrDIkp~NILl--d~~~--~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~ 524 (670)
+++|+.|||. ++|.|||+|++|||+ |++. ...|+|||++-.-+... ....-...|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999998 999999999999998 4443 57899999885433211 1122234677889999987543
Q ss_pred C--C----CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhcc
Q 035655 525 K--A----SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSH 598 (670)
Q Consensus 525 ~--~----t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 598 (670)
+ . -.|+|.|+.|.+.||++....||.....-..+.. ...+.--|.+ +..+...+.+++...++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-------~Yqe~qLPal----p~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-------TYQESQLPAL----PSRVPPVARQLVFDLLK 495 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-------hhhhhhCCCC----cccCChHHHHHHHHHhc
Confidence 2 1 3589999999999999999999976222111111 1111111222 22233456778888999
Q ss_pred CCCCCCCCHHHHHHHh
Q 035655 599 QKAEARPTMRQVLRYL 614 (670)
Q Consensus 599 ~dP~~RPs~~evl~~L 614 (670)
.||++||+..-....|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999976555544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-17 Score=166.76 Aligned_cols=158 Identities=16% Similarity=0.170 Sum_probs=122.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hH---------HHHHHHHHHHhccccCceeeeeeeeecc-
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RM---------REFAAEIESLGRLRHKHLVNLQGWCKRK- 415 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~---------~~f~~Ei~~L~~l~H~nIv~l~g~~~~~- 415 (670)
..++|+..+.+|.|+||.||+..... .. ..|.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 36789999999999999999864421 11 1267999999999999999998885532
Q ss_pred -------CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEE
Q 035655 416 -------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR 488 (670)
Q Consensus 416 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 488 (670)
+..++||||++|.+|.++.. ++. ....+++.+|..||+ .+++||||||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence 35899999999999988731 222 346699999999998 9999999999999999988 99
Q ss_pred EEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 035655 489 LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544 (670)
Q Consensus 489 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t 544 (670)
|+|||........... ..+.....+..++|+|+||+.+.-+..
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999988755332111 013334456679999999998876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=164.39 Aligned_cols=217 Identities=20% Similarity=0.264 Sum_probs=140.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcccc----------Cceeeeeeee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRH----------KHLVNLQGWC 412 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H----------~nIv~l~g~~ 412 (670)
..+...+.||.|+++.||.+++.. ..+++++|.-.+..+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 445667899999999999998754 35667777766655432 1222222221
Q ss_pred ---------eccC--------eeEEEEeccCCCCchhhccc---C--CccccCHHHHHHHHHHHHHHhhhccccccceEE
Q 035655 413 ---------KRKR--------DLLLVYDYIPNGSLDSLLFD---N--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470 (670)
Q Consensus 413 ---------~~~~--------~~~lV~E~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iv 470 (670)
.... +.+++|+-+ -++|.+++.- . ....+....++.+..|+++.+++||+ .+++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceE
Confidence 1111 347788877 5688887632 1 12345667778888999999999999 9999
Q ss_pred ecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCcccccc--------CCCCccchhHHHHHHHHHH
Q 035655 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART--------GKASCSTDVFAYGVLLLEI 542 (670)
Q Consensus 471 HrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~el 542 (670)
|+||||+|++++.+|.++|+||+.....+... .. ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998776544321 11 345678999997643 2578899999999999999
Q ss_pred HhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCC
Q 035655 543 ATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEAR 604 (670)
Q Consensus 543 ~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 604 (670)
.||+.||+..... ..+| .+ ..+. +.++.+..|+...|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999853211 0011 11 1233 556788889999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.3e-17 Score=158.54 Aligned_cols=126 Identities=19% Similarity=0.212 Sum_probs=96.8
Q ss_pred cceEeeeCceeEEEeeccch------------------------HHHH-----------------HHHHHHHhccccCce
Q 035655 367 SEVIGTGGFGEVYKGVLPTR------------------------MREF-----------------AAEIESLGRLRHKHL 405 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~~------------------------~~~f-----------------~~Ei~~L~~l~H~nI 405 (670)
...||+|+||.||+|..+.+ ...| ..|++.|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999986431 0112 239999999988776
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhc-cccccceEEecccCCCcEEecCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL-HEEWEQVVIHRDVKSGNVLIDAD 484 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDIkp~NILld~~ 484 (670)
.....+. ....++||||+++++|...+.. ...+++.+..+++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 4332221 1234899999999877655322 23688999999999999999999 56 7999999999999998 4
Q ss_pred CcEEEEeecCceeccC
Q 035655 485 MNARLGDFGLARLFDH 500 (670)
Q Consensus 485 ~~~kL~DFGla~~~~~ 500 (670)
+.++|+|||++....+
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=155.53 Aligned_cols=122 Identities=16% Similarity=0.222 Sum_probs=97.4
Q ss_pred ccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-----ccCceeeeeeeeeccC---e-eE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-----RHKHLVNLQGWCKRKR---D-LL 419 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-----~H~nIv~l~g~~~~~~---~-~~ 419 (670)
+...+.||+|+||.||. .+. ..+.+.+|+.+++++ .||||++++|+++++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 322 345789999999999 5799999999998863 3 34
Q ss_pred EEEec--cCCCCchhhcccCCccccCHHHHHHHHHHHHHHh-hhccccccceEEecccCCCcEEecC----CCcEEEEee
Q 035655 420 LVYDY--IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL-LYLHEEWEQVVIHRDVKSGNVLIDA----DMNARLGDF 492 (670)
Q Consensus 420 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDIkp~NILld~----~~~~kL~DF 492 (670)
+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +.+++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 6689999999553 35555 35678888787 99999 99999999999999974 348999995
Q ss_pred cCc
Q 035655 493 GLA 495 (670)
Q Consensus 493 Gla 495 (670)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-17 Score=175.41 Aligned_cols=173 Identities=25% Similarity=0.360 Sum_probs=130.4
Q ss_pred eeEEEEeccCCCCchhhcccC-CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 417 DLLLVYDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
.+++.|++|...+|.+||..+ .....+|...+++++|++.|+.| ++.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 589999999999999999743 34568899999999999999999 57899999999999999999999999998
Q ss_pred eeccCCC-----cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 496 RLFDHGK-----ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 496 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. -..+++ ..+..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--------------r~~t~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--------------RIATL 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--------------HHHhh
Confidence 7665544 334566799999999999999999999999999999999987 233322 11111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHH
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQV 610 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 610 (670)
.++-|..+...+..+.+ .=..++.+++.+.|.+||+..++
T Consensus 470 ~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 TDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 11212222111111111 12357778999999999954443
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-14 Score=146.32 Aligned_cols=195 Identities=17% Similarity=0.169 Sum_probs=122.4
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
+.+.|+|.+. ++.|+||++...+.|+++|+.|+++ .+|+|+|+|+|.+.....+||||||+++...
T Consensus 22 w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~-------------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~ 87 (248)
T cd06901 22 WDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYL-------------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKER 87 (248)
T ss_pred EEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccC-------------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCC
Confidence 9999999997 7799999998888999999999976 5799999999998766678999999999764
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCC-CCCCCCeeEEec-CCcccccccccccccCCCcc--cccc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNET-SDSQGNHVGINV-NSMKSIKLEPAAYYENGTKE--DFTL 197 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-~Dp~~~Hvgidv-ns~~s~~~~~~~~~~~~~~~--~~~l 197 (670)
. ..|..+|--+. -.=+||-|||+.| .+. .....+-|-+-+ ++...-....-+. ..... ....
T Consensus 88 ~----~~G~~fG~~~~-------f~Gl~I~~Dt~~n-~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~--~~~~~~C~~~~ 153 (248)
T cd06901 88 M----QPGPVFGSKDN-------FHGLAIFFDTYSN-QNGEHEHVHPYISAMVNNGSLSYDHDRDGT--HTELAGCSAPF 153 (248)
T ss_pred C----ccCcccccCCC-------CceEEEEEECCCC-CCCcccCCCceEEEEEcCCCeeecccCCCc--hhhcCceeeec
Confidence 2 23333343221 1127999999988 321 011112232222 2211100000000 00000 0112
Q ss_pred -CCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcc-cccccceeeEeecCCceeeeEEEecc
Q 035655 198 -ESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSP-AFQETMYVGFSASTGRKVSSHFILGW 275 (670)
Q Consensus 198 -~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~-~l~~~~~vGFsastg~~~~~h~i~sW 275 (670)
..+.+.+++|.|... .+.|.+...+. .. -...+ +... .||...|+||||+||...+.|+|++-
T Consensus 154 rn~~~~t~~rI~Y~~~--~l~v~vd~~~~--------~~-w~~Cf----~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv 218 (248)
T cd06901 154 RNKDHDTFVAIRYSKG--RLTVMTDIDGK--------NE-WKECF----DVTGVRLPTGYYFGASAATGDLSDNHDIISM 218 (248)
T ss_pred cCCCCCeEEEEEEECC--eEEEEEecCCC--------Cc-eeeeE----EeCCeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence 235667899999964 57676653221 00 01111 1222 46777999999999998899999886
Q ss_pred cccc
Q 035655 276 SFSM 279 (670)
Q Consensus 276 ~fs~ 279 (670)
.+..
T Consensus 219 ~~~~ 222 (248)
T cd06901 219 KLYE 222 (248)
T ss_pred EEec
Confidence 6654
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.5e-16 Score=151.12 Aligned_cols=127 Identities=20% Similarity=0.207 Sum_probs=98.5
Q ss_pred cceEeeeCceeEEEeeccch-----------------------------------------HHHHHHHHHHHhccccCce
Q 035655 367 SEVIGTGGFGEVYKGVLPTR-----------------------------------------MREFAAEIESLGRLRHKHL 405 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~~-----------------------------------------~~~f~~Ei~~L~~l~H~nI 405 (670)
...||+|++|.||+|....+ ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999986420 0012478899999999987
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
.....+... ..++||||++++++...... ...++..+..+++.|++.+|.+||+ +.+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 544333322 24899999998865443222 2357788999999999999999997 37999999999999999 89
Q ss_pred cEEEEeecCceeccC
Q 035655 486 NARLGDFGLARLFDH 500 (670)
Q Consensus 486 ~~kL~DFGla~~~~~ 500 (670)
.++|+|||++....+
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.3e-17 Score=177.14 Aligned_cols=170 Identities=27% Similarity=0.358 Sum_probs=143.6
Q ss_pred EeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCC
Q 035655 370 IGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
+|+|.||.|++..--. .......|-.++...+ ||.++++.-.++.+..++++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 5788888887643211 1113446778888887 99999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|.|...+.+.. .++..........++-++.++|+ .+++|||+|++||+++.+|.+++.|||+++..-..+..
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998886553 47777788888999999999998 99999999999999999999999999999866543322
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~ 551 (670)
+||..|||||++. ......|-||||++++||++|..||..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999988 456789999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.9e-16 Score=174.73 Aligned_cols=128 Identities=20% Similarity=0.272 Sum_probs=108.6
Q ss_pred HHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeec
Q 035655 357 LYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR 414 (670)
Q Consensus 357 l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 414 (670)
.......|...++||+|+||.||+|.+.. ..+.+.+|++++++++|++++....++..
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33444556778999999999999975432 11347789999999999999988888877
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
....++||||+++++|.+++. ...+++.+++++|.|||+ .+++||||||+|||+ .++.++|+|||+
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 778899999999999999874 456799999999999998 899999999999999 678999999999
Q ss_pred ceec
Q 035655 495 ARLF 498 (670)
Q Consensus 495 a~~~ 498 (670)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-15 Score=174.74 Aligned_cols=235 Identities=19% Similarity=0.189 Sum_probs=167.7
Q ss_pred HhhcCccccceEeeeCceeEEEeeccchH------------HHHHHHHHHHhccc---cCceeeeeeeeeccCeeEEEEe
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPTRM------------REFAAEIESLGRLR---HKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~~~------------~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~E 423 (670)
..-..|.+.+.||+|+||+||+|...++. =+|.--.+++.||+ -+-|..+.....-.+.-+||+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 34456888999999999999999876621 12333445566666 2334444444455677899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-------CCcEEEEeecCce
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-------DMNARLGDFGLAR 496 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-------~~~~kL~DFGla~ 496 (670)
|.+.|+|.+++. ..+.++|..+..++.|++..+..||. .+|||+||||+|.||.. +.-++|+|||.+-
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999996 44579999999999999999999999 99999999999999942 3458999999986
Q ss_pred eccC-CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 497 LFDH-GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 497 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
.+.- .....-+..++|-.+-.+|...+.+++++.|.|.++.+++-|+.|+..= ........+++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---------------~~~g~~~~~~~ 914 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---------------VKNGSSWMVKT 914 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---------------hcCCcceeccc
Confidence 4432 1123445668899999999999999999999999999999999987431 11111122233
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+..-...+....+..+++ ++|-..=|...++...|++
T Consensus 915 ~~~Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 915 NFPRYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEE 952 (974)
T ss_pred cchhhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHH
Confidence 2222223333444555444 4555555777777766653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=148.88 Aligned_cols=120 Identities=23% Similarity=0.365 Sum_probs=103.3
Q ss_pred ceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 368 EVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+.||+|++|.||+|...+ ....+.+|+.++..++|+++.....++...+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999996422 1134678999999999999988777777778899999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
++++|.+++... .+ .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998542 22 888999999999999999 8999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.5e-15 Score=145.21 Aligned_cols=116 Identities=22% Similarity=0.348 Sum_probs=96.6
Q ss_pred eEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 369 VIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.||+|+||.||+|.... ....+.+|++++..++|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999998422 12446689999999999876655555566677899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
+++|.+++..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998744211 789999999999998 9999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-13 Score=132.37 Aligned_cols=195 Identities=18% Similarity=0.208 Sum_probs=126.9
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
..+.|+|.+. ++.|+||++..++.|.++.+.|++. -+|+.+|+|+|.... ..+||||||.+....
T Consensus 24 W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~-------------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~ 88 (225)
T cd06902 24 WSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSF-------------ENWEVEVTFRVTGRG-RIGADGLAIWYTKER 88 (225)
T ss_pred eEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCC-------------CCEEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence 8899999996 8899999998999999999999963 469999999998653 357899999998754
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecC-CcccccccccccccCCCcc--cccc-
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVN-SMKSIKLEPAAYYENGTKE--DFTL- 197 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvn-s~~s~~~~~~~~~~~~~~~--~~~l- 197 (670)
. ..|..+|.-+. -.=+||.|||+.| .+ ..+...|-+-+| +.+......-.. ..... ....
T Consensus 89 ~----~~G~~~G~~~~-------f~Gl~I~~Dt~~n-~~--~~~~p~i~~~~NDGt~~yd~~~D~~--~~~~~~C~~~~r 152 (225)
T cd06902 89 G----EEGPVFGSSDK-------WNGVGIFFDSFDN-DG--KKNNPAILVVGNDGTKSYDHQNDGL--TQALGSCLRDFR 152 (225)
T ss_pred C----CCCCccCCCCc-------ccEEEEEEECCCC-CC--CCCCcEEEEEECCCCeeccccCCCc--ccccceEEEecc
Confidence 2 23444544222 1236999999987 22 223345544333 222111100000 00000 1122
Q ss_pred CCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcc-cccccceeeEeecCCceeeeEEEeccc
Q 035655 198 ESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSP-AFQETMYVGFSASTGRKVSSHFILGWS 276 (670)
Q Consensus 198 ~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~-~l~~~~~vGFsastg~~~~~h~i~sW~ 276 (670)
..+.+.+++|.|.. .+|.|.+..... +...-...-.++.. .||+..|+||||+||...+.|+|++|.
T Consensus 153 n~~~p~~~rI~Y~~--~~l~V~~d~~~~----------~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~ 220 (225)
T cd06902 153 NKPYPVRAKITYYQ--NVLTVSINNGFT----------PNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFL 220 (225)
T ss_pred CCCCCeEEEEEEEC--CeEEEEEeCCcC----------CCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEE
Confidence 23568999999988 468888763211 11111111223333 467889999999999999999999999
Q ss_pred ccc
Q 035655 277 FSM 279 (670)
Q Consensus 277 fs~ 279 (670)
+.+
T Consensus 221 ~~s 223 (225)
T cd06902 221 TFS 223 (225)
T ss_pred Eec
Confidence 863
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.2e-14 Score=139.61 Aligned_cols=130 Identities=21% Similarity=0.234 Sum_probs=101.1
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccch-------------------------------------HHHHHHHHHHHh
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPTR-------------------------------------MREFAAEIESLG 398 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~-------------------------------------~~~f~~Ei~~L~ 398 (670)
++......|...+.||+|+||.||++..+.+ ...+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3334444477789999999999999977421 012567889999
Q ss_pred ccccCc--eeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCC
Q 035655 399 RLRHKH--LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476 (670)
Q Consensus 399 ~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp 476 (670)
.+.|++ +.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 998874 4444443 355899999999999776421 2345788999999999999 8999999999
Q ss_pred CcEEecCCCcEEEEeecCceeccC
Q 035655 477 GNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 477 ~NILld~~~~~kL~DFGla~~~~~ 500 (670)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-14 Score=162.89 Aligned_cols=208 Identities=25% Similarity=0.295 Sum_probs=138.9
Q ss_pred hcCccccceEeeeCceeEEEeeccchHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCcc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF 440 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~ 440 (670)
..+|..++.|-.|+||.||..+++...+.|.. +++..|+|-= +.-..-+..+.| |+=...+....
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~------kiNkq~lilR-nilt~a~npfvv------gDc~tllk~~g-- 146 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM------KINKQNLILR-NILTFAGNPFVV------GDCATLLKNIG-- 146 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh------cccccchhhh-ccccccCCccee------chhhhhcccCC--
Confidence 45788899999999999999999888887764 2232222210 011111222333 33333332222
Q ss_pred ccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc--------------cee
Q 035655 441 VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI--------------SHT 506 (670)
Q Consensus 441 ~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~--------------~~~ 506 (670)
.++- +++.+++|||+ .+|+|||+||+|.+++.-|.+|+.|||+.+....... -..
T Consensus 147 ~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 147 PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 2332 22789999999 9999999999999999999999999999875432110 112
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
+.++||+.|.|||++....|..-.|-|++|+|+||.+-|+.||.++-. .+...+.. ......+. |+.+
T Consensus 216 KqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--d~i~wpE~-dea~-------- 284 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--DDIEWPEE-DEAL-------- 284 (1205)
T ss_pred ccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh--hhcccccc-CcCC--------
Confidence 346899999999999988999999999999999999999999987522 22221111 11111111 2222
Q ss_pred HHHHHHHHHhhccCCCCCCC
Q 035655 586 MELVLQLGLLCSHQKAEARP 605 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RP 605 (670)
..+..+++...++.+|.+|-
T Consensus 285 p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhc
Confidence 23455666777889999984
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.3e-14 Score=142.68 Aligned_cols=128 Identities=21% Similarity=0.275 Sum_probs=99.5
Q ss_pred CccccceEeeeCceeEEEee-c-cc-----------hH----------------------------HHHHHHHHHHhccc
Q 035655 363 GFKQSEVIGTGGFGEVYKGV-L-PT-----------RM----------------------------REFAAEIESLGRLR 401 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~-~-~~-----------~~----------------------------~~f~~Ei~~L~~l~ 401 (670)
.|++.+.||+|++|.||+|+ . .. .. ..+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 2 11 00 12457999999997
Q ss_pred cCc--eeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce-EEecccCCCc
Q 035655 402 HKH--LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV-VIHRDVKSGN 478 (670)
Q Consensus 402 H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDIkp~N 478 (670)
+.. +.+++++ ...++||||+++++|...+... ..+...+...++.|++.+|.+||+ .+ ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 633 4444543 2358999999998887765332 245666778999999999999999 88 9999999999
Q ss_pred EEecCCCcEEEEeecCceeccC
Q 035655 479 VLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 479 ILld~~~~~kL~DFGla~~~~~ 500 (670)
|+++ +++++|+|||.+....+
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999875443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.3e-13 Score=128.03 Aligned_cols=123 Identities=22% Similarity=0.209 Sum_probs=105.3
Q ss_pred ccceEeeeCceeEEEeeccc----------h--HHHHHHHHHHHhcccc--CceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 366 QSEVIGTGGFGEVYKGVLPT----------R--MREFAAEIESLGRLRH--KHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~----------~--~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
+.+.||+|.++.||++...+ . ...+.+|+..++.++| .+++++++++...+..++++||++++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 35789999999999987632 1 2478999999999987 59999999988888999999999988776
Q ss_pred hhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 432 SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 432 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 82 ~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 5567788999999999999985445899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-14 Score=165.15 Aligned_cols=240 Identities=23% Similarity=0.255 Sum_probs=177.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~l 420 (670)
...|...+.||+|.|+.|-...... .......|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677789999999987654422 1122224777777776 9999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcc-ccccceEEecccCCCcEEecCCC-cEEEEeecCceec
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH-EEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLF 498 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~ 498 (670)
+.||..++++.+-+........+....-..+.|+..++.|+| + .++.||||||+|.+++..+ ..|++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999884222224556667789999999999999 6 8999999999999999999 9999999999877
Q ss_pred cC--CCcceeecccc-CcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 499 DH--GKISHTTNVVG-TIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 499 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~----------~~~~~~ 245 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR----------YSSWKS 245 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----------ceeecc
Confidence 66 33333445678 9999999998874 4467899999999999999999998753221111 011111
Q ss_pred CC--CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 575 PN--LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 575 ~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. ..............++...++..+|..|.+.+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 10 0011112223445677778888999999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.9e-13 Score=136.53 Aligned_cols=203 Identities=20% Similarity=0.308 Sum_probs=141.8
Q ss_pred HHHhccccCceeeeeeeeecc-----CeeEEEEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccc
Q 035655 395 ESLGRLRHKHLVNLQGWCKRK-----RDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467 (670)
Q Consensus 395 ~~L~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 467 (670)
.-|-.+-|.|||+++.|+.+. .+..++.|||+.|+|..+|++- ....+......+++.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 445566799999999987644 3578999999999999999763 23457888889999999999999998 679
Q ss_pred eEEecccCCCcEEecCCCcEEEEeecCceecc---CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 035655 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFD---HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544 (670)
Q Consensus 468 ~ivHrDIkp~NILld~~~~~kL~DFGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t 544 (670)
.|+|+++..+.|++..++-+|++----..... ...........+-++|.+||+-.....+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999999885322111100 000111222356789999998887788889999999999999988
Q ss_pred CCCC-CCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 545 GRRP-IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 545 G~~p-f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+.-- -........+- . ..+..-.....+ -...+..|++..|..||+|++++.|.
T Consensus 278 lEiq~tnseS~~~~ee----~-ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEE----N-IANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhh----h-hhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 6543 22211111100 0 000100011111 12355679999999999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=132.16 Aligned_cols=100 Identities=25% Similarity=0.228 Sum_probs=80.7
Q ss_pred HHHHHHHHHHhccccCce--eeeeeeeeccC----eeEEEEeccCC-CCchhhcccCCccccCHHHHHHHHHHHHHHhhh
Q 035655 388 REFAAEIESLGRLRHKHL--VNLQGWCKRKR----DLLLVYDYIPN-GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H~nI--v~l~g~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~y 460 (670)
..+.+|++++.+|+|++| ++.++++.... ..++|+|++++ .+|.+++.+. .++.. .+.+++.+|.+
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~ 157 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIAR 157 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHH
Confidence 346789999999999885 67777654332 23599999997 6998887542 34443 36789999999
Q ss_pred ccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 461 LH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
||+ .+|+||||||.|||++.++.++|+|||.+..
T Consensus 158 lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 158 FHD---AGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHH---CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999 9999999999999999999999999998875
|
|
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.4e-11 Score=116.81 Aligned_cols=184 Identities=20% Similarity=0.248 Sum_probs=117.4
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
..+.|+|.+. ++.|+||++ .++.|.++-+.|+++- .+|..+|+|+|..+. ..+||||||.+...+
T Consensus 23 W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~------------~~w~ie~~Fri~G~~-~~~gdGla~W~t~~~ 87 (215)
T cd06903 23 WQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLK------------DEWTIEWTFRSTGPE-GRSGGGLNFWLVKDG 87 (215)
T ss_pred eEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCC------------CCEEEEEEEEecccC-CcCCCEEEEEEECCC
Confidence 8999999997 889999999 9999999999999761 179999999998653 378999999998654
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccccccccccCCCcc--ccc-cC
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKE--DFT-LE 198 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~~~~--~~~-l~ 198 (670)
..+.+ ....|-.+. .+ =+||.|||+.| . .| .+.++--++-....... . . ..... .+. ..
T Consensus 88 ~~~~g--~~~fG~~~~---f~----Gl~I~~Dt~~n-~---~p--~i~~~~NDGt~~yd~~~-d-~-~~~~g~C~~~~rn 149 (215)
T cd06903 88 NADVG--TSSIYGPSK---FD----GLQLLIDNNGG-S---GG--SLRGFLNDGSKDYKNED-V-D-SLAFGSCLFAYQD 149 (215)
T ss_pred cccCC--ccccCCCCC---Cc----EEEEEEECCCC-C---Cc--eEEEEECCCCeeccccC-C-c-ccccceeeEeccC
Confidence 32111 022222111 11 16999999976 1 12 12222222322111111 0 0 00000 011 23
Q ss_pred CCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccc-cccCCccccc-ccceeeEeecCCceeeeEEEeccc
Q 035655 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLS-LPLDLSPAFQ-ETMYVGFSASTGRKVSSHFILGWS 276 (670)
Q Consensus 199 ~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls-~~~dl~~~l~-~~~~vGFsastg~~~~~h~i~sW~ 276 (670)
.+.+.+++|.|....+.|.|.+.. . ..+. ..+ .|| .-.|+||||+||...+.|+|++-.
T Consensus 150 ~~~p~~iri~Y~~~~~~l~v~vd~--~-------------~Cf~~~~v----~lP~~~y~fGiSAaTg~~~d~hdIl~~~ 210 (215)
T cd06903 150 SGVPSTIRLSYDALNSLFKVQVDN--R-------------LCFQTDKV----QLPQGGYRFGITAANADNPESFEILKLK 210 (215)
T ss_pred CCCCEEEEEEEECCCCEEEEEECC--C-------------EEEecCCe----ecCCCCCEEEEEEcCCCCCCcEEEEEEE
Confidence 567899999999877788888742 1 1111 112 345 456799999999999999999865
Q ss_pred c
Q 035655 277 F 277 (670)
Q Consensus 277 f 277 (670)
+
T Consensus 211 ~ 211 (215)
T cd06903 211 V 211 (215)
T ss_pred E
Confidence 4
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.3e-12 Score=122.54 Aligned_cols=124 Identities=23% Similarity=0.273 Sum_probs=86.5
Q ss_pred cceEeeeCceeEEEeeccch-----------------HHHH----------------------HHHHHHHhccccCc--e
Q 035655 367 SEVIGTGGFGEVYKGVLPTR-----------------MREF----------------------AAEIESLGRLRHKH--L 405 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~~-----------------~~~f----------------------~~Ei~~L~~l~H~n--I 405 (670)
.+.||+|+||.||++....+ ...+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999987621 0111 24555555554432 3
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
.+.++. ...++||||++++.+......... .. .+..+++.+++.++.++|. +.+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 333332 246899999999654322111100 11 5678899999999999997 37899999999999999 89
Q ss_pred cEEEEeecCceeccC
Q 035655 486 NARLGDFGLARLFDH 500 (670)
Q Consensus 486 ~~kL~DFGla~~~~~ 500 (670)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.4e-10 Score=113.91 Aligned_cols=196 Identities=22% Similarity=0.275 Sum_probs=116.4
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
..+.|+|.+. ++.|+||++.+++.|.++.+.|++. .+|+.+|+|+|.......+||||||.+....
T Consensus 24 W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~-------------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~ 89 (229)
T PF03388_consen 24 WDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPF-------------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDP 89 (229)
T ss_dssp EEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEE-------------SEEEEEEEEEEESS-SSS-S-EEEEEEESSS
T ss_pred EEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCc-------------cCEEEEEEEEEeccccCcCCCeEEEEEEcCc
Confidence 8999999998 9999999999999999999999976 4699999999998755668999999998654
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCC-CCCCCeeEEecC-CcccccccccccccCCCcc--cccc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETS-DSQGNHVGINVN-SMKSIKLEPAAYYENGTKE--DFTL 197 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~-Dp~~~Hvgidvn-s~~s~~~~~~~~~~~~~~~--~~~l 197 (670)
.. .|..+|.-+.- .=+||=||||.| .+.. .-....|.+-+| +-.......-+. ..... ....
T Consensus 90 ~~----~G~~fG~~~~f-------~Gl~i~idt~~N-~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~--~~~~~~C~~~~ 155 (229)
T PF03388_consen 90 GS----DGPVFGGPDKF-------DGLGIFIDTYDN-DEGGHKRGFPYISAMLNDGTKSYDHDNDGK--DQSLGSCSADY 155 (229)
T ss_dssp SS----SCSBTTB-SS--------EEEEEEEEES-T-TCTTCTSTSSEEEEEEEESSS---GGGTTT--TT-SEEEE---
T ss_pred cc----cccccCCCccc-------ceEEEEEEcccC-CCcccccccceEEEEecCCCccccccccCc--ccccccceecc
Confidence 32 44555542211 126899999988 3311 122344544444 211111110000 00111 1122
Q ss_pred C-CCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEeccc
Q 035655 198 E-SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWS 276 (670)
Q Consensus 198 ~-~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~ 276 (670)
. .+.+.+++|.|... .+.|.+...-.+. ...-...+... .-.||+..|+||||+||...+.|+|++-.
T Consensus 156 rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~------~~~~~~Cf~~~---~v~LP~~~yfGvSA~Tg~~~d~hdi~s~~ 224 (229)
T PF03388_consen 156 RNSDVPTRIRISYSKN--TLTVSIDSNYLKN------QDDWELCFTTD---GVDLPEGYYFGVSAATGELSDNHDILSVK 224 (229)
T ss_dssp BTESSEEEEEEEEETT--EEEEEEETSCCSE------CCTTEEEEEES---TEEGGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred CcCCCCEEEEEEEECC--eEEEEEecccccC------CcCCcEEEEcC---CeecCCCCEEEEEecCCCCCCcEEEEEEE
Confidence 2 35678999999875 5666664210000 01111222211 12467889999999999999999998743
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.8e-11 Score=132.24 Aligned_cols=232 Identities=21% Similarity=0.279 Sum_probs=167.7
Q ss_pred CccccceEee--eCceeEEEeec--cchH------------------HHHHHHHHHHhccc-cCceeeeeeeeeccCeeE
Q 035655 363 GFKQSEVIGT--GGFGEVYKGVL--PTRM------------------REFAAEIESLGRLR-HKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 363 ~f~~~~~lG~--G~fg~Vykg~~--~~~~------------------~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~ 419 (670)
.|...+.+|. |.+|.||.+.. +... ..=.+|+....+++ |+|.++....+.+.+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999877 3311 11125666666664 899999888888899999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHH----HhhhccccccceEEecccCCCcEEecCC-CcEEEEeecC
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA----GLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGL 494 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGl 494 (670)
+-.|++ +.+|..+.+.... .++....+....+..+ ||.++|+ ..++|-|+||.||++..+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999988 5788888765432 3666777778888888 9999999 999999999999999999 8999999999
Q ss_pred ceeccCCCc----ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcc
Q 035655 495 ARLFDHGKI----SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVL 570 (670)
Q Consensus 495 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~ 570 (670)
...+..... .......|...|++||... +.++..+|+|++|.+++|..++..+..... ...|. ..+..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~--~~r~~--- 341 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK--NSSWS--QLRQG--- 341 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC--CCCcc--ccccc---
Confidence 988766542 1223346888999999765 567889999999999999999877654321 01121 00000
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
. +..++...-...+...+..+++.+|..|++.+.+..
T Consensus 342 --~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 111111111223344777889999999999888776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-10 Score=123.36 Aligned_cols=165 Identities=19% Similarity=0.243 Sum_probs=127.2
Q ss_pred eEeeeCceeEEEeeccch--HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHH
Q 035655 369 VIGTGGFGEVYKGVLPTR--MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446 (670)
Q Consensus 369 ~lG~G~fg~Vykg~~~~~--~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~ 446 (670)
....|++-.|+....... .....+-++.|+.||||||++++...+..+..|||.|-+. .|..++.+ +....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence 445677888887776666 4556788999999999999999999999999999999873 56666643 33556
Q ss_pred HHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCC
Q 035655 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526 (670)
Q Consensus 447 ~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 526 (670)
..-.+.||+.||.+||+. ..++|++|....|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 667889999999999973 7899999999999999999999999998864433221 111112223566777544322
Q ss_pred CccchhHHHHHHHHHHHhC
Q 035655 527 SCSTDVFAYGVLLLEIATG 545 (670)
Q Consensus 527 t~ksDV~S~Gvvl~el~tG 545 (670)
...|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-10 Score=124.93 Aligned_cols=104 Identities=19% Similarity=0.231 Sum_probs=72.4
Q ss_pred HHHHHHHHhccc----cCceeeeeeee-eccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHH-Hhhhccc
Q 035655 390 FAAEIESLGRLR----HKHLVNLQGWC-KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAA-GLLYLHE 463 (670)
Q Consensus 390 f~~Ei~~L~~l~----H~nIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 463 (670)
|..|...+.+++ |.+-+.+-..+ ......+|||||++|++|.++...... .. .+.+++.+++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh
Confidence 334555555553 32223333333 224567999999999999987643211 12 23456666666 4677887
Q ss_pred cccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 464 ~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
.+++|+|+||.||+++.+++++++|||++.....
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-09 Score=103.88 Aligned_cols=117 Identities=21% Similarity=0.164 Sum_probs=85.2
Q ss_pred cceEeeeCceeEEEeeccc----------h---HHHHHHHHHHHhccccCcee-eeeeeeeccCeeEEEEeccCCCCchh
Q 035655 367 SEVIGTGGFGEVYKGVLPT----------R---MREFAAEIESLGRLRHKHLV-NLQGWCKRKRDLLLVYDYIPNGSLDS 432 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~----------~---~~~f~~Ei~~L~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 432 (670)
.+.|+.|.++.||+..... . ...+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 4567888888888875432 1 23467899999999766554 4554432 34589999999988865
Q ss_pred hcccCCccccCHHHHHHHHHHHHHHhhhccccc--cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 433 LLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW--EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 433 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.- . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 81 ~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 31 0 11245789999999999832 22369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-08 Score=95.33 Aligned_cols=129 Identities=19% Similarity=0.231 Sum_probs=99.6
Q ss_pred ccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 366 QSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
....|-+|+-+.|+++.+.. ..+.-++|++.|.+++--.|.--.-++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46788899999999887654 23556789999999876555544445566677789999
Q ss_pred ccCC-CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEEeecCcee
Q 035655 424 YIPN-GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDFGLARL 497 (670)
Q Consensus 424 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DFGla~~ 497 (670)
|+++ -++.+++..........+....++++|-+.+.-||. ..++|+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 478888866543333334447899999999999999 9999999999999997665 458999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-09 Score=115.57 Aligned_cols=233 Identities=21% Similarity=0.210 Sum_probs=160.1
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc-------------hHHHHH------HHHHHHhcc-ccCceeeeeeeeeccCe
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFA------AEIESLGRL-RHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~------~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 417 (670)
..-+.+|..+..||.|.|+.|++..... ....+. .|+.+...+ .|.+++++...+...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3445678899999999999999865321 111222 455555555 48888887777777777
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCce
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLAR 496 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~ 496 (670)
.++=-||++++++...+ .-...+....++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||++.
T Consensus 341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence 78999999999887766 223457888899999999999999998 999999999999999876 888999999986
Q ss_pred eccCCCcceeeccccCcCCC--CccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 497 LFDHGKISHTTNVVGTIGYI--APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
.+.-.. ......-+++ +|+......+-.+.|+||||.-+.|.+++..--... ..| ..+..-.-
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~-------~~i~~~~~ 480 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQS-------LTIRSGDT 480 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc----ccc-------eeeecccc
Confidence 422111 1112223333 566666677889999999999999999876542211 111 11111112
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.+.+.. +.+..+...+..+++..||...+...+..
T Consensus 481 p~~~~~~-----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 PNLPGLK-----LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cCCCchH-----HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 2222211 33445556677899999999888776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.1e-08 Score=94.82 Aligned_cols=98 Identities=20% Similarity=0.189 Sum_probs=74.8
Q ss_pred HHHHHHhcccc--CceeeeeeeeeccCeeEEEEeccCCCCchh-hcccCCccccCHHHHHHHHHHHHHHhhhc-cccccc
Q 035655 392 AEIESLGRLRH--KHLVNLQGWCKRKRDLLLVYDYIPNGSLDS-LLFDNENFVLSWEQRFNIIKGIAAGLLYL-HEEWEQ 467 (670)
Q Consensus 392 ~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~ 467 (670)
+|++.|+++.. -++.+.+++ ...+|||||+.+..+.. .+.+ ..++..+..++..+++.+|..| |. .
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~ 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---C 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---C
Confidence 89999999964 455666654 56789999997654422 2211 2345556778889999999999 76 8
Q ss_pred eEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 468 ~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
+++|+||++.|||++ ++.+.|+|||.+....+
T Consensus 145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999999999997 46899999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=113.14 Aligned_cols=76 Identities=14% Similarity=0.182 Sum_probs=54.8
Q ss_pred cCeeEEEEeccCCCCchhh--cccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----c
Q 035655 415 KRDLLLVYDYIPNGSLDSL--LFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----N 486 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~--l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~ 486 (670)
....+|||||++|+.|.++ +...+ ...+.......++.|+. . .+++|+|+||.||+++.++ +
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~---~GffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R---DGFFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h---CCeeeCCCChHHeEEecCCCCCCe
Confidence 3457899999999999874 22211 11233333444444443 2 7899999999999999988 9
Q ss_pred EEEEeecCceeccC
Q 035655 487 ARLGDFGLARLFDH 500 (670)
Q Consensus 487 ~kL~DFGla~~~~~ 500 (670)
+++.|||+......
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.1e-08 Score=94.02 Aligned_cols=97 Identities=20% Similarity=0.297 Sum_probs=79.7
Q ss_pred HHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc
Q 035655 388 REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 467 (670)
..-.+|+.+|.+++--.|..-.=+..+.....|+|||.++-.|.+.+... +..++..|-.-+.-||. .
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~ 111 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK---A 111 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---c
Confidence 34558999999987665555555556778889999999999999888554 25678888888889998 9
Q ss_pred eEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 468 VVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 468 ~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
+|+|+||.++||++..+. +.++||||+..
T Consensus 112 givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999999998765 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.2e-08 Score=96.14 Aligned_cols=127 Identities=22% Similarity=0.235 Sum_probs=98.2
Q ss_pred ceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhcccc--CceeeeeeeeeccC---eeEEEEeccC
Q 035655 368 EVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRH--KHLVNLQGWCKRKR---DLLLVYDYIP 426 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~---~~~lV~E~~~ 426 (670)
+.|+.|..+.||+....+ ....+..|+++++.+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 567788888888865432 13467899999999976 34677888776643 5689999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc------------------------------------------
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE------------------------------------------ 464 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------ 464 (670)
+.++.+.+.. ..++..++..++.++++.|..||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9998886532 2467788888899999999999852
Q ss_pred -----------ccceEEecccCCCcEEecC--CCcEEEEeecCcee
Q 035655 465 -----------WEQVVIHRDVKSGNVLIDA--DMNARLGDFGLARL 497 (670)
Q Consensus 465 -----------~~~~ivHrDIkp~NILld~--~~~~kL~DFGla~~ 497 (670)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 56789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=89.19 Aligned_cols=186 Identities=17% Similarity=0.209 Sum_probs=122.1
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
..+.|.+.+. +.-++||.+..++.|.++=.+||.. -+|.-.+.|.+..+.....|||||+..+-..
T Consensus 74 W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s-------------~~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er 139 (351)
T KOG3839|consen 74 WNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFS-------------RDWEVLVHFKVHGQSKNLFGDGMAIWYTKER 139 (351)
T ss_pred ccccccEEEE-eeeeeccccccccccccccCCCccc-------------cceeEEEEEEEecCCCcccccceEEEeeccc
Confidence 7888999998 6779999999999999999999964 3599999999998877889999999998654
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCee----EEecCCcccccccccccccCCCcc----
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHV----GINVNSMKSIKLEPAAYYENGTKE---- 193 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hv----gidvns~~s~~~~~~~~~~~~~~~---- 193 (670)
.. .|..+|-++.- +-+||=.|||.|. + + | ..|| .+.+|- -+.+|+-..+-.
T Consensus 140 ~q----~GPvFG~~dkF-------~GL~vfidtY~n~-~-g-~-~~~v~P~isvmv~~------gs~sYD~~~Dg~~tel 198 (351)
T KOG3839|consen 140 AQ----PGPVFGSKDKF-------TGLAVFIDTYGNH-N-G-P-HEHVFPYISVMVNI------GSLSYDHSKDGTHTEL 198 (351)
T ss_pred cc----CCCCCCCcccc-------eeEEEEEeccCCc-C-C-C-cccceeeEEEEecc------CCcccccCCCCCcccc
Confidence 33 44555554332 3479999999772 2 1 1 2222 222211 111121000000
Q ss_pred ---ccccCCC-CcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccc-ccccceeeEeecCCceee
Q 035655 194 ---DFTLESG-DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPA-FQETMYVGFSASTGRKVS 268 (670)
Q Consensus 194 ---~~~l~~g-~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~-l~~~~~vGFsastg~~~~ 268 (670)
...+++. -.-..-|.|+. ++|++.....+. . ....-.++..+ ||.--|+|+||+||...+
T Consensus 199 ~gc~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~~-----------~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd 263 (351)
T KOG3839|consen 199 AGCTANFRNLPHDTLVVIRYEK--KTLSISIDLEGP-----------N--EWIDCFSLNNVELPLGYFFGVSASTGDLSD 263 (351)
T ss_pred ccceeeeccCCCcceeEEEecC--CceEEEEecCCC-----------c--eeeeeeeecceecccceEEeeeeccCccch
Confidence 0111111 12356788887 566666554332 2 23444566664 677789999999999999
Q ss_pred eEEEecccc
Q 035655 269 SHFILGWSF 277 (670)
Q Consensus 269 ~h~i~sW~f 277 (670)
.|.|.|-.+
T Consensus 264 ~HdivS~kl 272 (351)
T KOG3839|consen 264 SHDIVSLKL 272 (351)
T ss_pred hhHHHHhhh
Confidence 999988665
|
|
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-06 Score=84.34 Aligned_cols=203 Identities=20% Similarity=0.225 Sum_probs=113.3
Q ss_pred CCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcc
Q 035655 53 SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHY 131 (670)
Q Consensus 53 ~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~ 131 (670)
+|.||||+...+++|-+.|.++++--+ --...+|.+..-.. ...+|||+||||+-..- ...+..||-
T Consensus 31 ~g~LRLT~~~~nqata~~~~~~FPs~~-----------n~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGs 98 (255)
T cd06900 31 NNRLRLTDASGNQATAVTLQRLFPSAG-----------NYVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGS 98 (255)
T ss_pred cCeEEeccCccCcceeEEEeeeeccCC-----------CeEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcc
Confidence 689999999999999999999987511 12666777766544 56789999999984332 235778999
Q ss_pred cccccCCC-CCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc---ccc-cccccccc-CCCccc-cccC------
Q 035655 132 LGILNSTN-DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK---SIK-LEPAAYYE-NGTKED-FTLE------ 198 (670)
Q Consensus 132 lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~---s~~-~~~~~~~~-~~~~~~-~~l~------ 198 (670)
||+--++. ......-.++|-||-|-|+....|....-.|---++|. |-. +..-.|.. +....+ .+..
T Consensus 99 LGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~gt~~~~~~id~~~~~~~~ 178 (255)
T cd06900 99 LGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITGTGVLPPGIDNNSTSTPA 178 (255)
T ss_pred cccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecccCCCCcccccCCCCCCC
Confidence 99976642 22234557899999987742212221111222222221 111 11111111 111111 1111
Q ss_pred CCCcEEEEEEec-CcccEEEEEEeecCCcccccccCCCCCCcccc--cccCCc--ccccccceeeEeecCCceeeeEEEe
Q 035655 199 SGDPVQAWIDYD-GVNRLVNVTICPMNKKNKLSFHFGKPSQPLLS--LPLDLS--PAFQETMYVGFSASTGRKVSSHFIL 273 (670)
Q Consensus 199 ~g~~~~a~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls--~~~dl~--~~l~~~~~vGFsastg~~~~~h~i~ 273 (670)
-+-.+++.||=. +....|+|.-...+. .. ..+++. ..++.. ..+|+..+++|++|||...-.|.|.
T Consensus 179 ~~hrY~i~Ids~~~~~~~vsV~R~~~~g--------g~-~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEId 249 (255)
T cd06900 179 PGHRYRITIDSTNGDNAWLSVERDIGNG--------GA-YFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEID 249 (255)
T ss_pred CceEEEEEEecCCCCceEEEEEEEccCC--------ce-eEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeec
Confidence 122344444433 222344554432211 00 111221 112333 5789999999999999999999987
Q ss_pred ccc
Q 035655 274 GWS 276 (670)
Q Consensus 274 sW~ 276 (670)
...
T Consensus 250 nf~ 252 (255)
T cd06900 250 NFQ 252 (255)
T ss_pred ceE
Confidence 543
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-07 Score=96.31 Aligned_cols=106 Identities=18% Similarity=0.189 Sum_probs=82.9
Q ss_pred HHHHHHHHHhccccCce--eeeeeeeec-----cCeeEEEEeccCCC-CchhhcccCCccccCHHHHHHHHHHHHHHhhh
Q 035655 389 EFAAEIESLGRLRHKHL--VNLQGWCKR-----KRDLLLVYDYIPNG-SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460 (670)
Q Consensus 389 ~f~~Ei~~L~~l~H~nI--v~l~g~~~~-----~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~y 460 (670)
.+.+|...+.+|...+| ++.+++.+. ....+||+|++++. +|.+++........+...+..++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999998864443 334445433 23578999999986 89998854323345667788999999999999
Q ss_pred ccccccceEEecccCCCcEEecC-------CCcEEEEeecCcee
Q 035655 461 LHEEWEQVVIHRDVKSGNVLIDA-------DMNARLGDFGLARL 497 (670)
Q Consensus 461 LH~~~~~~ivHrDIkp~NILld~-------~~~~kL~DFGla~~ 497 (670)
||. .+|+|+|++++|||++. +..+.|+||+.++.
T Consensus 154 LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999 99999999999999975 46899999998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.4e-08 Score=112.80 Aligned_cols=234 Identities=22% Similarity=0.232 Sum_probs=151.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccchHH----HHHHHHHHHhc---------------cccCceeeeeeeeeccCeeEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTRMR----EFAAEIESLGR---------------LRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~~~----~f~~Ei~~L~~---------------l~H~nIv~l~g~~~~~~~~~l 420 (670)
..++|.+.+.+-+|.++.+....-..... ....++..+.+ .++|-+++..--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45667777788889999888765433221 11122222221 122334433222334567899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
+++|..+++|..-|+... ..+.+........+..++.|||. ..+.|||++|.|+|...++..++.|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999987654 34555555667778899999998 5689999999999999999999999984322110
Q ss_pred ---------------------C----Cc-----ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 501 ---------------------G----KI-----SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 501 ---------------------~----~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
. .. .......||+.|++||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 01223578999999999999999999999999999999999999998
Q ss_pred CCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHH
Q 035655 551 SDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMR 608 (670)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 608 (670)
......+ .+.+....-+-. .-+.+...+..+++..-+..+|.+|-.+.
T Consensus 1037 a~tpq~~--------f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI--------FENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh--------hhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 6432211 011111111111 11112223344555566678888886655
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.1e-07 Score=96.15 Aligned_cols=136 Identities=25% Similarity=0.415 Sum_probs=109.7
Q ss_pred HHHHHHhccccCceeeeeeeee----ccCeeEEEEeccCC-CCchhhcccC-------------CccccCHHHHHHHHHH
Q 035655 392 AEIESLGRLRHKHLVNLQGWCK----RKRDLLLVYDYIPN-GSLDSLLFDN-------------ENFVLSWEQRFNIIKG 453 (670)
Q Consensus 392 ~Ei~~L~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l~~~-------------~~~~l~~~~~~~i~~q 453 (670)
.-+++++++.|+|+|++..++. .+..+++||+|.|+ ++|.++-... .+...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 4578999999999999999886 34568999999986 6787765432 1234788999999999
Q ss_pred HHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhH
Q 035655 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVF 533 (670)
Q Consensus 454 ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~ 533 (670)
+..||.++|+ .|+..+-|.+.+||++.+.+++|+..|+......+.. |.+.+ -.+-|.=
T Consensus 402 LtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~le~---~Qq~D~~ 460 (655)
T KOG3741|consen 402 LTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPLES---QQQNDLR 460 (655)
T ss_pred HHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cchhH---HhhhhHH
Confidence 9999999999 8999999999999999999999999998876655431 11111 2467889
Q ss_pred HHHHHHHHHHhCCCC
Q 035655 534 AYGVLLLEIATGRRP 548 (670)
Q Consensus 534 S~Gvvl~el~tG~~p 548 (670)
.||.+++.|.||..-
T Consensus 461 ~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 461 DLGLLLLALATGTEN 475 (655)
T ss_pred HHHHHHHHHhhcccc
Confidence 999999999999654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.6e-06 Score=85.53 Aligned_cols=182 Identities=18% Similarity=0.295 Sum_probs=120.7
Q ss_pred cccceEeeeCceeEEEe-eccchH---------HHHHHHHHHHhcc-ccCceeeeeeee------ec-cCeeEEEEeccC
Q 035655 365 KQSEVIGTGGFGEVYKG-VLPTRM---------REFAAEIESLGRL-RHKHLVNLQGWC------KR-KRDLLLVYDYIP 426 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg-~~~~~~---------~~f~~Ei~~L~~l-~H~nIv~l~g~~------~~-~~~~~lV~E~~~ 426 (670)
...+.||+|+-+.+|-- ...+.. ..-.+.+..|... .||-+-.-+.|= -+ +...-++|..++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~ 93 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVS 93 (637)
T ss_pred CCCccccCCccceeeecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCC
Confidence 34678999999998842 111111 1111233334333 355433323331 11 222566777766
Q ss_pred CC-Cchhhccc----CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 427 NG-SLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 427 ~g-sL~~~l~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+. ...+++.. ..-....|...++.++.+|.+.+.||+ .|.+-+|+.++|+|+.+++.+.|.|=..-.....+
T Consensus 94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeeccCC
Confidence 53 22233321 112347899999999999999999998 89999999999999999999999985544333222
Q ss_pred CcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCC
Q 035655 502 KISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATG-RRPIDS 551 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG-~~pf~~ 551 (670)
....-.+|...|.+||... +...+...|.|.+|+++++++.| ++||.+
T Consensus 171 --~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 171 --TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred --ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2223347889999999754 33557889999999999999885 999976
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-07 Score=105.04 Aligned_cols=154 Identities=19% Similarity=0.269 Sum_probs=102.3
Q ss_pred HHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-c---e----eeccccCcCCCCcccc
Q 035655 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-S---H----TTNVVGTIGYIAPELA 521 (670)
Q Consensus 450 i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~---~----~~~~~gt~~y~aPE~~ 521 (670)
=+.+++.||.|+|. ..++||++|.|++|.+++++..||+.|+.+........ . . ..-..-...|.|||++
T Consensus 104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34556699999999 48999999999999999999999999998865443111 0 0 0111345689999999
Q ss_pred ccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCC
Q 035655 522 RTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQK 600 (670)
Q Consensus 522 ~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 600 (670)
.....+.++|+||+|++++-+.. |+.-+......+... .. ....+.-- ..+....+.++.+-+.+.+..+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~----~~~~~~~~----~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FS----RNLLNAGA----FGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hh----hccccccc----ccccccCcHHHHHHHHHHhcCC
Confidence 98778899999999999999985 444444322111110 00 00000000 1112233345555566678899
Q ss_pred CCCCCCHHHHHHHh
Q 035655 601 AEARPTMRQVLRYL 614 (670)
Q Consensus 601 P~~RPs~~evl~~L 614 (670)
+..||++.++....
T Consensus 253 ~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 253 SAVRPTLDLLLSIP 266 (700)
T ss_pred cccCcchhhhhccc
Confidence 99999888877643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.9e-06 Score=85.61 Aligned_cols=108 Identities=25% Similarity=0.323 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHhccccCc--eeeeeeeeecc----CeeEEEEeccCCC-CchhhcccCCccccCHHHHHHHHHHHHHHhh
Q 035655 387 MREFAAEIESLGRLRHKH--LVNLQGWCKRK----RDLLLVYDYIPNG-SLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459 (670)
Q Consensus 387 ~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~ 459 (670)
.....+|...+.+|+... ..+.+++.+.. ...++|+|++++. +|.+++..... ++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 446778988888886433 34555665543 2458999999984 89999865333 566778899999999999
Q ss_pred hccccccceEEecccCCCcEEecCCC---cEEEEeecCceecc
Q 035655 460 YLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDFGLARLFD 499 (670)
Q Consensus 460 yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DFGla~~~~ 499 (670)
-||+ .+|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 9999999999999999887 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.5e-06 Score=82.82 Aligned_cols=110 Identities=16% Similarity=0.148 Sum_probs=86.2
Q ss_pred cchHHHHHHHHHHHhccccCc--eeeeeeeee-cc----CeeEEEEeccCC-CCchhhcccCCccccCHHHHHHHHHHHH
Q 035655 384 PTRMREFAAEIESLGRLRHKH--LVNLQGWCK-RK----RDLLLVYDYIPN-GSLDSLLFDNENFVLSWEQRFNIIKGIA 455 (670)
Q Consensus 384 ~~~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~-~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia 455 (670)
+-+...|.+|+..|.+|...+ +.+.. ++. .. ...+||+|-+++ -+|.+++.+....+.+..++..++.+++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va 138 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence 346678999999999996433 44444 332 21 246899997754 6899998665444677888899999999
Q ss_pred HHhhhccccccceEEecccCCCcEEecCCCc--EEEEeecCcee
Q 035655 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMN--ARLGDFGLARL 497 (670)
Q Consensus 456 ~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kL~DFGla~~ 497 (670)
..+.-||+ .++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 139 ~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 139 LAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999 99999999999999986667 99999986653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.9e-06 Score=82.63 Aligned_cols=101 Identities=25% Similarity=0.312 Sum_probs=68.0
Q ss_pred HHHHHHHHHHhccccC--ceeeeeeeeeccCeeEEEEeccC--CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhc-c
Q 035655 388 REFAAEIESLGRLRHK--HLVNLQGWCKRKRDLLLVYDYIP--NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL-H 462 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yL-H 462 (670)
....+|.+.|.++..- ++.+.+.+- ..+|||||++ +..+.... .. .++......++.+++..+..+ |
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHH
Confidence 4556899999999865 456666542 4579999998 55554432 21 122445567788888866664 6
Q ss_pred ccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 463 ~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
. .+++|+|+.+.||+++++ .+.|+|||.+....+
T Consensus 125 ~---~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 125 K---AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH 158 (188)
T ss_dssp C---TTEEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred h---cCceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence 6 899999999999999988 999999999875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.7e-05 Score=77.18 Aligned_cols=189 Identities=20% Similarity=0.280 Sum_probs=117.7
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
....|+|..+ .-.|+|++...++.|-+|-+..+.+ -.|..+-+|.|... ...++|||||--+...
T Consensus 56 W~~~GdAIas-~eqvRlaPSmrsrkGavWtka~~~f-------------e~weVev~~rVtGr-GRiGAdGlaiWYt~~~ 120 (497)
T KOG3838|consen 56 WSHHGDAIAS-SEQVRLAPSMRSRKGAVWTKASVPF-------------ENWEVEVQFRVTGR-GRIGADGLAIWYTRGR 120 (497)
T ss_pred eeecCccccc-ccceeeccccccccCceeecccCCc-------------ccceEEEEEEeccc-ccccCCceEEEEecCC
Confidence 5567899875 6679999999889999987766654 34788999999876 3578999999998644
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC-cccccccccccccCCCcc-----cc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS-MKSIKLEPAAYYENGTKE-----DF 195 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns-~~s~~~~~~~~~~~~~~~-----~~ 195 (670)
. --|..+|-.+.= | =+++=||.|.| . +--|+.-|.+-.|. -++-.... .++.. -.
T Consensus 121 G----~~GpVfGg~d~W------n-GigiffDSfdn-D--~qknnP~Is~~lndGt~~ydh~~-----DGasQ~LssCqr 181 (497)
T KOG3838|consen 121 G----HVGPVFGGLDSW------N-GIGIFFDSFDN-D--GQKNNPAISVLLNDGTIPYDHPG-----DGASQGLSSCQR 181 (497)
T ss_pred C----cccccccccccc------c-ceEEEeecccc-c--CCcCCccEEEEecCCcccccCCC-----ccHHHHHHHhhH
Confidence 2 122223321111 1 15888999877 2 22344455555542 11100000 11101 12
Q ss_pred ccCC-CCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcc-cccccceeeEeecCCceeeeEEEe
Q 035655 196 TLES-GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSP-AFQETMYVGFSASTGRKVSSHFIL 273 (670)
Q Consensus 196 ~l~~-g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~-~l~~~~~vGFsastg~~~~~h~i~ 273 (670)
++.| --+.+|+|+|=. .+|.|.+...=. |..+ --.-++... +||..-|+|.||+||....-|+|+
T Consensus 182 DFRNkPyPvRarItY~~--nvLtv~innGmt----------p~d~-yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl 248 (497)
T KOG3838|consen 182 DFRNKPYPVRARITYYG--NVLTVMINNGMT----------PSDD-YEFCVRVENLLLPPNGYFGVSAATGGLADDHDVL 248 (497)
T ss_pred HhccCCCCceEEEEEec--cEEEEEEcCCCC----------CCCC-cceeEeccceeccCCCeeeeeeccccccccccee
Confidence 3333 347899999964 688888864322 2211 111123333 468889999999999999999999
Q ss_pred cccc
Q 035655 274 GWSF 277 (670)
Q Consensus 274 sW~f 277 (670)
++.-
T Consensus 249 ~Flt 252 (497)
T KOG3838|consen 249 SFLT 252 (497)
T ss_pred eeEE
Confidence 9753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.1e-06 Score=82.23 Aligned_cols=122 Identities=23% Similarity=0.285 Sum_probs=85.2
Q ss_pred cccceEeeeCceeEEEeeccch-------------------------------------HHHHHHHHHHHhccccC--ce
Q 035655 365 KQSEVIGTGGFGEVYKGVLPTR-------------------------------------MREFAAEIESLGRLRHK--HL 405 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~~-------------------------------------~~~f~~Ei~~L~~l~H~--nI 405 (670)
.+..+||-|.-+.||.|..+.+ .....+|.+.|++|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999987641 12234799999999755 67
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
.+.++| +...+||||.++-.|...-- +-+..-.++..|++-+.-+-. .++||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 777765 55789999999877755421 122222233333333322223 7999999999999999999
Q ss_pred cEEEEeecCceeccC
Q 035655 486 NARLGDFGLARLFDH 500 (670)
Q Consensus 486 ~~kL~DFGla~~~~~ 500 (670)
.+.++||-.+....+
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999987754433
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.2e-05 Score=76.71 Aligned_cols=104 Identities=25% Similarity=0.240 Sum_probs=83.9
Q ss_pred HHHHHHhcccc-CceeeeeeeeeccCeeEEEEeccCCCCchhhccc-CCccccCHHHHHHHHHHHHHHhhhccccccceE
Q 035655 392 AEIESLGRLRH-KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469 (670)
Q Consensus 392 ~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 469 (670)
.|.-+|+.+++ +++.+++|.|-+ ++|.||...+++...-.. ..-...+|.+|.+|+.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58889999987 699999999943 679999987766432000 011246999999999999999999998665668
Q ss_pred EecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 470 IHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 470 vHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
.-.|++++|+-+++++++|+.|...+....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 999999999999999999999998775443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.3e-06 Score=96.30 Aligned_cols=174 Identities=18% Similarity=0.160 Sum_probs=129.6
Q ss_pred ccceEeeeCceeEEEeeccch----------HHHHHHHHHHHhccccCc-eeeeeeeeeccCeeEEEEeccCCC-Cchhh
Q 035655 366 QSEVIGTGGFGEVYKGVLPTR----------MREFAAEIESLGRLRHKH-LVNLQGWCKRKRDLLLVYDYIPNG-SLDSL 433 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~~----------~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~g-sL~~~ 433 (670)
.-+-+++++++++||.+.... .....-++++|.+++||| .++.++-+..+....++++++..+ +-..-
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~ 325 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALE 325 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccccc
Confidence 335568899999999875432 123345889999999999 777777777888899999999877 22222
Q ss_pred cccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCc
Q 035655 434 LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513 (670)
Q Consensus 434 l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~ 513 (670)
... ....+...+...++..-+++++|+|+ -.=+||| ||+..+ ...|.+||+....+.... ......+|+
T Consensus 326 ~~~-se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~ 394 (829)
T KOG0576|consen 326 MTV-SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTP 394 (829)
T ss_pred CCh-hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCC
Confidence 211 11234445556677788899999998 3347888 777655 789999999987665543 345568999
Q ss_pred CCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 514 ~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
.++|||+.....+..+-|+|+.|.-..++.-|..|-.
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999987778877777643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00014 Score=73.28 Aligned_cols=122 Identities=18% Similarity=0.199 Sum_probs=76.4
Q ss_pred ceEeeeCceeEEEeeccc----------hHHHHHHHHHHHhccccCce--eeeeeeeeccCeeEEEEeccCCCC-chhhc
Q 035655 368 EVIGTGGFGEVYKGVLPT----------RMREFAAEIESLGRLRHKHL--VNLQGWCKRKRDLLLVYDYIPNGS-LDSLL 434 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~----------~~~~f~~Ei~~L~~l~H~nI--v~l~g~~~~~~~~~lV~E~~~~gs-L~~~l 434 (670)
..||+|..+.||+....+ ......+|.++++.+..-.+ .+.++++...+...+|||+++|.. +...+
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~ 86 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRII 86 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhh
Confidence 568899999988842111 23457899999999875444 677788777777889999999863 22111
Q ss_pred ccCCccccCHHHHHHHHHHHHHHhh---------------------------------------hccc-cccceEEeccc
Q 035655 435 FDNENFVLSWEQRFNIIKGIAAGLL---------------------------------------YLHE-EWEQVVIHRDV 474 (670)
Q Consensus 435 ~~~~~~~l~~~~~~~i~~qia~gL~---------------------------------------yLH~-~~~~~ivHrDI 474 (670)
.. +......++.++++.+. +|.. .....++|+|+
T Consensus 87 ~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 87 SD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred cC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 10 00001111111111111 1111 11346799999
Q ss_pred CCCcEEecCCCcEEEEeecCce
Q 035655 475 KSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 475 kp~NILld~~~~~kL~DFGla~ 496 (670)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00027 Score=69.94 Aligned_cols=68 Identities=22% Similarity=0.356 Sum_probs=54.0
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
...+++|||++|..|.++.. ++. .++..+.+++.-||+ .|++|+|.+|.|++++++ .+++.||+..
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECccc
Confidence 45679999999988877641 222 255667788999998 999999999999999855 5999999876
Q ss_pred ee
Q 035655 496 RL 497 (670)
Q Consensus 496 ~~ 497 (670)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0011 Score=66.23 Aligned_cols=131 Identities=21% Similarity=0.209 Sum_probs=74.3
Q ss_pred cceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCc--eeeeeeeee---ccCeeEEEEeccCCCC
Q 035655 367 SEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKH--LVNLQGWCK---RKRDLLLVYDYIPNGS 429 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~---~~~~~~lV~E~~~~gs 429 (670)
.+.|+.|..+.||+....+ ....+..|..+++.|.... +.+++.++. .....+++|+++++..
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 4678888888888876533 2356778999999886443 456666443 2335799999999988
Q ss_pred chh----------------hc---ccC--CccccCHHH---------HHHH------------HHHHHH-Hhhhccc---
Q 035655 430 LDS----------------LL---FDN--ENFVLSWEQ---------RFNI------------IKGIAA-GLLYLHE--- 463 (670)
Q Consensus 430 L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~qia~-gL~yLH~--- 463 (670)
+.. .+ +.. ......+.. .... ...+.. .+..+++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 877 11 011 000111100 0000 111222 2233332
Q ss_pred -cccceEEecccCCCcEEec-CCCcEEEEeecCcee
Q 035655 464 -EWEQVVIHRDVKSGNVLID-ADMNARLGDFGLARL 497 (670)
Q Consensus 464 -~~~~~ivHrDIkp~NILld-~~~~~kL~DFGla~~ 497 (670)
.....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1347899999999999999 667778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.001 Score=67.64 Aligned_cols=109 Identities=18% Similarity=0.175 Sum_probs=66.4
Q ss_pred HHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCCCCchhhcc-------------------cCC--ccccC--
Q 035655 388 REFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLF-------------------DNE--NFVLS-- 443 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~-------------------~~~--~~~l~-- 443 (670)
....+|+++++.+. +--+.+++++....+..++|||+++|.+|..... ... ...+.
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~ 115 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRR 115 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchh
Confidence 45778999998885 3445677787776667899999999988765421 000 00110
Q ss_pred HHHHHHH-----------------------HHHHHHHhhhcc-ccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 444 WEQRFNI-----------------------IKGIAAGLLYLH-EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 444 ~~~~~~i-----------------------~~qia~gL~yLH-~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
....... ..++..-|.... ......++|+|+.|.|||++++..+.|+||+.+.
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 116 LDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 0011100 011111111100 0123679999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00038 Score=77.96 Aligned_cols=102 Identities=18% Similarity=0.224 Sum_probs=64.3
Q ss_pred HHHHHHhccc----cCceeeeeeee-eccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHh-hhccccc
Q 035655 392 AEIESLGRLR----HKHLVNLQGWC-KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL-LYLHEEW 465 (670)
Q Consensus 392 ~Ei~~L~~l~----H~nIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~ 465 (670)
.|...+.+++ ...-+++=.++ +-.+...|+|||++|-.+.+...-.. ...+-+ .++..++++. ..+=
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~--- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHH---
Confidence 5555555553 22222232333 33567899999999999988842222 223322 2333222221 1111
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
..++.|.|.+|.||+++.++++-+.|||+......
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 26899999999999999999999999999977654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0019 Score=65.33 Aligned_cols=31 Identities=29% Similarity=0.434 Sum_probs=26.3
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++|+|+.+.||+++++...-|.||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3569999999999999876656799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00087 Score=79.32 Aligned_cols=195 Identities=19% Similarity=0.202 Sum_probs=132.8
Q ss_pred HHHHHHhccccCceeeeeeeeeccCe----eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc
Q 035655 392 AEIESLGRLRHKHLVNLQGWCKRKRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467 (670)
Q Consensus 392 ~Ei~~L~~l~H~nIv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 467 (670)
-|+..+.++.|+|++.+..|-.+... ..+..|++..-++...+... ...+..+.+.+..+..+||.|+|+ .
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~---~ 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS---L 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH---h
Confidence 57778889999999999998765432 34556788888887777543 357888999999999999999998 5
Q ss_pred eEEecccCCC---cEEecCCCcEEEE--eecCceeccCCCcceeeccccCcCCCCccccccCCCC--ccchhHHHHHHHH
Q 035655 468 VVIHRDVKSG---NVLIDADMNARLG--DFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS--CSTDVFAYGVLLL 540 (670)
Q Consensus 468 ~ivHrDIkp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t--~ksDV~S~Gvvl~ 540 (670)
...|.-+..+ +-..+.++...++ ||+..+......... ...-+..|-+||......+. ...|+|.+|....
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 5555544444 4445666677777 888876554433221 12334567788877665544 4579999999999
Q ss_pred HHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 541 EIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 541 el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+..|..+-.... .....++. ... ....+....|+..++++|++..+++.+.-
T Consensus 384 ~~~~~~~i~~~~~--------------~~~~~l~~----~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA--------------VPVSLLDV----LST----SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhcCccccccc--------------chhhhhcc----ccc----hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999876633210 00000110 010 13456777899999999999999998753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0032 Score=75.62 Aligned_cols=44 Identities=14% Similarity=0.281 Sum_probs=34.8
Q ss_pred HHHHHHHHHHhccc-cCce--eeeeeeeecc---CeeEEEEeccCCCCch
Q 035655 388 REFAAEIESLGRLR-HKHL--VNLQGWCKRK---RDLLLVYDYIPNGSLD 431 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~-H~nI--v~l~g~~~~~---~~~~lV~E~~~~gsL~ 431 (670)
..+.+|+++|+.|. |.++ .+++.+|.+. +..++||||+++..+.
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~ 132 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFV 132 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccC
Confidence 56889999999996 6665 7888888764 4678999999986543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0066 Score=63.86 Aligned_cols=66 Identities=12% Similarity=0.076 Sum_probs=49.4
Q ss_pred cccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhcccc---Cceeeeeeeeec---cCeeEEEEeccC
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRH---KHLVNLQGWCKR---KRDLLLVYDYIP 426 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H---~nIv~l~g~~~~---~~~~~lV~E~~~ 426 (670)
...+.||.|..+.||+-...+ ....|..|...|+.|.. -.+.+++++|.. .+..++|||+++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 345678999999999843211 12478899999999853 367888888764 366899999999
Q ss_pred CCCc
Q 035655 427 NGSL 430 (670)
Q Consensus 427 ~gsL 430 (670)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0016 Score=72.79 Aligned_cols=81 Identities=22% Similarity=0.312 Sum_probs=54.2
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC----CCcEEEE
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA----DMNARLG 490 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~----~~~~kL~ 490 (670)
.....|+||||+|..+.+.-.-. +..++...+..-+.+. |++.-...|++|+|-+|.||+++. ++.+.+-
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~-----~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEA-----YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHH-----HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEE
Confidence 35689999999998887753211 1234444333332222 222222368999999999999984 6789999
Q ss_pred eecCceeccCC
Q 035655 491 DFGLARLFDHG 501 (670)
Q Consensus 491 DFGla~~~~~~ 501 (670)
|||+.....+.
T Consensus 348 DhGl~~~is~~ 358 (538)
T KOG1235|consen 348 DHGLYAVISHK 358 (538)
T ss_pred cccccccccHH
Confidence 99998866543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0061 Score=59.98 Aligned_cols=116 Identities=22% Similarity=0.355 Sum_probs=80.5
Q ss_pred ccceEeeeCceeEEEee----------ccc-------------------hHHHHHHHHHHHhccc------cCceeeeee
Q 035655 366 QSEVIGTGGFGEVYKGV----------LPT-------------------RMREFAAEIESLGRLR------HKHLVNLQG 410 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~----------~~~-------------------~~~~f~~Ei~~L~~l~------H~nIv~l~g 410 (670)
....||+|+.-.||.-- .+. ..+++.+|+.....+. +.+|.+++|
T Consensus 5 ~~~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CCcccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 35678888888888521 111 2467778887777766 789999999
Q ss_pred eeeccCeeEEEEeccCC------CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC
Q 035655 411 WCKRKRDLLLVYDYIPN------GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD 484 (670)
Q Consensus 411 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 484 (670)
+.+++...-+|+|...+ -+|.+++.+. .++. ...+.+.+. ..||-+ ..|+.+|++|.||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccEEEEec
Confidence 99999999999998754 2577777433 3444 333333333 455555 789999999999999543
Q ss_pred C----cEEEEe
Q 035655 485 M----NARLGD 491 (670)
Q Consensus 485 ~----~~kL~D 491 (670)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 466766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0075 Score=60.61 Aligned_cols=99 Identities=22% Similarity=0.285 Sum_probs=64.3
Q ss_pred HHHHHHhcccc--CceeeeeeeeeccCeeEEEEeccCCCCc-hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce
Q 035655 392 AEIESLGRLRH--KHLVNLQGWCKRKRDLLLVYDYIPNGSL-DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468 (670)
Q Consensus 392 ~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 468 (670)
+|+.-|+++.. -.+.+-+++. .-.|||||+....+ .=.|.+ -.+...+...+..++++.+.-|-. ..+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~ 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAG 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcC
Confidence 57777777743 2333333332 34799999965311 111111 123333566667777777766654 378
Q ss_pred EEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 469 ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
+||+||..-|||+. ++.+.|+|+|.|....+
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 88999999999876554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.00017 Score=86.75 Aligned_cols=161 Identities=14% Similarity=0.042 Sum_probs=119.5
Q ss_pred HHHHHHHHHhccccCceeeeeeeee--ccCeeEEEEeccCCCCchhhcccCCc--cccCHHHHHHHHHHHHHHhhhcccc
Q 035655 389 EFAAEIESLGRLRHKHLVNLQGWCK--RKRDLLLVYDYIPNGSLDSLLFDNEN--FVLSWEQRFNIIKGIAAGLLYLHEE 464 (670)
Q Consensus 389 ~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~ 464 (670)
....|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|-+... ..+...-+....++...+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445666677778999887655443 34567899999999999999876432 3344444444555546666665552
Q ss_pred --ccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHH
Q 035655 465 --WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542 (670)
Q Consensus 465 --~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el 542 (670)
.....+|+++|+-|.+|..+.++|++++|+.+...+. ........+++.|+.|+....-.++.++|+|..|+-+++.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2345799999999999999999999999999844432 2233445778899999998888899999999999999999
Q ss_pred HhCCCCCC
Q 035655 543 ATGRRPID 550 (670)
Q Consensus 543 ~tG~~pf~ 550 (670)
..|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88887763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.033 Score=54.70 Aligned_cols=111 Identities=27% Similarity=0.411 Sum_probs=80.7
Q ss_pred cCccccceEeeeCc-eeEEEeeccc-----------------------------------hHHHHHHHHHHHhccc---c
Q 035655 362 KGFKQSEVIGTGGF-GEVYKGVLPT-----------------------------------RMREFAAEIESLGRLR---H 402 (670)
Q Consensus 362 ~~f~~~~~lG~G~f-g~Vykg~~~~-----------------------------------~~~~f~~Ei~~L~~l~---H 402 (670)
.+++..+.||.|.- |.|||....+ ...-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78888999999999 9999986533 1134778999888885 4
Q ss_pred Cce--eeeeeeeecc------------------CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcc
Q 035655 403 KHL--VNLQGWCKRK------------------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462 (670)
Q Consensus 403 ~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH 462 (670)
.++ |+++||..-. ....||.||.+... .+. .+-+.+|.+-|.-+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence 466 9999997322 12366777765422 122 234566777778899
Q ss_pred ccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 463 ~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
. .+|+-+|+|+.|.. ..||+|||.+
T Consensus 182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---CCeeeccCcccccc-----CCEEEecccC
Confidence 8 99999999999976 4689999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.021 Score=54.47 Aligned_cols=118 Identities=15% Similarity=0.198 Sum_probs=78.3
Q ss_pred ccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCcee-eeeeeeeccCeeEEEEeccCCCCc
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLV-NLQGWCKRKRDLLLVYDYIPNGSL 430 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL 430 (670)
....+.|++|.+|.||+|.+.. ....+..|+++|..+.-.++- +++.+.. -++.|||..|-.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 3456789999999999987753 456788999999999866554 3444433 2445999998888
Q ss_pred hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccC-CCcEEecCCCcEEEEeecCcee
Q 035655 431 DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK-SGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 431 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIk-p~NILld~~~~~kL~DFGla~~ 497 (670)
.+.-... +- +-...+++. +|.-+ ..+|-|..|. |...+|-.+..+.|+||.-|..
T Consensus 100 ~~~~~~~-----~r----k~l~~vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-----DR----KHLLRVLEK-AYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-----cH----HHHHHHHHH-HHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7764321 11 233344444 33333 2678888876 4444444455999999998863
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.043 Score=55.27 Aligned_cols=31 Identities=26% Similarity=0.438 Sum_probs=27.3
Q ss_pred cceEEecccCCCcEEecC-CCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDA-DMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~-~~~~kL~DFGla~ 496 (670)
...++|+|+.+.|||+++ +..+.++||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 367999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.027 Score=58.91 Aligned_cols=111 Identities=18% Similarity=0.135 Sum_probs=64.0
Q ss_pred hHHHHHHHHHHHhccccCc--eeeeeeee------eccCeeEEEEeccCCCCchh----hc----------cc---C-C-
Q 035655 386 RMREFAAEIESLGRLRHKH--LVNLQGWC------KRKRDLLLVYDYIPNGSLDS----LL----------FD---N-E- 438 (670)
Q Consensus 386 ~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~------~~~~~~~lV~E~~~~gsL~~----~l----------~~---~-~- 438 (670)
.......|++++..|.+.+ +.+++... ...+..++|++|++|..+.. .+ +. . .
T Consensus 49 ~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~ 128 (296)
T cd05153 49 SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPG 128 (296)
T ss_pred ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 3456678888888886433 34443321 22345689999999877643 11 10 0 0
Q ss_pred ----ccccCHHHHHH----------HHHHHHHHhhhccc----cccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 439 ----NFVLSWEQRFN----------IIKGIAAGLLYLHE----EWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 439 ----~~~l~~~~~~~----------i~~qia~gL~yLH~----~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.....|..... ....+...+.++.+ ....+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 129 ERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 01122222110 11112223333332 123579999999999999998777999998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.012 Score=64.38 Aligned_cols=50 Identities=18% Similarity=0.315 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHhccccCceeeeeeeeeccC-eeEEEEeccCCCCchhhcccC
Q 035655 387 MREFAAEIESLGRLRHKHLVNLQGWCKRKR-DLLLVYDYIPNGSLDSLLFDN 437 (670)
Q Consensus 387 ~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~ 437 (670)
..+..-...+++.+.|+|+..++.+..... ...+|+|++ +.||++++..+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 456667788999999999999999887654 467788887 77999988544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.07 Score=54.64 Aligned_cols=30 Identities=23% Similarity=0.313 Sum_probs=26.3
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++|+|+.|.||++++++ ++|+||..+.
T Consensus 145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 35789999999999999877 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.063 Score=56.78 Aligned_cols=105 Identities=21% Similarity=0.213 Sum_probs=72.3
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
+....|++|++. +++|... ..-.|++...++.+.+.-+.-+.. +-..=|||+.-.||||+ +|++.|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence 344567777775 5555332 235789999999999998888887 46678999999999999 9999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHH
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAY 535 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~ 535 (670)
+++........ . -...--|-.+. |.-+.+=|||-+
T Consensus 367 lsRl~~~q~~i-s-----y~rldhp~lF~-G~dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQGII-S-----YNRLDHPDLFN-GVDDYQFEIYRL 401 (488)
T ss_pred eeecccCCcee-e-----ccccCchhhhc-CccceeeeHHHH
Confidence 99854332211 1 11122344444 444667788864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.16 Score=53.84 Aligned_cols=31 Identities=35% Similarity=0.394 Sum_probs=26.7
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..+++|+|+++.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999976556899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.047 Score=56.89 Aligned_cols=134 Identities=17% Similarity=0.170 Sum_probs=85.7
Q ss_pred cchhhHHHhhcC---ccccceEeeeCceeEEEeeccchH--------------------H-----------------HHH
Q 035655 352 FRYSDLYTATKG---FKQSEVIGTGGFGEVYKGVLPTRM--------------------R-----------------EFA 391 (670)
Q Consensus 352 ~~~~~l~~~t~~---f~~~~~lG~G~fg~Vykg~~~~~~--------------------~-----------------~f~ 391 (670)
++|-.|.+-.++ +..++.||-|.-+-+|.+....+. + ...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 344444443332 567899999999999998765310 1 122
Q ss_pred HHHHHHhcccc--CceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceE
Q 035655 392 AEIESLGRLRH--KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469 (670)
Q Consensus 392 ~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 469 (670)
+|+..|+.|.. --+.+.+++ +..++|||++.+-.|...-+ ..+..+++.-+.+++ .-|-. .|+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~I---v~la~---~Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLI---VRLAN---HGL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHH---HHHHH---cCc
Confidence 57777777743 223334443 45789999999888866532 122333333322222 22333 899
Q ss_pred EecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 470 vHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+|..-=||+++++..++++||-......+
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhccCC
Confidence 9999999999999999999999976654433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.24 Score=52.20 Aligned_cols=31 Identities=39% Similarity=0.415 Sum_probs=27.7
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..+++|+|+++.||++++++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999988777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.2 Score=54.75 Aligned_cols=30 Identities=17% Similarity=0.459 Sum_probs=25.9
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++|+|+.+.|||+..+ .++++||.++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 3679999999999999776 69999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.32 Score=51.41 Aligned_cols=107 Identities=21% Similarity=0.246 Sum_probs=70.6
Q ss_pred hHHHHHHHHHHHhcccc--CceeeeeeeeeccC--eeEEEEeccCCCCchhhcccCCccccCHHHHHHHH-HHHHHHhhh
Q 035655 386 RMREFAAEIESLGRLRH--KHLVNLQGWCKRKR--DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNII-KGIAAGLLY 460 (670)
Q Consensus 386 ~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~-~qia~gL~y 460 (670)
......+|..+|+.+.- --..+.++.|.++. ..+.||+|.+|..+.+.+..... . .+.+ ..+++.|+-
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~---~----~~~~~~~l~~~La~ 136 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL---G----RQFALDALADFLAE 136 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc---h----HHHHHHHHHHHHHH
Confidence 34556688888887743 33455677787665 77999999988655444322111 0 1111 244444444
Q ss_pred ccc-------------------------------------------------------cccceEEecccCCCcEEecCCC
Q 035655 461 LHE-------------------------------------------------------EWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 461 LH~-------------------------------------------------------~~~~~ivHrDIkp~NILld~~~ 485 (670)
||+ .....++|+|+++.|++++.+.
T Consensus 137 LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~ 216 (321)
T COG3173 137 LHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR 216 (321)
T ss_pred HhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC
Confidence 442 1136799999999999999999
Q ss_pred cEEEEeecCceecc
Q 035655 486 NARLGDFGLARLFD 499 (670)
Q Consensus 486 ~~kL~DFGla~~~~ 499 (670)
.+-+.||+++..-+
T Consensus 217 ~~gVlDwe~~~lGD 230 (321)
T COG3173 217 PTGVLDWELATLGD 230 (321)
T ss_pred eeEEEeccccccCC
Confidence 99999999987543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.24 Score=53.18 Aligned_cols=31 Identities=29% Similarity=0.445 Sum_probs=27.0
Q ss_pred cceEEecccCCCcEEecC-CCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDA-DMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~-~~~~kL~DFGla~ 496 (670)
...++|+|+++.|||+++ ++.++++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 357899999999999986 4689999998875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.85 E-value=0.56 Score=48.76 Aligned_cols=31 Identities=35% Similarity=0.636 Sum_probs=26.0
Q ss_pred ceEEecccCCCcEEecCCCc-EEEEeecCcee
Q 035655 467 QVVIHRDVKSGNVLIDADMN-ARLGDFGLARL 497 (670)
Q Consensus 467 ~~ivHrDIkp~NILld~~~~-~kL~DFGla~~ 497 (670)
..++|+|+++.||+++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 56899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.97 E-value=0.47 Score=49.55 Aligned_cols=129 Identities=26% Similarity=0.338 Sum_probs=63.6
Q ss_pred cccceEeeeCceeEEEeecc-----------chHHHHHHHHHHHhccc---cCceeeeeeeeeccCeeEEEEeccCCC--
Q 035655 365 KQSEVIGTGGFGEVYKGVLP-----------TRMREFAAEIESLGRLR---HKHLVNLQGWCKRKRDLLLVYDYIPNG-- 428 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~-----------~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~g-- 428 (670)
+..+.++.|....+|+.... .....|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~~ 99 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGSP 99 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-------
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCCC
Confidence 34566777777777765432 23457899999999884 345778899888777789999999876
Q ss_pred Cchhh---------ccc-CCc-------------------cccCHHH-----HHHHHH--------------HHHHHh-h
Q 035655 429 SLDSL---------LFD-NEN-------------------FVLSWEQ-----RFNIIK--------------GIAAGL-L 459 (670)
Q Consensus 429 sL~~~---------l~~-~~~-------------------~~l~~~~-----~~~i~~--------------qia~gL-~ 459 (670)
+..+. |++ ... ..-+|.. |+.-.. ++.+.+ .
T Consensus 100 ~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~~ 179 (288)
T PF03881_consen 100 SPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLPS 179 (288)
T ss_dssp -CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHHH
Confidence 11110 122 110 0123322 111111 111111 2
Q ss_pred hccc-cccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 460 YLHE-EWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 460 yLH~-~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
.|+. ..++.++|+||-+.|++.+.++.+.|.|=.
T Consensus 180 ~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 180 LLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp CCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 2231 225789999999999999999889988865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.29 E-value=0.81 Score=45.48 Aligned_cols=143 Identities=15% Similarity=0.165 Sum_probs=87.4
Q ss_pred EeeeCceeEEEeeccc-----hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCH
Q 035655 370 IGTGGFGEVYKGVLPT-----RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSW 444 (670)
Q Consensus 370 lG~G~fg~Vykg~~~~-----~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~ 444 (670)
+|+...|..+.-+.+. ...-|..+.+++.+++ .|++|..- .....-++.|+|..- ....
T Consensus 80 ~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------~i~~- 143 (308)
T PF07387_consen 80 IGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------KINF- 143 (308)
T ss_pred EeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------ccch-
Confidence 4444455555433332 3455778888888773 56666632 334567888887321 0111
Q ss_pred HHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC
Q 035655 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524 (670)
Q Consensus 445 ~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 524 (670)
..++.-=+.+|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|-+... .+ +..|.--| ..
T Consensus 144 ---~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~vN~~---Y~ 203 (308)
T PF07387_consen 144 ---SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNMVNIE---YE 203 (308)
T ss_pred ---hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeEEeee---cc
Confidence 11222224667788864 4789999999999999999999999976532 11 11122211 12
Q ss_pred CCCccchhHHHHHHHHHHHhCCCC
Q 035655 525 KASCSTDVFAYGVLLLEIATGRRP 548 (670)
Q Consensus 525 ~~t~ksDV~S~Gvvl~el~tG~~p 548 (670)
..|.++.+-+|=.-+++++...+.
T Consensus 204 ~lT~~aE~~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 204 SLTQEAEVKVFVKSCLKLVEKQRS 227 (308)
T ss_pred ccChHHHHHHHHHHHHHHHHHHhc
Confidence 346788888888888888775444
|
The function of this family is unknown. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.17 E-value=0.59 Score=49.01 Aligned_cols=32 Identities=31% Similarity=0.373 Sum_probs=28.2
Q ss_pred ccceEEecccCCCcEEecCC----CcEEEEeecCce
Q 035655 465 WEQVVIHRDVKSGNVLIDAD----MNARLGDFGLAR 496 (670)
Q Consensus 465 ~~~~ivHrDIkp~NILld~~----~~~kL~DFGla~ 496 (670)
....++|+|+.+.||+++++ +.++++||..+.
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 34789999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.27 E-value=0.72 Score=45.63 Aligned_cols=49 Identities=27% Similarity=0.323 Sum_probs=29.3
Q ss_pred HHHHHHHHHHHhhhccccccceEEecccCCCcEEe-cCCCcEEEEeecCcee
Q 035655 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI-DADMNARLGDFGLARL 497 (670)
Q Consensus 447 ~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-d~~~~~kL~DFGla~~ 497 (670)
..+.+..+-+.+.-..+ ...++|+|+.+.|||+ +.++.++++||..|..
T Consensus 125 l~~~~~~~~~~l~~~~~--~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 125 LQEELEELEKLLEKSNS--PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp HHHHHHHHHHHHHTSCG--GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred HHHHHhhhhhhhhccCC--CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 33334444444433333 3678999999999999 8899999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=88.18 E-value=3.5 Score=45.17 Aligned_cols=30 Identities=27% Similarity=0.472 Sum_probs=24.9
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++|+|+.+.||++++++ .++.|..++.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 46799999999999999875 8888876554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.87 E-value=1.1 Score=47.75 Aligned_cols=28 Identities=39% Similarity=0.589 Sum_probs=25.9
Q ss_pred EEecccCCCcEEecCCCc-EEEEeecCce
Q 035655 469 VIHRDVKSGNVLIDADMN-ARLGDFGLAR 496 (670)
Q Consensus 469 ivHrDIkp~NILld~~~~-~kL~DFGla~ 496 (670)
+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999885 8999999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 670 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-31 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 3e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-20 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 6e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 6e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-15 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 8e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-14 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 6e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 8e-14 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 8e-14 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 8e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 2e-13 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 2e-13 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 3e-13 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 3e-13 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 3e-13 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-13 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 8e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2b7y_A | 182 | Fava Bean Lectin-Glucose Complex Length = 182 | 6e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 1e-11 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-11 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 7e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-11 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 9e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 4e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-10 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-08 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 7e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1n3o_A | 252 | Pterocarcpus Angolensis Lectin In Complex With Alph | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 1q8o_A | 252 | Pterocartpus Angolensis Lectin Pal In Complex With | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 1fx5_A | 242 | Crystal Structure Analysis Of Ulex Europaeus Lectin | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 670 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-122 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-105 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-104 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-73 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-58 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 3e-55 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-54 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 3e-54 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 8e-54 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 1e-53 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 2e-53 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 2e-53 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 6e-53 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 1e-52 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 2e-52 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-52 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 3e-52 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-51 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 2e-51 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-51 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 7e-51 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-51 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-51 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 2e-50 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 6e-50 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-49 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 2e-49 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-49 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 6e-49 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-49 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 9e-49 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 1e-48 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 4e-48 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 1e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-46 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-46 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 8e-46 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 1e-45 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 4e-44 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 1e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-36 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-35 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-35 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-35 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-32 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-32 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-32 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-32 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-32 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-32 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-32 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-31 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-31 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 2e-31 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-31 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-31 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-31 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-31 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-31 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-30 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-30 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-30 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-30 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-30 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-30 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-30 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-30 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-29 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-29 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-28 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-28 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-28 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-28 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-28 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-27 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-27 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-27 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-27 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-27 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-27 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-27 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 4e-27 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 4e-15 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-27 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-27 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-26 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-26 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-26 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-25 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-25 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-25 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-25 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-25 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-25 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-25 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-25 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-24 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-24 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-24 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-24 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-24 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-23 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-23 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-23 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-22 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-22 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-21 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-21 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-21 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-21 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-21 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-21 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-20 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-20 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-20 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-20 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-20 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-20 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 9e-20 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-19 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 1e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-19 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-19 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-19 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-19 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-19 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-19 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-19 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-19 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-19 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-19 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-19 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 9e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-18 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-18 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-18 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-18 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-17 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-17 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-17 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-16 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-16 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-16 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 8e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-13 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-05 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-12 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 5e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-10 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-10 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-09 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 4e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-09 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 5e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-09 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-122
Identities = 120/320 (37%), Positives = 171/320 (53%), Gaps = 26/320 (8%)
Query: 339 EILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT------------- 385
E + L RF +L A+ F ++G GGFG+VYKG L
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 386 ---RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENF 440
+F E+E + H++L+ L+G+C + LLVY Y+ NGS+ S L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 441 VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500
L W +R I G A GL YLH+ + +IHRDVK+ N+L+D + A +GDFGLA+L D+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 501 GKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS------DH 553
+H TT V GTIG+IAPE TGK+S TDVF YGV+LLE+ TG+R D D
Sbjct: 187 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
+L+DWV ++ +VD +L +Y E+E ++Q+ LLC+ RP M +V+R
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 614 LNGDELLPIIDNWSSLDSQR 633
L GD L + W + R
Sbjct: 306 LEGDGLAERWEEWQKEEMFR 325
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-105
Identities = 94/299 (31%), Positives = 146/299 (48%), Gaps = 34/299 (11%)
Query: 349 PHRFRYSDLYTATKGFKQSE------VIGTGGFGEVYKGVLPTRM--------------- 387
H F + +L T F + +G GGFG VYKG +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 388 ---REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF-VLS 443
++F EI+ + + +H++LV L G+ DL LVY Y+PNGSL L + LS
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
W R I +G A G+ +LHE IHRD+KS N+L+D A++ DFGLAR +
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 504 SH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS--DHFILVDWV 560
+ T+ +VGT Y+APE A G+ + +D++++GV+LLEI TG +D + +L+D
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 561 LE-FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618
E + D +D + +E + + C H+K RP +++V + L
Sbjct: 248 EEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-104
Identities = 102/290 (35%), Positives = 147/290 (50%), Gaps = 25/290 (8%)
Query: 350 HRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRM---------------REFAAEI 394
+R DL AT F +IG G FG+VYKGVL EF EI
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 395 ESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLF--DNENFVLSWEQRFNIIK 452
E+L RH HLV+L G+C + +++L+Y Y+ NG+L L+ D +SWEQR I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH-TTNVVG 511
G A GL YLH +IHRDVKS N+L+D + ++ DFG+++ +H +T V G
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID----SDHFILVDWVLEFQHLG 567
T+GYI PE G+ + +DV+++GV+L E+ R I + L +W +E + G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617
Q+ +VDPNL + + C +E RP+M VL L
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-73
Identities = 80/304 (26%), Positives = 131/304 (43%), Gaps = 43/304 (14%)
Query: 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKG----------VLPTRMR---EFAAEIESLG 398
+LY + + EV G FG V+K + P + + + E+ SL
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 399 RLRHKHLVNLQGWCKRKRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGI 454
++H++++ G KR L L+ + GSL L N V+SW + +I + +
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETM 130
Query: 455 AAGLLYLHEE-------WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH-T 506
A GL YLHE+ + + HRD+KS NVL+ ++ A + DFGLA F+ GK + T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 507 TNVVGTIGYIAPELARTG-----KASCSTDVFAYGVLLLEIATGRRPIDSDH----FILV 557
VGT Y+APE+ A D++A G++L E+A+ D
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 558 DWVLEFQHLGQVLDVV-----DPNLGSSYVVAE-MELVLQLGLLCSHQKAEARPTMRQVL 611
+ + + L + +VV P L + M ++ + C AEAR + V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 612 RYLN 615
+
Sbjct: 311 ERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-58
Identities = 69/315 (21%), Positives = 110/315 (34%), Gaps = 54/315 (17%)
Query: 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKG----------VLPTR-MREFAAEIE--SLG 398
S+ K E+IG G +G VYKG V + F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62
Query: 399 RLRHKHLVNLQGWCKR-----KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453
+ H ++ +R + + LLV +Y PNGSL L + W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHS 119
Query: 454 IAAGLLYLHEEWEQ------VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH-- 505
+ GL YLH E + + HRD+ S NVL+ D + DFGL+ ++
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 506 -----TTNVVGTIGYIAPELAR-------TGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ VGTI Y+APE+ A D++A G++ EI +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 554 FI------LVDWVLEFQHLGQVLDVVD-----PNLGSSYVVAEMELVLQLGLL--CSHQK 600
+ V + +V P ++ + + + C Q
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 601 AEARPTMRQVLRYLN 615
AEAR T + +
Sbjct: 300 AEARLTAQXAEERMA 314
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-55
Identities = 60/262 (22%), Positives = 102/262 (38%), Gaps = 36/262 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNA--HNVIGHAFYNKPIQMLDKSTSL 84
F + F + G + + + + G L + + + HA Y P+ + D +T
Sbjct: 3 FNYTRFK----DDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATG- 57
Query: 85 SSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPS 144
N +SF T F F + G+ F ++P + + G L T+
Sbjct: 58 ----NVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNS--QGGYLGITDSSNSQ 111
Query: 145 NHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQ 204
N A+EFD+ + + +H+GI+VNS+ S+K ++ SG +
Sbjct: 112 NQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLK-----------AVNWNRVSGSLEK 160
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST- 263
A I YD +++ V + N +S +DL E + VGFSA+T
Sbjct: 161 ATIIYDSDTKILTVVMTHQN-----------GQITTISQEIDLKTVLPEKVSVGFSATTW 209
Query: 264 GRKVSSHFILGWSFSMNGAAPS 285
+ H I WSF+ P
Sbjct: 210 NPERERHDIYSWSFTSTLKEPE 231
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 71/292 (24%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGV----------------LPT 385
+D ++ + DL E IG G FG V++
Sbjct: 30 DDMDIP------WCDL-------NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 76
Query: 386 RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN-FVLSW 444
R+ EF E+ + RLRH ++V G + +L +V +Y+ GSL LL + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504
+R ++ +A G+ YLH ++HR++KS N+L+D ++ DFGL+RL +S
Sbjct: 137 RRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564
+ GT ++APE+ R ++ +DV+++GV+L E+AT ++P + + V + F+
Sbjct: 196 SKSA-AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
Query: 565 HLG-QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
++ ++P + ++ C + RP+ ++ L
Sbjct: 255 CKRLEIPRNLNPQVA--------AIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 185 bits (469), Expect = 3e-54
Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 27/254 (10%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
F+ F+ + N LI + L LT N +G A Y+ PI + D+ T
Sbjct: 6 FLITKFSPDQQN--LIFQGDGYT--TKEKLTLTKAVKNTVGRALYSSPIHIWDRET---- 57
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
N ++F T F F I PNS G F ++P + YLG+ NS + +
Sbjct: 58 -GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDT-KPQTGGGYLGVFNSAE-YDKTTQ 114
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAW 206
A+EFDT ++ H+GI+VNS+KS+ + + L++G+
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSV-----------NTKSWKLQNGEEANVV 163
Query: 207 IDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRK 266
I ++ ++ V++ N + + + LS + L E + +GFSA+TG +
Sbjct: 164 IAFNAATNVLTVSLTYPN-----NSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAE 218
Query: 267 VSSHFILGWSFSMN 280
++H +L WSF
Sbjct: 219 YAAHEVLSWSFHSE 232
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 8e-54
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 44/274 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F +N F + N + + +I+ SG L+L N +G A Y+ PI + DK
Sbjct: 6 FSWNKFVPKQPN---MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDK 62
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
T + +SF+ F F P++ + GLAF ++P + P + G L N+
Sbjct: 63 ETG-----SVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT----HAGYLGLFNE 113
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
++ + + A+EFDT + + D H+GINVNS++SIK + L +
Sbjct: 114 NESGDQVVAVEFDT---FRNSWDPPNPHIGINVNSIRSIKTTS-----------WDLANN 159
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
+ I YD L+ ++ ++ + +LS +DL + E + +GFS
Sbjct: 160 KVAKVLITYDASTSLLVASLVYPSQ----------RTSNILSDVVDLKTSLPEWVRIGFS 209
Query: 261 ASTGRKV--SSHFILGWSFSMNGAAPSLNLSQIP 292
A+TG + SH +L WSF+ N S N+ +
Sbjct: 210 AATGLDIPGESHDVLSWSFASNLPHASSNIDPLD 243
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-53
Identities = 63/256 (24%), Positives = 108/256 (42%), Gaps = 35/256 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLT-DNAHNVIGHAFYNKPIQMLDKSTSLS 85
F FN F+ + N + + ++L +G ++LT N N +G Y P+++ +T
Sbjct: 6 FNFNSFS--EGNPAINFQGDVTVL-SNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG-- 60
Query: 86 SKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSN 145
N +SF T F F++ G+ F ++P+ + + G +D K +
Sbjct: 61 ---NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIG--GGTLGVSDTKGAG 115
Query: 146 HLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQA 205
H +EFDT + +E +D +HVGI+VNS+ S+K P + SG V+
Sbjct: 116 HFVGVEFDTYSN-SEYNDPPTDHVGIDVNSVDSVKTVP-----------WNSVSGAVVKV 163
Query: 206 WIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGR 265
+ YD + ++V + ++ +DL E + GFSAS
Sbjct: 164 TVIYDSSTKTLSV-----------AVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSL 212
Query: 266 K-VSSHFILGWSFSMN 280
H I WSF+
Sbjct: 213 GGRQIHLIRSWSFTST 228
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 183 bits (464), Expect = 2e-53
Identities = 63/267 (23%), Positives = 107/267 (40%), Gaps = 38/267 (14%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F F + + + + + + + AL+LT +G A Y PI++
Sbjct: 6 FTFTDFESGQQD---LIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQ- 61
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
S +SF T F F I +S F SP P G LG+ S+N+
Sbjct: 62 -----SSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNN 116
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
N + ++EFDT + D H+GI+VNS++S + +G
Sbjct: 117 AGSDNGVVSVEFDTYP-NTDIGDPNYRHIGIDVNSIRSKAASKWDWQ-----------NG 164
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
A I Y+ ++ ++V + S ++S ++L+ + + VGFS
Sbjct: 165 KTATAHISYNSASKRLSVV-----------SSYPNSSPVVVSFDVELNNVBPBWVRVGFS 213
Query: 261 ASTGRKVSSHFILGWSFSMNGAAPSLN 287
A+TG+ ++ IL WSF + N
Sbjct: 214 ATTGQYTQTNNILAWSFRSSLMGYQAN 240
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 183 bits (464), Expect = 2e-53
Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 41/287 (14%)
Query: 11 LFFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------ 64
+ + S F F F+ + N + + + + L+LT N
Sbjct: 1 MLLNRANSTDSLS---FSFINFDRDERN---LIFQGDAHTSRNNILQLTRTDSNGAPVRS 54
Query: 65 VIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFP 124
+G ++ +++ +KST+ ++ T F F + +P S F P + P
Sbjct: 55 TVGRILHSAQVRLWEKSTN-----RVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIP 109
Query: 125 GGKAEHYLGILN-STNDHKPSNHLFAIEFDTV-NGYNETSDSQGNHVGINVNSMKSIKLE 182
G A LG+ N T ++ +N + A+EFDT + T D H+GI+VNS++S K+
Sbjct: 110 SGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVV 169
Query: 183 PAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLS 242
+ G + + Y+ R ++V + + LS
Sbjct: 170 R-----------WERREGKTLNVLVTYNPSTRTIDVVA-----------TYPDGQRYQLS 207
Query: 243 LPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPSLNLS 289
+DL+ E + VGFSA++G + +H + WSF+ +
Sbjct: 208 HVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFTSTLLYTAQKED 254
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-53
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 41/273 (15%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLD 79
F+F+ F + N + + +++ +G L+LT+ N +G A Y+ PI + D
Sbjct: 5 SFVFSKFKPLEPN---LILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWD 61
Query: 80 KSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+T +SF+T F F I PN GLAF ++P S P +LG+ +S
Sbjct: 62 SATG-----LVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGG-GFLGLFDSAV 115
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
+ A+EFDT +D H+G +VNS+ SIK ++L +
Sbjct: 116 SG-STYQTVAVEFDTYENT-VFTDPPYTHIGFDVNSISSIKTVK-----------WSLAN 162
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G+ + I Y+ +L+ ++ + + +L+ +DLS E + VGF
Sbjct: 163 GEAAKVLITYNSAVKLLVASLVYPS----------SKTSFILADIVDLSSVLPEWVRVGF 212
Query: 260 SASTG---RKVSSHFILGWSFSMNGAAPSLNLS 289
SA+TG K+ +H + WSF+ A S
Sbjct: 213 SAATGASGGKIETHDVFSWSFASKLAGXXTKDS 245
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 41/265 (15%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F F F + + + +++ +G L+LT+ + V +G A Y P Q+ D +
Sbjct: 6 FSFPKFAPNQPY---LINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
T N +SF T F F I PN GLAF ++P + P LGI
Sbjct: 63 TG-----NVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGG-MLGIFKDGY-F 115
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
SN + A+EFDT + + D +G H+GINVNS++SIK P + +G+
Sbjct: 116 NKSNQIVAVEFDTFSNGDW--DPKGRHLGINVNSIESIKTVP-----------WNWTNGE 162
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
+I Y+ + + ++ + + ++ +D+ E + GFSA
Sbjct: 163 VANVFISYEASTKSLTASLVYPSL----------ETSFIIDAIVDVKIVLPEWVRFGFSA 212
Query: 262 STGRK---VSSHFILGWSFSMNGAA 283
+TG V ++ +L WSF N
Sbjct: 213 TTGIDKGYVQTNDVLSWSFESNLPG 237
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 36/276 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F F + +I + A+ +G L+L G A Y+ P+Q+ D
Sbjct: 7 FTFPNFW-SDVEDSIIFQGDANT--TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 63
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
T + +SF T F F + +G GLAF ++P S E+ ST
Sbjct: 64 KT-----ESVASFYTEFTFFLKITGNG-PADGLAFFLAPPDSDVKDAGEYLGLFNKSTAT 117
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
N + A+EFDT + H+GINVNS+ S+ + ED + SG
Sbjct: 118 QPSKNQVVAVEFDTWTNP-NFPEPSYRHIGINVNSIVSVATKRW--------EDSDIFSG 168
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
A I YDG ++ V + S +LS +D+ E++ VG S
Sbjct: 169 KIATARISYDGSAEILTV-----------VLSYPDGSDYILSHSVDMRQNLPESVRVGIS 217
Query: 261 ASTGRKVS-SHFILGWSFSMNGAAPSLNLSQIPSLP 295
ASTG + +IL W FS N + S+ + P +
Sbjct: 218 ASTGNNQFLTVYILSWRFSSNLQSTSVKAAMEPEIT 253
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 3e-52
Identities = 80/278 (28%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F FNET + +R + + SG LRLT+ N +G AFY+ PIQ+ D
Sbjct: 6 FNFQRFNETN-----LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
+T +SF+T F F I PN+ GLAF + P S P G L +
Sbjct: 61 TTG-----TVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD----KGGFLGLFDG 111
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
+ H A+EFDT+ + D H+GI+VNS++SIK + +G
Sbjct: 112 SNSNFHTVAVEFDTLYNKDW--DPTERHIGIDVNSIRSIKTTRWDFV-----------NG 158
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
+ + I YD L+ ++ ++ + ++S +DL E + VGFS
Sbjct: 159 ENAEVLITYDSSTNLLVASLVYPSQ----------KTSFIVSDTVDLKSVLPEWVSVGFS 208
Query: 261 ASTG---RKVSSHFILGWSFSMN----GAAPSLNLSQI 291
A+TG V ++ +L WSF+ + LNL+ +
Sbjct: 209 ATTGINKGNVETNDVLSWSFASKLSDETTSEGLNLANL 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-52
Identities = 66/273 (24%), Positives = 115/273 (42%), Gaps = 44/273 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVL------------PTRMREFAAEIESLGRLRHKHLVNLQGW 411
+ EV+G G FG V K + + F E+ L R+ H ++V L G
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C + LV +Y GSL ++L E + + + G+ YLH + +I
Sbjct: 70 CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 471 HRDVKSGNVLIDADMN-ARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
HRD+K N+L+ A ++ DFG A +H TN G+ ++APE+ S
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 530 TDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG----QVLDVVDPNLG---SSYV 582
DVF++G++L E+ T R+P F +G +++ V +
Sbjct: 184 CDVFSWGIILWEVITRRKP--------------FDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+E ++ C + RP+M ++++ +
Sbjct: 230 PKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 62/313 (19%), Positives = 122/313 (38%), Gaps = 66/313 (21%)
Query: 336 AQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR--------- 386
++F L +++ + + IG GGFG V+KG L
Sbjct: 6 SEFPKSRLPTLA------DNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL 52
Query: 387 --------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDS 432
+EF E+ + L H ++V L G +V +++P G L
Sbjct: 53 ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYH 110
Query: 433 LLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-----ADMNA 487
L ++ + W + ++ IA G+ Y+ ++HRD++S N+ + A + A
Sbjct: 111 RL-LDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCA 168
Query: 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST--DVFAYGVLLLEIATG 545
++ DFGL++ H + ++G ++APE + S + D +++ ++L I TG
Sbjct: 169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 546 RRPIDSDHFILVDWVLEFQHLGQVLDV---VDPNLGSSYVVAEMELVLQLGLLCSHQKAE 602
P D + + ++ + G + P L + LC +
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR------------NVIELCWSGDPK 272
Query: 603 ARPTMRQVLRYLN 615
RP +++ L+
Sbjct: 273 KRPHFSYIVKELS 285
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 2e-51
Identities = 77/272 (28%), Positives = 118/272 (43%), Gaps = 50/272 (18%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F FN F++ + + +R + + + L LT + V G A Y KP+Q+ D +
Sbjct: 6 FNFNQFHQNEEQ---LKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQ-GGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
T N +SF T F F I P GL F ++P P+ G+ Y GI N +
Sbjct: 63 TG-----NVASFETRFSFSIRQPFPRPHPADGLVFFIAP-PNTQTGEGGGYFGIYNPLS- 115
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
A+EFDT + T D Q H+GI+VNS+ S K P FTL++G
Sbjct: 116 ---PYPFVAVEFDT---FRNTWDPQIPHIGIDVNSVISTKTVP-----------FTLDNG 158
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
I YD ++++V + + + ++ +DL E++ VGFS
Sbjct: 159 GIANVVIKYDASTKILHVVLVFPSL----------GTIYTIADIVDLKQVLPESVNVGFS 208
Query: 261 ASTG-------RKVSSHFILGWSFSMNGAAPS 285
A+TG +H IL WSFS + +
Sbjct: 209 AATGDPSGKQRNATETHDILSWSFSASLPGTN 240
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 46/296 (15%)
Query: 339 EILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL--------------- 383
+ +DWE+ + + IG+G FG VYKG
Sbjct: 14 DAADDWEIP------DGQI-------TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 60
Query: 384 PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
P +++ F E+ L + RH +++ G+ L +V + SL L +E
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET-KFE 118
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
++ +I + A G+ YLH + +IHRD+KS N+ + D ++GDFGLA
Sbjct: 119 MKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 504 SHT-TNVVGTIGYIAPELARTGKASCST---DVFAYGVLLLEIATGRRPIDS-DHFILVD 558
SH + G+I ++APE+ R ++ + DV+A+G++L E+ TG+ P + ++ +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
++ L L V N L+ + C +K + RP+ ++L +
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMK----RLMAE----CLKKKRDERPSFPRILAEI 283
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-51
Identities = 65/271 (23%), Positives = 105/271 (38%), Gaps = 36/271 (13%)
Query: 21 SQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV---IGHAFYNKPIQM 77
F F+ F + N I + + + +G L++T + IG A Y PIQ+
Sbjct: 2 LSDDLSFNFDKFVPNQKN---IIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQI 58
Query: 78 LDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNS 137
D T +SF+T F F + S F P G + G+ +S
Sbjct: 59 WDSIT-----GKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSS 113
Query: 138 TNDHKPSNHLFAIEFDTV-NGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFT 196
++ K SN + A+EFDT D H+GI+VNS+KSIK +
Sbjct: 114 SD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-----------WD 161
Query: 197 LESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256
+G+ I Y + + V + + +++ +DL E +
Sbjct: 162 WRNGEVADVVITYRAPTKSLTVCLSYPSDGTS----------NIITASVDLKAILPEWVS 211
Query: 257 VGFSASTGR--KVSSHFILGWSFSMNGAAPS 285
VGFS G + +H +L W F+ N A +
Sbjct: 212 VGFSGGVGNAAEFETHDVLSWYFTSNLEANN 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-51
Identities = 67/318 (21%), Positives = 109/318 (34%), Gaps = 86/318 (27%)
Query: 341 LEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----------------P 384
+ SDL EV+G G FG+ K
Sbjct: 2 MPHRIFR------PSDL-------IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE 48
Query: 385 TRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSW 444
R F E++ + L H +++ G + + L + +YI G+L ++ ++ W
Sbjct: 49 ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPW 107
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504
QR + K IA+G+ YLH +IHRD+ S N L+ + N + DFGLARL K
Sbjct: 108 SQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 505 -------------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551
VVG ++APE+ DVF++G++L EI
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--- 221
Query: 552 DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM---------------ELVLQLGLLC 596
DP+ + + + + C
Sbjct: 222 ----------------------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
Query: 597 SHQKAEARPTMRQVLRYL 614
E RP+ ++ +L
Sbjct: 260 CDLDPEKRPSFVKLEHWL 277
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-51
Identities = 54/296 (18%), Positives = 109/296 (36%), Gaps = 54/296 (18%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----------------PT 385
+ +D + L + GE++KG
Sbjct: 3 KHSGID------FKQL-------NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR 49
Query: 386 RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
+ R+F E L H +++ + G C+ L+ ++P GSL ++L + NFV+
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
Q +A G+ +LH E ++ + S +V+ID DM AR+ + F
Sbjct: 110 QSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----- 163
Query: 504 SHTTNVVGTIGYIAPELARTGKASCST---DVFAYGVLLLEIATGRRPIDSDHFILVDWV 560
+ + ++APE + + D++++ VLL E+ T P + +
Sbjct: 164 -QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222
Query: 561 LEFQHLG-QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ + L + + P++ +L+ C ++ RP ++ L
Sbjct: 223 VALEGLRPTIPPGISPHVS--------KLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 44/264 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F F FN + N + + +++ +G L LT A +G A Y PI + D +
Sbjct: 6 FSFTNFNPNQNN---LILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
T +SF+T F F + P + GLAF ++P + P + + +D
Sbjct: 63 TL-------ASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHD- 114
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
S A+EFDT Y+ D H+GI+ N ++S K P F + G+
Sbjct: 115 -ASYQTVAVEFDT---YSNAWDPNYTHIGIDTNGIESKKTTP-----------FDMVYGE 159
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
I Y + + ++ + +S +DL E + VGFSA
Sbjct: 160 KANIVITYQASTKALAASL----------VFPVSQTSYAVSARVDLRDILPEYVRVGFSA 209
Query: 262 STGRK---VSSHFILGWSFSMNGA 282
+TG V +H I+ WSF+++ A
Sbjct: 210 TTGLNAGVVETHDIVSWSFAVSLA 233
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 6e-50
Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 43/265 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLDK 80
F F+ F N +T + A+++ SG L+LT N G Y KP+ M D
Sbjct: 6 FSFSEFEPGNDN---LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDS 62
Query: 81 STSLSSKPNASSFSTCFVFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+T +SF T F F I P GL F + P S P YLG+ N++
Sbjct: 63 TTG-----TVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNSK 116
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
S A+EFDT + N Q H+GI+VNS++SIK +P F L++
Sbjct: 117 QDN-SYQTLAVEFDTFS--NPWDPPQVPHIGIDVNSIRSIKTQP-----------FQLDN 162
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G I YD +++++V + + + ++ +D+ + + VG
Sbjct: 163 GQVANVVIKYDAPSKILHVVLVYPSS----------GAIYTIAEIVDVKQVLPDWVDVGL 212
Query: 260 SASTGRK---VSSHFILGWSFSMNG 281
S +TG + +H + WSF +
Sbjct: 213 SGATGAQRDAAETHDVYSWSFQASL 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 344 WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGV------------------LPT 385
E+D +++L E+IG GGFG+VY+ +
Sbjct: 2 LEID------FAEL-------TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQ 48
Query: 386 RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWE 445
+ E + L+H +++ L+G C ++ +L LV ++ G L+ +L + +
Sbjct: 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPD 105
Query: 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID--------ADMNARLGDFGLARL 497
N IA G+ YLH+E +IHRD+KS N+LI ++ ++ DFGLAR
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV 557
+ + + G ++APE+ R S +DV++YGVLL E+ TG P + V
Sbjct: 166 WHR---TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222
Query: 558 DWVLEFQHL-GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ + L + +L+ C + +RP+ +L L
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFA--------KLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 35/260 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV----IGHAFYNKPIQMLDKST 82
F F F++ + ++ + + + +G L+L +N+ G A Y PI + + +T
Sbjct: 6 FKFKNFSQNGKD---LSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNT 62
Query: 83 SLSSKPNASSFSTCFVFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
+SF T F F + T N GL F ++P P P +A Y G+ N T
Sbjct: 63 G-----ELASFITSFSFFMETSANPKAATDGLTFFLAP-PDSPLRRAGGYFGLFNDTK-C 115
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
S A+EFDT+ D H+GI+VN +KSI E + +
Sbjct: 116 DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW---------NKRYGLNN 166
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
I Y+ ++ + ++ + + ++ +DL E + VGFS
Sbjct: 167 VANVEIIYEASSKTLTASL----------TYPSDQTSISVTSIVDLKEILPEWVSVGFSG 216
Query: 262 STGRKV-SSHFILGWSFSMN 280
ST ++H +L W F+
Sbjct: 217 STYIGRQATHEVLNWYFTST 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-49
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 57/303 (18%)
Query: 341 LEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL---------------PT 385
L++W++ + L + E+IG G FG+VY G
Sbjct: 25 LQEWDIP------FEQL-------EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNED 71
Query: 386 RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWE 445
+++ F E+ + + RH+++V G C L ++ +L S++ D + VL
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVN 130
Query: 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505
+ I + I G+ YLH + ++H+D+KS NV D + + DFGL + +
Sbjct: 131 KTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186
Query: 506 ----TTNVVGTIGYIAPELARTGKASCST---------DVFAYGVLLLEIATGRRPIDSD 552
G + ++APE+ R DVFA G + E+ P +
Sbjct: 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
Query: 553 HFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ W + PNL + E+ +L C + E RPT +++
Sbjct: 247 PAEAIIWQMGTGMK--------PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMD 295
Query: 613 YLN 615
L
Sbjct: 296 MLE 298
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 171 bits (433), Expect = 6e-49
Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F FN + I + A++ S LRLT N +G AFY+ PIQ+ DK
Sbjct: 6 FSFKNFNSS----SFILQGDATV--SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDK 59
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
ST +S++T F I PN G+AF + P S P + +LG+ +S
Sbjct: 60 STG-----AVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSG-FLGVFDSDVY 113
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
S A+EFDT + + D H+GI+VNS+KSI+ L +G
Sbjct: 114 D-NSAQTVAVEFDTFSNTDW--DPTSRHIGIDVNSIKSIRTASW-----------GLANG 159
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
+ I Y+ L+ ++ + + + ++S +D++ E + +GFS
Sbjct: 160 QNAEILITYNAATSLLVASLVHPS----------RRTSYIVSERVDITNELPEYVSIGFS 209
Query: 261 ASTGRK---VSSHFILGWSFSMN----GAAPSLNLSQI 291
A+TG +H +L WSF+ L+++
Sbjct: 210 ATTGLSEGYTETHDVLSWSFASKLPDDSTTEPLDIASY 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-49
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 49/291 (16%)
Query: 368 EVIGTGGFGEVYKG----------VLPTR-MREFAAEIE--SLGRLRHKHLVNLQGWCKR 414
E +G G +GEV++G + +R + + E E + LRH++++
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 415 KRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ--- 467
R L L+ Y GSL L L I+ IA+GL +LH E
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 468 --VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS---HTTNVVGTIGYIAPEL-- 520
+ HRD+KS N+L+ + + D GLA + VGT Y+APE+
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 521 ----ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV---DWVLEFQHLGQVLDVV 573
+ D++A+G++L E+A D V + VV
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 574 ---------DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
S + + +++ C +Q AR T ++ + L
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 47/260 (18%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV---IGHAFYNKPIQMLDKSTS 83
F FN+T + + + + G L LT+ N +G AFY+ PIQ+ D++
Sbjct: 6 FNVETFNKTN-----LILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 84 LSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKP 143
N +SFST F F+I N +GLAF + P S P K YLG+ N+TN
Sbjct: 61 -----NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGR-YLGLFNTTNYD-R 113
Query: 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPV 203
H A+ FDT N + I+VNS++ I E +F +G+
Sbjct: 114 DAHTVAVVFDT----------VSNRIEIDVNSIRPIATESC---------NFGHNNGEKA 154
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST 263
+ I YD + V++ + + +S + L ++ + VGFSA++
Sbjct: 155 EVRITYDSPKNDLRVSLLYPSS----------EEKCHVSATVPLEKEVEDWVSVGFSATS 204
Query: 264 G---RKVSSHFILGWSFSMN 280
G +H +L WSFS N
Sbjct: 205 GSKKETTETHNVLSWSFSSN 224
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 4e-48
Identities = 79/271 (29%), Positives = 118/271 (43%), Gaps = 49/271 (18%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F+ F E + +R + +K +G L LT N G A Y +PI++ D
Sbjct: 5 FNFDHFEENSKE---LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDS 61
Query: 81 STSLSSKPNASSFSTCFVFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+T N +SF T F F I P + GL F + P P+ P G+ LG+
Sbjct: 62 TTG-----NVASFETRFSFNITQPYAYPEPADGLTFFMVP-PNSPQGEDGGNLGVFKPPE 115
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
++ FA+EFDT + T D Q H+GI+VNS+ S K F LE+
Sbjct: 116 ----GDNAFAVEFDT---FQNTWDPQVPHIGIDVNSIVSSK-----------TLHFQLEN 157
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAF--QETMYV 257
G I YD +++NV + + + LS +DL F E + V
Sbjct: 158 GGVANVVIKYDSPTKILNVVLAFHS----------VGTVYTLSNIVDLKQEFPNSEWVNV 207
Query: 258 GFSASTGRK---VSSHFILGWSFSMNGAAPS 285
G SA+TG + V +H I+ WSF+ + +
Sbjct: 208 GLSATTGYQKNAVETHEIISWSFTSSLQETN 238
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 70/261 (26%), Positives = 116/261 (44%), Gaps = 39/261 (14%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F N F + + + + + + +G L+LT + +G A Y P+++ +
Sbjct: 6 FTINNFVPNEAD---LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNT 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTND 140
T + +SFST F F + PN GLAF ++P S P G YLG+ N++N
Sbjct: 63 TG-----SVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN- 116
Query: 141 HKPSNHLFAIEFDTV-NGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
SN + A+EFDT + D H+GI+VN ++SIK + +
Sbjct: 117 SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI-----------N 165
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G A I Y N+ + ++ + + ++ +DL E + VGF
Sbjct: 166 GGVAFATITYLAPNKTLIASL----------VYPSNQTTFSVAASVDLKEILPEWVRVGF 215
Query: 260 SASTGR--KVSSHFILGWSFS 278
SA+TG +V +H +L WSF+
Sbjct: 216 SAATGYPTEVETHDVLSWSFT 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 49/291 (16%)
Query: 368 EVIGTGGFGEVYKG----------VLPTR-MREFAAEIE--SLGRLRHKHLVNLQGWCKR 414
E IG G FGEV++G + +R R + E E LRH++++ +
Sbjct: 48 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 415 KRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ--- 467
L LV DY +GSL L ++ E + A+GL +LH E
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 468 --VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVVGTIGYIAPEL-- 520
+ HRD+KS N+L+ + + D GLA D + + VGT Y+APE+
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 521 ----ARTGKASCSTDVFAYGVLLLEIATGRRPIDS-DHFILV--DWVLEFQHLGQVLDVV 573
+ ++ D++A G++ EIA + + L D V + ++ VV
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284
Query: 574 ---------DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
S + M +++ C + AR T ++ + L+
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 60/288 (20%), Positives = 107/288 (37%), Gaps = 43/288 (14%)
Query: 368 EVIGTGGFGEVYKG----------VLPTR-MREFA--AEIESLGRLRHKHLVNLQGWCKR 414
+ IG G +GEV+ G V T + EI +RH++++ +
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 415 KRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE-----W 465
L L+ DY NGSL L L + + +GL +LH E
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH---TTNVVGTIGYIAPEL-- 520
+ + HRD+KS N+L+ + + D GLA F VGT Y+ PE+
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 521 ----ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ---HLGQVLDVV 573
++ D++++G++L E+A + + + ++V
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 574 D-----PNLGSSYVVAE-MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
P+ + + E + + +L C +R T +V + L
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 8e-46
Identities = 62/267 (23%), Positives = 98/267 (36%), Gaps = 38/267 (14%)
Query: 27 FIFNGF--NETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQML 78
F + F K + A+ + GAL+LT N G A Y++P+ +
Sbjct: 6 FTYPDFWSYSLKNGTEITFLGDATRI--PGALQLTKTDANGNPVRSSAGQASYSEPVFLW 63
Query: 79 DKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNST 138
D S A+SF T F F + GLAF ++P S + T
Sbjct: 64 D------STGKAASFYTSFTFLL-KNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHET 116
Query: 139 NDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLE 198
N + A+EFDT + +D H+GI+VNS+ S+ E+
Sbjct: 117 AADPSKNQVVAVEFDTWI-NKDWNDPPYPHIGIDVNSIVSVATTRW--------ENDDAY 167
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
A I YD ++++ V + +LS +DL+ + + +G
Sbjct: 168 GSSIATAHITYDARSKILTVL-----------LSYEHGRDYILSHVVDLAKVLPQKVRIG 216
Query: 259 FSASTGRKVSSHFILGWSFSMNGAAPS 285
FSA G +IL W F +
Sbjct: 217 FSAGVGY-DEVTYILSWHFFSTLDGTN 242
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 73/277 (26%), Positives = 108/277 (38%), Gaps = 53/277 (19%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLD 79
F F F+ T+ LI + A+I G L+LT N +G AFY+ PIQ+
Sbjct: 5 SFNFPNFH---TDDKLILQGNATIS-SKGQLQLTGVGSNELPRVDSLGRAFYSDPIQI-- 58
Query: 80 KSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
N +SF+T F F I N +GLAF + P + P K + +LGI N+ N
Sbjct: 59 -----KDSNNVASFNTNFTFIIRAKNQSISAYGLAFALVP-VNSPPQKKQEFLGIFNTNN 112
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
P+ A+ F+T N + + N +K E DF +
Sbjct: 113 PE-PNARTVAVVFNTFK----------NRIDFDKNFIKPYVNENC---------DFHKYN 152
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G+ I YD N + V + + +S + L E + VGF
Sbjct: 153 GEKTDVQITYDSSNNDLRVFLHFTVS----------QVKCSVSATVHLEKEVDEWVSVGF 202
Query: 260 SASTG---RKVSSHFILGWSFSMNGAAPSLN--LSQI 291
S ++G +H +L WSFS N L+ I
Sbjct: 203 SPTSGLTEDTTETHDVLSWSFSSKFRNKLSNILLNNI 239
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 55/275 (20%), Positives = 98/275 (35%), Gaps = 62/275 (22%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLS 85
FI + FN+T + + + + +G L+L+ N+++ + AFY+ PIQ+ D +T
Sbjct: 5 SFIIDAFNKTN-----LILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTG-- 57
Query: 86 SKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSN 145
N +SF T F I T GL F + P
Sbjct: 58 ---NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPE-------------------SKG 95
Query: 146 HLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQA 205
+EFDT + + I+VN+ D G +
Sbjct: 96 DTVTVEFDTFL----------SRISIDVNNNDI----------KSVPWDVHDYDGQNAEV 135
Query: 206 WIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGR 265
I Y+ ++ +V++ +S ++L + + VGFSA++G
Sbjct: 136 RITYNSSTKVFSVSLSNP----------STGKSNNVSTTVELEKEVYDWVSVGFSATSGA 185
Query: 266 ---KVSSHFILGWSFSMNGAAPSLNLSQIPSLPIE 297
+H +L WSFS S+ ++ +
Sbjct: 186 YQWSYETHDVLSWSFSSKFINLKDQKSERSNIVLN 220
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 22/194 (11%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
F+ F+ + N LI + L LT N +G A Y+ PI + D+ T
Sbjct: 6 FLITKFSPDQQN--LIFQGDGYT--TKEKLTLTKAVKNTVGRALYSSPIHIWDRETG--- 58
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
N ++F T F F I PNS G F ++P YLG+ NS +
Sbjct: 59 --NVANFVTSFTFVINAPNSYNVADGFTFFIAPVD-TKPQTGGGYLGVFNSAEYD-KTTQ 114
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAW 206
A+EFDT ++ H+GI+VNS+KS+ + + L++G+
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----------WKLQNGEEANVV 163
Query: 207 IDYDGVNRLVNVTI 220
I ++ ++ V++
Sbjct: 164 IAFNAATNVLTVSL 177
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 368 EVIGTGGFGEVYKG------------VLPTRMRE-------FAAEIESLGRLRHKHLVNL 408
+ +G GG VY + RE F E+ + +L H+++V++
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ LV +YI +L + + LS + N I G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
++HRD+K N+LID++ ++ DFG+A+ ++ T +V+GT+ Y +PE A+
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 529 STDVFAYGVLLLEIATGRRPIDSD 552
TD+++ G++L E+ G P + +
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 368 EVIGTGGFGEVYKG------------VLPTRMRE-------FAAEIESLGRLRHKHLVNL 408
++G GG G+VY+ ++ + E + GRL+ H+V +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ + L + I L ++L L+ + I++ I + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
HRDVK N+L+ AD A L DFG+A K++ N VGT+ Y+APE A+
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 529 STDVFAYGVLLLEIATGRRPIDSD 552
D++A +L E TG P D
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGD 238
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 68/299 (22%), Positives = 114/299 (38%), Gaps = 50/299 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------PTRMREFAAEIESLGRLRHKHLVNL 408
+G G +GEVY+GV + EF E + ++H +LV L
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
G C R+ ++ +++ G+L L + +S + I++ + YL + +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KN 338
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
IHR++ + N L+ + ++ DFGL+RL + I + APE K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 529 STDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD-------PNLGSS 580
+DV+A+GVLL EIAT G P L QV ++++ P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP------------YPGIDLSQVYELLEKDYRMERPEGCPE 446
Query: 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSR 639
V M C RP+ ++ + + S D E+ R
Sbjct: 447 KVYELM-------RACWQWNPSDRPSFAEIHQAFE-----TMFQESSISDEVEKELGKR 493
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 51/280 (18%)
Query: 368 EVIGTGGFGEVYKG------------VLPTRMRE-------FAAEIESLGRLRHKHLVNL 408
E++G GG EV+ VL + F E ++ L H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 409 --QGWCKRKRDLL--LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
G + L +V +Y+ +L ++ + ++ ++ +I L + H+
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQ- 134
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK--ISHTTNVVGTIGYIAPELAR 522
+IHRDVK N++I A ++ DFG+AR ++ T V+GT Y++PE AR
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582
+DV++ G +L E+ TG P D + V +QH+ + D + P+ +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----AYQHVRE--DPIPPSARHEGL 246
Query: 583 VAEME-LVLQLGLLCSHQKAEAR-PTMRQVLRYLNGDELL 620
A+++ +VL KA A+ P RY E+
Sbjct: 247 SADLDAVVL---------KALAKNPEN----RYQTAAEMR 273
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 61/280 (21%)
Query: 368 EVIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRLRHKHLVNLQG 410
E IG G FGEV+ G L P +F E L + H ++V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C +K+ + +V + + G + L L + ++ AAG+ YL + I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI-----APELARTGK 525
HRD+ + N L+ ++ DFG++R G + + G + + APE G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS----GGLRQVPVKWTAPEALNYGR 291
Query: 526 ASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL--GQVLDVVD-------P 575
S +DV+++G+LL E + G P + +L Q + V+ P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--------------YPNLSNQQTREFVEKGGRLPCP 337
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
L V M C + RP+ + + L
Sbjct: 338 ELCPDAVFRLM-------EQCWAYEPGQRPSFSTIYQELQ 370
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFA-AEIESLGRLRHKHL 405
+ + + IG G FG+ + ++ RE + E+ L ++H ++
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V + + L +V DY G L + + + +Q + I L ++H+
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-- 143
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+ ++HRD+KS N+ + D +LGDFG+AR+ + +GT Y++PE+
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
+ +D++A G +L E+ T +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------EFAAEIESLGRLRHKHLVNLQGWCK 413
+G G FGEV+ G R F E + + +LRH+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ + +V +Y+ GSL L L Q ++ IA+G+ Y+ +HRD
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVF 533
+++ N+L+ ++ ++ DFGLARL + + + I + APE A G+ + +DV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 534 AYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD-------PNLGSSYVVAE 585
++G+LL E+ T GR P +VLD V+ P +
Sbjct: 366 SFGILLTELTTKGRVPYPG------------MVNREVLDQVERGYRMPCPPECPESLHDL 413
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
M C ++ E RPT + +L
Sbjct: 414 M-------CQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 1e-33
Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------EFAAEIESLGRLRHKHLVNLQGWCK 413
+G G FGEV+ G R F E + + +LRH+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ + +V +Y+ GSL L L Q ++ IA+G+ Y+ +HRD
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVF 533
+++ N+L+ ++ ++ DFGLARL + + + I + APE A G+ + +DV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 534 AYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVD-------PNLGSSYVVAE 585
++G+LL E+ T GR P +VLD V+ P +
Sbjct: 449 SFGILLTELTTKGRVPYPG------------MVNREVLDQVERGYRMPCPPECPESLHDL 496
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
M C ++ E RPT + +L
Sbjct: 497 M-------CQCWRKEPEERPTFEYLQAFLE 519
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 58/277 (20%), Positives = 111/277 (40%), Gaps = 50/277 (18%)
Query: 364 FKQSEVIGTGGFGEVYKG------------VLPTRMREFAAEIESLGRLRHKHLV----- 406
FK+ E+IG+GGFG+V+K + + E+++L +L H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 407 -----------NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
+ + + L + ++ G+L+ + L + + I
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
G+ Y+H + +I+RD+K N+ + ++GDFGL + T GT+ Y
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRTRSKGTLRY 187
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575
++PE + D++A G++L E+ F+ D+ D
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------------AFETSKFFTDLRDG 234
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ + E L+ +L L +K E RP ++LR
Sbjct: 235 IISDIFDKKEKTLLQKL-L---SKKPEDRPNTSEILR 267
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 71/302 (23%), Positives = 118/302 (39%), Gaps = 64/302 (21%)
Query: 368 EVIGTGGFGEVYKGVL---------------PTRMREFAAEIESLGRLRHKHLVNLQGWC 412
+G G +GEVY+GV + EF E + ++H +LV L G C
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472
R+ ++ +++ G+L L + +S + I++ + YL ++ IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 473 DVKSGNVLIDADMNARLGDFGLARLFD--------HGKISHTTNVVGTIGYIAPELARTG 524
D+ + N L+ + ++ DFGL+RL K I + APE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--------IKWTAPESLAYN 187
Query: 525 KASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQ--HLGQVLDVVDPNLGSSY 581
K S +DV+A+GVLL EIAT G P + L QV ++++ Y
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLE----KDY 229
Query: 582 VVAEMEL----VLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMN 637
+ E V +L C RP+ ++ + + S D E+
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE-----TMFQESSISDEVEKELG 284
Query: 638 SR 639
R
Sbjct: 285 KR 286
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMR------------- 388
++WE+ R + K E +G G FGEV+ G +
Sbjct: 6 DEWEVP-----RET--------LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP 52
Query: 389 -EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR 447
F AE + +L+H+ LV L + + ++ +Y+ NGSL L L+ +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507
++ IA G+ ++ E + IHRD+++ N+L+ ++ ++ DFGLARL + + +
Sbjct: 112 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
I + APE G + +DV+++G+LL EI T GR P
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 49/272 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------EFAAEIESLGRLRHKHLVNLQGWCK 413
+ +G+G FG V G + EF E +++ +L H LV G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
++ + +V +YI NG L + L + L Q + + G+ +L IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELARTGKASCST 530
+ + N L+D D+ ++ DFG+ R + VGT + + APE+ K S +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 531 DVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL--GQVLDVVDPNLGSSYVVAEME 587
DV+A+G+L+ E+ + G+ P + +V+ V + +
Sbjct: 187 DVWAFGILMWEVFSLGKMP--------------YDLYTNSEVVLKVS----QGHRLYRPH 228
Query: 588 L----VLQLGLLCSHQKAEARPTMRQVLRYLN 615
L + Q+ C H+ E RPT +Q+L +
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 364 FKQSEVIGTGGFGEVYKGVLP--------------TRMREFAAEIESLGRLRHKHLVNLQ 409
K + +G G FGEV+ + F AE + L+H LV L
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
++ + ++ +++ GSL L +E + + IA G+ ++ + +
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 305
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
IHRD+++ N+L+ A + ++ DFGLAR+ + + + I + APE G +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 530 TDVFAYGVLLLEIAT-GRRP 548
+DV+++G+LL+EI T GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 49/272 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------EFAAEIESLGRLRHKHLVNLQGWCK 413
+ +GTG FG V G + EF E + + L H+ LV L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
++R + ++ +Y+ NG L + L + + +Q + K + + YL + +HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELARTGKASCST 530
+ + N L++ ++ DFGL+R T+ VG+ + + PE+ K S +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 531 DVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL--GQVLDVVDPNLGSSYVVAEME 587
D++A+GVL+ EI + G+ P ++ + + + +
Sbjct: 203 DIWAFGVLMWEIYSLGKMP--------------YERFTNSETAEHIA----QGLRLYRPH 244
Query: 588 L----VLQLGLLCSHQKAEARPTMRQVLRYLN 615
L V + C H+KA+ RPT + +L +
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 56/318 (17%)
Query: 368 EVIGTGGFGEVYKGVLPTRM--------------------REFAAEIESLGRLRHKHLVN 407
+V+G G FGEV G L R+F E +G+ H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L+G + + +++V +Y+ NGSLDS L ++ + Q +++GIA+G+ YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLS---DM 166
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELARTGK 525
+HRD+ + N+LI++++ ++ DFGL R+ + + T G I + +PE K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 526 ASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG--QVLDVVDPNLGSSYV 582
+ ++DV++YG++L E+ + G RP + + V+ VD Y
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP--------------YWEMSNQDVIKAVD----EGYR 268
Query: 583 VAEMEL----VLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNS 638
+ + QL L C + RP Q++ L+ +I N SL S
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD-----KLIRNPGSLKIITSAAAR 323
Query: 639 RYLEIISTDNITTSQLSS 656
++ N+ + +
Sbjct: 324 PSNLLLDQSNVDITTFRT 341
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 36/229 (15%)
Query: 352 FRYSDLYTATKGF---------KQSEVIGTGGFGEVYKGVLPTRMR-------------- 388
Y + A + F ++IG+G GEV G L +
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 389 ------EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVL 442
+F +E +G+ H +++ L+G R R ++V +Y+ NGSLD+ L ++
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QF 148
Query: 443 SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502
+ Q +++G+ AG+ YL + +HRD+ + NVL+D+++ ++ DFGL+R+ +
Sbjct: 149 TIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 503 ISHTTNVVGT--IGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+ T G I + APE S ++DV+++GV++ E+ G RP
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGV--------------LPTRM----REFA-AEIESLGRLRHKH 404
F+ + IG G F EVY+ + M R EI+ L +L H +
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL---------FDNENFVLSWEQRFNIIKGIA 455
++ +L +V + G L ++ E V + +
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTVWKY------FVQLC 146
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
+ L ++H + V+HRD+K NV I A +LGD GL R F K + ++VGT Y
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 202
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
++PE + +D+++ G LL E+A + P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 368 EVIGTGGFGEVYKGVLPTRMR--------------EFAAEIESLGRLRHKHLVNLQGWCK 413
+ IG+G FG V+ G + + +F E E + +L H LV L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+ + LV +++ +G L L + + E + + G+ YL E VIHRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELARTGKASCST 530
+ + N L+ + ++ DFG+ R T+ GT + + +PE+ + S +
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 531 DVFAYGVLLLEIAT-GRRP 548
DV+++GVL+ E+ + G+ P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+V+G+G FG VYKG+ P +E E + + + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C + L+ +P G L + ++++ + + N IA G+ YL +
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELART 523
+ ++HRD+ + NVL+ + ++ DFGLA+L + + G I ++A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
+ +DV++YGV + E+ T G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 73/307 (23%), Positives = 143/307 (46%), Gaps = 60/307 (19%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
+ +VIG G FGEVYKG+L + +F E +G+ H
Sbjct: 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+++ L+G + + ++++ +Y+ NG+LD L + + S Q +++GIAAG+ YL
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA 164
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGT---IGYIAP 518
+HRD+ + N+L+++++ ++ DFGL+R L D + ++TT+ G I + AP
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAP 219
Query: 519 ELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG--QVLDVVDP 575
E K + ++DV+++G+++ E+ T G RP + L +V+ ++
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP--------------YWELSNHEVMKAIN- 264
Query: 576 NLGSSYVVAEMEL----VLQLGLLCSHQKAEARPTMRQVLRYLN----GDELLPIIDNWS 627
+ + + QL + C Q+ RP ++ L+ + L + ++
Sbjct: 265 ---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFD 321
Query: 628 SLDSQRS 634
S R
Sbjct: 322 PRVSIRL 328
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 42/238 (17%)
Query: 335 IAQFEILED-WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL---------- 383
+A EI LD L K +G+G FG V KG
Sbjct: 1 MALEEIRPKEVYLD------RKLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVA 48
Query: 384 ----------PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSL 433
P E AE + +L + ++V + G C+ + +LV + G L+
Sbjct: 49 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKY 107
Query: 434 LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
L N + + + ++ ++ G+ YL E E +HRD+ + NVL+ A++ DFG
Sbjct: 108 LQQNRH--VKDKNIIELVHQVSMGMKYL--E-ESNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 494 LARLFDHGKISHTTNVVGT--IGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
L++ + + G + + APE K S +DV+++GVL+ E + G++P
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 27/201 (13%)
Query: 370 IGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQG 410
+G G FG V +GV R E E + + +L + ++V L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
C+ + L+LV + G L L + ++ ++ G+ YL E + +
Sbjct: 78 VCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE---KNFV 132
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELARTGKASC 528
HRD+ + NVL+ A++ DFGL++ +T G + + APE K S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 529 STDVFAYGVLLLEIAT-GRRP 548
+DV++YGV + E + G++P
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 48/241 (19%), Positives = 86/241 (35%), Gaps = 44/241 (18%)
Query: 343 DWELDCPH-RFRYSDLYTATKG------FKQSEVIGTGGFGEVY--------------KG 381
E CP+ YS L G ++ I GG G +Y KG
Sbjct: 54 ASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG 113
Query: 382 VLPTRMREFAA----EIESLGRLRHKHLVNL--QGWCKRKRDLLLVY---DYIPNGSLDS 432
++ + E A E + L + H +V + + + Y +Y+ SL
Sbjct: 114 LVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR 173
Query: 433 LLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492
L + + I L YLH +++ D+K N+++ + +L D
Sbjct: 174 SKGQK----LPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDL 225
Query: 493 GLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
G +I+ + GT G+ APE+ R + +TD++ G L + +
Sbjct: 226 GAVS-----RINSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGR 279
Query: 553 H 553
+
Sbjct: 280 Y 280
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-31
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 23/141 (16%)
Query: 145 NHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQ 204
+++ A+EFDT + D H+GI+VNS++S + +G
Sbjct: 1 SNVVAVEFDTYLN-PDYGDPNYIHIGIDVNSIRSKVTAKWDWQ-----------NGKIAT 48
Query: 205 AWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTG 264
A I Y+ V++ ++VT K LS ++L E + VG SASTG
Sbjct: 49 AHISYNSVSKRLSVTSYYAGSKP-----------ATLSYDIELHTVLPEWVRVGLSASTG 97
Query: 265 RKVSSHFILGWSFSMNGAAPS 285
+ + + WSF+ +
Sbjct: 98 QDKERNTVHSWSFTSSLWTNV 118
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 368 EVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWC-KR 414
+ IG G FG+V G + F AE + +LRH +LV L G +
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV 474
K L +V +Y+ GSL L VL + + + YL +HRD+
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDL 143
Query: 475 KSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELARTGKASCSTD 531
+ NVL+ D A++ DFGL + ++ + + APE R K S +D
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 532 VFAYGVLLLEIAT-GRRP 548
V+++G+LL EI + GR P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 21/195 (10%)
Query: 368 EVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWC-KR 414
+ IG G FG+V G + F AE + +LRH +LV L G +
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDV 474
K L +V +Y+ GSL L VL + + + YL +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDL 315
Query: 475 KSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFA 534
+ NVL+ D A++ DFGL + + T + + + APE R K S +DV++
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWS 371
Query: 535 YGVLLLEIAT-GRRP 548
+G+LL EI + GR P
Sbjct: 372 FGILLWEIYSFGRVP 386
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 39/275 (14%)
Query: 364 FKQSEVIGTGGFGEVYK-----------------GVLPTRMREFA-AEIESLGRLRHKHL 405
++ IGTG +G K G + ++ +E+ L L+H ++
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 406 VNLQGW--CKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYL 461
V + L +V +Y G L S++ E L E ++ + L
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 462 HE--EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
H + V+HRD+K NV +D N +LGDFGLAR+ +H S VGT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPE 186
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPID-SDHFILVDWVLEFQHLGQVLDVVDPNLG 578
+ +D+++ G LL E+ P L + E G+ +
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKF-----RRIP 237
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
Y E++ + + K RP++ ++L
Sbjct: 238 YRYSDELNEIITR----MLNLKDYHRPSVEEILEN 268
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 364 FKQSEVIGTGGFGEVYKG------------------VLPTRMREFAAEIESLGRLRHKHL 405
K IG G F VYKG + + + F E E L L+H ++
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 406 VNLQG----WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
V K K+ ++LV + + +G+L + L V+ + + + I GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 462 HEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
H +IHRD+K N+ I + ++GD GLA L S V+GT ++APE+
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM 201
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRP 548
S DV+A+G+ +LE+AT P
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL------------------ 383
D+E+ R + IG G FG+V++G+
Sbjct: 8 RDYEIQ-----RER--------IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 54
Query: 384 --PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFV 441
+ +F E ++ + H H+V L G + ++ + G L S L +
Sbjct: 55 TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY-S 112
Query: 442 LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501
L ++ L YL + +HRD+ + NVL+ ++ +LGDFGL+R +
Sbjct: 113 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+ I ++APE + + ++DV+ +GV + EI G +P
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 53/309 (17%)
Query: 368 EVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVN 407
+G G FG V P + R+F EI+ L L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 408 LQGWCKRKRD--LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+G L LV +Y+P+G L L + L + I G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLG--- 144
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELART 523
+ +HRD+ + N+L++++ + ++ DFGLA+L K + G I + APE
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP--IDSDHFILVDWVLEFQHLGQVLDVVD------ 574
S +DV+++GV+L E+ T + ++ ++ + L ++L++++
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP 264
Query: 575 -PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQR 633
P + V M LC + RP+ + L+ WS
Sbjct: 265 APPACPAEVHELM-------KLCWAPSPQDRPSFSALGPQLD--------MLWSGSRGCE 309
Query: 634 SEMNSRYLE 642
+ + + E
Sbjct: 310 THAFTAHPE 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 69/286 (24%), Positives = 114/286 (39%), Gaps = 48/286 (16%)
Query: 365 KQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHK 403
K+ +G G FG+V P + EI+ L L H+
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 404 HLVNLQGWCKRKRD--LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++ +G C+ L LV +Y+P GSL L + + Q + I G+ YL
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 150
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPE 519
H Q IHRD+ + NVL+D D ++GDFGLA+ G + G + + APE
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQ--HLGQVLDVVD-- 574
+ K ++DV+++GV L E+ T L + + ++ ++++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267
Query: 575 -----PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
P+ + V M C +A RPT ++ L
Sbjct: 268 ERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPILK 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 27/204 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------------AEIESLGRL-RHKH 404
F++ +G G +GEV+K R +A AE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
V L+ + L L + SL + L Q + ++ L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHS- 175
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
Q ++H DVK N+ + +LGDFGL G Y+APEL + G
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-G 230
Query: 525 KASCSTDVFAYGVLLLEIATGRRP 548
+ DVF+ G+ +LE+A
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 46/283 (16%)
Query: 368 EVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVN 407
+ +G G FG V +R+F EIE L L+H ++V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 408 LQGWCKR--KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+G C +R+L L+ +Y+P GSL L ++ + + I G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELART 523
+ IHRD+ + N+L++ + ++GDFGL ++ K G I + APE
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG----QVLDVVD----- 574
K S ++DV+++GV+L E+ T S + + + +++++
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 575 --PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
P+ + M C + RP+ R + ++
Sbjct: 252 PRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVD 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+V+G+G FG VYKG+ P +E E + + + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C + L+ +P G L + ++++ + + N IA G+ YL +
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELART 523
+ ++HRD+ + NVL+ + ++ DFGLA+L + + G I ++A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
+ +DV++YGV + E+ T G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 36/278 (12%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+G G FG+V + + EIE L L H+++V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 407 NLQGWCKRKRD--LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+G C + L+ +++P+GSL L N+N ++ +Q+ I G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGS- 144
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELAR 522
+ +HRD+ + NVL++++ ++GDFGL + + K +T + + APE
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 523 TGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581
K ++DV+++GV L E+ T L + V +V+ L
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT-VTRLVN-TLKEGK 260
Query: 582 VVAEMEL----VLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ V QL C + R + + ++
Sbjct: 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 30/210 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRLR 401
+ E +G G FG V +G P M +F E+ ++ L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++L+ L G + +V + P GSL L ++ +A G+ YL
Sbjct: 80 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYL 137
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPE 519
+ IHRD+ + N+L+ ++GDFGL R + + APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+T S ++D + +GV L E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 66/283 (23%)
Query: 368 EVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVN 407
++G G FGEVY+GV +F +E + L H H+V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L G + + ++ + P G L L N+N L I + YL
Sbjct: 78 LIGIIEEEP-TWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLES---I 132
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFD--------HGKISHTTNVVGTIGYIAPE 519
+HRD+ N+L+ + +LGDFGL+R + ++ I +++PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--------IKWMSPE 184
Query: 520 LARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL--GQVLDVVDPN 576
+ + ++DV+ + V + EI + G++P F L V+ V++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP--------------FFWLENKDVIGVLE-- 228
Query: 577 LGSSYVVAEMEL----VLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ + +L + L C RP +++ L+
Sbjct: 229 --KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 57/317 (17%), Positives = 103/317 (32%), Gaps = 65/317 (20%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
F+ + +G GGFG V++ + E+++L +L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 407 ---------NLQGWCKRKRDLLLVY---DYIPNGSLDSLLFDNENFVLSWEQR-FNIIKG 453
N + + +Y +L + +I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV---- 509
IA + +LH + ++HRD+K N+ D ++GDFGL D + T
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 510 -------VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562
VGT Y++PE S D+F+ G++L E+ P +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-------ER 233
Query: 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPI 622
+ L V ++ P L + E +V + L RP ++ +
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINIIEN-------AV 282
Query: 623 IDNWSSLDSQRSEMNSR 639
++ SR
Sbjct: 283 FEDLDFPGKTVLRQRSR 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 62/283 (21%), Positives = 115/283 (40%), Gaps = 46/283 (16%)
Query: 368 EVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVN 407
+ +G G FG V +R+F EIE L L+H ++V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 408 LQGWCKR--KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+G C +R+L L+ +Y+P GSL L ++ + + I G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELART 523
+ IHRD+ + N+L++ + ++GDFGL ++ K + G I + APE
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG----QVLDVVD----- 574
K S ++DV+++GV+L E+ T S + + + +++++
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 575 --PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
P+ + M C + RP+ R + ++
Sbjct: 283 PRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVD 318
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 368 EVIGTGGFGEVYKGVL-------------------PTRM--REFAAEIESLGRLRHKHLV 406
+V+G+G FG V+KGV R + + ++G L H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C L LV Y+P GSL + + L + N IA G+ YL E
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPELART 523
++HR++ + NVL+ + ++ DFG+A L I ++A E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHF 191
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
GK + +DV++YGV + E+ T G P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 63/304 (20%), Positives = 116/304 (38%), Gaps = 65/304 (21%)
Query: 369 VIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQ 409
+G G FG V +GV R E E + + +L + ++V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G C+ + L+LV + G L L + ++ ++ G+ YL E +
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT--IGYIAPELARTGKAS 527
+HR++ + NVL+ A++ DFGL++ +T G + + APE K S
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 528 CSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG--QVLDVVD-------PNL 577
+DV++YGV + E + G++P ++ + +V+ ++ P
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP--------------YKKMKGPEVMAFIEQGKRMECPPE 563
Query: 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMN 637
+ A M C K E RP V + + + SL S+ +
Sbjct: 564 CPPELYALM-------SDCWIYKWEDRPDFLTVEQRMR--------ACYYSLASKVEGGS 608
Query: 638 SRYL 641
+ +
Sbjct: 609 ALEV 612
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 47/209 (22%), Positives = 79/209 (37%), Gaps = 37/209 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGV--------------LPTRMREFAAEIESLGRLRHKHLVNLQ 409
+G G FGEV++ L E E+ + L +V L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---ELVACAGLSSPRIVPLY 116
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
G + + + + + GSL L+ E+ L + GL YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRAL------YYLGQALEGLEYLH-- 167
Query: 465 WEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPE 519
+ ++H DVK+ NVL+ +D A L DFG A + + + GT ++APE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ D+++ ++L + G P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 47/202 (23%), Positives = 85/202 (42%), Gaps = 26/202 (12%)
Query: 368 EVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVN 407
IG G FG+V++G+ + +F E ++ + H H+V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L G + ++ + G L S L + L ++ L YL +
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---K 510
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
+HRD+ + NVL+ ++ +LGDFGL+R + + I ++APE + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 528 CSTDVFAYGVLLLEIAT-GRRP 548
++DV+ +GV + EI G +P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 368 EVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRLRHKHLVN 407
EVIG G FG VY G L + +F E + H ++++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 408 LQGWCKRKRD-LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C R L+V Y+ +G L + + + + + + +A G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLAS--- 146
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLF---DHGKISHTTNVVGTIGYIAPELART 523
+ +HRD+ + N ++D ++ DFGLAR ++ + + T + ++A E +T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP 548
K + +DV+++GVLL E+ T G P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 70/292 (23%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-----------------------PTRMREFAAEIESLGRL 400
+E +G G F +++KGV F + +L
Sbjct: 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
HKHLV G C + +LV +++ GSLD+ L N+N ++ + + K +AA + +
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHF 128
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNAR--------LGDFGLARLF---DHGKISHTTNV 509
L E +IH +V + N+L+ + + + L D G++ D +
Sbjct: 129 LE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER----- 180
Query: 510 VGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW----VLEF 563
I ++ PE K + +TD +++G L EI + G +P L L+F
Sbjct: 181 ---IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------LSALDSQRKLQF 230
Query: 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
L P L C + + RP+ R ++R LN
Sbjct: 231 YEDRHQLP--APKAAELA---------NLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 368 EVIGTGGFGEVYKGV----------------LPTRMRE-FAAEIESLGRLRHKHLVNL-- 408
E +GTGGFG V + + L + RE + EI+ + +L H ++V+
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 409 ----QGWCKRKRDLLLVYDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHE 463
LL +Y G L L EN L ++ I++ L YLHE
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 464 EWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
+IHRD+K N+++ + ++ D G A+ D G++ VGT+ Y+APEL
Sbjct: 140 ---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPEL 194
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSD--------------HFILVDWVLEFQHL 566
K + + D +++G L E TG RP + + +V + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ PN S + ++E LQ L+ ++ R T Q
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ---RGTDPQNPN 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 37/222 (16%)
Query: 359 TATKGFKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLR 401
T+ + S+++G G V++G + E E L +L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 402 HKHLVNLQG--WCKRKRDLLLVYDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGL 458
HK++V L R +L+ ++ P GSL ++L + N + L + +++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 459 LYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIG 514
+L E ++HR++K GN++ D +L DFG AR + + + + GT
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEE 180
Query: 515 YIAPELARTGKA--------SCSTDVFAYGVLLLEIATGRRP 548
Y+ P++ + D+++ GV ATG P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 37/215 (17%)
Query: 364 FKQSEVIGTGGFGEVYKG------------VLP------TRMRE-FAAEIESLGRLRHKH 404
+ + +G GGF + ++ ++P RE + EI L H+H
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGL 458
+V G+ + + +V + SL + + + ++ I G
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSL----LE----LHKRRKALTEPEARYYLRQIVLGC 128
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
YLH VIHRD+K GN+ ++ D+ ++GDFGLA ++ + GT YIAP
Sbjct: 129 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
E+ S DV++ G ++ + G+ P ++
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 66/304 (21%), Positives = 125/304 (41%), Gaps = 54/304 (17%)
Query: 368 EVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRLRHKHLVN 407
EVIG G FG VY G L + +F E + H ++++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 408 LQGWCKRKRD-LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L G C R L+V Y+ +G L + + + + + + +A G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLAS--- 210
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLF---DHGKISHTTNVVGTIGYIAPELART 523
+ +HRD+ + N ++D ++ DFGLAR + + + T + ++A E +T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
K + +DV+++GVLL E+ T G P +++ + + G+ L P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLL--QPEYCP 322
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSR 639
+ M L C H KAE RP+ +++ + + + + +N+
Sbjct: 323 DPLYEVM-------LKCWHPKAEMRPSFSELVSRI--SAIFS-----TFIGEHYVHVNAT 368
Query: 640 YLEI 643
Y+ +
Sbjct: 369 YVNV 372
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 37/215 (17%)
Query: 364 FKQSEVIGTGGFGEVYKG------------VLP------TRMRE-FAAEIESLGRLRHKH 404
+ + +G GGF + ++ ++P RE + EI L H+H
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGL 458
+V G+ + + +V + SL + + + ++ I G
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSL----LE----LHKRRKALTEPEARYYLRQIVLGC 154
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
YLH VIHRD+K GN+ ++ D+ ++GDFGLA ++ + GT YIAP
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
E+ S DV++ G ++ + G+ P ++
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 50/221 (22%)
Query: 368 EVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRL-RHKHLVN 407
+VIG G FG+V K + R+FA E+E L +L H +++N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLL--------------FDNENFVLSWEQRFNIIKG 453
L G C+ + L L +Y P+G+L L ++ LS +Q +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
+A G+ YL ++ IHRD+ + N+L+ + A++ DFGL+R + V T+
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200
Query: 514 GYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
G + A E + ++DV++YGVLL EI + G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 75/344 (21%), Positives = 128/344 (37%), Gaps = 74/344 (21%)
Query: 332 YRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL-------- 383
Y A + ++WE+ + S +G G FG VY+GV
Sbjct: 8 YFSAADVYVPDEWEVA-REKITMS------------RELGQGSFGMVYEGVAKGVVKDEP 54
Query: 384 PTR--------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429
TR EF E + H+V L G + + L++ + + G
Sbjct: 55 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 430 LDSLL--------FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481
L S L + S + + IA G+ YL+ +HRD+ + N ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171
Query: 482 DADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI-----APELARTGKASCSTDVFAY 535
D ++GDFG+ R I T G G + +PE + G + +DV+++
Sbjct: 172 AEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 536 GVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594
GV+L EIAT +P + + VL F G +LD P+ + M
Sbjct: 227 GVVLWEIATLAEQPYQG---LSNEQVLRFVMEGGLLDK--PDNCPDMLFELM-------R 274
Query: 595 LCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNS 638
+C + RP+ +++ + E + + + SE N
Sbjct: 275 MCWQYNPKMRPSFLEIISSI--KEEME--PGFREVSFYYSEENK 314
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 29/209 (13%)
Query: 365 KQSEVIGTGGFGEVYKGVLPTR--------------------MREFAAEIESLGRLRHKH 404
VIG G FG VY G + + F E + L H +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 405 LVNLQGWCKRKRD-LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
++ L G ++ Y+ +G L + + + + + +A G+ YL E
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAE 142
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT---IGYIAPEL 520
Q +HRD+ + N ++D ++ DFGLAR + + + A E
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 521 ARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+T + + +DV+++GVLL E+ T G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 46/235 (19%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA---------------AEIESLGRLRHKHLVNL 408
F++ V+G G FG+V K R +A +E+ L L H+++V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 409 -------------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
K+K L + +Y NG+L L+ +EN ++ + + + I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL 126
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH-------------GK 502
L Y+H Q +IHRD+K N+ ID N ++GDFGLA+ G
Sbjct: 127 EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 503 ISHTTNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL 556
+ T+ +GT Y+A E L TG + D+++ G++ E+ IL
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 44/222 (19%), Positives = 74/222 (33%), Gaps = 44/222 (19%)
Query: 364 FKQSEVIGTGGFGEVY-------------KGVLPTRMREFAA---EIESLGRLRHKHLVN 407
+ + +G GGF V K +L ++ E + H +++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 408 LQGWCKRKRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRF------NIIKGIAAG 457
L +C R+R L+ + G+L ++ + ++ GI G
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT--------NV 509
L +H + HRD+K N+L+ + L D G
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 510 VGTIGYIAPEL---ARTGKASCSTDVFAYGVLLLEIATGRRP 548
TI Y APEL TDV++ G +L + G P
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 39/214 (18%)
Query: 364 FKQSEVIGTGGFGEVY------------------KGVLPTRMRE-FAAEIESLGRLRHKH 404
F+ +G G FG VY + + E+E LRH +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGL 458
++ L G+ + L+ +Y P G++ + L +F+ I +A L
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTV----YR----ELQKLSKFDEQRTATYITELANAL 122
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
Y H + VIHRD+K N+L+ + ++ DFG + + T + GT+ Y+ P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPP 176
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
E+ D+++ GVL E G+ P +++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
+ S+++G G V++G + E E L +L HK++V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 407 NLQGW--CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF-NIIKGIAAGLLYLHE 463
L R +L+ ++ P GSL ++L + N E F +++ + G+ +L E
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 464 EWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
++HR++K GN++ D +L DFG AR + + + + GT Y+ P+
Sbjct: 131 ---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPD 185
Query: 520 L--------ARTGKASCSTDVFAYGVLLLEIATGRRP 548
+ K + D+++ GV ATG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 364 FKQSEVIGTGGFGEVYKG------------------VLPTRMRE-FAAEIESLGRLRHKH 404
FK ++G G F VY+ + M + E++ +L+H
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
++ L + + + LV + NG ++ L + E R + I G+LYLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHS- 130
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
++HRD+ N+L+ +MN ++ DFGLA H T + GT YI+PE+A
Sbjct: 131 --HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+DV++ G + + GR P D+D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDT 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 69/294 (23%)
Query: 368 EVIGTGGFGEVYKGVLPTRM----------------------REFAAEIESLGRLRHKHL 405
E +G FG+VYKG L EF E RL+H ++
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--------------ENFVLSWEQRFNII 451
V L G + + L +++ Y +G L L L +++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 452 KGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVG 511
IAAG+ YL V+H+D+ + NVL+ +N ++ D GL R + +
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYKLL 187
Query: 512 TIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP----IDSDHFILVDWVL 561
+ APE GK S +D+++YGV+L E+ + G +P + D V+
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VV 240
Query: 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
E QVL P+ ++V A M + C ++ RP + + L
Sbjct: 241 EMIRNRQVLPC--PDDCPAWVYALM-------IECWNEFPSRRPRFKDIHSRLR 285
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 61/288 (21%)
Query: 368 EVIGTGGFGEVYKGVLPTR---------------------MREFAAEIESLGRLRHKHLV 406
+G G FG+V+ ++F E E L L+H+H+V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLL-------------FDNENFVLSWEQRFNIIKG 453
G C R LL+V++Y+ +G L+ L D L Q +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
+AAG++YL +HRD+ + N L+ + ++GDFG++R VG
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGR 219
Query: 514 GYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW-VLEFQHL 566
+ PE K + +DV+++GV+L EI T G++P + L + ++
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WYQLSNTEAIDCITQ 275
Query: 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
G+ L+ P V A M C ++ + R +++ V L
Sbjct: 276 GRELER--PRACPPEVYAIM-------RGCWQREPQQRHSIKDVHARL 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 365 KQSEVIGTGGFGEVYKGVLPTRMREFA----------------AEIESLGRLRHKHLVNL 408
V+G G +G VY G + A EI L+HK++V
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF-NIIKGIAAGLLYLHEEWEQ 467
G + + + +P GSL +LL + EQ K I GL YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 141
Query: 468 VVIHRDVKSGNVLIDADM-NARLGDFGLA-RLFDHGKISHTTNVVGTIGYIAPELARTGK 525
++HRD+K NVLI+ ++ DFG + RL + T GT+ Y+APE+ G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 526 ASCST--DVFAYGVLLLEIATGRRP 548
D+++ G ++E+ATG+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 4e-27
Identities = 32/137 (23%), Positives = 59/137 (43%), Gaps = 23/137 (16%)
Query: 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPV 203
++ + A+E DT + D H+GI++ S++S K + +++G
Sbjct: 1 ADTIVAVELDTYPNT-DIGDPSYPHIGIDIKSVRSKKTAK-----------WNMQNGKVG 48
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST 263
A I Y+ V++ ++ + + +S +DL E + VG SAST
Sbjct: 49 TAHIIYNSVDKRLSAVV-----------SYPNADSATVSYDVDLDNVLPEWVRVGLSAST 97
Query: 264 GRKVSSHFILGWSFSMN 280
G ++ IL WSF+
Sbjct: 98 GLYKETNTILSWSFTSK 114
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 4e-15
Identities = 28/134 (20%), Positives = 47/134 (35%), Gaps = 12/134 (8%)
Query: 12 FFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVI----- 66
F + + S + + FN+ +Q + + + G L LT + N
Sbjct: 110 SFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSS 169
Query: 67 -GHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPG 125
G A + P+ + + S +SF F F I +P+S F + S P
Sbjct: 170 VGRALFYAPVHIWESSA------VVASFEATFTFLIKSPDSHPADGIAFFISNIDSSIPS 223
Query: 126 GKAEHYLGILNSTN 139
G LG+ N
Sbjct: 224 GSTGRLLGLFPDAN 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 57/284 (20%)
Query: 368 EVIGTGGFGEVYKGVL--------PTR--------------MREFAAEIESLGRLRHKHL 405
+G G FGEVY+G + P + +F E + + H+++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN-----ENFVLSWEQRFNIIKGIAAGLLY 460
V G + ++ + + G L S L + + L+ ++ + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 461 LHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDHGKISHT-TNVVGTIGYI 516
L E IHRD+ + N L+ A++GDFG+AR I G +
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207
Query: 517 -----APELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVL 570
PE G + TD +++GVLL EI + G P S VLEF G +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRM 264
Query: 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
D P V M C + E RP +L +
Sbjct: 265 DP--PKNCPGPVYRIM-------TQCWQHQPEDRPNFAIILERI 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 62/289 (21%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+G G FG+V+ ++F E E L L+H+H+V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--------------ENFVLSWEQRFNIIK 452
G C L++V++Y+ +G L+ L + L Q +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGT 512
IA+G++YL Q +HRD+ + N L+ A++ ++GDFG++R S VG
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV----YSTDYYRVGG 193
Query: 513 IGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW-VLEFQH 565
+ PE K + +DV+++GV+L EI T G++P F L + V+E
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSNTEVIECIT 249
Query: 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
G+VL+ P + V M L C ++ + R ++++ + L
Sbjct: 250 QGRVLER--PRVCPKEVYDVM-------LGCWQREPQQRLNIKEIYKIL 289
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 67/284 (23%), Positives = 103/284 (36%), Gaps = 57/284 (20%)
Query: 368 EVIGTGGFGEVYKGVLPTR----------------------MREFAAEIESLGRLRHKHL 405
+G G FGEVY+G + +F E + + H+++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN-----ENFVLSWEQRFNIIKGIAAGLLY 460
V G + ++ + + G L S L + + L+ ++ + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 461 LHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDHGKISHT-TNVVGTIGYI 516
L E IHRD+ + N L+ A++GDFG+AR I G +
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248
Query: 517 -----APELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVL 570
PE G + TD +++GVLL EI + G P S VLEF G +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRM 305
Query: 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
D P V M C + E RP +L +
Sbjct: 306 DP--PKNCPGPVYRIM-------TQCWQHQPEDRPNFAIILERI 340
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/343 (19%), Positives = 111/343 (32%), Gaps = 83/343 (24%)
Query: 341 LEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----------------- 383
LED + ++G G FG V + L
Sbjct: 15 LEDVLIP------EQQF-------TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 384 ----PTRMREFAAEIESLGRLRHKHLVNLQGWC------KRKRDLLLVYDYIPNGSLDSL 433
+ + EF E + H H+ L G R +++ ++ +G L +
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 434 L----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489
L F L + + IA G+ YL + IHRD+ + N ++ DM +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178
Query: 490 GDFGLARLFDHGKISHTTNVVGTIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT 544
DFGL+R G G + A E + +DV+A+GV + EI T
Sbjct: 179 ADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
Query: 545 -GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQK 600
G+ P I++ + + G L P V M C
Sbjct: 235 RGQTPYAGIENAE------IYNYLIGGNRLKQ--PPECMEEVYDLM-------YQCWSAD 279
Query: 601 AEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRSEMNSRYLEI 643
+ RP+ + L + +L L + + Y+ I
Sbjct: 280 PKQRPSFTCLRMEL--ENIL------GHLSVLSTSQDPLYINI 314
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 54/273 (19%), Positives = 106/273 (38%), Gaps = 39/273 (14%)
Query: 364 FKQSEVIGTGGFGEVY------------KGVLPTRMREFAAEIESLGRL-RHKHLVNLQG 410
F +V+G G G + K +LP E++ L H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
K ++ + + +L + + ++F + +++ +GL +LH ++
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIV 140
Query: 471 HRDVKSGNVLI-----DADMNARLGDFGLARLFDHGKIS--HTTNVVGTIGYIAPEL--- 520
HRD+K N+LI + A + DFGL + G+ S + V GT G+IAPE+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 521 ARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
+ + D+F+ G + + + G P LD + P
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----QRQANILLGACSLDCLHPEKHE 256
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ EL+ + ++ + RP+ + VL+
Sbjct: 257 DVIAR--ELIEK--MIAMDPQ--KRPSAKHVLK 283
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV-LPT----------------RMREFAAEIESLGRLRHKHLV 406
F + E IG G FGEV+KG+ T + + EI L + ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G + L ++ +Y+ GS LL E L Q I++ I GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 137
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPELAR 522
+ IHRD+K+ NVL+ +L DFG+A G+++ T VGT ++APE+ +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRP 548
D+++ G+ +E+A G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 43/217 (19%)
Query: 368 EVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRHKHLV 406
+++G G FG V +G L + EF +E + H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 407 NLQGWCKRKRDLLLVYDYI-----PNGSLDSLL----FDNENFVLSWEQRFNIIKGIAAG 457
L G C + + G L + L + + + + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI- 516
+ YL + +HRD+ + N ++ DM + DFGL++ G G I +
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 517 ----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
A E + +DV+A+GV + EIAT G P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 39/324 (12%), Positives = 76/324 (23%), Gaps = 71/324 (21%)
Query: 344 WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA----------- 392
W + S L + K E + G V+ R+ +FA
Sbjct: 45 WPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR 103
Query: 393 --------EIESLGRLRHKHLVNLQGWCK--------------------------RKRDL 418
+ RL + + + +
Sbjct: 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163
Query: 419 LLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
LL+ + L+ L + + L + ++H
Sbjct: 164 LLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH 219
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL--ARTGKASCSTD 531
N+ I D LGD + + Y E A T + + +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 532 VFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM-ELVL 590
+ G+ + + P F LV ++ L V + + + + V
Sbjct: 276 AWQLGLSIYRVWCLFLP-----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK 330
Query: 591 QL--GLLCSHQKAEARPTMRQVLR 612
L L R + +
Sbjct: 331 TLIGRFLNFD--RRRRLLPLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 25/244 (10%), Positives = 61/244 (25%), Gaps = 58/244 (23%)
Query: 364 FKQSEVIGTGGFGEVYKG------------VLPT----------RMREFAAEIESLGRLR 401
+ V+G + V +M+E + L ++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 402 HKHLVNLQGWCKRKRDLLLVYD--------------YIPN------------GSLDSLLF 435
++ + DL+ ++ + + +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 436 DN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493
+ + L R + + L LH ++H ++ ++++D L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 494 LARLFDHGKISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRP 548
+S A + + + D + G+ + I P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 549 IDSD 552
D
Sbjct: 317 NTDD 320
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHK- 403
+ + + IG+GG +V++ + + + + EI L +L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 404 -HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ L + + + +V + N L+S L ++ +R + K + + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIH 125
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPEL- 520
+ ++H D+K N LI D +L DFG+A + VGT+ Y+ PE
Sbjct: 126 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 521 ----------ARTGKASCSTDVFAYGVLLLEIATGRRP 548
K S +DV++ G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGV--------------LPTRMREFAAEIESLGRLRHKHLVNLQ 409
F E +G G +G VYK + + + ++E EI + + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G + DL +V +Y GS+ ++ L+ ++ I++ GL YLH
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF---MRK 146
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPELARTGK 525
IHRD+K+GN+L++ + +A+L DFG+A G+++ T V+GT ++APE+ +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMAPEVIQEIG 201
Query: 526 ASCSTDVFAYGVLLLEIATGRRP 548
+C D+++ G+ +E+A G+ P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHK- 403
+ + + IG+GG +V++ + + + + EI L +L+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 404 -HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ L + + + +V + N L+S L ++ +R + K + + +H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIH 144
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPEL- 520
+ ++H D+K N LI D +L DFG+A + VGT+ Y+ PE
Sbjct: 145 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 521 ----------ARTGKASCSTDVFAYGVLLLEIATGRRP 548
K S +DV++ G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 369 VIGTGGFGEVY------------------KGVLPTRMRE-FAAEIESLGRLRHKHLVNLQ 409
+G G FG VY + + EIE LRH +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLYLHE 463
+ ++ + L+ ++ P G L + L RF+ ++ +A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGEL----YK----ELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+ VIHRD+K N+L+ ++ DFG + + T GT+ Y+ PE+
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RTM--CGTLDYLPPEMIEG 186
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
D++ GVL E G P DS
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 43/218 (19%), Positives = 86/218 (39%), Gaps = 38/218 (17%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHK- 403
+ + + IG+GG +V++ + + + + EI L +L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 404 -HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ L + + + +V + N L+S L ++ +R + K + + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIH 172
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPEL- 520
+ ++H D+K N LI D +L DFG+A + VG + Y+ PE
Sbjct: 173 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 521 ----------ARTGKASCSTDVFAYGVLLLEIATGRRP 548
K S +DV++ G +L + G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 75/351 (21%), Positives = 132/351 (37%), Gaps = 89/351 (25%)
Query: 331 LYRRIAQFEILED--WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----- 383
+ ++++E+ ED WE + + +G G FG+V
Sbjct: 15 MLAGVSEYELPEDPKWEFP-RDKLTLG------------KPLGEGAFGQVVMAEAVGIDK 61
Query: 384 -------------------PTRMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYD 423
+ + +E+E + + +HK+++NL G C + L ++ +
Sbjct: 62 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121
Query: 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKG--------------IAAGLLYLHEEWEQVV 469
Y G+L L + + N + +A G+ YL Q
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKC 178
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI-----APELART 523
IHRD+ + NVL+ + ++ DFGLAR I++ T G + APE
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
+ +DV+++GVL+ EI T G P I + + + G +D P +
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLKEGHRMDK--PANCT 285
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLD 630
+ + M C H RPT +Q++ L D +L + N LD
Sbjct: 286 NELYMMM-------RDCWHAVPSQRPTFKQLVEDL--DRILTLTTNEEYLD 327
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 34/169 (20%), Positives = 71/169 (42%), Gaps = 13/169 (7%)
Query: 393 EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF---- 448
E++ + +++++ + +G ++ ++Y+Y+ N S+ ++
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 449 --NIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
IIK + Y+H E + + HRDVK N+L+D + +L DFG + KI
Sbjct: 153 IKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI-KG 209
Query: 507 TNVVGTIGYIAPEL--ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ GT ++ PE + D+++ G+ L + P
Sbjct: 210 S--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 37/211 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKH 404
FK +++G G F V RE+A E + + RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGL 458
V L + L Y NG L + F+ I + L
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGEL----L----KYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYIA 517
YLH + +IHRD+K N+L++ DM+ ++ DFG A++ N VGT Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRP 548
PEL A S+D++A G ++ ++ G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 51/292 (17%), Positives = 99/292 (33%), Gaps = 68/292 (23%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFA-AEIESLGRL-RHKH 404
F + E IG+G FG V+K V + + A E+ + L +H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--VLSWEQRFNIIKGIAAGLLYLH 462
+V +L+ +Y GSL + +N + +++ + GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 463 EEWEQVVIHRDVKSGNVLIDAD-------------------MNARLGDFGLARLFDHGKI 503
++H D+K N+ I + ++GD G +I
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-----TRI 184
Query: 504 SHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562
S G ++A E+ + D+FA + ++ A + +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------Q 236
Query: 563 FQHL--GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ + G++ P + EL+ H E RP+ +++
Sbjct: 237 WHEIRQGRL-----PRIPQVLSQEFTELLKV----MIHPDPERRPSAMALVK 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGV-LPT----------------RMREFAAEIESLGRLRHKHLV 406
++ EVIG+G V P M E EI+++ + H ++V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLY 460
+ K +L LV + GS+ ++ + I++ + GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL-ARLFDHGKISHTTN---VVGTIGYI 516
LH+ IHRDVK+GN+L+ D + ++ DFG+ A L G I+ VGT ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 517 APELARTGKA-SCSTDVFAYGVLLLEIATGRRP 548
APE+ + D++++G+ +E+ATG P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/346 (21%), Positives = 124/346 (35%), Gaps = 94/346 (27%)
Query: 331 LYRRIAQFEILED--WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----- 383
L + F+ILED WE + +G G FG+V K
Sbjct: 3 LSLSVDAFKILEDPKWEFP-RKNLVLG------------KTLGEGEFGKVVKATAFHLKG 49
Query: 384 -----------------PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426
P+ +R+ +E L ++ H H++ L G C + LLL+ +Y
Sbjct: 50 RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109
Query: 427 NGSLDSLL------FDNENFVLSWEQRFNIIKG----------------IAAGLLYLHEE 464
GSL L ++ I+ G+ YL E
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE- 168
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI-----AP 518
++HRD+ + N+L+ ++ DFGL+R + + V + G I A
Sbjct: 169 --MKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEEDSYVKRSQGRIPVKWMAI 221
Query: 519 ELARTGKASCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVD 574
E + +DV+++GVLL EI T G P I + + G ++
Sbjct: 222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMER-- 273
Query: 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELL 620
P+ S + M L C Q+ + RP + + L ++++
Sbjct: 274 PDNCSEEMYRLM-------LQCWKQEPDKRPVFADISKDL--EKMM 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 71/333 (21%), Positives = 127/333 (38%), Gaps = 81/333 (24%)
Query: 331 LYRRIAQFEILED--WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----- 383
+ ++++E+ ED WE + + +G G FG+V
Sbjct: 61 MLAGVSEYELPEDPKWEFP-RDKLTLG------------KPLGEGCFGQVVMAEAVGIDK 107
Query: 384 -------------------PTRMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYD 423
+ + +E+E + + +HK+++NL G C + L ++ +
Sbjct: 108 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 167
Query: 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKG--------------IAAGLLYLHEEWEQVV 469
Y G+L L + + N + +A G+ YL Q
Sbjct: 168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKC 224
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI-----APELART 523
IHRD+ + NVL+ + ++ DFGLAR I++ T G + APE
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFD 279
Query: 524 GKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582
+ +DV+++GVL+ EI T G P I V+ + + G +D P ++ +
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGHRMDK--PANCTNEL 334
Query: 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
M C H RPT +Q++ L+
Sbjct: 335 YMMM-------RDCWHAVPSQRPTFKQLVEDLD 360
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/338 (19%), Positives = 118/338 (34%), Gaps = 86/338 (25%)
Query: 337 QFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLP------------ 384
Q WE +R + + +G G FG+V +
Sbjct: 11 QLPYDHKWEFP-RNRLSFG------------KTLGAGAFGKVVEATAYGLIKSDAAMTVA 57
Query: 385 ----------TRMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSL 433
T +E++ L L H ++VNL G C L++ +Y G L +
Sbjct: 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 434 L----------------FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSG 477
L +++ L E + +A G+ +L + IHRD+ +
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR 174
Query: 478 NVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI-----APELARTGKASCSTD 531
N+L+ ++ DFGLAR I + +N VV + APE + +D
Sbjct: 175 NILLTHGRITKICDFGLAR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 532 VFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587
V++YG+ L E+ + G P + D + G + P + + M
Sbjct: 230 VWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKEGFRMLS--PEHAPAEMYDIM- 281
Query: 588 LVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDN 625
C RPT +Q+++ + ++ + N
Sbjct: 282 ------KTCWDADPLKRPTFKQIVQLI--EKQISESTN 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGV-LPT---------------RMREFAAEIESLGRLRHKHLVN 407
++ +G G FG+VYK T + ++ EIE L H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L G L ++ ++ P G++D+++ + + L+ Q + + + L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHS---K 136
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPELART 523
+IHRD+K+GNVL+ + + RL DFG++ K T +GT ++APE+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 524 GKAS-----CSTDVFAYGVLLLEIATGRRP 548
D+++ G+ L+E+A P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 64/302 (21%), Positives = 111/302 (36%), Gaps = 79/302 (26%)
Query: 368 EVIGTGGFGEVYKGVLP----------------------TRMREFAAEIESLGRLRHKHL 405
IG G FG V++ P +F E + + ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLL----------------------FDNENFVLS 443
V L G C + + L+++Y+ G L+ L LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
++ I + +AAG+ YL E+ +HRD+ + N L+ +M ++ DFGL+R I
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224
Query: 504 SHTTN--VVGTIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP---IDSD 552
++ + I PE + + +DV+AYGV+L EI + G +P + +
Sbjct: 225 -YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 553 HFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
V+ + G +L P + M LC + RP+ + R
Sbjct: 284 E------VIYYVRDGNILAC--PENCPLELYNLM-------RLCWSKLPADRPSFCSIHR 328
Query: 613 YL 614
L
Sbjct: 329 IL 330
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 30/193 (15%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHLVNLQGW 411
E +G+G FG V++ V R F A EI + +L H L+NL
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ K +++L+ +++ G L FD E++ +S + N ++ GL ++HE
Sbjct: 117 FEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HS 169
Query: 469 VIHRDVKSGNVLIDADMNARL--GDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
++H D+K N++ + + + DFGLA + +I T + APE+
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPV 227
Query: 527 SCSTDVFAYGVLL 539
TD++A GVL
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 68/304 (22%)
Query: 368 EVIGTGGFGEVYKGVL------------------------PTRMREFAAEIESLGRL-RH 402
+ +G G FG+V + + +E+E + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL--------------FDNENFVLSWEQRF 448
K+++NL G C + L ++ +Y G+L L N LS +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 449 NIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508
+ +A G+ YL + IHRD+ + NVL+ D ++ DFGLAR I H
Sbjct: 195 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246
Query: 509 -VVGTIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVL 561
T G + APE + +DV+++GVLL EI T G P + V+ +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPVEELF 303
Query: 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLP 621
+ G +D P+ ++ + M C H RPT +Q++ L D ++
Sbjct: 304 KLLKEGHRMDK--PSNCTNELYMMM-------RDCWHAVPSQRPTFKQLVEDL--DRIVA 352
Query: 622 IIDN 625
+ N
Sbjct: 353 LTSN 356
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGV----------------LPTRMREFAAEIESLGRLRHKHLVN 407
+ + E IG G G VY + + EI + ++ ++VN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
+L +V +Y+ GSL ++ + Q + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS---N 135
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPELART 523
VIHRD+KS N+L+ D + +L DFG +I+ + +VGT ++APE+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
D+++ G++ +E+ G P +++
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 67/298 (22%), Positives = 112/298 (37%), Gaps = 69/298 (23%)
Query: 368 EVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRL-RHKH 404
+ +G G FG+V + +E++ + L +H++
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL------------FDNENFVLSWEQRFNIIK 452
+VNL G C +L++ +Y G L + L F N S +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVG 511
+A G+ +L + IHRDV + NVL+ A++GDFGLAR I + +N +V
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVK 223
Query: 512 TIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP---IDSDHFILVDWVLE 562
+ APE + +DV++YG+LL EI + G P I + +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-----FYK 278
Query: 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELL 620
G + P + + M C + RPT +Q+ +L E
Sbjct: 279 LVKDGYQMAQ--PAFAPKNIYSIM-------QACWALEPTHRPTFQQICSFL--QEQA 325
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 364 FKQSEVIGTGGFGEVYKG---------------VLPTRMREFAAEIESLGRL-RHKHLVN 407
F+ E++G G +G+VYKG V E EI L + H+++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 408 LQG------WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
G L LV ++ GS+ L+ + + L E I + I GL +L
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H+ VIHRD+K NVL+ + +L DFG++ D T +GT ++APE+
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 201
Query: 522 RTGKASCST-----DVFAYGVLLLEIATGRRP 548
+ +T D+++ G+ +E+A G P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGV----------------LPTRMREFAAEIESLGRLRHKHLVN 407
IG G G V R E+ + +H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
+ +L ++ +++ G+L ++ L+ EQ + + + L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHA---Q 160
Query: 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN----VVGTIGYIAPELART 523
VIHRD+KS ++L+ D +L DFG +IS +VGT ++APE+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ D+++ G++++E+ G P SD
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQ----SEVIGTGGFGEVYKGVLPTRMREFAA----- 392
+++ D ++ + E +GTG FG V++ FAA
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 393 -----------EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD---NE 438
EI+++ LRH LVNL + +++++Y+++ G L F+ +E
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADE 248
Query: 439 NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL--GDFGLAR 496
+ +S ++ ++ + GL ++HE +H D+K N++ + L DFGL
Sbjct: 249 HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLL 539
D + GT + APE+A TD+++ GVL
Sbjct: 306 HLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA--------------------EIESLGRLRHK 403
F IG G FG VY R E A E+ L +LRH
Sbjct: 56 FSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ + +G R+ LV +Y + D L + L + + G GL YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+IHRDVK+GN+L+ +LGDFG A ++ + VGT ++APE+
Sbjct: 173 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILA 224
Query: 524 GKAS---CSTDVFAYGVLLLEIATGRRP 548
DV++ G+ +E+A + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 368 EVIGTGGFGEVYKGVLP----------------------TRMREFAAEIESLGRL-RHKH 404
+ +G G FG+V + + R +E++ L + H +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 405 LVNLQGWC-KRKRDLLLVYDYIPNGSLDSLL--------------FDNENFVLSWEQRFN 449
+VNL G C K L+++ ++ G+L + L D L+ E
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN- 508
+A G+ +L + IHRD+ + N+L+ ++ DFGLAR I +
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204
Query: 509 VVGTIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
V + APE + +DV+++GVLL EI + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
++ ++G G +G V K V MRE I+ L +LR
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQLR 82
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++LVNL CK+K+ LV++++ + ++ L + L ++ + I G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-L 520
H +IHRD+K N+L+ +L DFG AR + V T Y APE L
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELL 196
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGR 546
K + DV+A G L+ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 66/317 (20%), Positives = 116/317 (36%), Gaps = 78/317 (24%)
Query: 368 EVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRL-RHKH 404
+V+G+G FG+V + +E++ + +L H++
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL---------------------FDNENFVLS 443
+VNL G C + L+++Y G L + L + + VL+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
+E +A G+ +L + +HRD+ + NVL+ ++ DFGLAR I
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DI 222
Query: 504 SHTTN-VVGTIGYI-----APELARTGKASCSTDVFAYGVLLLEIAT-GRRP---IDSDH 553
+N VV + APE G + +DV++YG+LL EI + G P I D
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
+ G +D P + + M C + RP+ + +
Sbjct: 283 N-----FYKLIQNGFKMDQ--PFYATEEIYIIM-------QSCWAFDSRKRPSFPNLTSF 328
Query: 614 LNGDELLPIIDNWSSLD 630
L L + +
Sbjct: 329 L--GCQLADAEEAMYQN 343
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLG 398
+ YT ++E++G G FG+V+K + AA EI +
Sbjct: 86 NSFYT----VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIA 455
+L H +L+ L + K D++LV +Y+ G L FD +E++ L+ +K I
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQIC 197
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL--GDFGLARLFDHGKISHTTNVVGTI 513
G+ ++H+ ++H D+K N+L ++ DFGLAR + + GT
Sbjct: 198 EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTP 252
Query: 514 GYIAPELARTGKASCSTDVFAYGVLL 539
++APE+ S TD+++ GV+
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 39/213 (18%), Positives = 76/213 (35%), Gaps = 31/213 (14%)
Query: 364 FKQSEVIGTG--GFGEVYKGV-LPT-----------------RMREFAAEIESLGRLRHK 403
++ VIG G V PT + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
++V + +L +V ++ GS L+ + ++ I++G+ L Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFG-LARLFDHGKISHT-----TNVVGTIGYIA 517
+HR VK+ ++LI D L + HG+ V + +++
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 518 PELARTGKA--SCSTDVFAYGVLLLEIATGRRP 548
PE+ + +D+++ G+ E+A G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ E IG G +G V+K GV + +RE I L L+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 59
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
HK++V L + L LV+++ L D+ N L E + + + GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL- 520
H V+HRD+K N+LI+ + +L +FGLAR F ++ VV T+ Y P++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 521 --ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
A+ S S D+++ G + E+A RP+
Sbjct: 174 FGAKL--YSTSIDMWSAGCIFAELANAGRPL 202
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 39/192 (20%), Positives = 83/192 (43%), Gaps = 29/192 (15%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA---------------EIESLGRLRHKHLVNLQGWC 412
E +G G FG V++ V + + + A EI L RH+++++L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ +L++++++I +F+ F L+ + + + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 470 IHRDVKSGNVLIDADMNARL--GDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
H D++ N++ ++ + +FG AR G + Y APE+ + S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVS 181
Query: 528 CSTDVFAYGVLL 539
+TD+++ G L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 41/222 (18%), Positives = 74/222 (33%), Gaps = 40/222 (18%)
Query: 368 EVIGTGGFGEVYKG---------VL-------PTRMREFAAEIESLGRLR-HKHLVNLQG 410
V+ GGF VY+ L + R E+ + +L H ++V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 411 WCKRKRD--------LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++ LL+ + ++ L LS + I + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT-----------NVVG 511
+ + +IHRD+K N+L+ +L DFG A H +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 512 TIGYIAPEL---ARTGKASCSTDVFAYGVLLLEIATGRRPID 550
T Y PE+ D++A G +L + + P +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 33/206 (16%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ IG G +G V+K + +RE I L +L+
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQLK 60
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H +LVNL +RKR L LV++Y + ++ L D + +I + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-L 520
H+ IHRDVK N+LI +L DFG ARL G + + V T Y +PE L
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELL 174
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGR 546
+ DV+A G + E+ +G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 42/309 (13%)
Query: 264 GRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTVAVILL 323
GR ++ +F+ + P ++ + + F ++ LS
Sbjct: 102 GRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVA----- 156
Query: 324 GTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVY---- 379
F Y F W+ + F+Q V+G GGFGEV
Sbjct: 157 ----PFADYLDSIYFNRFLQWKWLERQPVTKNT-------FRQYRVLGKGGFGEVCACQV 205
Query: 380 -------------KGVLPTRMREFAAEIES--LGRLRHKHLVNLQGWCKRKRDLLLVYDY 424
K + R E A E L ++ + +V+L + K L LV
Sbjct: 206 RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265
Query: 425 IPNGSLDSLLFDNENFVLSWEQ-RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483
+ G L ++ + F + I GL LH + +++RD+K N+L+D
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDD 321
Query: 484 DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIA 543
+ R+ D GLA G+ VGT+GY+APE+ + + + S D +A G LL E+
Sbjct: 322 HGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 544 TGRRPIDSD 552
G+ P
Sbjct: 380 AGQSPFQQR 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMREFAAEIE-----SLGRLR 401
F +IG GGFGEVY K + + E A E +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
+V + L + D + G L L + F + + RF + I GL ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAE-IILGLEHM 308
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H + V++RD+K N+L+D + R+ D GLA F K VGT GY+APE+
Sbjct: 309 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVL 362
Query: 522 RTGKA-SCSTDVFAYGVLLLEIATGRRP 548
+ G A S D F+ G +L ++ G P
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 49/240 (20%), Positives = 84/240 (35%), Gaps = 31/240 (12%)
Query: 387 MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446
M + +I + K+ V K L + +L + + + E
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM-NRRCSLEDREH 163
Query: 447 RF--NIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504
+I IA + +LH + ++HRD+K N+ D ++GDFGL D +
Sbjct: 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 505 HT-----------TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
T T VGT Y++PE S D+F+ G++L E+
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV 280
Query: 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
I+ D V ++ P L + E +V + S RP ++
Sbjct: 281 RIITD----------VRNLKFPLLFTQKYPQEHMMVQD---MLSP-SPTERPEATDIIEN 326
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 55/209 (26%), Positives = 82/209 (39%), Gaps = 43/209 (20%)
Query: 369 VIGTGGFGEVY-----------------KGVLPTRMREFA---AEIESLGRLRHKHLVNL 408
IG G FG+V K E E++ + L H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-VERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNI------IKGIAAGLLYLH 462
+ + D+ +V D + G L + L F I + L YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDL----R----YHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
Q +IHRD+K N+L+D + + DF +A + T + GT Y+APE+
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 523 TGKA---SCSTDVFAYGVLLLEIATGRRP 548
+ K S + D ++ GV E+ GRRP
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ IG G FGEV+K G T +RE I+ L L+
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLK 74
Query: 402 HKHLVNLQG--------WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453
H+++VNL + + K + LV+D+ + L LL N + + +++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQM 132
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVV 510
+ GL Y+H ++HRD+K+ NVLI D +L DFGLAR F K S TN V
Sbjct: 133 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 511 GTIGYIAPEL---ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
T+ Y PEL R D++ G ++ E+ T R PI
Sbjct: 190 VTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLRHKHL 405
E +G+G F V K + E+AA E+ L ++ H ++
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + + D++L+ + + G L FD + LS E+ + IK I G+ YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 464 EWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ + H D+K N+++ + +L DFGLA + G N+ GT ++APE
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 520 LARTGKASCSTDVFAYGVLL 539
+ D+++ GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRLRHKHLV 406
F++ +G G G V+K P + E++ L ++V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF---VLSWEQRFNIIKGIAAGLLYLHE 463
G ++ + +++ GSLD +L +L + + GL YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 149
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLA-RLFDHGKISHTTNVVGTIGYIAPELAR 522
+ + ++HRDVK N+L+++ +L DFG++ +L D S + VGT Y++PE +
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 203
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
S +D+++ G+ L+E+A GR PI
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 72/314 (22%), Positives = 112/314 (35%), Gaps = 50/314 (15%)
Query: 265 RKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNS-FSLQIKILIAALSTVAVILL 323
R + + L + + F ++ ++A L
Sbjct: 103 RPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQ------ 156
Query: 324 GTLLIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVY---- 379
F+ + F W+ F V+G GGFGEV+
Sbjct: 157 ---APFQEFLDSLYFLRFLQWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFACQM 206
Query: 380 -------------KGVLPTRMREFAAEIES--LGRLRHKHLVNLQGWCKRKRDLLLVYDY 424
K L R A +E L ++ + +V+L + K DL LV
Sbjct: 207 KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266
Query: 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGLLYLHEEWEQVVIHRDVKSGN 478
+ G + + V F + I +GL +LH+ + +I+RD+K N
Sbjct: 267 MNGGDI----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPEN 319
Query: 479 VLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVL 538
VL+D D N R+ D GLA G+ + T GT G++APEL + S D FA GV
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 539 LLEIATGRRPIDSD 552
L E+ R P +
Sbjct: 379 LYEMIAARGPFRAR 392
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 364 FKQSEVIGTGGFGEVY------------KGVLPTRMREFAAEIESLGRL-RHKHLVNLQG 410
+++G G G V K +L EI+ L H +++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
R L + + N +L L+ D + ++++ IA+G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 466 EQVVIHRDVKSGNVLID-------------ADMNARLGDFGLARLFDHGKISHTTN---V 509
+IHRD+K N+L+ ++ + DFGL + D G+ S TN
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 510 VGTIGYIAPEL-------ARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDH 553
GT G+ APEL + + S D+F+ G + I + G+ P +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 49/274 (17%)
Query: 368 EVIGTGGFGEVYKGVL-----------------PTRMREFAAEIE-SLGRLRHKHLVNLQ 409
+G G +G V K + +++ S+ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLYLHE 463
G R+ D+ + + + + SLD V+ Q I I L +LH
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGL-ARLFDHGKISHTTNVVGTIGYIAPE--- 519
+ VIHRDVK NVLI+A ++ DFG+ L D ++ + G Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDID-AGCKPYMAPERIN 182
Query: 520 -LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
S +D+++ G+ ++E+A R P D W FQ L QV++ P L
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYD-------SWGTPFQQLKQVVEEPSPQLP 235
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ AE C + ++ RPT ++++
Sbjct: 236 ADKFSAEFVDFTS---QCLKKNSKERPTYPELMQ 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLRHKHL 405
E +G+G F V K + E+AA E+ L ++ H ++
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + + D++L+ + + G L FD + LS E+ + IK I G+ YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 464 EWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ + H D+K N+++ + +L DFGLA + G N+ GT ++APE
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 520 LARTGKASCSTDVFAYGVLL 539
+ D+++ GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 55/247 (22%)
Query: 343 DWELDCP---HRFRYSDLYTATKGFKQSEVIGTGGFGEVYK------------------- 380
D++ R R DL+ +G K +G G +G VYK
Sbjct: 4 DYDFKVKLSSERERVEDLFE-YEGCK----VGRGTYGHVYKAKRKDGKDDKDYALKQIEG 58
Query: 381 -GVLPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRD--LLLVYDYIPN---GSLDSL- 433
G+ + RE I L L+H ++++LQ D + L++DY + +
Sbjct: 59 TGISMSACRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114
Query: 434 --LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR--- 488
+ + L +++ I G+ YLH W V+HRD+K N+L+ + R
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171
Query: 489 -LGDFGLARLFD--HGKISHTTNVVGTIGYIAPEL---ARTGKASCSTDVFAYGVLLLEI 542
+ D G ARLF+ ++ VV T Y APEL AR + + D++A G + E+
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAEL 229
Query: 543 ATGRRPI 549
T PI
Sbjct: 230 LT-SEPI 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 36/207 (17%)
Query: 364 FKQSEVIGTGGFGEVYK---------------------GVLPTRMREFAAEIESLGRLRH 402
+++ E +G G +G VYK G+ T +RE I L L H
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHH 78
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V+L +R L LV++++ L +L D L Q + + G+ + H
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+ ++HRD+K N+LI++D +L DFGLAR F S+T VV T+ Y AP++
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGR 546
++ S S D+++ G + E+ TG+
Sbjct: 193 GSKK--YSTSVDIWSIGCIFAEMITGK 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 45/331 (13%), Positives = 87/331 (26%), Gaps = 89/331 (26%)
Query: 344 WELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKG------------VLPT------ 385
W P R S+L + + V+G + V
Sbjct: 56 WNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS 114
Query: 386 ----RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD------------------ 423
+M+E + L ++++ + DL+
Sbjct: 115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 174
Query: 424 -----YIPNGSLDSLL-----FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473
+L + + + L R + + L LH ++H
Sbjct: 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 231
Query: 474 VKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-----------AR 522
++ ++++D L F + + G+ PEL R
Sbjct: 232 LRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDR 286
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSY 581
+ S D +A G+++ I PI D + +W+ N+
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS----------CKNI-PQP 335
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
V L+ G L E R Q +
Sbjct: 336 V---RALL--EGFLRYP--KEDRLLPLQAME 359
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 364 FKQSEVIGTGGFGEVYK---------------------GVLPTRMREFAAEIESLGRLRH 402
+ E IG G +G VYK G+ T +RE I L L+H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKH 59
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V L K+ L+LV++++ L LL D L + + + G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+ V+HRD+K N+LI+ + ++ DFGLAR F +T +V T+ Y AP++
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGR 546
++ S + D+++ G + E+ G
Sbjct: 174 GSKK--YSTTIDIWSVGCIFAEMVNGT 198
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 42/221 (19%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRL-RHKHL 405
K IG G +G V K V ++ +++ + R ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLL 459
V G R+ D + + + + S D + + I L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFY---KYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVVGTIGYI 516
+L E + +IHRD+K N+L+D N +L DFG++ G++ + T G Y+
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYM 192
Query: 517 APE----LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
APE A +DV++ G+ L E+ATGR P +
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 36/207 (17%)
Query: 364 FKQSEVIGTGGFGEVYK---------------------GVLPTRMREFAAEIESLGRLRH 402
+ + + +G G + VYK G T +RE + L L+H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
++V L ++ L LV++Y+ L L D+ +++ + + GL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+ V+HRD+K N+LI+ +L DFGLAR ++ VV T+ Y P++
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGR 546
+ S D++ G + E+ATGR
Sbjct: 174 GST--DYSTQIDMWGVGCIFYEMATGR 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLRHKHL 405
E +G+G F V K +E+AA E+ L +RH ++
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + K D++L+ + + G L FD E L+ ++ +K I G+ YLH
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 464 EWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ + H D+K N+++ + +L DFG+A + G N+ GT ++APE
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPE 181
Query: 520 LARTGKASCSTDVFAYGVLL 539
+ D+++ GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 42/261 (16%), Positives = 85/261 (32%), Gaps = 45/261 (17%)
Query: 327 LIFKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL--- 383
L+ L + ++ + +W+ P ++ +K ++G G F +VY+
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 384 ---------------PTRMREFAAEIESLGRLR---HKHLVNLQGWCKRKRDLLLVYDYI 425
P EF + + RL+ + + +LV +
Sbjct: 90 NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELY 149
Query: 426 PNGSLDSLLFDNENF---VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI- 481
G+L + + +N V+ + + + +H + +IH D+K N ++
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILG 206
Query: 482 ----------DADMNARLGDFGLA---RLFDHGKISHTTNVVGTIGYIAPELARTGKA-S 527
D L D G + +LF G I T G+ E+ + K +
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVEM-LSNKPWN 263
Query: 528 CSTDVFAYGVLLLEIATGRRP 548
D F + + G
Sbjct: 264 YQIDYFGVAATVYCMLFGTYM 284
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGV-----------------LPTRMRE-FAAEIESLGRLRH 402
++ +++ + +G+G +GEV + T E+ L L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+++ L + + KR+ LV + G L + F + IIK + +G+ YLH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLH 153
Query: 463 EEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ ++HRD+K N+L+ + D ++ DFGL+ +F++ K +GT YIAPE
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPE 208
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ R K DV++ GV+L + G P
Sbjct: 209 VLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 364 FKQSEVIGTGGFGEVYK---------------------GVLPTRMREFAAEIESLGRLRH 402
FKQ E +G G + VYK G T +RE I + L+H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPN---GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
+++V L + L LV++++ N +DS N L + GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ HE ++HRD+K N+LI+ +LGDFGLAR F + ++ VV T+ Y AP+
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178
Query: 520 L---ARTGKASCSTDVFAYGVLLLEIATGR 546
+ +RT S S D+++ G +L E+ TG+
Sbjct: 179 VLMGSRT--YSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 44/220 (20%)
Query: 364 FKQSEVIGTGGFGEVYK-------------------------GVLPTRMREFAAEIESLG 398
+++ + +G G F VYK G+ T +RE I+ L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQ 67
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
L H +++ L K ++ LV+D++ L+ ++ + + VL+ + GL
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
YLH+ W ++HRD+K N+L+D + +L DFGLA+ F ++T VV T Y AP
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAP 181
Query: 519 EL---ARTGKASCSTDVFAYGVLLLEIATGRRPI---DSD 552
EL AR D++A G +L E+ R P DSD
Sbjct: 182 ELLFGAR--MYGVGVDMWAVGCILAELLL-RVPFLPGDSD 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/216 (25%), Positives = 84/216 (38%), Gaps = 37/216 (17%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMRE--FAAEIESLGRLRHKH 404
++ +VIG G FGEV K + R F E + +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLL----FDNENFVLSWEQRFNIIKGIAAGLLY 460
+V L + R L +V +Y+P G L +L+ + RF + + L
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK------WARFYTAE-VVLALDA 183
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE- 519
+H IHRDVK N+L+D + +L DFG + + VGT YI+PE
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 520 LARTGKASC---STDVFAYGVLLLEIATGRRPIDSD 552
L G D ++ GV L E+ G P +D
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLRHKHL 405
E +G+G F V K + ++AA E+ L ++H ++
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + K D++L+ + + G L FD E L+ E+ +K I G+ YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 464 EWEQVVIHRDVKSGNVLI----DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+ H D+K N+++ ++ DFGLA D G N+ GT ++APE
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPE 187
Query: 520 LARTGKASCSTDVFAYGVLL 539
+ D+++ GV+
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 340 ILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA------- 392
++ D+ +D +R SD + +G G VY+ + +A
Sbjct: 37 LVPDYWIDGSNRDALSDFFEV------ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV 90
Query: 393 -------EIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD----NENFV 441
EI L RL H +++ L+ + ++ LV + + G LFD +
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYY- 145
Query: 442 LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLF 498
S + +K I + YLH E ++HRD+K N+L D ++ DFGL+++
Sbjct: 146 -SERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
Query: 499 DHGKISHTTNVVGTIGYIAPE-LART--GKASCSTDVFAYGVLL 539
+H + T V GT GY APE L G D+++ G++
Sbjct: 202 EHQVLMKT--VCGTPGYCAPEILRGCAYGPEV---DMWSVGIIT 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 54/233 (23%), Positives = 86/233 (36%), Gaps = 51/233 (21%)
Query: 348 CPHRFRYSDLYTA-----TKGFKQ----SEVIGTGGFGEVYKGV---------------- 382
F + DL K + S+ +G+G GEV
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 383 --------LPTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL 434
EIE L +L H ++ ++ + D +V + + G L
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGE----L 226
Query: 435 FDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARL 489
FD N L + + YLH E +IHRD+K NVL+ + D ++
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGKASCST--DVFAYGVLL 539
DFG +++ + T + GT Y+APE L G A + D ++ GV+L
Sbjct: 284 TDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-20
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA-------------------EIESLGRLR 401
+ +K V+G G FGEV +E A E++ L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H +++ L + + K LV + G L + + F S II+ + +G+ Y+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGITYM 142
Query: 462 HEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
H + ++HRD+K N+L+ D N R+ DFGL+ F+ K +GT YIAP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRP 548
E+ G DV++ GV+L + +G P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 43/219 (19%), Positives = 79/219 (36%), Gaps = 41/219 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRL-RHKHL 405
+ +G+G G+V+K + +++ + + ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF---VLSWEQRFNIIKGIAAGLLYLH 462
V G D+ + + + + +L + I L YL
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLK 141
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---TNVVGTIGYIAPE 519
E + VIHRDVK N+L+D +L DFG++ G++ G Y+APE
Sbjct: 142 E--KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194
Query: 520 -----LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
DV++ G+ L+E+ATG+ P +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 36/202 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
F +G+G FG+V+ M + AEIE L L H +++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLY 460
+ + ++ +V + G L + + + + ++K + L Y
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 461 LHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
H Q V+H+D+K N+L ++ DFGLA LF + S GT Y+A
Sbjct: 140 FH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMA 194
Query: 518 PELARTGKASCSTDVFAYGVLL 539
PE+ + + D+++ GV++
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVM 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 30/214 (14%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMRE---FAAEIESLGRLRHK 403
F+ +VIG G FGEV K + + E F E + L K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDSK 134
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + +L LV DY G L +LL E+ + RF + + + + +H+
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQ 193
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+HRD+K N+L+D + + RL DFG ++ VGT YI+PE+ +
Sbjct: 194 ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 524 GKASCST-----DVFAYGVLLLEIATGRRPIDSD 552
+ D ++ GV + E+ G P ++
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 47/218 (21%)
Query: 360 ATKGFKQ----SEVIGTGGFGEVYKGVLPTRMREFAA----------------------- 392
+T GF + E++G G V + + +E+A
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 393 --EIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQR 447
E++ L ++ H +++ L+ + LV+D + G L FD E LS ++
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKET 126
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507
I++ + + LH+ ++HRD+K N+L+D DMN +L DFG + D G+
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182
Query: 508 NVVGTIGYIAPELARTGKASCST------DVFAYGVLL 539
V GT Y+APE+ D+++ GV++
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-19
Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 17/119 (14%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F F+ + + LI + A+ + L++T G Y+ P+++ +
Sbjct: 6 FSFTKFDPNQED--LIFQGHATS--TNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED 61
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
S +SF T F+I TP + + GLAF ++P S +LG+ + N
Sbjct: 62 SA------VLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGG-FLGLFPNAN 113
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 43/213 (20%)
Query: 364 FKQSEVIGTGGFGEVYK----------------------GVLPTRMREFAAEIESLGRLR 401
+++ +G G +GEVYK GV T +RE + L L+
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQ 91
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H++++ L+ L L+++Y N L + N + + + F + + G+ +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLINGVNFC 148
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNAR-----LGDFGLARLFDHGKISHTTNVVGTIGYI 516
H +HRD+K N+L+ + +GDFGLAR F T ++ T+ Y
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYR 204
Query: 517 APEL---ARTGKASCSTDVFAYGVLLLEIATGR 546
PE+ +R S S D+++ + E+
Sbjct: 205 PPEILLGSRH--YSTSVDIWSIACIWAEMLMKT 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 44/205 (21%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRHKHLV 406
EVIG G F V + + ++FA E L+H H+V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFD------NENFVLSWEQRFNIIKGIAAGLLY 460
L L +V++++ L + FV S + ++ I L Y
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 461 LHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
H + +IHRDVK VL+ + +LG FG+A + VGT ++A
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMA 201
Query: 518 PE-LART--GKASCSTDVFAYGVLL 539
PE + R GK DV+ GV+L
Sbjct: 202 PEVVKREPYGKPV---DVWGCGVIL 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 30/215 (13%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMRE--FAAEIESLGRLRHKH 404
F+ +VIG G F EV K + R F E + L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+ L + + L LV +Y G L +LL + + RF + + I + +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-IVMAIDSVHR- 180
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LART 523
+HRD+K N+L+D + RL DFG + VGT Y++PE L
Sbjct: 181 --LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 524 GKASCST------DVFAYGVLLLEIATGRRPIDSD 552
G + D +A GV E+ G+ P +D
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 370 IGTGGFGEVYKGV------------------LPTRMREFAAEIESLGRLRHKHLVNLQGW 411
IG G F +V PT +++ E+ + L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ ++ L L+ +Y G + FD + + ++ + + I + + Y H+ + +
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRI 135
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK--AS 527
+HRD+K+ N+L+DADMN ++ DFG + F G G Y APEL + GK
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDG 192
Query: 528 CSTDVFAYGVLLLEIATGRRPIDSDH 553
DV++ GV+L + +G P D +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQN 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 361 TKGFKQ----SEVIGTGGFGEVYKGVLPTRMREFAA------------------EIESLG 398
+ F E +G G F V + V T EFAA E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAA 456
+L+H ++V L + + LV+D + G LF++ S + I+ I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
+ Y H ++HR++K N+L+ +L DFGLA + + H GT
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTP 171
Query: 514 GYIAPE-LART--GKASCSTDVFAYGVLL 539
GY++PE L + K D++A GV+L
Sbjct: 172 GYLSPEVLKKDPYSKPV---DIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 53/193 (27%), Positives = 78/193 (40%), Gaps = 31/193 (16%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHLVNLQGW 411
IG G +GEV V AA EIE + L H +++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ D+ LV + G LF+ V I+K + + + Y H + V
Sbjct: 75 FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNV 127
Query: 470 IHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
HRD+K N L D +L DFGLA F GK+ T VGT Y++P++ G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLE-GLY 184
Query: 527 SCSTDVFAYGVLL 539
D ++ GV++
Sbjct: 185 GPECDEWSAGVMM 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 35/216 (16%)
Query: 368 EVIGTGGFGEVYKG------------------VLPTRMREFAA------EIESLGRLRHK 403
+G+G FG V+ VL E EI L R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYL 461
+++ + + + LV + +G LD LF + + L I + + + + YL
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-L 520
+ +IHRD+K N++I D +L DFG A + GK+ +T GTI Y APE L
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEVL 201
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL 556
++++ GV L + P +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 50/247 (20%), Positives = 82/247 (33%), Gaps = 69/247 (27%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA---------------------EIESLGRLRHKHLV 406
IG G +G V + A E+ + +L H ++
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSL------------------------------------ 430
L + ++ + LV + G L
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 431 --DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR 488
++ +FV + NI++ I + L YLH Q + HRD+K N L + +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208
Query: 489 L--GDFGLARLFDHGKISHT---TNVVGTIGYIAPELARTGKAS--CSTDVFAYGVLLLE 541
+ DFGL++ F T GT ++APE+ T S D ++ GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 542 IATGRRP 548
+ G P
Sbjct: 269 LLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 41/198 (20%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHLVNLQGW 411
EV+G+G F EV+ + FA EI L +++H+++V L+
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
+ LV + G LFD + + + +I+ + + + YLH E
Sbjct: 75 YESTTHYYLVMQLVSGGE----LFDRILERGVY--TEKDASLVIQQVLSAVKYLH---EN 125
Query: 468 VVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LART 523
++HRD+K N+L + + + DFGL+++ +G + + GT GY+APE LA+
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQK 182
Query: 524 --GKASCSTDVFAYGVLL 539
KA D ++ GV+
Sbjct: 183 PYSKAV---DCWSIGVIT 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 37/217 (17%)
Query: 368 EVIGTGGFGEVYKGV-LPT------------RMREFAA---------EIESLGRLRHK-- 403
++G+GGFG VY G+ + R+ ++ E+ L ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYL 461
++ L W +R +L+ + P D LFD E L E + + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 462 HEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
H V+HRD+K N+LID + +L DFG L GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDF--DGTRVYSPPEW 219
Query: 521 ARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFIL 556
R + S V++ G+LL ++ G P + D I+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 256
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 46/218 (21%)
Query: 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA-----------EIESL 397
P ++ +D Y +K +V+G G G+V + ++ A E++
Sbjct: 21 PKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH 75
Query: 398 GRL-RHKHLVNLQGWC----KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN--- 449
+ H+V + KR LL++ + + G L F +Q F
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSR--IQERGDQAFTERE 129
Query: 450 ---IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKI 503
I++ I + +LH + HRDVK N+L + D +L DFG A+ +
Sbjct: 130 AAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 504 SHTTNVVGTIGYIAPE-LARTG-KASCSTDVFAYGVLL 539
T Y+APE L SC D+++ GV++
Sbjct: 187 ---QTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 38/198 (19%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA------------------EIESLGRLRHKHLVNLQ 409
E +G G F V + V T EFAA E +L+H ++V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
+ + LV+D + G L F+ S + I+ I + Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHS---N 147
Query: 468 VVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LART 523
++HR++K N+L+ +L DFGLA + + H GT GY++PE L +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKKD 205
Query: 524 --GKASCSTDVFAYGVLL 539
K D++A GV+L
Sbjct: 206 PYSKPV---DIWACGVIL 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 58/255 (22%), Positives = 95/255 (37%), Gaps = 50/255 (19%)
Query: 329 FKLYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMR 388
K + A+ + L+ WE + + F + + +GTG FG V
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 389 EFA-------------------AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429
+A E L + LV L+ K +L +V +Y+ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 430 LDSLLFDNENFVLSWEQRFNIIKG------IAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483
+ F L RF+ I YLH +I+RD+K N+LID
Sbjct: 128 M----F----SHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 484 DMNARLGDFGLARLFDHGKISHTTN-VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
++ DFG A+ ++ T + GT +APE+ + + + D +A GVL+ E+
Sbjct: 177 QGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 543 ATGRRP-IDSDHFIL 556
A G P +
Sbjct: 232 AAGYPPFFADQPIQI 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 33/208 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMRE-FAAEIESLGRLRHKHL 405
+ ++G G FGEV K + E+E L +L H ++
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L + +V + G L FD + S IIK + +G+ Y+H+
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 464 EWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
++HRD+K N+L+ + D + ++ DFGL+ F +GT YIAPE+
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV 194
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRP 548
R G DV++ GV+L + +G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 364 FKQSEVIGTGGFGEVYK-----------------------GVLPTRMREFAAEIESLGRL 400
++ IG G +G+V+K G+ + +RE A + L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETF 71
Query: 401 RHKHLVNLQ-----GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
H ++V L R+ L LV++++ L + L + E +++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
GL +LH V+HRD+K N+L+ + +L DFGLAR++ +++ T+ VV T+ Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVV-TLWY 185
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
APE+ + D+++ G + E+ R+P+
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 40/213 (18%)
Query: 368 EVIGTGGFGEVYKGV-----------------------------LPTRMREFAAEIESLG 398
+G+G +GEV + E EI L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGL 458
L H +++ L + K+ LV ++ G L + + F NI+K I +G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGI 159
Query: 459 LYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGY 515
YLH+ ++HRD+K N+L+ ++ +N ++ DFGL+ F +GT Y
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYY 214
Query: 516 IAPELARTGKASCSTDVFAYGVLLLEIATGRRP 548
IAPE+ + K + DV++ GV++ + G P
Sbjct: 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 35/196 (17%)
Query: 367 SEVIGTGGFGEVYKGV------------LPTRMREFAAEIESLGRL-RHKHLVNLQGWCK 413
E IG G + + + + R+ EIE L R +H +++ L+
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD 86
Query: 414 RKRDLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
+ + +V + + G L D + F S + ++ I + YLH Q V
Sbjct: 87 DGKYVYVVTELMKGGE----LLDKILRQKFF--SEREASAVLFTITKTVEYLH---AQGV 137
Query: 470 IHRDVKSGNVL-IDADMNA---RLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTG 524
+HRD+K N+L +D N R+ DFG A+ T T ++APE L R G
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEVLERQG 196
Query: 525 -KASCSTDVFAYGVLL 539
A+C D+++ GVLL
Sbjct: 197 YDAAC--DIWSLGVLL 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 45/208 (21%), Positives = 89/208 (42%), Gaps = 34/208 (16%)
Query: 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA------------------EIES 396
++ Y T + +G G F V + + + +E+AA EI
Sbjct: 27 NNFYILTS-----KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 397 LGRLRH-KHLVNLQGWCKRKRDLLLVYDYIPNGSL-DSLLFDNENFVLSWEQRFNIIKGI 454
L + ++NL + +++L+ +Y G + L + +S +IK I
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQI 140
Query: 455 AAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVG 511
G+ YLH + ++H D+K N+L+ + ++ DFG++R H ++G
Sbjct: 141 LEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMG 195
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLL 539
T Y+APE+ + +TD++ G++
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 59/226 (26%)
Query: 368 EVIGTGGFGEVYKGV-LPT------------RMREFAA-------EIESLGRLRHKHLVN 407
+++G G +G+V + + T ++R EI+ L RLRHK+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 408 LQG--WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------------ 453
L + + K+ + +V +Y G + + D+ + +
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDS------------VPEKRFPVCQAHGYFC 116
Query: 454 -IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS---HTTNV 509
+ GL YLH Q ++H+D+K GN+L+ ++ G+A T+
Sbjct: 117 QLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171
Query: 510 VGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDH 553
G+ + PE+A + D+++ GV L I TG P + D+
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 41/199 (20%)
Query: 368 EVIGTGGFGEVYKGV-----------------LPTRMRE-FAAEIESLGRLRHKHLVNLQ 409
++G G FGEV K + E+E L +L H +++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ +V + G LFD + F S IIK + +G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGE----LFDEIIKRKRF--SEHDAARIIKQVFSGITYMH--- 138
Query: 466 EQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LA 521
+ ++HRD+K N+L+ + D + ++ DFGL+ F +GT YIAPE L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR 196
Query: 522 RT-GKASCSTDVFAYGVLL 539
T + DV++ GV+L
Sbjct: 197 GTYDEKC---DVWSAGVIL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 42/208 (20%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA------------------------EIESLGR 399
+ S+ +G+G GEV ++ A EIE L +
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAG 457
L H ++ ++ + D +V + + G LFD N L +
Sbjct: 72 LNHPCIIKIKNFFD-AEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIG 514
+ YLH E +IHRD+K NVL+ + D ++ DFG +++ + T + GT
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPT 181
Query: 515 YIAPE-LARTGKASCST--DVFAYGVLL 539
Y+APE L G A + D ++ GV+L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 42/205 (20%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA------------------------EIESLGRLR-H 402
+VIG G V + V EFA E L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLY 460
H++ L + + LV+D + G L FD E LS ++ +I++ + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
LH ++HRD+K N+L+D +M RL DFG + + G+ + GT GY+APE+
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPEI 270
Query: 521 ARTGKASCST------DVFAYGVLL 539
+ D++A GV+L
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 368 EVIGTGGFGEVYKG------------------VLPTRMRE-FAAEIESLGRLRHKHLVNL 408
+ +G G FG+V G + + EI++L RH H++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
D +V +Y+ G L FD ++ + + + + I + + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCHR--- 129
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGK 525
+V+HRD+K NVL+DA MNA++ DFGL+ + G+ T+ G+ Y APE ++
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGRLY 187
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDH 553
A D+++ GV+L + G P D +H
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 364 FKQSEVIGTGGFGEVYK-------------------------GVLPTRMREFAAEIESLG 398
++ IG G +G VYK G+ + +RE A + L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLE 69
Query: 399 RLRHKHLVNLQ-----GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453
H ++V L R+ + LV++++ L + L L E ++++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
GL +LH ++HRD+K N+L+ + +L DFGLAR++ + +++ T VV T+
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALTPVVV-TL 183
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPI 549
Y APE+ + D+++ G + E+ R+P+
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 23/204 (11%), Positives = 49/204 (24%), Gaps = 54/204 (26%)
Query: 368 EVIGTGGFGEVYKG------------VL-------PTRMREFAAEIESLGRLRHKHLVNL 408
G + ++ + ++E + L R+ + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ L+V ++I GSL + + S ++ +AA H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASC 528
V V + D + L + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDANPQ------ 182
Query: 529 STDVFAYGVLLLEIATGRRPIDSD 552
D+ G L + R P+
Sbjct: 183 -DDIRGIGASLYALLVNRWPLPEA 205
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMREFA---AEIESLGRLRHK 403
F+ +GTG FG V+ K ++ R+++ E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHP 66
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAG 457
++ + G + + + ++ DYI G L F +L QRF +
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGEL----F----SLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYI 516
L YLH + +I+RD+K N+L+D + + ++ DFG A+ + T + GT YI
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYI 170
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRP-IDSDHFIL 556
APE+ T + S D +++G+L+ E+ G P DS+
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 35/197 (17%)
Query: 366 QSEVIGTGGFGEVYKGVLPTRMREFAA-------------EIESLGRLR-HKHLVNLQGW 411
+ + +G G F K V + FA EI +L H ++V L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
+ LV + + G LF+ ++F S + I++ + + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGE----LFERIKKKKHF--SETEASYIMRKLVSAVSHMH---DV 125
Query: 468 VVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LART 523
V+HRD+K N+L + ++ ++ DFG ARL T T+ Y APE L +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQN 184
Query: 524 G-KASCSTDVFAYGVLL 539
G SC D+++ GV+L
Sbjct: 185 GYDESC--DLWSLGVIL 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 41/200 (20%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA------------------EIESLGRLRHKHLVNLQ 409
E +G G F V + V +E+AA E L+H ++V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+ L++D + G L F+ E + S + I+ I +L+ H+
Sbjct: 77 DSISEEGHHYLIFDLVTGGEL----FEDIVAREYY--SEADASHCIQQILEAVLHCHQ-- 128
Query: 466 EQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LA 521
V+HR++K N+L+ +L DFGLA + + + GT GY++PE L
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLR 186
Query: 522 RT--GKASCSTDVFAYGVLL 539
+ GK D++A GV+L
Sbjct: 187 KDPYGKPV---DLWACGVIL 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 52/219 (23%), Positives = 81/219 (36%), Gaps = 39/219 (17%)
Query: 368 EVIGTGGFGEVYKG------------------VLPTRMREFAA----EIESLGRLR---- 401
++G GGFG V+ G VL + E+ L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLL 459
H ++ L W + + +LV + D LFD E L + A +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
+ H + V+HRD+K N+LID +L DFG L GT Y P
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDF--DGTRVYSPP 207
Query: 519 ELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFIL 556
E + + V++ G+LL ++ G P + D IL
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL 246
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 52/217 (23%)
Query: 370 IGTGGFGEVYKGV-LPTRMREFAA------------------EIESLGRLRHKHLVNLQG 410
+G G +GEV V T E A EI L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTE--EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN----------IIKGIAAGLLY 460
+ L +Y G L FD + + ++ G+ Y
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDR----IEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS---HTTNVVGTIGYIA 517
LH + HRD+K N+L+D N ++ DFGLA +F + + GT+ Y+A
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVA 175
Query: 518 PE-LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
PE L R + DV++ G++L + G P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPT-------RMREFAA----EIESLGRLRHKHLVNL---- 408
+ +VIG G FG V++ L ++ + E++ + ++H ++V+L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 409 --QGWCKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKG----IAAGLLY 460
G K + L LV +Y+P ++ + + IK + L Y
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLL----IKLYMYQLLRSLAY 156
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
+H + HRD+K N+L+D +L DFG A++ G+ + + + + Y APE
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSYICSRYYRAPE 211
Query: 520 L---ARTGKASCSTDVFAYGVLLLEIATGR 546
L A + + D+++ G ++ E+ G+
Sbjct: 212 LIFGAT--NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 368 EVIGTGGFGEVYKG------------------VLPTRMRE-FAAEIESLGRLRHKHLVNL 408
+ +G G FG+V G + + EI++L RH H++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFD--------NENFVLSWEQRFNIIKGIAAGLLY 460
D+ +V +Y+ G L FD +E E R + + I +G+ Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEK-----ESR-RLFQQILSGVDY 131
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE- 519
H +V+HRD+K NVL+DA MNA++ DFGL+ + G+ T+ G+ Y APE
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 186
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
++ A D+++ GV+L + G P D DH
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 36/198 (18%)
Query: 367 SEVIGTGGFGEVYKGVLPTRMREFAA-----------EIESLGRL-RHKHLVNLQGWC-- 412
S+V+G G G+V + +FA E+E R + H+V +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 413 --KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF------NIIKGIAAGLLYLHEE 464
++ LL+V + + G L F +Q F I+K I + YLH
Sbjct: 127 LYAGRKCLLIVMECLDGGEL----FSR--IQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179
Query: 465 WEQVVIHRDVKSGNVL-IDADMNA--RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
+ HRDVK N+L NA +L DFG A+ T T Y+APE+
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 235
Query: 522 RTGKASCSTDVFAYGVLL 539
K S D+++ GV++
Sbjct: 236 GPEKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 50/212 (23%), Positives = 79/212 (37%), Gaps = 48/212 (22%)
Query: 370 IGTGGFGEVY-----------------KGVLPTRMREFAAEIESLGRLRHKHLVNLQGWC 412
+G G +GEV EI L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN----------IIKGIAAGLLYLH 462
+ L +Y G L FD + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDR----IEPDIGMPEPDAQRFFHQLMAGVV----YLH 122
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS---HTTNVVGTIGYIAPE 519
+ HRD+K N+L+D N ++ DFGLA +F + + GT+ Y+APE
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE 177
Query: 520 -LARTGKASCSTDVFAYGVLLLEIATGRRPID 550
L R + DV++ G++L + G P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 45/225 (20%), Positives = 91/225 (40%), Gaps = 55/225 (24%)
Query: 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGV-LPTRMREFAA----------------EIE 395
R+ D+Y + +V+G G V + L T +E+A E+E
Sbjct: 9 RFEDVYQLQE-----DVLGEGAHARVQTCINLITS-QEYAVKIIEKQPGHIRSRVFREVE 62
Query: 396 SLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN----- 449
L + + H++++ L + + + LV++ + GS + + + + FN
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS----ILSH----IHKRRHFNELEAS 114
Query: 450 -IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISH 505
+++ +A+ L +LH + + HRD+K N+L + ++ DF L
Sbjct: 115 VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 506 TTN------VVGTIGYIAPELARTGKASCST-----DVFAYGVLL 539
+ G+ Y+APE+ S D+++ GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 48/215 (22%)
Query: 369 VIGTGGFGEVY-----------------KGVLPTRMREFAAEIES-------LGRLRHKH 404
++G G FG+V K V+ + E+ L RH
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-----EVAHTLTENRVLQNSRHPF 209
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGL 458
L L+ + L V +Y G L F F LS E+ F+ + I + L
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGEL----F----FHLSRERVFSEDRARFYGAEIVSAL 261
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYIA 517
YLH E + V++RD+K N+++D D + ++ DFGL + G T GT Y+A
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
PE+ + D + GV++ E+ GR P +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-PT-------RMREFAA----EIESLGRLRHKHLVNL--- 408
+ ++VIG G FG VY+ L + ++ + E++ + +L H ++V L
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 409 ---QGWCKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
G K + L LV DY+P ++ + + L + + L Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 464 EWEQVVIHRDVKSGNVLIDADMNA-RLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL-- 520
+ HRD+K N+L+D D +L DFG A+ G+ + + + + Y APEL
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIF 229
Query: 521 -ARTGKASCSTDVFAYGVLLLEIATGRRPI 549
A + S DV++ G +L E+ G +PI
Sbjct: 230 GAT--DYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 369 VIGTGGFGEVY--------------------KGVLPTRMREFA---AEIESLGRLRHKHL 405
V+G GG+G+V+ K ++ ++ A AE L ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGLL 459
V+L + L L+ +Y+ G L F L E F I+ L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGEL----F----MQLEREGIFMEDTACFYLAEISMALG 135
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYIAP 518
+LH+ + +I+RD+K N++++ + +L DFGL + G ++HT GTI Y+AP
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
E+ + + D ++ G L+ ++ TG P +
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 393 EIESLGRLRHKHLVNL-QGWCKRKRDLL-LVYDYIPNGSLDSLLFD-NENFVLSWEQRFN 449
EI L +L H ++V L + D L +V++ + G + + LS +Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQARF 141
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTN 508
+ + G+ YLH Q +IHRD+K N+L+ D + ++ DFG++ F + T
Sbjct: 142 YFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT- 197
Query: 509 VVGTIGYIAPELAR------TGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
VGT ++APE +GKA DV+A GV L G+ P +
Sbjct: 198 -VGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCPFMDER 244
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 368 EVIGTGGFGEVYKG------------------VLPTRMRE-FAAEIESLGRLRHKHLVNL 408
E +G G FG+V + + M EI L LRH H++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
D+++V +Y G L FD E ++ ++ + I + Y H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQQIICAIEYCHR--- 126
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE-LARTGK 525
++HRD+K N+L+D ++N ++ DFGL+ + G T+ G+ Y APE +
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVINGKLY 184
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDH 553
A DV++ G++L + GR P D +
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 369 VIGTGGFGEVY--------------------KGVLPTRMREFA---AEIESLGRLRHKH- 404
V+GTG +G+V+ K + + + E + L +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGL 458
LV L + + L L+ DYI G L F LS +RF + I L
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL----F----THLSQRERFTEHEVQIYVGEIVLAL 172
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518
+LH+ +I+RD+K N+L+D++ + L DFGL++ F + + GTI Y+AP
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 519 ELARTGKA--SCSTDVFAYGVLLLEIATGRRPIDSD 552
++ R G + + D ++ GVL+ E+ TG P D
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 369 VIGTGGFGEVY-----------------KGVLPTRMREFAAEIES-------LGRLRHKH 404
++G G FG+V K V+ + E+ L RH
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVLQNTRHPF 66
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGL 458
L L+ + L V +Y G L F F LS E+ F + I + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL----F----FHLSRERVFTEERARFYGAEIVSAL 118
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYIA 517
YLH + V++RD+K N+++D D + ++ DFGL + G T GT Y+A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
PE+ + D + GV++ E+ GR P +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 49/216 (22%)
Query: 369 VIGTGGFGEVY---KGVLPTRMREFA------------------AEIESLGRLRHKHLVN 407
V+G G FG+V+ K + +A E + L + H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 408 L----QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAG 457
L Q + L L+ D++ G L F LS E F +A
Sbjct: 91 LHYAFQ----TEGKLYLILDFLRGGDL----F----TRLSKEVMFTEEDVKFYLAELALA 138
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYI 516
L +LH +I+RD+K N+L+D + + +L DFGL++ DH K +++ GT+ Y+
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
APE+ + S D +++GVL+ E+ TG P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 51/214 (23%), Positives = 80/214 (37%), Gaps = 49/214 (22%)
Query: 370 IGTGGFGEVYKGV-LPTRMREFAA----------------EIESLGRLRHKHLVNLQGWC 412
IG+G FG T+ E A EI + LRH ++V +
Sbjct: 28 IGSGNFGVARLMRDKLTK--ELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN----------IIKGIAAGLLYLH 462
L ++ +Y G L ++ + RF+ ++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YE----RICNAGRFSEDEARFFFQQLLSGVS----YCH 133
Query: 463 EEWEQVVIHRDVKSGNVLIDAD--MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE- 519
+ HRD+K N L+D ++ DFG ++ +T VGT YIAPE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 188
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
L R DV++ GV L + G P +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 50/221 (22%)
Query: 364 FKQSEVIGTGGFGEVY-----------------KGVLPTRMREFAAEIESL--------G 398
F V+G G FG+V K V+ ++E
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-----DVECTMVEKRVLAL 397
Query: 399 RLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIK 452
+ L L + L V +Y+ G L + + RF
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----M----YHIQQVGRFKEPHAVFYAA 449
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVG 511
IA GL +L + +I+RD+K NV++D++ + ++ DFG+ + G + T G
Sbjct: 450 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCG 504
Query: 512 TIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
T YIAPE+ S D +A+GVLL E+ G+ P + +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 40/211 (18%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------AEIESLGRLRH------------KH--LVNL 408
++G G FG+V+ + FA + + +H L ++
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNI------IKGIAAGLLYLH 462
+ K +L V +Y+ G L + + +F++ I GL +LH
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDL----M----YHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPELA 521
+ +++RD+K N+L+D D + ++ DFG+ + ++T GT YIAPE+
Sbjct: 136 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEIL 190
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
K + S D +++GVLL E+ G+ P
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 40/211 (18%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------------AEIES--------LGRLRHKHLVNL 408
VIG G FG+V +A E + L ++H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNI------IKGIAAGLLYLH 462
+ L V DYI G L F + L E+ F IA+ L YLH
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----F----YHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYIAPELA 521
+++RD+K N+L+D+ + L DFGL + +H + T GT Y+APE+
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVL 211
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
+ D + G +L E+ G P S
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 40/211 (18%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------AEIESLGRLRH------------KH--LVNL 408
V+G G FG+V + +A I + H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLYLH 462
+ L V +++ G L F + +RF+ I + L++LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDL----M----FHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPELA 521
+ + +I+RD+K NVL+D + + +L DFG+ + +G + T GT YIAPE+
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEIL 196
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
+ + D +A GVLL E+ G P +++
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 40/211 (18%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------AEIESLGRLRH------------KH--LVNL 408
V+G G FG+V +A + + K L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------IIKGIAAGLLYLH 462
+ L V +Y+ G L + + RF IA GL +L
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDL----M----YHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL-FDHGKISHTTNVVGTIGYIAPELA 521
+ +I+RD+K NV++D++ + ++ DFG+ + G + T GT YIAPE+
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEII 193
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552
S D +A+GVLL E+ G+ P + +
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 40/207 (19%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------------AEIESLGRLRH------KH--LVNL 408
VIG G + +V L R +A +I+ + +H H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGLLYLH 462
+ + L V +Y+ G L F + +++ I+ L YLH
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDL----M----FHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPELA 521
E + +I+RD+K NVL+D++ + +L D+G+ + G + T GT YIAPE+
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEIL 182
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRP 548
R S D +A GVL+ E+ GR P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 40/207 (19%)
Query: 369 VIGTGGFGEVYKGVLPTRMREFA------------AEIESLGRLRH------KH--LVNL 408
VIG G + +V L R +A +I+ + +H H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG------IAAGLLYLH 462
+ + L V +Y+ G L F + +++ I+ L YLH
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDL----M----FHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF-DHGKISHTTNVVGTIGYIAPELA 521
E + +I+RD+K NVL+D++ + +L D+G+ + G + T GT YIAPE+
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEIL 225
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRP 548
R S D +A GVL+ E+ GR P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKISHTTNVVGT 512
+A G+ +L + IHRD+ + N+L+ ++ DFGLAR ++ +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 513 IGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRP 548
+ ++APE + +DV+++GVLL EI + G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 24/99 (24%)
Query: 368 EVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGRL-RHKH 404
+ +G G FG+V + + R +E++ L + H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 405 LVNLQGWC-KRKRDLLLVYDYIPNGSLDSLLFDNENFVL 442
+VNL G C K L+++ ++ G+L + L N +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 33/216 (15%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGVL----------------PTRMREFAAEIESLGRLRHKH 404
F+ + G G FG V G R RE ++ L L H +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPN 80
Query: 405 LVNLQ-----GWCKRKRD--LLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIA 455
+V LQ + +RD L +V +Y+P+ +L + + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLGDFGLARLFDHGKISHTTNVVGTIG 514
+ LH V HRD+K NVL++ AD +L DFG A+ + + + +
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAYICSRY 196
Query: 515 YIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPI 549
Y APEL + + + D+++ G + E+ G PI
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 32/202 (15%)
Query: 368 EVIGTGGFGEVYKGV-------------LPTRMREFAAEIESLGRLR-HKHLVNLQG--W 411
+G G + EV++ + P + ++ EI+ L LR +++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 412 CKRKRDLLLVYDYIPNGSLDSLL--FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
R LV++++ N L + + + + + I L Y H +
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RFY--MYEILKALDYCHSMG---I 151
Query: 470 IHRDVKSGNVLID-ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA-S 527
+HRDVK NV+ID RL D+GLA + G+ + V + + PEL +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVA-SRYFKGPELLVDYQMYD 209
Query: 528 CSTDVFAYGVLLLEIATGRRPI 549
S D+++ G +L + + P
Sbjct: 210 YSLDMWSLGCMLASMIFRKEPF 231
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 5e-12
Identities = 34/225 (15%), Positives = 62/225 (27%), Gaps = 37/225 (16%)
Query: 53 SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFG 112
+ +R+ + + G + ++ F++ T G G
Sbjct: 61 ADQIRIAPSLKSQRGSVWTKTKA-------------AFENWEVEVTFRV-TGRGRIGADG 106
Query: 113 LAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGIN 172
LA + G G + N I FD+ + ++ V N
Sbjct: 107 LAIWYTENQGLDGP----VFGSADMWNG-------VGIFFDS-FDNDGKKNNPAIVVVGN 154
Query: 173 VNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFH 232
+ A + + PV+A I Y V + KN F
Sbjct: 155 NGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFC 214
Query: 233 FGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSF 277
+ + +P + G SA+TG H +L +
Sbjct: 215 AKVEN---MVIP--------TQGHFGISAATGGLADDHDVLSFLT 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 350 HRFRYSD-LYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------- 392
+ D +T K ++ + IG+G G V + A
Sbjct: 49 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKR 107
Query: 393 ---EIESLGRLRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
E+ + + HK++++L Q + +D+ LV + +D+ L L
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELD 162
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
E+ ++ + G+ +LH +IHRD+K N+++ +D ++ DFGLAR
Sbjct: 163 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 217
Query: 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR 546
T V T Y APE+ + D+++ G ++ E+ +
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 350 HRFRYSD-LYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA---------------- 392
+ D +T K ++ + IG+G G V + A
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTHAKR 70
Query: 393 ---EIESLGRLRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLS 443
E+ + + HK+++ L Q + +D+ +V + + +L ++ L
Sbjct: 71 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----LD 125
Query: 444 WEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503
E+ ++ + G+ +LH +IHRD+K N+++ +D ++ DFGLAR
Sbjct: 126 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180
Query: 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR 546
T V T Y APE+ + D+++ G ++ E+ G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 393 EIESLGRLRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446
E+ L +RH++++ L D LV ++ L L+ + L ++
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDR 129
Query: 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
++ + GL Y+H +IHRD+K GN+ ++ D ++ DFGLAR D S
Sbjct: 130 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEM 182
Query: 507 TNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
T V T Y APE + + + + D+++ G ++ E+ TG+
Sbjct: 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 393 EIESLGRLRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446
E+ L ++H++++ L + D LV ++ L ++ S E+
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEK 127
Query: 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
++ + GL Y+H V+HRD+K GN+ ++ D ++ DFGLAR D +
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEM 180
Query: 507 TNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
T V T Y APE + + + D+++ G ++ E+ TG+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD--HGKISHTTNVVGTIG 514
GL Y+H V+HRD+K N+L++ + ++ DFGLAR+ D H T V T
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 515 YIAPELARTGKA-SCSTDVFAYGVLLLEIATGR 546
Y APE+ K + S D+++ G +L E+ + R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 393 EIESLGRLRHKHLVNL------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446
E+ L ++H++++ L + D+ LV + L++++ + L+ +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK---LTDDH 133
Query: 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506
+I I GL Y+H +IHRD+K N+ ++ D ++ DFGLAR
Sbjct: 134 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEM 186
Query: 507 TNVVGTIGYIAPE-LARTGKASCSTDVFAYGVLLLEIATGR 546
T V T Y APE + + + D+++ G ++ E+ TGR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 40/242 (16%), Positives = 79/242 (32%), Gaps = 60/242 (24%)
Query: 359 TATKGFKQSEVIGTGGFGEVYKGVLPTRMREFAA-------------EIESLGRLRHKHL 405
T++K + + +GTG FG V + + A E++ + L H ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFD-IESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 406 VNLQ---GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN------------- 449
+ L + N N +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 450 ----IIKG-------------------IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN 486
++K + + ++H + HRD+K N+L+++ N
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDN 179
Query: 487 A-RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIAT 544
+L DFG A+ + S + + Y APEL + S D+++ G + E+
Sbjct: 180 TLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 545 GR 546
G+
Sbjct: 238 GK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYI 516
GL LHE V+HRD+ GN+L+ + + + DF LAR ++ T+ V Y
Sbjct: 146 GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYR 200
Query: 517 APE-LARTGKASCSTDVFAYGVLLLEIATGR 546
APE + + + D+++ G ++ E+ +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 2e-09
Identities = 35/211 (16%), Positives = 55/211 (26%), Gaps = 63/211 (29%)
Query: 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL----------------------PTR 386
P F + T+ ++ E IG G FGEV++ +
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 387 MREFAAEIESLGRL---------RHKHLVNLQGWC----KRKRDLLLVYDY--IPNGSLD 431
E EI L R + + L LL +D+ GS +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 432 ---------------------SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
L + S +I+ + A L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHG 501
HRD+ GNVL+ +L +
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 49/322 (15%), Positives = 99/322 (30%), Gaps = 85/322 (26%)
Query: 354 YSDLYTATKGFKQSEVI---GTGGFGEVYKGVLPTRMREFAAEIESLGRLRHK-----HL 405
Y L A + ++ + G G G K + A ++ +++ K
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG---KTWV-------ALDVCLSYKVQCKMDFKIFW 186
Query: 406 VNLQGWCKRKRDLL-----LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+NL C +L L+Y PN + + + + R + I+ LL
Sbjct: 187 LNL-KNCNSPETVLEMLQKLLYQIDPNWT------SRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG-KISHTTNVVGTIGYIAPE 519
+++ +V++ +A F+ KI TT +++
Sbjct: 240 SKPYENCLLVLLNVQNAKA-WNA--------------FNLSCKILLTTRFKQVTDFLSAA 284
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWV-LEFQHLGQVLDVVDPNLG 578
+ L + P + +L+ ++ Q L + + +P
Sbjct: 285 TTTH-------------ISLDHHSMTLTPDEVKS-LLLKYLDCRPQDLPREVLTTNP--- 327
Query: 579 SSYVVAEMELVLQL-GLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSLDSQRS-EM 636
L + +++N D+L II+ SSL+ E
Sbjct: 328 ---------RRLSIIAESIRD-----GLATWDNWKHVNCDKLTTIIE--SSLNVLEPAEY 371
Query: 637 NSRY--LEIISTD-NITTSQLS 655
+ L + +I T LS
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLS 393
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 5e-09
Identities = 108/655 (16%), Positives = 196/655 (29%), Gaps = 173/655 (26%)
Query: 5 VSFALRLFFFPVIAALSQQKEEFIFNGFNET--KTNQG-LITRERASILKPSGALRLTDN 61
VS LRLF LS+Q+E + F E + N L++ + +PS R+
Sbjct: 61 VSGTLRLF----WTLLSKQEE--MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 62 AHNVI---GHAF--YN----KPIQMLDKS-TSLSSKPNASSFSTCFVFQIVTPNSGQGGF 111
+ + F YN +P L ++ L N + G G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV------LID-------GVLGS 161
Query: 112 G---LAFTV----SPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDS 164
G +A V Q +L + N + L + + + SD
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKI--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 165 QGNHVGINVNSMKS-----IKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVT 219
N + + ++S+++ +K +P YEN + V
Sbjct: 220 SSN-IKLRIHSIQAELRRLLKSKP---YEN---------------CLLVLLNVQ------ 254
Query: 220 ICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILG---WS 276
N K +F+ + LL+ T + + ++H L +
Sbjct: 255 ----NAKAWNAFNLS--CKILLT-----------TRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 277 F----SMNGAAPSLNLSQIPSLPIERSSSNSFSLQIKILIAALSTVAVILLG---TLLIF 329
+ L+ LP E ++N L +IA + +
Sbjct: 298 LTPDEVKSLLLKYLDCR-PQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKHVNCD 353
Query: 330 KLYRRIAQF-EILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMR 388
KL I +LE E R + L F S I T ++ V+ + +
Sbjct: 354 KLTTIIESSLNVLEPAEY----RKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 389 EFAAEIESLGRLRHKHLVNLQGWCKRKR----DLLLVYDYIPNG--SLDSLLFDNENFVL 442
+ L LV K + L +L + D+ N
Sbjct: 406 VVVNK------LHKYSLVE--KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 443 SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL---FD 499
+++ ++I Y H + H L + + R+ F + L F
Sbjct: 458 TFDS-DDLIPPYLDQYFYSH-----IGHH--------LKNIEHPERMTLFRMVFLDFRFL 503
Query: 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW 559
KI H + G I L + Y + D
Sbjct: 504 EQKIRHDSTAWNASGSILNTL---------QQLKFY---------------KPYICDNDP 539
Query: 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQK--AEARPTMRQVLR 612
E + + +LD + P + + + ++ +L++ L+ + EA +QV R
Sbjct: 540 KYE-RLVNAILDFL-PKIEENLICSKYTDLLRIALMAEDEAIFEEA---HKQVQR 589
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA-----------------EIESLGRLRHKHLV 406
+ + +G GG G V+ V + A EI+ + RL H ++V
Sbjct: 13 YMDLKPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 407 NL--------------QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIK 452
+ G + +V +Y+ L ++L L E +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHARLFMY 127
Query: 453 GIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFD--HGKISHTTNV 509
+ GL Y+H V+HRD+K N+ I+ D+ ++GDFGLAR+ D + H +
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 510 VGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGR 546
+ T Y +P L + + + D++A G + E+ TG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-09
Identities = 16/45 (35%), Positives = 25/45 (55%)
Query: 241 LSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGAAPS 285
LS + L E + +GFSA+TG + ++H +L WSF + S
Sbjct: 6 LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSGTS 50
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 13/100 (13%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD---------HGKISHTT 507
+ LH VIHRD+K N+LI+++ + ++ DFGLAR+ D G+ S
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 508 NVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGR 546
V T Y APE+ T S + DV++ G +L E+ R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 5e-09
Identities = 33/230 (14%), Positives = 68/230 (29%), Gaps = 44/230 (19%)
Query: 53 SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTP-NSGQGGF 111
S +RLT + + G + ++P + F++ G
Sbjct: 37 SQYVRLTPDERSKEGSIWNHQPC-------------FLKDWEMHVHFKVHGTGKKNLHGD 83
Query: 112 GLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGI 171
G+A + PG + + D+ AI DT +ET++ ++ +
Sbjct: 84 GIALWYTRDRLVPGP--------VFGSKDNFHG---LAIFLDTYPN-DETTERVFPYISV 131
Query: 172 NVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQ---AWIDYDGVNRLVNVTICPMNKKNK 228
VN NG+ + G + D+ + + + +
Sbjct: 132 MVN--------------NGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRGRLT 177
Query: 229 LSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFS 278
+ ++ + + Y G SA TG +H I+
Sbjct: 178 VMTDLEDKNEWKNCIDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLF 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 29/159 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGV--------------LPTRMREFAA----EIESLGRLRHKHL 405
++ +IGTG +G V + EI L RL H H+
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 406 VNLQ-----GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
V + ++ +L +V + + L L+ ++ + G+ Y
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY--LTELHIKTLLYNLLVGVKY 171
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499
+H ++HRD+K N L++ D + ++ DFGLAR D
Sbjct: 172 VH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 40/153 (26%), Positives = 60/153 (39%), Gaps = 34/153 (22%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA-----------EIESLGRL-RHKHLVNLQGWC--- 412
+V+G G G+V + +FA E+E R + H+V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 83
Query: 413 -KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRF------NIIKGIAAGLLYLHEEW 465
++ LL+V + + G LF +Q F I+K I + YLH
Sbjct: 84 YAGRKCLLIVMECLDGGE----LFS--RIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 134
Query: 466 EQVVIHRDVKSGNVL-IDADMNA--RLGDFGLA 495
+ HRDVK N+L NA +L DFG A
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 24/85 (28%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---------- 506
G ++HE +IHRD+K N L++ D + ++ DFGLAR + K ++
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 507 -----------TNVVGTIGYIAPEL 520
T+ V T Y APEL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPEL 222
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 29/196 (14%), Positives = 61/196 (31%), Gaps = 57/196 (29%)
Query: 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---- 484
L + + L II+ + GL YLH + +IH D+K N+L+ +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187
Query: 485 ---------------------------------------------MNARLGDFGLARLFD 499
+ ++ D G A
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247
Query: 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW 559
H T + T Y + E+ + D+++ + E+ATG + ++
Sbjct: 248 K----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP--HSGEEY 301
Query: 560 VLEFQHLGQVLDVVDP 575
+ H+ +++++
Sbjct: 302 TRDEDHIALIIELLGK 317
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 23/84 (27%), Positives = 39/84 (46%), Gaps = 23/84 (27%)
Query: 457 GLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT---------- 506
+ YLH ++HRD+K N+L++A+ + ++ DFGL+R F + +
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 507 ----------TNVVGTIGYIAPEL 520
T+ V T Y APE+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEI 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID------ 482
+L +L+ E+ + I K + GL Y+H +IH D+K NVL++
Sbjct: 115 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 172
Query: 483 ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEI 542
+ ++ D G A +D H TN + T Y +PE+ C D+++ L+ E+
Sbjct: 173 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228
Query: 543 ATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575
TG + D + + H+ Q+++++
Sbjct: 229 ITGDFLFEPDE--GHSYTKDDDHIAQIIELLGE 259
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 27/155 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVN-------LQG------ 410
++ IG+G FG++Y G E A ++E + + +H L +QG
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 411 --WCKRKRDL-LLVYDYIPNG-SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
WC + D ++V + + G SL+ LF+ + S + + + + + Y+H
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123
Query: 467 QVVIHRDVKSGNVLIDADMNA---RLGDFGLARLF 498
+ IHRDVK N L+ + DFGLA+ +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVN-------LQG------ 410
F+ IG+G FGE+Y G E A ++E++ + +H L+ LQG
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPN 67
Query: 411 --WCKRKRDL-LLVYDYIPNG-SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
W + D +LV D + G SL+ LF+ + LS + + + + ++H
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH---S 121
Query: 467 QVVIHRDVKSGNVLIDADMNAR---LGDFGLARLF-DHGKISH-----TTNVVGTIGY 515
+ +HRD+K N L+ A + DFGLA+ + D H N+ GT Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 41/184 (22%), Positives = 66/184 (35%), Gaps = 43/184 (23%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLG----RLRH-----KHLVNLQGWCKR 414
+K IG G FG +++G ++ A + E +LR K L G
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN- 70
Query: 415 KRDLLLVYDYIPNG------------SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
VY + G SL+ L D S + K + A + +H
Sbjct: 71 ------VYYFGQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNAR-----LGDFGLARLF-DHGKISH-----TTNVVG 511
E + +++RD+K N LI + + DFG+ + + D H N+ G
Sbjct: 124 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 512 TIGY 515
T Y
Sbjct: 181 TARY 184
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 34/192 (17%), Positives = 63/192 (32%), Gaps = 42/192 (21%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLRHKHLVN-------LQG---WCK 413
+ + IG+GGFG +Y + + A + + + L + + K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 414 RKRDLLLVYDYIPN----GSLDS-----------LLFDNENFVLSWEQRFNI--IKGIAA 456
L Y IP G + L + + F + +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 457 GLL----YLHEEWEQVVIHRDVKSGNVLIDADMNAR--LGDFGLARLF-DHGKISH---- 505
+L Y+HE +H D+K+ N+L+ + L D+GL+ + +G
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 506 -TTNVVGTIGYI 516
GTI +
Sbjct: 216 PRKGHNGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 31/193 (16%), Positives = 64/193 (33%), Gaps = 53/193 (27%)
Query: 370 IGTGGFGEVYKGV--------LPTRMREFAAEIESL-GRLRHKHLV--------NLQGWC 412
G +Y+ + ++F+ ++++ GRL ++ + W
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 413 KRKRDLLL----VYDYIPNG-------------SLDSLLFDNENFVLSWEQRFNIIKGIA 455
K LL + + SL S L + VLS + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLL 169
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR--LGDFGLARLF----------DHGKI 503
L +LHE +H +V + N+ +D + ++ L +G A + + +
Sbjct: 170 DALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 504 SHTTNVVGTIGYI 516
H G + +I
Sbjct: 227 PHE----GDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 35/189 (18%), Positives = 62/189 (32%), Gaps = 45/189 (23%)
Query: 370 IGTGGFGEVYKGVLPTRM-----REFAAEIESL--GRLRH-----KHLVNLQGWCKRKRD 417
IG GGFG +Y + + ++E G L + + K R
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 418 LLLVYDYIPN----GSLDSLLFDNENFVL-----SWEQRFNIIKG---------IAAGLL 459
L Y +P G D ++ ++ + ++ +L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 460 ----YLHEEWEQVVIHRDVKSGNVLIDADMNAR--LGDFGLARLF-DHGKISH-----TT 507
Y+HE +H D+K+ N+L++ + L D+GLA + G
Sbjct: 163 DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 508 NVVGTIGYI 516
GTI +
Sbjct: 220 CHDGTIEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 37/161 (22%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAAEIESLGRLR---------HKHLVNLQGWCKR 414
F+ + IG G FGE+ G A ++E + +K L + G +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ- 69
Query: 415 KRDLLLVYDYIPNG------------SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
VY + P G SL+ L FD + S + I + + + Y+H
Sbjct: 70 ------VYYFGPCGKYNAMVLELLGPSLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNAR-----LGDFGLARLF 498
+ +I+RDVK N LI N + DF LA+ +
Sbjct: 123 SK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.98 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.44 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.44 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.14 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.87 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.62 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 91.11 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.64 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 85.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 84.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 84.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 83.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.6 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 82.73 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.26 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-64 Score=511.40 Aligned_cols=239 Identities=35% Similarity=0.573 Sum_probs=204.4
Q ss_pred HHHHHHHHHhhhhccCCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCC------eEEEEEecCceeeecC
Q 035655 7 FALRLFFFPVIAALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLDK 80 (670)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~------~~Gr~~y~~pv~l~~~ 80 (670)
+.+.+|++++..+.++..++|+|++|+. .+ |.++|+|.+. +|.|+||++..+ ++|||+|++||+|||+
T Consensus 9 ~~~~~fl~l~~~~~sa~~~sF~f~~F~~--~n---L~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~ 82 (281)
T 3ujo_A 9 KRIVLFLILLTKAASANLISFTFKKFNE--TN---LILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDN 82 (281)
T ss_dssp ---------------CEEEEEEESSCCS--TT---EEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCS
T ss_pred HHHHHHHHHHcccCcCCcceEEcCCCCc--cC---EEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccC
Confidence 3344455555666677889999999975 67 9999999998 999999998755 8999999999999999
Q ss_pred CCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCC
Q 035655 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNE 160 (670)
Q Consensus 81 ~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~ 160 (670)
.+| +++||+|+|+|+|.+++...+||||||||+|.+..| ++.||||||+|.+++ ++.||+|||||||++| .+
T Consensus 83 ~tg-----~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p-~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N-~e 154 (281)
T 3ujo_A 83 TTG-----TVASWATSFTFNLQAPNAASPADGLAFALVPVGSQP-KDKGGFLGLFDSKNY-ASSNQTVAVEFDTFYN-GG 154 (281)
T ss_dssp SSC-----CBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CTTSCCEEEEECCSCC-CS
T ss_pred CCC-----CceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCC-CCCcceeeeccccCC-CccCcEEEEEEecccc-cc
Confidence 999 899999999999998877789999999999988665 478999999998876 7889999999999999 67
Q ss_pred CCCCCCCeeEEecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcc
Q 035655 161 TSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPL 240 (670)
Q Consensus 161 ~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ 240 (670)
+ ||++|||||||||++|+++++ +++.+|+.++|||+||+.+++|+|++++.+. |.+|+
T Consensus 155 ~-Dp~~nHVGIDvNSi~S~~t~~-----------~~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~----------~~~~~ 212 (281)
T 3ujo_A 155 W-DPTERHIGIDVNSIKSIKTTS-----------WDFANGENAEVLITYDSSTNLLVASLVHPSQ----------KTSFI 212 (281)
T ss_dssp S-CCSSSEEEEEESSSCCSCEEE-----------CCCCSSCCEEEEEEECTTTCEEEEEEECTTT----------CCCEE
T ss_pred C-CCCCCeEEEEcCCCCcccccc-----------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC----------CCCce
Confidence 4 999999999999999988876 4567999999999999999999999997653 44789
Q ss_pred cccccCCcccccccceeeEeecCCc---eeeeEEEeccccccCC
Q 035655 241 LSLPLDLSPAFQETMYVGFSASTGR---KVSSHFILGWSFSMNG 281 (670)
Q Consensus 241 ls~~~dl~~~l~~~~~vGFsastg~---~~~~h~i~sW~fs~~~ 281 (670)
|++.|||+++|||+||||||||||. ..|.|+|++|+|+++.
T Consensus 213 lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~IlsWSFss~l 256 (281)
T 3ujo_A 213 VSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSFASKL 256 (281)
T ss_dssp EEEECCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEEEEEEEEE
T ss_pred EEEEechHHhccCcEEEEEEeecCCCCcccceeEEEEEEEEEEc
Confidence 9999999999999999999999996 5899999999999864
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-63 Score=496.21 Aligned_cols=231 Identities=27% Similarity=0.465 Sum_probs=206.2
Q ss_pred hhccCCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCcc
Q 035655 18 AALSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNAS 91 (670)
Q Consensus 18 ~~~~~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~ 91 (670)
.+.++..++|+|++|.+...+ |.++|+|.+.++|.|+||+... +++|||+|++||+|||+.+| +++
T Consensus 5 ~~~sa~~~sF~f~~F~~~~~~---l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg-----~va 76 (261)
T 3zyr_A 5 RANSTDSLSFSFINFDRDERN---LIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTN-----RVA 76 (261)
T ss_dssp ---CCEEEEEEESSCCSCCTT---EEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTC-----CBE
T ss_pred ccCcCcccEEEcCCCCCCCCC---eEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCC-----Cce
Confidence 455667899999999854456 9999999997799999998765 79999999999999999999 899
Q ss_pred ceeEEEEEEEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCC-CCCcEEEEEeeec---CCCCCCCCCCC
Q 035655 92 SFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHK-PSNHLFAIEFDTV---NGYNETSDSQG 166 (670)
Q Consensus 92 sFst~F~f~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~~Dp~~ 166 (670)
||+|+|+|.|.++ ...+||||||||+|.+. +|.+++||||||+|.+++++ ..||+|||||||+ +| .++ ||++
T Consensus 77 SFsT~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n-~~~-Dp~~ 153 (261)
T 3zyr_A 77 NLQTQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNS-NTW-DPNY 153 (261)
T ss_dssp EEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTT-CTT-SCSS
T ss_pred eEEEEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccC-cCC-CCCC
Confidence 9999999999987 66789999999999876 48889999999999987754 5689999999999 88 674 9999
Q ss_pred CeeEEecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccC
Q 035655 167 NHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLD 246 (670)
Q Consensus 167 ~Hvgidvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~d 246 (670)
|||||||||++|+++++ +.+.+|+.++|||+||+.+++|+|+|++.+. .+|+|++.||
T Consensus 154 nHVGIdvNsi~S~~s~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-----------~~~~ls~~vd 211 (261)
T 3zyr_A 154 QHIGIDVNSIRSSKVVR-----------WERREGKTLNVLVTYNPSTRTIDVVATYPDG-----------QRYQLSHVVD 211 (261)
T ss_dssp CEEEEEESSSSCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEECTTC-----------CEEEEEEECC
T ss_pred CeEEEEcCCCCcccccc-----------ccccCCceEEEEEEEcCCCCEEEEEEEcCCC-----------CCeEEEEEec
Confidence 99999999999998876 4667999999999999999999999987543 3789999999
Q ss_pred CcccccccceeeEeecCCceeeeEEEeccccccCC
Q 035655 247 LSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 247 l~~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
|+++|||+||||||||||...|.|+|++|+|+++.
T Consensus 212 L~~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~l 246 (261)
T 3zyr_A 212 LTTILPEWVRVGFSAASGEQFQTHNLESWSFTSTL 246 (261)
T ss_dssp GGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred hHHhCcCcEEEEEEecCCCccceEEEEEEEEEEEc
Confidence 99999999999999999999999999999999864
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-63 Score=496.49 Aligned_cols=227 Identities=30% Similarity=0.527 Sum_probs=205.7
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCC------eEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~------~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+.++|+|++|.+...+ |.++|+|.+.++|.|+||+...+ ++|||+|++||+|||+.+| +++||+|+
T Consensus 2 ~~~sF~f~~F~~~~~n---l~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg-----~vaSFsT~ 73 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPN---LILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATG-----LVASFATS 73 (251)
T ss_dssp EEEEEEESSCCSSCTT---EEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred cceEEEeCCCCCCCCC---eEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCC-----ceeeEEEE
Confidence 4689999999854456 99999999977999999998755 8999999999999999999 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|.|.+++...+||||||||+|.+..|+ ..||||||+|.+++ +..||+|||||||++| .+++||++|||||||||+
T Consensus 74 F~F~I~~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n-~~~~Dp~~nHVGIdvNsi 150 (251)
T 3ipv_A 74 FRFTIYAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYEN-TVFTDPPYTHIGFDVNSI 150 (251)
T ss_dssp EEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCC-GGGTCCSSCEEEEEESSS
T ss_pred EEEEEeCCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccc-cccCCCCCCeEEEEcCCC
Confidence 99999988777899999999999887655 67999999998776 7789999999999999 777799999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
+|+++++ +.+.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|||+||
T Consensus 151 ~S~~t~~-----------~~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~v~ 209 (251)
T 3ipv_A 151 SSIKTVK-----------WSLANGEAAKVLITYNSAVKLLVASLVYPSS----------KTSFILADIVDLSSVLPEWVR 209 (251)
T ss_dssp SCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEECTTT----------CCEEEEEEECCHHHHSCSEEE
T ss_pred cccccce-----------eEecCCCEEEEEEEEeCCCCEEEEEEecCCC----------CccceEEEEechHHhCCCcEE
Confidence 9988875 5678999999999999999999999986543 467899999999999999999
Q ss_pred eeEeecCCce---eeeEEEeccccccCC
Q 035655 257 VGFSASTGRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~~---~~~h~i~sW~fs~~~ 281 (670)
||||||||.. .|.|+|++|+|+++.
T Consensus 210 VGFSAsTG~~~~~~e~h~IlsWsF~s~l 237 (251)
T 3ipv_A 210 VGFSAATGASGGKIETHDVFSWSFASKL 237 (251)
T ss_dssp EEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEecCCCccccceeEEEEEEEEEEC
Confidence 9999999998 999999999999864
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=483.68 Aligned_cols=227 Identities=31% Similarity=0.516 Sum_probs=204.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg-----~vaSFsT~F 73 (239)
T 1dbn_A 2 DELSFTINNFVPNEAD---LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTG-----SVASFSTSF 73 (239)
T ss_dssp CEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCC-----CccceEEEE
Confidence 4689999999853356 999999999878999999876 689999999999999999998 899999999
Q ss_pred EEEEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCC--CCCCCCCCCeeEEecC
Q 035655 98 VFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGY--NETSDSQGNHVGINVN 174 (670)
Q Consensus 98 ~f~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~--~~~~Dp~~~Hvgidvn 174 (670)
+|.|.+++...+||||||||+|.+. +|.++.||||||+|.++ +++.||+|||||||++|. .+ |||++||||||||
T Consensus 74 ~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvN 151 (239)
T 1dbn_A 74 TFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVN 151 (239)
T ss_dssp EEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEES
T ss_pred EEEEeCCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecC
Confidence 9999988777899999999999876 68889999999999764 477899999999999982 24 7999999999999
Q ss_pred CcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccc
Q 035655 175 SMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQET 254 (670)
Q Consensus 175 s~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~ 254 (670)
|++|+++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+
T Consensus 152 s~~S~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~ 210 (239)
T 1dbn_A 152 GIESIKTVQ-----------WDWINGGVAFATITYLAPNKTLIASLVYPSN----------QTTFSVAASVDLKEILPEW 210 (239)
T ss_dssp SSSCSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSE
T ss_pred CccccceEc-----------ccccCCCEEEEEEEEeCCCcEEEEEEccCCC----------CCcceEEEEechHHhCCcc
Confidence 999988876 4588999999999999999999999987543 4568999999999999999
Q ss_pred ceeeEeecCCce--eeeEEEeccccccC
Q 035655 255 MYVGFSASTGRK--VSSHFILGWSFSMN 280 (670)
Q Consensus 255 ~~vGFsastg~~--~~~h~i~sW~fs~~ 280 (670)
||||||||||.. .|.|+|++|+|+++
T Consensus 211 v~VGFSAsTG~~~~~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 211 VRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp EEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred EEEEEEeccCCCccceeeEEEEEEeEec
Confidence 999999999998 99999999999864
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=483.25 Aligned_cols=225 Identities=31% Similarity=0.540 Sum_probs=201.3
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg-----~vaSFsT~F 73 (237)
T 1fny_A 2 GSLSFSFPKFAPNQPY---LINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTG-----NVASFVTSF 73 (237)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCC-----CccceEEEE
Confidence 3578999999853356 999999999878999999876 689999999999999999998 899999999
Q ss_pred EEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc
Q 035655 98 VFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK 177 (670)
Q Consensus 98 ~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~ 177 (670)
+|+|.+++...+||||||||+|.+..| ++.||||||+|.++ +++.||+|||||||++| .+ |||++|||||||||+.
T Consensus 74 ~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n-~~-~Dp~~nHVGIdvNsi~ 149 (237)
T 1fny_A 74 TFIIQAPNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSN-GD-WDPKGRHLGINVNSIE 149 (237)
T ss_dssp EEECCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCC-TT-TCCSSSEEEEEESSSS
T ss_pred EEEEeCCCCCCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccC-cc-cCCCCCceEEecCCcc
Confidence 999998877789999999999987654 58999999999764 47799999999999999 67 8999999999999999
Q ss_pred cccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccccee
Q 035655 178 SIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 178 s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+|||
T Consensus 150 S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~v~V 208 (237)
T 1fny_A 150 SIKTVP-----------WNWTNGEVANVFISYEASTKSLTASLVYPSL----------ETSFIIDAIVDVKIVLPEWVRF 208 (237)
T ss_dssp CSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEEE
T ss_pred cccccc-----------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC----------CCcceEEEEechHHhCCCcEEE
Confidence 988876 4588999999999999999999999987543 5578999999999999999999
Q ss_pred eEeecCCce---eeeEEEeccccccC
Q 035655 258 GFSASTGRK---VSSHFILGWSFSMN 280 (670)
Q Consensus 258 GFsastg~~---~~~h~i~sW~fs~~ 280 (670)
|||||||.. .|.|+|++|+|+++
T Consensus 209 GFSAsTG~~~~~~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 209 GFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEEeeCCCCcccceeEEEEEEEEEe
Confidence 999999998 99999999999875
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-61 Score=480.04 Aligned_cols=227 Identities=28% Similarity=0.429 Sum_probs=204.1
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC---CCeEEE-EEecCceeeecCCCCCCCCCCccceeEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA---HNVIGH-AFYNKPIQMLDKSTSLSSKPNASSFSTCFV 98 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~---~~~~Gr-~~y~~pv~l~~~~~~~~~~~~~~sFst~F~ 98 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|| |+|++||+|||+.++ +++||+|+|+
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg-----~vaSFsT~F~ 73 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKD---LSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTG-----ELASFITSFS 73 (242)
T ss_dssp CEEEEEESSCCTTCSS---EEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTT-----EECEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCC-----CccceEEEEE
Confidence 4689999999853356 999999999878999999886 689999 999999999999998 8999999999
Q ss_pred EEEecC-CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCC-CCCCCCeeEEecCCc
Q 035655 99 FQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNET-SDSQGNHVGINVNSM 176 (670)
Q Consensus 99 f~i~~~-~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-~Dp~~~Hvgidvns~ 176 (670)
|+|.++ +...+||||||||+|....| ++.||||||+|.++ +++.||+|||||||++| .++ |||++|||||||||+
T Consensus 74 F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N-~~~~~Dp~~nHVGIdvNs~ 150 (242)
T 1fx5_A 74 FFMETSANPKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGS-PVNFWDPGFPHIGIDVNCV 150 (242)
T ss_dssp EEEEESSCGGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCT-TTSTTSCSSCEEEEEESSS
T ss_pred EEEecCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEeccccC-cccccCCCCCeEEEecCCc
Confidence 999987 56678999999999987654 48899999999765 47789999999999999 787 999999999999999
Q ss_pred ccccccccccccCCCccccccCCC--CcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccc
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESG--DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQET 254 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g--~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~ 254 (670)
+|.++++ ++|.+| +.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+
T Consensus 151 ~S~~~~~-----------~~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~ 209 (242)
T 1fx5_A 151 KSINAER-----------WNKRYGLNNVANVEIIYEASSKTLTASLTYPSD----------QTSISVTSIVDLKEILPEW 209 (242)
T ss_dssp SCSEEEE-----------CCCCCSGGGCEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCGGGTSCSE
T ss_pred cccceec-----------ccccCCCceeEEEEEEEeCCCCEEEEEEecCCC----------CccceeeEEechHHhCCcc
Confidence 9988876 457899 9999999999999999999987543 4568999999999999999
Q ss_pred ceeeEeecC--CceeeeEEEeccccccCCC
Q 035655 255 MYVGFSAST--GRKVSSHFILGWSFSMNGA 282 (670)
Q Consensus 255 ~~vGFsast--g~~~~~h~i~sW~fs~~~~ 282 (670)
||||||||| |.. |.|+|++|+|+++..
T Consensus 210 v~VGFSAsT~~G~~-~~h~IlsWsF~s~l~ 238 (242)
T 1fx5_A 210 VSVGFSGSTYIGRQ-ATHEVLNWYFTSTFI 238 (242)
T ss_dssp EEEEEEEEEETTSC-EEEEEEEEEEEEESS
T ss_pred EEEEEEecccCCCc-ceeEEEEEEeEeecc
Confidence 999999999 999 999999999998643
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-61 Score=477.56 Aligned_cols=223 Identities=28% Similarity=0.509 Sum_probs=203.3
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCC-CCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDN-AHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQI 101 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~-~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i 101 (670)
..++|+|++|++...+ |.++|+|.+.++|.|+||++ ..++.|||+|++||+|||+.+| +++||+|+|+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg-----~vaSFsT~F~F~I 73 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPA---INFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG-----NVASFLTSFSFEM 73 (232)
T ss_dssp EEEEEEESSCCTTCTT---EEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTC-----CBCEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCC-----CccceEEEEEEEE
Confidence 3579999999853356 99999999987899999998 8899999999999999999998 8999999999999
Q ss_pred ecCCCCCCCCcEEEEEcCCCC-CCCCC-CCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccc
Q 035655 102 VTPNSGQGGFGLAFTVSPQPS-FPGGK-AEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179 (670)
Q Consensus 102 ~~~~~~~~g~GlaF~l~~~~~-~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~ 179 (670)
.+++...+||||||||+|.+. +|.++ .||||||+|. ++.||+|||||||++| .++|||++|||||||||++|.
T Consensus 74 ~~~~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n-~~~~Dp~~nHVGIdvns~~S~ 148 (232)
T 1v6i_A 74 KDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSN-SEYNDPPTDHVGIDVNSVDSV 148 (232)
T ss_dssp ECCSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCC-GGGTCCSSCEEEEEEEESSCS
T ss_pred ecCCCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccc-cccCCCCCCeEEEEcCCcccc
Confidence 988777899999999999874 68888 9999999986 5679999999999999 889999999999999999998
Q ss_pred cccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeE
Q 035655 180 KLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259 (670)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGF 259 (670)
++++ ++|.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|||+|||||
T Consensus 149 ~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~----------~~~~~~ls~~vdL~~~l~e~v~VGF 206 (232)
T 1v6i_A 149 KTVP-----------WNSVSGAVVKVTVIYDSSTKTLSVAVTN-D----------NGDITTIAQVVDLKAKLPERVKFGF 206 (232)
T ss_dssp EEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEC-T----------TSCEEEEEEECCHHHHSCSEEEEEE
T ss_pred cccc-----------ccccCCCEEEEEEEEeCCCcEEEEEEec-C----------CCCcceEEEEechHHhCCccEEEEE
Confidence 8876 4588999999999999999999999987 4 3567899999999999999999999
Q ss_pred eecCCc--eeeeEEEeccccccCC
Q 035655 260 SASTGR--KVSSHFILGWSFSMNG 281 (670)
Q Consensus 260 sastg~--~~~~h~i~sW~fs~~~ 281 (670)
| |||. ..|.|+|++|+|+++.
T Consensus 207 S-sTG~~~~~~~h~IlsWsF~s~l 229 (232)
T 1v6i_A 207 S-ASGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp E-EECCSSBCCEEEEEEEEEEEEE
T ss_pred E-ecCCCccccEEEEEEEEEEeec
Confidence 9 9998 6999999999999763
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=475.10 Aligned_cols=226 Identities=31% Similarity=0.520 Sum_probs=204.8
Q ss_pred CCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC---CCeEEEEEecCceeeecCCCCCCCCCCccceeEEEE
Q 035655 22 QQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA---HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFV 98 (670)
Q Consensus 22 ~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~ 98 (670)
+..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.++ +++||+|+|+
T Consensus 3 ~~~~~F~f~~F~~~~~~---l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg-----~vasFsT~F~ 74 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKN---IIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITG-----KVASFATSFS 74 (242)
T ss_dssp CCSEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTC-----CBCEEEEEEE
T ss_pred ccceEEEcCCCCCCCCC---eEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCC-----CcccEEEEEE
Confidence 45789999999853356 999999999878999999986 689999999999999999998 8999999999
Q ss_pred EEEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCCCCCcEEEEEeeec----CCCCCCCCCCCCeeEEec
Q 035655 99 FQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTV----NGYNETSDSQGNHVGINV 173 (670)
Q Consensus 99 f~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~~Dp~~~Hvgidv 173 (670)
|+|.++ ...+||||||||+|.+. +|.++.||||||+|.++ +++.+|+|||||||+ +| . |||++|||||||
T Consensus 75 F~I~~~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N-~--~Dp~~nHVGIdv 149 (242)
T 1qnw_A 75 FVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYN-P--WDPDFKHIGIDV 149 (242)
T ss_dssp EECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTC-T--TSCSSCEEEEEE
T ss_pred EEEecC-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccC-C--CCCCCCcEEEec
Confidence 999987 67789999999999874 68889999999999765 477899999999999 88 4 899999999999
Q ss_pred CCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccc
Q 035655 174 NSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE 253 (670)
Q Consensus 174 ns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~ 253 (670)
||+.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||
T Consensus 150 Ns~~S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e 208 (242)
T 1qnw_A 150 NSIKSIKTVK-----------WDWRNGEVADVVITYRAPTKSLTVCLSYPSD----------GTSNIITASVDLKAILPE 208 (242)
T ss_dssp SSSSCSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEECTTT----------CCEEEEEEECCHHHHSCS
T ss_pred CCccccceec-----------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC----------CcceeEEEeechHHhcCC
Confidence 9999988876 4588999999999999999999999986543 567899999999999999
Q ss_pred cceeeEeecCCce--eeeEEEeccccccCC
Q 035655 254 TMYVGFSASTGRK--VSSHFILGWSFSMNG 281 (670)
Q Consensus 254 ~~~vGFsastg~~--~~~h~i~sW~fs~~~ 281 (670)
+||||||||||.. .|.|+|++|+|+++.
T Consensus 209 ~v~VGFSAsTG~~~~~~~h~IlsWsF~s~l 238 (242)
T 1qnw_A 209 WVSVGFSGGVGNAAEFETHDVLSWYFTSNL 238 (242)
T ss_dssp EEEEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred ceEEEEEeccCCCccceEEEEEEEEeEeec
Confidence 9999999999999 999999999999864
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=475.07 Aligned_cols=225 Identities=31% Similarity=0.533 Sum_probs=200.9
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.++ +++||+|+
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg-----~vaSFsT~ 73 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDN---LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTG-----TVASFETR 73 (239)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred eeEEEEeCCCCCCCCC---eEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCC-----CccceEEE
Confidence 3579999999853356 999999999878999999876 579999999999999999998 89999999
Q ss_pred EEEEEecCC-CCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC
Q 035655 97 FVFQIVTPN-SGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS 175 (670)
Q Consensus 97 F~f~i~~~~-~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns 175 (670)
|+|+|.+++ ...+||||||||+|....| ++.||||||+|.++ +++.||+|||||||++| . +.||++|||||||||
T Consensus 74 F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n-~-~dDp~~nHVGIdvns 149 (239)
T 1gzc_A 74 FSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSN-P-WDPPQVPHIGIDVNS 149 (239)
T ss_dssp EEEECCCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCC-T-TSCSSSSEEEEEESS
T ss_pred EEEEEeCCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEecccc-c-CCCCCCCeEEEecCC
Confidence 999999876 6678999999999987654 58999999999764 47789999999999999 5 556999999999999
Q ss_pred cccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccc
Q 035655 176 MKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETM 255 (670)
Q Consensus 176 ~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~ 255 (670)
+.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+|
T Consensus 150 ~~S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~v 208 (239)
T 1gzc_A 150 IRSIKTQP-----------FQLDNGQVANVVIKYDAPSKILHVVLVYPSS----------GAIYTIAEIVDVKQVLPDWV 208 (239)
T ss_dssp SSCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEECTTT----------CCEEEEEEECCHHHHSCSEE
T ss_pred cccccccc-----------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC----------CccceEEEEechHHhCCCce
Confidence 99988765 4588999999999999999999999986543 55789999999999999999
Q ss_pred eeeEeecCCc---eeeeEEEeccccccC
Q 035655 256 YVGFSASTGR---KVSSHFILGWSFSMN 280 (670)
Q Consensus 256 ~vGFsastg~---~~~~h~i~sW~fs~~ 280 (670)
|||||||||. ..|.|+|++|+|+++
T Consensus 209 ~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 209 DVGLSGATGAQRDAAETHDVYSWSFQAS 236 (239)
T ss_dssp EEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEEEeccCCCccccceEEEEEEEeEEe
Confidence 9999999997 489999999999875
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-60 Score=477.89 Aligned_cols=242 Identities=30% Similarity=0.457 Sum_probs=201.6
Q ss_pred CceeEEeCCCC-CCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeE
Q 035655 23 QKEEFIFNGFN-ETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFST 95 (670)
Q Consensus 23 ~~~~f~~~~f~-~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst 95 (670)
..++|+|++|. +...+ |.++|+|.+. +|.|+||++. .++.|||+|++||+|||+.+| +++||+|
T Consensus 3 ~~~~F~f~~F~~~~~~~---l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg-----~vasFsT 73 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDS---IIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTE-----SVASFYT 73 (257)
T ss_dssp -CCEEEESCSCSCGGGT---EEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTC-----CCCEEEE
T ss_pred cceEEEcCCCCCCCCCC---EEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCC-----CeeceEE
Confidence 45899999998 22256 9999999998 9999999875 579999999999999999998 8999999
Q ss_pred EEEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCC-CCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecC
Q 035655 96 CFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN-DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVN 174 (670)
Q Consensus 96 ~F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvn 174 (670)
+|+|+|.++ ...+||||||||+|.... .++.||||||+|.++ ++++.||+|||||||++| .++.||++||||||||
T Consensus 74 ~F~F~I~~~-~~~~gdGlAF~l~p~~~~-~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N-~~~~Dp~~nHVGIdvN 150 (257)
T 1hql_A 74 EFTFFLKIT-GNGPADGLAFFLAPPDSD-VKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTN-PNFPEPSYRHIGINVN 150 (257)
T ss_dssp EEEEEEEEC-SSCCCCEEEEEEECTTCC-CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCC-SSSCCCSSCEEEEEES
T ss_pred EEEEEEecC-CCCCCCcEEEEEecCCCC-CCCCCccccccccccccCCccCceEEEEeccccc-ccccCCCCCceeeeeC
Confidence 999999987 677899999999998764 458899999999875 367889999999999999 7777999999999999
Q ss_pred CcccccccccccccCCCcccc-ccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccc
Q 035655 175 SMKSIKLEPAAYYENGTKEDF-TLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE 253 (670)
Q Consensus 175 s~~s~~~~~~~~~~~~~~~~~-~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~ 253 (670)
|+.|.+++++. + +|.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+.+|||
T Consensus 151 s~~S~~s~~~~---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-----------~~~~ls~~vdL~~~l~e 210 (257)
T 1hql_A 151 SIVSVATKRWE---------DSDIFSGKIATARISYDGSAEILTVVLSYPDG-----------SDYILSHSVDMRQNLPE 210 (257)
T ss_dssp SSSCSEEEECC---------HHHHTSCSCEEEEEEEETTTTEEEEEEEETTT-----------EEEEEEEECCGGGTSCS
T ss_pred CccccceeccC---------cccccCCceEEEEEEEeCCCCEEEEEEecCCC-----------CceeeEEeechHHhcCC
Confidence 99999887731 2 255799999999999999999999987532 35799999999999999
Q ss_pred cceeeEeecCC-ceeeeEEEeccccccCCCCCCCCCCCCCCCCC
Q 035655 254 TMYVGFSASTG-RKVSSHFILGWSFSMNGAAPSLNLSQIPSLPI 296 (670)
Q Consensus 254 ~~~vGFsastg-~~~~~h~i~sW~fs~~~~~~~l~~s~~p~~p~ 296 (670)
+|||||||||| ...|.|+|++|+|+++...+..+.+.+|.+|.
T Consensus 211 ~~~vGFSAsTG~~~~~~H~IlsWsF~s~~~~~~~~~~~~p~~~~ 254 (257)
T 1hql_A 211 SVRVGISASTGNNQFLTVYILSWRFSSNLQSTSVKAAMEPEITR 254 (257)
T ss_dssp EEEEEEEEECCSCCCEEEEEEEEEEEEEC---------------
T ss_pred ceEEEEEeccCCCccceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence 99999999999 99999999999999998888888888887763
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-60 Score=469.08 Aligned_cols=220 Identities=28% Similarity=0.459 Sum_probs=200.2
Q ss_pred eeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCC--CCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 25 EEFIFNGFNETKTNQGLITRERASILKPSGALRLTDN--AHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 25 ~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~--~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
++|+|++|. ...+ |.++|+|.+.++|.|+||++ ..++.|||+|++||+|||+.++ +++||+|+|+|+|.
T Consensus 1 ~sF~f~~F~-~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg-----~vaSFsT~F~F~I~ 71 (234)
T 2eig_A 1 VSFNYTRFK-DDGS---LIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATG-----NVASFITSFSFIVS 71 (234)
T ss_dssp CEEEESSCC-SSSS---EEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTC-----CBCEEEEEEEEEEE
T ss_pred CeEEcCCCC-CCCC---eEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCC-----CccceEEEEEEEEe
Confidence 479999998 2256 99999999977899999998 7789999999999999999998 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCC---CeeEEecCCccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQG---NHVGINVNSMKS 178 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~---~Hvgidvns~~s 178 (670)
+++...+||||||||+|.+. +|.++.||||||+|.+ ++.||+|||||||++| . |||++ |||||||||+.|
T Consensus 72 ~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N-~--~Dp~~~~~nHVGIdvNsi~S 145 (234)
T 2eig_A 72 NVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPN-V--WDPKSLRSSHIGIDVNSIMS 145 (234)
T ss_dssp ECTTSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCC-T--TSCTTTCSSEEEEEESSSSC
T ss_pred CCCCCCCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccC-c--cCCCCCCCCceEEecCCccc
Confidence 88777899999999999874 7888999999999875 6689999999999999 4 89999 999999999999
Q ss_pred ccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceee
Q 035655 179 IKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258 (670)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vG 258 (670)
.++++ ++|.+|+.++|||+||+.+++|+|+|++ +. |..|+|++.+||+++|||+||||
T Consensus 146 ~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~~----------~~~~~ls~~vdL~~~l~e~v~VG 203 (234)
T 2eig_A 146 LKAVN-----------WNRVSGSLEKATIIYDSDTKILTVVMTH-QN----------GQITTISQEIDLKTVLPEKVSVG 203 (234)
T ss_dssp SEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEE-TT----------SCEEEEEEECCHHHHSCSEEEEE
T ss_pred cceec-----------ccccCCCEEEEEEEEeCCCcEEEEEEec-CC----------CCcceEeEeechHHhcCCceEEE
Confidence 88876 4578999999999999999999999998 43 55789999999999999999999
Q ss_pred EeecC--CceeeeEEEeccccccCCC
Q 035655 259 FSAST--GRKVSSHFILGWSFSMNGA 282 (670)
Q Consensus 259 Fsast--g~~~~~h~i~sW~fs~~~~ 282 (670)
||||| |.. |.|+|++|+|+++..
T Consensus 204 FSAsT~~G~~-~~h~IlsWsF~s~l~ 228 (234)
T 2eig_A 204 FSATTWNPER-ERHDIYSWSFTSTLK 228 (234)
T ss_dssp EEEEECSSCC-EEEEEEEEEEEEECC
T ss_pred EEeeecCCCc-ceeEEEEEEEEecCC
Confidence 99999 998 999999999998743
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=472.98 Aligned_cols=223 Identities=32% Similarity=0.545 Sum_probs=201.4
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg-----~vaSFsT~ 73 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPN---MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETG-----SVASFAAS 73 (253)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCC-----cccceEEE
Confidence 3579999999853356 999999999778999999876 579999999999999999998 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|+|.+++...+||||||||+|.+..| ++.||||||+|.+ ++.||+|||||||++| . |||++|||||||||+
T Consensus 74 F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N-~--~Dp~~nHVGIdvNs~ 146 (253)
T 1sbf_A 74 FNFTFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRN-S--WDPPNPHIGINVNSI 146 (253)
T ss_dssp EEEEEECSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCC-T--TCCSSSEEEEEESSS
T ss_pred EEEEEeCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccC-C--CCCCCCcEEEEcCCc
Confidence 9999998877789999999999987654 5889999999876 6789999999999999 4 899999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+||
T Consensus 147 ~S~~t~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~~~ 205 (253)
T 1sbf_A 147 RSIKTTS-----------WDLANNKVAKVLITYDASTSLLVASLVYPSQ----------RTSNILSDVVDLKTSLPEWVR 205 (253)
T ss_dssp SCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEE
T ss_pred cccceec-----------ccccCCCeeEEEEEEeCCCcEEEEEEecCCC----------CCcceEEEEechHHhCCCceE
Confidence 9988876 4588999999999999999999999987543 457899999999999999999
Q ss_pred eeEeecCCce--eeeEEEeccccccCC
Q 035655 257 VGFSASTGRK--VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~~--~~~h~i~sW~fs~~~ 281 (670)
||||||||.. .|.|+|++|+|+++.
T Consensus 206 VGFSAsTG~~~~~~~H~IlsWsF~s~l 232 (253)
T 1sbf_A 206 IGFSAATGLDIPGESHDVLSWSFASNL 232 (253)
T ss_dssp EEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred EEEEeccCCCccceeeEEEEEEeEeec
Confidence 9999999998 999999999999864
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=467.53 Aligned_cols=226 Identities=29% Similarity=0.520 Sum_probs=203.6
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
..++|+|++|.+...+ |.++|+|.. ++|.|+||++..++.|||+|++||+|||+.+| +++||+|+|+|+|.
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~~-~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~-----~~~sFst~F~F~I~ 72 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQN---LIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWDRETG-----NVANFVTSFTFVIN 72 (234)
T ss_dssp EEEEEEESSBCTTCTT---EEEEETCEE-ETBEEEEECSCTTCEEEEEESSCEECBCTTTC-----CBCEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---EEEeeceec-CCCEEEeCCCCCCCEEEEEECCCEEcccCCCC-----ceeeEEEEEEEEEe
Confidence 3579999999853356 999999994 58999999999999999999999999999998 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCC--CCeeEEecCCccccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQ--GNHVGINVNSMKSIK 180 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~--~~Hvgidvns~~s~~ 180 (670)
+++...+||||||+|+|.+..|. +.|+||||+|.++ ++..||+|||||||++| .+ |||+ +|||||||||+.|.+
T Consensus 73 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N-~~-~Dp~~~~nHVgIdvns~~S~~ 148 (234)
T 2bqp_A 73 APNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYN-AA-WDPSNRDRHIGIDVNSIKSVN 148 (234)
T ss_dssp CSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCC-TT-TSCTTCCCEEEEEESSSSCSE
T ss_pred CCCCCCCCCcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccC-cc-cCCCCCCCceeEeeCCccccc
Confidence 88777899999999999877666 8899999999874 47789999999999999 67 7999 999999999999988
Q ss_pred ccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCC---CCCCcccccccCCccccccccee
Q 035655 181 LEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFG---KPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~---~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
+++ +++.+|+.++|||+||+.+++|+|+|++.+. + ||..|+|+..+||+.+|||+|||
T Consensus 149 s~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--------~~~~~p~~~~ls~~vdL~~~l~~~~yv 209 (234)
T 2bqp_A 149 TKS-----------WKLQNGEEANVVIAFNAATNVLTVSLTYPNN--------SLEEEVTSYTLSDVVSLKDVVPEWVRI 209 (234)
T ss_dssp EEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEECC--------------CEEEEEEEECCGGGTSCSEEEE
T ss_pred eEe-----------eEEcCCCEEEEEEEEeCCCCEEEEEEecCCC--------CcccCCCcceEEEEechHHhCCCceEE
Confidence 765 4577999999999999999999999998765 4 67889999999999999999999
Q ss_pred eEeecCCceeeeEEEeccccccC
Q 035655 258 GFSASTGRKVSSHFILGWSFSMN 280 (670)
Q Consensus 258 GFsastg~~~~~h~i~sW~fs~~ 280 (670)
|||||||...|.|+|++|+|+++
T Consensus 210 GFSAsTG~~~~~H~IlsWsF~s~ 232 (234)
T 2bqp_A 210 GFSATTGAEYAAHEVLSWSFHSE 232 (234)
T ss_dssp EEEEECSSSCCEEEEEEEEEEEE
T ss_pred EEEeccCCCcccEEEEEEEEEee
Confidence 99999999999999999999874
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-59 Score=466.96 Aligned_cols=226 Identities=27% Similarity=0.437 Sum_probs=201.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++.. ++.|||+|++||+|||+ ++ +++||+|+
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g-----~~~sFst~ 72 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQD---LIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SS-----LVASFETT 72 (240)
T ss_dssp CEEEEEESSCCTTCTT---EEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TC-----SEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CC-----CcCcEEEE
Confidence 4689999999853356 9999999997789999999875 79999999999999999 88 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCC-CCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGG-KAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS 175 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns 175 (670)
|+|+|.++ ...+||||||+|+|.+..|.+ +.|+||||+|.+++++..||+|||||||++| .++|||++|||||||||
T Consensus 73 F~F~I~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N-~~~~Dp~~nHvgIdvns 150 (240)
T 2fmd_A 73 FTFSISQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPN-TDIGDPNYRHIGIDVNS 150 (240)
T ss_dssp EEEECCBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCC-GGGTCCSSCEEEEEESS
T ss_pred EEEEEecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccc-cccCCCCCCceeecccc
Confidence 99999987 677899999999998876665 8999999999887777899999999999999 78899999999999999
Q ss_pred cccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccc
Q 035655 176 MKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETM 255 (670)
Q Consensus 176 ~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~ 255 (670)
+.|.++++ +++.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+.+||++|
T Consensus 151 ~~S~~s~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-----------~~~~ls~~vdL~~~l~~~~ 208 (240)
T 2fmd_A 151 IRSKAASK-----------WDWQNGKTATAHISYNSASKRLSVVSSYPNS-----------SPVVVSFDVELNNVBPBWV 208 (240)
T ss_dssp SSCSEEEE-----------CCCCSSCEEEEEEEEETTTTEEEEEEECTTS-----------CCEEEEEECCGGGTSCSEE
T ss_pred ccccceeE-----------EEeeCCCEEEEEEEEeCCCCEEEEEEecCCC-----------CceEEEEEechHHhCCCce
Confidence 99988765 3577999999999999999999999986432 3689999999999999999
Q ss_pred eeeEeecCCceeeeEEEeccccccCC
Q 035655 256 YVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 256 ~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
|||||||||...|.|+|++|+|+++.
T Consensus 209 yvGFSAsTG~~~~~H~IlsWsF~s~~ 234 (240)
T 2fmd_A 209 RVGFSATTGQYTQTNNILAWSFRSSL 234 (240)
T ss_dssp EEEEEEECCSSCBCCEEEEEEEEEEE
T ss_pred EEEEEeccCCccccEEEEEEEeEecC
Confidence 99999999999999999999999763
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=471.94 Aligned_cols=223 Identities=31% Similarity=0.547 Sum_probs=202.1
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.. .+ |.++|+|.+. +|.|+||++. .++.|||+|++||+|||+.+| +++||+|+
T Consensus 2 ~~~~F~f~~F~~--~~---l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg-----~vaSFsT~ 70 (253)
T 1g7y_A 2 DIQSFSFKNFNS--SS---FILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTG-----AVASWATS 70 (253)
T ss_dssp EEEEEEESSCCS--SC---EEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred cceEEEcCCCCc--CC---EEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCC-----CccceEEE
Confidence 357999999985 67 9999999998 9999999876 579999999999999999999 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|+|.+++...+||||||||+|.+..| ++.||||||+|.++ ++..||+|||||||++| .+ |||++|||||||||+
T Consensus 71 F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N-~~-~Dp~~nHVGIdvns~ 146 (253)
T 1g7y_A 71 FTANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSN-TD-WDPTSRHIGIDVNSI 146 (253)
T ss_dssp EEEECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCC-TT-TCCSSCEEEEEESSS
T ss_pred EEEEEecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceec-cC-cCCCCCcEeeccCCc
Confidence 9999998766678999999999987654 58899999999774 46789999999999999 67 899999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..+||+++|||+||
T Consensus 147 ~S~~t~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~~~ 205 (253)
T 1g7y_A 147 KSIRTAS-----------WGLANGQNAEILITYNAATSLLVASLVHPSR----------RTSYIVSERVDITNELPEYVS 205 (253)
T ss_dssp SCSEEEE-----------CCCCTTSEEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEE
T ss_pred cccceec-----------cccCCCCeEEEEEEEeCCCCEEEEEEecCCC----------CCcceEEEEechHHhCCCceE
Confidence 9988876 4578999999999999999999999987543 557899999999999999999
Q ss_pred eeEeecCCce---eeeEEEeccccccCC
Q 035655 257 VGFSASTGRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~~---~~~h~i~sW~fs~~~ 281 (670)
||||||||.. .|.|+|++|+|+++.
T Consensus 206 VGFSAsTG~~~~~~~~H~IlsWsF~s~l 233 (253)
T 1g7y_A 206 IGFSATTGLSEGYTETHDVLSWSFASKL 233 (253)
T ss_dssp EEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred EEEEeCcCCCCcccceeEEEEEEEEeeC
Confidence 9999999998 999999999999864
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=471.25 Aligned_cols=222 Identities=35% Similarity=0.580 Sum_probs=201.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.. .+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+
T Consensus 2 ~~~~F~f~~F~~--~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg-----~vaSFsT~ 71 (252)
T 1fat_A 2 NDIYFNFQRFNE--TN---LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTG-----TVASFATS 71 (252)
T ss_dssp CCEEEEESSCCG--GG---EEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTT-----EEEEEEEE
T ss_pred cceEEEcCCCCc--CC---EEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCC-----cccceEEE
Confidence 468999999985 66 999999999778999999875 579999999999999999998 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|+|.+++...+||||||||+|.+..| ++.||||||+|.+ ++.||+|||||||++| .+ |||++|||||||||+
T Consensus 72 F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N-~~-~Dp~~nHVGIdvNs~ 145 (252)
T 1fat_A 72 FTFNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYN-KD-WDPTERHIGIDVNSI 145 (252)
T ss_dssp EEEECCCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCC-TT-TCCSSCEEEEEESSS
T ss_pred EEEEEeCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccC-CC-CCCCCCeEEEecCCc
Confidence 9999998876778999999999987654 5889999999976 6689999999999999 67 899999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.++++ +++.+|+.++|||+||+.+++|+|+|++.+. |.+|+|++.+||+.+|||+||
T Consensus 146 ~S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~~~ 204 (252)
T 1fat_A 146 RSIKTTR-----------WDFVNGENAEVLITYDSSTNLLVASLVYPSQ----------KTSFIVSDTVDLKSVLPEWVS 204 (252)
T ss_dssp SCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEE
T ss_pred cccceec-----------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC----------CCcceEEEEechHHhCCCceE
Confidence 9988866 4578999999999999999999999987543 457899999999999999999
Q ss_pred eeEeecCCce---eeeEEEeccccccCC
Q 035655 257 VGFSASTGRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~~---~~~h~i~sW~fs~~~ 281 (670)
||||||||.. .|.|+|++|+|+++.
T Consensus 205 VGFSAsTG~~~~~~~~H~IlsWsF~s~l 232 (252)
T 1fat_A 205 VGFSATTGINKGNVETNDVLSWSFASKL 232 (252)
T ss_dssp EEEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred EEEEeccCCCCcccceEEEEEEEEEeeC
Confidence 9999999998 999999999999864
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=466.67 Aligned_cols=222 Identities=34% Similarity=0.543 Sum_probs=199.6
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
+.++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg-----~vaSFsT~F 73 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQ---LKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTG-----NVASFETRF 73 (242)
T ss_dssp CEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCC-----CeeeEEEEE
Confidence 4689999999853356 999999999778999999876 689999999999999999998 899999999
Q ss_pred EEEEecC-CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 98 VFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 98 ~f~i~~~-~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
+|+|.++ +...+||||||||+|.... +++.||||||+|.+ +.||+|||||||++| . |||++|||||||||+
T Consensus 74 ~F~I~~~~~~~~~gdGlAF~l~p~~~~-~~~~g~~LGl~n~~----~~~~~vAVEFDT~~N-~--~Dp~~nHVGIdvNs~ 145 (242)
T 1wbf_A 74 SFSIRQPFPRPHPADGLVFFIAPPNTQ-TGEGGGYFGIYNPL----SPYPFVAVEFDTFRN-T--WDPQIPHIGIDVNSV 145 (242)
T ss_dssp EEECCCSCCSSCCCEEEEEEEECSSCC-CCCCGGGTTTCCTT----SCCCCEEEEEECSCC-T--TCCSSSEEEEEESSS
T ss_pred EEEEeCCCCCCCCCCcEEEEEecCCCC-CCCCCCccccccCC----CcCcEEEEEeccccC-C--CCCCCCeEEEECCCc
Confidence 9999987 5677899999999998764 45889999999865 678999999999999 4 899999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..+||+++|||+||
T Consensus 146 ~S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~v~ 204 (242)
T 1wbf_A 146 ISTKTVP-----------FTLDNGGIANVVIKYDASTKILHVVLVFPSL----------GTIYTIADIVDLKQVLPESVN 204 (242)
T ss_dssp SCSEEEE-----------CCCCTTSCEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEE
T ss_pred cccceee-----------eEecCCCEEEEEEEEeCCCCEEEEEEccCCC----------CCcceEEEEechHHhcCCceE
Confidence 9988765 4688999999999999999999999987643 456899999999999999999
Q ss_pred eeEeecC----Cce---eeeEEEeccccccCC
Q 035655 257 VGFSAST----GRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsast----g~~---~~~h~i~sW~fs~~~ 281 (670)
||||||| |.. .|.|+|++|+|+++.
T Consensus 205 VGFSAsTg~~~G~~~~~~~~h~IlsWsF~s~l 236 (242)
T 1wbf_A 205 VGFSAATGDPSGKQRNATETHDILSWSFSASL 236 (242)
T ss_dssp EEEEEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred EEEEEeecCcCCccccccceEEEEEEEeEecC
Confidence 9999999 888 999999999999864
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=464.14 Aligned_cols=221 Identities=34% Similarity=0.538 Sum_probs=199.2
Q ss_pred ceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 24 KEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 24 ~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
.++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+| +++||+|+|
T Consensus 2 ~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g-----~vasFsT~F 73 (238)
T 1f9k_A 2 TQSFNFDHFEENSKE---LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTG-----NVASFETRF 73 (238)
T ss_dssp EEEEEESSCCSSCTT---EEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred CeEEEcCCCCCCCCC---eEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCC-----CeeeEEEEE
Confidence 578999999853356 999999999778999999876 579999999999999999998 899999999
Q ss_pred EEEEecC-CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 98 VFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 98 ~f~i~~~-~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
+|+|.++ +...+||||||||+|.+..| ++.||||||+|.+ ++ +|+|||||||++| . |||++|||||||||+
T Consensus 74 ~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N-~--~Dp~~nHVgIdvns~ 145 (238)
T 1f9k_A 74 SFNITQPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQN-T--WDPQVPHIGIDVNSI 145 (238)
T ss_dssp EEEEECCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCC-T--TCCSSSEEEEEESSS
T ss_pred EEEEecCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccC-C--CCCCCCeEEEecCCc
Confidence 9999987 66778999999999987654 5889999999876 45 9999999999999 4 899999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccc--c
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE--T 254 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~--~ 254 (670)
.|.++++ ++|.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..+||+++||| +
T Consensus 146 ~S~~s~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~~~~~ 204 (238)
T 1f9k_A 146 VSSKTLH-----------FQLENGGVANVVIKYDSPTKILNVVLAFHSV----------GTVYTLSNIVDLKQEFPNSEW 204 (238)
T ss_dssp SCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCHHHHSTTCSE
T ss_pred cccceEe-----------ecccCCCEEEEEEEEeCCCCEEEEEEecCCC----------CCceeEEEEechHHhCCCCce
Confidence 9988765 4588999999999999999999999987543 456899999999999999 9
Q ss_pred ceeeEeecCCce---eeeEEEeccccccCC
Q 035655 255 MYVGFSASTGRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 255 ~~vGFsastg~~---~~~h~i~sW~fs~~~ 281 (670)
||||||||||.. .|.|+|++|+|+++.
T Consensus 205 ~~vGFSAsTG~~~~~~~~h~IlsWsF~s~~ 234 (238)
T 1f9k_A 205 VNVGLSATTGYQKNAVETHEIISWSFTSSL 234 (238)
T ss_dssp EEEEEEEEECSSTTCCCEEEEEEEEEEEEC
T ss_pred EEEEEEeCcCCCCcccceEEEEEeEeEeec
Confidence 999999999999 999999999999864
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=461.83 Aligned_cols=222 Identities=30% Similarity=0.538 Sum_probs=198.6
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
..++|+|++|.+...+ |.++|+|.+.++|.|+||++. .++.|||+|++||+|||+.+ ++||+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~-------~~sFsT~F 71 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNN---LILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT-------LASFTTSF 71 (233)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC-------BCEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC-------cCCEEEEE
Confidence 3579999999853356 999999999778999999876 47999999999999998653 79999999
Q ss_pred EEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc
Q 035655 98 VFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK 177 (670)
Q Consensus 98 ~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~ 177 (670)
+|+|.+++...+||||||||+|.+..|. +.||||||+|.++ ++..||+|||||||++| . |||++|||||||||+.
T Consensus 72 ~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N-~--~Dp~~nHvGIdvns~~ 146 (233)
T 1n47_A 72 SFVMAAPAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSN-A--WDPNYTHIGIDTNGIE 146 (233)
T ss_dssp EEECCCSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCC-T--TSCSSCEEEEEESSSS
T ss_pred EEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEeccccC-C--CCCCCCcEEEccCCcc
Confidence 9999988767789999999999877665 8899999999774 57789999999999999 4 8999999999999999
Q ss_pred cccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccccee
Q 035655 178 SIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 178 s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
|.++++ +++.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+|||
T Consensus 147 S~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~~~~~v 205 (233)
T 1n47_A 147 SKKTTP-----------FDMVYGEKANIVITYQASTKALAASLVFPVS----------QTSYAVSARVDLRDILPEYVRV 205 (233)
T ss_dssp CSEEEE-----------CCCCTTSCEEEEEEEETTTTEEEEEEEETTT----------TEEEEEEEECCGGGTSCSEEEE
T ss_pred cccccc-----------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC----------CCcceEEEEechHHhCCCceEE
Confidence 988765 4678999999999999999999999987654 3468999999999999999999
Q ss_pred eEeecCCce---eeeEEEeccccccC
Q 035655 258 GFSASTGRK---VSSHFILGWSFSMN 280 (670)
Q Consensus 258 GFsastg~~---~~~h~i~sW~fs~~ 280 (670)
|||||||.. .|.|+|++|+|+++
T Consensus 206 GFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 206 GFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEeccCCCccccceeEEEEEEEEee
Confidence 999999998 99999999999874
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=463.67 Aligned_cols=223 Identities=28% Similarity=0.429 Sum_probs=198.6
Q ss_pred CceeEEeCCC----CCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccc
Q 035655 23 QKEEFIFNGF----NETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASS 92 (670)
Q Consensus 23 ~~~~f~~~~f----~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~s 92 (670)
+.++|+|++| .+...+ |.++|+|.+. +|.|+||++. .++.|||+|++||+||| .++ +++|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~---l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg-----~vas 71 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTE---ITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STG-----KAAS 71 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSS---EEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTS-----CBCE
T ss_pred cceEEEcCCCccccCCCCCC---EEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCC-----CcCc
Confidence 4679999999 532345 9999999998 9999999876 57999999999999999 888 8999
Q ss_pred eeEEEEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCC-CCCCCcEEEEEeeecCCCCCCCCCCCCeeEE
Q 035655 93 FSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND-HKPSNHLFAIEFDTVNGYNETSDSQGNHVGI 171 (670)
Q Consensus 93 Fst~F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgi 171 (670)
|+|+|+|+|.++ ...+||||||||+|.+.. +++.||||||+|.+++ +++.||+|||||||++| .++.||++|||||
T Consensus 72 FsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~-~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N-~~~~Dp~~nHvGI 148 (243)
T 1gsl_A 72 FYTSFTFLLKNY-GAPTADGLAFFLAPVDSS-VKDYGGFLGLFRHETAADPSKNQVVAVEFDTWIN-KDWNDPPYPHIGI 148 (243)
T ss_dssp EEEEEEEEEEES-SSSCBCEEEEEEEETTCC-CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCC-GGGTCCSSCEEEE
T ss_pred eEEEEEEEEecC-CCCCCCCEEEEEecCCCC-CCCCCCcccccccccccCCccCcEEEEEeccccc-cccCCCCCCceee
Confidence 999999999987 667899999999998764 4588999999998764 67889999999999999 7777999999999
Q ss_pred ecCCcccccccccccccCCCccccccCC---CCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCc
Q 035655 172 NVNSMKSIKLEPAAYYENGTKEDFTLES---GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLS 248 (670)
Q Consensus 172 dvns~~s~~~~~~~~~~~~~~~~~~l~~---g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~ 248 (670)
||||+.|+++.+ +++.+ |+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+
T Consensus 149 dvns~~S~~~~~-----------~~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-----------~~~~ls~~vdL~ 206 (243)
T 1gsl_A 149 DVNSIVSVATTR-----------WENDDAYGSSIATAHITYDARSKILTVLLSYEHG-----------RDYILSHVVDLA 206 (243)
T ss_dssp EESSSSCSEEEE-----------CCHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS-----------CEEEEEEECCHH
T ss_pred ccCCccccceee-----------eEEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC-----------CceeEEEEechH
Confidence 999999988876 34666 99999999999999999999987542 358999999999
Q ss_pred ccccccceeeEeecCCceeeeEEEeccccccCC
Q 035655 249 PAFQETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 249 ~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
.+|||+|||||||||| ..|.|+|++|+|+++.
T Consensus 207 ~~l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~l 238 (243)
T 1gsl_A 207 KVLPQKVRIGFSAGVG-YDEVTYILSWHFFSTL 238 (243)
T ss_dssp HHSCSEEEEEEEEEEC-BSEEEEEEEEEEEEEC
T ss_pred HhCCCceEEEEEeccC-CcceeEEEEEEEEeec
Confidence 9999999999999999 9999999999999864
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-58 Score=454.35 Aligned_cols=217 Identities=34% Similarity=0.563 Sum_probs=196.2
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCC---CCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDN---AHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVF 99 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f 99 (670)
..++|+|++|+. .+ |.++|+|.+.++|.|+||++ ..++.|||+|++||+|||+.+| +++||+|+|+|
T Consensus 2 ~~~~F~f~~F~~--~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g-----~vaSFsT~F~F 71 (226)
T 1avb_A 2 NDASFNVETFNK--TN---LILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID-----NLASFSTNFTF 71 (226)
T ss_dssp EEEEEEESSCCG--GG---EEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGT-----EEEEEEEEEEE
T ss_pred cceEEEcCCCCc--cC---EEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCC-----CcccEEEEEEE
Confidence 357999999985 66 99999999977899999998 6789999999999999999998 89999999999
Q ss_pred EEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccc
Q 035655 100 QIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179 (670)
Q Consensus 100 ~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~ 179 (670)
+|.+++...+||||||||+|.+..|. +.||||||+|.+ ++++.||+|||||||+ +|||||||||++|.
T Consensus 72 ~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~----------~nHVGIdvNs~~S~ 139 (226)
T 1avb_A 72 RINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV----------SNRIEIDVNSIRPI 139 (226)
T ss_dssp EEEESSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT----------TTEEEEEESSSSCS
T ss_pred EEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc----------CCccceeecCcccC
Confidence 99988777899999999999877666 889999999976 4477899999999997 48999999999999
Q ss_pred cccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeE
Q 035655 180 KLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259 (670)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGF 259 (670)
+++++ +..|.+|+.++|||+||+.+++|+|+|++.+. +.+|+|++.+||+++|||+|||||
T Consensus 140 ~t~~~---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~~~VGF 200 (226)
T 1avb_A 140 ATESC---------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS----------EEKCHVSATVPLEKEVEDWVSVGF 200 (226)
T ss_dssp EEEEC---------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT----------TEEEEEEEECCHHHHSCSEEEEEE
T ss_pred ccccC---------CccccCCCeEEEEEEEeCCCcEEEEEEeecCC----------CccceEEEEechHHhCCCceEEEE
Confidence 88772 36777999999999999999999999987654 337899999999999999999999
Q ss_pred eecCCce---eeeEEEeccccccC
Q 035655 260 SASTGRK---VSSHFILGWSFSMN 280 (670)
Q Consensus 260 sastg~~---~~~h~i~sW~fs~~ 280 (670)
|||||.. .|.|+|++|+|+++
T Consensus 201 SAsTG~~~~~~~~h~IlsWsF~s~ 224 (226)
T 1avb_A 201 SATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp EEEECSSGGGCEEEEEEEEEEEEE
T ss_pred EeccCCCCcccceeEEEEEEEEee
Confidence 9999999 99999999999864
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=444.82 Aligned_cols=217 Identities=30% Similarity=0.502 Sum_probs=192.9
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
..++|+|++|.. .+. |.++|+|.+.++|.|+||++.. ++.|||+|++||+|||+. +++||+|+
T Consensus 2 ~~~~F~f~~F~~--~~~--l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~-------~vaSFsT~ 70 (240)
T 1ioa_A 2 TETSFNFPNFHT--DDK--LILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN-------NVASFNTN 70 (240)
T ss_dssp CCCEEEESSCCT--TSS--EEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS-------CBEEEEEE
T ss_pred cceEEEcCCCCC--CCc--EEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC-------ccccEEEE
Confidence 357999999975 332 9999999997789999998765 799999999999999865 48999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|+|.+++...+||||||||+|.+..|. +.||||||+|.+ ++++.||+|||||||+ +|||||||||+
T Consensus 71 F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~----------~nHVGIdvNs~ 138 (240)
T 1ioa_A 71 FTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF----------KNRIDFDKNFI 138 (240)
T ss_dssp EEEECCBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT----------TTEEEEEESSS
T ss_pred EEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc----------CCceeeeeCCc
Confidence 99999988777899999999999877666 899999999976 4477899999999997 48999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.+++++ +..|.+|+.++|||+||+.+++|+|+|++.+. |.+|+|+..+||+++|||+||
T Consensus 139 ~S~~t~~~---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdL~~~l~e~v~ 199 (240)
T 1ioa_A 139 KPYVNENC---------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS----------QVKCSVSATVHLEKEVDEWVS 199 (240)
T ss_dssp SCSEEEEC---------CHHHHCSSCEEEEEEEETTTTEEEEEEEETTT----------CCEEEEEEECCGGGTSCSEEE
T ss_pred cccccccC---------CccccCCCEEEEEEEEeCCCcEEEEEEecCCC----------CccceeEEEechHHhCCCceE
Confidence 99988762 35677999999999999999999999987654 347899999999999999999
Q ss_pred eeEeecCCce---eeeEEEeccccccCC
Q 035655 257 VGFSASTGRK---VSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~~---~~~h~i~sW~fs~~~ 281 (670)
||||||||.. .|.|+|++|+|+++.
T Consensus 200 VGFSAsTG~~~~~~~~H~IlsWsF~s~~ 227 (240)
T 1ioa_A 200 VGFSPTSGLTEDTTETHDVLSWSFSSKF 227 (240)
T ss_dssp EEEEEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred EEEEeccCCCCcccceeEEEEEEEEeeC
Confidence 9999999998 999999999999864
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=414.71 Aligned_cols=201 Identities=29% Similarity=0.472 Sum_probs=175.0
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
..++|+|++|.. .+ |.++|+|.+.++|.|+||++..++.|||+|++||+|||+.+| +++||+|+|+|+|.
T Consensus 2 ~~~~F~f~~F~~--~~---l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g-----~vaSFsT~F~F~I~ 71 (223)
T 1dhk_B 2 TETSFIIDAFNK--TN---LILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTG-----NVASFDTNFTMNIR 71 (223)
T ss_dssp CCCEEEESSCCG--GG---EEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTT-----EECEEEEEEEEEEE
T ss_pred cceEEEcCCCCc--CC---EEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCC-----CccceEEEEEEEEe
Confidence 357999999985 66 999999999778999999998899999999999999999998 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLE 182 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~ 182 (670)
+++...+||||||||+|.+..|+ +++|||||||+ +|||||||||+ |++++
T Consensus 72 ~~~~~~~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT~----------~nHVGIdvNsi-S~~~~ 121 (223)
T 1dhk_B 72 THRQANSAVGLDFVLVPVQPESK-------------------GDTVTVEFDTF----------LSRISIDVNNN-DIKSV 121 (223)
T ss_dssp CCC---CCSEEEEEEEEC-------------------------CCEEEEEETT----------TTEEEEEETTE-EEEEE
T ss_pred CCCCCCCCCceEEEEecCCCCCC-------------------ccEEEEEecCC----------CCcccccCCcc-ccccc
Confidence 88777899999999999765432 34899999997 48999999999 98877
Q ss_pred ccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeec
Q 035655 183 PAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262 (670)
Q Consensus 183 ~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsas 262 (670)
++ +..|.+|+.++|||+||+.+++|+|+|++.+. +.+|+|+..+||+++|||+||||||||
T Consensus 122 ~~---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~----------~~~~~ls~~vdLs~~l~e~~~VGFSAs 182 (223)
T 1dhk_B 122 PW---------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPST----------GKSNNVSTTVELEKEVYDWVSVGFSAT 182 (223)
T ss_dssp EC---------CGGGTTTSCEEEEEEEETTTTEEEEEEECTTT----------CCEEEEEEECCCCSGGGSEEEEEEEEE
T ss_pred cC---------CccccCCCEEEEEEEEeCCCCEEEEEEecCCC----------CccceEEEEechHHhCCCceEEEEEec
Confidence 62 46777999999999999999999999987654 347899999999999999999999999
Q ss_pred CCce---eeeEEEeccccccCCC
Q 035655 263 TGRK---VSSHFILGWSFSMNGA 282 (670)
Q Consensus 263 tg~~---~~~h~i~sW~fs~~~~ 282 (670)
||.. .|.|+|++|+|+++..
T Consensus 183 TG~~~~~~~~H~IlsWsF~s~~~ 205 (223)
T 1dhk_B 183 SGAYQWSYETHDVLSWSFSSKFI 205 (223)
T ss_dssp ECSGGGSCCEEEEEEEEEEEEC-
T ss_pred cCCCccccceEEEEEEEEEeccc
Confidence 9998 9999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=426.27 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=195.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.+++...++||+|+||+||+|++.. ..+.|.+|+++|++++|||||+++|+|.+ +.++||||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 3567788999999999999998644 34679999999999999999999999865 5689999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-cc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK-IS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~-~~ 504 (670)
++|+|.++|.... ..++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+...... ..
T Consensus 114 ~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 114 EGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999997653 369999999999999999999998 899999999999999999999999999998765433 23
Q ss_pred eeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|||||++.+ ++|+.++|||||||++|||+||+.||....... ........+ ...|.+ ...
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~----~~~p~~-~~~ 262 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRG----YASPDL-SKL 262 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTT----CCCCCS-TTS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcC----CCCCCc-ccc
Confidence 3455689999999999864 468999999999999999999999997633211 111111111 111211 112
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC-CCCCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD-ELLPI 622 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~ 622 (670)
+...+..+.+++..||+.||.+|||+.||+++|+.. .++|.
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 223446688899999999999999999999998754 34444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=431.83 Aligned_cols=241 Identities=29% Similarity=0.414 Sum_probs=199.7
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.+++..++||+|+||+||+|.+.. ..++|.+|+.+|++|+|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 345668899999999999997521 2468999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 420 LVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
||||||++|+|.++|..+. ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 9999999999999996532 2469999999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCceeccCCC-cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHH
Q 035655 486 NARLGDFGLARLFDHGK-ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEF 563 (670)
Q Consensus 486 ~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~ 563 (670)
.+||+|||+++...... ....+...||+.|||||++.++.++.++|||||||++|||+| |+.||...... +.. ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~-~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV-EM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH-HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH-HH
Confidence 99999999998664432 223345689999999999999999999999999999999998 89999864321 111 11
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...+... +.+...+..+.+++..||+.||.+|||++||+++|+..
T Consensus 260 i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122211 11223345688999999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=430.44 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=198.4
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|...++||+|+||+||+|.+.. ..++|.+|+++|++|+|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467888999999999999997531 34679999999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC-----------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEE
Q 035655 421 VYDYIPNGSLDSLLFDNE-----------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARL 489 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL 489 (670)
|||||++|+|.++|+... ...++|.++++++.|||+||+|||+ ++|+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 3469999999999999999999999 89999999999999999999999
Q ss_pred EeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... +.. .....+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~-~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI-ECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH-HHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH-HHHHcC
Confidence 999999876543322 2234579999999999999999999999999999999999 99999864322 111 111122
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
... . .+...+..+.+++..||+.||++|||++||++.|++.
T Consensus 247 ~~~-----~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 247 RVL-----Q----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp CCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----C----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 211 1 1222345678999999999999999999999998753
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=380.79 Aligned_cols=177 Identities=28% Similarity=0.528 Sum_probs=159.9
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
..++|+|++|.+...+ |.++|+|. .++|.|+||+...+++|||+|++||+|||+.+| +++||+|+|+|.|.
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg-----~vaSFsT~F~F~I~ 72 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQN---LIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETG-----NVANFVTSFTFVIN 72 (181)
T ss_dssp EEEEEEESSCCSSCTT---EEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTTTC-----CBCEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---EEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCCCC-----CccceEEEEEEEEe
Confidence 3579999999853356 99999999 568999999998899999999999999999998 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCC--CCeeEEecCCccccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQ--GNHVGINVNSMKSIK 180 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~--~~Hvgidvns~~s~~ 180 (670)
+++...+||||||||+|....|. +.||||||+|.++ +++.||+|||||||++| .+ |||+ +|||||||||+.|++
T Consensus 73 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~-~~~~n~~vAVEFDT~~n-~~-~Dp~~~~nHVGIdvNs~~S~~ 148 (181)
T 2ltn_A 73 APNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYN-AA-WDPSNRDRHIGIDVNSIKSVN 148 (181)
T ss_dssp CSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCTTSCCEEEEEECSCC-TT-TSCTTCCCEEEEEESSSSCSE
T ss_pred cCCCCCCCCceEEEEecCCCCCC-CCCccccccccCC-CCccccEEEEEeccccc-cc-cCCCCCCCEEEEEcCCccccc
Confidence 88777899999999999877666 8999999999874 57889999999999999 67 8999 999999999999998
Q ss_pred ccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeec
Q 035655 181 LEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPM 223 (670)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~ 223 (670)
+++ ++|.+|+.|+|||+||+.+++|+|+|++.
T Consensus 149 t~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 149 TKS-----------WKLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp EEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred eec-----------cccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 876 45789999999999999999999999763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=432.17 Aligned_cols=240 Identities=26% Similarity=0.418 Sum_probs=192.4
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|...++||+|+||+||+|++.. ..++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457778999999999999997531 34679999999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCC-------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 421 VYDYIPNGSLDSLLFDNE-------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
|||||++|+|.++|++.. ..+++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997642 2469999999999999999999998 899999999999999999999
Q ss_pred EEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHh
Q 035655 488 RLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQ 564 (670)
Q Consensus 488 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~ 564 (670)
||+|||+++....... ...+...||+.|||||++.+..++.++|||||||++|||+| |+.||...... .... .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----I 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----H
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----H
Confidence 9999999987654332 23345689999999999999999999999999999999999 99999764321 1111 1
Q ss_pred hcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 565 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..+. .+.. +......+.+++.+||+.||++|||++||+++|+..
T Consensus 274 ~~g~-----~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 274 TQGR-----ELER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHTC-----CCCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCC-----CCCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111 1111 222335678899999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=418.63 Aligned_cols=236 Identities=22% Similarity=0.390 Sum_probs=193.0
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..++||+|+||+||+|+... ..+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999997643 24578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
||++|+|.++|.......+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999987666678999999999999999999999 999999999999999999999999999998664321
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +..... ..+.. +.+...
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i-~~~~~-----~~~~~~--- 248 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVLKI-ISGSF-----PPVSLH--- 248 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH-HHTCC-----CCCCTT---
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH-HcCCC-----CCCCcc---
Confidence 2234568999999999999999999999999999999999999999864422 111111 11111 112112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++.+||+.||.+|||++|+++|
T Consensus 249 -~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 249 -YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23567889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=421.36 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=199.2
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcccc-Cceeeeeeeeecc
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRH-KHLVNLQGWCKRK 415 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~ 415 (670)
...++|+..++||+|+||+||+|.+.. ..++|.+|+++|++++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999996421 24679999999999976 8999999999764
Q ss_pred -CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEE
Q 035655 416 -RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 480 (670)
+.+++|||||++|+|.++|++.. +..++|.+++.++.|||+||+|||+ ++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 57899999999999999997542 2358999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHH
Q 035655 481 IDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVD 558 (670)
Q Consensus 481 ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~ 558 (670)
|++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~ 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999987655432 33445689999999999999999999999999999999998 99999763321 1
Q ss_pred HHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.. +.. +......+.+++..||+.||.+|||+.||+++|+.
T Consensus 296 ~~~~~i~~g~~-----~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 296 EFCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHcCCC-----CCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 11111111211 111 11223567889999999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=404.10 Aligned_cols=231 Identities=29% Similarity=0.445 Sum_probs=185.8
Q ss_pred ccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec----cCeeEEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----KRDLLLV 421 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV 421 (670)
|+..++||+|+||+||+|.+.. ..+.|.+|+++|++|+|||||+++++|.. ++.++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3566789999999999998643 23568999999999999999999999865 3568999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEecC-CCcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDA-DMNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld~-~~~~kL~DFGla~~~ 498 (670)
||||++|+|.++|.+. ..+++..+..++.||+.||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999754 469999999999999999999998 66 999999999999984 799999999999854
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.. ......+||+.|||||++.+ +|+.++|||||||++|||+||+.||....... .. ......+. .|
T Consensus 183 ~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~-~~~i~~~~-----~~--- 248 (290)
T 3fpq_A 183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI-YRRVTSGV-----KP--- 248 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH-HHHHTTTC-----CC---
T ss_pred CC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HH-HHHHHcCC-----CC---
Confidence 33 23445689999999998864 69999999999999999999999997532211 11 11111111 01
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..++......+.+++..||+.||.+|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122223457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=410.28 Aligned_cols=236 Identities=21% Similarity=0.302 Sum_probs=198.0
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+.|+..++||+|+||+||+|+... ..+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 568889999999999999998753 2456889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.+ ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 99999999964 359999999999999999999999 999999999999999999999999999999775533 23
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.+..+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ..... ....+.+. .....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~------~~~~~~~~--~~~~~ 296 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIR------DNLPPRLK--NLHKV 296 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH------HSSCCCCS--CGGGS
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHH------cCCCCCCC--ccccC
Confidence 4567899999999999999999999999999999999999999986432211 11111 11122221 12233
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+.+++.+||+.||++|||++|+++|-
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 45678899999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=406.64 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=190.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------hHHHHH--HHHHHHhccccCceeeeeeeeeccC----eeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFA--AEIESLGRLRHKHLVNLQGWCKRKR----DLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~--~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~E~ 424 (670)
++|...++||+|+||+||+|++.+ ..+++. .|+..+.+++|||||+++|+|.+++ .++|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 457788999999999999998754 223343 5666677899999999999998654 58999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-----cceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-----EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|++|+|.++|+.. .++|+.+.+++.|+++||+|||+.+ +++|+||||||+||||+.++++||+|||+|+...
T Consensus 83 ~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999653 5899999999999999999999832 3499999999999999999999999999998776
Q ss_pred CCCcc---eeeccccCcCCCCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCcch------------hHH
Q 035655 500 HGKIS---HTTNVVGTIGYIAPELARTG------KASCSTDVFAYGVLLLEIATGRRPIDSDHFI------------LVD 558 (670)
Q Consensus 500 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~------------~~~ 558 (670)
..... .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+...... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 54322 22345899999999998754 4678999999999999999998876431110 001
Q ss_pred HHHHHhhcCCcccccCCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 559 WVLEFQHLGQVLDVVDPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...... .....+|.+.... ..+..+.+.+++.+||+.||.+|||+.||++.|+.
T Consensus 240 ~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 240 EMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111 1112334443322 23556788999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=409.86 Aligned_cols=240 Identities=20% Similarity=0.223 Sum_probs=194.2
Q ss_pred hcCccccceEeeeCceeEEEeeccchH-----------HHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTRM-----------REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~~-----------~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
.+.|...++||+|+||.||+|++.... ....+|+.+|++|+|||||++++++.+++.+|||||||++|+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 356888899999999999999876421 223589999999999999999999999999999999999999
Q ss_pred chhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCcc----
Q 035655 430 LDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKIS---- 504 (670)
Q Consensus 430 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~~---- 504 (670)
|.++|.+. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|+........
T Consensus 137 L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 137 LGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999754 369999999999999999999999 8999999999999999998 6999999999987654322
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +...+. ....... +.+.
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~~~~~~~--------~~~~ 280 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA---SEPPPIR--------EIPP 280 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH---HSCCGGG--------GSCT
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---cCCCCch--------hcCc
Confidence 123458999999999999999999999999999999999999999763321 111111 1111011 1122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.....+.+++.+||++||.+|||+.|++++|..
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 234567889999999999999999999998863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=402.62 Aligned_cols=233 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||+||+++... ..+.+.+|+++|++|+|||||++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999998643 2356889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.++|.+. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999754 369999999999999999999999 999999999999999999999999999999875433
Q ss_pred -cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 -ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 -~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||........ . ......+ ..+...
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~-~~i~~~~------~~~p~~- 256 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--F-AKIIKLE------YDFPEK- 256 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHTC------CCCCTT-
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHcCC------CCCCcc-
Confidence 2344567999999999999999999999999999999999999999986442211 1 1111111 111112
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
....+.+++.+||+.||.+|||++|+++
T Consensus 257 ---~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 257 ---FFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---cCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 2345778999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=410.66 Aligned_cols=237 Identities=21% Similarity=0.303 Sum_probs=198.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.+.|+..++||+|+||.||+|+... ..+.+.+|+.+|++|+|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4569999999999999999998643 345688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
|++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 9999999998543 59999999999999999999999 999999999999999999999999999998775533 2
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .... . ....+.+. ....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i-~-----~~~~~~~~--~~~~ 372 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMI-R-----DNLPPRLK--NLHK 372 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH-H-----HSCCCCCS--CTTS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHH-H-----cCCCCCCc--cccc
Confidence 34567899999999999999999999999999999999999999976432211 1111 1 11111111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
....+.+++.+||+.||.+|||++|+++|-
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 235678899999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=389.48 Aligned_cols=233 Identities=23% Similarity=0.346 Sum_probs=181.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||+||+|+... ..+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999997643 2356889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+ +|+|.+++.++ ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 68999999765 359999999999999999999999 999999999999999999999999999998765432
Q ss_pred cceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ...... ..+. +.+..
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i-~~~~------~~~p~-- 233 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNI-SNGV------YTLPK-- 233 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-HHTC------CCCCT--
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HcCC------CCCCC--
Confidence 2345689999999999998876 57999999999999999999999864322 111111 1111 11111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.+++.+||+.||.+|||++|+++|-+
T Consensus 234 --~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 234 --FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 12355778999999999999999999999643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=397.07 Aligned_cols=233 Identities=23% Similarity=0.311 Sum_probs=186.5
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|+..+.||+|+||+||+++... ....+.+|+++|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 579999999999999999986421 22468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
|||||++|+|.++|.+. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999754 369999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||........ .... .... +..
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i-~~~~------~~~--- 245 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMI-LKAK------LGM--- 245 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHCC------CCC---
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HHHH-HcCC------CCC---
Confidence 32 233456899999999999999999999999999999999999999986442211 1111 1111 111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
+......+.+++.+||+.||.+||| ++|+++|
T Consensus 246 -p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 246 -PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1122356788999999999999998 5788765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.39 Aligned_cols=235 Identities=20% Similarity=0.325 Sum_probs=178.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC--------
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR-------- 416 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-------- 416 (670)
++|+..+.||+|+||+||+|+... ..+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458899999999999999997643 2356889999999999999999999987544
Q ss_pred ----eeEEEEeccCCCCchhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 417 ----DLLLVYDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 417 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
.+|+|||||++|+|.+++..... ...++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976543 245677789999999999999999 8999999999999999999999999
Q ss_pred ecCceeccCCCcc-----------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHH
Q 035655 492 FGLARLFDHGKIS-----------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWV 560 (670)
Q Consensus 492 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~ 560 (670)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||........ ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~-~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR-TL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH-HH
Confidence 9999877553321 1234589999999999999999999999999999999996 7764211111 11
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. .. .... ..........+.+++.+||++||.+|||+.|+++|
T Consensus 238 ~~-~~--------~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TD-VR--------NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-HH--------TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-Hh--------cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 11 1111 11222333456789999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=379.22 Aligned_cols=276 Identities=42% Similarity=0.715 Sum_probs=241.3
Q ss_pred cCCCccchhhHHHhhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeee
Q 035655 347 DCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 347 ~~~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
.....+++.++..++++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 346789999999999999999999999999999997643 1236889999999999999999999
Q ss_pred eeeccCeeEEEEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEE
Q 035655 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNAR 488 (670)
Q Consensus 411 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 488 (670)
+|...+..++||||+++|+|.+++.... ...++|..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999997653 33599999999999999999999993333999999999999999999999
Q ss_pred EEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC------CcchhHHHHHH
Q 035655 489 LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS------DHFILVDWVLE 562 (670)
Q Consensus 489 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~------~~~~~~~~~~~ 562 (670)
|+|||+++..............||+.|+|||++.+..++.++|||||||+++||++|+.||+. ......+|...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999998766555555566799999999999988999999999999999999999999962 33445666666
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPI 622 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 622 (670)
...........+..+...+.......+.+++.+||+.||.+|||++|++++|++......
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 666677777788888888889999999999999999999999999999999998655443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=377.04 Aligned_cols=185 Identities=25% Similarity=0.411 Sum_probs=160.6
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
..+.|++.++||+|+||+||+|+.+. ....+.+|+++|+++ +||||+++++++.+.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 45789999999999999999996521 235688999999998 699999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCceeccC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDH 500 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~~~~~ 500 (670)
|||+++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999982 48999999999999999999999 999999999999999877 7999999999986543
Q ss_pred CCc---------------------------ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 035655 501 GKI---------------------------SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSD 552 (670)
Q Consensus 501 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~ 552 (670)
... ...+..+||+.|||||++.+. .++.++||||+||+++||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 221 112345799999999998775 5899999999999999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=368.93 Aligned_cols=265 Identities=38% Similarity=0.662 Sum_probs=227.4
Q ss_pred CccchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeec
Q 035655 350 HRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKR 414 (670)
Q Consensus 350 ~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 414 (670)
.++.+.++..++++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||++++++|.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 345566677788999999999999999999998643 34678999999999999999999999999
Q ss_pred cCeeEEEEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
.+..++||||+++|+|.+++.... ...++|.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997643 2359999999999999999999999 89999999999999999999999999
Q ss_pred cCceeccCCC-cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC----cchhHHHHHHHhhcC
Q 035655 493 GLARLFDHGK-ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD----HFILVDWVLEFQHLG 567 (670)
Q Consensus 493 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~----~~~~~~~~~~~~~~~ 567 (670)
|+++...... ........||+.|+|||++.+..++.++|||||||+++||++|+.||... ......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654322 22233456899999999999899999999999999999999999999752 223455655556666
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.+...+++.+...........+.+++..||+.||.+||+++|++++|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 77777888887778888899999999999999999999999999999754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=379.97 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=191.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec------cC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR------KR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~ 416 (670)
.++|+..+.||+|+||+||+|+... ..+.+.+|+++|++|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3579999999999999999998643 23567899999999999999999998764 36
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.+|||||||+ |+|.+++.+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 7899999654 469999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCC---cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCc--
Q 035655 497 LFDHGK---ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQV-- 569 (670)
Q Consensus 497 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~-- 569 (670)
...... .......+||+.|||||++.+. .++.++||||+||+++||++|+.||...... ....+.........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764322 2233457899999999998775 5689999999999999999999999864321 11111111100000
Q ss_pred ------------ccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 ------------LDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 ------------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.....+ .......+.+|+.+||+.||.+|||++|+++|-+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 000011100000 0112356788999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=391.14 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|++.+.||+|+||.||+|+... ..+.+.+|+++|++|+|||||++++++.+.+.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4689999999999999999998643 245688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC--CcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD--MNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~--~~~kL~DFGla~~~~~~~ 502 (670)
|++|+|.++|.+.. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999996543 369999999999999999999999 999999999999999854 899999999999876543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||........ ..... .. +..+.....
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~~i~-~~------~~~~~~~~~ 380 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVK-SC------DWNMDDSAF 380 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH-TT------CCCCCSGGG
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHH-hC------CCCCCcccc
Confidence 33456899999999999999999999999999999999999999986432211 11111 11 111111222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+|+..||+.||.+||++.|+++|=+
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 223456788999999999999999999999744
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=387.21 Aligned_cols=235 Identities=23% Similarity=0.266 Sum_probs=189.6
Q ss_pred cCccccceEeeeCceeEEEeeccch-------------------HHHHH---HHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFA---AEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~---~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|++.++||+|+||+||+++.... ...+. .++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999986541 12233 3466777889999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||++||+|.++|.+. ..+++..+..++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999764 359999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.................. ...+
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~------~~~~- 413 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------AVEL- 413 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC------CCCC-
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC------CCCC-
Confidence 532 345689999999999965 57999999999999999999999999753221111111111111 1111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 614 (670)
+......+.+++..||+.||.+|++ ++||++|-
T Consensus 414 ---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 414 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 1122356788999999999999998 78888764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.62 Aligned_cols=264 Identities=35% Similarity=0.608 Sum_probs=218.5
Q ss_pred CCccchhhHHHhhcCcccc------ceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCc
Q 035655 349 PHRFRYSDLYTATKGFKQS------EVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKH 404 (670)
Q Consensus 349 ~~~~~~~~l~~~t~~f~~~------~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~n 404 (670)
.+.|++.++..++++|... ++||+|+||.||+|.... ..+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 5689999999999999888 899999999999997533 2467889999999999999
Q ss_pred eeeeeeeeeccCeeEEEEeccCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC
Q 035655 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483 (670)
Q Consensus 405 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~ 483 (670)
|+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999996532 3469999999999999999999998 89999999999999999
Q ss_pred CCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHH
Q 035655 484 DMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWV 560 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~ 560 (670)
++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||+++||++|+.||..... ....+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543322 2334579999999998764 588999999999999999999999976322 222222
Q ss_pred HHHhhc-CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 561 LEFQHL-GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 561 ~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...... ..+.+.+++.+ ...+....+.+.+++..||+.||.+||++++++++|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 222222 22333444444 345667788899999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.32 Aligned_cols=238 Identities=23% Similarity=0.367 Sum_probs=197.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4679999999999999999997532 346688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|+|.+++.+. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999653 58999999999999999999999 8999999999999999999999999999987655432
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...... +.+ ..+..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~------~~~--~~~~~ 241 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNGT------PEL--QNPEK 241 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHCS------CCC--SCGGG
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCC------CCC--CCccc
Confidence 23446799999999999999999999999999999999999999976443211111 111111 111 11223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+.+++..||+.||.+||+++|++++-.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 3456788999999999999999999998644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=350.93 Aligned_cols=243 Identities=27% Similarity=0.424 Sum_probs=195.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|...++||+|+||.||++.... ..+.|.+|++++++++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4578889999999999999997643 346788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999997643 469999999999999999999999 89999999999999999999999999999876543321
Q ss_pred e-------------eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 505 H-------------TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 505 ~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
. .....||+.|+|||++.+..++.++|||||||+++||++|..|+........... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------~~~~~ 238 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------LNVRG 238 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------BCHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------hhhhc
Confidence 1 1145799999999999999999999999999999999999999865221100000 00000
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..++... ......+.+++..||+.||.+||+++++++.|+..
T Consensus 239 ~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 239 FLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000001 11123577899999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.38 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=197.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4678899999999999999996420 235788999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+.+++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997643 2358999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999987654332 22334467889999999999999999999999999999999 9999976432211
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
... ...+. .+ ..+......+.+++..||+.||.+||++.|+++.|+.
T Consensus 315 ~~~-~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 315 FKL-LKEGH-----RM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHH-HHTTC-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HhcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 11111 11 1122233567889999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.73 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=191.3
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
....++|++.+.||+|+||.||+|.... ..++|.+|++++++++||||+++++++.+.+..++|
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3445689999999999999999997533 235788999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999997653 2349999999999999999999998 78 999999999999999999999999999855
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ...
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~-----~~~-- 259 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKCK-----RLE-- 259 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSCC-----CCC--
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC-----CCC--
Confidence 4322 223445799999999999999999999999999999999999999986432211 111111111 011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.+......+.+++.+||+.||.+||+++++++.|+..
T Consensus 260 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 260 --IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122235678899999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.58 Aligned_cols=244 Identities=23% Similarity=0.422 Sum_probs=193.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||++.... ..+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4579999999999999999997532 235788999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999654 369999999999999999999998 89999999999999999999999999999876554
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .... .... +......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~-~~~~-----~~~~~~~ 236 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHI-QDSV-----PNVTTDV 236 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHH-SSCC-----CCHHHHS
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHh-hccC-----CCcchhc
Confidence 434445567999999999999999999999999999999999999999864322111 1111 1111 0000111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHhcCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-TMRQVLRYLNGD 617 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 617 (670)
.......+.+++.+|++.||.+|| +++++.+.|+..
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 122335678899999999999998 899999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.20 Aligned_cols=241 Identities=29% Similarity=0.475 Sum_probs=195.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.+.. ..+.|.+|+.++++++||||++++++|.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 3568889999999999999998631 24578899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 369999999999999999999999 8999999999999999999999999999987755
Q ss_pred CCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.... ......+|+.|+|||++.+..++.++|||||||+++||++ |+.||........ ..... .+. ..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~-~~~-----~~-- 273 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--ISSVE-EGY-----RL-- 273 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHH-TTC-----CC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHH-cCC-----CC--
Confidence 3322 2223456788999999998999999999999999999999 9999976332211 11111 110 11
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..+......+.+++..||+.||.+||+++|+++.|+..
T Consensus 274 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 --PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222335688899999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=363.35 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=203.8
Q ss_pred ccchhhHHHhhcCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeee
Q 035655 351 RFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGW 411 (670)
Q Consensus 351 ~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~ 411 (670)
.+.+.++...+++|+..++||+|+||+||+++.... ...+.+|+.++.+++||||++++++
T Consensus 63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 455667777889999999999999999999987541 1237899999999999999999999
Q ss_pred eeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
|.+.+.+++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999997643 469999999999999999999999 8999999999999999999999999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH 565 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~ 565 (670)
||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ....+.....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999877655444445568999999999987 567899999999999999999999999864322 1111111110
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHhc
Q 035655 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYLN 615 (670)
Q Consensus 566 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 615 (670)
. ..-|..... ....+.+++..||+.+|++ ||+++|+++|-.
T Consensus 299 ~-----~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 299 R-----FQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp H-----CCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred c-----ccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 0 011111111 2245678888898888887 999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.46 Aligned_cols=242 Identities=27% Similarity=0.452 Sum_probs=201.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4678999999999999999997644 34678999999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 87 NGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999996643 369999999999999999999999 8999999999999999999999999999987766544444
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....+|+.|+|||.+.+..++.++||||||++++||++ |+.||........ ...... +. ....+. ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~-~~--~~~~~~-------~~ 230 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLKVSQ-GH--RLYRPH-------LA 230 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHT-TC--CCCCCT-------TS
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHHHHc-CC--CCCCCC-------cC
Confidence 44567788999999998889999999999999999999 9999976432211 111111 11 111111 11
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
...+.+++..||+.||.+||+++|++++|+...
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 246788999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.53 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=204.0
Q ss_pred CCccchhhHHHhhcC----------ccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhcccc
Q 035655 349 PHRFRYSDLYTATKG----------FKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRH 402 (670)
Q Consensus 349 ~~~~~~~~l~~~t~~----------f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H 402 (670)
+..++++++..+++. |+..++||+|+||.||+|+... ..+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888888765 7778899999999999997642 24678899999999999
Q ss_pred CceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 403 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 9999999999999999999999999999999854 358999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~ 562 (670)
.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||....... ....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~ 252 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKR 252 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH
T ss_pred CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 99999999999998765432 22345689999999999999999999999999999999999999997643221 1111
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. ....+.+.. .......+.+++..||+.||.+||+++|++++-.
T Consensus 253 ~~------~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 253 LR------DSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HH------HSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred Hh------cCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11 111122211 1122356788999999999999999999998644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.37 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=194.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..++||+|+||.||+|++.. ..+.|.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3568899999999999999997522 2357889999999999999999999998754 78
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997654 469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... ...+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~--------- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGE--------- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTC---------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---HHcCC---------
Confidence 44322 2233467889999999999999999999999999999999 9999986433222111 11111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....+......+.+++..||+.||.+||+++|++++|+..
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111122335678899999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.97 Aligned_cols=240 Identities=26% Similarity=0.460 Sum_probs=198.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|+||.||+|.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 3578899999999999999997633 35679999999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999996543 368999999999999999999998 8999999999999999999999999999986654332333
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....+|+.|+|||.+.+..++.++||||||++++||++ |+.||....... ....... . .....+ ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~-~--~~~~~~-------~~~ 232 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST-G--FRLYKP-------RLA 232 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT-T--CCCCCC-------TTS
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhc-C--ccCCCC-------CcC
Confidence 34567888999999999999999999999999999999 999997643221 1111111 1 011111 112
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++..||+.||.+||+++|++++|+.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 3567889999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=372.86 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=203.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|...++||+|+||.||+|.+.. ..++|.+|+.+|++++||||++++++|.+.+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4678889999999999999998653 3578999999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 99999999987666679999999999999999999999 899999999999999999999999999998775544333
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....++..|+|||++....++.++|||||||++|||++ |+.||........ ......+ .....+..
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~---------~~~~~~~~ 443 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKD---------YRMERPEG 443 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTT---------CCCCCCTT
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC---------CCCCCCCC
Confidence 334467789999999999999999999999999999999 9999976432211 1111111 11112223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....+.+++.+||+.||.+||++.++++.|+..
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 345678899999999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=349.54 Aligned_cols=253 Identities=31% Similarity=0.436 Sum_probs=194.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccccCceeeeeeeeeccC----eeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR----DLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~E 423 (670)
.++|+..++||+|+||.||+|...+ ....+..|+.++++++||||+++++++.... .+++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4679999999999999999997644 2345567899999999999999999998754 4799999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-------cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-------EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
|+++|+|.+++... .++|..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 103 FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999999653 4899999999999999999999820 1199999999999999999999999999998
Q ss_pred eccCCCcc-eeeccccCcCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc---
Q 035655 497 LFDHGKIS-HTTNVVGTIGYIAPELARTG-----KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL--- 566 (670)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~--- 566 (670)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+.......
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76554322 23345799999999998763 4567899999999999999999999752110 00110000000
Q ss_pred -----CCcccccCCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 567 -----GQVLDVVDPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 567 -----~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
........+.+...+ .......+.+++.+||+.||.+|||++|+++.|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000111122222211 22456778999999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.03 Aligned_cols=241 Identities=28% Similarity=0.493 Sum_probs=185.3
Q ss_pred hcCccccceEeeeCceeEEEeecc----c----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|+.. . ..+.|.+|+.++++++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999754 1 23578999999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997643 469999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ... ...+. ..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~-i~~~~-----~~-- 269 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKA-VDEGY-----RL-- 269 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHH-HHTTE-----EC--
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-HHcCC-----CC--
Confidence 33211 122345778999999999999999999999999999998 9999976432211 111 11110 00
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..+......+.+++..||+.||.+||+++++++.|+..
T Consensus 270 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 --PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11112335688899999999999999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.92 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=193.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhc--cccCceeeeeeeeec----cCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGR--LRHKHLVNLQGWCKR----KRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~----~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||+|.... ..+.+..|.+++.. ++||||+++++++.. ....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 5689999999999999999997643 34566677777766 799999999998754 356899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-----cceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-----EQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
|+++|+|.+++.. ..+++..+++++.|++.||+|||... +++|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 87 YHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp CCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 9999999999943 36999999999999999999999211 289999999999999999999999999999876
Q ss_pred cCCCcce---eeccccCcCCCCccccccC------CCCccchhHHHHHHHHHHHhC----------CCCCCCCcch--hH
Q 035655 499 DHGKISH---TTNVVGTIGYIAPELARTG------KASCSTDVFAYGVLLLEIATG----------RRPIDSDHFI--LV 557 (670)
Q Consensus 499 ~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~el~tG----------~~pf~~~~~~--~~ 557 (670)
....... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 5543322 2334799999999998876 455799999999999999999 8888642111 11
Q ss_pred HHHHHHhhcCCcccccCCCCC-CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 558 DWVLEFQHLGQVLDVVDPNLG-SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 558 ~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.......... ...+.+. ..........+.+++..||+.||.+|||++|+++.|+.
T Consensus 244 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 244 EDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp HHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1111111111 1122222 12344567889999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.63 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999997642 12557899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999654 359999999999999999999998 8999999999999999999999999999987643332
Q ss_pred -ceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 -SHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.......||+.|+|||++.+..+ +.++|||||||+++||++|+.||.........+...... ... ...
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~---------~~~ 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTY---------LNP 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTT---------STT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-ccc---------CCc
Confidence 22345689999999999987765 779999999999999999999997643322221111111 000 001
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.......+.+++..||+.||.+||+++|++++-+-..
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1122356678999999999999999999999866443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=340.78 Aligned_cols=240 Identities=18% Similarity=0.277 Sum_probs=197.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|...+.||+|+||.||++.... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 4689999999999999999997643 2356789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC--CCcEEEEeecCceeccCCCc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA--DMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kL~DFGla~~~~~~~~ 503 (670)
++|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999996543 369999999999999999999999 89999999999999987 7899999999998775543
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .. .........
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~------~~~~~~~~~ 228 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMN-AE------YTFDEEAFK 228 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-TC------CCCCHHHHT
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHc-CC------CCCChhhhc
Confidence 334567999999999999888899999999999999999999999764322 11111111 11 001111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.+++..||+.||.+|||+.|+++|-+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 22456789999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=370.43 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=202.1
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.+.....++|+..+.||+|+||.||+|.... ..+.|.+|+++|++++||||+++++++. .+..++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3334456789999999999999999998643 3578999999999999999999999987 567899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999976555578999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
..........+|..|+|||++..+.++.++|||||||++|||++ |+.||....... ....... +. ..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~-~~-----~~---- 404 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALER-GY-----RM---- 404 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHH-TC-----CC----
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-CC-----CC----
Confidence 32222233456789999999999999999999999999999999 999997643211 1111111 11 00
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
..+......+.+++..||+.||.+||++++|++.|+...
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111223456788999999999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.89 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=204.6
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
...++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 346789999999999999999997653 34678999999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999987666779999999999999999999999 8999999999999999999999999999987765554
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......+|+.|+|||.+.+..++.++||||||++++||++ |+.||.......... .... . ..+ ..+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~--~~~~-~-----~~~----~~~ 234 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--LLEK-D-----YRM----ERP 234 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--HHHT-T-----CCC----CCC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHhc-c-----CCC----CCC
Confidence 44455678889999999999999999999999999999999 999997643221111 1111 1 011 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.+++..||+.||.+||+++|+++.|+.
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 2223567889999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.37 Aligned_cols=240 Identities=26% Similarity=0.416 Sum_probs=195.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|...+.||+|+||.||+|.... ..++|.+|+++|++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 4678899999999999999998742 12467899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999997543 368999999999999999999999 8999999999999999999999999999986543321
Q ss_pred cee-eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 SHT-TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 ~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
... ....+++.|+|||.+.++.++.++|||||||++|||++ |+.||........ ......+... ..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~~~~~~~~---------~~ 336 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REFVEKGGRL---------PC 336 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHHHHTTCCC---------CC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCC---------CC
Confidence 111 12245778999999998899999999999999999998 9999976432211 1111111110 11
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++..||+.||.+|||++++++.|+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 12223567889999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.80 Aligned_cols=241 Identities=27% Similarity=0.448 Sum_probs=195.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
..++|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 35678999999999999999997643 3467999999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999997643 369999999999999999999999 899999999999999999999999999998665433222
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....+|+.|+|||.+.+..++.++||||||++++||++ |+.||........ ...... + .....+ ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~-~--~~~~~~-------~~ 245 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQ-G--LRLYRP-------HL 245 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHT-T--CCCCCC-------TT
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHHhc-c--cCCCCC-------Cc
Confidence 334467788999999998999999999999999999998 9999986432211 111111 1 011111 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+.+++..||+.||.+||+++|++++|+.
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 12567889999999999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=339.30 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=183.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678899999999999999997632 2356889999999999999999999985 467899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997543 369999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
..........+|+.|+|||.+.+..++.++|||||||+++||++ |+.||........ ..... .+.. +.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~-~~~~-----~~~-- 238 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIE-NGER-----LPM-- 238 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHH-TTCC-----CCC--
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHH-cCCC-----CCC--
Confidence 44333344567889999999998999999999999999999997 9999976432211 11111 1110 111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++..||+.||.+||++.|+++.|+.
T Consensus 239 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 239 --PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 12223567889999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.46 Aligned_cols=235 Identities=23% Similarity=0.352 Sum_probs=195.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4679999999999999999997632 2356789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999654 358999999999999999999999 899999999999999999999999999998665432
Q ss_pred cceeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||++.+..+. .++|||||||+++||++|+.||........ ... ...+.. ..
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~~------~~---- 233 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RER-VLRGKY------RI---- 233 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHCCC------CC----
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HHH-HHhCCC------CC----
Confidence 23456899999999999888775 799999999999999999999986442211 111 111111 11
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+......+.+++..||+.||.+|||++|+++|-+
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 1112345778999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=363.29 Aligned_cols=243 Identities=26% Similarity=0.435 Sum_probs=194.1
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
..++|+..++||+|+||.||+|.+.. ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35678889999999999999998654 24689999999999999999999999976 6789999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.......+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999976544569999999999999999999999 899999999999999999999999999998765443333
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....+|..|+|||.+.++.++.++|||||||++|||++ |+.||...... +..... ..+. ....+..
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~---------~~~~~~~ 405 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGY---------RMPCPPE 405 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH-HTTC---------CCCCCTT
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCC---------CCCCCCC
Confidence 334567889999999999999999999999999999999 99999764321 111111 1111 0111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
..+.+.+++..||+.||.+||+++++++.|+...
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3456788999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.77 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=200.1
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeee
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNL 408 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l 408 (670)
+...+.....++|+..+.||+|+||.||+|.+.. ..+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3444555567899999999999999999996311 235689999999999 78999999
Q ss_pred eeeeeccC-eeEEEEeccCCCCchhhcccCCc------------------------------------------------
Q 035655 409 QGWCKRKR-DLLLVYDYIPNGSLDSLLFDNEN------------------------------------------------ 439 (670)
Q Consensus 409 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 439 (670)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999976432
Q ss_pred ----------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 440 ----------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 440 ----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128999999999999999999999 8999999999999999999999999999986644332
Q ss_pred -ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 -SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.......||+.|+|||++.+..++.++|||||||+++||++ |+.||........ .......+.. +...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~-----~~~~--- 318 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTR-----MRAP--- 318 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCC-----CCCC---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCC-----CCCC---
Confidence 23345678999999999999999999999999999999998 9999976432211 1111111111 1111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.+++..||+.||.+||+++|++++|+.
T Consensus 319 -~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 319 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1123457889999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.39 Aligned_cols=237 Identities=29% Similarity=0.395 Sum_probs=194.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-eeEEEEeccCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR-DLLLVYDYIPN 427 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~ 427 (670)
.++|+..+.||+|+||.||+|.... ..+.|.+|+++|++++||||++++++|.+.. ..++||||+++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 4678889999999999999997643 3578999999999999999999999987665 79999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence 999999987655568999999999999999999999 89999999999999999999999999999854332 12
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..... ..+. . ...+....
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i-~~~~-----~----~~~p~~~~ 412 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV-EKGY-----K----MDAPDGCP 412 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHH-HTTC-----C----CCCCTTCC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-HcCC-----C----CCCCCcCC
Confidence 2367889999999999999999999999999999998 999997633211 11111 1111 1 11122234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++..||+.||.+||++.++++.|+.
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 567889999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=343.88 Aligned_cols=232 Identities=23% Similarity=0.301 Sum_probs=185.0
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..++||+|+||+||+|.+.. ....+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 679999999999999999998752 123455666666655 8999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+ +++|.+++.... ..++|.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 779999886653 469999999999999999999999 899999999999999999999999999998765432
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||++.+ .++.++|||||||+++||++|..|+.... .+ .....+. ....+.
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~--~~~~~~~--------~~~~~~ 274 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GW--QQLRQGY--------LPPEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HH--HHHTTTC--------CCHHHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HH--HHHhccC--------CCcccc
Confidence 2344579999999998875 78999999999999999999977765421 11 1111111 111222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++..||+.||.+||+++|++++-+
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 233467889999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.35 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=198.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|...+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 5678999999999999999996511 236788999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCc----------------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCC
Q 035655 419 LLVYDYIPNGSLDSLLFDNEN----------------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp 476 (670)
++||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999976432 348999999999999999999999 8999999999
Q ss_pred CcEEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc
Q 035655 477 GNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF 554 (670)
Q Consensus 477 ~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~ 554 (670)
+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||+++||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2233467889999999998889999999999999999999 9999976433
Q ss_pred hhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 555 ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.... .....+. .+. .+......+.+++..||+.||.+||++.|++++|+.
T Consensus 259 ~~~~---~~~~~~~-----~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ERLF---NLLKTGH-----RME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGHH---HHHHTTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH---HHhhcCC-----cCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2111 1111111 111 112223567889999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.77 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=192.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|+.++++++||||++++++|. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3578899999999999999997532 1245678999999999999999999986 46689
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999997653 469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... ......||..|+|||++.+..++.++|||||||++|||++ |+.||.......... ........ ..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~--~~~~- 240 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD---LLEKGERL--AQPQ- 240 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH---HHHTTCBC--CCCT-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH---HHHcCCCC--CCCC-
Confidence 44322 2344578889999999999999999999999999999999 999998643221111 11111110 0111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.....+.+++..||+.||.+||+++|++++|+..
T Consensus 241 ------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 241 ------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1123466789999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.00 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=201.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC--eeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR--DLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV 421 (670)
.++|...++||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3578999999999999999997653 2366889999999999999999999988655 78999
Q ss_pred EeccCCCCchhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe----cCCCcEEEEeecCce
Q 035655 422 YDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFGLAR 496 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kL~DFGla~ 496 (670)
|||+++++|.+++..... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976533 349999999999999999999999 899999999999999 888899999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCc--chhHHHHHHHhhc
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELAR--------TGKASCSTDVFAYGVLLLEIATGRRPIDSDH--FILVDWVLEFQHL 566 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~--~~~~~~~~~~~~~ 566 (670)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 765543 223457999999999886 5678999999999999999999999996421 1111111111111
Q ss_pred C---Cccccc-----------CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 567 G---QVLDVV-----------DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 567 ~---~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
. ...... +..............+.+++..||+.||.+||+++|++++...+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0 000000 1111224456777888999999999999999999999999875543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.57 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=199.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
.++|...++||+|+||.||+|.... ..+.+.+|+++++++ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4678899999999999999997411 236788999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+..++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999997643 2359999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+++||++ |+.||....... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 999997643221 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
. .....+. .+.. +......+.+++..||+.||.+||+++|++++|+..
T Consensus 303 ~-~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 303 F-KLLKEGH-----RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp H-HHHHTTC-----CCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHHHcCC-----CCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111111 1111 112235678899999999999999999999999765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.58 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=191.1
Q ss_pred hcCccccceEeeeCceeEEEeecc----c----------------hHHHHHHHHHHHhccccCceeeeeeeeecc--Cee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~ 418 (670)
.++|+..++||+|+||.||+++.. . ..+.|.+|++++++++||||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 467889999999999999999731 1 236788999999999999999999998654 568
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997653 359999999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh----hcCCcccc
Q 035655 499 DHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ----HLGQVLDV 572 (670)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~----~~~~~~~~ 572 (670)
..... .......++..|+|||.+.+..++.++|||||||+++||++|..|+............... ......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 54332 1223345778899999999999999999999999999999999998752211110000000 00000000
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+........+......+.+++..||+.||.+||+++|+++.|+.
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11111111222334668889999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.41 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=196.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5679999999999999999997642 135788999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----cEEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----NARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kL~DFGl 494 (670)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999654 469999999999999999999999 8999999999999998877 799999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ...
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~~i~-~~~------ 234 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANIT-AVS------ 234 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH-TTC------
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-hcC------
Confidence 98765532 2344679999999999999899999999999999999999999997643211 111111 110
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.......+.+++..||+.||.+||++.|+++|-+
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 11111111223456788999999999999999999998644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.80 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=196.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+.+|++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568899999999999999997642 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----cEEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----NARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kL~DFGl 494 (670)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999654 469999999999999999999998 8999999999999999887 899999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
++...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ....... .
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~-------~ 233 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVSAV-------N 233 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHHHT-------C
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHhc-------C
Confidence 98765432 23345799999999999989999999999999999999999999976432111 1111110 1
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..............+.+++..||+.||.+|||++|+++|-.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 11111111222356788999999999999999999999643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.44 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=195.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3578899999999999999998421 234688999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC-----ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEE
Q 035655 419 LLVYDYIPNGSLDSLLFDNE-----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLG 490 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~ 490 (670)
++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 2458999999999999999999999 8999999999999999555 59999
Q ss_pred eecCceeccCCC-cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCC
Q 035655 491 DFGLARLFDHGK-ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 491 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
|||+++...... ........||+.|+|||++.+..++.++|||||||+++||++ |+.||........ ... ...+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~-i~~~~ 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEF-VTSGG 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHH-HHTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-HHcCC
Confidence 999997553322 222334578999999999999999999999999999999998 9999976432211 111 11111
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
. +. .+......+.+++..||+.||.+||++.+|+++|+..
T Consensus 304 ~-----~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 R-----MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp C-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 11 1112235678899999999999999999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.07 Aligned_cols=235 Identities=22% Similarity=0.263 Sum_probs=194.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||+||+++... ....+.+|+.+|++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3578999999999999999997643 234678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999999654 358999999999999999999999 89999999999999999999999999999854322
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ..... ..+
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~-i~~~~------~~~---- 224 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FEL-ILMEE------IRF---- 224 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHCC------CCC----
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HHH-HHcCC------CCC----
Confidence 2 233456899999999999999999999999999999999999999976432211 111 11111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+......+.+++..||+.||.+|| +++|+++|-
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 112235678899999999999999 899999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.00 Aligned_cols=240 Identities=28% Similarity=0.474 Sum_probs=197.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4678999999999999999997643 34678999999999999999999999874 56899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.......+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 9999999976544469999999999999999999998 8999999999999999999999999999987765443333
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||.+.+..++.++||||||++++||++ |+.||...... +....... + ..+.. +...
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~-~-----~~~~~----~~~~ 235 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLER-G-----YRMVR----PDNC 235 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT-T-----CCCCC----CTTC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhc-c-----cCCCC----cccc
Confidence 44567889999999998889999999999999999999 99999764321 11111111 1 01111 1122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+.+++..||+.||.+||+++++++.|+.
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 3567889999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.32 Aligned_cols=243 Identities=26% Similarity=0.429 Sum_probs=198.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
..++|+..+.||+|+||.||+|.... ..+.|.+|+.++++++||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 35789999999999999999997641 23568899999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCC----------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccC
Q 035655 418 LLLVYDYIPNGSLDSLLFDNE----------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIk 475 (670)
.++||||+++|+|.+++.... ...+++.+++.++.||++||.|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999997642 1469999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCc
Q 035655 476 SGNVLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDH 553 (670)
Q Consensus 476 p~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~ 553 (670)
|+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 22334578999999999999999999999999999999999 999997643
Q ss_pred chhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.... . .....+... .. +......+.+++..||+.||.+||++.+++++|+..
T Consensus 282 ~~~~--~-~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 282 HEEV--I-YYVRDGNIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp HHHH--H-HHHHTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHHH--H-HHHhCCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 2211 1 111111111 11 112235678899999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.57 Aligned_cols=236 Identities=29% Similarity=0.489 Sum_probs=186.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||++++++|.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3578999999999999999997533 2357889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce---EEecccCCCcEEecC--------CCcEEEEe
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV---VIHRDVKSGNVLIDA--------DMNARLGD 491 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~---ivHrDIkp~NILld~--------~~~~kL~D 491 (670)
||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 368999999999999999999999 66 999999999999986 67899999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
||+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||.........+. .. ....
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~-~~~~-- 231 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG--VA-MNKL-- 231 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH--HH-TSCC--
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh--hh-cCCC--
Confidence 99998654432 2245799999999999999999999999999999999999999986433222111 11 1111
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.. ..+......+.+++..||+.||.+||+++|++++|+.
T Consensus 232 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 --AL----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 1112223568889999999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=342.25 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=195.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3568899999999999999997642 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc---EEEEeecC
Q 035655 420 LVYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN---ARLGDFGL 494 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kL~DFGl 494 (670)
+||||+++|+|.+++.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 3358999999999999999999999 89999999999999987665 99999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ..+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i----~~~~~----- 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI----IKGKY----- 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH----HHTCC-----
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH----HcCCC-----
Confidence 98765533 223445799999999999999999999999999999999999999986432221111 11110
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.............+.+++..||+.||.+||++.|+++|-
T Consensus 250 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 250 -KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 000001112235678899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.98 Aligned_cols=236 Identities=23% Similarity=0.384 Sum_probs=193.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ..+.|.+|+.++++++||||++++++|.+. +..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3578899999999999999997643 245789999999999999999999999877 7889999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||+++|+|.+++.......+++.+++.++.|++.||.|||+ .+ ++||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987766679999999999999999999998 77 99999999999999999999999998754322
Q ss_pred CCcceeeccccCcCCCCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASC---STDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
....||+.|+|||.+.+..++. ++|||||||+++||++|+.||........ ........ ..+..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-----~~~~~ 232 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--GMKVALEG-----LRPTI 232 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--HHHHHHSC-----CCCCC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--HHHHHhcC-----CCCCC
Confidence 2346899999999998765444 89999999999999999999976432211 11111111 11112
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
. ......+.+++..||+.||.+||+++|+++.|+.
T Consensus 233 ~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 233 P----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 2223567889999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.18 Aligned_cols=243 Identities=19% Similarity=0.200 Sum_probs=197.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4579999999999999999998532 235688999999999 7999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc-----EEEEeecCceeccC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN-----ARLGDFGLARLFDH 500 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-----~kL~DFGla~~~~~ 500 (670)
+++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 89 -~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999999997653 369999999999999999999998 89999999999999988776 99999999987765
Q ss_pred CCcc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hH---HHHHHHhhcCCcc
Q 035655 501 GKIS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LV---DWVLEFQHLGQVL 570 (670)
Q Consensus 501 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~---~~~~~~~~~~~~~ 570 (670)
.... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .. ............
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL- 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH-
Confidence 4321 234457999999999999999999999999999999999999999763211 11 111111111111
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....+ ...+.+.+++..||+.||.+||++++|++.|+..
T Consensus 243 ~~~~~--------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 243 RELCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHh--------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 11111 1235678899999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.32 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=194.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
..++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35679999999999999999997532 235688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec---CCCcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID---ADMNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kL~DFGla~~~ 498 (670)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999765 359999999999999999999999 8999999999999998 4578999999999866
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ...+.. ....+.
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~~-i~~~~~-~~~~~~-- 236 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQQ-IKAGAY-DFPSPE-- 236 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHTCC-CCCTTT--
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HHH-HHhCCC-CCCccc--
Confidence 5433 223456899999999999999999999999999999999999999976432211 111 111111 111111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+++..||+.||.+||++.|+++|-+
T Consensus 237 ---~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 237 ---WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 1122356788999999999999999999999743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.32 Aligned_cols=242 Identities=18% Similarity=0.203 Sum_probs=195.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4679999999999999999998532 234688999999999 9999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc-----EEEEeecCceeccC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN-----ARLGDFGLARLFDH 500 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-----~kL~DFGla~~~~~ 500 (670)
+++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 88 -~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 -GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999999765 3479999999999999999999999 89999999999999999887 99999999987654
Q ss_pred CCcc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc--CCccc
Q 035655 501 GKIS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL--GQVLD 571 (670)
Q Consensus 501 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~--~~~~~ 571 (670)
.... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... ..+........ ....+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 3321 124568999999999999999999999999999999999999999863221 11111111000 00000
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
... .. .+ .+.+++..||+.||.+||++++|++.|+.
T Consensus 243 ~~~----~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 243 VLC----EN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHT----TT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHh----cc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 11 12 67889999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.37 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=192.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..++||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4679999999999999999998643 13568899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|++ |+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 998 58888886543 369999999999999999999998 899999999999999999999999999998765432
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCc------------
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQV------------ 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~------------ 569 (670)
.......||+.|+|||++.+ ..++.++|||||||+++||++|+.||..... ...............
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22344578999999999876 5689999999999999999999999976321 111111111100000
Q ss_pred ----ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 ----LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 ----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...................+.+++..||+.||.+|||++|+++|-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000000000011112356788999999999999999999998643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.14 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeec
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKR 414 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~ 414 (670)
....++|...+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456789999999999999999997521 235688999999999 89999999999999
Q ss_pred cCeeEEEEeccCCCCchhhcccCC------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNE------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence 999999999999999999996532 2358999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWV 560 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~ 560 (670)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||+++||++ |+.||........ .
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 9999999999999866543322 2334567889999999999999999999999999999998 9999976332211 1
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
........ .+.. +......+.+++..||+.||.+||++.|++++|+.
T Consensus 277 ~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 277 YKLVKDGY-----QMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCC-----CCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 11111110 0111 11123567889999999999999999999999973
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.21 Aligned_cols=240 Identities=28% Similarity=0.432 Sum_probs=188.7
Q ss_pred cCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
++|+..+.||+|+||.||++.... ..+.|.+|++++++++||||+++++++.+ ..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 568889999999999999997643 35678999999999999999999999874 4899999999999
Q ss_pred chhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc-EEEEeecCceeccCCCcceee
Q 035655 430 LDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN-ARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 430 L~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-~kL~DFGla~~~~~~~~~~~~ 507 (670)
|.+++..... ..+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||++...... ..
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~ 161 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT 161 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence 9999976543 34789999999999999999999854468999999999999998886 799999999755432 23
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++.+..++.++|||||||+++||++|+.||...........+.... +. .+.... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-----~~~~~~----~~~~ 231 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT-----RPPLIK----NLPK 231 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC-----CCCCBT----TCCH
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC-----CCCccc----ccCH
Confidence 3469999999999999999999999999999999999999997533222222221111 11 111111 2235
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.+.+++..||+.||.+||++++++++|+..
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 678899999999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=343.32 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=198.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
..++|...+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 45789999999999999999998510 235788999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCCc---------------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccC
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNEN---------------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVK 475 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIk 475 (670)
..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 99999999999999999976532 248999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCc
Q 035655 476 SGNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDH 553 (670)
Q Consensus 476 p~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~ 553 (670)
|+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||+++||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876544322 2334578899999999999999999999999999999998 999997643
Q ss_pred chhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.... .......+. .+. .+......+.+++..||+.||.+||++.+++++|+..
T Consensus 280 ~~~~--~~~~~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VDAN--FYKLIQNGF-----KMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CSHH--HHHHHHTTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHH--HHHHHhcCC-----CCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2111 111111110 111 1112235678899999999999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.55 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=182.9
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
..++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||++++++|.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 45679999999999999999998753 2356789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEEeecCceeccCCC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~DFGla~~~~~~~ 502 (670)
++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 131 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 131 TGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999999654 358999999999999999999998 89999999999999975 8899999999998664432
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+ ........ .... ...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~i~~~~~-~~~~-----~~~ 275 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF--RRILNCEY-YFIS-----PWW 275 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH--HHHHTTCC-CCCT-----TTT
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH--HHHHhCCC-ccCC-----chh
Confidence 2334579999999999999999999999999999999999999997643221111 11111111 0111 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.+++..||+.||.+||++.|++++-.-
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 2233567889999999999999999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.20 Aligned_cols=235 Identities=23% Similarity=0.357 Sum_probs=187.4
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------------------------------------HHHHHHHHHHHh
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------------------------------------MREFAAEIESLG 398 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------------------------------------~~~f~~Ei~~L~ 398 (670)
.++|+..+.||+|+||.||+|+.... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999975320 245789999999
Q ss_pred ccccCceeeeeeeeec--cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCC
Q 035655 399 RLRHKHLVNLQGWCKR--KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476 (670)
Q Consensus 399 ~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp 476 (670)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.||+.||.|||+ .+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 9999999999999986 5689999999999999987643 369999999999999999999999 8999999999
Q ss_pred CcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCc
Q 035655 477 GNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK---ASCSTDVFAYGVLLLEIATGRRPIDSDH 553 (670)
Q Consensus 477 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~el~tG~~pf~~~~ 553 (670)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||+++||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998765433 2234457999999999987765 3788999999999999999999997643
Q ss_pred chhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
... ...... .... .. +. .. .....+.+++.+||+.||.+||+++|+++|
T Consensus 245 ~~~--~~~~~~-~~~~-~~--~~-~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMC--LHSKIK-SQAL-EF--PD-QP----DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHH--HHHHHH-HCCC-CC--CS-SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHH--HHHHHh-cccC-CC--CC-cc----ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 221 111111 1111 00 00 01 123567889999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.07 Aligned_cols=245 Identities=28% Similarity=0.481 Sum_probs=185.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..++||+|+||.||+|.... ..+.|.+|++++++++||||+++++++ .....++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 4679999999999999999997643 246789999999999999999999976 455689999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC-cc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK-IS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~-~~ 504 (670)
++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 102 EGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred CCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999996553 469999999999999999999999 899999999999999999999999999997654322 22
Q ss_pred eeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||.+. +..++.++|||||||+++||++|+.||...... +........+... +.+ ...
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~----~~~-~~~ 250 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLS----PDL-SKV 250 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCC----CCT-TSS
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccC----cch-hhc
Confidence 234457999999999886 567889999999999999999999999763221 1111111111111 111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.......+.+++..||+.||.+||+++|+++.|+..
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 122335688899999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.23 Aligned_cols=240 Identities=26% Similarity=0.444 Sum_probs=197.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 3578889999999999999997643 34678999999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999997653 368999999999999999999999 8999999999999999999999999999986544322222
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....++..|+|||++.+..++.++||||||++++||++ |+.||....... ....... +. ....+ ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~-~~--~~~~~-------~~~ 230 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST-GF--RLYKP-------RLA 230 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT-TC--CCCCC-------TTS
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhc-CC--cCCCC-------ccC
Confidence 33467889999999998899999999999999999999 899997643221 1111111 10 01111 112
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+.+++.+||+.||.+||++++++++|+.
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3567889999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.69 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=190.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|+..++||+|+||.||+|.+.. ..+.+.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4679999999999999999997522 3467899999999999999999999998764 88
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997654 369999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........... ...+. ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~-----~~-- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGE-----RL-- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTC-----CC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCC-----CC--
Confidence 4332 22233467889999999999999999999999999999999 9999986433222111 11111 01
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
..+......+.+++..||+.||.+||+++|+++.|+...
T Consensus 239 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 --PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111122346788999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.38 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=195.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
..++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35679999999999999999997642 235688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DFGla~~~ 498 (670)
|||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998654 358999999999999999999999 8999999999999998654 5999999999876
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...+.. ...
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~-i~~~~~------~~~ 250 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQ-IKAGAY------DYP 250 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHTCC------CCC
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHhCCC------CCC
Confidence 5432 2334679999999999999899999999999999999999999997643221 1111 111111 011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..........+.+++..||+.||.+||++.|++++-
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 111122335678899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=350.47 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=200.6
Q ss_pred chhhHHHhhcCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceeeeeeeee
Q 035655 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVNLQGWCK 413 (670)
Q Consensus 353 ~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~ 413 (670)
.+.++....++|+..++||+|+||+||+++.... .+.+.+|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445566778999999999999999999987541 123779999999999999999999999
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
+.+.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999998643 58999999999999999999999 899999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCC
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGK----ASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQ 568 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~ 568 (670)
+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ....+......
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 291 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-- 291 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--
Confidence 99877655444445678999999999987655 788999999999999999999999864422 11111110000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHhc
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEA--RPTMRQVLRYLN 615 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 615 (670)
..-|.. . .....+.+++..||+.+|.+ ||+++||++|-.
T Consensus 292 ---~~~p~~-~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 292 ---LTFPDD-N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp ---CCCCTT-C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ---ccCCCc-c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 001110 0 11255778889999999988 999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=350.46 Aligned_cols=251 Identities=22% Similarity=0.239 Sum_probs=201.4
Q ss_pred ccchhhHHHhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeee
Q 035655 351 RFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGW 411 (670)
Q Consensus 351 ~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~ 411 (670)
.+.+++.....++|+..+.||+|+||+||+++... ..+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 45566667778999999999999999999998743 11347789999999999999999999
Q ss_pred eeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
+.+.+.+++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999997543 369999999999999999999998 8999999999999999999999999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHH
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELAR-------TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEF 563 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~ 563 (670)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999877654433344568999999999987 3568999999999999999999999998643221 1111110
Q ss_pred hhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCC---CCHHHHHHHhc
Q 035655 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEAR---PTMRQVLRYLN 615 (670)
Q Consensus 564 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~ 615 (670)
.... ..|... ......+.+++..||+ +|.+| |+++|+++|-.
T Consensus 286 ~~~~-----~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 286 KEHL-----SLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHC-----CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred ccCc-----CCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 0000 011111 1123567789999999 99998 69999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.58 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=187.4
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeee
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCK 413 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~ 413 (670)
+++....++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3444456789999999999999999997532 2356889999999999999999999998
Q ss_pred ccCee------EEEEeccCCCCchhhcccCC----ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC
Q 035655 414 RKRDL------LLVYDYIPNGSLDSLLFDNE----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483 (670)
Q Consensus 414 ~~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~ 483 (670)
..... ++|+||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence 77654 99999999999999996432 2258999999999999999999999 89999999999999999
Q ss_pred CCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHH
Q 035655 484 DMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVL 561 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~ 561 (670)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+++||++ |+.||........ ..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~ 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH
Confidence 99999999999986654332 22233467889999999999999999999999999999999 9999976432211 11
Q ss_pred HHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 562 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
... .+.. + ..+......+.+++..||+.||.+||++.++++.|+...
T Consensus 251 ~~~-~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 251 YLI-GGNR-----L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHH-TTCC-----C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-cCCC-----C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 1110 1 111222356889999999999999999999999988653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=339.11 Aligned_cols=240 Identities=20% Similarity=0.323 Sum_probs=196.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||+|.... ....+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4679999999999999999997643 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC--CCcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA--DMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kL~DFGla~~~~~~~ 502 (670)
+++|+|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999996543 369999999999999999999998 89999999999999974 4679999999998775543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ .. ..++.. .
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~-~~--~~~~~~----~ 274 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRC-DW--EFDEDA----F 274 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHC-CC--CCCSST----T
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-CC--CCCccc----c
Confidence 233457999999999999999999999999999999999999999864321 111111111 10 011111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++..||+.||.+||++.|++++-.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 122356788999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.61 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=195.3
Q ss_pred chhhHHHhhcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeee
Q 035655 353 RYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGW 411 (670)
Q Consensus 353 ~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~ 411 (670)
.-.++....++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||++++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 334566778899999999999999999997633 23568899999999999999999999
Q ss_pred eeccCeeEEEEeccCCCCchhhcccC--------------------------------------CccccCHHHHHHHHHH
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDN--------------------------------------ENFVLSWEQRFNIIKG 453 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~q 453 (670)
|.+.+..++||||+++|+|.+++... ....+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 99999999999999999999998521 0223467888999999
Q ss_pred HHHHhhhccccccceEEecccCCCcEEecCCC--cEEEEeecCceeccCCCc---ceeeccccCcCCCCcccccc--CCC
Q 035655 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM--NARLGDFGLARLFDHGKI---SHTTNVVGTIGYIAPELART--GKA 526 (670)
Q Consensus 454 ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~--~~kL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~ 526 (670)
|+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+ ..+
T Consensus 177 i~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 177 IFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 9999999999 8999999999999998776 899999999987644221 12345679999999999865 678
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCC
Q 035655 527 SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPT 606 (670)
Q Consensus 527 t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 606 (670)
+.++|||||||+++||++|+.||....... .......... .............+.+++..||+.||.+||+
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999999997643221 1111111110 0111111122356788999999999999999
Q ss_pred HHHHHHHh
Q 035655 607 MRQVLRYL 614 (670)
Q Consensus 607 ~~evl~~L 614 (670)
+.|++++-
T Consensus 325 ~~~~l~hp 332 (345)
T 3hko_A 325 AMRALQHP 332 (345)
T ss_dssp HHHHHHSH
T ss_pred HHHHhcCh
Confidence 99999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.36 Aligned_cols=248 Identities=19% Similarity=0.248 Sum_probs=193.9
Q ss_pred hcCccccceEeee--CceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTG--GFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G--~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..++||+| +||.||+++... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999999 999999998653 23567789999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999987655679999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCc------ceeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 501 GKI------SHTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 501 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......... . ...+.....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~~ 257 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--E-KLNGTVPCL 257 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--H-C--------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--H-HhcCCCCcc
Confidence 211 11223478999999999987 578999999999999999999999997632211100 0 000000000
Q ss_pred cC------------------------------CC------CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 573 VD------------------------------PN------LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 573 ~d------------------------------~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+ +. ....+.......+.+++.+||+.||.+|||++|+++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00 00 00011222345688999999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.66 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=190.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..++||+|+||+||+|.... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578999999999999999997643 23678899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 5656554432 469999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcchh--HHHHHHHhhc---CC---cccccC
Q 035655 504 SHTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFIL--VDWVLEFQHL---GQ---VLDVVD 574 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~--~~~~~~~~~~---~~---~~~~~d 574 (670)
.......||+.|+|||++.+.. ++.++|||||||+++||++|..|+....... .......... .. .....+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2234457899999999987765 7999999999999999999988864422211 1111111000 00 000000
Q ss_pred ---------CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 575 ---------PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 575 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..............+.+++..||+.||.+|||++|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 00001111223456788999999999999999999998644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.67 Aligned_cols=242 Identities=22% Similarity=0.349 Sum_probs=198.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 417 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 4679999999999999999997410 246788999999999 99999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCc----------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 418 LLLVYDYIPNGSLDSLLFDNEN----------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999976542 248999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||+++||++ |+.||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 99999999999999876554322 2234567889999999999999999999999999999999 99999764322111
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....... ..+.. +......+.+++..||+.||.+||+++|++++|+.
T Consensus 258 -~~~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 258 -YKMIKEG-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -HHHHHHT-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHhccC-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111 01111 11223567889999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.81 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=190.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578899999999999999986432 24678899999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc--------EEE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN--------ARL 489 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--------~kL 489 (670)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997653 358999999999999999999999 89999999999999998887 999
Q ss_pred EeecCceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCC-CCCCcchhHHHHHHHhhcC
Q 035655 490 GDFGLARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRP-IDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 490 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~p-f~~~~~~~~~~~~~~~~~~ 567 (670)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||+++||++|..| +......... .......
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~~~~~~ 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--QFYEDRH 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHHTTC
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--HHhhccC
Confidence 99999864432 233468999999999987 6789999999999999999996554 4432221111 1111111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
.. .+ .. ...+.+++..||+.||.+||+++|++++|+....
T Consensus 236 ~~----~~----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QL----PA----PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CC----CC----CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CC----CC----CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 11 11 2346789999999999999999999999997654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.71 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=191.4
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
..++|...+.||+|+||.||+|+... ..+.|.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35679999999999999999987421 246788999999999999999999998754 568
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997543 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
...........+|+.|+|||.+.+..++.++|||||||+++||++ |+.||......... .... .+.. +..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~~~~-~~~~-----~~~- 235 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--GVLE-KGDR-----LPK- 235 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--HHHH-HTCC-----CCC-
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--HHHh-cCCC-----CCC-
Confidence 544333444567889999999998999999999999999999998 99999753322111 1111 1111 011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++..||+.||.+||++.|++++|+.
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 236 ---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11123567889999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.84 Aligned_cols=235 Identities=26% Similarity=0.347 Sum_probs=192.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+.+|++++||||++++++|.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 578999999999999999997643 2356789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999754 359999999999999999999999 899999999999999999999999999998765432
Q ss_pred cceeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||................... ..
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------~~--- 238 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------VT--- 238 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------CC---
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------cC---
Confidence 3345689999999999864 458999999999999999999999997532221111111111110 11
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPT-MRQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 613 (670)
++......+.+++..||+.||.+||+ ++++++|
T Consensus 239 -~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 239 -YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 11122356788999999999999998 8888764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.19 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=189.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 478899999999999999997632 135788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 975 9999886543 468999999999999999999999 899999999999999999999999999998664322 2
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC------Cc--ccccC
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG------QV--LDVVD 574 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~------~~--~~~~d 574 (670)
......||+.|+|||++.+. .++.++|||||||+++||++|+.||...... ............ .. ....+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 23345789999999998764 5899999999999999999999999764321 111111110000 00 00111
Q ss_pred CCCC-------CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 575 PNLG-------SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 575 ~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+... ..+.......+.+++.+||+.||.+||+++|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 1110 011122345678899999999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.32 Aligned_cols=237 Identities=25% Similarity=0.497 Sum_probs=192.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4679999999999999999997632 0167889999999999999999999997665
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEecCCCc-----EEEE
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDADMN-----ARLG 490 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~-----~kL~ 490 (670)
++||||+++|+|.+++.+.. ..+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999886654 469999999999999999999998 78 999999999999988776 9999
Q ss_pred eecCceeccCCCcceeeccccCcCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC
Q 035655 491 DFGLARLFDHGKISHTTNVVGTIGYIAPELAR--TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 491 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
|||+++.... ......||+.|+|||++. ...++.++|||||||+++||++|+.||..................
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 246 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG- 246 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-
Confidence 9999974433 234467999999999984 456789999999999999999999999864433222222221111
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+ +......+.+++..||+.||.+||+++|+++.|+.
T Consensus 247 ----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 ----LRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----CCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 22223567889999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.30 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=199.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
...++|+..++||+|+||.||+|.+.. ..++|.+|+++|++++||||++++++|.+ +..++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 345678899999999999999998654 24689999999999999999999999976 678999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|+|.++|.......+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999976544569999999999999999999999 89999999999999999999999999999865432222
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......++..|+|||++....++.++|||||||++|||++ |+.||...... +..... ..+.. ...+.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~~---------~~~~~ 487 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGYR---------MPCPP 487 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHH-HTTCC---------CCCCT
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCC---------CCCCC
Confidence 2233457789999999999999999999999999999999 99999763321 111111 11110 11122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...+.+.+++..||+.||.+||++++|++.|+..
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2345678899999999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.34 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=202.3
Q ss_pred CCccchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccc-----cCceeee
Q 035655 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLR-----HKHLVNL 408 (670)
Q Consensus 349 ~~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~-----H~nIv~l 408 (670)
...+++++-....++|...++||+|+||.||+|.... ..+.+..|+.++++++ ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 4456777777778999999999999999999998643 2356778999999996 9999999
Q ss_pred eeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-----
Q 035655 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA----- 483 (670)
Q Consensus 409 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~----- 483 (670)
++++...+..++||||+ +++|.+++.......+++.++..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccc
Confidence 99999999999999999 9999999987766679999999999999999999998 89999999999999975
Q ss_pred --------------------CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHH
Q 035655 484 --------------------DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIA 543 (670)
Q Consensus 484 --------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~ 543 (670)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999865442 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCCcch-hHHHHHHHh-----------hcCCccccc--------CCCCCCc-------------ccHHHHHHHH
Q 035655 544 TGRRPIDSDHFI-LVDWVLEFQ-----------HLGQVLDVV--------DPNLGSS-------------YVVAEMELVL 590 (670)
Q Consensus 544 tG~~pf~~~~~~-~~~~~~~~~-----------~~~~~~~~~--------d~~l~~~-------------~~~~~~~~l~ 590 (670)
+|+.||...... ......... ......... .+..... +.....+.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999999763321 111111100 000000000 0000000 0001125677
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 035655 591 QLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 591 ~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+++..||+.||.+|||++|+++|
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=342.35 Aligned_cols=235 Identities=23% Similarity=0.279 Sum_probs=189.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||+||+++... ..+.+.+|..+++++ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4689999999999999999997643 224567899999988 69999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.+. ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999664 359999999999999999999999 8999999999999999999999999999985433
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+. ..
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~-~~~------~~---- 242 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAIL-NDE------VV---- 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HCC------CC----
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHHHHH-cCC------CC----
Confidence 22 23345689999999999998889999999999999999999999998643221 111111 111 11
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHHh
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTM------RQVLRYL 614 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 614 (670)
++......+.+++..||+.||.+||++ +|+++|-
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 111123557789999999999999998 8888754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.35 Aligned_cols=237 Identities=20% Similarity=0.288 Sum_probs=188.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC-------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------- 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------- 416 (670)
.++|+..+.||+|+||.||+|+... ..+.+.+|+++|++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4578999999999999999997642 3467899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeccCCCCchhhcccCCc-cccCHH
Q 035655 417 --------------------------------------------------DLLLVYDYIPNGSLDSLLFDNEN-FVLSWE 445 (670)
Q Consensus 417 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 445 (670)
..++||||+++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999976532 346777
Q ss_pred HHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-----------ceeeccccCcC
Q 035655 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-----------SHTTNVVGTIG 514 (670)
Q Consensus 446 ~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 514 (670)
.++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999998 8999999999999999999999999999987765421 12234579999
Q ss_pred CCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHH
Q 035655 515 YIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGL 594 (670)
Q Consensus 515 y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 594 (670)
|+|||++.+..++.++|||||||+++||++|..|+... .... ..... ... ..........+.+++.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~-~~~~~--------~~~-~~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRII-TDVRN--------LKF-PLLFTQKYPQEHMMVQ 307 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHH-HHHHT--------TCC-CHHHHHHCHHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHH-HHhhc--------cCC-CcccccCChhHHHHHH
Confidence 99999999999999999999999999999987774311 1100 10111 111 1222334456788999
Q ss_pred hhccCCCCCCCCHHHHHHHh
Q 035655 595 LCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 595 ~Cl~~dP~~RPs~~evl~~L 614 (670)
.||+.||.+||+++|++++-
T Consensus 308 ~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 308 DMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHCSSGGGSCCHHHHHHST
T ss_pred HHccCCCCcCCCHHHHhhch
Confidence 99999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.58 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=202.8
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeee
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQ 409 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~ 409 (670)
+..++.....++|...+.||+|+||.||+|.... ....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 4444555667889999999999999999986531 234688999999999999999999
Q ss_pred eeeeccCeeEEEEeccCCCCchhhcccCC--------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNE--------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 410 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+++.+.+..++||||+++|+|.+++.... ...+++..+++++.||+.||.|||+ .+|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 99999999999999999999999996532 1357999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+++||++ |+.||....... .
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--V 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--H
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--H
Confidence 9999999999999986543321 11223467889999999999999999999999999999999 899997643211 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
......+... . .+......+.+++..||+.||.+||++.|++++|+...
T Consensus 250 -~~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 -LRFVMEGGLL-----D----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -HHHHHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHHHHcCCcC-----C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111111111 1 11122356788999999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.08 Aligned_cols=232 Identities=24% Similarity=0.311 Sum_probs=193.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3578999999999999999997643 234567899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999997643 58999999999999999999998 89999999999999999999999999999875432
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .. ..+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~-~~------~~~---- 222 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEKILN-AE------LRF---- 222 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH-CC------CCC----
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CC------CCC----
Confidence 334589999999999999999999999999999999999999997643211 1111111 11 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+......+.+++..||+.||.+|| +++|+++|-
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 111235677899999999999999 899999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.19 Aligned_cols=240 Identities=28% Similarity=0.491 Sum_probs=189.2
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
++|...+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999986531 23468899999999999999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997643 469999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.... ......+|+.|+|||++.+..++.++|||||||+++||++ |+.||....... .... ...+. .+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~-~~~~~-----~~~~ 271 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKA-INDGF-----RLPT 271 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH-HHTTC-----CCCC
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHH-HHCCC-----cCCC
Confidence 3211 1222356789999999999999999999999999999999 999997543211 1111 11111 0111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+......+.+++.+||+.||.+||++.+++++|+..
T Consensus 272 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 272 ----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112235678899999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.53 Aligned_cols=234 Identities=23% Similarity=0.354 Sum_probs=192.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999998633 1246889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+ +|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 78999988654 359999999999999999999999 899999999999999999999999999998665432
Q ss_pred cceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+.... ...
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------------~~~~~i~~~~-~~~ 227 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP------------NLFKKVNSCV-YVM 227 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST------------TCBCCCCSSC-CCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH------------HHHHHHHcCC-CCC
Confidence 2234579999999999988776 68999999999999999999999753211 0111110000 011
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++..||+.||.+|||++|++++-+-
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 22223567789999999999999999999997553
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.96 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=192.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..++||+|+||+||+++... ..+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4679999999999999999997643 123477899999887 89999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999754 359999999999999999999999 8999999999999999999999999999985332
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc------hhHHHHHHHhhcCCcccccC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF------ILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~------~~~~~~~~~~~~~~~~~~~d 574 (670)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..........
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 278 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 278 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence 22 234456899999999999999999999999999999999999999964211 11111111111111
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHHh
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTM------RQVLRYL 614 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 614 (670)
..+ +......+.+++..||+.||.+||++ +|+++|-
T Consensus 279 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 279 IRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred cCC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 111 11223567789999999999999984 7887764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=326.19 Aligned_cols=234 Identities=24% Similarity=0.385 Sum_probs=191.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999997643 134678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999654 358999999999999999999998 89999999999999999999999999998654332
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||.+.+..++.++||||||++++||++|+.||........ ....... ....
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-------~~~~---- 226 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISRV-------EFTF---- 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHT-------CCCC----
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHhC-------CCCC----
Confidence 23445789999999999999999999999999999999999999986432211 1111110 1111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+......+.+++..||+.||.+||+++|+++|-+
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 1112355778999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.65 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=192.0
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhcc--ccCceeeeeeeeecc----CeeEEE
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGRL--RHKHLVNLQGWCKRK----RDLLLV 421 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~l--~H~nIv~l~g~~~~~----~~~~lV 421 (670)
...++|+..++||+|+||.||+|.... ....+..|.+++..+ +||||+++++++... ...++|
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 445789999999999999999998653 234555666666654 899999999999877 689999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-----cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-----EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
|||+++|+|.+++... .+++..++.++.|++.||+|||+.+ +++|+||||||+|||++.++.+||+|||+++
T Consensus 114 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp ECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999999543 5899999999999999999999821 1299999999999999999999999999998
Q ss_pred eccCCCcce---eeccccCcCCCCccccccCCCCcc------chhHHHHHHHHHHHhC----------CCCCCCCcch--
Q 035655 497 LFDHGKISH---TTNVVGTIGYIAPELARTGKASCS------TDVFAYGVLLLEIATG----------RRPIDSDHFI-- 555 (670)
Q Consensus 497 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvvl~el~tG----------~~pf~~~~~~-- 555 (670)
......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 665433221 124579999999999987766654 9999999999999999 6666542111
Q ss_pred hHHHHHHHhhcCCcccccCCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 556 LVDWVLEFQHLGQVLDVVDPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........... ....+.+...+ .......+.+++.+||+.||.+||++.|++++|+..
T Consensus 271 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 271 SYEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 11111111111 11222222222 235677899999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.67 Aligned_cols=248 Identities=18% Similarity=0.184 Sum_probs=190.9
Q ss_pred hhcCccccceEeeeCceeEEEeeccch-----------------H---------------HHHHHHHHHHhccccCceee
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR-----------------M---------------REFAAEIESLGRLRHKHLVN 407 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~-----------------~---------------~~f~~Ei~~L~~l~H~nIv~ 407 (670)
..++|+..++||+|+||.||+|.+..+ . ..+..|+..+++++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999966321 1 12334556677788999999
Q ss_pred eeeeeecc----CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-
Q 035655 408 LQGWCKRK----RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID- 482 (670)
Q Consensus 408 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld- 482 (670)
+++++... ...++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 99998765 4589999999 999999997643 469999999999999999999999 8999999999999999
Q ss_pred -CCCcEEEEeecCceeccCCCcc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC--c
Q 035655 483 -ADMNARLGDFGLARLFDHGKIS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD--H 553 (670)
Q Consensus 483 -~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~--~ 553 (670)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||... .
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876543211 113346999999999999999999999999999999999999999752 2
Q ss_pred chhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 554 FILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.......... ....+...+++.+.. ......+.+++..||+.+|.+||+++++++.|+.
T Consensus 268 ~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 268 PKYVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 2222111111 111222222222111 1113567889999999999999999999999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.47 Aligned_cols=235 Identities=23% Similarity=0.335 Sum_probs=186.2
Q ss_pred cccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCCC
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNG 428 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 428 (670)
...+.||+|+||.||+|.... ..+.+.+|+++|++++||||++++++|.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 346789999999999997532 3467889999999999999999999999999999999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe--cCCCcEEEEeecCceeccCCCccee
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI--DADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl--d~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9999986543 469999999999999999999999 899999999999999 667899999999998765433 22
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....||+.|+|||++.+..++.++|||||||+++||++|+.||....... ........ .. .+.........
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~-~~------~~~~~~~~~~~ 316 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNNILAC-RW------DLEDEEFQDIS 316 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHT-CC------CSCSGGGTTSC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhc-cC------CCChhhhccCC
Confidence 34479999999999998899999999999999999999999997643221 11111111 00 01111111223
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..+.+++..||+.||.+||+++|++++-
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 5678899999999999999999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.83 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=197.6
Q ss_pred hcCccccceEeeeCceeEEEeecc----c----------------hHHHHHHHHHHHhccccCceeeeeeeee--ccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T----------------RMREFAAEIESLGRLRHKHLVNLQGWCK--RKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~ 418 (670)
.++|+..+.||+|+||.||++... . ..+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 367899999999999999999731 1 2356899999999999999999999886 45678
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 369999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHHhhcCCccccc
Q 035655 499 DHGKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWV---LEFQHLGQVLDVV 573 (670)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~---~~~~~~~~~~~~~ 573 (670)
...... ......||..|+|||++.+..++.++|||||||+++||++|+.||........... ............+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 554322 22334688889999999988899999999999999999999999865221110000 0000000111111
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........+......+.+++..||+.||.+||+++|++++|+..
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111222233346688999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.04 Aligned_cols=238 Identities=23% Similarity=0.331 Sum_probs=194.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5789999999999999999997643 2356789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc---EEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN---ARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kL~DFGla~~~~ 499 (670)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999988654 358999999999999999999999 89999999999999987665 9999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... ......||+.|+|||++.+..++.++||||||++++||++|+.||........ .... ..+.. ....+.
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~-~~~~~-~~~~~~--- 230 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YAQI-KAGAY-DYPSPE--- 230 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHTCC-CCCTTT---
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HHHH-Hhccc-cCCchh---
Confidence 433 22345799999999999999999999999999999999999999976432211 1111 11111 111111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.......+.+++..||+.||.+||+++|++++-
T Consensus 231 --~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 231 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred --hcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 111235578899999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.32 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=192.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccch---------------------HHHHHHHHHHHhccc---cCceeeeeeeeecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR---------------------MREFAAEIESLGRLR---HKHLVNLQGWCKRK 415 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~---------------------~~~f~~Ei~~L~~l~---H~nIv~l~g~~~~~ 415 (670)
.+++|+..++||+|+||.||+|+.... ...+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999985331 246778888888775 99999999999765
Q ss_pred C-----eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEE
Q 035655 416 R-----DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 416 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
. ..++||||++ |+|.+++.......+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 699999987766669999999999999999999999 899999999999999999999999
Q ss_pred eecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCC-
Q 035655 491 DFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQ- 568 (670)
Q Consensus 491 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~- 568 (670)
|||+++...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .............
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998654332 234568999999999999999999999999999999999999999764322 1111111110000
Q ss_pred --cc-------cccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 --VL-------DVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 --~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.. ....+... ........+.+.+++..||+.||.+|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 00 00000000 001112346678899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.94 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=195.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeee--ccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCK--RKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~l 420 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4678999999999999999997642 2356889999999999999999999874 4678999
Q ss_pred EEeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccce-----EEecccCCCcEEecCCCcEEEEeec
Q 035655 421 VYDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQV-----VIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 3459999999999999999999998 66 9999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 573 (670)
+++...... .......||+.|+|||.+.+..++.++||||||++++||++|+.||........ . .....+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~i~~~~~---- 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--A-GKIREGKF---- 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHTCC----
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--H-HHHhhccc----
Confidence 998665432 122345789999999999998999999999999999999999999986432211 1 11111111
Q ss_pred CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCCC
Q 035655 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLP 621 (670)
Q Consensus 574 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 621 (670)
+.+.. .....+.+++.+||+.||.+||+++|++++++..++.+
T Consensus 234 -~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 234 -RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp -CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred -ccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 11111 22356788999999999999999999999887665544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.37 Aligned_cols=233 Identities=24% Similarity=0.242 Sum_probs=194.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3579999999999999999998643 234677899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.+. ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999999754 358999999999999999999998 89999999999999999999999999999876442
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.....||+.|+|||++.+..++.++|||||||+++||++|+.||....... .... ...+. ..+..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~-i~~~~------~~~p~-- 259 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEK-IVSGK------VRFPS-- 259 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHCC------CCCCT--
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HHHH-HHcCC------CCCCC--
Confidence 234579999999999999999999999999999999999999998643221 1111 11111 11111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 615 (670)
.....+.+++..||+.||.+||+ ++|+++|-.
T Consensus 260 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 260 --HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp --TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred --CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 22356788999999999999998 899988643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=337.15 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=192.6
Q ss_pred ccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeecc--CeeEE
Q 035655 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RDLLL 420 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~~~l 420 (670)
|+..++||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 4889999999999998875311 245688999999999999999999999874 67899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 48999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHHhhcCCcccccCC
Q 035655 501 GKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWV---LEFQHLGQVLDVVDP 575 (670)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~---~~~~~~~~~~~~~d~ 575 (670)
.... ......+|..|+|||++.+..++.++|||||||+++||++|+.||........... ..........+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4322 22345688899999999998999999999999999999999999875221110000 000000011111111
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+......+.+++.+||+.||.+||+++|+++.|+.
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11112223334678899999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.74 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=185.2
Q ss_pred hcCcccc-ceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhc-cccCceeeeeeeeec----cCeeEEEEe
Q 035655 361 TKGFKQS-EVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGR-LRHKHLVNLQGWCKR----KRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~-~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~-l~H~nIv~l~g~~~~----~~~~~lV~E 423 (670)
.++|... +.||+|+||+||++.... ....+.+|+.++.+ .+||||+++++++.. ...+++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 3456665 689999999999998754 23567889998754 589999999999875 567899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~DFGla~~~~~ 500 (670)
|+++|+|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999999987665679999999999999999999998 89999999999999998 78999999999986543
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........+.. ....+.
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~--- 290 (400)
T 1nxk_A 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPE--- 290 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCTTT---
T ss_pred CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-cCCCcc---
Confidence 22 2345678999999999999999999999999999999999999997632211 0001111111111 001111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+++..||+.||.+||++.|+++|-+
T Consensus 291 --~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 291 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred --cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 1122356788999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.50 Aligned_cols=248 Identities=17% Similarity=0.187 Sum_probs=188.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------------hHHHHHHHHHHHhccccCceeeeee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------------RMREFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999998642 0123567888899999999999999
Q ss_pred eeec----cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-
Q 035655 411 WCKR----KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM- 485 (670)
Q Consensus 411 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~- 485 (670)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 9987 67899999999 999999997654 69999999999999999999999 8999999999999999887
Q ss_pred -cEEEEeecCceeccCCCc------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC--cchh
Q 035655 486 -NARLGDFGLARLFDHGKI------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD--HFIL 556 (670)
Q Consensus 486 -~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~--~~~~ 556 (670)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643221 1113457999999999999999999999999999999999999999642 1111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 557 VDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
......... ............ .......+.+++..||+.||.+||++++|++.|+...
T Consensus 270 ~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLL-DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH-HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhc-ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111 011000000000 0012356888999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=345.07 Aligned_cols=238 Identities=26% Similarity=0.453 Sum_probs=182.3
Q ss_pred CccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeec-cCeeEEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-KRDLLLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV 421 (670)
.|...+.||+|+||.||+|.... ..+.|.+|+.++++++||||++++++|.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999987521 24678999999999999999999998754 4678999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.... ..+++.+++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 468999999999999999999999 89999999999999999999999999999866443
Q ss_pred Ccc---eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCC
Q 035655 502 KIS---HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 502 ~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 576 (670)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ..+.. ...+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~~--~~~p- 318 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR--LLQP- 318 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTCC--CCCC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCCC--CCCC-
Confidence 211 2233467889999999999999999999999999999999 67777653221 11111 11111 0111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+.+++..||+.||.+||+++|+++.|+..
T Consensus 319 ------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 319 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11235678899999999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.32 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=179.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999997643 23578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCC----ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 424 YIPNGSLDSLLFDNE----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|++ |+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999986532 2358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc--CCc------
Q 035655 500 HGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL--GQV------ 569 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~--~~~------ 569 (670)
... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ........... ...
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 432 12234578999999999876 46899999999999999999999999864322 11111111000 000
Q ss_pred ccccCCCCC----Cc--------ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 570 LDVVDPNLG----SS--------YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 570 ~~~~d~~l~----~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+... .. ........+.+++..||+.||.+|||++|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 000000000 00 0011235688999999999999999999999853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.88 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=194.8
Q ss_pred hcCccccceEeeeCceeEEEeecc----c-----------------hHHHHHHHHHHHhccccCceeeeeeeeecc--Ce
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--RD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--~~ 417 (670)
.+.|+..+.||+|+||.||+++.. . ..+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 345888999999999999999731 1 236788999999999999999999999876 66
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 359999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---HhhcCCcccc
Q 035655 498 FDHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE---FQHLGQVLDV 572 (670)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~---~~~~~~~~~~ 572 (670)
...... .......||..|+|||.+.+..++.++|||||||+++||++|+.|+............. ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 765442 22334578889999999999899999999999999999999999865311000000000 0000000001
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+........+......+.+++..||+.||.+||+++|+++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111111222334668899999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.65 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=193.2
Q ss_pred hcCccccc-eEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSE-VIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~-~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|...+ .||+|+||.||+|.... ..+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 89999999999997421 346788999999999999999999999 5567999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++++|.+++... ...+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999654 3469999999999999999999999 8999999999999999999999999999987754
Q ss_pred CCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 501 GKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... .....+|+.|+|||++.+..++.++|||||||+++||++ |+.||........ . .....+. .+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~-~~i~~~~-----~~~- 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--M-AFIEQGK-----RME- 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--H-HHHHTTC-----CCC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--H-HHHhcCC-----cCC-
Confidence 33221 223457889999999988889999999999999999998 9999976432211 1 1111111 111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.+++..||+.||.+||++.+++++|+.
T Consensus 234 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 234 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 122233568889999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.43 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=197.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 4689999999999999999997421 235688999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCCc--------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNEN--------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+..++||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999976432 348999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||+++||++ |+.||....... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence 99999999999999876553322 2233467889999999998889999999999999999999 999997643221 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..... .+. .+.. +......+.+++..||+.||.+||+++|+++.|+..
T Consensus 269 ~~~~~-~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 269 FKLLK-EGH-----RMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHH-HTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHh-cCC-----CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 111 1111 112235678899999999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.22 Aligned_cols=238 Identities=30% Similarity=0.455 Sum_probs=192.8
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578899999999999999997532 235688999999999 899999999999999999999
Q ss_pred EeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 422 YDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
|||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2468999999999999999999999 899999999999999999999
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhc
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~ 566 (670)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||+++||++ |+.||...... ..... ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~-~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK-LPQ 256 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-GGG
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHHHH-hhc
Confidence 99999999743221 12233467889999999998889999999999999999998 99999764321 11111 111
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+ ..+.. +......+.+++.+||+.||.+||+++|++++|+.
T Consensus 257 ~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 257 G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp T-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 11111 11223567889999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.28 Aligned_cols=236 Identities=25% Similarity=0.329 Sum_probs=192.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999997643 346789999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceeccCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~~~~ 501 (670)
+++++|.+++... ..+++.+++.++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999998654 358999999999999999999998 899999999999999 88899999999999876543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. ......||+.|+|||.+.+ .++.++||||||++++||++|+.||........ ..... .+.. ......
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~-~~~~------~~~~~~ 230 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--MLKIR-EGTF------TFPEKD 230 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HCCC------CCCHHH
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-hCCC------CCCchh
Confidence 3 2334579999999998865 489999999999999999999999976432211 11111 1110 000000
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.......+.+++..||+.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123567889999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.46 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=187.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhcccc--CceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRH--KHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H--~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.+|++++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568999999999999999997643 23678899999999987 9999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|| +.+++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5688999999764 368999999999999999999999 8999999999999997 678999999999876543
Q ss_pred Ccc-eeeccccCcCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 502 KIS-HTTNVVGTIGYIAPELART-----------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------- 231 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--------- 231 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH---------
Confidence 322 2345689999999999865 6789999999999999999999999975322211111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+++.....++......+.+++..||+.||.+||++.|++++.+-
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 232 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp -HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 1111111112222223567889999999999999999999998653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.78 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=200.0
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeee
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNL 408 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l 408 (670)
+...+.....++|+..+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3344444557889999999999999999996311 235688999999999 78999999
Q ss_pred eeeeeccC-eeEEEEeccCCCCchhhcccCCc--------------cccCHHHHHHHHHHHHHHhhhccccccceEEecc
Q 035655 409 QGWCKRKR-DLLLVYDYIPNGSLDSLLFDNEN--------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRD 473 (670)
Q Consensus 409 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD 473 (670)
+++|...+ ..++|+||+++|+|.+++..... ..+++..++.++.|++.||.|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987754 58999999999999999976542 228999999999999999999999 8999999
Q ss_pred cCCCcEEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 035655 474 VKSGNVLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDS 551 (670)
Q Consensus 474 Ikp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~ 551 (670)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+++||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986654332 22344578899999999999999999999999999999998 9999976
Q ss_pred CcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 552 DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...... .......+.. ...... ....+.+++..||+.||.+||++.|++++|+.
T Consensus 254 ~~~~~~--~~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDEE--FCRRLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCCSHH--HHHHHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHH--HHHHhccCcc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 332111 1111111111 111111 23457889999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.14 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=184.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD---- 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~---- 417 (670)
.++|+..+.||+|+||.||++.... ....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4679999999999999999998532 12468899999999999999999999876543
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 49999999999999999654 358999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 498 FDHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+ ..........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~---- 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVREDPIPP---- 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHCCCCCH----
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCCCCCc----
Confidence 654322 22334579999999999999999999999999999999999999998654322211 1111111000
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..........+.+++..||+.||.+||+..+++++-
T Consensus 240 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 275 (311)
T 3ork_A 240 ---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275 (311)
T ss_dssp ---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence 000111235678899999999999999877776643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.92 Aligned_cols=239 Identities=26% Similarity=0.445 Sum_probs=189.1
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeee-ccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCK-RKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~-~~~~~~l 420 (670)
.+|+..++||+|+||.||+|.... ..+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999997432 2356889999999999999999999865 4567899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 468999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCc---ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 501 GKI---SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 501 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
... .......+|+.|+|||.+.+..++.++|||||||+++||++ |..||........ ...... +. ....+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~~~-~~--~~~~~- 254 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQ-GR--RLLQP- 254 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHHHT-TC--CCCCC-
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhc-CC--CCCCC-
Confidence 321 12234567889999999999999999999999999999999 5556654222111 111111 11 00111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.+++..||+.||.+||+++|+++.|+.
T Consensus 255 ------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 255 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1122467889999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=325.22 Aligned_cols=237 Identities=26% Similarity=0.361 Sum_probs=187.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|...++||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3578899999999999999987532 24678999999999999999999999999999999999
Q ss_pred ccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceec
Q 035655 424 YIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLF 498 (670)
Q Consensus 424 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~ 498 (670)
|+++|+|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653 23569999999999999999999998 899999999999999 45678999999999865
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......||+.|+|||.+. +.++.++|||||||+++||++|+.||.......... .............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~---- 248 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ--KATYKEPNYAVEC---- 248 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCCCCCCC------
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh--hhccCCccccccc----
Confidence 4432 234457999999999875 568999999999999999999999998644222111 1111111000000
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. ....+.+++..||+.||.+||+++|++++
T Consensus 249 ~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 249 RP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred Cc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 12457789999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.85 Aligned_cols=248 Identities=26% Similarity=0.276 Sum_probs=189.1
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|+..++||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578999999999999999997643 13567899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988654 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHH-----------hhcCCc-
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEF-----------QHLGQV- 569 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~-----------~~~~~~- 569 (670)
.......||+.|+|||++.+ ..++.++|||||||+++||++|+.||........ ...... ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 22334578999999999876 5689999999999999999999999976432211 111110 000000
Q ss_pred --ccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 --LDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 --~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....++...... .......+.+++..||+.||.+|||++|+++|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 011111110000 0122356788999999999999999999998743
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.95 Aligned_cols=237 Identities=29% Similarity=0.390 Sum_probs=188.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeecc-CeeEEEEeccCC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-RDLLLVYDYIPN 427 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-~~~~lV~E~~~~ 427 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+. +..++|+||+++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 4678999999999999999997643 356789999999999999999999997654 578999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...... ..
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~ 172 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 172 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc----cc
Confidence 999999976554458999999999999999999999 89999999999999999999999999999755432 22
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...+++.|+|||.+.+..++.++||||||++++||++ |+.||....... ..... ..+ ..+. .+....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~-~~~-----~~~~----~~~~~~ 240 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV-EKG-----YKMD----APDGCP 240 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH-TTT-----CCCC----CCTTCC
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-hcC-----CCCC----CcccCC
Confidence 3367889999999999999999999999999999998 999997643211 11111 111 1111 112233
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++..||+.||.+||++.|+++.|+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 567889999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.42 Aligned_cols=236 Identities=23% Similarity=0.350 Sum_probs=193.0
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCee
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~ 418 (670)
...++|...+.||+|+||.||+++... ..+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 346789999999999999999998643 124567899999887 899999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999654 358999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ... .+.+.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i-~~~------~~~~p 238 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSI-RMD------NPFYP 238 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHC------CCCCC
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HHHH-HhC------CCCCC
Confidence 3322 224456899999999999999999999999999999999999999986432211 1111 111 11111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMR-QVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~ 613 (670)
. .....+.+++..||+.||.+||++. ++++|
T Consensus 239 ~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 239 R----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp T----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred c----ccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1 1235677899999999999999998 77754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.61 Aligned_cols=238 Identities=23% Similarity=0.354 Sum_probs=195.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4578999999999999999997642 145789999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----cEEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----NARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kL~DFGl 494 (670)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999654 368999999999999999999999 8999999999999999888 799999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
++...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... +....... . .
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~-~------~ 234 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITS-V------S 234 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT-T------C
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh-c------c
Confidence 98765432 223457999999999999999999999999999999999999999764321 11111111 0 0
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..............+.+++..||+.||.+||+++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0111111112235678899999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=334.89 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=192.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3578999999999999999997643 124577899999988 89999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999654 358999999999999999999999 8999999999999999999999999999985432
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc------hhHHHHHHHhhcCCcccccC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF------ILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~------~~~~~~~~~~~~~~~~~~~d 574 (670)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 22 234456899999999999999999999999999999999999999964211 11111111111111
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCH------HHHHHHh
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTM------RQVLRYL 614 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 614 (670)
..+ +......+.+++..||+.||.+||++ +|+++|-
T Consensus 236 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 236 IRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred CCC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 111 11223567789999999999999995 7888764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=335.03 Aligned_cols=235 Identities=22% Similarity=0.267 Sum_probs=193.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||+||++.... ..+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4689999999999999999997643 234577899999988 79999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999654 358999999999999999999999 8999999999999999999999999999985432
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ... ..+
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~-~~~------~~~--- 240 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIM-EHN------VAY--- 240 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HCC------CCC---
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHHHHH-hCC------CCC---
Confidence 22 23345689999999999999999999999999999999999999998643221 111111 111 111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHHh
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRYL 614 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 614 (670)
+......+.+++..||+.||.+||+ ++++++|-
T Consensus 241 -p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 241 -PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 1122356788999999999999995 68888764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.91 Aligned_cols=239 Identities=19% Similarity=0.229 Sum_probs=183.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 4679999999999999999998643 2367889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc--EEEEeecCceeccCCCc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN--ARLGDFGLARLFDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kL~DFGla~~~~~~~~ 503 (670)
++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 999999999654 359999999999999999999998 89999999999999988776 9999999997443222
Q ss_pred ceeeccccCcCCCCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCS-TDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..... ........... ... .. .
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~~~------~~--~ 242 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-VKY------SI--P 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-TCC------CC--C
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-CCC------CC--C
Confidence 2334579999999999988887665 8999999999999999999976321 11111111111 110 00 0
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........+.+++.+||+.||.+|||+.|+++|-+
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 00112256788999999999999999999999744
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.18 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=186.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
-++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4679999999999999999997542 125688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999654 358999999999999999999999 89999999999999999999999999999876554
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.........||+.|+|||.+.+..++.++||||||++++||++|+.||.......... .............
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~------- 258 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA--HINQAIPRPSTVR------- 258 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH--HHHSCCCCGGGTS-------
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH--HhccCCCCccccC-------
Confidence 4333445679999999999999999999999999999999999999998654321111 1111111111111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHhcCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-TMRQVLRYLNGD 617 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 617 (670)
......+.+++..||+.||.+|| +++++++.|+..
T Consensus 259 -~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 259 -PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp -TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred -CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 12234577899999999999999 999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.35 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=198.1
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhc--cccCceeeeeeeeeccC----eeEE
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGR--LRHKHLVNLQGWCKRKR----DLLL 420 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~--l~H~nIv~l~g~~~~~~----~~~l 420 (670)
....++|...+.||+|+||.||+|.... ..+.+.+|++++.. ++||||+++++++.... ..++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 3456789999999999999999997643 34677889999887 78999999999998775 7899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-----cceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-----EQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
||||+++|+|.+++.+. .+++.+++.++.|++.||.|||... +.+|+||||||+|||++.++.+||+|||++
T Consensus 118 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999999999643 5899999999999999999999210 189999999999999999999999999999
Q ss_pred eeccCCCcc---eeeccccCcCCCCccccccCC------CCccchhHHHHHHHHHHHhC----------CCCCCCCcc--
Q 035655 496 RLFDHGKIS---HTTNVVGTIGYIAPELARTGK------ASCSTDVFAYGVLLLEIATG----------RRPIDSDHF-- 554 (670)
Q Consensus 496 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~el~tG----------~~pf~~~~~-- 554 (670)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||++| +.||.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 877654422 223457999999999987652 34689999999999999999 778865211
Q ss_pred -hhHHHHHHHhhcCCcccccCCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 555 -ILVDWVLEFQHLGQVLDVVDPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 555 -~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+. ..... ....+.+...+ .......+.+++.+||+.||.+||+++|++++|+.
T Consensus 275 ~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 275 PSVEEMR-KVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCHHHHH-HHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccHHHHH-HHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111111 11111 11223322222 23567789999999999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.26 Aligned_cols=243 Identities=18% Similarity=0.271 Sum_probs=193.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeee-eccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWC-KRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~E~~ 425 (670)
.++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++|++++..++++ .+.+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 5789999999999999999998532 235789999999999998877766665 5667789999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceeccCCC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~~~~~ 502 (670)
+++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999999997543 369999999999999999999999 899999999999999 588999999999998766543
Q ss_pred cc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc----hhHHHHHHHhhcCCcccc
Q 035655 503 IS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF----ILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 503 ~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 572 (670)
.. ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .............. ...
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hHH
Confidence 21 12445899999999999999999999999999999999999999975221 11111111111100 011
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..+ .....+.+++..||+.||.+||+++++++.|+..
T Consensus 242 ~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 242 LCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HTT--------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHh--------hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 111 1125678899999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.70 Aligned_cols=236 Identities=24% Similarity=0.401 Sum_probs=173.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3578999999999999999997532 125688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999997643 468999999999999999999999 89999999999999999999999999999876533
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.. ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ . . .. ...+...
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~-----~~-~~~~~~~---- 231 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L-N-----KV-VLADYEM---- 231 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C-CSSCCCC----
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H-H-----HH-hhcccCC----
Confidence 21 22345789999999999988899999999999999999999999976332100 0 0 00 0001111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+......+.+++.+||+.||.+||++++++++-
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 112235677899999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.85 Aligned_cols=237 Identities=21% Similarity=0.235 Sum_probs=172.8
Q ss_pred cceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCCCCchh
Q 035655 367 SEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDS 432 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 432 (670)
.+.||+|+||.||++.... ....+.+|+.++++++ ||||+++++++.+....++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 4789999999999998753 3467889999999997 9999999999999999999999999999999
Q ss_pred hcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEEeecCceeccCCCcceeecc
Q 035655 433 LLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDFGLARLFDHGKISHTTNV 509 (670)
Q Consensus 433 ~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DFGla~~~~~~~~~~~~~~ 509 (670)
++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 96 ~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 169 (325)
T 3kn6_A 96 RIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTP 169 (325)
T ss_dssp HHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccccc
Confidence 99765 469999999999999999999998 8999999999999997765 89999999998665432 223445
Q ss_pred ccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh----HHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL----VDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 510 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.||+.|+|||++.+..++.++|||||||+++||++|+.||....... ..........+. ...........
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~~~~~~ 243 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGEAWKNV 243 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSHHHHTS
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcccccCC
Confidence 78999999999999999999999999999999999999997632210 011111111111 11112222233
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++..||+.||.+||+++|++++-+
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 567889999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.45 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=190.0
Q ss_pred CccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee-EEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL-LLV 421 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~-~lV 421 (670)
.|...++||+|+||.||+|.... ..+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999997421 236788999999999999999999999876655 999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 468999999999999999999999 89999999999999999999999999999865432
Q ss_pred C---cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC-CCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 502 K---ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID-SDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 502 ~---~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~-~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
. ........+|+.|+|||.+.+..++.++|||||||+++||++|..|+. ....... ... ...... ..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~~~-~~~~~~-----~~- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--THF-LAQGRR-----LP- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--HHH-HHTTCC-----CC-
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--HHH-hhcCCC-----CC-
Confidence 2 122234578899999999999999999999999999999999666543 3222111 111 111110 11
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.+......+.+++..||+.||.+|||++++++.|+..
T Consensus 249 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 ---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111235678899999999999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.00 Aligned_cols=244 Identities=18% Similarity=0.270 Sum_probs=191.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeee-eccCeeEEEEec
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWC-KRKRDLLLVYDY 424 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~-~~~~~~~lV~E~ 424 (670)
..++|+..+.||+|+||.||+|.... ..+.+.+|++++++++|++++..++++ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 45789999999999999999998533 234688999999999998877777766 566788999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceeccCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~~~~ 501 (670)
+ +++|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 87 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9 999999997543 369999999999999999999999 899999999999999 78999999999999877554
Q ss_pred Cc------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc----hhHHHHHHHhhcCCccc
Q 035655 502 KI------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF----ILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 502 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~----~~~~~~~~~~~~~~~~~ 571 (670)
.. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .............. ..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-hh
Confidence 32 122345899999999999999999999999999999999999999975221 11111111111000 01
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...+ .....+.+++..||+.||.+||+++++++.|+..
T Consensus 241 ~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 241 VLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHTT--------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhc--------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 1111 1135678899999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.69 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=197.8
Q ss_pred cchhhHHHhhcCcccc-ceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccc-cCceeeeeee
Q 035655 352 FRYSDLYTATKGFKQS-EVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLR-HKHLVNLQGW 411 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~-~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~ 411 (670)
..++......+.|... +.||+|+||.||+|.... ....+.+|+.++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3445555556677776 889999999999997643 2467889999999995 6999999999
Q ss_pred eeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEE
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNAR 488 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~k 488 (670)
+.+.+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999999977656679999999999999999999999 89999999999999998 78999
Q ss_pred EEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC
Q 035655 489 LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 489 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||......... .......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~- 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY--LNISQVN- 249 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHTC-
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HHHHhcc-
Confidence 99999998765432 223457999999999999999999999999999999999999999764322111 1111100
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..............+.+++..||+.||.+||+++|++++-.
T Consensus 250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 250 ------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred ------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 01111111223356788999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.29 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=190.1
Q ss_pred hhhHHHhhcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeee
Q 035655 354 YSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWC 412 (670)
Q Consensus 354 ~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~ 412 (670)
+.++....++|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34444556789999999999999999986532 235688999999999999999999999
Q ss_pred eccC-----eeEEEEeccCCCCchhhccc----CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC
Q 035655 413 KRKR-----DLLLVYDYIPNGSLDSLLFD----NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483 (670)
Q Consensus 413 ~~~~-----~~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~ 483 (670)
.+.+ ..++|+||+++|+|.+++.. .....+++.+++.++.||++||.|||+ .+|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence 8754 35999999999999999843 233569999999999999999999999 89999999999999999
Q ss_pred CCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHH
Q 035655 484 DMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVL 561 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~ 561 (670)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+++||++ |+.||........ ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~ 260 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD 260 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH
Confidence 99999999999986644322 22234467889999999999999999999999999999999 8999976432211 11
Q ss_pred HHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 562 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.. ..+. .+ ..+......+.+++..||+.||.+||++.+++++|+..
T Consensus 261 ~~-~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 261 YL-LHGH-----RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HH-HTTC-----CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HcCC-----CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1111 01 11122335678899999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.29 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=194.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4678999999999999999997642 23678899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999654 458999999999999999999998 8999999999999999999999999999986643321
Q ss_pred -ceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 -SHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
.......||+.|+|||.+.+..+ +.++||||||++++||++|+.||.........+... ...... . ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~------~~ 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTY---L------NP 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-HTTCTT---S------TT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-hhcccc---c------Cc
Confidence 22334578999999999987665 779999999999999999999997643221111111 110000 0 01
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+++..||+.||.+||+++|++++-.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 1122356778999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=335.20 Aligned_cols=235 Identities=29% Similarity=0.412 Sum_probs=190.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.+.|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||++++++|...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3458889999999999999997532 125688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||++ |+|.+++.... ..+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 68888875433 469999999999999999999999 8999999999999999999999999999976543
Q ss_pred CcceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KISHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.....||+.|+|||++. .+.++.++|||||||+++||++|+.||...... .......... .+.+.
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~~------~~~~~ 274 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNE------SPALQ 274 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC------CCCCC
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcC------CCCCC
Confidence 23457999999999884 567899999999999999999999999764321 1111111111 11111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
. ....+.+.+++..||+.||.+||++++++++..-
T Consensus 275 ~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 275 S---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred C---CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 1 1122457789999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.35 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=196.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeec--------------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-------------- 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------------- 414 (670)
.++|+..+.||+|+||.||++.... ....+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 4578999999999999999998753 23568899999999999999999998854
Q ss_pred --cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 415 --KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 415 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcc
Confidence 4558999999999999999977655679999999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
|++....... ......||+.|+|||++.+..++.++||||||++++||++|..|+... ...... ....
T Consensus 167 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~-~~~~----- 234 (284)
T 2a19_B 167 GLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SKFFTD-LRDG----- 234 (284)
T ss_dssp TTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHHHH-HHTT-----
T ss_pred hhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHHHH-hhcc-----
Confidence 9998765432 223457999999999999999999999999999999999999886421 111111 1111
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCCC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLP 621 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 621 (670)
.+...++ ..+.+++..||+.||.+||++.|++++|+....-+
T Consensus 235 ---~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 ---IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1111222 44678899999999999999999999998654433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=337.18 Aligned_cols=244 Identities=24% Similarity=0.322 Sum_probs=194.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccch------------HHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccC
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~------------~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
..++|+..+.||+|+||.||++..... ...+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 356799999999999999999987542 23456899999988 79999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC----CcEEEEeecCceeccCCC
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD----MNARLGDFGLARLFDHGK 502 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~----~~~kL~DFGla~~~~~~~ 502 (670)
+|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||+..+ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999654 358999999999999999999999 899999999999998443 359999999998765433
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.................+.. .+...+.
T Consensus 175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~------~~~~~~~ 247 (342)
T 2qr7_A 175 -GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF------SLSGGYW 247 (342)
T ss_dssp -CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC------CCCSTTT
T ss_pred -CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc------ccCcccc
Confidence 223445799999999999888889999999999999999999999975322111111111111111 1111122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+.+++..||+.||.+||++.|+++|-+
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 223456788999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=342.22 Aligned_cols=248 Identities=18% Similarity=0.189 Sum_probs=196.4
Q ss_pred hcCccccceEeeeCceeEEEeeccch-------------------HHHHHHHHHHHhccccCceee--------------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAAEIESLGRLRHKHLVN-------------- 407 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~Ei~~L~~l~H~nIv~-------------- 407 (670)
.++|...+.||+|+||.||+|..... .+.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 36799999999999999999987531 245889999999999999998
Q ss_pred -eeeeeec-cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 408 -LQGWCKR-KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 408 -l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
+++++.. ....++||||+ +++|.+++.......+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETTE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCCC
Confidence 5667665 67899999999 9999999987655679999999999999999999999 8999999999999999998
Q ss_pred --cEEEEeecCceeccCCCcc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch--
Q 035655 486 --NARLGDFGLARLFDHGKIS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-- 555 (670)
Q Consensus 486 --~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-- 555 (670)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 276 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE 276 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence 9999999999866432211 123458999999999999999999999999999999999999999763211
Q ss_pred -hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 556 -LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 556 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......... .......++... .......+.+++..||+.||.+||+++++++.|+..
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 277 DIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 111111111 111111111111 011235678899999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.39 Aligned_cols=238 Identities=25% Similarity=0.368 Sum_probs=192.8
Q ss_pred hcCccccc-eEeeeCceeEEEeecc--c------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSE-VIGTGGFGEVYKGVLP--T------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~-~lG~G~fg~Vykg~~~--~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
.++|...+ .||+|+||.||+|.+. . ..+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999431 1 246788999999999999999999999 567789
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+|+||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999764 358999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 500 HGKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 500 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
...... .....+|+.|+|||.+.+..++.++||||||++++||++ |+.||........ ......+. .+.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~-----~~~ 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGE-----RMG 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTC-----CCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCC-----CCC
Confidence 543222 222356789999999998889999999999999999999 9999986433211 11111111 111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.+++..||+.||.+||++.++++.|+.
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112233568889999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=331.46 Aligned_cols=236 Identities=23% Similarity=0.301 Sum_probs=185.7
Q ss_pred hcCccccceEeeeCceeEEEeecc----c-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
.++|+..+.||+|+||.||+++.. . ....+.+|+.+|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999998752 1 12346789999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999654 358999999999999999999999 8999999999999999999999999999975
Q ss_pred ccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .. ..+
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~-~~------~~~ 240 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TIDKILK-CK------LNL 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-TC------CCC
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHh-CC------CCC
Confidence 43322 22344579999999999999899999999999999999999999998643221 1111111 11 111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHhc
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYLN 615 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 615 (670)
+......+.+++..||+.||.+|| ++.|+++|-.
T Consensus 241 ----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 241 ----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 112235678899999999999999 8889998644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=330.82 Aligned_cols=247 Identities=22% Similarity=0.217 Sum_probs=191.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeee----ccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCK----RKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~----~~~~~~l 420 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4679999999999999999997532 3467889999999999999999999987 3457899
Q ss_pred EEeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 421 VYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
|+||+++|+|.+++... ....+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999752 33569999999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCcc--------eeeccccCcCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcC
Q 035655 499 DHGKIS--------HTTNVVGTIGYIAPELARTGK---ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 499 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
...... ......||+.|+|||++.+.. ++.++|||||||+++||++|+.||............. ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQN- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-HHC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-hhc-
Confidence 321110 012346799999999987554 6889999999999999999999985310000000000 000
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCCC
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELL 620 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 620 (670)
.. .. .........+.+++..||+.||.+||++++++++|+...+.
T Consensus 263 ~~----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 263 QL----SI----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp C------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cC----CC----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 00 01112235678899999999999999999999999877543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=361.74 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=188.8
Q ss_pred cCccccc-eEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSE-VIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~-~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
+++...+ .||+|+||.||+|.+.. ..++|.+|+++|++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444445 79999999999986531 35789999999999999999999999976 569999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999754 3469999999999999999999999 89999999999999999999999999999876443
Q ss_pred Ccce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ......+..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~~~~--------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGKR--------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHHTTCC---------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCC---------
Confidence 2211 122346789999999999999999999999999999998 9999986432211 111111111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...+......+.+++..||+.||.+||++++|++.|+.
T Consensus 558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11222334678889999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.64 Aligned_cols=237 Identities=22% Similarity=0.258 Sum_probs=186.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..++||+|+||.||++.... ....+.+|+.++++++||||++++++|...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3578999999999999999987543 124567899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999999654 368999999999999999999996 268999999999999999999999999999854332
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. .......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ..... ... ..+
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~-~~~------~~~---- 368 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELIL-MEE------IRF---- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HCC------CCC----
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHH-hCC------CCC----
Confidence 2 233456899999999999999999999999999999999999999976432211 11111 111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 615 (670)
+......+.+++..||+.||.+|| +++|+++|-.
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 111235678899999999999999 9999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.85 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=185.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3578999999999999999997532 235688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 422 YDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998642 23468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... .......|++.|+|||++.+..++.++||||||++++||++|+.||................ ... +...
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-----~~~~- 259 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDY-----PPLP- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCS-----CCCC-
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccC-----CCCc-
Confidence 432 22234578999999999999999999999999999999999999997644332222222211 111 1111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
.......+.+++..||+.||.+||+++++++.|+..
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011235678899999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.05 Aligned_cols=237 Identities=21% Similarity=0.343 Sum_probs=186.2
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc--cCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR--HKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||++.... ..+.+.+|+.+|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999997543 2367889999999997 599999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999997653 68999999999999999999999 8999999999999995 5899999999998765433
Q ss_pred cc-eeeccccCcCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcc
Q 035655 503 IS-HTTNVVGTIGYIAPELART-----------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVL 570 (670)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~ 570 (670)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~~-------- 279 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHA-------- 279 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHH--------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-HHH--------
Confidence 22 2345679999999999865 46899999999999999999999999753221111 111
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+++.....++......+.+++..||+.||.+||++.|++++.+
T Consensus 280 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 280 -IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp -HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 11111111111112356788999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=337.02 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=193.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3578999999999999999997652 23578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
|+++++|.+++.... .+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999996543 58999999999999999999998 5 8999999999999999999999999999755332
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC--------------
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ-------------- 568 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~-------------- 568 (670)
......||+.|+|||++.+..++.++|||||||+++||++|+.||.................+.
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234579999999999999999999999999999999999999997643322211111000000
Q ss_pred --------------------cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 --------------------VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 --------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......+... .......+.+++..||+.||.+|||++|+++|-.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCC---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCC---cccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000001110 0112346788999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.61 Aligned_cols=236 Identities=22% Similarity=0.363 Sum_probs=191.4
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 568899999999999999997642 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----cEEEEeecCc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----NARLGDFGLA 495 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kL~DFGla 495 (670)
+||||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999653 368999999999999999999998 8999999999999998877 8999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
....... ......||+.|+|||++.+..++.++||||||++++||++|+.||....... ...... .. ..
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-~~------~~ 228 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNIS-AV------NY 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH-TT------CC
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHhH-hc------cc
Confidence 8765432 2234578999999999999999999999999999999999999997643211 111111 00 01
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.............+.+++.+||+.||.+||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11111112224567899999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.12 Aligned_cols=239 Identities=25% Similarity=0.325 Sum_probs=197.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||++.... ....+.+|+++|++++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999997643 234577999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987665669999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+....... ...+
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------~~~~--- 408 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------PEEY--- 408 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------CCCC---
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------cccC---
Confidence 3 234458999999999999989999999999999999999999999864221 111111111111 1111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHh
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYL 614 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 614 (670)
+......+.+++..||+.||.+|| +++|+++|-
T Consensus 409 -p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 409 -SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred -CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 122235678899999999999999 789999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.36 Aligned_cols=234 Identities=28% Similarity=0.412 Sum_probs=187.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec----cCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----KRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~ 419 (670)
+.|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 347788899999999999997643 23568899999999999999999998865 35689
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEec-CCCcEEEEeecCce
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLID-ADMNARLGDFGLAR 496 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld-~~~~~kL~DFGla~ 496 (670)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+ ++||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999654 358999999999999999999998 67 99999999999998 78999999999997
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
..... ......||+.|+|||++. +.++.++|||||||+++||++|+.||........ ...... .+...
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~-~~~~~------ 248 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVT-SGVKP------ 248 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHT-TTCCC------
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-HHHHHh-ccCCc------
Confidence 54432 233457999999999876 4689999999999999999999999976332211 111111 11111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+......+.+++..||+.||.+||+++|++++-
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 111122234678899999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.21 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=185.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------hHHHHHHHHHH--HhccccCceeeeeeeee-----ccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIES--LGRLRHKHLVNLQGWCK-----RKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~--L~~l~H~nIv~l~g~~~-----~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ....+..|.++ +..++||||+++++++. .....++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 4679999999999999999997643 23455555555 45589999999998553 234679999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc------cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW------EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
||+++|+|.+++... ..++..++.++.||+.||.|||+.+ +++|+||||||+|||++.++.+||+|||+++
T Consensus 92 e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp CCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 999999999999654 3589999999999999999999821 1199999999999999999999999999998
Q ss_pred eccCCCc-------ceeeccccCcCCCCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCCCcch---hH--
Q 035655 497 LFDHGKI-------SHTTNVVGTIGYIAPELART-------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI---LV-- 557 (670)
Q Consensus 497 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~---~~-- 557 (670)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...... ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7654321 12234579999999999876 35667999999999999999998776431110 00
Q ss_pred ----------HHHHHHhhcCCcccccCCCCCC--cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 558 ----------DWVLEFQHLGQVLDVVDPNLGS--SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 558 ----------~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........... ..+.+.. .........+.+++.+||+.||.+|||++|+++.|+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 00000111111 1111111 11234566789999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.20 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=192.9
Q ss_pred CccchhhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc-ccCceeeeeeeee
Q 035655 350 HRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL-RHKHLVNLQGWCK 413 (670)
Q Consensus 350 ~~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~ 413 (670)
..+++.++....++|+..+.||+|+||.||+|.... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 345666667778899999999999999999998632 346789999999999 7999999999997
Q ss_pred c------cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 414 R------KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 414 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
. .+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 6 4678999999999999999987655679999999999999999999999 899999999999999999999
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLE 562 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~ 562 (670)
||+|||++....... .......||+.|+|||++. +..++.++|||||||+++||++|+.||.........+ .
T Consensus 169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~ 245 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--L 245 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H
T ss_pred EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--H
Confidence 999999998654322 1223457999999999986 5678999999999999999999999997643221111 1
Q ss_pred HhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 563 FQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 563 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
... .. .+.+.. ......+.+++..||+.||.+||+++|++++-
T Consensus 246 ~~~-~~-----~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 246 IPR-NP-----APRLKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHH-SC-----CCCCSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred hhc-Cc-----cccCCc---cccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 111 11 111111 11124677899999999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.81 Aligned_cols=235 Identities=24% Similarity=0.401 Sum_probs=194.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678899999999999999997643 235678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999988654 368999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. .......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ...... ... ..+...
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-~~~------~~~~~~- 237 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIK-KNE------YSIPKH- 237 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH-TTC------CCCCTT-
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh-hcc------CCCccc-
Confidence 2 22334579999999999998889999999999999999999999998643221 111111 111 111111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
....+.+++.+||+.||.+||+++|++++-
T Consensus 238 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 238 ---INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 224577899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.46 Aligned_cols=232 Identities=22% Similarity=0.342 Sum_probs=193.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 578999999999999999997643 1356889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999996543 58999999999999999999998 899999999999999999999999999997654322
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....|++.|+|||++.+..++.++||||||++++||++|+.||........ ..... .. +..+.
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-~~------~~~~~---- 232 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--HRRIV-NV------DLKFP---- 232 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHH-TT------CCCCC----
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--HHHHh-cc------ccCCC----
Confidence 2345789999999999999999999999999999999999999976432211 11111 11 11111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
......+.+++..||+.||.+||+++|++++-
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 12235677899999999999999999999854
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.02 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=182.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccch------------------------HHHHHHHHHHHhccccCceeeeeeeeecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR------------------------MREFAAEIESLGRLRHKHLVNLQGWCKRK 415 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~------------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~ 415 (670)
..++|...+.||+|+||.||+|..... ...+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999976431 1247899999999999999999999854
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cEEEEee
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NARLGDF 492 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kL~DF 492 (670)
+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 5589999999999999998654 469999999999999999999998 8999999999999997544 5999999
Q ss_pred cCceeccCCCcceeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcC
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLG 567 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~ 567 (670)
|+++..... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||..... .+.... ..+
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----~~~ 360 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSG 360 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----HTT
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----hcC
Confidence 999876543 23345689999999999853 5778899999999999999999999975321 111111 111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. .............+.+++..||+.||.+||+++|+++|-+
T Consensus 361 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 361 KY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp CC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 10 0001111123466889999999999999999999999643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=321.30 Aligned_cols=236 Identities=28% Similarity=0.439 Sum_probs=196.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.+.|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4568999999999999999997532 34678999999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999854 368999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
.......||+.|+|||++.+..++.++||||||++++||++|+.||.......... ... .. ..+.+...+
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~-~~-----~~~~~~~~~-- 243 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIP-KN-----NPPTLEGNY-- 243 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH-HS-----CCCCCCSSC--
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH--Hhh-cC-----CCCCCcccc--
Confidence 22344578999999999999999999999999999999999999997643221111 111 11 112222222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+.+++..||+.||.+||++.|++++..
T Consensus 244 --~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 244 --SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 245788999999999999999999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.09 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=192.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|...+.||+|+||.||+|.... ...++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4679999999999999999998321 245788999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCc-----cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEE
Q 035655 419 LLVYDYIPNGSLDSLLFDNEN-----FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLG 490 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~ 490 (670)
++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 358999999999999999999999 89999999999999984 4469999
Q ss_pred eecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCC
Q 035655 491 DFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 491 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
|||+++....... .......||+.|+|||++.+..++.++|||||||+++||++ |+.||....... .. .....+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~-~~~~~~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL-EFVTSGG 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH-HHHHTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HH-HHHhcCC
Confidence 9999976543322 22334578999999999999999999999999999999998 999997643221 11 1111111
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
. +.. +......+.+++..||+.||.+||++.+++++|+..
T Consensus 263 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 R-----MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 111 112235678899999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.54 Aligned_cols=233 Identities=26% Similarity=0.422 Sum_probs=193.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|...+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 578999999999999999997642 1246789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.++ ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999654 459999999999999999999998 899999999999999999999999999998765433
Q ss_pred cceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||++.+..+ +.++|||||||+++||++|+.||........ .... ..+.. ....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~~i-~~~~~------~~p~-- 237 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FKKI-CDGIF------YTPQ-- 237 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HHHH-HTTCC------CCCT--
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HHHH-hcCCc------CCCc--
Confidence 2344579999999999988765 6899999999999999999999986432211 1111 11110 0111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+.+++..||+.||.+|||++|+++|-
T Consensus 238 --~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 238 --YLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp --TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --cCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 1124577899999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.34 Aligned_cols=235 Identities=24% Similarity=0.415 Sum_probs=194.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4578889999999999999997643 235688999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++++|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998654 368999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. .......||+.|+|||++.+..++.++|||||||+++||++|+.||...... +....... .. ..+...+
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~------~~~~~~~ 264 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKK-NE------YSIPKHI 264 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-TC------CCCCTTS
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhc-CC------CCCCccC
Confidence 2 2234457999999999999888999999999999999999999999864321 11111111 11 1111112
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+.+++.+||+.||.+||+++|++++-
T Consensus 265 ----~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 265 ----NPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 24577899999999999999999999853
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.53 Aligned_cols=242 Identities=14% Similarity=0.107 Sum_probs=195.2
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeecc------------------chHHHHHHHHHHHhccc---cCceeeeeeeee
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLP------------------TRMREFAAEIESLGRLR---HKHLVNLQGWCK 413 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~------------------~~~~~f~~Ei~~L~~l~---H~nIv~l~g~~~ 413 (670)
.++....++|...++||+|+||.||+|+.. ....++..|++++++++ |+||+++++++.
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 344455678999999999999999999421 13467888888888887 999999999999
Q ss_pred ccCeeEEEEeccCCCCchhhcccC---CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-------
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDN---ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA------- 483 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~------- 483 (670)
..+..++||||+++|+|.+++... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999642 23569999999999999999999999 89999999999999998
Q ss_pred ----CCcEEEEeecCceeccCC-CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 035655 484 ----DMNARLGDFGLARLFDHG-KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD 558 (670)
Q Consensus 484 ----~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~ 558 (670)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 899999999999865432 223445568999999999999999999999999999999999999998642110
Q ss_pred HHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCC-CCHHHHHHHhcC
Q 035655 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEAR-PTMRQVLRYLNG 616 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~ 616 (670)
.......+..... .+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 292 -----------~~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 -----------ECKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -----------EEEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -----------ceeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0001111111111 3456678888999999999 678888777764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.20 Aligned_cols=231 Identities=21% Similarity=0.338 Sum_probs=187.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+|.... ...++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4679999999999999999997642 345788999999999 999999999999999999999
Q ss_pred EeccCCCCchhhcccCCc--cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---------------
Q 035655 422 YDYIPNGSLDSLLFDNEN--FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD--------------- 484 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~--------------- 484 (670)
|||+++++|.+++..... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976432 468999999999999999999999 899999999999999844
Q ss_pred ----CcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH
Q 035655 485 ----MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW 559 (670)
Q Consensus 485 ----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~ 559 (670)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||+++||++|+.++..... +
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----H
Confidence 479999999998765432 23589999999998766 566899999999999999999887654321 1
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+.. +.+... ....+.+++..||+.||.+||++.|++++-
T Consensus 238 --~~~~~~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 238 --HEIRQGRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp --HHHHTTCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred --HHHHcCCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 11111111 112122 235678899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=320.17 Aligned_cols=238 Identities=21% Similarity=0.319 Sum_probs=189.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeee--eccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWC--KRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~--~~~~~~ 418 (670)
.++|...+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999997643 235688999999999999999999998 455689
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||++++ |.+++.......+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777776556679999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCC-cceeeccccCcCCCCccccccCCC--CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 499 DHGK-ISHTTNVVGTIGYIAPELARTGKA--SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 499 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~--t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
.... ........||+.|+|||++.+... +.++|||||||+++||++|+.||...... ....... .+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~-~~~------~ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIG-KGS------Y 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH-HCC------C
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHh-cCC------C
Confidence 5432 222344579999999999876543 78999999999999999999999864322 1111111 111 1
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+... ....+.+++.+||+.||.+||+++|++++-.
T Consensus 231 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 231 AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11112 2346778999999999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.03 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=198.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC--eeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR--DLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~~lV 421 (670)
.++|...++||+|+||.||+|.+.. ..+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578999999999999999998653 2366789999999999999999999998655 78999
Q ss_pred EeccCCCCchhhcccCCc-cccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe----cCCCcEEEEeecCce
Q 035655 422 YDYIPNGSLDSLLFDNEN-FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFGLAR 496 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kL~DFGla~ 496 (670)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976432 239999999999999999999999 899999999999999 888889999999998
Q ss_pred eccCCCcceeeccccCcCCCCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCc--chhHHHHHHHhhc
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART--------GKASCSTDVFAYGVLLLEIATGRRPIDSDH--FILVDWVLEFQHL 566 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~--~~~~~~~~~~~~~ 566 (670)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 765432 2334579999999998865 467789999999999999999999996421 1111111111111
Q ss_pred C--Cccccc------------CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 567 G--QVLDVV------------DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 567 ~--~~~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
. .....+ +..............+.+++..||+.||.+||+++|+++.++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 0 000000 1111223446677888999999999999999999999998865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=335.01 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=194.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~ 416 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|+++|+++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 4679999999999999999987621 124567899999999 5999999999999999
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999654 358999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcCCcccc
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 572 (670)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------ 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------ 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc------
Confidence 7654443344556899999999998853 478999999999999999999999975321 111111111111
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 616 (670)
.+.. +......+.+++..||+.||.+|| +++|++++..-
T Consensus 282 -~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 -EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp -CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred -CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 1111 122235677899999999999999 99999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.69 Aligned_cols=231 Identities=22% Similarity=0.313 Sum_probs=192.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 416 (670)
.++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4679999999999999999997533 1124668999999999999999999999999
Q ss_pred eeEEEEeccCCC-CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 417 DLLLVYDYIPNG-SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 417 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999877 9999996543 59999999999999999999999 89999999999999999999999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
+...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~~ 242 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAIH 242 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTCCC
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------HhhccC
Confidence 8765543 2334579999999999988776 78999999999999999999999742110 000001
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+ +......+.+++..||+.||.+||+++|++++-+-.
T Consensus 243 ~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 243 P------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp C------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred C------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 1 111234578899999999999999999999975543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.48 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=186.4
Q ss_pred cCccccceEeeeCceeEEEeeccch-----------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-----------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|...++||+|+||.||+|..... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5789999999999999999986531 11345799999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++ |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 97 59999887653 368999999999999999999998 899999999999999999999999999998654332 2
Q ss_pred eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC---Ccccc-------
Q 035655 505 HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG---QVLDV------- 572 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~---~~~~~------- 572 (670)
......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ............ .....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2334578999999999876 56899999999999999999999999864322 111111111000 00000
Q ss_pred --cCCCCCCc----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 --VDPNLGSS----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 --~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+..... ........+.+++..||+.||.+|||++|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00000000 01112356789999999999999999999999654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.90 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=194.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|...+.||+|+||.||+++... ..+.+.+|+.+|++++||||+++++++...+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 4678999999999999999998643 124678899999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCC--ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 422 YDYIPNGSLDSLLFDNE--NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 4469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ... ..
T Consensus 341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~~------~~- 411 (543)
T 3c4z_A 341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQA------VT- 411 (543)
T ss_dssp TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HCC------CC-
T ss_pred CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hcc------cC-
Confidence 433 223345899999999999999999999999999999999999999976321 1111111111 111 11
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
++......+.+++..||+.||.+||++ +++++|
T Consensus 412 ---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 ---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 112223567789999999999999965 777764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.59 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=181.1
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccc-cCceeeeeeeeecc--Cee
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRK--RDL 418 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~--~~~ 418 (670)
..++|+..+.||+|+||.||+|.+.. ..+.+.+|+.+++++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45789999999999999999997543 2356779999999997 99999999999754 378
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 689999865 368999999999999999999999 89999999999999999999999999999875
Q ss_pred cCCC--------------------cceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-h
Q 035655 499 DHGK--------------------ISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-L 556 (670)
Q Consensus 499 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~ 556 (670)
.... ....+..+||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311 112344589999999999876 67899999999999999999999999764321 1
Q ss_pred HHHHHHHhhcCCccc---------------------ccCCCCCCccc------------HHHHHHHHHHHHhhccCCCCC
Q 035655 557 VDWVLEFQHLGQVLD---------------------VVDPNLGSSYV------------VAEMELVLQLGLLCSHQKAEA 603 (670)
Q Consensus 557 ~~~~~~~~~~~~~~~---------------------~~d~~l~~~~~------------~~~~~~l~~l~~~Cl~~dP~~ 603 (670)
............... .........++ ......+.+++.+||+.||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 111111000000000 00000000010 011346789999999999999
Q ss_pred CCCHHHHHHHh
Q 035655 604 RPTMRQVLRYL 614 (670)
Q Consensus 604 RPs~~evl~~L 614 (670)
|||++|+++|-
T Consensus 320 R~t~~e~l~Hp 330 (388)
T 3oz6_A 320 RISANDALKHP 330 (388)
T ss_dssp SCCHHHHTTST
T ss_pred CCCHHHHhCCH
Confidence 99999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=361.03 Aligned_cols=231 Identities=26% Similarity=0.380 Sum_probs=185.0
Q ss_pred ceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++||+|+||.||+|.+.. ..++|.+|+++|++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 479999999999995421 24689999999999999999999999964 568999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc--ce
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI--SH 505 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~--~~ 505 (670)
|+|.+++... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999654 358999999999999999999999 8999999999999999999999999999987654332 22
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ......+.. + ..+..
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~~~~-----~----~~p~~ 596 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGER-----M----GCPAG 596 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCC-----C----CCCTT
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC-----C----CCCCC
Confidence 233467889999999999999999999999999999998 9999986433211 111111111 1 11222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
....+.+++..||+.||.+||++++|++.|+.
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 34668889999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.31 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=183.6
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
..++|+..++||+|+||.||+++... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45679999999999999999997532 134577999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe-----cCCCcEEEEeecCce
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI-----DADMNARLGDFGLAR 496 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-----d~~~~~kL~DFGla~ 496 (670)
|||++ |+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 59999997653 58999999999999999999999 899999999999999 455569999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc----
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD---- 571 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~---- 571 (670)
...... .......||+.|+|||++.+. .++.++|||||||+++||++|+.||.......... ......+....
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF-KIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTST
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH-HHHHHhCCCchhhhh
Confidence 665332 223445789999999998875 48999999999999999999999997643221111 00110000000
Q ss_pred ---------ccCCCCCCc-----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 572 ---------VVDPNLGSS-----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 572 ---------~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+..... ........+.+++..||+.||.+|||++|+++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 000011111 0111235678999999999999999999999854
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=329.24 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=186.0
Q ss_pred cCcccc-ceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQS-EVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~-~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
+.|.+. +.||+|+||.||++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467764 789999999999997532 246788999999985 79999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc---EEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN---ARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kL~DFGla~~~~~ 500 (670)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999764 358999999999999999999999 89999999999999998776 99999999976543
Q ss_pred CCc------ceeeccccCcCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH----------
Q 035655 501 GKI------SHTTNVVGTIGYIAPELART-----GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW---------- 559 (670)
Q Consensus 501 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~---------- 559 (670)
... .......||+.|+|||++.. ..++.++|||||||+++||++|+.||.........|
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11223469999999999875 457899999999999999999999997632211000
Q ss_pred --HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 560 --VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 560 --~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.......+. ..+...........+.+++.+||+.||.+||+++|++++-.-
T Consensus 247 ~~~~~~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 247 NMLFESIQEGK------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHCC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHhccC------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 111111111 011000001123567899999999999999999999997543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.50 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=189.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||++++++|.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3578899999999999999997643 1345779999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999999887543 359999999999999999999999 899999999999999999999999999998654432
Q ss_pred cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHH------------HhhcCC
Q 035655 503 ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLE------------FQHLGQ 568 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~------------~~~~~~ 568 (670)
.......||+.|+|||++.+. .++.++|||||||+++||++|+.||........ ..... ......
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345789999999998775 789999999999999999999999986432211 10000 000000
Q ss_pred cccccCCCCCCcc-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 569 VLDVVDPNLGSSY-----VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 569 ~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......+.+.... .....+.+.+++..||+.||.+||+++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 11234678899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=341.48 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=185.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc------C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK------R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~ 416 (670)
.++|+..++||+|+||.||++.... ..+.+.+|+.+|++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 5789999999999999999997543 245678999999999999999999999654 4
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++||||+++ +|.+.+. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999976 4666653 248999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc-------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV------- 569 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~------- 569 (670)
..... ...+...||+.|+|||++.+..++.++|||||||+++||++|+.||...... ..+.......+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence 66543 2234568999999999999999999999999999999999999999864321 1111111100000
Q ss_pred -----cccc--CCCC----------------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 -----LDVV--DPNL----------------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 -----~~~~--d~~l----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+ .+.. ...........+.+++.+||+.||.+|||++|+++|-.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0000 0000 01111223567889999999999999999999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=324.86 Aligned_cols=243 Identities=24% Similarity=0.344 Sum_probs=190.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4678999999999999999997421 2356889999999999999999999998765 8
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 468999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 499 DHGKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
...... ......+|..|+|||++.+..++.++||||||++++||++ |+.||...... +........... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~-----~ 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGER-----L 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCC-----C
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCC-----C
Confidence 554322 1233467889999999998889999999999999999999 99999764322 111111111110 1
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCCC
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDEL 619 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 619 (670)
. .+......+.+++..||+.||.+||++.+++++|+...+
T Consensus 245 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1 111223567889999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.94 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=193.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCc------eeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKH------LVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~n------Iv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++|+| ++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4689999999999999999997521 2356889999999998765 99999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---------------
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA--------------- 483 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~--------------- 483 (670)
++||||+ +++|.+++.......+++.++..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 8999999987766679999999999999999999999 89999999999999987
Q ss_pred ----CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH-
Q 035655 484 ----DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD- 558 (670)
Q Consensus 484 ----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~- 558 (670)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||.........
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 23457899999999999999999999999999999999999999764322111
Q ss_pred HHHHHhhc-----------CCcccc-----------------cCCCCC--CcccHHHHHHHHHHHHhhccCCCCCCCCHH
Q 035655 559 WVLEFQHL-----------GQVLDV-----------------VDPNLG--SSYVVAEMELVLQLGLLCSHQKAEARPTMR 608 (670)
Q Consensus 559 ~~~~~~~~-----------~~~~~~-----------------~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 608 (670)
........ ...... ....+. ........+.+.+++..||+.||.+|||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 11100000 000000 000000 011234467789999999999999999999
Q ss_pred HHHHH
Q 035655 609 QVLRY 613 (670)
Q Consensus 609 evl~~ 613 (670)
|++++
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.38 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=188.2
Q ss_pred CccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
+|.....||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 35556699999999999997532 24678899999999999999999999999999999999999
Q ss_pred CCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-CCcEEEEeecCceeccCCCcc
Q 035655 427 NGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 427 ~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++...... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999997653 3357789999999999999999999 89999999999999987 8999999999998765422 2
Q ss_pred eeeccccCcCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 505 HTTNVVGTIGYIAPELARTGK--ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||++.+.. ++.++||||||++++||++|+.||............. ... ...+.+..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~-----~~~~~~~~--- 249 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMF-----KVHPEIPE--- 249 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHH-----CCCCCCCT---
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-ccc-----cccccccc---
Confidence 233457899999999987654 7899999999999999999999996532211111111 000 11122222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.....+.+++..||+.||.+||+++|++++-
T Consensus 250 -~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 250 -SMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp -TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 2235677899999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.11 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=179.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||.||++.... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 5789999999999999999997532 23567899999999999999999999999999999999
Q ss_pred ccCCCCchhhccc------CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 424 YIPNGSLDSLLFD------NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 424 ~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
|+++++|.+++.. .....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999864 123468999999999999999999999 8999999999999999999999999999976
Q ss_pred ccCCCc----ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc-CCcc-
Q 035655 498 FDHGKI----SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL-GQVL- 570 (670)
Q Consensus 498 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~-~~~~- 570 (670)
...... .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......... ...... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~ 249 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPPSLET 249 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHHTSSCCCTTC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HHhccCCCcccc
Confidence 543221 12234579999999999875 568999999999999999999999998643221111 111110 0000
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...++.....+ ...+.+++..||+.||.+||++.|++++-
T Consensus 250 ~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 250 GVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp -----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 01111111222 34678899999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.06 Aligned_cols=252 Identities=27% Similarity=0.314 Sum_probs=191.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccch---------------------HHHHHHHHHHHhccccCceeeeeeeeeccCe
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPTR---------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~~---------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~ 417 (670)
...++|+..+.||+|+||.||+|..... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999976431 2367799999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++||||+++ +|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999985 8988886543 468999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC---Cccc-
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG---QVLD- 571 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~---~~~~- 571 (670)
..... .......||+.|+|||++.+. .++.++|||||||+++||++|..||...... ............ ....
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 64432 223445789999999998764 5889999999999999999999999764321 111111110000 0000
Q ss_pred --ccC---CCCCCccc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 572 --VVD---PNLGSSYV-----VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 572 --~~d---~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+ .......+ ......+.+++..||+.||.+|||++|++++-.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 000 00000001 1223678899999999999999999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.06 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=193.2
Q ss_pred hcCccccceEeeeCceeEEEeecc----c----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC--ee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLP----T----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR--DL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~----~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~--~~ 418 (670)
.++|+..+.||+|+||.||++... . ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 356888999999999999999731 1 2467899999999999999999999987654 78
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
++|+||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997653 369999999999999999999998 89999999999999999999999999999877
Q ss_pred cCCCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHH----hhcCCcccc
Q 035655 499 DHGKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF----QHLGQVLDV 572 (670)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~----~~~~~~~~~ 572 (670)
....... .....++..|+|||.+.+..++.++|||||||+++||++|+.|+.............. .....+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 6543221 2234677889999999988899999999999999999999999864211110000000 000000001
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+........+......+.+++..||+.||.+||++.|+++.|+.
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11110111122234568889999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=322.77 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=191.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccc-cCceeeeeeeeec--cCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLR-HKHLVNLQGWCKR--KRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~--~~~~~lV~E~ 424 (670)
.++|+..++||+|+||.||+|+... ..+.+.+|++++++++ ||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 3678999999999999999997532 4578999999999997 9999999999987 5678999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKI 503 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~ 503 (670)
+++++|.+++. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 115 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp CCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred cCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 99999999983 48999999999999999999998 8999999999999999777 89999999998765433
Q ss_pred ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh-----------hcCC---
Q 035655 504 SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ-----------HLGQ--- 568 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~-----------~~~~--- 568 (670)
......||..|+|||++.+ ..++.++|||||||+++||++|+.||............... ....
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2334578999999999877 67899999999999999999999999653221111110000 0000
Q ss_pred ---cccccCC--------CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 ---VLDVVDP--------NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 ---~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+.... .............+.+++..||+.||.+|||++|+++|-.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0000000 0001111123467889999999999999999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.74 Aligned_cols=243 Identities=26% Similarity=0.430 Sum_probs=191.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
..++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 35788999999999999999997543 235677899999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC--
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK-- 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~-- 502 (670)
+++++|.+++.... ..+++.+++.++.||+.||+|||+ .+++||||||+|||++ ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 111 CKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999997643 469999999999999999999999 8999999999999998 6799999999987653211
Q ss_pred --cceeeccccCcCCCCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc
Q 035655 503 --ISHTTNVVGTIGYIAPELART---------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571 (670)
Q Consensus 503 --~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 571 (670)
........||+.|+|||++.. ..++.++|||||||+++||++|+.||.........+ ... .+.
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-~~~--- 259 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW--QMG-TGM--- 259 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH--HHH-TTC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--Hhc-cCC---
Confidence 112233468999999998864 457899999999999999999999998644322211 111 111
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 572 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.+.... ......+.+++..||+.||.+||+++++++.|+...
T Consensus 260 --~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 260 --KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp --CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred --CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111110 011234778999999999999999999999998754
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.10 Aligned_cols=114 Identities=30% Similarity=0.453 Sum_probs=105.1
Q ss_pred CcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecC
Q 035655 145 NHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMN 224 (670)
Q Consensus 145 ~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~ 224 (670)
||+|||||||++| .++|||++|||||||||+.|.++++ +++.+|+.++|||+||+.+++|+|+|++.+
T Consensus 1 n~~vAVEFDT~~N-~e~~Dp~~nHVGIdvNsi~S~~s~~-----------~~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~ 68 (133)
T 1qmo_E 1 SNVVAVEFDTYLN-PDYGDPNYIHIGIDVNSIRSKVTAK-----------WDWQNGKIATAHISYNSVSKRLSVTSYYAG 68 (133)
T ss_dssp CCCEEEEEECSCC-GGGTCCSSCEEEEEESSSSCSEEEE-----------CCCCTTSCEEEEEEEETTTTEEEEEEECSS
T ss_pred CCEEEEEEeCCcC-ccccCCCCCeeEEecccccccceee-----------eEEcCCCEEEEEEEEeCCCcEEEEEEccCC
Confidence 6899999999999 7889999999999999999998876 457899999999999999999999998754
Q ss_pred CcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEeccccccCC
Q 035655 225 KKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 225 ~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
. ..|+|+..+||+++|||+||||||||||...|.|+|++|+|+++.
T Consensus 69 ~-----------~~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l 114 (133)
T 1qmo_E 69 S-----------KPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL 114 (133)
T ss_dssp S-----------CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred C-----------ccceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence 3 268999999999999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.84 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=192.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccc--------cCceeeeeeeee----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLR--------HKHLVNLQGWCK---- 413 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~--------H~nIv~l~g~~~---- 413 (670)
.++|+..++||+|+||.||+|+... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 4689999999999999999997643 2367889999999996 788999999987
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCC-------
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADM------- 485 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~------- 485 (670)
.....++||||+ +++|.+++.......+++..++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 566899999999 6677777766555579999999999999999999998 7 999999999999999775
Q ss_pred ------------------------------------------cEEEEeecCceeccCCCcceeeccccCcCCCCcccccc
Q 035655 486 ------------------------------------------NARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523 (670)
Q Consensus 486 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 523 (670)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876543 234578999999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCCCCcch----hHHHHH-HHhhcCCc---------------------ccccCCCC
Q 035655 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI----LVDWVL-EFQHLGQV---------------------LDVVDPNL 577 (670)
Q Consensus 524 ~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~----~~~~~~-~~~~~~~~---------------------~~~~d~~l 577 (670)
..++.++|||||||++|||++|+.||...... ..+... .....+.. ....+...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999753211 000000 00000000 00000000
Q ss_pred ---------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 578 ---------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 578 ---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
....+......+.+++.+||+.||.+|||++|+++|-
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 0123456677899999999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.69 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=176.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec-----cCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-----KRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-----~~~ 417 (670)
.++|+..+.||+|+||.||+|+... ..+.+.+|+++|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4679999999999999999997542 23578899999999999999999999843 357
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 57999998654 459999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCc--------------------------ceeeccccCcCCCCcccc-ccCCCCccchhHHHHHHHHHHHh------
Q 035655 498 FDHGKI--------------------------SHTTNVVGTIGYIAPELA-RTGKASCSTDVFAYGVLLLEIAT------ 544 (670)
Q Consensus 498 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~el~t------ 544 (670)
...... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 643221 123445889999999976 56679999999999999999999
Q ss_pred -----CCCCCCCCcc---------------------hhHHHHHHHhhcC--------------CcccccCCCCC---Ccc
Q 035655 545 -----GRRPIDSDHF---------------------ILVDWVLEFQHLG--------------QVLDVVDPNLG---SSY 581 (670)
Q Consensus 545 -----G~~pf~~~~~---------------------~~~~~~~~~~~~~--------------~~~~~~d~~l~---~~~ 581 (670)
|+.+|.+... ............. ........... ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 5555543210 0000000000000 00000000000 011
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+|+..||+.||.+|||++|+++|-.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 1122456789999999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.98 Aligned_cols=237 Identities=24% Similarity=0.369 Sum_probs=189.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..++||+|+||.||+|+... ....+.+|+.++++++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4568999999999999999997642 2457889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~~ 499 (670)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.. +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988654 358999999999999999999999 899999999999999764 459999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... ......||+.|+|||++. +.++.++||||+||++|||++|+.||....... ..... ..+.. ....
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i-~~~~~------~~~~ 258 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKV-EKGKY------TFDS 258 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHTCC------CCCS
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HhCCC------CCCc
Confidence 432 234457999999999886 568999999999999999999999998643221 11111 11111 0111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.........+.+++..||+.||.+|||+.|+++|-
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 11112235678899999999999999999999763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.97 Aligned_cols=240 Identities=26% Similarity=0.422 Sum_probs=191.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
..++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 35679999999999999999997653 2467899999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++++|.+++... ...+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 107 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 181 (314)
T 3com_A 107 GAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AK 181 (314)
T ss_dssp TTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SC
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cc
Confidence 999999998643 2468999999999999999999998 899999999999999999999999999998765432 22
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....||+.|+|||++.+..++.++||||||++++||++|+.||.........+ ...... .+.+ ..+...
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~------~~~~--~~~~~~ 251 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNP------PPTF--RKPELW 251 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSC------CCCC--SSGGGS
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCC------Cccc--CCcccC
Confidence 334578999999999999899999999999999999999999997643221111 111110 1111 111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...+.+++..||+.||.+||++.+++++-
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 35678899999999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.40 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=194.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhcc------ccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRL------RHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l------~H~nIv~l~g~~~~~~~~~ 419 (670)
..+|+..++||+|+||.||+|.... ..+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4568999999999999999997643 235677899988887 4679999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc--EEEEeecCcee
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN--ARLGDFGLARL 497 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kL~DFGla~~ 497 (670)
+||||+. ++|.+++.......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 699999987766679999999999999999999999 89999999999999999987 99999999976
Q ss_pred ccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh---------cC
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH---------LG 567 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~---------~~ 567 (670)
.... .....||+.|+|||++.+..++.++|||||||+++||++|+.||...... .......... ..
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 5432 23457899999999999999999999999999999999999999764321 1111111000 00
Q ss_pred CcccccC--------------------------------CCCCCcc----cHHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 035655 568 QVLDVVD--------------------------------PNLGSSY----VVAEMELVLQLGLLCSHQKAEARPTMRQVL 611 (670)
Q Consensus 568 ~~~~~~d--------------------------------~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 611 (670)
+....++ +.....+ .......+.+++..||+.||.+|||++|++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 0000000 0000000 001135678999999999999999999999
Q ss_pred HHhcCCCCC
Q 035655 612 RYLNGDELL 620 (670)
Q Consensus 612 ~~L~~~~~~ 620 (670)
+|-+-....
T Consensus 408 ~Hpw~~~~~ 416 (429)
T 3kvw_A 408 RHPWLRRRL 416 (429)
T ss_dssp TSTTTC---
T ss_pred CChhhccCC
Confidence 976544333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=330.22 Aligned_cols=240 Identities=21% Similarity=0.268 Sum_probs=174.5
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccc-cCceeeeeeeee--------c
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLR-HKHLVNLQGWCK--------R 414 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~--------~ 414 (670)
...+|+..++||+|+||.||++.... ..+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34679999999999999999998632 2457889999999996 999999999983 3
Q ss_pred cCeeEEEEeccCCCCchhhcccC-CccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEecCCCcEEEEe
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kL~D 491 (670)
....++|+||+. |+|.+++... ....+++.+++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 445899999995 7999988652 23469999999999999999999998 77 99999999999999999999999
Q ss_pred ecCceeccCCCcc-----------eeeccccCcCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH
Q 035655 492 FGLARLFDHGKIS-----------HTTNVVGTIGYIAPELA---RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV 557 (670)
Q Consensus 492 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~ 557 (670)
||+++........ ......||+.|+|||++ .+..++.++|||||||+++||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 9999876543211 11234689999999998 56678999999999999999999999997532110
Q ss_pred HHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 558 DWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 558 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.. .... .. .. .......+.+++..||+.||.+||+++|++++|+...
T Consensus 261 -~~-----~~~~-~~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 -IV-----NGKY-SI---PP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------C-CC---CT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hh-----cCcc-cC---Cc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0000 00 00 0111134678899999999999999999999997653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.07 Aligned_cols=234 Identities=24% Similarity=0.277 Sum_probs=183.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHH-HhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIES-LGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~-L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+++... ..+.+.+|..+ ++.++||||+++++++.+.+.+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3578999999999999999997643 12345567666 577899999999999999999999
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999654 358999999999999999999998 8999999999999999999999999999985433
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ... ..+...
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~-~~~------~~~~~~ 261 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNIL-NKP------LQLKPN 261 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HHHHH-HSC------CCCCSS
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-hcc------cCCCCC
Confidence 22 234456899999999999999999999999999999999999999976432211 11111 111 111111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHH----HHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMR----QVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~ 613 (670)
....+.+++..||+.||.+||++. ++++|
T Consensus 262 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 262 ----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred ----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 224577899999999999999974 55544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.82 Aligned_cols=247 Identities=18% Similarity=0.293 Sum_probs=195.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------h-------H--------------HHHHHHHHHHhccccCceeeee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------R-------M--------------REFAAEIESLGRLRHKHLVNLQ 409 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------~-------~--------------~~f~~Ei~~L~~l~H~nIv~l~ 409 (670)
.++|...+.||+|+||.||++.... . . +.+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4689999999999999999997622 0 0 7899999999999999999999
Q ss_pred eeeeccCeeEEEEeccCCCCchhh------cccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC
Q 035655 410 GWCKRKRDLLLVYDYIPNGSLDSL------LFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA 483 (670)
Q Consensus 410 g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~ 483 (670)
+++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ +.+++||||||+||+++.
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 999999999999999999999999 665445679999999999999999999996 379999999999999999
Q ss_pred CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCcchhHHHHH
Q 035655 484 DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-KASC-STDVFAYGVLLLEIATGRRPIDSDHFILVDWVL 561 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~ 561 (670)
++.+||+|||++...... ......||..|+|||.+.+. .++. ++|||||||+++||++|+.||...... .+...
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~ 263 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELFN 263 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH
Confidence 999999999999876543 34456799999999999877 5666 999999999999999999999864321 11111
Q ss_pred HHhhcCCcccccC------CCC---CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 562 EFQHLGQVLDVVD------PNL---GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 562 ~~~~~~~~~~~~d------~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. ...+......+ +.. ...........+.+++..||+.||.+||+++|++++-
T Consensus 264 ~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 264 N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1 11111100000 000 0000122345678899999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.48 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=193.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4678999999999999999997642 234688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceeccCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~~~~ 501 (670)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999998654 358999999999999999999999 899999999999999 78899999999999754432
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|+|||++.+..++.++|||||||+++||++|+.||....... .... ...+.. . .....
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-i~~~~~-~-----~~~~~ 230 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEK-IKEGYY-E-----FESPF 230 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH-HHHCCC-C-----CCTTT
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHcCCC-C-----CCccc
Confidence 2234579999999999999999999999999999999999999997643211 1111 111110 0 01111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.......+.+++..||+.||.+||+++|++++-.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1223356788999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.69 Aligned_cols=234 Identities=24% Similarity=0.397 Sum_probs=184.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 3578999999999999999997642 124678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
+||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999654 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
. ......||+.|+|||.+.+..+ +.++||||||++++||++|+.||....... ..... ..+. ..+...
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-~~~~------~~~~~~ 233 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKI-RGGV------FYIPEY 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHCC------CCCCTT
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHh-hcCc------ccCchh
Confidence 2 2234578999999999987765 689999999999999999999997643221 11111 1111 011111
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
....+.+++..||+.||.+||+++|++++-
T Consensus 234 ----~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 234 ----LNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ----cCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 224577899999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.45 Aligned_cols=228 Identities=15% Similarity=0.157 Sum_probs=178.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHH---HHHhccccCceeeee-------e
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEI---ESLGRLRHKHLVNLQ-------G 410 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei---~~L~~l~H~nIv~l~-------g 410 (670)
..++|...+.||+|+||.||+|+... ..+.|.+|+ +.|++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 35779999999999999999998632 236788999 555666899999998 5
Q ss_pred eeeccC-----------------eeEEEEeccCCCCchhhcccCC-----ccccCHHHHHHHHHHHHHHhhhccccccce
Q 035655 411 WCKRKR-----------------DLLLVYDYIPNGSLDSLLFDNE-----NFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468 (670)
Q Consensus 411 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 468 (670)
++...+ ..++||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+ .+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 555443 289999999 689999997532 2245578999999999999999999 89
Q ss_pred EEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC-----------CCCccchhHHHHH
Q 035655 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-----------KASCSTDVFAYGV 537 (670)
Q Consensus 469 ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gv 537 (670)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 3345577 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 538 LLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 538 vl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
++|||++|+.||...... ........ .. ..+ ...+.+++..||+.||.+||++.|++++
T Consensus 302 il~elltg~~Pf~~~~~~-----------~~~~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL-----------GGSEWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC-----------------CCSGGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccc-----------cchhhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999752210 00001111 00 111 2567889999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.44 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=187.9
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeec-----------
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----------- 414 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----------- 414 (670)
....++|+..+.||+|+||.||+|.... ..+...+|++++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4557789999999999999999997643 22334589999999999999999999843
Q ss_pred ---------------------------cCeeEEEEeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccc
Q 035655 415 ---------------------------KRDLLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEW 465 (670)
Q Consensus 415 ---------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 465 (670)
....++||||++ |+|.+.+.. .....+++..+..++.||+.||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 334889999998 588877754 234569999999999999999999998
Q ss_pred cceEEecccCCCcEEec-CCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHH
Q 035655 466 EQVVIHRDVKSGNVLID-ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIA 543 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~ 543 (670)
.+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||+++||+
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 8999999999999998 68899999999998765433 23345789999999988765 4899999999999999999
Q ss_pred hCCCCCCCCcch-hHHHHHHHhh----------cCCcccccCCCCCC-----cccHHHHHHHHHHHHhhccCCCCCCCCH
Q 035655 544 TGRRPIDSDHFI-LVDWVLEFQH----------LGQVLDVVDPNLGS-----SYVVAEMELVLQLGLLCSHQKAEARPTM 607 (670)
Q Consensus 544 tG~~pf~~~~~~-~~~~~~~~~~----------~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 607 (670)
+|+.||...... .......... .....+..-+.+.. .++......+.+++..||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999864321 1111111000 00011111111111 1122234568899999999999999999
Q ss_pred HHHHHHh
Q 035655 608 RQVLRYL 614 (670)
Q Consensus 608 ~evl~~L 614 (670)
.|+++|-
T Consensus 317 ~e~l~hp 323 (383)
T 3eb0_A 317 YEAMAHP 323 (383)
T ss_dssp HHHHTSG
T ss_pred HHHhcCH
Confidence 9999763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.38 Aligned_cols=236 Identities=24% Similarity=0.338 Sum_probs=187.8
Q ss_pred hcCccccceEeeeCceeEEEeeccch------------------------HHHHHHHHHHHhccccCceeeeeeeeeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPTR------------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~~------------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~ 416 (670)
.++|...+.||+|+||.||+|..... ...+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999976431 124779999999999999999999987655
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc---EEEEeec
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN---ARLGDFG 493 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kL~DFG 493 (670)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999998654 468999999999999999999998 89999999999999987665 9999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHHHHhhcCC
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIATGRRPIDSDHF--ILVDWVLEFQHLGQ 568 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~--~~~~~~~~~~~~~~ 568 (670)
+++...... ......||+.|+|||++. ...++.++|||||||+++||++|+.||..... .+..... .+.
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~ 236 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----SGK 236 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----HTC
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----hCc
Confidence 998765422 223457999999999874 56789999999999999999999999975322 1111111 111
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. .............+.+++..||+.||.+||++.|++++-
T Consensus 237 ~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 237 Y------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred c------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 0 000111112246678999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=316.33 Aligned_cols=237 Identities=23% Similarity=0.283 Sum_probs=177.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||++.... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4679999999999999999998632 1123445556688899999999999999999999999
Q ss_pred eccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
||++ |+|.+++.. .....+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588888754 233579999999999999999999998 7 99999999999999999999999999998665
Q ss_pred CCCcceeeccccCcCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELA----RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
... ......||+.|+|||++ .+..++.++|||||||+++||++|+.||............... . . .+
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~-~-----~~ 232 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-E-P-----SP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-S-C-----CC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-c-C-----CC
Confidence 432 22334799999999996 5567899999999999999999999999753322222211111 1 1 11
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
... .......+.+++..||+.||.+|||++|++++
T Consensus 233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 QLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred Ccc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111 11123557889999999999999999999884
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.40 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=190.8
Q ss_pred cchhhHHHhhcCccccceEeeeCceeEEEeeccch--------------------------HHHHHHHHHHHhccccCce
Q 035655 352 FRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR--------------------------MREFAAEIESLGRLRHKHL 405 (670)
Q Consensus 352 ~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~~--------------------------~~~f~~Ei~~L~~l~H~nI 405 (670)
....++....++|...+.||+|+||.||+|....+ .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34567788899999999999999999999965331 2678999999999999999
Q ss_pred eeeeeeeec-----cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEE
Q 035655 406 VNLQGWCKR-----KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480 (670)
Q Consensus 406 v~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 480 (670)
+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 999999843 346899999997 68888886543 469999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHH
Q 035655 481 IDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVD 558 (670)
Q Consensus 481 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~ 558 (670)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999997544322 2344578999999998876 67899999999999999999999999864321 111
Q ss_pred HHHHHhhcC------------------CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 559 WVLEFQHLG------------------QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 559 ~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
......... .....................+.+++..||+.||.+|||++|+++|-.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 111100000 000000000001111122356789999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=326.45 Aligned_cols=248 Identities=27% Similarity=0.345 Sum_probs=190.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec--------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-------- 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------- 414 (670)
.++|+..++||+|+||.||+|+... ....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3679999999999999999998642 13478899999999999999999999976
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
.+..++||||+++ +|.+.+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999975 7777775543 359999999999999999999999 8999999999999999999999999999
Q ss_pred ceeccCCC---cceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCc
Q 035655 495 ARLFDHGK---ISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQV 569 (670)
Q Consensus 495 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~ 569 (670)
++...... ........||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ........ .+..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL--CGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCC
Confidence 98765322 122344578999999998876 45799999999999999999999999864322 11111111 1111
Q ss_pred ccccCCCC---------------CCcccHH-----HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 LDVVDPNL---------------GSSYVVA-----EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 ~~~~d~~l---------------~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+.. ....... ....+.+++..||+.||.+|||++|++++-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 00000000 0000000 0245788999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.36 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=194.0
Q ss_pred HHhhcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeee
Q 035655 358 YTATKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWC 412 (670)
Q Consensus 358 ~~~t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~ 412 (670)
....++|+..+.||+|+||.||+|.+.. ..+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3445779999999999999999997642 034577999999999 799999999999
Q ss_pred eccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 413 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999654 369999999999999999999999 89999999999999999999999999
Q ss_pred cCceeccCCCcceeeccccCcCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhc
Q 035655 493 GLARLFDHGKISHTTNVVGTIGYIAPELART------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 493 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~ 566 (670)
|++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ... ...
T Consensus 245 G~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~-i~~ 319 (365)
T 2y7j_A 245 GFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LRM-IME 319 (365)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHH
T ss_pred CcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHh
Confidence 9998765432 2344689999999998863 3578899999999999999999999976432111 111 111
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+.. .............+.+++..||+.||.+||+++|++++-
T Consensus 320 ~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 320 GQY------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp TCC------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCC------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 110 000000011235678899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.57 Aligned_cols=240 Identities=11% Similarity=0.033 Sum_probs=171.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc--ccCceeeee-------eee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL--RHKHLVNLQ-------GWC 412 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l--~H~nIv~l~-------g~~ 412 (670)
..+|...+.||+|+||.||+|.+.. ..+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4568999999999999999998642 234566785555555 699988755 333
Q ss_pred ecc-----------------CeeEEEEeccCCCCchhhcccCCccccCHHHH------HHHHHHHHHHhhhccccccceE
Q 035655 413 KRK-----------------RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR------FNIIKGIAAGLLYLHEEWEQVV 469 (670)
Q Consensus 413 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~i 469 (670)
... ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+ ++|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence 322 34899999999 899999976532 4566667 7888999999999998 899
Q ss_pred EecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCC
Q 035655 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRR 547 (670)
Q Consensus 470 vHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~ 547 (670)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986543 2224567799999999987 679999999999999999999999
Q ss_pred CCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 548 PIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 548 pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
||......... ..............+...........+.+++..||+.||.+||++.|+++|
T Consensus 292 Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKG----SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTT----CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCccccc----chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99764221100 000000001111111111112334667889999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.25 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=190.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
..++|++.+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45689999999999999999998753 34678899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999999986533 359999999999999999999999 899999999999999999999999999975432111
Q ss_pred ceeeccccCcCCCCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 504 SHTTNVVGTIGYIAPELA-----RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.......||+.|+|||++ ....++.++|||||||+++||++|+.||....... ......... .+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~------~~~~- 242 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSD------PPTL- 242 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC------CCCC-
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHhccC------Cccc-
Confidence 112335789999999988 36678999999999999999999999997643211 111111111 0111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..+......+.+++..||+.||.+||++.|++++-
T Consensus 243 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 243 -LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred -CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11122235678899999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.23 Aligned_cols=242 Identities=23% Similarity=0.331 Sum_probs=184.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 416 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 5679999999999999999997632 1356789999999999999999999997653
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899999865 358999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCc-----
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQV----- 569 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~----- 569 (670)
..... .+...+|+.|+|||++.+ ..++.++||||+||+++||++|+.||...... ....... ..+..
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~--~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK--VTGTPPAEFV 250 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--HHCCCCHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hcCCCCHHHH
Confidence 75432 334578999999999877 67999999999999999999999999864321 1111110 00000
Q ss_pred -----------ccccCCCCC---CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 -----------LDVVDPNLG---SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 -----------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
...+..... ..........+.+++.+||+.||.+|||++|+++|-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 000000000 0111122356788999999999999999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.87 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=192.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..++||+|+||.||++.... ....+.+|+++|++++||||+++++++.+....++|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 4679999999999999999997642 2457889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec---CCCcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID---ADMNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kL~DFGla~~~~ 499 (670)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999998654 358999999999999999999999 8999999999999995 45679999999998665
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ .... ..+.. ....
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i-~~~~~------~~~~ 243 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LKRV-ETGKY------AFDL 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHTCC------CSCS
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HhCCC------CCCC
Confidence 432 2344579999999999875 589999999999999999999999976432211 1111 11111 0111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.........+.+++..||+.||.+|||+.|+++|-+
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 111223456789999999999999999999999743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=340.72 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=194.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4578999999999999999997642 346788999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~ 498 (670)
+||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999998654 359999999999999999999999 899999999999999 56789999999999876
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ .... ..+.. ...
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i-~~~~~------~~~ 247 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKKV-EKGKY------TFE 247 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHCCC------CCC
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HcCCC------CCC
Confidence 5433 2344579999999999875 689999999999999999999999986432211 1111 11111 011
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..........+.+++..||+.||.+|||++|+++|-+
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 1112233456788999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.44 Aligned_cols=240 Identities=24% Similarity=0.421 Sum_probs=184.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeec-----------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----------- 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----------- 414 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4678999999999999999998642 24678899999999999999999998754
Q ss_pred --cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEee
Q 035655 415 --KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492 (670)
Q Consensus 415 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DF 492 (670)
.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 456899999999999999997643 468899999999999999999999 89999999999999999999999999
Q ss_pred cCceeccCCC-------------cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 035655 493 GLARLFDHGK-------------ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD 558 (670)
Q Consensus 493 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~ 558 (670)
|+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||.... ....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~~~ 236 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVN 236 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hHHH
Confidence 9998654321 1122345789999999998764 78999999999999999998 554311 1111
Q ss_pred HHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....... ....+...+.......+.+++..||+.||.+||++++++++-+
T Consensus 237 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 237 ILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 1111111 1111222233344466788999999999999999999998543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=338.25 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=192.4
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------------------hHHHHHHHHHHHhccccCceeeeee
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------------------RMREFAAEIESLGRLRHKHLVNLQG 410 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------------------~~~~f~~Ei~~L~~l~H~nIv~l~g 410 (670)
..++|...++||+|+||.||+|.... ..+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999997532 1346789999999999999999999
Q ss_pred eeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC---cE
Q 035655 411 WCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM---NA 487 (670)
Q Consensus 411 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~ 487 (670)
+|.+....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999998654 359999999999999999999999 8999999999999998776 69
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcC
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||....... ...... .+
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~-~~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVE-KG 262 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HC
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-cC
Confidence 999999998775532 234457999999999987 568999999999999999999999998643221 111111 11
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. .............+.+++..||+.||.+|||++|+++|-+
T Consensus 263 ~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 263 KY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 11 0000011122356788999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.06 Aligned_cols=184 Identities=27% Similarity=0.388 Sum_probs=155.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----Ce
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 417 (670)
.++|...+.||+|+||.||+|+... ..+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5689999999999999999997643 235788999999999999999999999766 57
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999986 6999999654 459999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCc---------------------ceeeccccCcCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 498 FDHGKI---------------------SHTTNVVGTIGYIAPELA-RTGKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 498 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
...... ...+..+||+.|+|||++ ....++.++|||||||+++||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 654321 123556899999999986 55679999999999999999998655543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=357.09 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=191.7
Q ss_pred hhcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
..++|+..+.||+|+||.||+|.... ..+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678889999999999999997532 13678899999999999999999999854 5689
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997543 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ...... .+.. +..
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~-~~~~-----~~~- 613 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE-NGER-----LPM- 613 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH-HTCC-----CCC-
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-cCCC-----CCC-
Confidence 544333344567889999999998999999999999999999997 999997643221 111111 1111 111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+.+++..||+.||.+||++.++++.|+.
T Consensus 614 ---~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 614 ---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11223567889999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.78 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=194.1
Q ss_pred HhhcCccccceEeeeCceeEEEeecc-c------------------hHHHHHHHHHHHhcc---ccCceeeeeeeee---
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLP-T------------------RMREFAAEIESLGRL---RHKHLVNLQGWCK--- 413 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~-~------------------~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~--- 413 (670)
.+.++|+..+.||+|+||.||++... . ....+.+|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999863 1 113577888888777 8999999999987
Q ss_pred --ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 414 --RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 414 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
.....++|+||++ |+|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999997 699999987666679999999999999999999999 8999999999999999999999999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC---
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG--- 567 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~--- 567 (670)
||+++...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... ............
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998654322 233457899999999999999999999999999999999999999864321 111111110000
Q ss_pred Ccc-------cccC---CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 568 QVL-------DVVD---PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 568 ~~~-------~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
... .... ......+.......+.+++..||+.||.+||++.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000 0000 0000111122345678899999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.47 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=182.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 416 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999997532 2356789999999999999999999997654
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++||||++ |+|.+++. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 57888874 248999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc-----
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD----- 571 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~----- 571 (670)
...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||....... .+.......+....
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence 654322 2334579999999999999999999999999999999999999997643211 11111000000000
Q ss_pred ---------ccCCCC----------------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 572 ---------VVDPNL----------------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 572 ---------~~d~~l----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.-.+.. ...........+.+++.+||+.||.+|||++|+++|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000 0111223456789999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=336.68 Aligned_cols=243 Identities=19% Similarity=0.244 Sum_probs=193.6
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhcccc-CceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRH-KHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|++.++||+|+||.||+|.... ...++..|+++++.|+| +++..+..++.+.+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4679999999999999999998642 23468899999999987 55666666677788899999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe---cCCCcEEEEeecCceeccCCC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kL~DFGla~~~~~~~ 502 (670)
+++|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||| +.++.+||+|||+++......
T Consensus 86 -g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999999997543 369999999999999999999999 899999999999999 688999999999998776543
Q ss_pred cc------eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-h---HHHHHHHhhcCCcccc
Q 035655 503 IS------HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-L---VDWVLEFQHLGQVLDV 572 (670)
Q Consensus 503 ~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~---~~~~~~~~~~~~~~~~ 572 (670)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ............. +.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HH
Confidence 21 123568999999999999999999999999999999999999999763221 1 1111111111111 11
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+. ......+.+++..||+.+|.+||++++|++.|+..
T Consensus 240 l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 LC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred Hh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 11235688999999999999999999999988653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.20 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=193.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------------hHHHHHHHHHHHhccc-cCceeeeeeeee
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------------RMREFAAEIESLGRLR-HKHLVNLQGWCK 413 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~ 413 (670)
..++|+..+.||+|+||.||+|.... ..+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999997643 1245779999999996 999999999999
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
..+..++||||+++++|.+++... ..+++.++..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999654 468999999999999999999998 899999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcC
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELAR------TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~ 567 (670)
++....... ......||+.|+|||++. ...++.++||||||++++||++|+.||........ .... ..+
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~-~~~ 244 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMI-MSG 244 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHT
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HHHH-hcC
Confidence 998765433 233457899999999875 45688999999999999999999999976432211 1111 111
Q ss_pred CcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 568 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.. .............+.+++..||+.||.+||++.|++++-
T Consensus 245 ~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 245 NY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp CC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred Cc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 11 011111122345688999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.49 Aligned_cols=244 Identities=19% Similarity=0.241 Sum_probs=192.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCc------eeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKH------LVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~n------Iv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||.||++.... ..+.+.+|+.++++++|++ ++.+.+++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 4689999999999999999997532 2356778999999998876 99999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe-----------------
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----------------- 481 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----------------- 481 (670)
++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 6788888876655679999999999999999999998 899999999999999
Q ss_pred --cCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HH
Q 035655 482 --DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VD 558 (670)
Q Consensus 482 --d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~ 558 (670)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||....... ..
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66889999999999865432 234579999999999999999999999999999999999999998643221 11
Q ss_pred HHHHHhhcCCccc----------c-cC-------------------CCCC--CcccHHHHHHHHHHHHhhccCCCCCCCC
Q 035655 559 WVLEFQHLGQVLD----------V-VD-------------------PNLG--SSYVVAEMELVLQLGLLCSHQKAEARPT 606 (670)
Q Consensus 559 ~~~~~~~~~~~~~----------~-~d-------------------~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 606 (670)
..... .+.... . .. +.+. ......+...+.+++..||+.||.+|||
T Consensus 250 ~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 250 MMEKI--LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHH--HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHH--cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11110 000000 0 00 0000 0111233557889999999999999999
Q ss_pred HHHHHHHh
Q 035655 607 MRQVLRYL 614 (670)
Q Consensus 607 ~~evl~~L 614 (670)
++|++++-
T Consensus 328 ~~e~l~hp 335 (355)
T 2eu9_A 328 LAEALLHP 335 (355)
T ss_dssp HHHHTTSG
T ss_pred HHHHhcCh
Confidence 99998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.90 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=192.6
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeecc---
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK--- 415 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~--- 415 (670)
+.....++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 333446789999999999999999997542 236788999999999999999999998654
Q ss_pred --CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 416 --RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 416 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
...++|+||++ |+|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCc
Confidence 46899999997 599998854 358999999999999999999999 899999999999999999999999999
Q ss_pred CceeccCCCcc--eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCc
Q 035655 494 LARLFDHGKIS--HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQV 569 (670)
Q Consensus 494 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~ 569 (670)
+++........ ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||..... ...............
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99876543211 1234589999999998654 4589999999999999999999999976432 111111110000000
Q ss_pred ---------------ccccCCCCC--CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 ---------------LDVVDPNLG--SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 ---------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+... ..........+.+++..||+.||.+|||++|+++|-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000000 0011112356789999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.98 Aligned_cols=192 Identities=21% Similarity=0.309 Sum_probs=164.7
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccc-cC-----ceeeeeeeee
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLR-HK-----HLVNLQGWCK 413 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~-H~-----nIv~l~g~~~ 413 (670)
..-....++|+..+.||+|+||.||+|.... ...++..|+.+++.++ |+ +|+++++++.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3344456899999999999999999997643 1356678899988885 44 4999999999
Q ss_pred ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec--CCCcEEEEe
Q 035655 414 RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID--ADMNARLGD 491 (670)
Q Consensus 414 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~~kL~D 491 (670)
..+..++||||++ |+|.+++.......+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999996 5999999876655799999999999999999999951 27899999999999994 577899999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSD 552 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~ 552 (670)
||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||...
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876442 23457899999999999999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=335.50 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=186.3
Q ss_pred cCccccceEeeeCceeEEEeeccch------------HHHHHHHHHHHhccccCceeeeeeeeecc------CeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWCKRK------RDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~lV~E 423 (670)
.+|+..+.||+|+||.||+|++... .+.+.+|+++|++++||||++++++|... ..+++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 4588899999999999999987541 23345799999999999999999998532 23689999
Q ss_pred ccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla~~~~~ 500 (670)
|+++ +|.+.+.. .....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 66666543 223569999999999999999999998 899999999999999965 5689999999987654
Q ss_pred CCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHh---------hcCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQ---------HLGQ 568 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~---------~~~~ 568 (670)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +........ ....
T Consensus 210 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 33 22345789999999998765 7899999999999999999999999864321 111111100 0011
Q ss_pred cccccCCCCCCc-----ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 VLDVVDPNLGSS-----YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 ~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+...+.+... +.......+.+|+.+||+.||.+||++.|+++|-.
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 111111111111 11222467889999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.99 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=185.9
Q ss_pred cCccccceEeeeCceeEEEeeccch-----------HHHHHHHHHHHhccccCceeeeeeeeeccC------eeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-----------MREFAAEIESLGRLRHKHLVNLQGWCKRKR------DLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-----------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------~~~lV~E~ 424 (670)
.+|...+.||+|+||.||+|..... .+...+|++++++++||||++++++|...+ ..++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 4688999999999999999987542 222347999999999999999999996543 38899999
Q ss_pred cCCCCchhhccc-CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL~DFGla~~~~~~~ 502 (670)
++++.+...... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 987544433221 223469999999999999999999999 8999999999999999 79999999999998765433
Q ss_pred cceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHH---------hhcCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEF---------QHLGQVL 570 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~---------~~~~~~~ 570 (670)
......||+.|+|||++.+. .++.++|||||||+++||++|+.||...... +....... .......
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 197 --PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp --CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred --CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 22345789999999998765 5899999999999999999999999864321 11111100 0000111
Q ss_pred cccCCCCCC-----cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 571 DVVDPNLGS-----SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 571 ~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
...-+.... .+.......+.+++.+||+.||.+||++.|+++|-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 111111110 11112345788999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.97 Aligned_cols=244 Identities=23% Similarity=0.269 Sum_probs=166.9
Q ss_pred hhcCccccc-eEeeeCceeEEEeeccch-----------HHHHHHHH-HHHhccccCceeeeeeeeec----cCeeEEEE
Q 035655 360 ATKGFKQSE-VIGTGGFGEVYKGVLPTR-----------MREFAAEI-ESLGRLRHKHLVNLQGWCKR----KRDLLLVY 422 (670)
Q Consensus 360 ~t~~f~~~~-~lG~G~fg~Vykg~~~~~-----------~~~f~~Ei-~~L~~l~H~nIv~l~g~~~~----~~~~~lV~ 422 (670)
..++|...+ .||+|+||.||+|..... .....+|+ ..++.++||||+++++++.. +...++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 356788854 699999999999987631 12333444 34667799999999999876 45589999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~~ 499 (670)
||+++|+|.+++.......+++.+++.++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999987766679999999999999999999999 899999999999999864 459999999998665
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW-VLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~ 578 (670)
.. ......||+.|+|||++.+..++.++|||||||+++||++|+.||.......... ........ .....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~ 253 (336)
T 3fhr_A 183 QN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------QYGFP 253 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------CCC
T ss_pred cc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc------ccccC
Confidence 32 2334578999999999988889999999999999999999999997532211100 00000000 00111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..........+.+++..||+.||.+||+++|++++-+
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 1111223456788999999999999999999999643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.55 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=172.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc------C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK------R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~ 416 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999997532 235678999999999999999999998654 5
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899999854 369999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC------C
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG------Q 568 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~------~ 568 (670)
..... .+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ............ .
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 344579999999999876 67899999999999999999999999764321 111111110000 0
Q ss_pred --------cccccCCCCCCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 569 --------VLDVVDPNLGSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 569 --------~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+...-...+ .......+.+++.+||+.||.+|||++|+++|-.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0000000000000 0112356788999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.20 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=189.0
Q ss_pred ccchhhHHHhhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhcccc--Cceeeeeee
Q 035655 351 RFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRH--KHLVNLQGW 411 (670)
Q Consensus 351 ~~~~~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H--~nIv~l~g~ 411 (670)
.+.++.+....++|+..+.||+|+||.||++.... ..+.+.+|++++++++| |||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34455555567789999999999999999997643 23678899999999974 999999999
Q ss_pred eeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
+...+..++||| +.+++|.+++... ..+++.+++.++.|+++||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEee
Confidence 999999999999 5688999999765 368999999999999999999999 8999999999999996 48999999
Q ss_pred ecCceeccCCCcc-eeeccccCcCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH
Q 035655 492 FGLARLFDHGKIS-HTTNVVGTIGYIAPELART-----------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW 559 (670)
Q Consensus 492 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~ 559 (670)
||+++........ ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||..........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 9999876543321 2234579999999999865 468889999999999999999999997533221111
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... .++.....++......+.+++..||+.||.+||+++|++++-.
T Consensus 250 -~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 250 -HAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp -HHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -HHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 111 1111111111112356788999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=349.19 Aligned_cols=235 Identities=22% Similarity=0.286 Sum_probs=194.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~ 419 (670)
..++|+..+.||+|+||.||++.... ..+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35679999999999999999998643 234577899999988 6999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999764 359999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... .... .
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~~i-~~~~------~---- 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSI-MEHN------V---- 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HSSC------C----
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HHHH-HhCC------C----
Confidence 322 234556899999999999999999999999999999999999999986432211 1111 1111 1
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTM-----RQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 613 (670)
.++......+.+++..||+.||.+||++ +||++|
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1122233567889999999999999997 888775
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=317.94 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=189.2
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----Ce
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RD 417 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 417 (670)
..++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35789999999999999999997642 235677999999999999999999988754 67
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++|+||++ |+|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999997 699998865 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCcc---------eeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhc
Q 035655 498 FDHGKIS---------HTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHL 566 (670)
Q Consensus 498 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~ 566 (670)
....... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6543211 1223478999999998764 6789999999999999999999999986432111 111110000
Q ss_pred CC---ccccc-----------CCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 567 GQ---VLDVV-----------DPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 567 ~~---~~~~~-----------d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.. ..... -+... ..........+.+++.+||+.||.+||+++|++++-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 00000 00000 0001122356788999999999999999999999654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.53 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=192.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccc-----------cCceeeeeeeeec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLR-----------HKHLVNLQGWCKR 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~-----------H~nIv~l~g~~~~ 414 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 3579999999999999999998633 2356789999999887 8999999999986
Q ss_pred cC----eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEec------C
Q 035655 415 KR----DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLID------A 483 (670)
Q Consensus 415 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld------~ 483 (670)
.+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+ + +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 8999999987666679999999999999999999998 7 999999999999994 4
Q ss_pred CCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch----hHHH
Q 035655 484 DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI----LVDW 559 (670)
Q Consensus 484 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~----~~~~ 559 (670)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.||...... ..+.
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999876542 23447899999999999999999999999999999999999999753211 0000
Q ss_pred HHHH-hhcCCc--------------------ccccCC-CC---------CCcccHHHHHHHHHHHHhhccCCCCCCCCHH
Q 035655 560 VLEF-QHLGQV--------------------LDVVDP-NL---------GSSYVVAEMELVLQLGLLCSHQKAEARPTMR 608 (670)
Q Consensus 560 ~~~~-~~~~~~--------------------~~~~d~-~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 608 (670)
.... ...+.. ...+.. .. ...++......+.+++..||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 0000 000000 000000 00 0123456678899999999999999999999
Q ss_pred HHHHHhc
Q 035655 609 QVLRYLN 615 (670)
Q Consensus 609 evl~~L~ 615 (670)
|+++|-.
T Consensus 330 ell~hp~ 336 (373)
T 1q8y_A 330 GLVNHPW 336 (373)
T ss_dssp HHHTCGG
T ss_pred HHhhChh
Confidence 9999654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.05 Aligned_cols=243 Identities=21% Similarity=0.315 Sum_probs=185.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL---- 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~---- 418 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4688999999999999999997543 136788999999999999999999999877654
Q ss_pred --EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 419 --LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 419 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
++||||++ ++|.+++. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 68888873 348999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcC-------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLG------- 567 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~------- 567 (670)
..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ............
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 65432 334578999999999877 67899999999999999999999999864321 111110000000
Q ss_pred -------CcccccCCCCCCc---ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 568 -------QVLDVVDPNLGSS---YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 568 -------~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
............. ........+.+++..||+.||.+||+++|++++-.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000000000001 11122467889999999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.94 Aligned_cols=241 Identities=25% Similarity=0.342 Sum_probs=169.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHH-HHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIE-SLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~-~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||++.... ...++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4678899999999999999998742 2234556665 778889999999999999999999999
Q ss_pred eccCCCCchhhccc---CCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceec
Q 035655 423 DYIPNGSLDSLLFD---NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLF 498 (670)
Q Consensus 423 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~ 498 (670)
||+++ +|.+++.. .....+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88877753 224578999999999999999999998 7 9999999999999999999999999999866
Q ss_pred cCCCcceeeccccCcCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELA----RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
.... ......||+.|+|||++ .+..++.++|||||||+++||++|+.||....... ...........
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHhcCCC
Confidence 4432 22334799999999998 45678999999999999999999999997532110 01111111112
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+.+...........+.+++..||+.||.+||++.|++++-
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 2222211122345678899999999999999999998853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.95 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=181.6
Q ss_pred hhHHHhhcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe--
Q 035655 355 SDLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD-- 417 (670)
Q Consensus 355 ~~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~-- 417 (670)
.+.....++|+..+.||+|+||.||+|.... ....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455667899999999999999999998643 23467788899999999999999999965433
Q ss_pred -----eEEEEeccCCCCchhhccc--CCccccCHHHHHHHHHHHHHHhhhcc--ccccceEEecccCCCcEEecC-CCcE
Q 035655 418 -----LLLVYDYIPNGSLDSLLFD--NENFVLSWEQRFNIIKGIAAGLLYLH--EEWEQVVIHRDVKSGNVLIDA-DMNA 487 (670)
Q Consensus 418 -----~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDIkp~NILld~-~~~~ 487 (670)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence 8999999986 55444432 23456899999999999999999999 7 89999999999999997 8999
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhh
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQH 565 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~ 565 (670)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999998765433 23345789999999998655 4899999999999999999999999864322 1111111000
Q ss_pred c--CCcccccCCCC----------------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 566 L--GQVLDVVDPNL----------------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 566 ~--~~~~~~~d~~l----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
. .......++.. ...........+.+++..||+.||.+|||+.|+++|-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0 00000001100 00111123567889999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.97 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=172.6
Q ss_pred ccc-cceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeee--ccCeeEEEEec
Q 035655 364 FKQ-SEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCK--RKRDLLLVYDY 424 (670)
Q Consensus 364 f~~-~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~--~~~~~~lV~E~ 424 (670)
|.. .++||+|+||.||+|.... ....+.+|+.+|++++||||+++++++. .....++||||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 444 4589999999999998542 1357889999999999999999999994 46789999999
Q ss_pred cCCCCchhhcccC-------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe----cCCCcEEEEeec
Q 035655 425 IPNGSLDSLLFDN-------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI----DADMNARLGDFG 493 (670)
Q Consensus 425 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kL~DFG 493 (670)
++ |+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 96 5888877532 12349999999999999999999999 899999999999999 778899999999
Q ss_pred CceeccCCCc--ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch----------hHHHH
Q 035655 494 LARLFDHGKI--SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI----------LVDWV 560 (670)
Q Consensus 494 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~----------~~~~~ 560 (670)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 9987654321 223446899999999998874 5899999999999999999999999753221 11111
Q ss_pred HHHhhc---CCccccc------------C-CCCCC-cc-------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 561 LEFQHL---GQVLDVV------------D-PNLGS-SY-------VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 561 ~~~~~~---~~~~~~~------------d-~~l~~-~~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...... ....... . ..... .. .......+.+|+..||+.||.+|||++|+++|-+-
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 000000 0000000 0 00000 00 00002457789999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.79 Aligned_cols=237 Identities=24% Similarity=0.344 Sum_probs=190.8
Q ss_pred hhcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
..++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 35679999999999999999997642 246788999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC---CcEEEEeecCceec
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD---MNARLGDFGLARLF 498 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kL~DFGla~~~ 498 (670)
+||+++++|.+++... ..+++.+++.++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999988654 358999999999999999999999 899999999999999764 46999999999865
Q ss_pred cCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 499 DHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......||+.|+|||.+.+ .++.++||||||++++||++|+.||...... +...... .+... ..
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~-~~~~~------~~ 242 (287)
T 2wei_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVE-TGKYA------FD 242 (287)
T ss_dssp CCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HCCCC------CC
T ss_pred cCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-cCCCC------CC
Confidence 4432 2233468999999998865 5899999999999999999999999764322 1111111 11110 00
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..........+.+++..||+.||.+||++.|++++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 01111223567889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.41 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=181.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeee-----------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCK----------- 413 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~----------- 413 (670)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4678999999999999999997653 2467889999999999999999999873
Q ss_pred ---ccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEE
Q 035655 414 ---RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARL 489 (670)
Q Consensus 414 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL 489 (670)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 699999854 358999999999999999999999 8999999999999997 5679999
Q ss_pred EeecCceeccCCCc--ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhh
Q 035655 490 GDFGLARLFDHGKI--SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQH 565 (670)
Q Consensus 490 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~ 565 (670)
+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643221 12234567999999998765 678999999999999999999999998643211 111100000
Q ss_pred ----------cCCcc----c-ccCCCCC-CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 566 ----------LGQVL----D-VVDPNLG-SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 566 ----------~~~~~----~-~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..... . ...+... ..........+.+++..||+.||.+||+++|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 00000 0 0000000 001112246688999999999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.96 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=185.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe-----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD----- 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~----- 417 (670)
.++|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4678999999999999999997642 13567899999999999999999999987654
Q ss_pred -eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 418 -LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 418 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.++||||++ ++|.+++. ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 69988873 248999999999999999999999 899999999999999999999999999997
Q ss_pred eccCCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc--------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL-------- 566 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~-------- 566 (670)
..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ...........
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 234578999999999876 67899999999999999999999999864321 11111000000
Q ss_pred ----------CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 567 ----------GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 567 ----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
..+.....+.+ ..........+.+++..||+.||.+||+++|+++|-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00000001111 1111233466888999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.02 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=177.7
Q ss_pred CccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCCCC
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGS 429 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 429 (670)
.|...+.||+|+||+||.+.... ..+.+.+|+++|+++ +||||+++++++.+.+..++||||+. |+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 45557889999999997543211 335678999999987 89999999999999999999999995 69
Q ss_pred chhhcccCCccc-----cCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-------------CcEEEEe
Q 035655 430 LDSLLFDNENFV-----LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-------------MNARLGD 491 (670)
Q Consensus 430 L~~~l~~~~~~~-----l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-------------~~~kL~D 491 (670)
|.+++....... .++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999997643211 2344567899999999999998 899999999999999754 4899999
Q ss_pred ecCceeccCCCcc---eeeccccCcCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 035655 492 FGLARLFDHGKIS---HTTNVVGTIGYIAPELART-------GKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWV 560 (670)
Q Consensus 492 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~ 560 (670)
||+++........ ......||+.|+|||++.+ ..++.++|||||||+++||++ |+.||...........
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~ 251 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHh
Confidence 9999977654322 2234589999999999865 578999999999999999999 9999975432221111
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
. .... .+.............+.+++.+||+.||.+||++.|+++|-
T Consensus 252 ~---~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 252 R---GIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp H---TCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c---CCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1 0000 01111122345567889999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.89 Aligned_cols=238 Identities=21% Similarity=0.270 Sum_probs=168.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
.++|+..+.||+|+||.||+|.... ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4678889999999999999998642 1123445556788889999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccc-eEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ-VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
||+ ++.+..+. ......+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 44444444 3334569999999999999999999998 5 8999999999999999999999999999765443
Q ss_pred CcceeeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 502 KISHTTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
. ......||+.|+|||++. ...++.++|||||||+++||++|+.||.........+ ...... . .+.
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~-----~~~ 249 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQE-E-----PPL 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-HHHHHS-C-----CCC
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH-HHHhcc-C-----CCC
Confidence 2 223457999999999984 4568899999999999999999999997633221111 111111 1 111
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
+.. .......+.+++..||+.||.+||+++|++++-
T Consensus 250 ~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 250 LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 110 001224577899999999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.07 Aligned_cols=231 Identities=24% Similarity=0.360 Sum_probs=182.4
Q ss_pred HhhcCccccceEeeeCceeEEEeeccch----------------------HHHHHHHHHHHhcc----ccCceeeeeeee
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPTR----------------------MREFAAEIESLGRL----RHKHLVNLQGWC 412 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~~----------------------~~~f~~Ei~~L~~l----~H~nIv~l~g~~ 412 (670)
...++|+..+.||+|+||.||+|..... ...+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999976331 12344799999999 899999999999
Q ss_pred eccCeeEEEEec-cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEEE
Q 035655 413 KRKRDLLLVYDY-IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLG 490 (670)
Q Consensus 413 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL~ 490 (670)
...+..++|+|+ +++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999 7899999999764 358999999999999999999999 8999999999999999 88999999
Q ss_pred eecCceeccCCCcceeeccccCcCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 491 DFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS-CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 491 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
|||+++...... .....||..|+|||++.+..+. .++|||||||+++||++|+.||...... .. ..
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~-~~- 249 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LE-AE- 249 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HH-TC-
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------hh-hc-
Confidence 999998765532 3345799999999998877664 5899999999999999999999752110 00 00
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+ +......+.+++..||+.||.+||+++|++++-.-
T Consensus 250 -----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 250 -----LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred -----cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 011 11223467789999999999999999999997553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.37 Aligned_cols=229 Identities=24% Similarity=0.371 Sum_probs=188.9
Q ss_pred hhcCccccceEeeeCceeEEEeeccch----------------------HHHHHHHHHHHhccc--cCceeeeeeeeecc
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPTR----------------------MREFAAEIESLGRLR--HKHLVNLQGWCKRK 415 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~~----------------------~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~ 415 (670)
..++|+..+.||+|+||.||+|+.... .+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 456799999999999999999975331 134668999999996 59999999999999
Q ss_pred CeeEEEEeccCC-CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec-CCCcEEEEeec
Q 035655 416 RDLLLVYDYIPN-GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID-ADMNARLGDFG 493 (670)
Q Consensus 416 ~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kL~DFG 493 (670)
+..++|+|++.+ ++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999986 8999999654 468999999999999999999998 8999999999999999 78999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccc
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 572 (670)
+++...... .....||+.|+|||++.+..+ +.++|||||||+++||++|+.||...... . ....
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~-~~~~--- 260 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I-RGQV--- 260 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H-HCCC---
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------h-cccc---
Confidence 998765432 334579999999999887765 68899999999999999999999752210 0 0110
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 573 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.....+ ...+.+++.+||+.||.+||+++|++++-.
T Consensus 261 ---~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 261 ---FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp ---CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 011112 246788999999999999999999998644
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.93 Aligned_cols=195 Identities=17% Similarity=0.164 Sum_probs=148.2
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCC-CCCCCcEEEEEcCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNS-GQGGFGLAFTVSPQ 120 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~-~~~g~GlaF~l~~~ 120 (670)
+.++|+|.+. +|.|+||++..++.|||+|++|+++ +||+|+|+|+|.+++. ..+||||||+|+|.
T Consensus 27 ~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~-------------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~ 92 (253)
T 2dur_A 27 WDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL-------------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRD 92 (253)
T ss_dssp EEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC-------------SSEEEEEEEEEECCCCTTCCCCEEEEEEESC
T ss_pred EEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc-------------CcEEEEEEEEEecCCCCCcCCCcEEEEEECC
Confidence 9999999995 9999999999999999999999965 6899999999998765 57899999999997
Q ss_pred CCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccccccccccCC-----Ccccc
Q 035655 121 PSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENG-----TKEDF 195 (670)
Q Consensus 121 ~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~-----~~~~~ 195 (670)
.. ..|++||+.+ .++.|||||||++| .+ +|+ |+++||+++.+..+++.....++ .....
T Consensus 93 ~~----~~G~~lG~~~-------~~~gvAVefDT~~n-~~--~~~--~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~ 156 (253)
T 2dur_A 93 RL----VPGPVFGSKD-------NFHGLAIFLDTYPN-DE--TTE--RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTA 156 (253)
T ss_dssp CS----CEETBTEECS-------SCEEEEEEEECSCC-CT--TCC--SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEEC
T ss_pred CC----CCCcccCcCC-------CCCEEEEEEECCCC-CC--CCC--CCCcEEEEEecCCceeeeccCCCcccccccccH
Confidence 54 3579999733 35789999999998 44 333 56666666655544321100011 00112
Q ss_pred cc-CCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEec
Q 035655 196 TL-ESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILG 274 (670)
Q Consensus 196 ~l-~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~s 274 (670)
.+ ..|..++|||+||+. +|+|++.+.+. .|.+++++ ++ ...||++|||||||+||...+.|+|++
T Consensus 157 ~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~---------~~~~~~~~--~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ils 222 (253)
T 2dur_A 157 DFRNRDHDTFLAVRYSRG--RLTVMTDLEDK---------NEWKNCID--IT-GVRLPTGYYFGASAGTGDLSDNHDIIS 222 (253)
T ss_dssp CCBTCSSCEEEEEEEETT--EEEEEEECSSS---------SCCEEEEE--EC-CEECCSSBEEEEEEEESSSCCEEEEEE
T ss_pred hhccCCCCeEEEEEEECC--EEEEEEeCCCC---------CCceEEEE--eC-CcccCCCcEEEEEeccCCCcceEEEEE
Confidence 34 348899999999975 89999987543 24444443 34 346999999999999999999999999
Q ss_pred cccccC
Q 035655 275 WSFSMN 280 (670)
Q Consensus 275 W~fs~~ 280 (670)
|+|.+-
T Consensus 223 wsf~sl 228 (253)
T 2dur_A 223 MKLFQL 228 (253)
T ss_dssp EEEEEC
T ss_pred EEEEec
Confidence 999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=323.27 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=179.1
Q ss_pred hhcCccccceEeeeCceeE-EEeeccc-----------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccC
Q 035655 360 ATKGFKQSEVIGTGGFGEV-YKGVLPT-----------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~V-ykg~~~~-----------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
...+|...+.||+|+||+| |++.... ....+.+|+++|+++ +||||+++++++.+....++||||++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 3456888999999999995 4443322 223467899999999 79999999999999999999999996
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-----CCcEEEEeecCceeccCC
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-----DMNARLGDFGLARLFDHG 501 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-----~~~~kL~DFGla~~~~~~ 501 (670)
|+|.+++..... .+.+..++.++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 102 -g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 -ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp -EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred -CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 699999976543 45556678999999999999999 89999999999999943 346889999999876543
Q ss_pred Cc--ceeeccccCcCCCCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 502 KI--SHTTNVVGTIGYIAPELAR---TGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
.. .......||+.|+|||++. ...++.++|||||||+++||++ |+.||.......... .. .........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---~~-~~~~~~~~~- 251 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LL-GACSLDCLH- 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---HT-TCCCCTTSC-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---Hh-ccCCccccC-
Confidence 21 2234567999999999987 4567889999999999999999 999996533221111 11 110011111
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
........+.+++..||+.||.+||+++|+++|-
T Consensus 252 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 252 -----PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp -----TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred -----ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 1123345577899999999999999999999753
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=290.86 Aligned_cols=206 Identities=14% Similarity=0.133 Sum_probs=155.9
Q ss_pred ceeEEeCCCCCC---CCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEE
Q 035655 24 KEEFIFNGFNET---KTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQ 100 (670)
Q Consensus 24 ~~~f~~~~f~~~---~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~ 100 (670)
..||.-+..... -.+ +.++|+|.+. +|.|+||++..++.||++|++|++ ++||+|+|+|+
T Consensus 33 ~~Sf~~P~~~~~~~~i~~---w~~~G~a~i~-~~~IrLT~~~~~~~G~~w~~~p~~-------------~~sF~t~F~F~ 95 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPF---WAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAA-------------FENWEVEVTFR 95 (260)
T ss_dssp GGCEECSSCSCTTSCBTT---EEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBC-------------CSSEEEEEEEE
T ss_pred ceeEcCccccCCCCccCC---eEEcccEEee-CCEEEeCCCCCCCEEEEEECCCcc-------------ccCEEEEEEEE
Confidence 356655544321 134 9999999995 899999999889999999999994 47999999999
Q ss_pred EecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCC-CCC------CCCeeEEec
Q 035655 101 IVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNET-SDS------QGNHVGINV 173 (670)
Q Consensus 101 i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-~Dp------~~~Hvgidv 173 (670)
|..++ ..+||||||+|+|... ..|++||+. ..++.||||||||+| .+. .+| |++|+|||+
T Consensus 96 I~~~~-~~~gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N-~~~~~~p~I~~~indg~~~~d~ 162 (260)
T 1gv9_A 96 VTGRG-RIGADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDN-DGKKNNPAIVVVGNNGQINYDH 162 (260)
T ss_dssp EECSS-SCCCCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC------CCEEEEEEEESCCCCCH
T ss_pred EecCC-CCCCCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCC-CCCCCCCceEEEeCCCceEeec
Confidence 99764 3689999999998754 357889983 245789999999998 432 123 467888888
Q ss_pred CC-cccccccccccccCCCccccccC-CCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccc
Q 035655 174 NS-MKSIKLEPAAYYENGTKEDFTLE-SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAF 251 (670)
Q Consensus 174 ns-~~s~~~~~~~~~~~~~~~~~~l~-~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l 251 (670)
|+ +.|..... ....+. +|..++|||+||+. +|+|++.+... +......++..+| +.+|
T Consensus 163 ~~d~~s~~~~~---------c~~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~--------~~~~~~~~~~~vd-~~~L 222 (260)
T 1gv9_A 163 QNDGATQALAS---------CQRDFRNKPYPVRAKITYYQK--TLTVMINNGFT--------PDKNDYEFCAKVE-NMVI 222 (260)
T ss_dssp HHHHHHHCSEE---------ECCCCBSCSSCEEEEEEEETT--EEEEEEECSSC--------CCTTCCEEEEEET-TCCC
T ss_pred CCCcccceeec---------cChhhccCCCcEEEEEEEECC--EEEEEEeeccC--------CCCCcceEEEEEc-cccc
Confidence 75 55543332 112333 58999999999986 89999975321 1111235777888 6789
Q ss_pred cccceeeEeecCCceeeeEEEecccccc
Q 035655 252 QETMYVGFSASTGRKVSSHFILGWSFSM 279 (670)
Q Consensus 252 ~~~~~vGFsastg~~~~~h~i~sW~fs~ 279 (670)
|+++||||||+||...+.|+|++|+|..
T Consensus 223 P~~~~vGfSAaTG~~~e~hdIlsw~~~~ 250 (260)
T 1gv9_A 223 PTQGHFGISAATGGLADDHDVLSFLTFQ 250 (260)
T ss_dssp CSSBEEEEEEECCSSCCEEEEEEEEEEE
T ss_pred CCCcEEEEEEeCCCCcceEEEEEEEEEE
Confidence 9999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.10 Aligned_cols=223 Identities=22% Similarity=0.281 Sum_probs=173.5
Q ss_pred hcCcccc-ceEeeeCceeEEEeeccc-----------hHHHHHHHHHHH-hccccCceeeeeeeeec----cCeeEEEEe
Q 035655 361 TKGFKQS-EVIGTGGFGEVYKGVLPT-----------RMREFAAEIESL-GRLRHKHLVNLQGWCKR----KRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~-~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L-~~l~H~nIv~l~g~~~~----~~~~~lV~E 423 (670)
.++|... +.||+|+||.||++.... ....+.+|+.++ +.++||||+++++++.. ....++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3567776 779999999999998743 246788999998 55689999999999876 677999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~DFGla~~~~~ 500 (670)
|+++|+|.+++.......+++.+++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999999987766679999999999999999999999 89999999999999998 7899999999986433
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
+..++.++|||||||+++||++|+.||......... .................
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCTTCCSSCHH
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----HHHHHHHhhccccCCch
Confidence 234678999999999999999999999753211000 00000000000011100
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
........+.+++..||+.||.+||+++|+++|-
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0112346788999999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=333.59 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=186.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeec------cCee
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKR------KRDL 418 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~~~ 418 (670)
++|+..++||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 679999999999999999987633 24568899999999999999999999865 6778
Q ss_pred EEEEeccCCCCchhhcccCC-ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc---EEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDNE-NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN---ARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kL~DFGl 494 (670)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 2368999999999999999999999 89999999999999997765 99999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCC----cc
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ----VL 570 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~----~~ 570 (670)
+....... ......||+.|+|||++.+..++.++|||||||+++||++|+.||..... ...|......... ..
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC------CCSC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhcccchhhhhh
Confidence 98765443 23446799999999999999999999999999999999999999975321 1111110000000 00
Q ss_pred ccc--------CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHH
Q 035655 571 DVV--------DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQV 610 (670)
Q Consensus 571 ~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 610 (670)
+.. ...............+.+++..||+.||.+||+++|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 0011122344466788999999999999999999664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=331.68 Aligned_cols=222 Identities=20% Similarity=0.276 Sum_probs=179.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCe-----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRD----- 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~----- 417 (670)
.++|++.+.||+|+||.||++.+.. ....+.+|++++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999997642 12467899999999999999999999987665
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.|+||||+++++|.+++.. .++|.+++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999998743 69999999999999999999999 899999999999999986 999999999987
Q ss_pred ccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
.... ....||+.|+|||++.++. +.++|||||||+++||++|..|+..... ..+.
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~~~~--- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------DGLP--- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC----------------SSCC---
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc----------------cccc---
Confidence 6543 3457999999999987654 8999999999999999999988764110 0000
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHHhc
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPT-MRQVLRYLN 615 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 615 (670)
...........+.+++..||+.||.+||+ ++++.+.|.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 01112223456889999999999999996 555554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.73 Aligned_cols=212 Identities=13% Similarity=0.062 Sum_probs=169.0
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||.||+|.... ..+.|.+|+..+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 579999999999999999998643 1267899999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++++|.+++... ....++.+++.|++.||.|||+ .+|+||||||+|||++.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~---------- 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP---------- 173 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC----------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec----------
Confidence 999999999999432 3555788999999999999999 89999999999999999999999743
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC--Cc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG--SS 580 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~ 580 (670)
+|++| ++.++|||||||++|||++|+.||........ ............. ..
T Consensus 174 -----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~--------~~~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 174 -----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG--------LAPAERDTAGQPIEPAD 227 (286)
T ss_dssp -----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC--------SEECCBCTTSCBCCHHH
T ss_pred -----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh--------hHHHHHHhccCCCChhh
Confidence 34443 68999999999999999999999986332100 0000000000000 01
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
........+.+++.+||+.||.+| |+.|+++.|+..
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 112234568899999999999999 999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.88 Aligned_cols=229 Identities=14% Similarity=0.129 Sum_probs=172.7
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcccc-Cceeeee---------
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRH-KHLVNLQ--------- 409 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H-~nIv~l~--------- 409 (670)
..+++|...++||+|+||.||+|.+.. ..+.|.+|+.+++.++| +|.....
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345568888999999999999998642 24678899999999987 3221111
Q ss_pred ------------eeeec-----cCeeEEEEeccCCCCchhhcc-----cCCccccCHHHHHHHHHHHHHHhhhccccccc
Q 035655 410 ------------GWCKR-----KRDLLLVYDYIPNGSLDSLLF-----DNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467 (670)
Q Consensus 410 ------------g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 467 (670)
.++.. ....+++|+++ +++|.+++. ......+++..++.++.||++||+|||+ +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~ 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 11111 12457777765 689999984 2334568999999999999999999998 8
Q ss_pred eEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCcccc----------ccCCCCccchhHHHHH
Q 035655 468 VVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA----------RTGKASCSTDVFAYGV 537 (670)
Q Consensus 468 ~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~S~Gv 537 (670)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999999865432 344577 999999998 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 538 LLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 538 vl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
++|||++|+.||...... .......... ..+ .+.+.+++..||+.||.+||++.|++++
T Consensus 306 il~elltg~~Pf~~~~~~-----------~~~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAAL-----------GGSEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGG-----------SCSGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchh-----------hhHHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999763211 0011111100 112 2567889999999999999998888763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=298.51 Aligned_cols=228 Identities=18% Similarity=0.215 Sum_probs=175.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccc---------cCceeeee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLR---------HKHLVNLQ 409 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~---------H~nIv~l~ 409 (670)
.++|+..++||+|+||.||+|+... ..+.+.+|+.++++++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4678899999999999999997633 1277899999999986 55555555
Q ss_pred ee-----------------eec-------------cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhh
Q 035655 410 GW-----------------CKR-------------KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459 (670)
Q Consensus 410 g~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~ 459 (670)
+. +.+ .+..++||||+++|++.+.+.+ ..+++.+++.++.||+.||.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 54 433 6789999999999987777643 35899999999999999999
Q ss_pred hcc-ccccceEEecccCCCcEEecCCC--------------------cEEEEeecCceeccCCCcceeeccccCcCCCCc
Q 035655 460 YLH-EEWEQVVIHRDVKSGNVLIDADM--------------------NARLGDFGLARLFDHGKISHTTNVVGTIGYIAP 518 (670)
Q Consensus 460 yLH-~~~~~~ivHrDIkp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 518 (670)
||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 7 8999999999999999887 8999999999876542 34799999999
Q ss_pred cccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc--ccCCCCCCcccHHHHHHHHHHHHh
Q 035655 519 ELARTGKASCSTDVFAYGVL-LLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD--VVDPNLGSSYVVAEMELVLQLGLL 595 (670)
Q Consensus 519 E~~~~~~~t~ksDV~S~Gvv-l~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~d~~l~~~~~~~~~~~l~~l~~~ 595 (670)
|++.+.. +.++||||++++ .+++++|..||.. ..|...... .+.. .................+.+++..
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTD--KMLKQMTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHH--HHHHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHH--hhhhhhccCcccchhhhhhcCHHHHHHHHH
Confidence 9998666 899999998777 6778889999742 112111100 0000 111112223445667889999999
Q ss_pred hccCCCCCCCCHHHHH-HH
Q 035655 596 CSHQKAEARPTMRQVL-RY 613 (670)
Q Consensus 596 Cl~~dP~~RPs~~evl-~~ 613 (670)
||+.| |++|++ +|
T Consensus 319 ~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 319 MLNFS-----SATDLLCQH 332 (336)
T ss_dssp GGGSS-----SHHHHHHHC
T ss_pred HhccC-----CHHHHHhcC
Confidence 99966 999998 65
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=278.54 Aligned_cols=116 Identities=28% Similarity=0.457 Sum_probs=105.5
Q ss_pred CCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeec
Q 035655 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPM 223 (670)
Q Consensus 144 ~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~ 223 (670)
.||+|||||||++| .++.||++|||||||||+.|+++++ +++.+|+.|+|||+||+.+++|+|+|++.
T Consensus 1 ~n~~vAVEFDT~~n-~~~~Dp~~nHVGIdvNs~~S~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~ 68 (237)
T 1nls_A 1 ADTIVAVELDTYPN-TDIGDPSYPHIGIDIKSVRSKKTAK-----------WNMQNGKVGTAHIIYNSVDKRLSAVVSYP 68 (237)
T ss_dssp CCCEEEEEEECSCC-GGGTCCSSCEEEEEESSSSCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred CCCEEEEEEeCCCC-cccCCCCCCeeeEecCCcccccccc-----------ccccCCCEEEEEEEEeCCCCEEEEEEecC
Confidence 37899999999999 7877999999999999999998876 45789999999999999999999999864
Q ss_pred CCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEeccccccCCC
Q 035655 224 NKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGA 282 (670)
Q Consensus 224 ~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~~ 282 (670)
+ . ..|+|++.+||+++|+|+||||||||||...|.|+|++|+|++...
T Consensus 69 ~----------~-~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~ 116 (237)
T 1nls_A 69 N----------A-DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK 116 (237)
T ss_dssp T----------S-CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred C----------C-CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence 3 1 4689999999999999999999999999999999999999998753
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=214.83 Aligned_cols=105 Identities=23% Similarity=0.423 Sum_probs=94.1
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+.++|+|++|.+...+ |.++|+|.+.+ |.|+||++.. +++|||+|++||+|||+ ++ +|+||+|+
T Consensus 2 ~~~~F~f~~F~~~~~n---l~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg-----~vaSFsT~ 71 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQED---LIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SA-----VLTSFDTI 71 (113)
T ss_dssp EEEEEEESSCCSSCTT---EEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TE-----EEEEEEEE
T ss_pred cceEEEcCCCCCCCCC---eEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CC-----CEEeeEEE
Confidence 3579999999864356 99999999985 9999998764 79999999999999999 88 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCC
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNST 138 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~ 138 (670)
|+|.|.+++...+||||||||+|....|. +.||||||+|.+
T Consensus 72 F~F~I~~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 72 INFEISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA 112 (113)
T ss_dssp EEEEEECSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred EEEEEecCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence 99999988777899999999999887776 999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-28 Score=280.33 Aligned_cols=153 Identities=24% Similarity=0.201 Sum_probs=116.4
Q ss_pred hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc
Q 035655 386 RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464 (670)
Q Consensus 386 ~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 464 (670)
..++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.+.. +++.. +|+.||+.||+|||+
T Consensus 284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~- 357 (569)
T 4azs_A 284 NKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK- 357 (569)
T ss_dssp HHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH-
Confidence 346799999999999 69999999999999999999999999999999997653 45553 589999999999999
Q ss_pred ccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 035655 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT 544 (670)
Q Consensus 465 ~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t 544 (670)
++||||||||+||||++++++||+|||+|+...... ......+||++|||||++.+ .+..++|+|++|++++++.+
T Consensus 358 --~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 358 --QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp --TTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred --CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 999999999999999999999999999998765433 23445689999999999875 56778999999999877765
Q ss_pred CCCC
Q 035655 545 GRRP 548 (670)
Q Consensus 545 G~~p 548 (670)
+..+
T Consensus 434 ~~~~ 437 (569)
T 4azs_A 434 PWSN 437 (569)
T ss_dssp THHH
T ss_pred ccch
Confidence 5433
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=216.91 Aligned_cols=183 Identities=17% Similarity=0.244 Sum_probs=140.7
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
+.+.|+|.+. ++.|+||++ .++.|+++.+.|+.+ +++|+|+|+|+|..+. ..+||||||++++..
T Consensus 33 w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~------------~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~ 97 (256)
T 2a6y_A 33 WQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDL------------KDSFTMEWTFRSVGYS-GQTDGGISFWFVQDS 97 (256)
T ss_dssp EEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEE------------SSCEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred eEEccceEEe-CCEEEECCC-CCceEEEeeCCCCcc------------cCCEEEEEEEEEecCC-CCCCCeEEEEEeCCC
Confidence 9999999995 999999998 678999888888864 4789999999999764 348999999999875
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCC------CCeeEEecCCcccccccccccccCCCcccc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQ------GNHVGINVNSMKSIKLEPAAYYENGTKEDF 195 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~------~~Hvgidvns~~s~~~~~~~~~~~~~~~~~ 195 (670)
..| ..|+.+|..+. ..-+||||||+.| . .|. +.|+++|.+++.+..... + ..
T Consensus 98 ~~~--~~g~~~G~~~~-------f~GlaV~fDT~~n-~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~-c--------~~ 155 (256)
T 2a6y_A 98 NIP--RDKQLYNGPVN-------YDGLQLLVDNNGP-L---GPTLRGQLNDGQKPVDKTKIYDQSFAS-C--------LM 155 (256)
T ss_dssp SSC--CCCTBTTBCTT-------CEEEEEEEESCST-T---CSEEEEEEEESSSCCCGGGHHHHCSEE-E--------EC
T ss_pred Ccc--cCCcccCcCCC-------CCEEEEEEECCCC-C---CceEEEEECCCceecccCCCcccceec-c--------ee
Confidence 432 56788888642 2358999999977 2 343 678888888744443332 1 11
Q ss_pred cc-CCCCcEEEEEEec-CcccEEEEEEeecCCcccccccCCCCCCcccccccCCccc-ccccc-eeeEeecCC---ceee
Q 035655 196 TL-ESGDPVQAWIDYD-GVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPA-FQETM-YVGFSASTG---RKVS 268 (670)
Q Consensus 196 ~l-~~g~~~~a~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~-l~~~~-~vGFsastg---~~~~ 268 (670)
.. .+|..++|||+|+ +..+.|+|.+.. . . -.++..+ ||+.+ ||||||+|| ...+
T Consensus 156 ~~rn~~~~~~v~I~Y~~~~~~~L~V~i~~--~-------------~----c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d 216 (256)
T 2a6y_A 156 GYQDSSVPSTIRVTYDLEDDNLLKVQVDN--K-------------V----CFQTRKVRFPSGSYRIGVTAQNGAVNNNAE 216 (256)
T ss_dssp CCTTCSSCEEEEEEEEGGGTSEEEEEETT--E-------------E----EEEESCEECCSEEEEEEEEEECCSGGGCCC
T ss_pred ecccCCCcEEEEEEEecCCCcEEEEEEcC--E-------------E----EEEECcEEeCCCCeEEEEEEeCCCCCCCcc
Confidence 22 3789999999999 888899999842 1 1 1223344 78887 699999999 8899
Q ss_pred eEEEeccccccC
Q 035655 269 SHFILGWSFSMN 280 (670)
Q Consensus 269 ~h~i~sW~fs~~ 280 (670)
.|+|++|+|...
T Consensus 217 ~hdIls~~~~~~ 228 (256)
T 2a6y_A 217 SFEIFKMQFFNG 228 (256)
T ss_dssp EEEEEEEEEEES
T ss_pred eEEEEEEEEEec
Confidence 999999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=252.88 Aligned_cols=173 Identities=17% Similarity=0.162 Sum_probs=137.2
Q ss_pred CccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.+...++||+|+||.||+|.... ..+.|.+|+++|++++||||+++..++...+..++
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp -----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred cCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 33456789999999999885422 13457899999999999999977777777788899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++++|.+++.+ +..++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999964 55899999999999998 89999999999999998 999999999998755
Q ss_pred CCcce------eeccccCcCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 501 GKISH------TTNVVGTIGYIAPELART--GKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 501 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
..... .....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 235689999999999976 567888999999999998888877763
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=216.01 Aligned_cols=107 Identities=24% Similarity=0.508 Sum_probs=94.1
Q ss_pred CCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeE
Q 035655 22 QQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFST 95 (670)
Q Consensus 22 ~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst 95 (670)
++.++|+|++|.+...+ |.++|+|.+.++|.|+||++.. +++|||+|++||+|||. ++ +++||+|
T Consensus 123 s~~~~F~~~~F~~~~~n---l~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~-----~vaSFsT 193 (237)
T 1nls_A 123 TNALHFMFNQFSKDQKD---LILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SA-----VVASFEA 193 (237)
T ss_dssp EEEEEEEESCCCTTCTT---EEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TE-----EEEEEEE
T ss_pred cccchhhhccccccCCC---eEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CC-----CEeeeEE
Confidence 35689999999864456 9999999997789999998763 78999999999999997 66 8999999
Q ss_pred EEEEEEecCCCCCCCCcEEEEEcCCC-CCCCCCCCcccccccCC
Q 035655 96 CFVFQIVTPNSGQGGFGLAFTVSPQP-SFPGGKAEHYLGILNST 138 (670)
Q Consensus 96 ~F~f~i~~~~~~~~g~GlaF~l~~~~-~~~~~~~g~~lGl~~~~ 138 (670)
+|+|.|.++ ...+||||||||+|.+ .+|.+++||||||||.+
T Consensus 194 ~F~F~I~~~-~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 194 TFTFLIKSP-DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp EEEEECCCS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred EEEEEEecC-CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 999999986 3468999999999987 48999999999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-20 Score=191.83 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=109.8
Q ss_pred hHHHhhcCccccceEeeeCceeEEEeeccc---------------------------------hHHHHHHHHHHHhcccc
Q 035655 356 DLYTATKGFKQSEVIGTGGFGEVYKGVLPT---------------------------------RMREFAAEIESLGRLRH 402 (670)
Q Consensus 356 ~l~~~t~~f~~~~~lG~G~fg~Vykg~~~~---------------------------------~~~~f~~Ei~~L~~l~H 402 (670)
.+......|...+.||+|+||.||+|.... ....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344445567778999999999999998632 1235789999999999
Q ss_pred CceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 403 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE
Confidence 5 666665543 56799999999999998 521 2244799999999999998 9999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccc
Q 035655 483 ADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 522 (670)
++.+||+|||+++. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999963 34578999874
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=157.75 Aligned_cols=181 Identities=19% Similarity=0.264 Sum_probs=123.6
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
+.+.|+|.+. ++.|+||++ .++.|.++.+.|+++. .+|+++|+|+|..+. ..+||||||.+++.+
T Consensus 26 W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~------------~~weie~~Fri~g~~-~~~gdGlA~W~t~~~ 90 (222)
T 2a6z_A 26 WQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK------------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDS 90 (222)
T ss_dssp EEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC------------SCEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred cEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCC------------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 9999999997 899999999 5778999999999752 369999999998763 357999999999765
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC-cccccc-----cccccccCCCcccc
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS-MKSIKL-----EPAAYYENGTKEDF 195 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns-~~s~~~-----~~~~~~~~~~~~~~ 195 (670)
..+ ..|..+|.-+. -.=+||+|||+.| . .++|.+.+|. -.+-.. ..++. -..
T Consensus 91 ~~~--~~g~~~G~~~~-------f~GL~I~~Dt~~n-~------~p~i~~~~ndG~~~yd~~~~~~~~~~~------C~~ 148 (222)
T 2a6z_A 91 NIP--RDKQLYNGPVN-------YDGLQLLVDNNGP-L------GPTLRGQLNDGQKPVDKTKIYDQSFAS------CLM 148 (222)
T ss_dssp SSC--CCCTBTTBCTT-------CEEEEEEEESCST-T------SSEEEEEEEESSSCCCGGGHHHHCSEE------EEC
T ss_pred ccc--CCCcccCCCCC-------CCEEEEEEECCCC-C------CceEEEEECCCCeeeccCCCccccccc------cce
Confidence 311 23444444221 1125999999976 2 3456655542 111000 11110 011
Q ss_pred cc-CCCCcEEEEEEec-CcccEEEEEEeecCCcccccccCCCCCCccc-ccccCCccccccc-ceeeEeecCC---ceee
Q 035655 196 TL-ESGDPVQAWIDYD-GVNRLVNVTICPMNKKNKLSFHFGKPSQPLL-SLPLDLSPAFQET-MYVGFSASTG---RKVS 268 (670)
Q Consensus 196 ~l-~~g~~~~a~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~l-s~~~dl~~~l~~~-~~vGFsastg---~~~~ 268 (670)
.. ..+.+.++||+|+ ...+.|+|.+.. . ..+ ...|+ ||+. .|+||||+|| ...+
T Consensus 149 ~~rn~~~~~~~rI~Y~~~~~~~l~v~id~--~-------------~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d 209 (222)
T 2a6z_A 149 GYQDSSVPSTIRVTYDLEDDNLLKVQVDN--K-------------VCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAE 209 (222)
T ss_dssp CCTTEEEEEEEEEEEEGGGTSEEEEEETT--E-------------EEEEESCCC----CCSSEEEEEEEEECCSGGGCCC
T ss_pred eccCCCCcEEEEEEEEcCCCcEEEEEEcC--e-------------EEEEeCCee----cCCCCcEEEEEEcCCCCCCCCc
Confidence 22 3477899999998 667789998742 1 111 12233 4555 4799999999 8889
Q ss_pred eEEEeccccc
Q 035655 269 SHFILGWSFS 278 (670)
Q Consensus 269 ~h~i~sW~fs 278 (670)
.|+|++|++.
T Consensus 210 ~hdil~~~~~ 219 (222)
T 2a6z_A 210 SFEIFKMQFF 219 (222)
T ss_dssp EEEEEEEEEE
T ss_pred cEEEEEEEEE
Confidence 9999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-16 Score=161.76 Aligned_cols=122 Identities=18% Similarity=0.142 Sum_probs=96.1
Q ss_pred ccccceEeeeCceeEEEeec-cch-H----------------------------------------HHHHHHHHHHhccc
Q 035655 364 FKQSEVIGTGGFGEVYKGVL-PTR-M----------------------------------------REFAAEIESLGRLR 401 (670)
Q Consensus 364 f~~~~~lG~G~fg~Vykg~~-~~~-~----------------------------------------~~f~~Ei~~L~~l~ 401 (670)
|+..+.||+|+||.||+|.. ..+ . ..+.+|+..|++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999976 111 0 14678999999999
Q ss_pred cCce--eeeeeeeeccCeeEEEEeccCC-C----CchhhcccCCccccCHHHHHHHHHHHHHHhhhcc-ccccceEEecc
Q 035655 402 HKHL--VNLQGWCKRKRDLLLVYDYIPN-G----SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH-EEWEQVVIHRD 473 (670)
Q Consensus 402 H~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrD 473 (670)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| + .+|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 8864 334432 357899999942 4 55555421 345677899999999999999 7 8999999
Q ss_pred cCCCcEEecCCCcEEEEeecCceecc
Q 035655 474 VKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 474 Ikp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997653
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.44 E-value=1.2e-14 Score=107.88 Aligned_cols=45 Identities=33% Similarity=0.478 Sum_probs=41.9
Q ss_pred CcccccccCCcccccccceeeEeecCCceeeeEEEeccccccCCC
Q 035655 238 QPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNGA 282 (670)
Q Consensus 238 ~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~~ 282 (670)
+|+|+..+||+++|+|+||||||||||...|.|+|++|+|++++.
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~ 47 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS 47 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence 378999999999999999999999999999999999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.44 E-value=7e-14 Score=149.38 Aligned_cols=125 Identities=14% Similarity=0.131 Sum_probs=88.7
Q ss_pred CccccceEeeeCceeEEEeeccch-----------------------------HHHH--------HHHHHHHhccccCce
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR-----------------------------MREF--------AAEIESLGRLRHKHL 405 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~-----------------------------~~~f--------~~Ei~~L~~l~H~nI 405 (670)
-|++.++||+|++|.||+|..+.+ .... .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999976431 0111 134555555544333
Q ss_pred eeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC
Q 035655 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM 485 (670)
Q Consensus 406 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 485 (670)
....-+ .....+|||||+++++|.++... +....++.|++.+|.|||+ .+||||||||.|||+++++
T Consensus 176 ~vp~p~--~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPI--AQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEE--EEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCCeee--eccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 211111 11234799999999998776421 1235688999999999998 8999999999999998877
Q ss_pred ----------cEEEEeecCceeccC
Q 035655 486 ----------NARLGDFGLARLFDH 500 (670)
Q Consensus 486 ----------~~kL~DFGla~~~~~ 500 (670)
.+.|+||+.+....+
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CcccccccccceEEEEeCCcccCCC
Confidence 389999998875444
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-11 Score=118.24 Aligned_cols=181 Identities=18% Similarity=0.166 Sum_probs=116.8
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
..+.|+|.+. ++.|+||++ +++.|.++-+.|+.+ ..+|+.+|+|+|..... .+||||||.+...+
T Consensus 29 W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~------------~~~weiev~Fri~G~~~-~~gdGlA~Wyt~~~ 93 (226)
T 2a6v_A 29 WTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSI------------KDAMTIEWTFRSFGFRG-STKGGLAFWLKQGN 93 (226)
T ss_dssp EEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCC------------SSCEEEEEEEEEESCCS-CCSCEEEEEEECSC
T ss_pred cEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCC------------CCCeEEEEEEEEecCCC-CCCCEEEEEEECCC
Confidence 8999999997 789999999 999999999999964 14699999999997643 37999999999654
Q ss_pred CCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecC-Ccccccc---cccccccCCCccccc-
Q 035655 122 SFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVN-SMKSIKL---EPAAYYENGTKEDFT- 196 (670)
Q Consensus 122 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvn-s~~s~~~---~~~~~~~~~~~~~~~- 196 (670)
.. ..|...|-... .-.=+||.|||+.| . ...|-+-+| +-.+-.. ..++.- ...
T Consensus 94 ~~---~~g~vfGg~~d------~f~GlgI~~Dt~~n-~------~p~i~~~~NDGt~~yd~~~~~~~g~C------~~~~ 151 (226)
T 2a6v_A 94 EG---DSTELFGGSSK------KFNGLMILLRLDDK-L------GESVTAYLNDGTKDLDIESSPYFASC------LFQY 151 (226)
T ss_dssp CC---CCCTBTTTBCS------SCEEEEEEEEEETT-T------EEEEEEEEEESSSCCCTTTSCCSEEE------ECCC
T ss_pred CC---CCcccccccCC------CccEEEEEEECCCC-C------CceEEEEECCCCcccCCCCCcccceE------eEec
Confidence 31 12222221000 01126999999976 1 122322222 2221111 111100 011
Q ss_pred cCCCCcEEEEEEec-CcccEEEEEEeecCCcccccccCCCCCCcccc-cccCCccccccc--ceeeEeecCCceeeeEEE
Q 035655 197 LESGDPVQAWIDYD-GVNRLVNVTICPMNKKNKLSFHFGKPSQPLLS-LPLDLSPAFQET--MYVGFSASTGRKVSSHFI 272 (670)
Q Consensus 197 l~~g~~~~a~I~Yd-~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls-~~~dl~~~l~~~--~~vGFsastg~~~~~h~i 272 (670)
...+...+++|.|+ ...++|+|.+.. . ..+. ..| .||.. +|+||||+||...+.|.|
T Consensus 152 rn~~~~t~~ri~Y~~~~~~~l~v~id~--~-------------~Cf~~~~v----~LP~g~~~yfGiSAaTg~~~D~hdi 212 (226)
T 2a6v_A 152 QDSMVPSTLRLTYNPLDNHLLKLQMDN--R-------------VCFQTRKV----KFMGSSPFRIGTSAINDASKESFEI 212 (226)
T ss_dssp SSCSSCEEEEEEEEGGGTSEEEEEETT--E-------------EEEEESCC----CGGGTSCBEEEEEEECCTTCCEEEE
T ss_pred cCCCCCEEEEEEEEccCCCEEEEEEcC--C-------------eeEEECCe----ecCCCCccEEEEEEcCCCCcccEEE
Confidence 23467899999997 456789998741 1 1221 112 24444 499999999999999999
Q ss_pred eccccc
Q 035655 273 LGWSFS 278 (670)
Q Consensus 273 ~sW~fs 278 (670)
++-.+.
T Consensus 213 ls~~~~ 218 (226)
T 2a6v_A 213 LKMKLY 218 (226)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 997665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-09 Score=110.13 Aligned_cols=131 Identities=14% Similarity=0.049 Sum_probs=102.2
Q ss_pred HhhcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEe
Q 035655 359 TATKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 359 ~~t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E 423 (670)
....+|.....++.|+.+.||+....+ ....+.+|+.+++.+. +..+.++++++...+..++|||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 344567777778888888899875321 2345889999999995 6778899999988889999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc---------------------------------------
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE--------------------------------------- 464 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 464 (670)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987642 1122347889999999999971
Q ss_pred -----------------ccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 465 -----------------WEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 465 -----------------~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11569999999999999876666799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.77 E-value=7.6e-09 Score=104.08 Aligned_cols=126 Identities=16% Similarity=0.121 Sum_probs=89.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCc--eeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKH--LVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
.++......+.|..+.||+....+ ....+.+|+.+++.+++.+ +.++++++...+..++||||++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 344443332344558888876432 1245789999999997655 45688888888889999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc------------------------------------------
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW------------------------------------------ 465 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------ 465 (670)
.+|. ... .. ...++.++++.|..||+..
T Consensus 100 ~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8884 211 11 2256777777777777621
Q ss_pred -------------cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 -------------EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 -------------~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 13499999999999998876678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.70 E-value=5e-08 Score=103.70 Aligned_cols=127 Identities=15% Similarity=0.193 Sum_probs=97.8
Q ss_pred cceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccc--cCceeeeeeeeecc---CeeEEEEec
Q 035655 367 SEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLR--HKHLVNLQGWCKRK---RDLLLVYDY 424 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~---~~~~lV~E~ 424 (670)
.+.|+.|.++.||+....+ ....+.+|+.+++.|+ +..+.+++.++.+. +..++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4667888888888764321 1246778999999997 45678899988776 458999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc---------------------------------------
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW--------------------------------------- 465 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 465 (670)
+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9998885422 124678888999999999999999720
Q ss_pred ----------------cceEEecccCCCcEEecCCCc--EEEEeecCcee
Q 035655 466 ----------------EQVVIHRDVKSGNVLIDADMN--ARLGDFGLARL 497 (670)
Q Consensus 466 ----------------~~~ivHrDIkp~NILld~~~~--~kL~DFGla~~ 497 (670)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 268999999999999997753 69999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=2.2e-08 Score=103.88 Aligned_cols=175 Identities=18% Similarity=0.178 Sum_probs=116.3
Q ss_pred cceEeeeCceeEEEeec------cc---hHHHHHHHHHHHhccc-cCc--eeeeeeeeeccC---eeEEEEeccCCCCch
Q 035655 367 SEVIGTGGFGEVYKGVL------PT---RMREFAAEIESLGRLR-HKH--LVNLQGWCKRKR---DLLLVYDYIPNGSLD 431 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~------~~---~~~~f~~Ei~~L~~l~-H~n--Iv~l~g~~~~~~---~~~lV~E~~~~gsL~ 431 (670)
.+.++.|....||+... +. ....+.+|+.+|+.+. +.. +.+++..+...+ ..++|||+++|.+|.
T Consensus 25 i~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~ 104 (304)
T 3sg8_A 25 IEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLT 104 (304)
T ss_dssp CCEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECC
T ss_pred eEecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECC
Confidence 45689999999997531 11 2457889999999884 322 445555544333 358899999998887
Q ss_pred hhcccCCccccCHHHHHHHHHHHHHHhhhcccc-----------------------------------------------
Q 035655 432 SLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE----------------------------------------------- 464 (670)
Q Consensus 432 ~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------------- 464 (670)
+... ..++..++..++.++++.|+.||+.
T Consensus 105 ~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 105 PLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp HHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred cccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 5432 2467777888888888888888851
Q ss_pred --------ccceEEecccCCCcEEecC--CCcEEEEeecCceeccCCCcceeeccccCcCC---CCcccccc-----CC-
Q 035655 465 --------WEQVVIHRDVKSGNVLIDA--DMNARLGDFGLARLFDHGKISHTTNVVGTIGY---IAPELART-----GK- 525 (670)
Q Consensus 465 --------~~~~ivHrDIkp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~- 525 (670)
....++|+|++|.||++++ ...+.|+||+.+....... .......+ ..|+.... +.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1246899999999999998 5568999999987543211 01111111 22321110 11
Q ss_pred --------CCccchhHHHHHHHHHHHhCCCCCC
Q 035655 526 --------ASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 526 --------~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
.....+.|+++.+++++.+|+.+|.
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1123689999999999999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=9.1e-05 Score=76.66 Aligned_cols=127 Identities=19% Similarity=0.147 Sum_probs=85.3
Q ss_pred cceEeeeCceeEEEee------ccc---hHHHHHHHHHHHhccccC---ceeeeeeeee-ccCeeEEEEeccCCCCchhh
Q 035655 367 SEVIGTGGFGEVYKGV------LPT---RMREFAAEIESLGRLRHK---HLVNLQGWCK-RKRDLLLVYDYIPNGSLDSL 433 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~------~~~---~~~~f~~Ei~~L~~l~H~---nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~ 433 (670)
.+.++.|....||+.- .+. ....+.+|+.+|+.|.+. .+.+.+.++. ..+..++|||+++|.+|.+.
T Consensus 24 v~~l~~G~~n~v~~vg~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~ 103 (306)
T 3tdw_A 24 VESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGED 103 (306)
T ss_dssp EEEEEECSSEEEEEETTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHH
T ss_pred eeecCCCcceeEEEECCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchh
Confidence 4567777777888651 111 245788999999999753 3566777764 44567899999999888763
Q ss_pred cccCCccccCHHHHHHHHHHHHHHhhhcccc-------------------------------------------------
Q 035655 434 LFDNENFVLSWEQRFNIIKGIAAGLLYLHEE------------------------------------------------- 464 (670)
Q Consensus 434 l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------------- 464 (670)
.. ..++..++..++.++++.|+.||+.
T Consensus 104 ~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 179 (306)
T 3tdw_A 104 GM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSY 179 (306)
T ss_dssp HH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHH
T ss_pred hh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHH
Confidence 21 1233444444555555555544431
Q ss_pred --------ccceEEecccCCCcEEecC---CCc-EEEEeecCcee
Q 035655 465 --------WEQVVIHRDVKSGNVLIDA---DMN-ARLGDFGLARL 497 (670)
Q Consensus 465 --------~~~~ivHrDIkp~NILld~---~~~-~kL~DFGla~~ 497 (670)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 180 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 180 MTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1246899999999999987 455 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=9.9e-05 Score=74.48 Aligned_cols=105 Identities=22% Similarity=0.231 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc-
Q 035655 387 MREFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE- 464 (670)
Q Consensus 387 ~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 464 (670)
..++.+|...|+.|. +--+.++++++.+.+..++|||++++.++.+.... .......++.+++..|.-||+.
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSC
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCC
Confidence 457889999999885 33467888999988999999999999887765422 1122334555555655555531
Q ss_pred ------------------------------------------------------ccceEEecccCCCcEEecCCCcEEEE
Q 035655 465 ------------------------------------------------------WEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 465 ------------------------------------------------------~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
....++|+|+++.|||+++++.+-|+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi 216 (272)
T 4gkh_A 137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI 216 (272)
T ss_dssp GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence 12358999999999999987777899
Q ss_pred eecCcee
Q 035655 491 DFGLARL 497 (670)
Q Consensus 491 DFGla~~ 497 (670)
||+.+..
T Consensus 217 Dwe~a~~ 223 (272)
T 4gkh_A 217 DVGRVGI 223 (272)
T ss_dssp CCTTCEE
T ss_pred ECccccc
Confidence 9998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00014 Score=76.70 Aligned_cols=46 Identities=7% Similarity=0.069 Sum_probs=35.2
Q ss_pred HHHHHHHHHHhcccc---Cceeeeeeeeecc---CeeEEEEeccCCCCchhh
Q 035655 388 REFAAEIESLGRLRH---KHLVNLQGWCKRK---RDLLLVYDYIPNGSLDSL 433 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H---~nIv~l~g~~~~~---~~~~lV~E~~~~gsL~~~ 433 (670)
..+.+|+.+++.|.. -.+.+++.++.+. +..++||||++|..+.+.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCBT
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhhc
Confidence 457899999999853 3567788887665 357899999999887653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=68.27 Aligned_cols=31 Identities=19% Similarity=0.308 Sum_probs=28.2
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4789999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.005 Score=63.73 Aligned_cols=127 Identities=16% Similarity=0.140 Sum_probs=81.9
Q ss_pred ccceEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhcccc---CceeeeeeeeeccCeeEEEEeccCCCCch
Q 035655 366 QSEVIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGRLRH---KHLVNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~l~H---~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
..+.|+.|....+|+..... ....|..|...|+.|.. ..+.+++.++...+..++||||+++..+.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 35677888888888764321 34568899999998853 56888899888888899999999998763
Q ss_pred hh-----------cccCCc--------------------cccCHHHHH---HHHH----------------HHHHHh-hh
Q 035655 432 SL-----------LFDNEN--------------------FVLSWEQRF---NIIK----------------GIAAGL-LY 460 (670)
Q Consensus 432 ~~-----------l~~~~~--------------------~~l~~~~~~---~i~~----------------qia~gL-~y 460 (670)
.- |+.... ..-+|.... ++.. .++..+ ..
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 21 121110 012454322 1111 111111 22
Q ss_pred ccc-cccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 461 LHE-EWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 461 LH~-~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 321 2247899999999999999887 8888874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.003 Score=67.45 Aligned_cols=31 Identities=19% Similarity=0.395 Sum_probs=26.7
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+.+.|||++.+ .+++.||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3789999999999999876 589999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.021 Score=58.73 Aligned_cols=129 Identities=17% Similarity=0.108 Sum_probs=70.0
Q ss_pred ceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCce--eeeeee------eeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHL--VNLQGW------CKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nI--v~l~g~------~~~~~~~~lV~E~~~~ 427 (670)
+.|+.|....+|+....+ ....+..|+.+++.|...++ .+++.. ....+..+++++|++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G 107 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 107 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCC
Confidence 445556667777654221 23467788888888854332 333321 1123567899999998
Q ss_pred CCchhh--------------cccC------Cc----cccCHHHHHHH------------HHHHHHHhhhccc----cccc
Q 035655 428 GSLDSL--------------LFDN------EN----FVLSWEQRFNI------------IKGIAAGLLYLHE----EWEQ 467 (670)
Q Consensus 428 gsL~~~--------------l~~~------~~----~~l~~~~~~~i------------~~qia~gL~yLH~----~~~~ 467 (670)
..+... ++.. .. ....|...+.- ...+...+..+++ ....
T Consensus 108 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~ 187 (322)
T 2ppq_A 108 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 187 (322)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCc
Confidence 765321 1110 00 00123321110 0112333333432 1246
Q ss_pred eEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 468 VVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 468 ~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
+++|+|+++.|||++++..+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 89999999999999987666899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.023 Score=58.11 Aligned_cols=31 Identities=19% Similarity=0.218 Sum_probs=26.4
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 367999999999999 5667889999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.91 E-value=0.023 Score=55.10 Aligned_cols=101 Identities=15% Similarity=0.093 Sum_probs=65.0
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
-||.++|.... .++++++++.++.|.+..|.-+-.. ... ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 47888886544 5899999999999999998776110 001 1223457899999999998764 1110
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCC
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR 546 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~ 546 (670)
.....+.|||... ...+.+.=|||+|+++|.-+--.
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456888753 34568889999999999987633
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.70 E-value=0.015 Score=62.93 Aligned_cols=40 Identities=28% Similarity=0.353 Sum_probs=28.6
Q ss_pred HHHHHHHHHHhccccCce-eeeeeeeeccCeeEEEEeccCCCCch
Q 035655 388 REFAAEIESLGRLRHKHL-VNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
..+.+|..+++.|...++ .++++.+.+ .+|+||+++.+|.
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 160 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcccC
Confidence 567789999999865444 566776543 2899999875553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.022 Score=59.07 Aligned_cols=33 Identities=30% Similarity=0.384 Sum_probs=28.6
Q ss_pred cceEEecccCCCcEEecCC----CcEEEEeecCceec
Q 035655 466 EQVVIHRDVKSGNVLIDAD----MNARLGDFGLARLF 498 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~----~~~kL~DFGla~~~ 498 (670)
...++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3689999999999999875 68999999988643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.061 Score=54.44 Aligned_cols=65 Identities=18% Similarity=0.217 Sum_probs=45.6
Q ss_pred CccccceEeeeCceeEEEeeccch---------------HHHHHHHHHHHhccccC---ceeeeeeeeeccCeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR---------------MREFAAEIESLGRLRHK---HLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~---------------~~~f~~Ei~~L~~l~H~---nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.....+.+|.|..+.||+....++ ...|.+|+..|+.|... -+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455578899999999999876441 23578999999988532 344555543 34789999
Q ss_pred cCCCCch
Q 035655 425 IPNGSLD 431 (670)
Q Consensus 425 ~~~gsL~ 431 (670)
++.+...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.62 E-value=0.11 Score=55.11 Aligned_cols=107 Identities=21% Similarity=0.213 Sum_probs=67.4
Q ss_pred HHHHHHHHHHHhccccCc-eeeeeeeeeccCeeEEEEeccCCCCchhh-c----------------ccCC---cccc--C
Q 035655 387 MREFAAEIESLGRLRHKH-LVNLQGWCKRKRDLLLVYDYIPNGSLDSL-L----------------FDNE---NFVL--S 443 (670)
Q Consensus 387 ~~~f~~Ei~~L~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l----------------~~~~---~~~l--~ 443 (670)
.....+|..+++.|...+ ..++++.+.++ +|+||++|..|..- + +... .... -
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 456779999999885333 35667666542 89999998766421 1 1110 1112 2
Q ss_pred HHHHHHHHHHHHHH-------------------hhhccc-----cccceEEecccCCCcEEecCC----CcEEEEeecCc
Q 035655 444 WEQRFNIIKGIAAG-------------------LLYLHE-----EWEQVVIHRDVKSGNVLIDAD----MNARLGDFGLA 495 (670)
Q Consensus 444 ~~~~~~i~~qia~g-------------------L~yLH~-----~~~~~ivHrDIkp~NILld~~----~~~kL~DFGla 495 (670)
|.++.++..++... +..|.+ .....++|+|+.+.||+++.+ +.+.++||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 45555555554321 222211 124679999999999999876 78999999987
Q ss_pred ee
Q 035655 496 RL 497 (670)
Q Consensus 496 ~~ 497 (670)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.39 E-value=0.1 Score=54.81 Aligned_cols=31 Identities=26% Similarity=0.404 Sum_probs=25.7
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+++.|||++++. +.|+||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 46799999999999998654 89999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=91.11 E-value=0.21 Score=53.43 Aligned_cols=77 Identities=14% Similarity=0.127 Sum_probs=46.6
Q ss_pred ceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeecc-ccCcCCCCccccccC---CCCccchhHHHHHHHHHH
Q 035655 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV-VGTIGYIAPELARTG---KASCSTDVFAYGVLLLEI 542 (670)
Q Consensus 467 ~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~el 542 (670)
..++|+|+++.|||++.++ ++++||+.+..-.... ...... .-...|++|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 8999999999999998876 9999999887543210 000000 001345666544311 112235555777777777
Q ss_pred HhC
Q 035655 543 ATG 545 (670)
Q Consensus 543 ~tG 545 (670)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.64 E-value=2.4 Score=40.76 Aligned_cols=116 Identities=10% Similarity=0.068 Sum_probs=80.1
Q ss_pred ccCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEE
Q 035655 401 RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVL 480 (670)
Q Consensus 401 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 480 (670)
.||+++.. .+-.+.+.+.+.|+.-+. ...|-. -..++...+++++.+|+....+++. -+|--++|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 57888876 455566677776665542 222211 1357888999999999998877775 367889999999
Q ss_pred ecCCCcEEEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 035655 481 IDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPID 550 (670)
Q Consensus 481 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~ 550 (670)
++.++.+++.-.|+-.. ++|. ..+...=.-.+=|++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775432 2222 11222223467789999999999886
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=85.52 E-value=0.74 Score=47.00 Aligned_cols=30 Identities=30% Similarity=0.413 Sum_probs=26.2
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 36789999999999999 4 899999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=84.64 E-value=2.3 Score=45.54 Aligned_cols=31 Identities=26% Similarity=0.477 Sum_probs=27.3
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 367899999999999 8888999999998863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=84.35 E-value=1.1 Score=48.49 Aligned_cols=17 Identities=29% Similarity=0.382 Sum_probs=15.5
Q ss_pred cceEEecccCCCcEEec
Q 035655 466 EQVVIHRDVKSGNVLID 482 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld 482 (670)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 36799999999999998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=83.61 E-value=1 Score=46.57 Aligned_cols=32 Identities=28% Similarity=0.471 Sum_probs=28.6
Q ss_pred cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 466 ~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 47899999999999999888999999987764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.60 E-value=0.69 Score=49.16 Aligned_cols=31 Identities=29% Similarity=0.464 Sum_probs=25.7
Q ss_pred ceEEecccCCCcEEe------cCCCcEEEEeecCcee
Q 035655 467 QVVIHRDVKSGNVLI------DADMNARLGDFGLARL 497 (670)
Q Consensus 467 ~~ivHrDIkp~NILl------d~~~~~kL~DFGla~~ 497 (670)
..++|+|+.+.|||+ +++..++++||..|..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 356899999999999 4566799999998853
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.73 E-value=0.68 Score=32.52 Aligned_cols=23 Identities=22% Similarity=0.197 Sum_probs=10.9
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhh
Q 035655 315 LSTVAVILLGTLLIFKLYRRIAQ 337 (670)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~rr~~~ 337 (670)
++.+++++++++++++++||+++
T Consensus 18 VgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 18 VGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHHHHHHHHHHHhhhhHh
Confidence 33344444444555555555543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.26 E-value=0.7 Score=32.41 Aligned_cols=23 Identities=13% Similarity=0.187 Sum_probs=11.0
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhh
Q 035655 315 LSTVAVILLGTLLIFKLYRRIAQ 337 (670)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~rr~~~ 337 (670)
++.+++++++++.+++++||+++
T Consensus 17 VgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 17 IGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCS
T ss_pred hHHHHHHHHHHHHHHHHhhhhhh
Confidence 33334444444555555555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 670 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-57 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-55 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 7e-55 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 4e-54 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 5e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-53 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-52 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 9e-52 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 9e-52 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-51 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 9e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-50 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 4e-50 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 6e-50 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 7e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 4e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-48 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 4e-48 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 6e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 3e-47 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 3e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-42 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 2e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-34 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 5e-32 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 2e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-23 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 8e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-17 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 5e-07 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 6e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 46/293 (15%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL---------------PTR 386
+DWE+ + + IG+G FG VYKG P +
Sbjct: 1 DDWEIP-DGQITVG------------QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 47
Query: 387 MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQ 446
++ F E+ L + RH +++ G+ L +V + SL L E +
Sbjct: 48 LQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIK 105
Query: 447 RFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH- 505
+I + A G+ YLH + +IHRD+KS N+ + D+ ++GDFGLA + SH
Sbjct: 106 LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 506 TTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPI-DSDHFILVDWVL 561
+ G+I ++APE+ R S +DV+A+G++L E+ TG+ P + ++ + +++
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+L L V N + + +L C +K + RP Q+L +
Sbjct: 223 GRGYLSPDLSKVRSNC--------PKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-59
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR--------------M 387
++WE+ + E +G G FGEV+ G
Sbjct: 6 DEWEVP-RETLKLV------------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP 52
Query: 388 REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR 447
F AE + +L+H+ LV L + + ++ +Y+ NGSL L L+ +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507
++ IA G+ ++ E IHRD+++ N+L+ ++ ++ DFGLARL + + +
Sbjct: 112 LDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567
I + APE G + +DV+++G+LL EI T R Q+L
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLE 224
Query: 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+ +V P+ E + QL LC ++ E RPT + L
Sbjct: 225 RGYRMVRPDNCP-------EELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-57
Identities = 57/265 (21%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTR--------------MREFAAEIESLGRLRHKHLVNLQ 409
+ IG+G FG V+ G + +F E E + +L H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G C + + LV++++ +G L + + + E + + G+ E V
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGM---AYLEEACV 122
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
IHRD+ + N L+ + ++ DFG+ R + + +T + + +PE+ + S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 530 TDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589
+DV+++GVL+ E+ + + + + + + P L S++V
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVY------ 232
Query: 590 LQLGLLCSHQKAEARPTMRQVLRYL 614
Q+ C ++ E RP ++LR L
Sbjct: 233 -QIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 189 bits (480), Expect = 3e-56
Identities = 67/260 (25%), Positives = 106/260 (40%), Gaps = 36/260 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV---IGHAFYNKPIQMLDKSTS 83
F F+ F + N I + + + +G L++T + IG A Y PIQ+ D T
Sbjct: 6 FNFDKFVPNQKN---IIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSIT- 61
Query: 84 LSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKP 143
+SF+T F F + S LAF ++P S + + L S++D K
Sbjct: 62 ----GKVASFATSFSFVVKADKSDGVDG-LAFFLAPANSQIPSGSSAGMFGLFSSSDSKS 116
Query: 144 SNHLFAIEFDTV-NGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDP 202
SN + A+EFDT D H+GI+VNS+KSIK + +G+
Sbjct: 117 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-----------WDWRNGEV 165
Query: 203 VQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262
I Y + + V + + +++ +DL E + VGFS
Sbjct: 166 ADVVITYRAPTKSLTVCLSYP----------SDGTSNIITASVDLKAILPEWVSVGFSGG 215
Query: 263 TGRKV--SSHFILGWSFSMN 280
G +H +L W F+ N
Sbjct: 216 VGNAAEFETHDVLSWYFTSN 235
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-56
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 42/287 (14%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPT--------------RM 387
+ WE+ R +G G FGEV+ G
Sbjct: 10 DAWEIP-RESLRLE------------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP 56
Query: 388 REFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQR 447
F E + + +LRH+ LV L + + +V +Y+ GSL L L Q
Sbjct: 57 EAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 115
Query: 448 FNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507
++ IA+G+ Y+ +HRD+++ N+L+ ++ ++ DFGLARL + + +
Sbjct: 116 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
Query: 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567
I + APE A G+ + +DV+++G+LL E+ T R
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----------VNR 221
Query: 568 QVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+VLD V+ E + L C ++ E RPT + +L
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 8e-56
Identities = 68/297 (22%), Positives = 133/297 (44%), Gaps = 48/297 (16%)
Query: 352 FRYSDLYTATKGFKQS---------EVIGTGGFGEVYKGVL------------------- 383
F + D A + F + +VIG G FGEV G L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 384 -PTRMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVL 442
+ R+F +E +G+ H ++++L+G + ++++ +++ NGSLDS L N+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 443 SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502
+ Q +++GIAAG+ YL + +HRD+ + N+L+++++ ++ DFGL+R +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 503 ISHTTN----VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD 558
T I + APE + K + ++DV++YG+++ E+ + D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------ 236
Query: 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
V++ ++ + + + QL L C + RP Q++ L+
Sbjct: 237 -----MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 5e-55
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 29/281 (10%)
Query: 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLP---------------TRMREFAAE 393
P Y +G G +GEVY+GV + EF E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 394 IESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKG 453
+ ++H +LV L G C R+ ++ +++ G+L L + +S +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 454 IAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTI 513
I++ + YL + + IHRD+ + N L+ + ++ DFGL+RL + I
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV 573
+ APE K S +DV+A+GVLL EIAT L QV +++
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELL 229
Query: 574 DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
+ + E V +L C RP+ ++ +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 7e-55
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 31/266 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRM--------------REFAAEIESLGRLRHKHLVNLQ 409
+ +GTG FG V G + EF E + + L H+ LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
G C ++R + ++ +Y+ NG L + L + + +Q + K + + YL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 470 IHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
+HRD+ + N L++ ++ DFGL+R + + + + + PE+ K S
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 530 TDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMEL 588
+D++A+GVL+ EI + G+ P + +H+ Q L + P+L S E
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHLAS-------EK 229
Query: 589 VLQLGLLCSHQKAEARPTMRQVLRYL 614
V + C H+KA+ RPT + +L +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 185 bits (471), Expect = 7e-55
Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 44/271 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLDK 80
F +N F + N + + +I+ SG L+L N +G A Y+ PI + DK
Sbjct: 6 FSWNKFVPKQPN---MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDK 62
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
T + +SF+ F F P++ + GLAF ++P + P + G L N+
Sbjct: 63 ET-----GSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT----HAGYLGLFNE 113
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
++ + + A+EFDT + + D H+GINVNS++SIK + L +
Sbjct: 114 NESGDQVVAVEFDT---FRNSWDPPNPHIGINVNSIRSIKTTS-----------WDLANN 159
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
+ I YD L+ ++ +++ +LS +DL + E + +GFS
Sbjct: 160 KVAKVLITYDASTSLLVASLVYPSQRTS----------NILSDVVDLKTSLPEWVRIGFS 209
Query: 261 ASTGRKV--SSHFILGWSFSMNGAAPSLNLS 289
A+TG + SH +L WSF+ N S N+
Sbjct: 210 AATGLDIPGESHDVLSWSFASNLPHASSNID 240
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 183 bits (465), Expect = 4e-54
Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 43/265 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F+ F N +T + A+++ SG L+LT N G Y KP+ M D
Sbjct: 6 FSFSEFEPGNDN---LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDS 62
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGF-GLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+T +SF T F F I P + GL F + P S P YLG+ N++
Sbjct: 63 TT-----GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNSK 116
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
S A+EFDT + N Q H+GI+VNS++SIK +P F L++
Sbjct: 117 QD-NSYQTLAVEFDTFS--NPWDPPQVPHIGIDVNSIRSIKTQP-----------FQLDN 162
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G I YD +++++V + + + ++ +D+ + + VG
Sbjct: 163 GQVANVVIKYDAPSKILHVVLVYPSS----------GAIYTIAEIVDVKQVLPDWVDVGL 212
Query: 260 SASTGRK---VSSHFILGWSFSMNG 281
S +TG + +H + WSF +
Sbjct: 213 SGATGAQRDAAETHDVYSWSFQASL 237
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 182 bits (464), Expect = 5e-54
Identities = 72/261 (27%), Positives = 106/261 (40%), Gaps = 36/261 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F F +I + A+ +G L+L G A Y+ P+Q+ D
Sbjct: 4 FTFPNFWSD-VEDSIIFQGDANT--TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 60
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
T + +SF T F F + +G GLAF ++P S E+ ST
Sbjct: 61 KTE-----SVASFYTEFTFFLKITGNG-PADGLAFFLAPPDSDVKDAGEYLGLFNKSTAT 114
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
N + A+EFDT + H+GINVNS+ S+ ED + SG
Sbjct: 115 QPSKNQVVAVEFDTWTNP-NFPEPSYRHIGINVNSIVSVA--------TKRWEDSDIFSG 165
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
A I YDG ++ V + + S +LS +D+ E++ VG S
Sbjct: 166 KIATARISYDGSAEILTVVL-----------SYPDGSDYILSHSVDMRQNLPESVRVGIS 214
Query: 261 ASTGR-KVSSHFILGWSFSMN 280
ASTG + + +IL W FS N
Sbjct: 215 ASTGNNQFLTVYILSWRFSSN 235
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 6e-54
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 368 EVIGTGGFGEVYKGVLPTRM-------------REFAAEIESLGRLRHKHLVNLQGWCKR 414
E IG G FGEV++G AEI LRH++++ +
Sbjct: 9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 415 KRD----LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE-----W 465
L LV DY +GSL L + ++ E + A+GL +LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH---TTNVVGTIGYIAPELAR 522
+ + HRD+KS N+L+ + + D GLA D + + VGT Y+APE+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 523 T------GKASCSTDVFAYGVLLLEIATGRRPIDSD--------HFILVDWVLEFQHLGQ 568
++ D++A G++ EIA + D +E
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 569 VLDVVDPNLGSSYVVAE-MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ PN+ + + E + ++ ++ C + AR T ++ + L+
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-54
Identities = 68/264 (25%), Positives = 102/264 (38%), Gaps = 31/264 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGW 411
K + IG G FG+V G + F AE + +LRH +LV L G
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 412 C-KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
+ K L +V +Y+ GSL L VL + + + YL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 125
Query: 471 HRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
HRD+ + NVL+ D A++ DFGL + S + + APE R K S +
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 531 DVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590
DV+++G+LL EI + R L V+ V+ V
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPR-----------IPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 591 QLGLLCSHQKAEARPTMRQVLRYL 614
++ C H A RP+ Q+ L
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-53
Identities = 67/289 (23%), Positives = 134/289 (46%), Gaps = 40/289 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRH 402
+ +VIG G FGEVYKG+L T + +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+++ L+G + + ++++ +Y+ NG+LD L + + S Q +++GIAAG+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLA 127
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG--KISHTTNVVGTIGYIAPEL 520
+HRD+ + N+L+++++ ++ DFGL+R+ + T+ I + APE
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580
K + ++DV+++G+++ E+ T + +V+ ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----------SNHEVMKAINDGFRLP 233
Query: 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSL 629
+ + QL + C Q+ RP ++ L D+L+ D+ +L
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL--DKLIRAPDSLKTL 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-53
Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-----------------PTRMREFAAEIESLGRLRHKHLV 406
F++ +G G G V+K P + E++ L ++V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G ++ + +++ GSLD +L + + + + GL YL E+
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-- 123
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
++HRDVK N+L+++ +L DFG++ S + VGT Y++PE +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 527 SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571
S +D+++ G+ L+E+A GR PI ++ + Q G +
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 179 bits (455), Expect = 2e-52
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 49/280 (17%)
Query: 25 EEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQML 78
+ F F FN + I + A++ S LRLT N +G AFY+ PIQ+
Sbjct: 4 QSFSFKNFNSS----SFILQGDATV--SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY 57
Query: 79 DKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNST 138
DKST +S++T F I PN G+AF + P S P + +LG+ +S
Sbjct: 58 DKSTG-----AVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNS-GFLGVFDSD 111
Query: 139 NDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLE 198
S A+EFDT + N D H+GI+VNS+KSI+ + L
Sbjct: 112 VY-DNSAQTVAVEFDTFS--NTDWDPTSRHIGIDVNSIKSIRTAS-----------WGLA 157
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
+G + I Y+ L+ ++ ++ + ++S +D++ E + +G
Sbjct: 158 NGQNAEILITYNAATSLLVASLVHPSR----------RTSYIVSERVDITNELPEYVSIG 207
Query: 259 FSASTGRK---VSSHFILGWSFSMN----GAAPSLNLSQI 291
FSA+TG +H +L WSF+ L+++
Sbjct: 208 FSATTGLSEGYTETHDVLSWSFASKLPDDSTTEPLDIASY 247
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-52
Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 37/273 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVL------------------PTRMREFAAEIESLGRLRHKHL 405
++ IGTG +G K + +E+ L L+H ++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 406 VNLQGWC--KRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYL 461
V + L +V +Y G L S++ E L E ++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 462 HE--EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
H + V+HRD+K NV +D N +LGDFGLAR+ +H S VGT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPE 184
Query: 520 LARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579
+ +D+++ G LL E+ P + + + G++ + +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRIPY 236
Query: 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
Y E++ + + K RP++ ++L
Sbjct: 237 RYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 176 bits (448), Expect = 9e-52
Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 48/267 (17%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F FN F++ + + +R + + + L LT + V G A Y KP+Q+ D +
Sbjct: 5 FNFNQFHQNEEQ---LKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 61
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
T N +SF T F F I P P+ G+ Y GI N +
Sbjct: 62 TG-----NVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLS-- 114
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
A+EFDT + T D Q H+GI+VNS+ S K FTL++G
Sbjct: 115 --PYPFVAVEFDT---FRNTWDPQIPHIGIDVNSVISTK-----------TVPFTLDNGG 158
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
I YD ++++V + + + ++ +DL E++ VGFSA
Sbjct: 159 IANVVIKYDASTKILHVVLVFPSL----------GTIYTIADIVDLKQVLPESVNVGFSA 208
Query: 262 STG-------RKVSSHFILGWSFSMNG 281
+TG +H IL WSFS +
Sbjct: 209 ATGDPSGKQRNATETHDILSWSFSASL 235
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 176 bits (448), Expect = 9e-52
Identities = 80/261 (30%), Positives = 123/261 (47%), Gaps = 46/261 (17%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F FNET + +R + + SG LRLT+ N +G AFY+ PIQ+ D
Sbjct: 6 FNFQRFNETN-----LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTND 140
+T +SF+T F F I PN+ GLAF + P S P K +LG+ +
Sbjct: 61 TTG-----TVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKG-GFLGL---FDG 111
Query: 141 HKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESG 200
+ H A+EFDT+ YN+ D H+GI+VNS++SIK + +G
Sbjct: 112 SNSNFHTVAVEFDTL--YNKDWDPTERHIGIDVNSIRSIKTTRWDFV-----------NG 158
Query: 201 DPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFS 260
+ + I YD L+ ++ ++ + ++S +DL E + VGFS
Sbjct: 159 ENAEVLITYDSSTNLLVASLVYPSQ----------KTSFIVSDTVDLKSVLPEWVSVGFS 208
Query: 261 ASTG---RKVSSHFILGWSFS 278
A+TG V ++ +L WSF+
Sbjct: 209 ATTGINKGNVETNDVLSWSFA 229
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 176 bits (446), Expect = 2e-51
Identities = 77/264 (29%), Positives = 111/264 (42%), Gaps = 49/264 (18%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDK 80
F F+ F E + +R + +K +G L LT N G A Y +PI++ D
Sbjct: 5 FNFDHFEENSKE---LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDS 61
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSG-QGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+T N +SF T F F I P + + GL F + P S G G
Sbjct: 62 TT-----GNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQG-----EDGGNLGVF 111
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
++ FA+EFDT + T D Q H+GI+VNS+ S K F LE+
Sbjct: 112 KPPEGDNAFAVEFDT---FQNTWDPQVPHIGIDVNSIVSSK-----------TLHFQLEN 157
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAF--QETMYV 257
G I YD +++NV + + + LS +DL F E + V
Sbjct: 158 GGVANVVIKYDSPTKILNVVLAFHS----------VGTVYTLSNIVDLKQEFPNSEWVNV 207
Query: 258 GFSASTG---RKVSSHFILGWSFS 278
G SA+TG V +H I+ WSF+
Sbjct: 208 GLSATTGYQKNAVETHEIISWSFT 231
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-51
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 40/272 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVL------------------PTRMREFAAEIESLGRLRHKHL 405
K IG G F VYKG+ + + F E E L L+H ++
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 406 VNLQGWC----KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
V K K+ ++LV + + +G+L + L + V+ + + + I GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128
Query: 462 HEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
H + IHRD+K N+ I + ++GD GLA L S V+GT ++APE+
Sbjct: 129 HTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM 184
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580
K S DV+A+G+ +LE+AT P Q +V V P
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPASFDK 236
Query: 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ E++ +++ C Q + R +++ +L
Sbjct: 237 VAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 174 bits (441), Expect = 9e-51
Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 35/254 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLT-DNAHNVIGHAFYNKPIQMLDKSTSLS 85
F FN F+E I + + +G ++LT N N +G Y P+++ +T
Sbjct: 6 FNFNSFSEGNPA---INFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG-- 60
Query: 86 SKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSN 145
N +SF T F F++ G+ F ++P+ + + G +D K +
Sbjct: 61 ---NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGS--IGGGTLGVSDTKGAG 115
Query: 146 HLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQA 205
H +EFDT + +E +D +HVGI+VNS+ S+K P + SG V+
Sbjct: 116 HFVGVEFDTYSN-SEYNDPPTDHVGIDVNSVDSVKTVP-----------WNSVSGAVVKV 163
Query: 206 WIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGR 265
+ YD + ++V + ++ +DL E + GFSAS
Sbjct: 164 TVIYDSSTKTLSVAVTND-----------NGDITTIAQVVDLKAKLPERVKFGFSASGSL 212
Query: 266 K-VSSHFILGWSFS 278
H I WSF+
Sbjct: 213 GGRQIHLIRSWSFT 226
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 1e-50
Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 49/310 (15%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGRLR 401
K F IG G FG VY + ++ E+ L +LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H + + +G R+ LV +Y + D L + L + + G GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H +IHRDVK+GN+L+ +LGDFG A + + VGT ++APE+
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVI 183
Query: 522 RT---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
G+ DV++ G+ +E+A + P+ + + L + P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQ 235
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVL------RYLNGDELLPIIDNWSSLDSQ 632
S + C + + RPT +L R ++ +I +
Sbjct: 236 SGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 292
Query: 633 RSEMNSRYLE 642
+ R ++
Sbjct: 293 LDNLQYRKMK 302
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 172 bits (437), Expect = 2e-50
Identities = 69/260 (26%), Positives = 110/260 (42%), Gaps = 47/260 (18%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV---IGHAFYNKPIQMLDKSTS 83
F FN+T + + + + G L LT+ N +G AFY+ PIQ+ D++
Sbjct: 6 FNVETFNKTN-----LILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 84 LSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKP 143
N +SFST F F+I N +GLAF + P S P K YLG+ N+TN
Sbjct: 61 -----NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKG-RYLGLFNTTN---- 110
Query: 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPV 203
+ D D+ N + I+VNS++ I E + +G+
Sbjct: 111 ------YDRDAHTVAVVF-DTVSNRIEIDVNSIRPIATESCNFG---------HNNGEKA 154
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST 263
+ I YD + V++ + + +S + L ++ + VGFSA++
Sbjct: 155 EVRITYDSPKNDLRVSLLYPSS----------EEKCHVSATVPLEKEVEDWVSVGFSATS 204
Query: 264 G---RKVSSHFILGWSFSMN 280
G +H +L WSFS N
Sbjct: 205 GSKKETTETHNVLSWSFSSN 224
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 172 bits (437), Expect = 4e-50
Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 35/258 (13%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN----VIGHAFYNKPIQMLDKST 82
F F F++ + L + AS++ +G L+L +N G A Y PI + + +T
Sbjct: 6 FKFKNFSQNGKD--LSFQGNASVI-ETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNT 62
Query: 83 SLSSKPNASSFSTCFVFQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
+SF T F F + T N GL F ++P P P +A Y G+ N T
Sbjct: 63 G-----ELASFITSFSFFMETSANPKAATDGLTFFLAP-PDSPLRRAGGYFGLFNDTKC- 115
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
S A+EFDT+ D H+GI+VN +KSI E + +
Sbjct: 116 DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW---------NKRYGLNN 166
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
I Y+ ++ + ++ + ++ +DL E + VGFS
Sbjct: 167 VANVEIIYEASSKTLTASLTYP----------SDQTSISVTSIVDLKEILPEWVSVGFSG 216
Query: 262 STGRKV-SSHFILGWSFS 278
ST ++H +L W F+
Sbjct: 217 STYIGRQATHEVLNWYFT 234
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 172 bits (436), Expect = 6e-50
Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLDK 80
F F F + N LI + A I + A++LT N +G ++ + + +K
Sbjct: 6 FGFPTFPSDQKN--LIFQGDAQI--KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEK 61
Query: 81 STSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILN-STN 139
S+S ++F + F F + +P S F P + P G LG+ T
Sbjct: 62 SSS-----RVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTA 116
Query: 140 DHKPSNHLFAIEFDTV-NGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLE 198
+ +N + A+EFDT + T D H+GI+VNS++S+K +
Sbjct: 117 QNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK-----------WDRR 165
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
G + + ++ R ++V + ++ +S +D+ E + VG
Sbjct: 166 DGQSLNVLVTFNPSTRNLDVVA-----------TYSDGTRYEVSYEVDVRSVLPEWVRVG 214
Query: 259 FSASTGRKVSSHFILGWSFS 278
FSA++G + +H + WSF+
Sbjct: 215 FSAASGEQYQTHTLESWSFT 234
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 171 bits (435), Expect = 7e-50
Identities = 67/262 (25%), Positives = 109/262 (41%), Gaps = 44/262 (16%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F F FN + N + + +++ +G L LT A +G A Y PI + D +
Sbjct: 6 FSFTNFNPNQNN---LILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
+SF+T F F + P + GLAF ++P + P + +LG+ H
Sbjct: 63 -------TLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARG-GFLGLFADRA-H 113
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
S A+EFDT Y+ D H+GI+ N ++S K P F + G+
Sbjct: 114 DASYQTVAVEFDT---YSNAWDPNYTHIGIDTNGIESKKTTP-----------FDMVYGE 159
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
I Y + + ++ + +S +DL E + VGFSA
Sbjct: 160 KANIVITYQASTKALAASLVFPVS----------QTSYAVSARVDLRDILPEYVRVGFSA 209
Query: 262 STGRK---VSSHFILGWSFSMN 280
+TG V +H I+ WSF+++
Sbjct: 210 TTGLNAGVVETHDIVSWSFAVS 231
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 9e-50
Identities = 74/323 (22%), Positives = 129/323 (39%), Gaps = 61/323 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGRL-RHK 403
K +VIG G FG+V K + R+FA E+E L +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--------------VLSWEQRFN 449
+++NL G C+ + L L +Y P+G+L L + LS +Q +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNV 509
+A G+ YL ++ IHRD+ + N+L+ + A++ DFGL+R + T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMG 186
Query: 510 VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569
+ ++A E + ++DV++YGVLL EI + ++
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----------MTCAEL 235
Query: 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGDELLPIIDNWSSL 629
+ + + + V L C +K RP+ Q+L LN L
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN-----------RML 284
Query: 630 DSQRSEMNSRYLEIISTDNITTS 652
+ +++ +N+ E + I S
Sbjct: 285 EERKTYVNTTLYEKFTYAGIDCS 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 42/280 (15%)
Query: 368 EVIGTGGFGEVYKGVL----------------PTRMREFAAEIESLGRLRHKHLVNLQGW 411
+G G FG+VYK + ++ EI+ L H ++V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471
+ +L ++ ++ G++D+++ + E L+ Q + K L YLH+ +IH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDNK---IIH 133
Query: 472 RDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA----- 526
RD+K+GN+L D + +L DFG++ I + +GT ++APE+ +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 527 SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE- 585
DV++ G+ L+E+A P + + L ++ P L +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELN--------PMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 586 -MELVLQLGLLCSHQKAEARPTMRQVLR--YLNGDELLPI 622
+ + + C + +AR T Q+L+ ++ D PI
Sbjct: 245 FKDFLKK----CLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 169 bits (429), Expect = 4e-49
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 41/263 (15%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F F F + + + +++ +G L+LT+ + V +G A Y P Q+ D +
Sbjct: 6 FSFPKFAPNQPY---LINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
T N +SF T F F I PN GLAF ++P + P LGI +
Sbjct: 63 T-----GNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGG-MLGIFKDGYFN 116
Query: 142 KPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGD 201
SN + A+EFDT N D +G H+GINVNS++SIK P + +G+
Sbjct: 117 -KSNQIVAVEFDTF--SNGDWDPKGRHLGINVNSIESIKTVPWNWT-----------NGE 162
Query: 202 PVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261
+I Y+ + + ++ + + ++ +D+ E + GFSA
Sbjct: 163 VANVFISYEASTKSLTASLVYPSL----------ETSFIIDAIVDVKIVLPEWVRFGFSA 212
Query: 262 STG---RKVSSHFILGWSFSMNG 281
+TG V ++ +L WSF N
Sbjct: 213 TTGIDKGYVQTNDVLSWSFESNL 235
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-49
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 43/275 (15%)
Query: 367 SEVIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLV 406
+EVIG G FG VY G L + +F E + H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 407 NLQGWC-KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
+L G C + + L+V Y+ +G L + NE + + +A G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK---ISHTTNVVGTIGYIAPELAR 522
+ +HRD+ + N ++D ++ DFGLAR + + + T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPI--DSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580
T K + +DV+++GVLL E+ T P D + F + ++L+ + L Q DP
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP----- 262
Query: 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ ++ L C H KAE RP+ +++ ++
Sbjct: 263 --------LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 5e-49
Identities = 59/330 (17%), Positives = 109/330 (33%), Gaps = 71/330 (21%)
Query: 331 LYRRIAQFEILEDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL------- 383
Y ++E WE + +V+G+G FG+V
Sbjct: 19 FYVDFREYEYDLKWEFP-RENLEFG------------KVLGSGAFGKVMNATAYGISKTG 65
Query: 384 ---------------PTRMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPN 427
+ +E++ + +L H+++VNL G C + L+++Y
Sbjct: 66 VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125
Query: 428 GSLDSLLFDNENF---------------------VLSWEQRFNIIKGIAAGLLYLHEEWE 466
G L + L VL++E +A G+ +L
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--- 182
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT-TNVVGTIGYIAPELARTGK 525
+ +HRD+ + NVL+ ++ DFGLAR N + ++APE G
Sbjct: 183 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585
+ +DV++YG+LL EI + ++
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVNPYPG----------IPVDANFYKLIQNGFKMDQPFYA 292
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
E + + C + RP+ + +L
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 1e-48
Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 59/296 (19%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRM----------------------REFAAEIESLGRLR 401
+ IG G FG V++ P + +F E +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF--------------------- 440
+ ++V L G C + + L+++Y+ G L+ L
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 441 -VLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499
LS ++ I + +AAG+ YL E +HRD+ + N L+ +M ++ DFGL+R
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 500 HGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVD 558
N I ++ PE + + +DV+AYGV+L EI + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--HE 249
Query: 559 WVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
V+ + G +L + + L LC + RP+ + R L
Sbjct: 250 EVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-48
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 40/283 (14%)
Query: 356 DLYTATKGFKQSEV-IGTGGFGEVYKGVLPTR-------------------MREFAAEIE 395
L+ +++ +G G FG V +GV R E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 396 SLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIA 455
+ +L + ++V L G C+ + L+LV + G L L + ++ ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 119
Query: 456 AGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLF--DHGKISHTTNVVGTI 513
G+ YL E+ +HRD+ + NVL+ A++ DFGL++ D + + +
Sbjct: 120 MGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 514 GYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDV 572
+ APE K S +DV++YGV + E + G++P V+ F G+ ++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMEC 233
Query: 573 VDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
E+ L C K E RP V + +
Sbjct: 234 PP------ECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 55/316 (17%), Positives = 105/316 (33%), Gaps = 66/316 (20%)
Query: 342 EDWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVL------------------ 383
WE +R + + +G G FG+V +
Sbjct: 16 HKWEFP-RNRLSFG------------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 384 ----PTRMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLL---- 434
T +E++ L L H ++VNL G C L++ +Y G L + L
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 435 ------------FDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482
+++ L E + +A G+ +L + IHRD+ + N+L+
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179
Query: 483 ADMNARLGDFGLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLE 541
++ DFGLAR + N + ++APE + +DV++YG+ L E
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 542 IATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKA 601
+ + + ++ + + C
Sbjct: 240 LFSLGSSPYPGM----------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 602 EARPTMRQVLRYLNGD 617
RPT +Q+++ +
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 41/270 (15%)
Query: 369 VIGTGGFGEVYKGVL--------------------PTRMREFAAEIESLGRLRHKHLVNL 408
+G+G FG V KG P E AE + +L + ++V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
G C+ + +LV + G L+ L N + + + ++ ++ G+ YL E
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN--- 127
Query: 469 VIHRDVKSGNVLIDADMNARLGDFGLARLF--DHGKISHTTNVVGTIGYIAPELARTGKA 526
+HRD+ + NVL+ A++ DFGL++ D T+ + + APE K
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 527 SCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585
S +DV+++GVL+ E + G++P +V +++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMGCPAGC 235
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ L LC E RP V L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-48
Identities = 59/268 (22%), Positives = 100/268 (37%), Gaps = 34/268 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-----------------AEIESLGRLRHKHLV 406
+ + +G G +GEV V A EI L H+++V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
G + L +Y G L + + + AG++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN-VVGTIGYIAPELARTGK 525
+ HRD+K N+L+D N ++ DFGLA +F + N + GT+ Y+APEL + +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 526 -ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584
+ DV++ G++L + G P D D E+ + ++P
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLNPWKKID---- 233
Query: 585 EMELVLQLGLLCSHQKAEARPTMRQVLR 612
L L + AR T+ + +
Sbjct: 234 --SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 166 bits (422), Expect = 6e-48
Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 41/262 (15%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNV-----IGHAFYNKPIQMLDKS 81
F N F + + + + + + +G L+LT + +G A Y P+++ +
Sbjct: 6 FTINNFVPNEAD---LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNT 62
Query: 82 TSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDH 141
T + +SFST F F + PN GLAF ++P S + L + ++
Sbjct: 63 T-----GSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS 117
Query: 142 KPSNHLFAIEFDT-VNGYNETSDSQGNHVGINVNSMKSIKLEPAAYY--ENGTKEDFTLE 198
SN + A+EFDT + D H+GI+VN ++SIK + L
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
+ A + Y + ++ +DL E + VG
Sbjct: 178 PNKTLIASLVYP-----------------------SNQTTFSVAASVDLKEILPEWVRVG 214
Query: 259 FSASTGRK--VSSHFILGWSFS 278
FSA+TG V +H +L WSF+
Sbjct: 215 FSAATGYPTEVETHDVLSWSFT 236
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 58/268 (21%), Positives = 102/268 (38%), Gaps = 40/268 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGRLRHKH 404
F+ +G G FG VY + E+E LRH +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
++ L G+ + L+ +Y P G++ L F ++ I +A L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCHS- 124
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+ VIHRD+K N+L+ + ++ DFG + S T + GT+ Y+ PE+
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTTLCGTLDYLPPEMIEGR 179
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584
D+++ GVL E G+ P +++ +Q + + V+
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANT---------YQETYKRISRVEFTFPDFVTEG 230
Query: 585 EMELVLQLGLLCSHQKAEARPTMRQVLR 612
+L+ + RP +R+VL
Sbjct: 231 ARDLISR----LLKHNPSQRPMLREVLE 254
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 164 bits (416), Expect = 3e-47
Identities = 60/260 (23%), Positives = 96/260 (36%), Gaps = 38/260 (14%)
Query: 27 FIFNGFNETKTNQG--LITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQML 78
F + F G + A+ GAL+LT N G A Y++P+ +
Sbjct: 6 FTYPDFWSYSLKNGTEITFLGDATR--IPGALQLTKTDANGNPVRSSAGQASYSEPVFLW 63
Query: 79 DKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNST 138
D + A+SF T F F ++ GLAF ++P S + T
Sbjct: 64 DSTG------KAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHET 116
Query: 139 NDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLE 198
N + A+EFDT + +D H+GI+VNS+ S+
Sbjct: 117 AADPSKNQVVAVEFDTWI-NKDWNDPPYPHIGIDVNSIVSVATTRWEN--------DDAY 167
Query: 199 SGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
A I YD ++++ V + + +LS +DL+ + + +G
Sbjct: 168 GSSIATAHITYDARSKILTVLL-----------SYEHGRDYILSHVVDLAKVLPQKVRIG 216
Query: 259 FSASTGRKVSSHFILGWSFS 278
FSA G +IL W F
Sbjct: 217 FSAGVGY-DEVTYILSWHFF 235
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 38/274 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVL---------------------PTRMREFAAEIESLGRLRH 402
FK+ +V+G+G FG VYKG+ P +E E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
H+ L G C + L+ +P G L + ++++ + + N IA G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG-KISHTTNVVGTIGYIAPELA 521
+ ++HRD+ + NVL+ + ++ DFGLA+L K H I ++A E
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 522 RTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581
+ +DV++YGV + E+ T ++ +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----------PASEISSILEKGERLPQ 234
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
V + + C A++RP R+++ +
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 51/306 (16%)
Query: 349 PHRFRYSDLYTATK------GFKQSEVIGTGGFGEVYKGVLPTRMR-------------- 388
P F +D+Y + S +G G FG VY+GV ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 389 --------EFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENF 440
EF E + H+V L G + + L++ + + G L S L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 441 V--------LSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDF 492
+ S + + IA G+ YL+ +HRD+ + N ++ D ++GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF 177
Query: 493 GLARLFDHGKISH-TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDS 551
G+ R + + +++PE + G + +DV+++GV+L EIAT
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 552 DHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVL 611
+ VL F G +LD D +++ +L +C + RP+ +++
Sbjct: 238 GLS--NEQVLRFVMEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 612 RYLNGD 617
+ +
Sbjct: 287 SSIKEE 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 7e-46
Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 33/268 (12%)
Query: 361 TKGFKQSEVIGTGGFGEVYKGVLPTRMREFA----------------AEIESLGRLRHKH 404
K + + E IG G G VY + +E A EI + ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
+VN +L +V +Y+ GSL ++ + Q + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN 135
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
VIHRD+KS N+L+ D + +L DFG + S + +VGT ++APE+
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRK 191
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584
D+++ G++ +E+ G P +++ + L ++ +P S
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPELQNPEKLS----- 243
Query: 585 EMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ C E R + +++L+
Sbjct: 244 --AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-45
Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 43/279 (15%)
Query: 362 KGFKQSEVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGR 399
K + E +G G FG V +G P M +F E+ ++
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
L H++L+ L G + +V + P GSL L ++ +A G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMG 125
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH--TTNVVGTIGYIA 517
YL + IHRD+ + N+L+ ++GDFGL R + + + A
Sbjct: 126 YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRP--IDSDHFILVDWVLEFQHLGQVLDVVDP 575
PE +T S ++D + +GV L E+ T + I + ++ + + +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614
++ + + C K E RPT + +L
Sbjct: 243 DI------------YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 55/294 (18%), Positives = 107/294 (36%), Gaps = 51/294 (17%)
Query: 343 DWELDCPHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTR---------------- 386
D+E+ R IG G FG+V++G+ +
Sbjct: 1 DYEIQ-RERIELG------------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT 47
Query: 387 ----MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVL 442
+F E ++ + H H+V L G + + ++ + G L S + L
Sbjct: 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF-LQVRKYSL 105
Query: 443 SWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502
++ L YL + +HRD+ + NVL+ ++ +LGDFGL+R +
Sbjct: 106 DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVL 561
+ I ++APE + + ++DV+ +GV + EI G +P
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------- 214
Query: 562 EFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+G++ + + + L+ + C RP ++ L+
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLS 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (408), Expect = 1e-44
Identities = 65/312 (20%), Positives = 125/312 (40%), Gaps = 38/312 (12%)
Query: 368 EVIGTGGFGEVYKGV----------------LPTRMREFAAEIESLGRLRHKHLVNLQGW 411
E +G+G FG V++ V P EI + +L H L+NL
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIH 471
+ K +++L+ +++ G L + E++ +S + N ++ GL ++HE ++H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVH 150
Query: 472 RDVKSGNVLIDADMNAR--LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCS 529
D+K N++ + + + DFGLA + +I T T + APE+
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFY 208
Query: 530 TDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELV 589
TD++A GVL + +G P + + Q++ + D + SS + +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 590 LQLGLLCSHQKAEARPTMRQVLR--YLNGD--ELLPIIDNWSSLDSQRSEMNSRYLEIIS 645
++ R T+ L +L GD L I + S + R ++ +Y + +
Sbjct: 264 KN----LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS-SRYNKIRQKIKEKYADWPA 318
Query: 646 TDNITTSQLSSS 657
+ S
Sbjct: 319 PQPAIGRIANFS 330
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (400), Expect = 1e-43
Identities = 59/267 (22%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA----------------EIESLGRLRHKHLVN 407
+ E +GTG FG V++ FAA EI+++ LRH LVN
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 408 LQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
L + +++++Y+++ G L + D N +S ++ ++ + GL ++HE
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 468 VVIHRDVKSGNVLIDADMNAR--LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+H D+K N++ + L DFGL D + T GT + APE+A
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP 201
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585
TD+++ GVL + +G P ++ +++ +D + S
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVKSCDWNMDDSAFSGISEDG 256
Query: 586 MELVLQLGLLCSHQKAEARPTMRQVLR 612
+ + + R T+ Q L
Sbjct: 257 KDFIRK----LLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-42
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 45/285 (15%)
Query: 349 PHRFRYSDLYTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFA----------------- 391
P + R D FK +++G G F V RE+A
Sbjct: 2 PRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY 54
Query: 392 --AEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFN 449
E + + RL H V L + L Y NG L + +F
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRF 112
Query: 450 IIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH-GKISHTTN 508
I + L YLH + +IHRD+K N+L++ DM+ ++ DFG A++ K + +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQ 568
VGT Y++PEL A S+D++A G ++ ++ G P + + E+ +
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQK 221
Query: 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613
++ ++ + + +LV + A R ++ Y
Sbjct: 222 IIK-LEYDFPEKFFPKARDLVEK----LLVLDATKRLGCEEMEGY 261
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 149 bits (376), Expect = 1e-41
Identities = 73/262 (27%), Positives = 107/262 (40%), Gaps = 51/262 (19%)
Query: 26 EFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHN------VIGHAFYNKPIQMLD 79
F F F+ T+ LI + A+I G L+LT N +G AFY+ PIQ+ D
Sbjct: 5 SFNFPNFH---TDDKLILQGNATIS-SKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60
Query: 80 KSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
+ N +SF+T F F I N +GLAF + P S P K E +LGI N+ N
Sbjct: 61 SN-------NVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQE-FLGIFNTNN 112
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
+P+ A+ F+T N + + N +K E DF +
Sbjct: 113 P-EPNARTVAVVFNTF----------KNRIDFDKNFIKPYVNENC---------DFHKYN 152
Query: 200 GDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259
G+ I YD N + V + + +S + L E + VGF
Sbjct: 153 GEKTDVQITYDSSNNDLRVFLHFTVS----------QVKCSVSATVHLEKEVDEWVSVGF 202
Query: 260 SASTG---RKVSSHFILGWSFS 278
S ++G +H +L WSFS
Sbjct: 203 SPTSGLTEDTTETHDVLSWSFS 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 54/292 (18%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTR------------------------MREFAAEIESLGR 399
+ +G G FG+V + + +E+E +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 400 L-RHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFD--------------NENFVLSW 444
+ +HK+++NL G C + L ++ +Y G+L L N LS
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504
+ + +A G+ YL + IHRD+ + NVL+ D ++ DFGLAR H
Sbjct: 135 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 505 HTTNV-VGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEF 563
T + ++APE + +DV+++GVLL EI T V+ + +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKL 249
Query: 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
G +D S E+ + C H RPT +Q++ L+
Sbjct: 250 LKEGHRMDK------PSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 144 bits (364), Expect = 2e-40
Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 62/255 (24%)
Query: 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSS 86
FI + FN+T + + + + +G L+L+ N+++ + AFY+ PIQ+ D +T
Sbjct: 6 FIIDAFNKTN-----LILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTT---- 56
Query: 87 KPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNH 146
N +SF T F I T GL F + P
Sbjct: 57 -GNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK-------------------GD 96
Query: 147 LFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAW 206
+EFDT + + I+VN+ D G +
Sbjct: 97 TVTVEFDTF----------LSRISIDVNNNDI----------KSVPWDVHDYDGQNAEVR 136
Query: 207 IDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGR- 265
I Y+ ++ +V++ + +S ++L + + VGFSA++G
Sbjct: 137 ITYNSSTKVFSVSL----------SNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAY 186
Query: 266 --KVSSHFILGWSFS 278
+H +L WSFS
Sbjct: 187 QWSYETHDVLSWSFS 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (373), Expect = 2e-40
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 38/280 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGRLRHKHLV 406
+ +V+GTG F EV L + EI L +++H ++V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L + L L+ + G L + + + + +I + + YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG- 127
Query: 467 QVVIHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
++HRD+K N+L D D + DFGL+++ D G + T GT GY+APE+
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVLAQ 183
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583
S + D ++ GV+ + G P ++ D L Q L + P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKLFEQILKAEYEFDSPYW-DDISD 238
Query: 584 AEMELVLQLGLLCSHQKAEARPTMRQVLR--YLNGDELLP 621
+ + + + E R T Q L+ ++ GD L
Sbjct: 239 SAKDFIRH----LMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 52/291 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVL----------------------PTRMREFAAEIESLGR-L 400
K + +G G FG+V + + R +E++ L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 401 RHKHLVNLQGWCKRKRD-LLLVYDYIPNGSLDSLLFDNENF--------------VLSWE 445
H ++VNL G C + L+++ ++ G+L + L N L+ E
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 446 QRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR-LFDHGKIS 504
+A G+ +L IHRD+ + N+L+ ++ DFGLAR ++
Sbjct: 135 HLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ 564
+ + ++APE + +DV+++GVLL EI + I +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRL 250
Query: 565 HLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
G + D Y EM Q L C H + RPT +++ +L
Sbjct: 251 KEGTRMRAPD------YTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 46/262 (17%), Positives = 107/262 (40%), Gaps = 32/262 (12%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFAA---------------EIESLGRLRHKHLVNLQGWC 412
E +G G FG V++ V + + + A EI L RH+++++L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 413 KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472
+ +L++++++I + + + F L+ + + + + L +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHF 126
Query: 473 DVKSGNVLIDADMNAR--LGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCST 530
D++ N++ ++ + +FG AR G Y APE+ + S +T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTAT 184
Query: 531 DVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVL 590
D+++ G L+ + +G P ++ + +++ D + M+ V
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 591 QLGLLCSHQKAEARPTMRQVLR 612
+ ++ ++R T + L+
Sbjct: 240 R----LLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 1e-39
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 48/281 (17%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------------AEIESLG 398
++ E++G G V + + +E+A E++ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 399 RLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAG 457
++ H +++ L+ + LV+D + G L L E LS ++ I++ +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEV 122
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
+ LH+ ++HRD+K N+L+D DMN +L DFG + D G V GT Y+A
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 518 PELARTGKA------SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD 571
PE+ D+++ GV++ + G P + L ++
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMIMS 229
Query: 572 VVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ GS + V L + + R T + L
Sbjct: 230 -GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (361), Expect = 5e-39
Identities = 62/283 (21%), Positives = 115/283 (40%), Gaps = 44/283 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGRLRHKH 404
++ E++G GG EV+ P+ F E ++ L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 405 LVNLQGWC----KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+V + +V +Y+ +L ++ ++ ++ +I L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK--ISHTTNVVGTIGYIAP 518
+ +IHRDVK N++I A ++ DFG+AR ++ T V+GT Y++P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 519 ELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578
E AR +DV++ G +L E+ TG P D + +QH+ + D + P+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVRE--DPIPPSAR 237
Query: 579 SSYVVAEMELVLQLGLLCSHQKAEARP-TMRQVL----RYLNG 616
+ A+++ V+ L + E R T ++ R NG
Sbjct: 238 HEGLSADLDAVVLKAL---AKNPENRYQTAAEMRADLVRVHNG 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-39
Identities = 64/314 (20%), Positives = 126/314 (40%), Gaps = 36/314 (11%)
Query: 367 SEVIGTGGFGEVYKGVLPTRMREFAA-----------EIESLGRL-RHKHLVNLQGWCK- 413
S+V+G G G+V + +FA E+E R + H+V + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 414 ---RKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVI 470
++ LL+V + + G L S + D + + + I+K I + YLH +
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 133
Query: 471 HRDVKSGNVLIDADMN---ARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKAS 527
HRDVK N+L + +L DFG A+ T T Y+APE+ K
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYD 191
Query: 528 CSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587
S D+++ GV++ + G P S+H + + ++ + + PN S V E++
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF--PNPEWSEVSEEVK 249
Query: 588 LVLQLGLLCSHQKAEARPTMRQVLR--YLNGDELLPIIDNWSS-----LDSQRSEMNSRY 640
++++ + R T+ + + ++ +P +S + ++
Sbjct: 250 MLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM 306
Query: 641 LEIISTDNITTSQL 654
++T + Q+
Sbjct: 307 TSALATMRVDYEQI 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 5e-36
Identities = 47/275 (17%), Positives = 94/275 (34%), Gaps = 32/275 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGV--------------LPTRMREFAAEIESLGRLRHKHLVNLQ 409
++ IG+G FG++Y G + T+ + E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 410 GWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVV 469
WC + D ++ + SL+ LF+ + S + + + + + Y+H +
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 470 IHRDVKSGNVLI---DADMNARLGDFGLARLFDHGKIS------HTTNVVGTIGYIAPEL 520
IHRDVK N L+ + DFGLA+ + + N+ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580
+ S D+ + G +L+ G P E + + + L
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-RISEKKMSTPIEVLCKG 243
Query: 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
Y + C + + +P + +
Sbjct: 244 YPSEFATYLNF----CRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 5e-36
Identities = 53/212 (25%), Positives = 80/212 (37%), Gaps = 31/212 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA----------------------AEIESLGRLR 401
F +IG GGFGEVY + +A + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
+V + L + D + G L L + F I GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHM 123
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELA 521
H + V++RD+K N+L+D + R+ D GLA F K VGT GY+APE+
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVL 177
Query: 522 RTGKA-SCSTDVFAYGVLLLEIATGRRPIDSD 552
+ G A S D F+ G +L ++ G P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (337), Expect = 9e-36
Identities = 60/282 (21%), Positives = 98/282 (34%), Gaps = 38/282 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLV 406
+ E IG G +G VYK EI L L+H ++V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L K+ L+LV++++ L L + + + G+ Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
V+HRD+K N+LI+ + ++ DFGLAR F +T +V L + K
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 527 SCSTDVFAYGVLLLEIATGRRPIDSDH--------------FILVDW--VLEFQHLGQVL 570
S + D+++ G + E+ G +W V E
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
V +P S++ E + L R T +Q L
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 26/210 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGR-LRHK 403
F +++G G FG+V+ + E L H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 404 HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
L ++ + K +L V +Y+ G L + F + I GL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFL-- 119
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
+ +++RD+K N+L+D D + ++ DFG+ + G T GT YIAPE+
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
K + S D +++GVLL E+ G+ P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 54/271 (19%), Positives = 91/271 (33%), Gaps = 52/271 (19%)
Query: 368 EVIGTGGFGEVYKGV----------------------LPTRMREFAAEIESLGRLRHKH- 404
++G+GGFG VY G+ E+ L ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 405 -LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463
++ L W +R +L+ + E L E + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHC-- 126
Query: 464 EWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELAR 522
V+HRD+K N+LID + +L DFG L + T+ GT Y PE R
Sbjct: 127 -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIR 182
Query: 523 TGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581
+ S V++ G+LL ++ G P + D I+ V Q +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC----------- 231
Query: 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
L+ C + RPT ++
Sbjct: 232 ----QHLIRW----CLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 43/282 (15%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFA---------------------AEIESLGRLRHKHLV 406
+ +G G F VYK + A EI+ L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 407 NLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWE 466
L K ++ LV+D++ + + + VL+ + GL YLH+ W
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
++HRD+K N+L+D + +L DFGLA+ F ++ T+ V T Y APEL +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 527 -SCSTDVFAYGVLLLEIATGRRPIDSDH--------------FILVDWVLEFQHLGQVLD 571
D++A G +L E+ + D W V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 572 VVDPNLGSSYVVAEM-ELVLQLGLLCSHQKAEARPTMRQVLR 612
P + ++ + + +L L AR T Q L+
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (332), Expect = 1e-34
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------------PTRMREFAAEIESLGRLRHKH 404
F+ +GTG FG V+ ++ E L + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
++ + G + + + ++ DYI G L SLL ++ F + + A L L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYL 120
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+ +I+RD+K N+L+D + + ++ DFG A+ T + GT YIAPE+ T
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTK 176
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ S D +++G+L+ E+ G P +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSN 205
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 22/208 (10%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------------AEIESLGRLRHKHL 405
F++ E IG G +G VYK A EI L L H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V L + L LV+++ + L + + + + + + GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
V+HRD+K N+LI+ + +L DFGLAR F ++T VV L
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 526 ASCSTDVFAYGVLLLEIATGRRPIDSDH 553
S + D+++ G + E+ T R D
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------AEIESLGRLRHKHLVNLQGW 411
+ ++VIG G FG VY+ L A E++ + +L H ++V L+ +
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 412 C------KRKRDLLLVYDYIPNGSLDSLL-FDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
K + L LV DY+P + L + + L Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 465 WEQVVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAP-ELAR 522
+ HRD+K N+L+D D +L DFG A+ G+ + + + + Y AP +
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPELIFG 196
Query: 523 TGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ S DV++ G +L E+ G+ D
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 42/275 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFAA----------------------EIESLGRLR 401
+ E +G+G F V K + ++AA E+ L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYL 461
H +++ L + K D++L+ + + G L L + E+ E+ +K I G+ YL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT--EEEATEFLKQILNGVYYL 129
Query: 462 HEEWEQVVIHRDVKSGNVLIDADMNAR----LGDFGLARLFDHGKISHTTNVVGTIGYIA 517
H + H D+K N+++ + + DFGLA D G + N+ GT ++A
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVA 184
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577
PE+ D+++ GV+ + +G P D + + L V V+
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSA-VNYEF 235
Query: 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
Y L + + R T++ L+
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 24/220 (10%)
Query: 357 LYTATKGFKQSEVIGTGGFGEVYKGV-----------------LPTRMREFAAEIESLGR 399
++ + IG G +G V T + EI+ L R
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 400 LRHKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN-ENFVLSWEQRFNIIKGIAAGL 458
RH++++ + + + Y+ + + L+ + LS + + I GL
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT--TNVVGTIGYI 516
Y+H V+HRD+K N+L++ + ++ DFGLAR+ D T V T Y
Sbjct: 123 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 517 APELARTGKASC-STDVFAYGVLLLEIATGRRPIDSDHFI 555
APE+ K S D+++ G +L E+ + R H++
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-34
Identities = 57/289 (19%), Positives = 96/289 (33%), Gaps = 45/289 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGV----------------------LPTRMREFAAEIESLGRLR 401
++ IG G +G+V+K +P A + L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 402 HKHLVNLQGWCKRKRDLLLVYDYIPN----GSLDSLLFDNENFVLSWEQRFNIIKGIAAG 457
H ++V L C R + L + L + E +++ + G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIA 517
L +LH V+HRD+K N+L+ + +L DFGLAR++ T+VV T+ Y A
Sbjct: 129 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRA 183
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILV--------------DWVLEF 563
PE+ + D+++ G + E+ + + DW +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 564 QHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
Q +V EL L L C R + L
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 5e-34
Identities = 45/278 (16%), Positives = 89/278 (32%), Gaps = 36/278 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA--------------AEIESLGRLRH-KHLVNL 408
+K IG G FG +++G ++ A E + L + N+
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 409 QGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468
+ + +LV D + D L D S + K + A + +HE +
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 469 VIHRDVKSGNVLIDADMN-----ARLGDFGLARLFDHGKIS------HTTNVVGTIGYIA 517
+++RD+K N LI + + DFG+ + + N+ GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 518 PELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577
+ S D+ A G + + G P ++ +G+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIGEKKQSTPLRE 239
Query: 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615
+ E + + +A P + +
Sbjct: 240 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 121 bits (306), Expect = 5e-32
Identities = 35/163 (21%), Positives = 66/163 (40%), Gaps = 23/163 (14%)
Query: 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPV 203
++ + A+E DT + D H+GI++ S++S K + +++G
Sbjct: 1 ADTIVAVELDTYPN-TDIGDPSYPHIGIDIKSVRSKKTAK-----------WNMQNGKVG 48
Query: 204 QAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAST 263
A I Y+ V++ ++ + +S +DL E + VG SAST
Sbjct: 49 TAHIIYNSVDKRLSAV-----------VSYPNADSATVSYDVDLDNVLPEWVRVGLSAST 97
Query: 264 GRKVSSHFILGWSFSMNGAAPSLNLSQIPSLPIERSSSNSFSL 306
G ++ IL WSF+ + S + + + S + L
Sbjct: 98 GLYKETNTILSWSFTSKLKSNSTHETNALHFMFNQFSKDQKDL 140
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 85.8 bits (212), Expect = 2e-19
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 14/115 (12%)
Query: 32 FNETKTNQGLITRERASILKPSGALRLTDNAHNV------IGHAFYNKPIQMLDKSTSLS 85
FN+ +Q + + + G L LT + N +G A + P+ + + S
Sbjct: 130 FNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSA--- 186
Query: 86 SKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTN 139
+SF F F I +P+S G+AF +S S P G LG+ N
Sbjct: 187 ---VVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-32
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------------AEIESLGRLRHKHL 405
+++ IG G FGEV+K ++ A EI+ L L+H+++
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 406 VNLQGWC--------KRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAG 457
VNL C + K + LV+D+ + L F LS +R +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQML 126
Query: 458 LLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS---HTTNVVGTIG 514
L L+ ++HRD+K+ NVLI D +L DFGLAR F K S TN V T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 515 YIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSD 552
Y PEL + D++ G ++ E+ T + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 25/209 (11%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKH 404
F +++G G FG+V R +A E L RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
L L+ + L V +Y G L L + V + E+ I + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL---EYL 121
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+ V++RD+K N+++D D + ++ DFGL + + GT Y+APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN 180
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ D + GV++ E+ GR P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 55/284 (19%), Positives = 95/284 (33%), Gaps = 40/284 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVL------------------PTRMREFAAEIESLGRLRHKHL 405
+++ E IG G +G V+K EI L L+HK++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW 465
V L + L LV+++ N + + F + L L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCH 118
Query: 466 EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGK 525
+ V+HRD+K N+LI+ + +L +FGLAR F ++ VV L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 526 ASCSTDVFAYGVLLLEIATGRRPI-----DSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580
S S D+++ G + E+A RP+ D + +L Q +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 581 YVVAEMELVLQLGLLCSHQKA------------EARPTMRQVLR 612
Y + L + + R + + L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (298), Expect = 7e-30
Identities = 54/209 (25%), Positives = 82/209 (39%), Gaps = 28/209 (13%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA-------------------AEIESLGRLRHKH 404
F + + +GTG FG V +A E L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE 464
LV L+ K +L +V +Y+ G + S L F S I YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--SEPHARFYAAQIVLTFEYLHSL 160
Query: 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTG 524
+I+RD+K N+LID ++ DFG A+ T + GT +APE+ +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSK 213
Query: 525 KASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ + D +A GVL+ E+A G P +D
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTR-----------------------MREFAAEIESLGRL 400
F+ +V+GTG +G+V+ + E + L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 401 RHK-HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLL 459
R LV L + + L L+ DYI G L + L E F + + +L
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVL 140
Query: 460 YLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPE 519
L + +I+RD+K N+L+D++ + L DFGL++ F + + GTI Y+AP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 520 LARTGKA--SCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ R G + + D ++ GVL+ E+ TG P D
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-28
Identities = 51/287 (17%), Positives = 100/287 (34%), Gaps = 44/287 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVLPTRMREFA------------------AEIESLGRLRHKHL 405
++ + +G+G +G V V + A E+ L +RH+++
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 406 VNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHE 463
+ L L D+ ++ L ++ ++ + GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 464 EWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELART 523
HRD+K GN+ ++ D ++ DFGLAR D T VV +
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNW 193
Query: 524 GKASCSTDVFAYGVLLLEIATGRRPIDSD------------------HFILVDWVLEFQH 565
+ + + D+++ G ++ E+ TG+ F+ E ++
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 566 LGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612
+ L ++ +S + L + L AE R T + L
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (275), Expect = 4e-27
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 28/222 (12%)
Query: 364 FKQSEVIGTGGFGEVYKGVL-------------PTRMREFAAEIESLGRLR-HKHLVNLQ 409
++ +G G + EV++ + P + ++ EI+ L LR +++ L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 410 GWCKR--KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQ 467
K R LV++++ N L L+ + I L Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 468 VVIHRDVKSGNVLIDAD-MNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKA 526
++HRDVK NV+ID + RL D+GLA + G+ V + + PEL +
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQM 206
Query: 527 -SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLG 567
S D+++ G +L + + P H V + LG
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-26
Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 35/231 (15%)
Query: 350 HRFRYSDL-YTATKGFKQSEVIGTGGFGEVYKGVLPTRMREFA----------------- 391
+ D +T K ++ + IG+G G V R A
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 392 -AEIESLGRLRHKHLVNLQGWCKRKR------DLLLVYDYIPNGSLDSLLFDNENFVLSW 444
E+ + + HK++++L ++ D+ LV + + + +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DH 118
Query: 445 EQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504
E+ ++ + G+ +LH +IHRD+K N+++ +D ++ DFGLAR
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173
Query: 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI 555
T V T Y APE+ + D+++ G ++ E+ + +I
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 40/213 (18%), Positives = 82/213 (38%), Gaps = 32/213 (15%)
Query: 364 FKQSEVIGTGGFGEVYKGVL------------------PTRMREFAAEIESLGRLRHKHL 405
++ +G+G +G V + E+ L ++H+++
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 406 VNLQGWCKRKRDL-----LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLY 460
+ L R L + + ++ L++++ + L+ + +I I GL Y
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 136
Query: 461 LHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTNVVGTIGYIAPEL 520
+H +IHRD+K N+ ++ D ++ DFGLAR D T V +
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 521 ARTGKASCSTDVFAYGVLLLEIATGRRPIDSDH 553
+ + D+++ G ++ E+ TGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.5 bits (229), Expect = 8e-22
Identities = 25/225 (11%), Positives = 51/225 (22%), Gaps = 37/225 (16%)
Query: 53 SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFG 112
+ +R+ + + G + ++ VT G G
Sbjct: 36 ADQIRIAPSLKSQRGSVWTKTKA-------------AFENWEVEV-TFRVTGRGRIGADG 81
Query: 113 LAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGIN 172
LA + G G + + I FD+ ++ + +
Sbjct: 82 LAIWYTENQGLDGP----VFGSADM-------WNGVGIFFDS---FDNDGKKNNPAIVVV 127
Query: 173 VNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFH 232
N+ + P + + V I +
Sbjct: 128 GNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMI---------NNG 178
Query: 233 FGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSF 277
F + + G SA+TG H +L +
Sbjct: 179 FTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.9 bits (232), Expect = 2e-21
Identities = 49/236 (20%), Positives = 82/236 (34%), Gaps = 35/236 (14%)
Query: 368 EVIGTGGFGEVYKGVLPTRMREFA---------------AEIESLGRLRHKHLVNLQGWC 412
+G G F V+ A EI+ L R+
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 413 KRKRDLLLVY--DYIPNGSL------------DSLLFDNENFVLSWEQRFNIIKGIAAGL 458
LL + PNG +L+ E+ + I K + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 459 LYLHEEWEQVVIHRDVKSGNVLIDA-DMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYI 516
Y+H +IH D+K NVL++ D L +A L + H TN + T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 517 APELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDV 572
+PE+ C D+++ L+ E+ TG + D + + H+ Q++++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH--SYTKDDDHIAQIIEL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.1 bits (189), Expect = 7e-17
Identities = 24/158 (15%), Positives = 45/158 (28%), Gaps = 34/158 (21%)
Query: 368 EVIGTGGFGEVYKGVLPT-------------------------RMREFAAEIESLGRLRH 402
+++G G V+ F+ R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 403 KHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLH 462
+ L LQG K Y + N L L+ E + + E ++ I + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 463 EEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500
++H D+ NVL+ + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 48.8 bits (116), Expect = 5e-07
Identities = 30/226 (13%), Positives = 55/226 (24%), Gaps = 48/226 (21%)
Query: 53 SGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFG 112
G LT + G + + D T + F+ G G
Sbjct: 34 EGRFVLTPGKNTK-GSLWLKPEYSIKDAMTIE------------WTFRSFGF-RGSTKGG 79
Query: 113 LAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGIN 172
LAF + + ++ I D G V
Sbjct: 80 LAFWLKQGNEGDST------ELFGGSSKKFNG---LMILLRL-------DDKLGESVTAY 123
Query: 173 VNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLV-NVTICPMNKKNKLSF 231
+N + L+ + + +S P + Y+ ++ + + + N++ F
Sbjct: 124 LND-GTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQM-----DNRVCF 177
Query: 232 HFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSF 277
K +G SA S IL
Sbjct: 178 QTRKVKFM-----------GSSPFRIGTSAINDASKESFEILKMKL 212
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 45.8 bits (108), Expect = 6e-06
Identities = 45/262 (17%), Positives = 81/262 (30%), Gaps = 51/262 (19%)
Query: 21 SQQKEEFIF-NGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLD 79
S+ ++ + N K T E+AS+ G + LT N ++ G + + + D
Sbjct: 4 SKLSSDYSLPDLINTRKVPNNWQTGEQASLE--EGRIVLTSNQNSK-GSLWLKQGFDLKD 60
Query: 80 KSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTN 139
SF+ + F+ V SGQ G++F + +
Sbjct: 61 ------------SFTMEWTFRSVGY-SGQTDGGISFWFVQDSN---------IPRDKQLY 98
Query: 140 DHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLES 199
+ + + D NG + + G I + A G +S
Sbjct: 99 NGPVNYDGLQLLVDN-NGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGY-----QDS 152
Query: 200 GDPVQAWIDYD-GVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVG 258
P + YD + L+ V + NK+ F K P + +G
Sbjct: 153 SVPSTIRVTYDLEDDNLLKVQV-----DNKVCFQTRKVRFP------------SGSYRIG 195
Query: 259 FSASTGRKVSSHFILGWSFSMN 280
+A G ++ F M
Sbjct: 196 VTAQNGAVNNNAESFEI-FKMQ 216
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.97 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.94 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.79 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.91 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=2.3e-56 Score=445.72 Aligned_cols=226 Identities=32% Similarity=0.489 Sum_probs=198.8
Q ss_pred ceeEEeCCCCCCC-CCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 24 KEEFIFNGFNETK-TNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 24 ~~~f~~~~f~~~~-~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+++|+|++|+++. .+ |.++|+|.+. +|.|+||+.. ..++|||+|++||+||++.++ +++||+|+
T Consensus 1 ~~sF~f~~F~~~~~~~---l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~-----~~asFsT~ 71 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDS---IIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTE-----SVASFYTE 71 (236)
T ss_dssp CCEEEESCSCSCGGGT---EEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTC-----CCCEEEEE
T ss_pred CEEEEeCCCCCCCcCC---EEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCCCC-----ceeEEEEE
Confidence 4799999998642 34 9999999996 8999999754 458899999999999999999 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCC-CCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHK-PSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS 175 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns 175 (670)
|+|.|.+. ...+||||||||+|... +.+..|++||+++..++++ ..+++|||||||++| .+++||++||||||+||
T Consensus 72 F~F~i~~~-~~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n-~~~~D~~~nHIgIdvns 148 (236)
T d1hqla_ 72 FTFFLKIT-GNGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTN-PNFPEPSYRHIGINVNS 148 (236)
T ss_dssp EEEEEEEC-SSCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCC-SSSCCCSSCEEEEEESS
T ss_pred EEEEEeCC-CCCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEeeCccC-CCCCCCCCCEEEEEcCC
Confidence 99999875 45789999999999764 4567899999999876554 579999999999999 78899999999999999
Q ss_pred cccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccc
Q 035655 176 MKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETM 255 (670)
Q Consensus 176 ~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~ 255 (670)
++|..+.+. ...++.+|+.++|||+||+.+++|+|+|++ .+|..|+|++.|||+++|+++|
T Consensus 149 ~~s~~~~~~--------~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~-----------~~~~~~~ls~~vdL~~~l~~~v 209 (236)
T d1hqla_ 149 IVSVATKRW--------EDSDIFSGKIATARISYDGSAEILTVVLSY-----------PDGSDYILSHSVDMRQNLPESV 209 (236)
T ss_dssp SSCSEEEEC--------CHHHHTSCSCEEEEEEEETTTTEEEEEEEE-----------TTTEEEEEEEECCGGGTSCSEE
T ss_pred ccccccccc--------ccccccCCCEEEEEEEEeCCCcEEEEEEec-----------CCCCCeeEEEEeCHHHhCCCcE
Confidence 999887663 346788999999999999999999999975 3566789999999999999999
Q ss_pred eeeEeecCCce-eeeEEEeccccccC
Q 035655 256 YVGFSASTGRK-VSSHFILGWSFSMN 280 (670)
Q Consensus 256 ~vGFsastg~~-~~~h~i~sW~fs~~ 280 (670)
|||||||||.. .+.|+|++|+|+++
T Consensus 210 ~vGFSasTG~~~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 210 RVGISASTGNNQFLTVYILSWRFSSN 235 (236)
T ss_dssp EEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred EEEEEeECCCCCceEEEEEEeEeEec
Confidence 99999999974 68899999999874
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=2.9e-55 Score=439.28 Aligned_cols=227 Identities=27% Similarity=0.401 Sum_probs=198.0
Q ss_pred CCceeEEeCCCCCC----CCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCcc
Q 035655 22 QQKEEFIFNGFNET----KTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNAS 91 (670)
Q Consensus 22 ~~~~~f~~~~f~~~----~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~ 91 (670)
+++++|+|++|.+. ..+ |.++|+|.+. +|.|+||+.. .+++|||+|++||+||++ ++ +++
T Consensus 1 ~~s~sF~f~~F~~~~~~~~~~---l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~-----~~a 70 (243)
T d1leda_ 1 ENTVNFTYPDFWSYSLKNGTE---ITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TG-----KAA 70 (243)
T ss_dssp CCCCEEEESCBCCTTSCTTTS---EEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TS-----CBC
T ss_pred CCceEEEcCCCCCCCCCCCCc---EEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CC-----cEe
Confidence 35799999999753 235 9999999997 8999999653 368999999999999985 56 899
Q ss_pred ceeEEEEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCC-CCCcEEEEEeeecCCCCCCCCCCCCeeE
Q 035655 92 SFSTCFVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHK-PSNHLFAIEFDTVNGYNETSDSQGNHVG 170 (670)
Q Consensus 92 sFst~F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~~Dp~~~Hvg 170 (670)
||+|+|+|.|.+. ...+||||||||+|.+. +.+..|++||+++..+.++ ..+++|||||||++| .+++||++||||
T Consensus 71 sFsT~F~f~i~~~-~~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n-~~~~d~~~nHVg 147 (243)
T d1leda_ 71 SFYTSFTFLLKNY-GAPTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWIN-KDWNDPPYPHIG 147 (243)
T ss_dssp EEEEEEEEEEEES-SSSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCC-GGGTCCSSCEEE
T ss_pred eEEEEEEEEcCCC-CCCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccc-cccCCCCCCceE
Confidence 9999999988765 45689999999999764 5567899999998877655 579999999999999 788899999999
Q ss_pred EecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccc
Q 035655 171 INVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPA 250 (670)
Q Consensus 171 idvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~ 250 (670)
||+|++.|..++++. ..++.+|+.++|||+||+.+++|+|+|++ .+|..|+|++.|||+++
T Consensus 148 Idvns~~s~~~~~~~--------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~-----------~~~~~p~ls~~idL~~~ 208 (243)
T d1leda_ 148 IDVNSIVSVATTRWE--------NDDAYGSSIATAHITYDARSKILTVLLSY-----------EHGRDYILSHVVDLAKV 208 (243)
T ss_dssp EEESSSSCSEEEECC--------HHHHTSCCEEEEEEEEETTTTEEEEEEEE-----------TTSCEEEEEEECCHHHH
T ss_pred EEecCcccccccccc--------cCCcccCceeEEEEEEECCCCEEEEEEee-----------CCCCCceEEEecCHHHh
Confidence 999999998877642 35788999999999999999999999985 35667899999999999
Q ss_pred ccccceeeEeecCCceeeeEEEeccccccCC
Q 035655 251 FQETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 251 l~~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
|+++||||||||||. .|.|+|++|+|+++.
T Consensus 209 l~~~vyvGFSAsTG~-~~~h~I~sWsF~s~l 238 (243)
T d1leda_ 209 LPQKVRIGFSAGVGY-DEVTYILSWHFFSTL 238 (243)
T ss_dssp SCSEEEEEEEEEECB-SEEEEEEEEEEEEEC
T ss_pred cCCcEEEEEEcccCC-cceeeEEEEEEEeeC
Confidence 999999999999995 699999999999763
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=9.9e-55 Score=436.45 Aligned_cols=230 Identities=26% Similarity=0.374 Sum_probs=201.2
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFV 98 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~ 98 (670)
+++||+|++|.+...+ |.++|+|.+.++|.|+||+.. .++.|||+|++||+|||+.++ +++||+|+|+
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~-----~~~sF~t~F~ 73 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKD---LSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTG-----ELASFITSFS 73 (240)
T ss_dssp CEEEEEESSCCTTCSS---EEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTT-----EECEEEEEEE
T ss_pred CceEEECCCCCCCCCC---EEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCC-----ceeeeEEEEE
Confidence 5799999999865566 999999998878999999765 357899999999999999999 8999999999
Q ss_pred EEEecC-CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc
Q 035655 99 FQIVTP-NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK 177 (670)
Q Consensus 99 f~i~~~-~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~ 177 (670)
|.|..+ +...+||||||||+|.. .|.+..|++|||++.++ +++.+++|||||||++|..+++||++||||||+||+.
T Consensus 74 f~i~~~~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~ 151 (240)
T d1fx5a_ 74 FFMETSANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVK 151 (240)
T ss_dssp EEEEESSCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSS
T ss_pred EEEeCCCCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCcc
Confidence 999755 34568999999999975 47789999999998765 3567899999999999834789999999999999999
Q ss_pred cccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccccee
Q 035655 178 SIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 178 s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
+..+.+. +..+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+|+..|||+++|+++|||
T Consensus 152 s~~~~~~---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~----------~~~~~~ls~~vdLs~~l~~~v~v 212 (240)
T d1fx5a_ 152 SINAERW---------NKRYGLNNVANVEIIYEASSKTLTASLTYPS----------DQTSISVTSIVDLKEILPEWVSV 212 (240)
T ss_dssp CSEEEEC---------CCCCSGGGCEEEEEEEETTTTEEEEEEEETT----------TTEEEEEEEECCGGGTSCSEEEE
T ss_pred ccccccc---------ccccCCCCeEEEEEEEcCCCCEEEEEEecCC----------CceeeEEeEEEchHHhCCCcEEE
Confidence 8777652 3567789999999999999999999998643 56788999999999999999999
Q ss_pred eEeecCCc-eeeeEEEeccccccCC
Q 035655 258 GFSASTGR-KVSSHFILGWSFSMNG 281 (670)
Q Consensus 258 GFsastg~-~~~~h~i~sW~fs~~~ 281 (670)
|||||||. ..|.|+|++|+|+++.
T Consensus 213 GFSasTG~~~~~~H~I~sWsFsst~ 237 (240)
T d1fx5a_ 213 GFSGSTYIGRQATHEVLNWYFTSTF 237 (240)
T ss_dssp EEEEEEETTSCEEEEEEEEEEEEES
T ss_pred EEEeECCCCCCceEEEEEEEeEEec
Confidence 99999995 6799999999999763
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=6.8e-54 Score=429.84 Aligned_cols=226 Identities=31% Similarity=0.538 Sum_probs=199.0
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC---CCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA---HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVF 99 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f 99 (670)
++++|+|++|++...+ |.++|+|.+.++|.|+||+.. ..++|||+|++||+||++.++ +++||+|+|+|
T Consensus 2 ~~lsF~f~~F~~~~~~---l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~-----~~~sF~t~F~f 73 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKN---IIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITG-----KVASFATSFSF 73 (237)
T ss_dssp CSEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTC-----CBCEEEEEEEE
T ss_pred CcEEEEcCCCCCCCCC---EEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCc-----ceeeEEEEEEE
Confidence 5799999999875556 999999999878999999865 468999999999999999998 89999999999
Q ss_pred EEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCC--CCCCCeeEEecCCc
Q 035655 100 QIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETS--DSQGNHVGINVNSM 176 (670)
Q Consensus 100 ~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~--Dp~~~Hvgidvns~ 176 (670)
.|.++ ...+||||||+|+|... .|.++.++++|+++..+ ..+.+++|||||||++| .+.. ||++||||||+|++
T Consensus 74 ~i~~~-~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~-~~~~~~~vAVEFDT~~n-~~~~~~d~~~nHvgid~ns~ 150 (237)
T d1qnwa_ 74 VVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFG-KAYNPWDPDFKHIGIDVNSI 150 (237)
T ss_dssp ECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCC-TTTCTTSCSSCEEEEEESSS
T ss_pred EEecC-CCCCcceeEEEEeCCCCCCCCCCccccccccCCCC-CCCcccEEEEEeeceec-CCcCCCCCCCCeEEEECCCC
Confidence 99775 45689999999999875 57788889999988643 46789999999999998 6544 79999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|..+++ +.+.+|+.++|||+||+.+++|+|++.+. .+|..|+|++.|||+++|+++||
T Consensus 151 ~s~~~~~-----------~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~----------~~~~~p~ls~~vDLs~~l~~~vy 209 (237)
T d1qnwa_ 151 KSIKTVK-----------WDWRNGEVADVVITYRAPTKSLTVCLSYP----------SDGTSNIITASVDLKAILPEWVS 209 (237)
T ss_dssp SCSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEECT----------TTCCEEEEEEECCHHHHSCSEEE
T ss_pred Ccccccc-----------cccCCCcEEEEEEEEcCCCcEEEEEEecC----------CCCccceEEEEEChHHhCCCcEE
Confidence 9877665 56789999999999999999999999754 36788999999999999999999
Q ss_pred eeEeecCCce--eeeEEEeccccccC
Q 035655 257 VGFSASTGRK--VSSHFILGWSFSMN 280 (670)
Q Consensus 257 vGFsastg~~--~~~h~i~sW~fs~~ 280 (670)
||||||||.. .|.|+|++|+|+++
T Consensus 210 vGFSasTG~~~~~q~h~I~sWsF~s~ 235 (237)
T d1qnwa_ 210 VGFSGGVGNAAEFETHDVLSWYFTSN 235 (237)
T ss_dssp EEEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred EEEEeECCCCCCccEeEEEEeEeEEe
Confidence 9999999975 48999999999975
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=7e-54 Score=429.98 Aligned_cols=226 Identities=30% Similarity=0.517 Sum_probs=198.7
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
++++|+|++|++...+ |.++|+|.+.++|+||||++.. +++|||+|++||+||++.++ +++||+|+
T Consensus 2 ~~~sF~f~~F~~~~~n---l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~-----~~~sFst~ 73 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDN---LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTG-----TVASFETR 73 (239)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred eeEEEEeCCCCCCCCC---eEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCC-----ceeeEEEE
Confidence 4789999999875556 9999999998789999998653 58899999999999999988 89999999
Q ss_pred EEEEEecCC-CCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC
Q 035655 97 FVFQIVTPN-SGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS 175 (670)
Q Consensus 97 F~f~i~~~~-~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns 175 (670)
|+|.|..+. ...+||||||+|+|... +.+..+|+||+++..+. ...++.|||||||++| +++||++||||||+|+
T Consensus 74 F~f~i~~~~~~~~g~dG~aF~l~p~~~-~~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n--~~~d~~~~HvgI~vn~ 149 (239)
T d1gzca_ 74 FSFSIEQPYTRPLPADGLVFFMGPTKS-KPAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSN--PWDPPQVPHIGIDVNS 149 (239)
T ss_dssp EEEECCCCCSSSCCCEEEEEEEECSSC-CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC--TTSCSSSSEEEEEESS
T ss_pred EEEEEecCCCCCCCCCeEEEEECCCCC-CCCCCcccccccccCCC-CCccceEEEEEEcccc--CCCCCCCCEEEEEECC
Confidence 999998654 34689999999999875 44578899999877654 3578899999999998 5789999999999999
Q ss_pred cccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccc
Q 035655 176 MKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETM 255 (670)
Q Consensus 176 ~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~ 255 (670)
+.|..+.+ .++.+|+.++|||+||+.+++|+|++.+. .+|..|+|++.|||+++|+++|
T Consensus 150 ~~s~~t~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~----------~~~~~~~ls~~vdL~~~l~~~v 208 (239)
T d1gzca_ 150 IRSIKTQP-----------FQLDNGQVANVVIKYDAPSKILHVVLVYP----------SSGAIYTIAEIVDVKQVLPDWV 208 (239)
T ss_dssp SSCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEECT----------TTCCEEEEEEECCHHHHSCSEE
T ss_pred ccccccCC-----------ccccCCCEEEEEEEEeCCCcEEEEEEecC----------CCCcceeeeeEechHHhcCCcE
Confidence 99987765 57889999999999999999999999753 3678899999999999999999
Q ss_pred eeeEeecCCc---eeeeEEEeccccccCC
Q 035655 256 YVGFSASTGR---KVSSHFILGWSFSMNG 281 (670)
Q Consensus 256 ~vGFsastg~---~~~~h~i~sW~fs~~~ 281 (670)
|||||||||. ..|.|+|++|+|+++.
T Consensus 209 yvGFSAsTG~~~~~~~~H~V~sWsF~s~l 237 (239)
T d1gzca_ 209 DVGLSGATGAQRDAAETHDVYSWSFQASL 237 (239)
T ss_dssp EEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEEEcCCCCCCceeeEEEEEEeEeeC
Confidence 9999999994 6799999999999864
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=1.5e-53 Score=426.77 Aligned_cols=222 Identities=34% Similarity=0.536 Sum_probs=194.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
++++|+|++|.++..+ |.+.|+|.+.++|+|+||++. .+++|||+|++||+|||+.++ +++||+|+|
T Consensus 1 ~t~sF~f~~F~~~~~~---l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~-----~~~sF~t~F 72 (237)
T d2d3sa1 1 KTISFNFNQFHQNEEQ---LKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTG-----NVASFETRF 72 (237)
T ss_dssp CEEEEEESSCCSSCTT---EEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred CeEEEEeCCCCCCCCC---EEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCC-----ceeeEEEEE
Confidence 4689999999865556 999999999878899999854 479999999999999999998 899999999
Q ss_pred EEEEecCC-CCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 98 VFQIVTPN-SGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 98 ~f~i~~~~-~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
+|.|..+. ...+||||||+|+|... +.+..|++||+++.. ..+++|||||||++| . +||++||||||+|++
T Consensus 73 ~f~i~~~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n-~--~d~~~nHvgI~vns~ 144 (237)
T d2d3sa1 73 SFSIRQPFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRN-T--WDPQIPHIGIDVNSV 144 (237)
T ss_dssp EEECCCSCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCC-T--TCCSSSEEEEEESSS
T ss_pred EEEeecCCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecC-C--CCCCCCcEEEEcCCC
Confidence 99997653 34689999999998764 567789999998763 457899999999998 3 799999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|.++.+ +.+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+++..|||+.+|+++||
T Consensus 145 ~s~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~----------~~~~~~ls~~vdL~~~l~~~vy 203 (237)
T d2d3sa1 145 ISTKTVP-----------FTLDNGGIANVVIKYDASTKILHVVLVFPS----------LGTIYTIADIVDLKQVLPESVN 203 (237)
T ss_dssp SCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEETT----------TTEEEEEEEECCHHHHSCSEEE
T ss_pred ccccccc-----------eeecCCCEEEEEEEEECCCCEEEEEEEcCC----------CCcccceeeEechHHhCCCcEE
Confidence 9876654 678899999999999999999999998754 4677899999999999999999
Q ss_pred eeEeecCCc-------eeeeEEEeccccccCC
Q 035655 257 VGFSASTGR-------KVSSHFILGWSFSMNG 281 (670)
Q Consensus 257 vGFsastg~-------~~~~h~i~sW~fs~~~ 281 (670)
||||||||. ..|.|+|++|+|+++.
T Consensus 204 vGFSasTG~~~~~~~~~~e~h~I~sWsFss~l 235 (237)
T d2d3sa1 204 VGFSAATGDPSGKQRNATETHDILSWSFSASL 235 (237)
T ss_dssp EEEEEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred EEEEeECCCCccCccccceeeEEEEeEeEeeC
Confidence 999999994 5799999999999763
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=1e-52 Score=424.55 Aligned_cols=227 Identities=31% Similarity=0.539 Sum_probs=193.0
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
.+++|+|++|.+...+ |.+.|+|.+.++|.|+||++. ..++|||+|++||+||++.++ +++||+|+
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~-----~~~sf~t~ 73 (251)
T d1g9fa_ 2 ETVSFSWNKFVPKQPN---MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETG-----SVASFAAS 73 (251)
T ss_dssp EEEEEEESSCCC-CTT---EEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CC-----CBCEEEEE
T ss_pred ceEEEEeCCCCCCCCC---EEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCc-----cceeeEEE
Confidence 4789999999875456 999999999878999999864 358999999999999999998 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|.|...+...+||||||+|+|... +++..+|+||+++.. ...++.|||||||++| .+||++||||||+|++
T Consensus 74 f~F~i~~~~~~~~gDGlAFvl~p~~~-~~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n---~~D~~~~Hvgi~~n~~ 146 (251)
T d1g9fa_ 74 FNFTFYAPDTKRLADGLAFFLAPIDT-KPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRN---SWDPPNPHIGINVNSI 146 (251)
T ss_dssp EEEEEECSCC--CCEEEEEEEEETTC-CCCCCGGGTTTCCTT---SCCCSCEEEEEECC-C---TTSCSSSEEEEEESSS
T ss_pred EEEEEecCCCCCCCCceEEEEecCCC-CCCCccCccCccccc---CCCcceEEEEEecccC---CCCCCCCcEeEEecCc
Confidence 99999988788899999999999765 456788999998864 4457899999999998 3799999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|..+.. +++.+|+.++|||+||+.+++|+|++... .+|..|+++..|||+.+|+++||
T Consensus 147 ~s~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~----------~~~~~~~l~~~vdL~~~l~~~~y 205 (251)
T d1g9fa_ 147 RSIKTTS-----------WDLANNKVAKVLITYDASTSLLVASLVYP----------SQRTSNILSDVVDLKTSLPEWVR 205 (251)
T ss_dssp SCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEEG----------GGTEEEEEEEECCC-CCSCSEEE
T ss_pred ccccccc-----------eEecCCCEEEEEEEEECCccEEEEEEecC----------CCCcceeEEEEecchhhCCCcEE
Confidence 9876654 67889999999999999999999999753 35788999999999999999999
Q ss_pred eeEeecCCcee--eeEEEeccccccCCCCCC
Q 035655 257 VGFSASTGRKV--SSHFILGWSFSMNGAAPS 285 (670)
Q Consensus 257 vGFsastg~~~--~~h~i~sW~fs~~~~~~~ 285 (670)
||||||||... |.|+|++|+|+++.+++.
T Consensus 206 vGFSAsTG~~~~~~~h~I~sWsF~s~~~~~~ 236 (251)
T d1g9fa_ 206 IGFSAATGLDIPGESHDVLSWSFASNLPHAS 236 (251)
T ss_dssp EEEEEEECSSSCCCEEEEEEEEEEEEECC--
T ss_pred EEEEeecCCCCCCceeEEEEeEeECCCCCCC
Confidence 99999999754 899999999998765543
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=3.1e-52 Score=416.65 Aligned_cols=221 Identities=35% Similarity=0.567 Sum_probs=192.7
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+++||+|++|..+..+ |.++|+|.+.++|.|+||+.. .+++|||+|++||+||++.++ +++||+|+
T Consensus 1 ~~~SF~f~~F~~~~~~---l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~-----~~~sFsT~ 72 (234)
T d1f9ka_ 1 ETQSFNFDHFEENSKE---LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTG-----NVASFETR 72 (234)
T ss_dssp CEEEEEESSCCSSCTT---EEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred CceEEEeCCCCCCCCC---EEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCC-----cCcceEEE
Confidence 3689999999864456 999999999878999999864 358899999999999999988 89999999
Q ss_pred EEEEEecCCC-CCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCC
Q 035655 97 FVFQIVTPNS-GQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNS 175 (670)
Q Consensus 97 F~f~i~~~~~-~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns 175 (670)
|+|.|.+++. ..+||||||+|+|... |.+..|+++|+++.. ..++.|||||||++| . +||++||||||+|+
T Consensus 73 F~f~i~~~~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n-~--~Dp~~nHvgi~~ns 144 (234)
T d1f9ka_ 73 FSFNITQPYAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQN-T--WDPQVPHIGIDVNS 144 (234)
T ss_dssp EEEEEECCCSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS----CCSCCEEEEEECSCC-T--TCCSSSEEEEEESS
T ss_pred EEEEEECCCCCCCccceEEEEECCCCC-CcccccccccccCCC----CccceEEEEEecccc-C--CCCCCCcEeEecCC
Confidence 9999987643 4578999999998764 677899999998763 456789999999998 3 79999999999999
Q ss_pred cccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccc--c
Q 035655 176 MKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQ--E 253 (670)
Q Consensus 176 ~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~--~ 253 (670)
+.|.++.+ +++.+|+.++|||+||+.+++|+|++++.+ +|..|+|++.|||+++|+ |
T Consensus 145 ~~s~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~----------~~~~~~ls~~idL~~~l~~~~ 203 (234)
T d1f9ka_ 145 IVSSKTLH-----------FQLENGGVANVVIKYDSPTKILNVVLAFHS----------VGTVYTLSNIVDLKQEFPNSE 203 (234)
T ss_dssp SSCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEETT----------TTEEEEEEEECCHHHHSTTCS
T ss_pred cccccccc-----------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC----------CCccceEEEEEcHHHhcCCCC
Confidence 98876654 678899999999999999999999998754 456789999999999997 6
Q ss_pred cceeeEeecCCc---eeeeEEEeccccccC
Q 035655 254 TMYVGFSASTGR---KVSSHFILGWSFSMN 280 (670)
Q Consensus 254 ~~~vGFsastg~---~~~~h~i~sW~fs~~ 280 (670)
+||||||||||. ..|.|+|++|+|+++
T Consensus 204 ~v~vGFSasTG~~~~~~~~h~I~sWsF~s~ 233 (234)
T d1f9ka_ 204 WVNVGLSATTGYQKNAVETHEIISWSFTSS 233 (234)
T ss_dssp EEEEEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred EEEEEEEeecCCCCCceeeeEEEEEEeEEe
Confidence 699999999994 578999999999874
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=3.7e-51 Score=411.72 Aligned_cols=228 Identities=31% Similarity=0.514 Sum_probs=199.9
Q ss_pred CCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 22 QQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 22 ~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+++++|+|++|.+...+ |.++|+|.+.++|.||||++. .+++|||+|++||+||++.++ +++||+|+
T Consensus 1 ~~~~sF~f~~F~~~~~~---l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~-----~~~sFst~ 72 (239)
T d1dbna_ 1 SDELSFTINNFVPNEAD---LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTG-----SVASFSTS 72 (239)
T ss_dssp CCEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred CCceEEEeCCCCCCCCC---EEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCc-----cceEEEEE
Confidence 35799999999875456 999999999888999999764 467899999999999999988 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCC-CCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCC--CCCCCCeeEEec
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPS-FPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNET--SDSQGNHVGINV 173 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--~Dp~~~Hvgidv 173 (670)
|+|.|.++....+||||||+|+|.+. .+.++.|++||+++..+ +++.++.+||||||++| .++ +||+.+|||||+
T Consensus 73 F~F~i~~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n-~~~~~~d~~~~hvgid~ 150 (239)
T d1dbna_ 73 FTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFA-HSYDPWDPNYRHIGIDV 150 (239)
T ss_dssp EEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCC-TTTCTTSCSSCEEEEEE
T ss_pred EEEEEECCCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeec-CCCCCCCCCCceeeEEc
Confidence 99999988777899999999998775 56778899999998654 45678999999999998 654 489999999999
Q ss_pred CCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccc
Q 035655 174 NSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQE 253 (670)
Q Consensus 174 ns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~ 253 (670)
|++.|..+.+ ..+.+|+.++|||+||+.+++|.|++.... +|..|.|+..+||+++|++
T Consensus 151 n~~~s~~~~~-----------~~~~~g~~~~~~i~y~~~~~~l~v~l~~~~----------~~~~~~ls~~vdL~~~l~~ 209 (239)
T d1dbna_ 151 NGIESIKTVQ-----------WDWINGGVAFATITYLAPNKTLIASLVYPS----------NQTTFSVAASVDLKEILPE 209 (239)
T ss_dssp SSSSCSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT----------TTEEEEEEEECCHHHHSCS
T ss_pred CCcccccccc-----------ceEeCCceeEEEEEEcCCCCEEEEEEEecC----------CCccEEEEEecchHHhcCC
Confidence 9999877655 345689999999999999999999997643 5677899999999999999
Q ss_pred cceeeEeecCCce--eeeEEEeccccccC
Q 035655 254 TMYVGFSASTGRK--VSSHFILGWSFSMN 280 (670)
Q Consensus 254 ~~~vGFsastg~~--~~~h~i~sW~fs~~ 280 (670)
+||||||||||.. .|.|+|++|+|+++
T Consensus 210 ~vyvGFSAsTG~~~~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 210 WVRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp EEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred cEEEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence 9999999999964 58899999999874
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.7e-51 Score=408.78 Aligned_cols=221 Identities=34% Similarity=0.581 Sum_probs=196.2
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
++++|+|++|+. .+ +.+.|+|.+.++|.||||+.. ..++|||+|++||+||++.++ .++||+|+
T Consensus 2 ~~~sF~f~~F~~--~n---l~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~-----~~~sF~t~ 71 (233)
T d1g8wa_ 2 NDIYFNFQRFNE--TN---LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTG-----TVASFATS 71 (233)
T ss_dssp EEEEEEESSCCG--GG---EEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTC-----CBEEEEEE
T ss_pred CceEEECCCCCc--Cc---EEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCC-----ceeeEEEE
Confidence 479999999987 67 999999999888999999754 358999999999999999988 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|.|.+++...+||||||+|+|.+. +.++.|++||+++.. +..++.|||||||++| .+ +||+++|||||+|++
T Consensus 72 f~f~i~~~~~~~~gDGlAF~l~~~~~-~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N-~~-~d~~~~Hvgi~~n~~ 145 (233)
T d1g8wa_ 72 FTFNIQVPNNAGPADGLAFALVPVGS-QPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYN-KD-WDPTERHIGIDVNSI 145 (233)
T ss_dssp EEEECCCCSSCBCCEEEEEEEEETTC-CCCCCGGGTTTCCSS---CCCCCCEEEEEECSCC-TT-TCCSSCEEEEEESSS
T ss_pred EEEEEecCCCCCCCCeEEEEEecCCC-CCCcccccCCccccC---CCcccEEEEEeecccC-CC-CCCCCCeEEEECCCc
Confidence 99999988777889999999999875 456789999998764 3457899999999999 55 699999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.+..+.+ .++.+|+.++|||+||+.+++|.|++.+.+ +|..|+++..+||+++||++||
T Consensus 146 ~s~~~~~-----------~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~----------~~~~~~l~~~vdL~~~l~~~~y 204 (233)
T d1g8wa_ 146 RSIKTTR-----------WDFVNGENAEVLITYDSSTNLLVASLVYPS----------QKTSFIVSDTVDLKSVLPEWVS 204 (233)
T ss_dssp SCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEETT----------TTEEEEEEEECCHHHHSCSEEE
T ss_pred ceeeecc-----------ccccCCcEEEEEEEEeCCCcEEEEEEEeCC----------CCCcEEEEEEechhHcCCCcEE
Confidence 8876654 567899999999999999999999997643 4677899999999999999999
Q ss_pred eeEeecCC---ceeeeEEEeccccccC
Q 035655 257 VGFSASTG---RKVSSHFILGWSFSMN 280 (670)
Q Consensus 257 vGFsastg---~~~~~h~i~sW~fs~~ 280 (670)
|||||||| ...|.|+|++|+|+++
T Consensus 205 vGFSAsTG~~~~~~~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 205 VGFSATTGINKGNVETNDVLSWSFASK 231 (233)
T ss_dssp EEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred EEEEEEcCCCCCCceeeEEEEEEEEEE
Confidence 99999999 4668899999999975
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=9.3e-51 Score=406.37 Aligned_cols=226 Identities=27% Similarity=0.435 Sum_probs=192.8
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-CCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQI 101 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i 101 (670)
++++|+|++|.+.+.+ |.++|+|.+.++|.||||++. .+++|||+|++||+||++.++ +++||+|+|+|.|
T Consensus 2 ~~~sF~~~~F~~~~~~---l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~-----~~~sf~t~f~f~i 73 (232)
T d1v6ia_ 2 ETVSFNFNSFSEGNPA---INFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG-----NVASFLTSFSFEM 73 (232)
T ss_dssp EEEEEEESSCCTTCTT---EEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTC-----CBCEEEEEEEEEE
T ss_pred ccEEEECCCCCCCCCC---EEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCC-----ccceeEEEEEEEe
Confidence 4799999999885455 999999998878999999865 489999999999999999998 8999999999999
Q ss_pred ecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccc
Q 035655 102 VTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKL 181 (670)
Q Consensus 102 ~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~ 181 (670)
.+.+...+||||||+|+|.+..+++ +++.|++....+.++.++.|||||||++| .+.+||+++|||||+|++.+...
T Consensus 74 ~~~~~~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n-~~~~d~~~~Higid~n~~~s~~~ 150 (232)
T d1v6ia_ 74 KDIKDYDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSN-SEYNDPPTDHVGIDVNSVDSVKT 150 (232)
T ss_dssp ECCSSSBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCC-GGGTCCSSCEEEEEEEESSCSEE
T ss_pred ccCCCCCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEec-CCCCCCCCccEeEeeCCcccccc
Confidence 9887788999999999998753222 22223333333345678999999999999 78889999999999999988765
Q ss_pred cccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEee
Q 035655 182 EPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSA 261 (670)
Q Consensus 182 ~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsa 261 (670)
.+ .++.+|+.++|||+||+.+++|+|++.. .++..|.++..|||+.+|+++|||||||
T Consensus 151 ~~-----------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~-----------~~~~~~~l~~~vdL~~~l~~~vyvGFSA 208 (232)
T d1v6ia_ 151 VP-----------WNSVSGAVVKVTVIYDSSTKTLSVAVTN-----------DNGDITTIAQVVDLKAKLPERVKFGFSA 208 (232)
T ss_dssp EE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEC-----------TTSCEEEEEEECCHHHHSCSEEEEEEEE
T ss_pred cc-----------cccCCCCEEEEEEEEeCCceEEEEEEec-----------CCCCcceEEEEEchhhccCCcEEEEEEE
Confidence 43 5678999999999999999999999875 3456788999999999999999999999
Q ss_pred cCCc-eeeeEEEeccccccCC
Q 035655 262 STGR-KVSSHFILGWSFSMNG 281 (670)
Q Consensus 262 stg~-~~~~h~i~sW~fs~~~ 281 (670)
|||. ..|.|+|++|+|+++.
T Consensus 209 sTG~~~~~~H~I~sWsFss~l 229 (232)
T d1v6ia_ 209 SGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp ECCSSBCCEEEEEEEEEEEEE
T ss_pred ECCCCCCcccEEEEeEeEEee
Confidence 9996 4699999999999763
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=6.9e-51 Score=412.38 Aligned_cols=222 Identities=31% Similarity=0.540 Sum_probs=196.4
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+..||+|++|+. .+ |.++|+|.+. ++.|+||++. ..++|||+|++||+||++.++ +++||+|+
T Consensus 2 ~~~sF~f~~F~~--~~---l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~-----~~~sF~t~ 70 (253)
T d1g7ya_ 2 DIQSFSFKNFNS--SS---FILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTG-----AVASWATS 70 (253)
T ss_dssp EEEEEEESSCCS--SC---EEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTC-----CBCEEEEE
T ss_pred cccEEecCCCCc--cc---EEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCC-----ceeeEEEE
Confidence 468999999987 67 9999999996 8889999754 358899999999999999998 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|+|.+++...+||||||+|+|.+.. .+..+|+||+++..+. ...++.+||||||++| .+ +||+++|||||+|++
T Consensus 71 F~F~i~~~~~~~ggDGlAF~l~~~~~~-~~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n-~~-~d~~~~Hvgi~~ns~ 146 (253)
T d1g7ya_ 71 FTANIFAPNKSSSADGIAFALVPVGSE-PKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSN-TD-WDPTSRHIGIDVNSI 146 (253)
T ss_dssp EEEECCCSSGGGCCCEEEEEEEETTCC-CCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCC-TT-TCCSSCEEEEEESSS
T ss_pred EEEEEecCCCCCCCCceEEEEeCCCCC-CCCCcccccccccCCC-CCcCceEEEEEeceec-CC-CCCCCCcEEEeeCCc
Confidence 999998877677999999999998764 4567899999987554 4567899999999999 56 699999999999999
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
.|..+++ ..+.+|+.++|||+||+.+++|+|++... .+|..|++++.+||+.+||++||
T Consensus 147 ~s~~~~~-----------~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~----------~~~~~~~ls~~vdL~~~l~~~~y 205 (253)
T d1g7ya_ 147 KSIRTAS-----------WGLANGQNAEILITYNAATSLLVASLVHP----------SRRTSYIVSERVDITNELPEYVS 205 (253)
T ss_dssp SCSEEEE-----------CCCCTTSEEEEEEEEETTTTEEEEEEEET----------TTTEEEEEEEECCHHHHSCSEEE
T ss_pred ccccccC-----------CCccCCCEEEEEEEEeCCcEEEEEEEecC----------CCCCceEEEEEechhhcCCCcEE
Confidence 9887765 56789999999999999999999999753 36788999999999999999999
Q ss_pred eeEeecCC---ceeeeEEEeccccccC
Q 035655 257 VGFSASTG---RKVSSHFILGWSFSMN 280 (670)
Q Consensus 257 vGFsastg---~~~~~h~i~sW~fs~~ 280 (670)
|||||||| ...|.|+|++|+|+++
T Consensus 206 vGFSAsTG~~~~~~~~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 206 IGFSATTGLSEGYTETHDVLSWSFASK 232 (253)
T ss_dssp EEEEEECCSSSSCCCCCEEEEEEEEEE
T ss_pred EEEEeEcCCCCCcccccEEEEEEeEEe
Confidence 99999999 4679999999999875
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=2.2e-50 Score=405.72 Aligned_cols=226 Identities=30% Similarity=0.519 Sum_probs=197.6
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC-----CCeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA-----HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
.++||+|++|.++..+ +.++|+|.+.++|.||||++. .+++|||+|++||+||++.++ +++||+|+|
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~-----~~~sF~t~F 73 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPY---LINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTG-----NVASFVTSF 73 (237)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTC-----CBCEEEEEE
T ss_pred ceEEEEeCCCCCCCCC---eEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCC-----cceeeEEEE
Confidence 4689999999875456 999999999878999999863 468999999999999999998 899999999
Q ss_pred EEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc
Q 035655 98 VFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK 177 (670)
Q Consensus 98 ~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~ 177 (670)
+|.|..++...+||||||+|+|.+. +.+..||+||+++..+ .+..++.+||||||++| .+ +||+++|||||+|++.
T Consensus 74 ~F~i~~~~~~~~gDG~AF~l~~~~~-~~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n-~~-~d~~~~Higi~~n~~~ 149 (237)
T d1fnya_ 74 TFIIQAPNPATTADGLAFFLAPVDT-QPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSN-GD-WDPKGRHLGINVNSIE 149 (237)
T ss_dssp EEECCCSSTTSCCEEEEEEEEETTC-CCCCCGGGTTTCC----CCTTSCCEEEEEECSCC-TT-TCCSSSEEEEEESSSS
T ss_pred EEEEecCCCCCCCCeeEEEEcCCCC-CcccccCcccccCCCC-ccCccceEEEEeccccc-cC-CCCCCceEEEecCCCc
Confidence 9999988777899999999999775 4467889999997643 34678899999999999 55 6999999999999999
Q ss_pred cccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccccee
Q 035655 178 SIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 178 s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
|..+.+ ..+.+|+.++|||+||+.+++|.|++.+.+ +|..|+++..+||+.+||++|||
T Consensus 150 s~~~~~-----------~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~----------~~~~~~l~~~vdL~~~l~~~~yv 208 (237)
T d1fnya_ 150 SIKTVP-----------WNWTNGEVANVFISYEASTKSLTASLVYPS----------LETSFIIDAIVDVKIVLPEWVRF 208 (237)
T ss_dssp CSEEEE-----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT----------TTEEEEEEEECCHHHHSCSEEEE
T ss_pred cccccc-----------ccccCCcEEEEEEEEeCCccEEEEEEEeCC----------CCcceeEEEEechhhcCCCcEEE
Confidence 877654 566799999999999999999999998654 46778999999999999999999
Q ss_pred eEeecCC---ceeeeEEEeccccccCC
Q 035655 258 GFSASTG---RKVSSHFILGWSFSMNG 281 (670)
Q Consensus 258 GFsastg---~~~~~h~i~sW~fs~~~ 281 (670)
||||||| ...|.|+|++|+|+++.
T Consensus 209 GFSAsTG~~s~~~e~H~I~sWsF~s~l 235 (237)
T d1fnya_ 209 GFSATTGIDKGYVQTNDVLSWSFESNL 235 (237)
T ss_dssp EEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEECCCCCCcccccEEEEeEeEEeC
Confidence 9999999 56789999999999863
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=4.1e-50 Score=401.97 Aligned_cols=222 Identities=29% Similarity=0.513 Sum_probs=194.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC-----CeEEEEEecCceeeecCCCCCCCCCCccceeEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH-----NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCF 97 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~-----~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F 97 (670)
++++|+|++|.+...+ |.+.|+|.+.++|.||||++.. +++|||+|++||+||+.. .++||+|+|
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~-------~~~sF~t~f 71 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNN---LILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT-------TLASFTTSF 71 (233)
T ss_dssp EEEEEEESSCCTTCTT---EEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS-------CBCEEEEEE
T ss_pred CceEEEeCCCCCCCCC---eEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC-------eeeeEEEEE
Confidence 5789999999865456 9999999998788999998653 689999999999999854 479999999
Q ss_pred EEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcc
Q 035655 98 VFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMK 177 (670)
Q Consensus 98 ~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~ 177 (670)
+|.|.+.+...+||||||+|+|.+. +.+..||+||+++..+. +..++.|||||||++| . +||++||||||+|++.
T Consensus 72 ~f~i~~~~~~~~gDGlAF~l~~~~~-~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n-~--~d~~~~higi~~n~~~ 146 (233)
T d1n47a_ 72 SFVMAAPAAAAVADGLAFFLAPPDT-QPQARGGFLGLFADRAH-DASYQTVAVEFDTYSN-A--WDPNYTHIGIDTNGIE 146 (233)
T ss_dssp EEECCCSSTTSCCEEEEEEEECTTC-CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC-T--TSCSSCEEEEEESSSS
T ss_pred EEEEeCCCCCCCCCceEEEECCCCC-CCCCCCCccccccccCC-CCcCceEEEEEEeeec-C--CCCCCCceeEccCCcc
Confidence 9999988777899999999999765 45678899999976554 4668899999999988 3 7999999999999998
Q ss_pred cccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccccccee
Q 035655 178 SIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYV 257 (670)
Q Consensus 178 s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~v 257 (670)
+..+.+ +.+.+|+.++|||+||+.+++|.|++... .+|..|.|+..+||+++||++|||
T Consensus 147 s~~~~~-----------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~----------~~~~~~~ls~~vdL~~~l~~~vyv 205 (233)
T d1n47a_ 147 SKKTTP-----------FDMVYGEKANIVITYQASTKALAASLVFP----------VSQTSYAVSARVDLRDILPEYVRV 205 (233)
T ss_dssp CSEEEE-----------CCCCTTSCEEEEEEEETTTTEEEEEEEET----------TTTEEEEEEEECCGGGTSCSEEEE
T ss_pred cccccc-----------ceecCCCEEEEEEEEcCCCeEEEEEEEeC----------CCCccEEEEEEechHHhcCCcEEE
Confidence 877654 57789999999999999999999999754 357788999999999999999999
Q ss_pred eEeecCC---ceeeeEEEeccccccC
Q 035655 258 GFSASTG---RKVSSHFILGWSFSMN 280 (670)
Q Consensus 258 GFsastg---~~~~~h~i~sW~fs~~ 280 (670)
||||||| ...|.|+|++|+|+++
T Consensus 206 GFSAsTG~~~~~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 206 GFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEEecCCCCCcccccEEEEEEeEEE
Confidence 9999999 4678999999999975
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=9.5e-49 Score=394.70 Aligned_cols=226 Identities=25% Similarity=0.487 Sum_probs=197.0
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+++||+|++|++...+ |.+.|+|.+. ++.|+||++. ..++|||+|++||+||++.++ +++||+|+
T Consensus 2 ~~~sF~f~~F~~~~~~---l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~-----~~~sF~t~ 72 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKN---LIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSS-----RVANFQSQ 72 (241)
T ss_dssp CEEEEEESSCCSCCSS---EEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTT-----EEEEEEEE
T ss_pred ccEEEEeCCCCCCCCC---EEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCC-----ceeeeEEE
Confidence 5799999999875556 9999999997 8899999864 479999999999999999988 89999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCC-CCCCCCCCcccccccCCCC-CCCCCcEEEEEeeecCCCCCC--CCCCCCeeEEe
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQP-SFPGGKAEHYLGILNSTND-HKPSNHLFAIEFDTVNGYNET--SDSQGNHVGIN 172 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~-~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~--~Dp~~~Hvgid 172 (670)
|+|+|..+. ..+|||||||+.|.. ..|.+..|+++|+++.... +.+.|+.|||||||++| .+. +||++||||||
T Consensus 73 F~f~i~~~~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n-~~~~~~~~~~~Higid 150 (241)
T d1ukga_ 73 FSFSLKSPL-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYA-QDSNTWDPNYPHIGID 150 (241)
T ss_dssp EEEEEECSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCC-TTTCTTSCSSCEEEEE
T ss_pred EEEEEecCC-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEec-CccCCCCCCCccEeee
Confidence 999998764 467999999998765 4577888999999876543 35678999999999988 543 46899999999
Q ss_pred cCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCccccc
Q 035655 173 VNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQ 252 (670)
Q Consensus 173 vns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~ 252 (670)
+|++.|.++.+ ..+.+|+.++|||+||+.+++|+|++... +|..|.+++.|||+++|+
T Consensus 151 ~n~~~s~~~~~-----------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~-----------~~~~~~l~~~vdL~~~l~ 208 (241)
T d1ukga_ 151 VNSIRSVKTVK-----------WDRRDGQSLNVLVTFNPSTRNLDVVATYS-----------DGTRYEVSYEVDVRSVLP 208 (241)
T ss_dssp ESSSSCSEEEE-----------CCCCTTCCEEEEEEEETTTTEEEEEEEET-----------TCCEEEEEEECCGGGTSC
T ss_pred cCCcccccccc-----------cccCCCcEEEEEEEEeCCCcEEEEEEccC-----------CCCceEEEEEEehHHhCC
Confidence 99999876654 56789999999999999999999999763 456788999999999999
Q ss_pred ccceeeEeecCCceeeeEEEeccccccCC
Q 035655 253 ETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 253 ~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
++||||||||||...|.|+|++|+|+++.
T Consensus 209 ~~~yvGFSAsTG~~~~~H~IlsWsFss~l 237 (241)
T d1ukga_ 209 EWVRVGFSAASGEQYQTHTLESWSFTSTL 237 (241)
T ss_dssp SEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred CcEEEEEEEecCCCCceeEEEEeEEEEEe
Confidence 99999999999999999999999999763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=413.37 Aligned_cols=249 Identities=27% Similarity=0.498 Sum_probs=193.1
Q ss_pred ccchhhHHHhhcC---------ccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccc
Q 035655 351 RFRYSDLYTATKG---------FKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLR 401 (670)
Q Consensus 351 ~~~~~~l~~~t~~---------f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~ 401 (670)
.++|+|...++++ |+..++||+|+||+||+|.+.. ..+.|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 3566666666544 4556899999999999997632 2457999999999999
Q ss_pred cCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 402 HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 402 H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
|||||+++|+|.+++..++|||||++|+|.+++.... ..++|.++++++.|||+||.|||+ ++|+||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEE
Confidence 9999999999999999999999999999999887643 369999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcce----eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-
Q 035655 482 DADMNARLGDFGLARLFDHGKISH----TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI- 555 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~- 555 (670)
+.++.+||+|||+++......... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998765433221 122468999999999999999999999999999999998 89999764321
Q ss_pred hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 556 LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+...+ ..+. ....+....+.+.+++.+||+.||.+|||++||++.|+.
T Consensus 242 ~~~~i----~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 242 VINAI----EQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp HHHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHH----HcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 1111 111222334668889999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=398.66 Aligned_cols=245 Identities=28% Similarity=0.449 Sum_probs=192.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..++||+|+||+||+|+... ..+.|.+|+++|++++|||||+++|++.+ +.+++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 4578889999999999999997643 35789999999999999999999999865 5689999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc-c
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-S 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~ 504 (670)
++|+|.++|.... ..++|.+++.++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 86 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 86 EGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999997653 369999999999999999999999 8999999999999999999999999999987654332 2
Q ss_pred eeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 505 HTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||........ .......+.. .|.+ ...
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~----~p~~-~~~ 234 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYL----SPDL-SKV 234 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSC----CCCG-GGS
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCC----CCcc-hhc
Confidence 3345689999999999864 3589999999999999999999999976332211 1111111111 1111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+....+.+.+++.+||+.||.+|||++||+++|+..
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222345678899999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=402.06 Aligned_cols=239 Identities=26% Similarity=0.457 Sum_probs=187.0
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|+..+.||+|+||+||+|.+.+ ..++|.+|++++++++||||++++|+|.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 578889999999999999998643 357899999999999999999999999999999999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|.+++.... ..++|..++.++.|||+||.|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 85 g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 85 GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999987653 468999999999999999999999 89999999999999999999999999999877655444444
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATG-RRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
...||+.|||||++.+..++.++|||||||++|||+|+ +.|+..... .+....... +. ....|. ...
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~-~~--~~~~p~-------~~~ 228 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDIST-GF--RLYKPR-------LAS 228 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHH-TC--CCCCCT-------TSC
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHh-cC--CCCCcc-------ccC
Confidence 56899999999999999999999999999999999995 555543221 111111111 11 111121 223
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++..||+.||.+|||++||+++|++
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 567889999999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=401.75 Aligned_cols=240 Identities=28% Similarity=0.435 Sum_probs=198.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..++||+|+||+||+|.++. ..++|.+|+++|++++|||||+++|+|.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4578889999999999999998754 35679999999999999999999998865 56799999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++.......++|.++++++.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 9999999876665679999999999999999999998 8999999999999999999999999999998876554555
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
....||+.|||||++.++.++.++|||||||++|||+||..|+...... .+.. .....+ ..+.. +....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~-~~i~~~-----~~~~~----p~~~~ 236 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVI-QNLERG-----YRMVR----PDNCP 236 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHH-HHHHTT-----CCCCC----CTTCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHH-HHHHhc-----CCCCC----cccCh
Confidence 5668999999999999999999999999999999999976665432211 1111 111111 11111 11223
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
+.+.+++.+||+.||++|||++||++.|+
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 56788999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-49 Score=408.47 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=204.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|+..++||+|+||+||+|++.. ..++|.+|+++|++++|||||+++|+|.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 4678889999999999999998643 3578999999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.+.....++|..++.++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999987766789999999999999999999999 899999999999999999999999999999776655455
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
.....||+.|||||++.+..++.++|||||||++|||++|..|+...... .. .......+ ..+ ..+...
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~-~~~~i~~~-----~~~----~~~~~~ 241 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ-VYELLEKD-----YRM----ERPEGC 241 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH-HHHHHHTT-----CCC----CCCTTC
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HH-HHHHHhcC-----CCC----CCCccc
Confidence 55567899999999999999999999999999999999977776442211 11 11111111 111 122223
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
...+.+++..||+.||.+|||++||++.|+..
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 45688999999999999999999999988743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=396.19 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=195.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..+.||+|+||+||+|+... ..+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3578999999999999999998643 23458899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.++|..+ ..+++.++..++.||++||+|||+ ++|+||||||+|||+++++++||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999654 469999999999999999999998 8999999999999999999999999999997754432
Q ss_pred -ceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 504 -SHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
...+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||............. ..... ....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-~~~~~---------~~~~ 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKT---------YLNP 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-HTTCT---------TSTT
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCC---------CCCc
Confidence 22345689999999999988776 578999999999999999999997643322221111 11110 0011
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.......+.+++.+||+.||.+|||++|+++|-+-
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11223566788999999999999999999886443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=389.11 Aligned_cols=231 Identities=24% Similarity=0.382 Sum_probs=194.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|++.+.||+|+||+||+|+... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999998753 2356789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++.+. ..+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999999654 359999999999999999999999 89999999999999999999999999999865543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ .......+ +.+ +
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~------~~~----p 224 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVE------FTF----P 224 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTTC------CCC----C
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHHHHcCC------CCC----C
Confidence 23456899999999999999999999999999999999999999976432211 11111111 111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+.+++.+||++||.+|||++|+++|
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1223567789999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=390.21 Aligned_cols=240 Identities=27% Similarity=0.441 Sum_probs=202.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 426 (670)
.++|+..++||+|+||+||+|+.++ ..++|.+|++++++++||||++++|+|.+++.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 3688999999999999999998753 35789999999999999999999999999999999999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCccee
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHT 506 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 506 (670)
+|+|.+++.... ..+++..+.+++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999976554 368999999999999999999998 8999999999999999999999999999987766554445
Q ss_pred eccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHH
Q 035655 507 TNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAE 585 (670)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 585 (670)
....||+.|+|||++.+..++.|+|||||||++|||+| |+.||......... .....+. ....| ...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~~~~--~~~~p-------~~~ 226 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGL--RLYRP-------HLA 226 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHTTC--CCCCC-------TTC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---HHHHhCC--CCCCc-------ccc
Confidence 55689999999999999999999999999999999998 89999864322111 1111111 11112 122
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 586 MELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 586 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+.+.+++..||+.||++|||++|++++|..
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3567899999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=403.62 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=197.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~ 417 (670)
.++|+..++||+|+||+||+|+... ....|.+|+.+|.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578999999999999999997531 235688999999998 89999999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCc---------------------cccCHHHHHHHHHHHHHHhhhccccccceEEecccCC
Q 035655 418 LLLVYDYIPNGSLDSLLFDNEN---------------------FVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKS 476 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp 476 (670)
.++||||+++|+|.++|..+.. ..++|..++.++.||++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999976432 358999999999999999999999 8999999999
Q ss_pred CcEEecCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc
Q 035655 477 GNVLIDADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHF 554 (670)
Q Consensus 477 ~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~ 554 (670)
+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876554432 3345678999999999999999999999999999999998 8999976332
Q ss_pred hhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 555 ILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
... .......+. .+ +.+....+.+.+++.+||+.||++|||++||+++|.
T Consensus 273 ~~~--~~~~~~~~~-----~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--FYKLIQNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--HHHHHHTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHHHHhcCC-----CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111 111111111 11 112223456889999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=393.58 Aligned_cols=242 Identities=26% Similarity=0.468 Sum_probs=190.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
+..|+..++||+|+||.||+|.+.. ...+|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3568889999999999999997532 2357899999999999999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++|+|.+++.... ..++|.++++++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999886554 469999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 500 HGKIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... ......||+.|||||++.++.++.++|||||||++|||++|..|+...... .+.. .....+ .
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~-~~i~~~---------~ 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVM-KAINDG---------F 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHH-HHHHTT---------C
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHH-HHHhcc---------C
Confidence 43322 223457899999999999999999999999999999999976665432211 1111 111111 1
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
....+...+..+.+++.+||+.||++||++.||++.|+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1122223346688999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=394.59 Aligned_cols=237 Identities=24% Similarity=0.371 Sum_probs=193.5
Q ss_pred cCccccc-eEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSE-VIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~-~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|...+ +||+|+||.||+|.+.. ..++|.+|+++|++++|||||+++|+|.. +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 49999999999996531 34679999999999999999999999965 568999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.... ..+++.++++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999986543 469999999999999999999999 89999999999999999999999999999987654
Q ss_pred Ccc--eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 502 KIS--HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 502 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
... ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... +. ......+.. +.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~-~~~i~~~~~-----~~-- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV-MAFIEQGKR-----ME-- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HH-HHHHHTTCC-----CC--
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HH-HHHHHcCCC-----CC--
Confidence 322 2234578999999999999999999999999999999998 99999864322 11 111112211 11
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
.+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 233 --~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 233 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 12223356788999999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=389.63 Aligned_cols=239 Identities=25% Similarity=0.380 Sum_probs=182.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec--cCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR--KRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~--~~~~~lV 421 (670)
++|+..+.||+|+||+||+|+... ..+.|.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 579999999999999999997643 23568899999999999999999999864 4568999
Q ss_pred EeccCCCCchhhcccC--CccccCHHHHHHHHHHHHHHhhhccccc--cceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 422 YDYIPNGSLDSLLFDN--ENFVLSWEQRFNIIKGIAAGLLYLHEEW--EQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
|||+++|+|.+++.+. .+..+++.+++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999653 2456999999999999999999999821 13499999999999999999999999999987
Q ss_pred ccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCC
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNL 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l 577 (670)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||........ . .....+.. +.+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~-~~i~~~~~-----~~~ 234 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--A-GKIREGKF-----RRI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHTCC-----CCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--H-HHHHcCCC-----CCC
Confidence 65433 233456899999999999999999999999999999999999999986432211 1 11111111 111
Q ss_pred CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 578 GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 578 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+ .+.+.+++.+||+.||.+|||++|+++|
T Consensus 235 ~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PYRY----SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1222 3467889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=392.25 Aligned_cols=230 Identities=26% Similarity=0.377 Sum_probs=187.7
Q ss_pred ceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 368 EVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 368 ~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++||+|+||+||+|.+.. ..++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999996431 23578999999999999999999999965 467899999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce--
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH-- 505 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~-- 505 (670)
|+|.+++.+. ..++|.++++++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999754 359999999999999999999998 899999999999999999999999999999775543322
Q ss_pred eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 506 TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||........ ......+.. +. .+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~~i~~~~~-----~~----~p~~ 234 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGER-----MG----CPAG 234 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCC-----CC----CCTT
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HHHHHcCCC-----CC----CCcc
Confidence 234579999999999999999999999999999999998 8999986432211 111111111 11 1222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
....+.+++.+||+.||.+|||+++|++.|+
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 3356788999999999999999999998875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=389.58 Aligned_cols=236 Identities=23% Similarity=0.370 Sum_probs=197.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
.++|+..++||+|+||+||+|+... ..+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 3579999999999999999998643 345788999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+++|+|.+++.++ .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...... .
T Consensus 99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999999987543 59999999999999999999998 899999999999999999999999999999775543 2
Q ss_pred eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHH
Q 035655 505 HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVA 584 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 584 (670)
......||+.|||||++.+..++.++|||||||++|||++|+.||......... ....... .+.+ ..+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~------~~~~--~~~~~ 241 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNG------TPEL--QNPEK 241 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHC------SCCC--SSGGG
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHHhCC------CCCC--CCccc
Confidence 334568999999999999999999999999999999999999999764322111 1111111 1111 11223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 585 EMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 585 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+++.+||++||.+|||++|+++|
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34567889999999999999999999875
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=4e-47 Score=379.40 Aligned_cols=216 Identities=31% Similarity=0.505 Sum_probs=186.0
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCC------CeEEEEEecCceeeecCCCCCCCCCCccceeEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAH------NVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTC 96 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~ 96 (670)
+.++|+|++|++. .+ |.+.|+|.+.++|.|+||++.. +++|||+|++||+||+. + +++||+|+
T Consensus 2 ~~~sF~f~~F~~~-~~---l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~~--~-----~~~sFst~ 70 (228)
T d1ioaa_ 2 TETSFNFPNFHTD-DK---LILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS--N-----NVASFNTN 70 (228)
T ss_dssp CCCEEEESSCCTT-SS---EEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCS--S-----CBEEEEEE
T ss_pred ccceEEcCCCCCC-Cc---EEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecCC--C-----ceeeEEEE
Confidence 4689999999762 34 9999999998789999998653 57899999999999974 4 68999999
Q ss_pred EEEEEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCc
Q 035655 97 FVFQIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSM 176 (670)
Q Consensus 97 F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~ 176 (670)
|+|.|.+.+...+||||||+|+|.+. +.+..|++||+++.+. ++..++.|||||||++| .+|++.+|||+++++.
T Consensus 71 F~f~i~~~~~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n---~~~~~~~~~~~~~~~~ 145 (228)
T d1ioaa_ 71 FTFIIRAKNQSISAYGLAFALVPVNS-PPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKN---RIDFDKNFIKPYVNEN 145 (228)
T ss_dssp EEEECCBSCTTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTT---EEEEEESSSSCSEEEE
T ss_pred EEEEEecCCCCCCCCEEEEEEeCCCC-CCCCCccccccccccC-CCCcceeEEEEecCccc---cccCCCCccceecccc
Confidence 99999998777899999999999765 5567899999998654 35678899999999987 3688888988888753
Q ss_pred ccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccce
Q 035655 177 KSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMY 256 (670)
Q Consensus 177 ~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~ 256 (670)
. ...+.+|+.++|||+||+.+++|+|++.+.. +|..|.|++.+||+++|+++||
T Consensus 146 ~----------------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~----------~~~~~~ls~~vdL~~~l~~~vy 199 (228)
T d1ioaa_ 146 C----------------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV----------SQVKCSVSATVHLEKEVDEWVS 199 (228)
T ss_dssp C----------------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT----------TCCEEEEEEECCGGGTSCSEEE
T ss_pred c----------------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC----------CCceeeEEEEEchHHcCCCcEE
Confidence 2 2456789999999999999999999998643 5778899999999999999999
Q ss_pred eeEeecCC---ceeeeEEEeccccccC
Q 035655 257 VGFSASTG---RKVSSHFILGWSFSMN 280 (670)
Q Consensus 257 vGFsastg---~~~~~h~i~sW~fs~~ 280 (670)
|||||||| +..|.|+|++|+|+++
T Consensus 200 vGFSAsTG~~~~~~~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 200 VGFSPTSGLTEDTTETHDVLSWSFSSK 226 (228)
T ss_dssp EEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred EEEEeecCCCCCCceEEEEEEEEeEEe
Confidence 99999999 5679999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=391.01 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=192.3
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEeccCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYIPN 427 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 427 (670)
++|++.+.||+|+||+||+|+++. ..+.|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 579999999999999999998754 34789999999999999999999999954 568999999999
Q ss_pred CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceee
Q 035655 428 GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTT 507 (670)
Q Consensus 428 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 507 (670)
|+|..++.......++|.+++.++.||+.||+|||+ ++|+||||||+|||||.++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999999977655679999999999999999999998 89999999999999999999999999999877655544455
Q ss_pred ccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHH
Q 035655 508 NVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEME 587 (670)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 587 (670)
...||+.|+|||++..+.++.++|||||||++|||++|..|+...... .+..... ..+. .+. .+....+
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i-~~~~-----~~~----~~~~~~~ 241 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV-ERGY-----RMP----CPPECPE 241 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH-HTTC-----CCC----CCTTSCH
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH-HhcC-----CCC----CCcccCH
Confidence 568999999999999999999999999999999999977766542211 1111111 1111 111 1222345
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHhcCCC
Q 035655 588 LVLQLGLLCSHQKAEARPTMRQVLRYLNGDE 618 (670)
Q Consensus 588 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 618 (670)
.+.+++.+||+.||++||++++|++.|+..-
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 6788999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=399.60 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=193.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
.++|+..++||+|+||+||+|+... ..+.+.+|+++|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5689999999999999999998643 24578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||+ +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999997543 59999999999999999999997 148999999999999999999999999999866432
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcc-------------
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVL------------- 570 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~------------- 570 (670)
.....+||+.|||||++.+.+++.++||||+||+++||++|+.||.................+...
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 234568999999999999999999999999999999999999999764322111110000000000
Q ss_pred ---------------------cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 ---------------------DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ---------------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+.. ......+.+++.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000011100 0112457889999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=389.54 Aligned_cols=237 Identities=25% Similarity=0.393 Sum_probs=194.0
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
+.|+..+.||+|+||+||+|+... ..+.|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 468889999999999999998643 3467889999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcce
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISH 505 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 505 (670)
++|+|.+++.+.. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999999986543 369999999999999999999998 899999999999999999999999999997654321 12
Q ss_pred eeccccCcCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCc
Q 035655 506 TTNVVGTIGYIAPELAR-----TGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSS 580 (670)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 580 (670)
.....||+.|||||++. +..++.++|||||||++|||++|+.||........ ...... .. .+.+ .
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~~-~~-----~~~~--~ 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAK-SE-----PPTL--A 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHH-SC-----CCCC--S
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHc-CC-----CCCC--C
Confidence 33468999999999884 45689999999999999999999999976432211 111111 11 1111 1
Q ss_pred ccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 581 YVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 581 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.+......+.+++.+||+.||.+|||++|+++|
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334567889999999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=384.70 Aligned_cols=230 Identities=29% Similarity=0.442 Sum_probs=184.8
Q ss_pred cccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec----cCeeEEEE
Q 035655 365 KQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR----KRDLLLVY 422 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~----~~~~~lV~ 422 (670)
+..++||+|+||+||+|++.. ..+.|.+|+++|++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 556789999999999997643 23568899999999999999999999864 34689999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccce--EEecccCCCcEEec-CCCcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQV--VIHRDVKSGNVLID-ADMNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILld-~~~~~kL~DFGla~~~~ 499 (670)
||+++|+|.+++.+. ..+++.+++.++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999654 369999999999999999999998 66 99999999999996 57899999999998644
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
.. ......||+.|||||++.+ +++.++|||||||++|||++|+.||........ .......+.. + .
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~~~~-----~---~ 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK-----P---A 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCC-----C---G
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHcCCC-----C---c
Confidence 32 2345689999999998865 699999999999999999999999975332111 1111111110 1 1
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.++......+.+++.+||++||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1222223457889999999999999999999985
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-46 Score=374.68 Aligned_cols=217 Identities=30% Similarity=0.499 Sum_probs=192.3
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCC---CCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEE
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDN---AHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVF 99 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f 99 (670)
+.++|+|++|+. .| +.+.|+|.+.++|.||||+. ...++|||+|++||+||++.++ .++||+|+|+|
T Consensus 2 ~~~sf~f~~F~~--~n---l~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~-----~~~sF~t~f~f 71 (226)
T d1avba_ 2 NDASFNVETFNK--TN---LILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID-----NLASFSTNFTF 71 (226)
T ss_dssp EEEEEEESSCCG--GG---EEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGT-----EEEEEEEEEEE
T ss_pred CceEEECCCCCc--cc---eeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCC-----cccceEEEEEE
Confidence 468999999987 67 99999999987889999964 4578999999999999999988 89999999999
Q ss_pred EEecCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccc
Q 035655 100 QIVTPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSI 179 (670)
Q Consensus 100 ~i~~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~ 179 (670)
.|.+.+...+||||||+|+|.+. +.+..||++|+++. ++|||||+.| ...+|+.+||||||+|+..+.
T Consensus 72 ~i~~~~~~~~gDG~aF~i~~~~~-~~g~~gg~~gl~~~----------~~v~fdt~~~-~~~~d~~~nhi~i~~n~~~s~ 139 (226)
T d1avba_ 72 RINAKNIENSAYGLAFALVPVGS-RPKLKGRYLGLFNT----------TNYDRDAHTV-AVVFDTVSNRIEIDVNSIRPI 139 (226)
T ss_dssp EEEESSTTSCCEEEEEEEEETTC-CCCCCGGGTTTCSC----------SSCCGGGCCE-EEEEETTTTEEEEEESSSSCS
T ss_pred EEecCCCCCCCceEEEEEccCCC-CCCCccccCCcccc----------ccccccceec-cccccCCCCEEEEeCCCCccc
Confidence 99998778899999999999875 44567889999764 3699999998 666799999999999999988
Q ss_pred cccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeE
Q 035655 180 KLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGF 259 (670)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGF 259 (670)
.+.+. ...+.+|+.++|||+||+.+++|+|++...+ +|..|.++..+||+.+||++|||||
T Consensus 140 ~~~~~---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~----------~~~~~~~~~~vdL~~~l~~~~y~GF 200 (226)
T d1avba_ 140 ATESC---------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPS----------SEEKCHVSATVPLEKEVEDWVSVGF 200 (226)
T ss_dssp EEEEC---------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETT----------TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred ccccc---------ccccCCCeEEEEEEEEcCCCcEEEEEEEeCC----------CCccEEEEEEecHHHccCCcEEEEE
Confidence 77763 3567899999999999999999999998654 4677889999999999999999999
Q ss_pred eecCCc---eeeeEEEeccccccC
Q 035655 260 SASTGR---KVSSHFILGWSFSMN 280 (670)
Q Consensus 260 sastg~---~~~~h~i~sW~fs~~ 280 (670)
||+||. ..|.|+|++|+|+++
T Consensus 201 SAaTG~~s~~~~~H~IlsWsF~s~ 224 (226)
T d1avba_ 201 SATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp EEEECSSGGGCEEEEEEEEEEEEE
T ss_pred EEEcCCCCCCeeeeEEEEEEeEEe
Confidence 999994 678999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=384.74 Aligned_cols=238 Identities=22% Similarity=0.383 Sum_probs=185.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.++|+..+.||+|+||.||+|++.. ..+.|.+|+++|++++||||++++|+|. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578899999999999999997532 2356899999999999999999999996 467899
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
||||+++|+|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999886543 469999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
..........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...+ ..+.. +.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~~~-----~~-- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGER-----LP-- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCC-----CC--
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCC-----CC--
Confidence 55445556688999999999999999999999999999999998 89999764332 22111 11111 11
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+......+.+++..||+.||.+|||++||+++|+.
T Consensus 230 --~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 230 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122233567889999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=385.03 Aligned_cols=234 Identities=23% Similarity=0.319 Sum_probs=192.1
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|+..+.||+|+||+||+|.... ..+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 569999999999999999997643 2346889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998654 369999999999999999999999 999999999999999999999999999999876443
Q ss_pred -cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 503 -ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 503 -~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
........||+.|||||++.+..++.++|||||||++|||++|+.||........ .......+ ..+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~~~~------~~~---- 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLE------YDF---- 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHTTC------CCC----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHHHcCC------CCC----
Confidence 2233456899999999999999999999999999999999999999986432211 11111111 111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
+......+.+++..||+.||.+|||++|++++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11223567889999999999999999997654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=381.29 Aligned_cols=235 Identities=30% Similarity=0.414 Sum_probs=188.3
Q ss_pred cCccccceEeeeCceeEEEeeccc------------hHHHHHHHHHHHhccccCceeeeeeeeec-cCeeEEEEeccCCC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-KRDLLLVYDYIPNG 428 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~g 428 (670)
++|+..++||+|+||.||+|++.+ ..+.|.+|++++++++||||++++|+|.+ .+.+++||||+++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 567888999999999999998754 35789999999999999999999999865 46789999999999
Q ss_pred CchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcceeec
Q 035655 429 SLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKISHTTN 508 (670)
Q Consensus 429 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 508 (670)
+|.++|.+.....++|..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~ 159 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 159 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----Ccc
Confidence 99999977655679999999999999999999999 89999999999999999999999999999865432 233
Q ss_pred cccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCCcccHHHH
Q 035655 509 VVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEM 586 (670)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 586 (670)
..+|..|+|||++.++.++.++|||||||++|||+| |+.||...... ...++ ..+ ..+.. +....
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~~-----~~~~~----~~~~~ 226 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKG-----YKMDA----PDGCP 226 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTT-----CCCCC----CTTCC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcC-----CCCCC----CccCC
Confidence 468999999999999999999999999999999998 68777653322 22221 111 11222 22223
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 587 ELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 587 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+++.+||+.||.+|||+++++++|+.
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 567889999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-46 Score=388.59 Aligned_cols=238 Identities=23% Similarity=0.326 Sum_probs=182.0
Q ss_pred hhcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 360 ATKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 360 ~t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
..+.|+..+.||+|+||+||+|+... ..+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34679999999999999999998643 1245678999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec---CCCcEEEEeecCceecc
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID---ADMNARLGDFGLARLFD 499 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kL~DFGla~~~~ 499 (670)
||+++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999654 469999999999999999999998 9999999999999994 57899999999998665
Q ss_pred CCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||........ ... ..... .....
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~-i~~~~------~~~~~ 230 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FEQ-ILKAE------YEFDS 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHTTC------CCCCT
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HHH-HhccC------CCCCC
Confidence 432 23446899999999999999999999999999999999999999986432211 111 11111 11111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.........+.+++..||++||.+|||++|+++|
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1122233567889999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=385.17 Aligned_cols=231 Identities=28% Similarity=0.423 Sum_probs=190.1
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
+.|+..+.||+|+||.||+|+... ..+.|.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 458899999999999999997643 2356889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
|||++|+|..++..+ ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998776544 469999999999999999999999 8999999999999999999999999999986543
Q ss_pred cceeeccccCcCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCC
Q 035655 503 ISHTTNVVGTIGYIAPELART---GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||....... ...... ... .+.+..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~~i~-~~~-----~~~~~~ 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA-QNE-----SPALQS 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH-HSC-----CCCCSC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-hCC-----CCCCCC
Confidence 234579999999999864 468999999999999999999999997643211 111111 111 111111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+.+++..||+.||.+|||++|+++|
T Consensus 237 ---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1123567889999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=389.42 Aligned_cols=238 Identities=25% Similarity=0.403 Sum_probs=192.8
Q ss_pred cCccccceEeeeCceeEEEeeccc---------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT---------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLL 420 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~---------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~l 420 (670)
.+|+..++||+|+||+||+|.+.. ..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999997531 346799999999999999999999999865 5678
Q ss_pred EEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccC
Q 035655 421 VYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDH 500 (670)
Q Consensus 421 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~ 500 (670)
++||+.+|+|.+++.... ..+++..+++++.|||.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999999887654 479999999999999999999999 8999999999999999999999999999987755
Q ss_pred CCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 501 GKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
.... ......||+.|||||++.++.++.++|||||||++|||+| |+.||......... .....+.. +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~~~~-----~--- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGER-----L--- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHHTCC-----C---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCC-----C---
Confidence 4432 2344578999999999999999999999999999999998 88898764322111 11111111 1
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+......+.+++.+||+.||.+|||++||+++|+.
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1122233567889999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-45 Score=387.49 Aligned_cols=238 Identities=23% Similarity=0.339 Sum_probs=197.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
-++|++.+.||+|+||.||+|+... ..+.+.+|+++|++++|||||++++++.+.+.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4689999999999999999998643 245688999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC--CCcEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA--DMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kL~DFGla~~~~~~~ 502 (670)
|++|+|.+++.+.. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999986543 369999999999999999999999 99999999999999964 6789999999998775543
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... +....... .. ........
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~-~~------~~~~~~~~ 249 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS-CD------WNMDDSAF 249 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TC------CCSCCGGG
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CC------CCCCcccc
Confidence 334568999999999999999999999999999999999999999764321 11111111 11 11111122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
....+.+.+++.+||+.||++|||++|+++|
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234567889999999999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-46 Score=386.69 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=198.4
Q ss_pred HHHhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeec
Q 035655 357 LYTATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR 414 (670)
Q Consensus 357 l~~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~ 414 (670)
++-..++|+..+.||+|+||+||+|+.+. ..++|.+|+++|++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 33356789999999999999999997431 24679999999999999999999999999
Q ss_pred cCeeEEEEeccCCCCchhhcccCC----------------------ccccCHHHHHHHHHHHHHHhhhccccccceEEec
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNE----------------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHR 472 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHr 472 (670)
.+..++|+||+++|+|.++|.... ...++|.+++.++.|++.||+|||+ ++++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence 999999999999999999996422 2348999999999999999999998 999999
Q ss_pred ccCCCcEEecCCCcEEEEeecCceeccCCC-cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 035655 473 DVKSGNVLIDADMNARLGDFGLARLFDHGK-ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR-RPID 550 (670)
Q Consensus 473 DIkp~NILld~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~-~pf~ 550 (670)
||||+|||||.++.+||+|||+++...... ....+...||+.|+|||++.+..++.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998664432 22334567899999999999999999999999999999999985 5676
Q ss_pred CCcch-hHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 551 SDHFI-LVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 551 ~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
..... .... ...+.. +.. +...+..+.+++..||+.+|.+||||.||++.|++.
T Consensus 245 ~~~~~e~~~~----v~~~~~-----~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAHEEVIYY----VRDGNI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCHHHHHHH----HHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCHHHHHHH----HHcCCC-----CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 53322 1111 111221 111 122235678999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=377.14 Aligned_cols=237 Identities=22% Similarity=0.357 Sum_probs=196.5
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..+.||+|+||+||+|+... ..+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999998643 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC----cEEEEeecC
Q 035655 419 LLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM----NARLGDFGL 494 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kL~DFGl 494 (670)
++|||||++|+|.++|... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999654 369999999999999999999999 9999999999999998776 599999999
Q ss_pred ceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 495 ARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 495 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .. .
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~-~~------~ 232 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVS-AV------N 232 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-TT------C
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHHHH-hc------C
Confidence 98775443 23445799999999999999999999999999999999999999986432211 11111 11 1
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..............+.+++.+||+.||.+|||++|+++|
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111222234567889999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-44 Score=384.60 Aligned_cols=237 Identities=20% Similarity=0.323 Sum_probs=196.5
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
++|++.+.||+|+||.||+|+... ..+.+.+|+++|++|+|||||++++++.+++.+++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 579999999999999999998643 2456789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec--CCCcEEEEeecCceeccCCCc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID--ADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~~kL~DFGla~~~~~~~~ 503 (670)
++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999998876543 369999999999999999999998 9999999999999998 67899999999999876543
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......||+.|||||++.+..++.++|||||||++|||+||+.||........ ..... ... .........
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i~-~~~------~~~~~~~~~ 253 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQNVK-RCD------WEFDEDAFS 253 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH-HCC------CCCCSSTTT
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-hCC------CCCCccccc
Confidence 33456799999999999999999999999999999999999999986432211 11111 111 111111122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++.+||+.||.+|||++|+++|
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 233567889999999999999999999997
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.1e-44 Score=352.07 Aligned_cols=199 Identities=28% Similarity=0.479 Sum_probs=166.5
Q ss_pred CceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEe
Q 035655 23 QKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIV 102 (670)
Q Consensus 23 ~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~ 102 (670)
..++|+|++|+. .+ |.++|+|.+.++|.||||++..+++|||+|++||+||++.++ +++||+|+|+|.|.
T Consensus 2 ~~~sF~~~~F~~--~~---l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~-----~~~sF~t~F~f~i~ 71 (204)
T d1dhkb_ 2 TETSFIIDAFNK--TN---LILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTG-----NVASFDTNFTMNIR 71 (204)
T ss_dssp CCCEEEESSCCG--GG---EEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTT-----EECEEEEEEEEEEE
T ss_pred ccceEECCCCCc--cC---eeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCc-----ccccEEEEEEEEEe
Confidence 468999999977 67 999999999878999999999999999999999999999998 89999999999999
Q ss_pred cCCCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccccc
Q 035655 103 TPNSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLE 182 (670)
Q Consensus 103 ~~~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~ 182 (670)
+.+...+||||||+++|... ...++.+||||||++| |+++|+++.......
T Consensus 72 ~~~~~~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt~~n----------~~~~d~~~~~~~~~~ 122 (204)
T d1dhkb_ 72 THRQANSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDTFLS----------RISIDVNNNDIKSVP 122 (204)
T ss_dssp CCC---CCSEEEEEEEEC-------------------------CCEEEEEETTTT----------EEEEEETTEEEEEEE
T ss_pred cCCCCCCCceEEEEecCCCC-------------------CCCCcEeeEeeEcccc----------cccCccccccccccc
Confidence 88777799999999998642 2335789999999854 677777765432211
Q ss_pred ccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeec
Q 035655 183 PAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262 (670)
Q Consensus 183 ~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsas 262 (670)
..+.+.+|+.++|||+||+.+++|+|++...+ +|..|.|+..+||+++||++||||||||
T Consensus 123 ----------~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~----------~~~~~~l~~~vdL~~~l~~~~yvGFSAa 182 (204)
T d1dhkb_ 123 ----------WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS----------TGKSNNVSTTVELEKEVYDWVSVGFSAT 182 (204)
T ss_dssp ----------CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT----------TCCEEEEEEECCCCSGGGSEEEEEEEEE
T ss_pred ----------cccEecCCCEEEEEEEEcCCCEEEEEEEecCC----------CCCceeEEEEecchhccCCcEEEEEEee
Confidence 23677899999999999999999999998654 3566889999999999999999999999
Q ss_pred CCc---eeeeEEEeccccccC
Q 035655 263 TGR---KVSSHFILGWSFSMN 280 (670)
Q Consensus 263 tg~---~~~~h~i~sW~fs~~ 280 (670)
||. ..|+|+|++|+|+++
T Consensus 183 TG~~~~~~e~H~IlsWsFss~ 203 (204)
T d1dhkb_ 183 SGAYQWSYETHDVLSWSFSSK 203 (204)
T ss_dssp ECSGGGSCCEEEEEEEEEEEE
T ss_pred cCCCCCCceeeEEEEEEEEec
Confidence 996 368999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=376.62 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=189.1
Q ss_pred cCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|+..+.||+|+||.||+|+... ..++|.+|+++|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999997421 23578999999999999999999999976 4678
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++|+|.+++..+. ..+++..+++++.|||.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887653 369999999999999999999999 899999999999999999999999999999875
Q ss_pred CCCcce--eeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHHhhcCCcccccCCC
Q 035655 500 HGKISH--TTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDWVLEFQHLGQVLDVVDPN 576 (670)
Q Consensus 500 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~ 576 (670)
...... .....||..|+|||++.+..++.++|||||||++|||+| |+.||........ .......+.. +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i~~~~~~-----~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDKEGER-----LP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTSCCC-----CC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHHHhCCCC-----CC
Confidence 543222 234578899999999999999999999999999999998 8999976432211 1111111111 11
Q ss_pred CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 577 LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 577 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.+...+..+.+++.+||+.||++|||++||++.|++
T Consensus 236 ----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 ----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111223567889999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=381.14 Aligned_cols=239 Identities=30% Similarity=0.431 Sum_probs=193.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|+..++||+|+||.||+|++.. ..++|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999997643 235789999999999 799999999999999999999
Q ss_pred EeccCCCCchhhcccC--------------CccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcE
Q 035655 422 YDYIPNGSLDSLLFDN--------------ENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNA 487 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 487 (670)
|||+++|+|.++|+.+ ....++|.++.+++.|||.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999754 23569999999999999999999999 899999999999999999999
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCcchhHHHHHHHhhc
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRR-PIDSDHFILVDWVLEFQHL 566 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~-pf~~~~~~~~~~~~~~~~~ 566 (670)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...... +.... ...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~-i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK-LPQ 241 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-GGG
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHH-HHh
Confidence 999999998554322 2234578999999999999999999999999999999999765 56543211 11111 111
Q ss_pred CCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 567 GQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 567 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
+ ..+.. +......+.+++.+||+.||++||||+||+++|+..
T Consensus 242 ~-----~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 242 G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp T-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11211 222335678899999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=376.78 Aligned_cols=236 Identities=27% Similarity=0.448 Sum_probs=190.5
Q ss_pred cceEeeeCceeEEEeeccc--------------------hHHHHHHHHHHHhccccCceeeeeeeeec-cCeeEEEEecc
Q 035655 367 SEVIGTGGFGEVYKGVLPT--------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-KRDLLLVYDYI 425 (670)
Q Consensus 367 ~~~lG~G~fg~Vykg~~~~--------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-~~~~~lV~E~~ 425 (670)
.++||+|+||+||+|++.. ..++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999997532 23679999999999999999999999875 56899999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc-
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS- 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~- 504 (670)
++|+|.+++.... ..+++..+++++.|+++||.|||+ ++|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999987553 468899999999999999999998 89999999999999999999999999999876544322
Q ss_pred --eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 505 --HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
......||+.|+|||.+.++.++.++|||||||++|||+||+.||..... ..+...... .+.. ...|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~-~g~~--~~~p------- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL-QGRR--LLQP------- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH-TTCC--CCCC-------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHH-cCCC--CCCc-------
Confidence 22345789999999999999999999999999999999998888765321 111111111 1111 1111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 583 VAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
......+.+++.+||+.||++||+|.||+++|++.
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235678899999999999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=375.03 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=187.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc-C
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK-R 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~-~ 416 (670)
.++|+..++||+|+||.||+|.... ..+.+.+|+..+.++ +|+||+++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3578999999999999999997421 235677888888887 689999999998764 5
Q ss_pred eeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID 482 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld 482 (670)
.+++||||+++|+|.++|.... ...+++.+++.++.||++||+|||+ ++|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 6899999999999999996542 2358999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCcchhHHHH
Q 035655 483 ADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR-RPIDSDHFILVDWV 560 (670)
Q Consensus 483 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~-~pf~~~~~~~~~~~ 560 (670)
+++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||++|. .||...... ...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999987654332 2334568999999999999999999999999999999999964 577653221 111
Q ss_pred HHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 561 LEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 561 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
......+.. +.. +......+.+++.+||+.||.+|||++||+++|+.
T Consensus 247 ~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 247 CRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111 111 11223567889999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=376.91 Aligned_cols=234 Identities=23% Similarity=0.293 Sum_probs=195.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
.++|+..+.||+|+||.||+|+... ..+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3579999999999999999998643 235678999999999999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999987643 58999999999999999999999 99999999999999999999999999999865432
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. ......+||+.|||||++.+..++.++||||+||++|||++|+.||........ ......+. +.+..
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i~~~~------~~~p~-- 226 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEE------IRFPR-- 226 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC------CCCCT--
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHHHhcCC------CCCCc--
Confidence 2 234456899999999999999999999999999999999999999987543211 11111111 11111
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
.....+.+++..||++||.+||+ ++|+++|
T Consensus 227 --~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --cCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 22345778999999999999995 8899886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-44 Score=373.18 Aligned_cols=230 Identities=24% Similarity=0.313 Sum_probs=193.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|++.+.||+|+||+||+|+... ..+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 569999999999999999998643 2356889999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999986654 58889999999999999999999 89999999999999999999999999999876542
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ ... ...+. ..+ +
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~-i~~~~------~~~----p 221 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEK-ILNAE------LRF----P 221 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH-HHHCC------CCC----C
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HHH-HHcCC------CCC----C
Confidence 3346899999999999999999999999999999999999999986442211 111 11111 111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
......+.+++.+||++||.+|| +++++++|
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11234577899999999999996 89999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=376.21 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=194.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------------hHHHHHHHHHHHhcc-ccCceeeeeeeeecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------------RMREFAAEIESLGRL-RHKHLVNLQGWCKRK 415 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~~ 415 (670)
.++|...+.||+|+||.||+|+... ...++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578889999999999999986421 246788999999998 799999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCC--------------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEe
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNE--------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLI 481 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 481 (670)
+..++||||+++|+|.++|.... ...+++.++++++.||+.||+|||+ ++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 2458999999999999999999999 999999999999999
Q ss_pred cCCCcEEEEeecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 035655 482 DADMNARLGDFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIAT-GRRPIDSDHFILVDW 559 (670)
Q Consensus 482 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~t-G~~pf~~~~~~~~~~ 559 (670)
+.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 99999999999999877654432 2344678999999999999999999999999999999998 788887543221
Q ss_pred HHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 560 VLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 560 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+......+. .+.. +......+.+++.+||+.||.+|||+.||++.|++
T Consensus 246 ~~~~i~~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 246 LFKLLKEGH-----RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHHHHHTTC-----CCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCC-----CCCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112211111 1111 12223568899999999999999999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=376.06 Aligned_cols=251 Identities=23% Similarity=0.275 Sum_probs=197.2
Q ss_pred hcCccccc-eEeeeCceeEEEeeccc-----------hHHHHHHHHHHHhcc-ccCceeeeeeeeec----cCeeEEEEe
Q 035655 361 TKGFKQSE-VIGTGGFGEVYKGVLPT-----------RMREFAAEIESLGRL-RHKHLVNLQGWCKR----KRDLLLVYD 423 (670)
Q Consensus 361 t~~f~~~~-~lG~G~fg~Vykg~~~~-----------~~~~f~~Ei~~L~~l-~H~nIv~l~g~~~~----~~~~~lV~E 423 (670)
.++|.+.+ .||+|+||+||+|+... ....+.+|+.++.++ +|||||++++++.+ ...+|+|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 35788765 59999999999998754 246778999987665 89999999999865 467899999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC---CCcEEEEeecCceeccC
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA---DMNARLGDFGLARLFDH 500 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kL~DFGla~~~~~ 500 (670)
||++|+|.++|.+.....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccC
Confidence 9999999999987655679999999999999999999998 99999999999999985 45799999999987655
Q ss_pred CCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhcCCcccccCCCCCC
Q 035655 501 GKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHLGQVLDVVDPNLGS 579 (670)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~ 579 (670)
.. ......||+.|||||++.+..++.++|||||||++|||+||+.||...... ........ .......+..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~------i~~~~~~~~~ 238 (335)
T d2ozaa1 167 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------IRMGQYEFPN 238 (335)
T ss_dssp CC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C------CCSCSSSCCT
T ss_pred CC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH------HhcCCCCCCC
Confidence 43 234568999999999999999999999999999999999999999753221 11111000 0001111111
Q ss_pred cccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH--hcCCCCCCC
Q 035655 580 SYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY--LNGDELLPI 622 (670)
Q Consensus 580 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~p~ 622 (670)
.........+.+++.+||+.||.+|||+.|+++| +.+....|.
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 2223445678899999999999999999999996 544444443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=371.20 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=190.5
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------hHHHHHH--HHHHHhccccCceeeeeeeeeccC----eeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------RMREFAA--EIESLGRLRHKHLVNLQGWCKRKR----DLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------~~~~f~~--Ei~~L~~l~H~nIv~l~g~~~~~~----~~~lV~E~ 424 (670)
+.|...+.||+|+||.||+|+..+ ..+.+.. |+..+.+++||||++++|+|.+.+ .+++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 457778899999999999998644 2334444 555566789999999999998654 58999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccc-----cceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEW-----EQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
|++|+|.++|++. .++|.++++++.|+|.||+|||+.. +++|+||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999653 5899999999999999999999731 4799999999999999999999999999998775
Q ss_pred CCCcc---eeeccccCcCCCCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCcch------------hHH
Q 035655 500 HGKIS---HTTNVVGTIGYIAPELARTGK------ASCSTDVFAYGVLLLEIATGRRPIDSDHFI------------LVD 558 (670)
Q Consensus 500 ~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~------------~~~ 558 (670)
..... ......||+.|||||++.+.. ++.|+|||||||++|||+||+.|+...... ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 54322 234568999999999987542 577999999999999999999887431100 011
Q ss_pred HHHHHhhcCCcccccCCCCCCcc-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 559 WVLEFQHLGQVLDVVDPNLGSSY-VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
...... .....+|.+.... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 240 ~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 240 EMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111 1112233333322 33456778999999999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=375.80 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCccchhhHH-HhhcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhcc-ccCc
Q 035655 349 PHRFRYSDLY-TATKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRL-RHKH 404 (670)
Q Consensus 349 ~~~~~~~~l~-~~t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l-~H~n 404 (670)
|.++.|.... ...++|+..++||+|+||.||+|++.. ...+|.+|+.+++++ +|||
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence 4444443322 234688899999999999999996421 345788999999999 6999
Q ss_pred eeeeeeeeeccCeeEEEEeccCCCCchhhcccCC----------------ccccCHHHHHHHHHHHHHHhhhccccccce
Q 035655 405 LVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNE----------------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQV 468 (670)
Q Consensus 405 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 468 (670)
||+++|+|.+.+..++||||+++|+|.++|++.. ...+++..+.+++.||++||+|||+ ++
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ 165 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KN 165 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 9999999999999999999999999999997543 2358999999999999999999999 89
Q ss_pred EEecccCCCcEEecCCCcEEEEeecCceeccCCCc-ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhC-C
Q 035655 469 VIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI-SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATG-R 546 (670)
Q Consensus 469 ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG-~ 546 (670)
++||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+ .
T Consensus 166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 99999999999999999999999999987765433 333456899999999999999999999999999999999994 5
Q ss_pred CCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 547 RPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 547 ~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
.|+........ .......+. .+. .+......+.+|+.+||+.||++|||++||++.|++
T Consensus 246 p~~~~~~~~~~--~~~~i~~~~-----~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 246 SPYPGMPVDSK--FYKMIKEGF-----RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp CSSTTCCSSHH--HHHHHHHTC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHH--HHHHHhcCC-----CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 55544322111 111111111 111 111223568899999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-43 Score=377.11 Aligned_cols=234 Identities=24% Similarity=0.285 Sum_probs=189.2
Q ss_pred cCccccceEeeeCceeEEEeeccch-------------------HHHHHH---HHHHHhccccCceeeeeeeeeccCeeE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR-------------------MREFAA---EIESLGRLRHKHLVNLQGWCKRKRDLL 419 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~-------------------~~~f~~---Ei~~L~~l~H~nIv~l~g~~~~~~~~~ 419 (670)
++|++.++||+|+||.||+|+.... ...+.+ |+++++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999987531 122333 467778888999999999999999999
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
+||||+++|+|.++|.+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999654 458999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCC
Q 035655 500 HGKISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLG 578 (670)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 578 (670)
... .....||+.|||||++.. ..++.++|||||||++|||++|+.||................. ..+.+.
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~------~~~~~~ 229 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVELP 229 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS------CCCCCC
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------CCCCCC
Confidence 532 344589999999999875 4689999999999999999999999976432211111111111 011111
Q ss_pred CcccHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 035655 579 SSYVVAEMELVLQLGLLCSHQKAEARPT-----MRQVLRY 613 (670)
Q Consensus 579 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 613 (670)
.. ....+.+++..||+.||.+||+ ++|+++|
T Consensus 230 ~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 230 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 12 2345788999999999999999 6899875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-43 Score=361.96 Aligned_cols=236 Identities=24% Similarity=0.373 Sum_probs=194.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------------hHHHHHHHHHHHhccc-cCceeeeeeeeecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------------RMREFAAEIESLGRLR-HKHLVNLQGWCKRK 415 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~ 415 (670)
++|+..+.||+|+||+||+|+... ..+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 579999999999999999997633 1135789999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCc
Q 035655 416 RDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLA 495 (670)
Q Consensus 416 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla 495 (670)
+..|+||||+++|+|.++|..+ ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999754 369999999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCcceeeccccCcCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELART------GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV 569 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~ 569 (670)
+...... ......||+.|+|||++.+ ..++.++||||+||+++||++|+.||......... .....+..
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~i~~~~~ 232 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMIMSGNY 232 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHTCC
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HHHHhCCC
Confidence 9776543 2344689999999998863 35688999999999999999999999875432211 11111111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...........+.+.+++.+||++||.+|||++|+++|
T Consensus 233 ------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 ------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111122334568889999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=374.30 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=197.2
Q ss_pred hcCccccceEeeeCceeEEEeeccc----------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCee
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT----------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDL 418 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~----------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~ 418 (670)
.++|+..++||+|+||+||+|.+.. ....|.+|++++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3678889999999999999987531 234688999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhcccCC--------ccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEE
Q 035655 419 LLVYDYIPNGSLDSLLFDNE--------NFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 419 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
++||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||+ ++|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999986432 2357999999999999999999998 899999999999999999999999
Q ss_pred eecCceeccCCCcc-eeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCcchhHHHHHHHhhcCC
Q 035655 491 DFGLARLFDHGKIS-HTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGR-RPIDSDHFILVDWVLEFQHLGQ 568 (670)
Q Consensus 491 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~-~pf~~~~~~~~~~~~~~~~~~~ 568 (670)
|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||..... .+.... ...+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~~~~-i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRF-VMEGG 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHH-HHTTC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHHHHH-HHhCC
Confidence 99999876543322 223347899999999999999999999999999999999985 66654322 111111 11222
Q ss_pred cccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcCC
Q 035655 569 VLDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNGD 617 (670)
Q Consensus 569 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 617 (670)
... .+......+.+++.+||+.+|.+|||++||+++|++.
T Consensus 253 ~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 253 LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 1112235688999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-43 Score=360.30 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=187.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC----e
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR----D 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~ 417 (670)
.++|++.+.||+|+||.||+|+... ..+.|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999997642 2346889999999999999999999987654 3
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++..+|+|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999998654 369999999999999999999998 9999999999999999999999999999976
Q ss_pred ccCCCc--ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCC
Q 035655 498 FDHGKI--SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDP 575 (670)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~ 575 (670)
...... .......||+.|||||++.+..++.++|||||||++|||+||+.||....... ............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~~~~~~~~~----- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VAYQHVREDPIP----- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHCCCCC-----
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--HHHHHHhcCCCC-----
Confidence 544322 23345689999999999999999999999999999999999999998643221 111111111110
Q ss_pred CCCCcccHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHhc
Q 035655 576 NLGSSYVVAEMELVLQLGLLCSHQKAEARP-TMRQVLRYLN 615 (670)
Q Consensus 576 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~ 615 (670)
.........+.+.+++.+||++||.+|| +++++++.|.
T Consensus 234 --~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 --PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp --GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 0111112235678899999999999999 8999988765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-43 Score=372.66 Aligned_cols=230 Identities=25% Similarity=0.273 Sum_probs=193.6
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVY 422 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~ 422 (670)
++|++.+.||+|+||.||+|+... ..+.+.+|+++|++++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 579999999999999999998643 2346789999999999999999999999999999999
Q ss_pred eccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCC
Q 035655 423 DYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGK 502 (670)
Q Consensus 423 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~ 502 (670)
||+.+|+|.+++.+.. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999996543 59999999999999999999998 89999999999999999999999999999876542
Q ss_pred cceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCccc
Q 035655 503 ISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYV 582 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 582 (670)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ ... ...+. +....
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~-i~~~~------~~~p~--- 259 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEK-IVSGK------VRFPS--- 259 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHCC------CCCCT---
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--HHH-HhcCC------CCCCc---
Confidence 3346899999999999999999999999999999999999999986442211 111 11111 11111
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CCHHHHHHH
Q 035655 583 VAEMELVLQLGLLCSHQKAEAR-----PTMRQVLRY 613 (670)
Q Consensus 583 ~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~evl~~ 613 (670)
.....+.+++..||+.||.+| |+++++++|
T Consensus 260 -~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 260 -HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 123457789999999999999 489999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=365.20 Aligned_cols=238 Identities=18% Similarity=0.283 Sum_probs=195.4
Q ss_pred hcCccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|.+.+.||+|+||+||+|+... ....+.+|+++|++++||||+++++++.+.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 3578999999999999999998753 2346789999999999999999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC--CcEEEEeecCceeccCCCc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD--MNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~--~~~kL~DFGla~~~~~~~~ 503 (670)
++|+|.++|.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999996543 369999999999999999999998 999999999999999854 489999999998765433
Q ss_pred ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcccH
Q 035655 504 SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSYVV 583 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 583 (670)
......+|+.|+|||.+.+..++.++||||+||++|||++|+.||....... ....... .. ..+......
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~~i~~-~~------~~~~~~~~~ 228 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMN-AE------YTFDEEAFK 228 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH-TC------CCCCHHHHT
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CC------CCCChhhcc
Confidence 3344679999999999999999999999999999999999999998644221 1111111 11 011111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 584 AEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 584 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+.+++..||+.||.+|||++|+++|
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223567889999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=363.76 Aligned_cols=246 Identities=27% Similarity=0.348 Sum_probs=191.5
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|++.++||+|+||+||+|++.. ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999998643 24578899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
|+.+ ++.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9965 55555555545679999999999999999999998 899999999999999999999999999998765433
Q ss_pred ceeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccccc------CC-
Q 035655 504 SHTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVV------DP- 575 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~------d~- 575 (670)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||........-+. .....+...+.. .+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH-HHHhcCCCchhhccccccccc
Confidence 2234458999999999877655 57899999999999999999999986432211110 000000000000 00
Q ss_pred ------CC-CCcc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 576 ------NL-GSSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 576 ------~l-~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.. .... .......+.+++.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000 01123567889999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=368.27 Aligned_cols=233 Identities=24% Similarity=0.359 Sum_probs=191.7
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHh-ccccCceeeeeeeeeccCeeEEE
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLG-RLRHKHLVNLQGWCKRKRDLLLV 421 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~-~l~H~nIv~l~g~~~~~~~~~lV 421 (670)
++|...+.||+|+||+||+|+... ..+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999998743 1235667777765 68999999999999999999999
Q ss_pred EeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCC
Q 035655 422 YDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHG 501 (670)
Q Consensus 422 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~ 501 (670)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997543 58999999999999999999999 89999999999999999999999999999865543
Q ss_pred CcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccCCCCCCcc
Q 035655 502 KISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVDPNLGSSY 581 (670)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 581 (670)
. ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+ .+.+..
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~~------~~~~p~-- 224 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMD------NPFYPR-- 224 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC------CCCCCT--
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHcC------CCCCCc--
Confidence 2 334456899999999999999999999999999999999999999986443211 1111111 112211
Q ss_pred cHHHHHHHHHHHHhhccCCCCCCCCHH-HHHHH
Q 035655 582 VVAEMELVLQLGLLCSHQKAEARPTMR-QVLRY 613 (670)
Q Consensus 582 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~ 613 (670)
.....+.+++.+||+.||.+||++. |+++|
T Consensus 225 --~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 225 --WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --cCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 2234578899999999999999996 77653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=360.65 Aligned_cols=242 Identities=26% Similarity=0.277 Sum_probs=187.2
Q ss_pred ccceEeeeCceeEEEeeccch---------------------HHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 366 QSEVIGTGGFGEVYKGVLPTR---------------------MREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 366 ~~~~lG~G~fg~Vykg~~~~~---------------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
..++||+|+||+||+|++... .+.+.+|+++|++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999986431 23578999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
++++++..++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 998887776643 3468999999999999999999999 9999999999999999999999999999986654332
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc---CCc---ccccCCC
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL---GQV---LDVVDPN 576 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~---~~~---~~~~d~~ 576 (670)
......||+.|+|||++... .++.++|||||||++|||++|+.||...... ........... ... .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 23345799999999988654 5799999999999999999999999764321 11111111000 000 0000000
Q ss_pred ---CCCccc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 577 ---LGSSYV-----VAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 577 ---l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
.....+ ....+.+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000011 1123568899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=358.75 Aligned_cols=225 Identities=24% Similarity=0.382 Sum_probs=185.8
Q ss_pred cCccccceEeeeCceeEEEeeccch----------------------HHHHHHHHHHHhccc--cCceeeeeeeeeccCe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPTR----------------------MREFAAEIESLGRLR--HKHLVNLQGWCKRKRD 417 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~~----------------------~~~f~~Ei~~L~~l~--H~nIv~l~g~~~~~~~ 417 (670)
++|++.++||+|+||+||+|+...+ ...+.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999986431 123568999999997 8999999999999999
Q ss_pred eEEEEeccCC-CCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCC-CcEEEEeecCc
Q 035655 418 LLLVYDYIPN-GSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDAD-MNARLGDFGLA 495 (670)
Q Consensus 418 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kL~DFGla 495 (670)
.++||||+.+ +++.+++..+ ..+++.++..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5777877554 469999999999999999999999 999999999999999854 79999999999
Q ss_pred eeccCCCcceeeccccCcCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCcccccC
Q 035655 496 RLFDHGKISHTTNVVGTIGYIAPELARTGKA-SCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d 574 (670)
+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ...
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------~-~~~------ 220 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I-RGQ------ 220 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H-HCC------
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------h-hcc------
Confidence 876543 2345689999999999987765 56799999999999999999999753210 0 011
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..+...+ ...+.+++.+||+.||.+|||++|+++|
T Consensus 221 ~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111122 2567889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-41 Score=352.20 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=188.4
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEec
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYDY 424 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E~ 424 (670)
++|+..++||+|+||+||+|+++. ..+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578999999999999999998653 135789999999999999999999999999999999999
Q ss_pred cCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCcc
Q 035655 425 IPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 425 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~~ 504 (670)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 9887777776443 469999999999999999999998 899999999999999999999999999998765432 2
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHHhhc------------CCcc
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEFQHL------------GQVL 570 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~~~~------------~~~~ 570 (670)
......|++.|+|||.+.+. .++.++|||||||+++||++|+.||....... .......... .+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23345789999999988754 56899999999999999999999997643211 1111110000 0000
Q ss_pred ccc---CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVV---DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
... .+.............+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000011112223567899999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=357.01 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=188.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc-------------------hHHHHHHHHHHHhcc---ccCceeeeeeeeec----
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-------------------RMREFAAEIESLGRL---RHKHLVNLQGWCKR---- 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-------------------~~~~f~~Ei~~L~~l---~H~nIv~l~g~~~~---- 414 (670)
.++|++.++||+|+||+||+|++.. ....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4689999999999999999998632 123466888887776 79999999999853
Q ss_pred -cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeec
Q 035655 415 -KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFG 493 (670)
Q Consensus 415 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFG 493 (670)
....++++||++++++..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 356899999998877655443 334568999999999999999999999 899999999999999999999999999
Q ss_pred CceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHHhhc-C----
Q 035655 494 LARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDWVLEFQHL-G---- 567 (670)
Q Consensus 494 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~~~~~~~~-~---- 567 (670)
+++..... .......||+.|+|||++.+.+++.++||||+||++|||++|+.||...... ........... .
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99865432 2334568999999999999999999999999999999999999999864321 11111111000 0
Q ss_pred ----Cccccc----CCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 568 ----QVLDVV----DPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 568 ----~~~~~~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...... .+.....+.....+.+.+|+.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0000011122233567789999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-40 Score=342.71 Aligned_cols=248 Identities=27% Similarity=0.333 Sum_probs=187.7
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec--------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR-------- 414 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~-------- 414 (670)
-++|++.++||+|+||+||+|++.. ..+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3679999999999999999998643 23568899999999999999999999855
Q ss_pred cCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecC
Q 035655 415 KRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGL 494 (670)
Q Consensus 415 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGl 494 (670)
.+..++||||++++.+..+... ...++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 3468999999988877766533 3468899999999999999999998 9999999999999999999999999999
Q ss_pred ceeccCCCc---ceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhcCCc
Q 035655 495 ARLFDHGKI---SHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHLGQV 569 (670)
Q Consensus 495 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~~~~ 569 (670)
++....... .......||+.|+|||++.+. .++.++||||+||+++||++|+.||........ ...... .+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~--~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL--CGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh--cCCC
Confidence 987654332 122335799999999998765 689999999999999999999999976432111 111111 1111
Q ss_pred ccccCCCC-------------CCcc-cHH------HHHHHHHHHHhhccCCCCCCCCHHHHHHHhc
Q 035655 570 LDVVDPNL-------------GSSY-VVA------EMELVLQLGLLCSHQKAEARPTMRQVLRYLN 615 (670)
Q Consensus 570 ~~~~d~~l-------------~~~~-~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 615 (670)
........ .... ... ....+++|+.+||+.||++|||++|+++|=.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 00000000 0000 011 1235678999999999999999999999744
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=347.76 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=180.9
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccC------
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR------ 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~------ 416 (670)
.++|+..++||+|+||+||+|.+.. ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999998643 2356789999999999999999999997654
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.+++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 5677776643 359999999999999999999998 999999999999999999999999999998
Q ss_pred eccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCc------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQV------ 569 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~------ 569 (670)
..... .+...||+.|+|||++.+. .++.++||||+||+++||++|+.||............. ...+..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM-KVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HHHCCCCHHHHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH-hccCCCcHHHHh
Confidence 76543 3456799999999988764 56899999999999999999999997643211110000 000000
Q ss_pred ----------ccccCCCCC----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 570 ----------LDVVDPNLG----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 570 ----------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
... .+... ..........+.+|+.+||+.||.+|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhcc-CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 00111122456789999999999999999999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=346.37 Aligned_cols=247 Identities=22% Similarity=0.270 Sum_probs=184.3
Q ss_pred hcCccccceEeeeCceeEEEeeccc-----------------hHHHHHHHHHHHhccccCceeeeeeeeeccC----eeE
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT-----------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKR----DLL 419 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~-----------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~----~~~ 419 (670)
+.+|+..++||+|+||+||+|+... ..+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999997643 2357889999999999999999999987543 334
Q ss_pred EEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceecc
Q 035655 420 LVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFD 499 (670)
Q Consensus 420 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~ 499 (670)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999999643 58999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCc--ceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHhhcCCccc-----
Q 035655 500 HGKI--SHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQHLGQVLD----- 571 (670)
Q Consensus 500 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~~~~~~~~----- 571 (670)
.... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||.........+............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 4322 12344679999999998854 567899999999999999999999997643221111110000000000
Q ss_pred ---------ccCCCCC-Ccc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 572 ---------VVDPNLG-SSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 572 ---------~~d~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...+... ..+ .......+.+++..||+.||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000 01112457889999999999999999999997
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=349.92 Aligned_cols=246 Identities=23% Similarity=0.278 Sum_probs=182.9
Q ss_pred CccccceEeeeCceeEEEeeccch------------HHHHHHHHHHHhccccCceeeeeeeeecc------CeeEEEEec
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPTR------------MREFAAEIESLGRLRHKHLVNLQGWCKRK------RDLLLVYDY 424 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~~------------~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~------~~~~lV~E~ 424 (670)
+|+..++||+|+||+||+|++... ...+.+|+++|++++||||++++++|... ..+++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 577889999999999999987542 22345899999999999999999998543 347999999
Q ss_pred cCCCCchhhccc-CCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCC
Q 035655 425 IPNGSLDSLLFD-NENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGK 502 (670)
Q Consensus 425 ~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~ 502 (670)
++++.+...... .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 986644443321 234469999999999999999999998 9999999999999999875 89999999998775543
Q ss_pred cceeeccccCcCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHH----------hhcCCcc
Q 035655 503 ISHTTNVVGTIGYIAPELART-GKASCSTDVFAYGVLLLEIATGRRPIDSDHFIL-VDWVLEF----------QHLGQVL 570 (670)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~-~~~~~~~----------~~~~~~~ 570 (670)
......||..|+|||.+.+ ..++.++||||+||+++||++|+.||....... ....... .......
T Consensus 178 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred --ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 2334579999999998765 568999999999999999999999997643211 1000000 0000000
Q ss_pred cccCCCCC-----CcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 571 DVVDPNLG-----SSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 571 ~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
...-+... ..........+.+|+.+||+.||.+|||++|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10001110 01111223567889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-39 Score=337.93 Aligned_cols=242 Identities=17% Similarity=0.238 Sum_probs=184.5
Q ss_pred cCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhccccCceeee-eeeeeccCeeEEEEeccC
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRHKHLVNL-QGWCKRKRDLLLVYDYIP 426 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H~nIv~l-~g~~~~~~~~~lV~E~~~ 426 (670)
++|+..+.||+|+||.||+|++.. ..+++..|++++++++|+|++.. .+++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 469999999999999999998643 23568899999999988765555 45556778899999999
Q ss_pred CCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEec---CCCcEEEEeecCceeccCCCc
Q 035655 427 NGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLID---ADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 427 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kL~DFGla~~~~~~~~ 503 (670)
+++|.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 567766665443 469999999999999999999999 9999999999999985 455799999999998765332
Q ss_pred ------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHHhh--cCCcccccC
Q 035655 504 ------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW-VLEFQH--LGQVLDVVD 574 (670)
Q Consensus 504 ------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~-~~~~~~--~~~~~~~~d 574 (670)
.......||+.|||||.+.+..++.++|||||||+++||++|+.||.......... ...... .........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 12345689999999999999999999999999999999999999997632211111 111000 000001111
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
+ ..+..+.+++..||+.+|.+||+++++.+.|+.
T Consensus 242 ~--------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 242 K--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp T--------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred c--------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1 123567889999999999999999988777653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=344.88 Aligned_cols=237 Identities=25% Similarity=0.336 Sum_probs=191.3
Q ss_pred cCccccceEeeeCceeEEEeeccc-----------------------hHHHHHHHHHHHhcccc-CceeeeeeeeeccCe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-----------------------RMREFAAEIESLGRLRH-KHLVNLQGWCKRKRD 417 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-----------------------~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~ 417 (670)
++|+..+.||+|+||+||+|.... ..+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 569999999999999999996411 13457799999999987 899999999999999
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++|+||+.+|+|.+++.... .++......++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999996654 47788999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCcceeeccccCcCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHHHHhhcCCcccccC
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTG--KASCSTDVFAYGVLLLEIATGRRPIDSDHF-ILVDWVLEFQHLGQVLDVVD 574 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d 574 (670)
.............|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ............. .
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------~ 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------E 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------C
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC------C
Confidence 765544445567899999999998754 468899999999999999999999976322 1111111111111 1
Q ss_pred CCCCCcccHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 035655 575 PNLGSSYVVAEMELVLQLGLLCSHQKAEARP-----TMRQVLRY 613 (670)
Q Consensus 575 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 613 (670)
+.+ +......+.+++..||++||.+|| +++|+++|
T Consensus 253 ~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 122346678899999999999999 48899875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-39 Score=335.04 Aligned_cols=242 Identities=19% Similarity=0.208 Sum_probs=193.1
Q ss_pred hcCccccceEeeeCceeEEEeeccc--------------hHHHHHHHHHHHhcccc-CceeeeeeeeeccCeeEEEEecc
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT--------------RMREFAAEIESLGRLRH-KHLVNLQGWCKRKRDLLLVYDYI 425 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~--------------~~~~f~~Ei~~L~~l~H-~nIv~l~g~~~~~~~~~lV~E~~ 425 (670)
.++|++.++||+|+||+||+|++.. ....+.+|++.++.|+| +|++.+++++.++...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 3579999999999999999998643 23457889999999976 89999999999999999999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecC-----CCcEEEEeecCceeccC
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDA-----DMNARLGDFGLARLFDH 500 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~-----~~~~kL~DFGla~~~~~ 500 (670)
+++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 -~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 789999986554 369999999999999999999999 99999999999999974 57899999999998754
Q ss_pred CCc------ceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hHHH---HHHHhhcCCcc
Q 035655 501 GKI------SHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI-LVDW---VLEFQHLGQVL 570 (670)
Q Consensus 501 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~-~~~~---~~~~~~~~~~~ 570 (670)
... .......||+.|||||.+.+..++.++|||||||+++||++|+.||...... .... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL- 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-
Confidence 321 1233468999999999999999999999999999999999999999753221 1111 1111111111
Q ss_pred cccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHhcC
Q 035655 571 DVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYLNG 616 (670)
Q Consensus 571 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 616 (670)
..+.+ .+ ++.+.+++..|++.+|.+||+++.+.+.|+.
T Consensus 238 ~~l~~----~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 238 RELCA----GF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHTT----TS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHhcC----CC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111 12 2457788899999999999999988887753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-39 Score=340.32 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=187.7
Q ss_pred cCccccceEeeeCceeEEEeeccc-------------hHHHHHHHHHHHhccc-cCceeeeeeeeec--cCeeEEEEecc
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT-------------RMREFAAEIESLGRLR-HKHLVNLQGWCKR--KRDLLLVYDYI 425 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~-------------~~~~f~~Ei~~L~~l~-H~nIv~l~g~~~~--~~~~~lV~E~~ 425 (670)
++|++.++||+|+||+||+|+... ..+.+.+|+++|++++ ||||+++++++.. ...+++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 579999999999999999998643 3567889999999996 9999999999874 35689999999
Q ss_pred CCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCC-cEEEEeecCceeccCCCcc
Q 035655 426 PNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADM-NARLGDFGLARLFDHGKIS 504 (670)
Q Consensus 426 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kL~DFGla~~~~~~~~~ 504 (670)
++++|..+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 115 NNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred CCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 999998774 358999999999999999999999 9999999999999998765 68999999998765543
Q ss_pred eeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHHHHHHh-----------h---cC--
Q 035655 505 HTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDWVLEFQ-----------H---LG-- 567 (670)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~~~~~~-----------~---~~-- 567 (670)
......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.........+..... . ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 23445789999999998765 4799999999999999999999999764332211111000 0 00
Q ss_pred -CcccccCCC--------CCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 568 -QVLDVVDPN--------LGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 568 -~~~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
......... ............+.+|+.+||+.||.+|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0001111223567889999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=334.41 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=192.2
Q ss_pred cCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeeccCeeEEEEe
Q 035655 362 KGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRKRDLLLVYD 423 (670)
Q Consensus 362 ~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~~~~~lV~E 423 (670)
++|++.++||+|+||+||+|++.. ..+.+.+|+.+|++++||||++++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999998643 24678899999999999999999999999999999999
Q ss_pred ccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCceeccCCCc
Q 035655 424 YIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARLFDHGKI 503 (670)
Q Consensus 424 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~~~~~~~ 503 (670)
++.+++|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887554 468999999999999999999998 8999999999999999999999999999987755432
Q ss_pred ceeeccccCcCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHHhhcC---C---cccccC
Q 035655 504 SHTTNVVGTIGYIAPELARTGK-ASCSTDVFAYGVLLLEIATGRRPIDSDHFI--LVDWVLEFQHLG---Q---VLDVVD 574 (670)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--~~~~~~~~~~~~---~---~~~~~d 574 (670)
......++..|+|||.+.... ++.++||||+||+++||++|+.||...... ....+....... . .....+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 233446788999999887665 689999999999999999999997542211 111111111000 0 000000
Q ss_pred ---------CCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 035655 575 ---------PNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRY 613 (670)
Q Consensus 575 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 613 (670)
..............+.+++.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011122223567788999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=337.62 Aligned_cols=243 Identities=20% Similarity=0.219 Sum_probs=179.8
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeec------cC
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKR------KR 416 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~------~~ 416 (670)
.++|++.++||+|+||+||+|++.. ..+.+.+|+.+|++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4689999999999999999998653 23457899999999999999999999863 36
Q ss_pred eeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 417 DLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 417 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
.+|+||||+.++.+.. +. ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 7899999997655544 32 358999999999999999999999 999999999999999999999999999988
Q ss_pred eccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcchhHHH-HHH-------------
Q 035655 497 LFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFILVDW-VLE------------- 562 (670)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~~~-~~~------------- 562 (670)
...... ......||+.|+|||++.+..++.++||||+||+++||++|+.||.......... ...
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 665432 3345579999999999999999999999999999999999999997643221110 000
Q ss_pred ------HhhcC-Cc---------ccccCCCCCCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 563 ------FQHLG-QV---------LDVVDPNLGSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 563 ------~~~~~-~~---------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
..... .. ..... .............+.+++.+||+.||++|||++|+++|=
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhHHHHhhcCccccccccccccccccc-cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00000 00 00000 011122334566788999999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-38 Score=332.82 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=183.0
Q ss_pred hcCccccceEeeeCceeEEEeeccc------------------hHHHHHHHHHHHhccccCceeeeeeeeecc-----Ce
Q 035655 361 TKGFKQSEVIGTGGFGEVYKGVLPT------------------RMREFAAEIESLGRLRHKHLVNLQGWCKRK-----RD 417 (670)
Q Consensus 361 t~~f~~~~~lG~G~fg~Vykg~~~~------------------~~~~f~~Ei~~L~~l~H~nIv~l~g~~~~~-----~~ 417 (670)
+++|+..++||+|+||+||+|+... ..+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999997643 234678999999999999999999998633 34
Q ss_pred eEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 418 LLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 418 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 5677788889999999854 359999999999999999999998 8999999999999999999999999999975
Q ss_pred ccCCCcceeeccccCcCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHHhhcCCccccc--
Q 035655 498 FDHGKISHTTNVVGTIGYIAPELARTG-KASCSTDVFAYGVLLLEIATGRRPIDSDHFILV-DWVLEFQHLGQVLDVV-- 573 (670)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~-- 573 (670)
... ......||+.|+|||...+. .++.++|||||||+++||++|+.||........ ......... ...+..
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~-~~~~~~~~ 245 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGAELLKK 245 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCHHHHTT
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-CChHHhhh
Confidence 433 23445789999999987665 468899999999999999999999976432211 111110000 000000
Q ss_pred ------------CCCCC-Ccc---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHh
Q 035655 574 ------------DPNLG-SSY---VVAEMELVLQLGLLCSHQKAEARPTMRQVLRYL 614 (670)
Q Consensus 574 ------------d~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 614 (670)
.+... ..+ .......+.+++.+||+.||.+|||++|+++|=
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 00000 000 011235678899999999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-33 Score=299.12 Aligned_cols=246 Identities=20% Similarity=0.233 Sum_probs=180.5
Q ss_pred CccccceEeeeCceeEEEeeccc---------------hHHHHHHHHHHHhccc-----------cCceeeeeeeeecc-
Q 035655 363 GFKQSEVIGTGGFGEVYKGVLPT---------------RMREFAAEIESLGRLR-----------HKHLVNLQGWCKRK- 415 (670)
Q Consensus 363 ~f~~~~~lG~G~fg~Vykg~~~~---------------~~~~f~~Ei~~L~~l~-----------H~nIv~l~g~~~~~- 415 (670)
+|++.++||+|+||+||+|+... ..+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 49999999999999999998643 1356678999998885 57899999988654
Q ss_pred -CeeEEEEeccCCCCc-hhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCc------E
Q 035655 416 -RDLLLVYDYIPNGSL-DSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMN------A 487 (670)
Q Consensus 416 -~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~------~ 487 (670)
...+++++++..+.. ...........+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 456677776655443 333334445678999999999999999999997 378999999999999987653 9
Q ss_pred EEEeecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcch--------hHHH
Q 035655 488 RLGDFGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLLLEIATGRRPIDSDHFI--------LVDW 559 (670)
Q Consensus 488 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el~tG~~pf~~~~~~--------~~~~ 559 (670)
|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...+.. +...
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999865432 23457999999999999999999999999999999999999999753211 0111
Q ss_pred HHHHhh-------c----------CCcccccCCCC----------CCcccHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 035655 560 VLEFQH-------L----------GQVLDVVDPNL----------GSSYVVAEMELVLQLGLLCSHQKAEARPTMRQVLR 612 (670)
Q Consensus 560 ~~~~~~-------~----------~~~~~~~d~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 612 (670)
...... . ........... ...........+.+++..|++.||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100000 0 00000000000 11233556778999999999999999999999999
Q ss_pred Hh
Q 035655 613 YL 614 (670)
Q Consensus 613 ~L 614 (670)
|=
T Consensus 328 Hp 329 (362)
T d1q8ya_ 328 HP 329 (362)
T ss_dssp CG
T ss_pred Cc
Confidence 73
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.97 E-value=1.3e-31 Score=263.81 Aligned_cols=115 Identities=28% Similarity=0.458 Sum_probs=105.8
Q ss_pred CCcEEEEEeeecCCCCCCCCCCCCeeEEecCCcccccccccccccCCCccccccCCCCcEEEEEEecCcccEEEEEEeec
Q 035655 144 SNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAYYENGTKEDFTLESGDPVQAWIDYDGVNRLVNVTICPM 223 (670)
Q Consensus 144 ~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~l~~g~~~~a~I~Yd~~~~~l~v~~~~~ 223 (670)
.|++|||||||++| .++|||++||||||+|++.|.++.+ +++.+|+.++|||+||+.+++|+|++..
T Consensus 1 an~ivAVEFDT~~N-~~~~Dp~~nHIgIdvns~~S~~~~~-----------~~l~~G~~~~v~I~Yd~~~~~L~V~~~~- 67 (237)
T d1nlsa_ 1 ADTIVAVELDTYPN-TDIGDPSYPHIGIDIKSVRSKKTAK-----------WNMQNGKVGTAHIIYNSVDKRLSAVVSY- 67 (237)
T ss_dssp CCCEEEEEEECSCC-GGGTCCSSCEEEEEESSSSCSEEEE-----------CCCCTTCEEEEEEEEETTTTEEEEEEEC-
T ss_pred CCCEEEEEEECCcC-CCCCCCCCCEEEEEeCCCCccceec-----------ccccCCCEEEEEEEEecCCcEEEEEEec-
Confidence 37899999999999 7889999999999999999877654 6788999999999999999999999974
Q ss_pred CCcccccccCCCCCCcccccccCCcccccccceeeEeecCCceeeeEEEeccccccCC
Q 035655 224 NKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTGRKVSSHFILGWSFSMNG 281 (670)
Q Consensus 224 ~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW~fs~~~ 281 (670)
.+|..|+|++.+||+++|+++||||||||||...|.|+|++|+|+++.
T Consensus 68 ----------~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 68 ----------PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp ----------TTSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred ----------CCCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 456778999999999999999999999999999999999999999764
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=5e-27 Score=233.32 Aligned_cols=214 Identities=14% Similarity=0.110 Sum_probs=141.3
Q ss_pred eeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecC
Q 035655 25 EEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTP 104 (670)
Q Consensus 25 ~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~ 104 (670)
.||+.|.+...+...+-+.+.|+|.+. ++.|+||++..+++|+++|++|+++ .+|+|+|+|.|..+
T Consensus 9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~-------------~~F~~~f~f~~~~~ 74 (228)
T d1gv9a_ 9 YSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAF-------------ENWEVEVTFRVTGR 74 (228)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCC-------------SSEEEEEEEEEECS
T ss_pred eccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCccc-------------cCcEEEEEEeccCC
Confidence 456655554322221226899999997 8899999999999999999999976 46999999999865
Q ss_pred CCCCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccc-ccccc
Q 035655 105 NSGQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKS-IKLEP 183 (670)
Q Consensus 105 ~~~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s-~~~~~ 183 (670)
...+||||||++++.. +..|+.+|. ....+-+||||||+.| .+|++.+|+.+++|.... ....+
T Consensus 75 -~~~ggdG~aF~i~~~~----~~~g~~~G~-------~~~~~glaVefDt~~n---~~~~~~~~~~~~~n~~~~~~~~~~ 139 (228)
T d1gv9a_ 75 -GRIGADGLAIWYTENQ----GLDGPVFGS-------ADMWNGVGIFFDSFDN---DGKKNNPAIVVVGNNGQINYDHQN 139 (228)
T ss_dssp -SSCCCCEEEEEEESSC----CCEEEETTE-------CSCCEEEEEEEECCCC--------CCEEEEEEEESCCCCCHHH
T ss_pred -CCCCCCEEEEEEecCC----CCCCCccCc-------CCCCceEEEEEEcccc---cCCCCCCcEEEEecCCcceeeecC
Confidence 3578999999999864 245666665 2234568999999988 268888888888874331 11110
Q ss_pred cccccCCCccccc-cCCCCcEEEEEEecCcccEEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeec
Q 035655 184 AAYYENGTKEDFT-LESGDPVQAWIDYDGVNRLVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSAS 262 (670)
Q Consensus 184 ~~~~~~~~~~~~~-l~~g~~~~a~I~Yd~~~~~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsas 262 (670)
..+.......... ..++..+++||+|+ .+.|+|++..... ..+..+.+...+ ....++++||||||||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~--------~~~~~~~~~~~~-~~~~l~~~~y~GFTAs 208 (228)
T d1gv9a_ 140 DGATQALASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFT--------PDKNDYEFCAKV-ENMVIPTQGHFGISAA 208 (228)
T ss_dssp HHHHHCSEEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSC--------CCTTCCEEEEEE-TTCCCCSSBEEEEEEE
T ss_pred CCccccccceeeeecCCceEEEEEEEec--CCEEEEEEecccc--------CCCcceeEEEEe-cccccCCCEEEEEEEe
Confidence 0000000000111 12345566666665 5778888875443 222222233333 3556889999999999
Q ss_pred CCceeeeEEEeccccc
Q 035655 263 TGRKVSSHFILGWSFS 278 (670)
Q Consensus 263 tg~~~~~h~i~sW~fs 278 (670)
||...+.|+|++|.+.
T Consensus 209 TG~~~~~H~I~s~~~~ 224 (228)
T d1gv9a_ 209 TGGLADDHDVLSFLTF 224 (228)
T ss_dssp CCSSCCEEEEEEEEEE
T ss_pred CCCCcCeEEEEEEEEE
Confidence 9999999999999874
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=6.1e-25 Score=215.88 Aligned_cols=110 Identities=25% Similarity=0.502 Sum_probs=95.4
Q ss_pred ccCCceeEEeCCCCCCCCCccceEEccceeeCCCCcEEecCCC------CCeEEEEEecCceeeecCCCCCCCCCCccce
Q 035655 20 LSQQKEEFIFNGFNETKTNQGLITRERASILKPSGALRLTDNA------HNVIGHAFYNKPIQMLDKSTSLSSKPNASSF 93 (670)
Q Consensus 20 ~~~~~~~f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sF 93 (670)
..++.++|+|++|.+...+ |.++|+|.+.++|.||||+.. ..++|||+|++||+|||. ++ +++||
T Consensus 121 ~esn~~~F~f~~F~~~~~n---l~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~-----~~~SF 191 (237)
T d1nlsa_ 121 HETNALHFMFNQFSKDQKD---LILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SA-----VVASF 191 (237)
T ss_dssp SCEEEEEEEESCCCTTCTT---EEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TE-----EEEEE
T ss_pred cccccceEEeeecCCCCCC---EEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CC-----cEeeE
Confidence 3457799999999875567 999999999879999999754 468999999999999995 66 89999
Q ss_pred eEEEEEEEecCCCCCCCCcEEEEEcCCC-CCCCCCCCcccccccCCC
Q 035655 94 STCFVFQIVTPNSGQGGFGLAFTVSPQP-SFPGGKAEHYLGILNSTN 139 (670)
Q Consensus 94 st~F~f~i~~~~~~~~g~GlaF~l~~~~-~~~~~~~g~~lGl~~~~~ 139 (670)
+|+|+|.|.+++ ..+||||||||+|.. .+|.++.||||||||.+|
T Consensus 192 sT~F~F~I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n 237 (237)
T d1nlsa_ 192 EATFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237 (237)
T ss_dssp EEEEEEECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred EEEEEEEEecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence 999999998865 468999999999965 578899999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=4.2e-20 Score=177.56 Aligned_cols=154 Identities=13% Similarity=0.140 Sum_probs=110.3
Q ss_pred cccceEeeeCceeEEEeeccch---------------------------------HHHHHHHHHHHhccccCceeeeeee
Q 035655 365 KQSEVIGTGGFGEVYKGVLPTR---------------------------------MREFAAEIESLGRLRHKHLVNLQGW 411 (670)
Q Consensus 365 ~~~~~lG~G~fg~Vykg~~~~~---------------------------------~~~f~~Ei~~L~~l~H~nIv~l~g~ 411 (670)
.+.++||+|+||.||+|.+.++ ......|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999976431 1223468889999999999988765
Q ss_pred eeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccccccceEEecccCCCcEEecCCCcEEEEe
Q 035655 412 CKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEEWEQVVIHRDVKSGNVLIDADMNARLGD 491 (670)
Q Consensus 412 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kL~D 491 (670)
.. .+++|||+++..+.+ ++.....+++.|++.+|+|||+ .+|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998765543 3444566899999999999998 899999999999999865 589999
Q ss_pred ecCceeccCCCcceeeccccCcCCCCccccccCCCCccchhHHHHHHH
Q 035655 492 FGLARLFDHGKISHTTNVVGTIGYIAPELARTGKASCSTDVFAYGVLL 539 (670)
Q Consensus 492 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl 539 (670)
||+|....+...... ....... -.|. ...+|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 999987654331110 0000000 0111 135678899999975444
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.79 E-value=7e-19 Score=172.72 Aligned_cols=200 Identities=15% Similarity=0.110 Sum_probs=123.2
Q ss_pred EEeCCCCCCCCCccceEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCC
Q 035655 27 FIFNGFNETKTNQGLITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNS 106 (670)
Q Consensus 27 f~~~~f~~~~~~~~~~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~ 106 (670)
|++|.+...+.-..-+.+.|+|.+. +|.|+||++ .++.|.+++++|++++ .+|+++|.|+|....
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~------------~~f~~~~~F~i~g~~- 74 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK------------DSFTMEWTFRSVGYS- 74 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC------------SCEEEEEEEEEESCC-
T ss_pred ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccC------------CCeEEEEEEEEeCCC-
Confidence 6666653322111129999999998 899999987 5788999999999985 259999999998653
Q ss_pred CCCCCcEEEEEcCCCCCCCCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccccccccccc
Q 035655 107 GQGGFGLAFTVSPQPSFPGGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKSIKLEPAAY 186 (670)
Q Consensus 107 ~~~g~GlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s~~~~~~~~ 186 (670)
..+||||||++++... .+..|+++|... ...-+||||||+.| +....|+.++.++..-...... .
T Consensus 75 ~~ggdG~af~~~~~~~--~~~~g~~~G~~~-------~~~GlaV~fDt~~n-----~~~~~~~~~ndgt~~~~~~~~~-~ 139 (221)
T d2a6za1 75 GQTDGGISFWFVQDSN--IPRDKQLYNGPV-------NYDGLQLLVDNNGP-----LGPTLRGQLNDGQKPVDKTKIY-D 139 (221)
T ss_dssp SCCSCEEEEEEEECSS--SCCCCTBTTBCT-------TCEEEEEEEESCST-----TSSEEEEEEEESSSCCCGGGHH-H
T ss_pred CCCCCcEEEEEEcCCC--ccccccccccCC-------CCceEEEEEECCCC-----CCCceEEEecCCCccccccCCc-c
Confidence 4689999999997542 223444555422 22358999999977 2222344444443321111100 0
Q ss_pred ccCCCccccc-cCCCCcEEEEEEecCccc-EEEEEEeecCCcccccccCCCCCCcccccccCCcccccccceeeEeecCC
Q 035655 187 YENGTKEDFT-LESGDPVQAWIDYDGVNR-LVNVTICPMNKKNKLSFHFGKPSQPLLSLPLDLSPAFQETMYVGFSASTG 264 (670)
Q Consensus 187 ~~~~~~~~~~-l~~g~~~~a~I~Yd~~~~-~l~v~~~~~~~~~~~~~~~~~p~~~~ls~~~dl~~~l~~~~~vGFsastg 264 (670)
......... ..++...+++|.|+..++ .|.|.+.. . ..+. ++--.+-++.+|+||||+||
T Consensus 140 -~~~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~--~-------------~c~~--~~~v~lp~~~~~fG~SA~TG 201 (221)
T d2a6za1 140 -QSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN--K-------------VCFQ--TRKVRFPSGSYRIGVTAQNG 201 (221)
T ss_dssp -HCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETT--E-------------EEEE--ESCCCCCSSEEEEEEEEECC
T ss_pred -cccceeeecccCCCCCEEEEEEEecCccceEEEEecC--c-------------EeEE--ECCeecCCCCEEEEEEEccC
Confidence 000001122 235777899999987654 47777631 1 0111 11111224678999999999
Q ss_pred ceeeeEEEec
Q 035655 265 RKVSSHFILG 274 (670)
Q Consensus 265 ~~~~~h~i~s 274 (670)
...+.|++..
T Consensus 202 ~~~~~hd~~~ 211 (221)
T d2a6za1 202 AVNNNAESFE 211 (221)
T ss_dssp SGGGCCCEEE
T ss_pred CccCCCceEE
Confidence 8777666443
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.78 E-value=2.7e-18 Score=167.91 Aligned_cols=184 Identities=17% Similarity=0.157 Sum_probs=125.9
Q ss_pred eEEccceeeCCCCcEEecCCCCCeEEEEEecCceeeecCCCCCCCCCCccceeEEEEEEEecCCCCCCCCcEEEEEcCCC
Q 035655 42 ITRERASILKPSGALRLTDNAHNVIGHAFYNKPIQMLDKSTSLSSKPNASSFSTCFVFQIVTPNSGQGGFGLAFTVSPQP 121 (670)
Q Consensus 42 ~~~~g~a~~~~~~~l~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~sFst~F~f~i~~~~~~~~g~GlaF~l~~~~ 121 (670)
+.+.|+|.+. +|.|+||++ .++.|+++++.|++++ .+|+++|+|.|... ...+||||||.+.+..
T Consensus 24 W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~------------~~f~i~~~F~i~g~-~~~~~dG~afw~~~~~ 88 (218)
T d2a6va1 24 WTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIK------------DAMTIEWTFRSFGF-RGSTKGGLAFWLKQGN 88 (218)
T ss_dssp EEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCS------------SCEEEEEEEEEESC-CSCCSCEEEEEEECSC
T ss_pred cEECCCEEEE-CCEEEECCC-CCCeeEEEeCCccccc------------ccceEEEEEEEeCC-CCCCCCcEEEEEEcCC
Confidence 8999999997 899999998 4678999999999885 25999999999865 3567999999998754
Q ss_pred CCC-CCCCCcccccccCCCCCCCCCcEEEEEeeecCCCCCCCCCCCCeeEEecCCccc-ccccccccccCCCccc--cc-
Q 035655 122 SFP-GGKAEHYLGILNSTNDHKPSNHLFAIEFDTVNGYNETSDSQGNHVGINVNSMKS-IKLEPAAYYENGTKED--FT- 196 (670)
Q Consensus 122 ~~~-~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~~Dp~~~Hvgidvns~~s-~~~~~~~~~~~~~~~~--~~- 196 (670)
... .+..+|..+.++. +||||||+.| . .+||.+.+|.=.. ....+ ...... ..
T Consensus 89 ~~~~~~~~~G~~~~f~G----------laV~fDt~~n-~------~~~i~~~~ndGs~~~~~~~-----d~~~g~c~~~~ 146 (218)
T d2a6va1 89 EGDSTELFGGSSKKFNG----------LMILLRLDDK-L------GESVTAYLNDGTKDLDIES-----SPYFASCLFQY 146 (218)
T ss_dssp CCCCCTBTTTBCSSCEE----------EEEEEEEETT-T------EEEEEEEEEESSSCCCTTT-----SCCSEEEECCC
T ss_pred cccCCCcccccCCCcce----------EEEEEECCCC-C------CCeEEEEeCCCCccccccC-----CcccceEEecc
Confidence 321 1222333343332 7999999977 1 3688877663111 00000 000111 11
Q ss_pred cCCCCcEEEEEEecCccc-EEEEEEeecCCcccccccCCCCCCccc-ccccCCcccccccceeeEeecCCceeeeEEEec
Q 035655 197 LESGDPVQAWIDYDGVNR-LVNVTICPMNKKNKLSFHFGKPSQPLL-SLPLDLSPAFQETMYVGFSASTGRKVSSHFILG 274 (670)
Q Consensus 197 l~~g~~~~a~I~Yd~~~~-~l~v~~~~~~~~~~~~~~~~~p~~~~l-s~~~dl~~~l~~~~~vGFsastg~~~~~h~i~s 274 (670)
..++...+++|.|+..+. .+.|.+. +. ..+ ...|+| ..++.+|+||||+||...+.|+|++
T Consensus 147 ~~~~~~~~~~i~Y~~~~~~~l~v~id--~~-------------~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls 209 (218)
T d2a6va1 147 QDSMVPSTLRLTYNPLDNHLLKLQMD--NR-------------VCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILK 209 (218)
T ss_dssp SSCSSCEEEEEEEEGGGTSEEEEEET--TE-------------EEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEE
T ss_pred cCCCCcEEEEEEEECcccceEEEEeC--Cc-------------EEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEE
Confidence 345788999999987664 4677653 11 111 222333 3457799999999999999999999
Q ss_pred ccccc
Q 035655 275 WSFSM 279 (670)
Q Consensus 275 W~fs~ 279 (670)
|++..
T Consensus 210 ~~~~~ 214 (218)
T d2a6va1 210 MKLYD 214 (218)
T ss_dssp EEEES
T ss_pred EEEEe
Confidence 99865
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.75 E-value=3.3e-05 Score=75.20 Aligned_cols=102 Identities=15% Similarity=0.088 Sum_probs=70.8
Q ss_pred HHHHHHHHHHhccc-cCceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhcccc--
Q 035655 388 REFAAEIESLGRLR-HKHLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHEE-- 464 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-- 464 (670)
..+.+|...+..|. +--+.+++.++..++..++|||++++.++.+..... ....+++.++++.++.||+.
T Consensus 54 ~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~ 126 (263)
T d1j7la_ 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCC
T ss_pred hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCc
Confidence 35678998888774 333567788888888899999999998876544211 11223344444445545421
Q ss_pred ------------------------------------------------------ccceEEecccCCCcEEecCCCcEEEE
Q 035655 465 ------------------------------------------------------WEQVVIHRDVKSGNVLIDADMNARLG 490 (670)
Q Consensus 465 ------------------------------------------------------~~~~ivHrDIkp~NILld~~~~~kL~ 490 (670)
....++|+|+.|.|||+++++.+-|.
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lI 206 (263)
T d1j7la_ 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEe
Confidence 02358999999999999987667799
Q ss_pred eecCce
Q 035655 491 DFGLAR 496 (670)
Q Consensus 491 DFGla~ 496 (670)
||+.+.
T Consensus 207 Dwe~a~ 212 (263)
T d1j7la_ 207 DLGRSG 212 (263)
T ss_dssp CCTTCE
T ss_pred echhcc
Confidence 999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.08 E-value=0.00047 Score=66.26 Aligned_cols=101 Identities=18% Similarity=0.147 Sum_probs=67.0
Q ss_pred hHHHHHHHHHHHhccccC--ceeeeeeeeeccCeeEEEEeccCCCCchhhcccCCccccCHHHHHHHHHHHHHHhhhccc
Q 035655 386 RMREFAAEIESLGRLRHK--HLVNLQGWCKRKRDLLLVYDYIPNGSLDSLLFDNENFVLSWEQRFNIIKGIAAGLLYLHE 463 (670)
Q Consensus 386 ~~~~f~~Ei~~L~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 463 (670)
....+..|+..++.|... .+.+++.++.+.+..++|||++++.++.+... .. ...+.++++.|+-||+
T Consensus 47 ~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~-------~~---~~~~~~l~~~la~LH~ 116 (255)
T d1nd4a_ 47 ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHL-------AP---AEKVSIMADAMRRLHT 116 (255)
T ss_dssp TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCC-------CH---HHHHHHHHHHHHHHTT
T ss_pred CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccc-------cH---HHHHHHHHHHHHHHcc
Confidence 445678899988887543 35677888888888999999999877654210 00 0111222222222221
Q ss_pred -------------------------------------------------------cccceEEecccCCCcEEecCCCcEE
Q 035655 464 -------------------------------------------------------EWEQVVIHRDVKSGNVLIDADMNAR 488 (670)
Q Consensus 464 -------------------------------------------------------~~~~~ivHrDIkp~NILld~~~~~k 488 (670)
.....++|+|+.|.|||++++..+-
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~ 196 (255)
T d1nd4a_ 117 LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSG 196 (255)
T ss_dssp SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEE
T ss_pred CChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEE
Confidence 1124589999999999999877778
Q ss_pred EEeecCce
Q 035655 489 LGDFGLAR 496 (670)
Q Consensus 489 L~DFGla~ 496 (670)
|+||+.+.
T Consensus 197 iID~~~~~ 204 (255)
T d1nd4a_ 197 FIDCGRLG 204 (255)
T ss_dssp ECCCTTCE
T ss_pred EEEchhcc
Confidence 99999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.86 E-value=0.0099 Score=60.96 Aligned_cols=30 Identities=20% Similarity=0.408 Sum_probs=26.1
Q ss_pred ceEEecccCCCcEEecCCCcEEEEeecCcee
Q 035655 467 QVVIHRDVKSGNVLIDADMNARLGDFGLARL 497 (670)
Q Consensus 467 ~~ivHrDIkp~NILld~~~~~kL~DFGla~~ 497 (670)
..++|+|+++.|||++++ .++|.||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 479999999999999876 489999988864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.65 E-value=0.029 Score=57.21 Aligned_cols=40 Identities=28% Similarity=0.353 Sum_probs=28.3
Q ss_pred HHHHHHHHHHhccccCce-eeeeeeeeccCeeEEEEeccCCCCch
Q 035655 388 REFAAEIESLGRLRHKHL-VNLQGWCKRKRDLLLVYDYIPNGSLD 431 (670)
Q Consensus 388 ~~f~~Ei~~L~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~ 431 (670)
....+|..+++.+.-.++ .+++++|.+ .+|+||+++..|.
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccCC
Confidence 345689999998864455 467777753 5899999876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.91 E-value=0.25 Score=47.95 Aligned_cols=32 Identities=34% Similarity=0.288 Sum_probs=28.5
Q ss_pred ccceEEecccCCCcEEecCCCcEEEEeecCce
Q 035655 465 WEQVVIHRDVKSGNVLIDADMNARLGDFGLAR 496 (670)
Q Consensus 465 ~~~~ivHrDIkp~NILld~~~~~kL~DFGla~ 496 (670)
...++||+|+.+.||+++.+...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35789999999999999988777899999875
|